data_1gkn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gkn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.921 0.391 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.629 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 30.4 m80 -149.08 144.16 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.509 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.29 119.09 19.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.24 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.415 HE21 ' HA ' ' A' ' 903' ' ' GLN . 2.8 mm100 -55.88 166.21 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.628 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.97 131.58 8.86 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.127 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.438 ' HB3' HD13 ' A' ' 943' ' ' ILE . 29.9 Cg_endo -63.27 138.32 65.76 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.415 2.077 . . . . 0.0 111.937 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.71 156.99 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -78.43 126.98 31.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.306 0.574 . . . . 0.0 111.542 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.57 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 2.0 m-85 -90.81 -33.36 15.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.614 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.9 mp 75.72 -48.44 0.6 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.8 OUTLIER -85.72 18.41 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.021 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.32 126.39 6.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 914' ' ' LYS . 52.2 mtmt -96.74 132.94 41.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.092 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 915' ' ' THR . 3.3 tm? -48.71 141.65 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.585 ' H ' HD23 ' A' ' 913' ' ' LEU . 74.7 mmtt -147.14 64.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.61 ' H ' HD12 ' A' ' 913' ' ' LEU . 17.6 m -167.46 139.55 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.066 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.457 ' O ' HG21 ' A' ' 917' ' ' THR . 13.8 pt20 -51.33 124.81 12.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.586 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 916' ' ' GLN . 75.1 p -152.06 135.42 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.6 p -148.59 44.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.491 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.64 156.09 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.0 m -84.1 -44.91 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.819 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.34 120.34 26.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.404 ' HE2' HD12 ' A' ' 928' ' ' LEU . 14.3 m-85 -96.81 141.32 22.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.02 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.58 132.43 14.67 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.581 2.188 . . . . 0.0 112.382 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 947' ' ' ASP . 65.7 mt -54.15 147.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.527 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 78.27 67.25 1.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 1.8 m -174.83 121.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.4 m -90.3 128.43 36.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.645 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 942' ' ' SER . 8.5 tp -97.64 127.51 43.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -80.64 133.59 35.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.495 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 19.7 m-85 -138.5 124.09 19.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.616 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.744 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 55.5 mt-10 -102.03 125.34 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.991 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 99.0 m -57.95 166.09 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.325 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 44.8 mtp85 -82.75 158.94 64.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 936' ' ' TYR . 90.1 Cg_exo -44.07 -46.44 11.13 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.635 2.223 . . . . 0.0 112.697 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.534 ' HA ' HD23 ' A' 1006 ' ' LEU . 56.1 mt-10 -73.77 26.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.43 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.503 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 67.3 m-85 -145.15 157.64 44.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.616 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 31.6 p90 -144.09 137.08 27.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 155.94 29.69 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.636 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.8 ptp85 46.71 164.36 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.497 0.719 . . . . 0.0 112.464 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.744 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 74.2 Cg_endo -75.2 116.44 4.55 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.294 1.996 . . . . 0.0 112.515 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.538 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 16.1 p90 -95.57 -159.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 81.1 p -171.86 136.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.719 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 3.3 pt -96.27 117.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.976 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.899 HG23 HD22 ' A' ' 946' ' ' LEU . 2.8 m -84.23 126.27 32.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 85.2 m -73.48 115.18 12.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.899 HD22 HG23 ' A' ' 944' ' ' THR . 94.5 mt -83.19 -59.93 2.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 55.5 t0 172.91 -37.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.874 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.438 ' HB2' HG13 ' A' ' 950' ' ' VAL . 74.5 m-80 -81.85 26.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.312 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.632 HD12 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 61.3 40.43 14.36 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 948' ' ' ASN . 7.1 p -136.43 152.71 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.341 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.639 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 46.7 m95 -93.72 141.46 28.47 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.907 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 88.5 p -48.14 140.96 6.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 59.9 p -79.02 108.53 8.48 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.919 0.39 . . . . 0.0 111.387 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 952' ' ' SER . 2.9 Cg_exo -76.29 129.59 11.33 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.054 2.503 . . . . 0.0 111.974 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.597 ' NZ ' ' HB2' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -80.65 -145.11 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.466 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -80.71 60.97 4.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.622 HG21 ' N ' ' A' ' 958' ' ' CYS . 26.0 m -80.53 -56.36 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.585 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.622 ' N ' HG21 ' A' ' 957' ' ' VAL . 6.2 t -89.87 135.03 33.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -150.36 130.12 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.871 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 935' ' ' GLU . 40.6 ttm180 -53.91 142.67 23.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.008 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.616 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 13.3 mmmm -54.51 149.28 10.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.161 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.703 ' HB3' HE21 ' A' ' 981' ' ' GLN . 63.7 p -142.49 131.57 23.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -81.53 146.74 30.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.64 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.654 ' HD3' ' N ' ' A' ' 965' ' ' THR . 2.0 tmtp? -66.77 133.41 50.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.047 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.654 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 47.4 m -53.22 130.77 51.56 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.332 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 60.1 Cg_endo -70.9 136.13 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.744 2.296 . . . . 0.0 112.384 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.54 134.58 64.25 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.151 1.901 . . . . 0.0 111.296 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -57.3 122.62 55.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 0.0 111.054 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.21 143.25 58.32 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.111 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' 1020 ' ' CYS . 22.0 t -49.21 129.2 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.23 45.77 16.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.031 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -174.54 -166.75 32.98 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.528 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -178.88 146.71 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.226 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.796 HG22 HD13 ' A' ' 986' ' ' ILE . 7.1 p -98.66 133.54 40.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.823 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.0 OUTLIER -109.89 117.77 34.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.625 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.531 ' O ' HG21 ' A' ' 976' ' ' VAL . 33.9 m -74.46 131.03 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.83 -30.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.875 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.8 p -144.72 -54.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.415 ' O ' HG21 ' A' ' 980' ' ' ILE . 54.7 m-20 -158.64 -142.18 0.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.415 HG21 ' O ' ' A' ' 979' ' ' ASP . 11.5 pt -151.05 37.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.703 HE21 ' HB3' ' A' ' 962' ' ' SER . 7.9 mp0 -76.99 174.17 10.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.198 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 961' ' ' LYS . 28.1 m -63.91 30.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.62 -32.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.272 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 47.7 t -75.97 134.63 40.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 39.1 ptt180 -104.14 134.95 46.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 974' ' ' VAL . 37.3 pt -97.94 137.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.0 p -96.98 135.48 38.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 0.0 111.697 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.412 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 6.7 m-85 -101.68 138.19 39.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.457 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 51.1 m -153.54 121.61 6.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.966 0.412 . . . . 0.0 111.146 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 64.4 m -80.87 157.67 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.3 t -63.93 146.23 54.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.38 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 89.3 m -44.46 122.07 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 128.91 -54.11 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -102.99 138.56 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.663 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.462 ' HB3' HD12 ' A' 1023 ' ' ILE . 39.0 ptt180 -95.13 147.24 23.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.314 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' 1019 ' ' ILE . 4.7 pp -71.63 139.74 49.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.593 ' CD1' ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -122.17 111.15 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 151.76 -60.36 0.41 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.246 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.465 ' CD2' ' HB ' ' A' 1015 ' ' THR . 98.1 m-70 -154.08 -122.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.518 0.199 . . . . 0.0 110.827 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 77.7 p -168.31 -46.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.4 p -156.0 107.62 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.443 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -88.02 132.63 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.409 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 7.4 pm0 -96.27 133.1 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.126 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 42.4 t -77.43 126.9 31.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.8 pt -135.75 -159.73 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.096 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 935' ' ' GLU . 28.0 tp -150.9 138.05 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.914 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 70.4 m -88.17 -44.21 11.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.34 -45.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.001 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.6 m120 -105.15 -31.48 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 98.5 m -142.69 138.53 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.051 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.416 ' HA ' HD11 ' A' 1006 ' ' LEU . . . -82.68 145.71 29.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.102 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.8 p80 -158.55 151.37 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' A' ' 966' ' ' PRO . 66.1 m95 -66.16 141.7 57.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 t -60.92 -30.78 70.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.465 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 61.8 p -144.06 139.29 28.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.52 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.524 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.7 pptp? -63.32 155.22 75.52 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.411 ' HB3' ' HE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -66.01 130.09 23.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.523 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_exo -64.88 -150.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.901 2.401 . . . . 0.0 112.628 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 996' ' ' LEU . 1.5 mt -136.91 -158.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.511 ' H ' ' CG2' ' A' 1019 ' ' ILE . 73.7 m -155.07 132.01 10.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.312 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' A' ' 997' ' ' ILE . 3.0 pt20 -152.42 142.26 22.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -48.51 128.92 15.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.359 0.599 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.622 HG21 ' HD2' ' A' 1024 ' ' PRO . 37.8 mt -74.83 128.98 84.34 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.039 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.622 ' HD2' HG21 ' A' 1023 ' ' ILE . 59.2 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.742 2.295 . . . . 0.0 112.34 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.408 ' N ' HD23 ' A' ' 949' ' ' LEU . 41.9 m80 -150.75 132.23 14.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.672 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 6.1 p -82.15 128.96 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.409 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.3 mm100 -69.85 170.63 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.291 0.567 . . . . 0.0 111.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.42 134.3 12.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.41 149.96 84.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.4 ' OD2' ' HD2' ' A' ' 907' ' ' HIS . 27.5 t70 -61.64 172.72 1.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.4 ' HD2' ' OD2' ' A' ' 906' ' ' ASP . 0.5 OUTLIER -77.96 130.4 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.242 0.544 . . . . 0.0 111.553 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.525 ' HZ ' HG22 ' A' ' 943' ' ' ILE . 1.5 m-85 -89.98 -43.46 10.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.585 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 82.2 mt 75.0 -43.01 0.5 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.929 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 908' ' ' PHE . 0.1 OUTLIER -83.55 -1.03 52.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -153.65 128.96 9.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.48 132.65 40.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 914' ' ' LYS . 3.3 tm? -44.65 144.89 0.99 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.995 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 38.5 ttpt -138.54 -36.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.514 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 917' ' ' THR . 4.6 m -64.63 143.64 57.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.618 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -49.4 125.29 10.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.221 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.468 HG23 HD12 ' A' ' 928' ' ' LEU . 81.0 p -152.04 143.77 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.239 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.3 m -159.48 -47.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.558 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.25 160.32 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.4 p -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -85.37 145.38 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -132.03 136.0 27.51 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.488 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.411 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.9 Cg_endo -69.54 141.86 47.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.838 2.358 . . . . 0.0 112.198 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.703 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 15.9 mm -54.63 151.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.489 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 90.09 -30.74 5.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.174 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.0 m -55.9 125.25 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 112.015 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 34.9 t -95.94 135.14 38.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.855 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.664 HD22 ' HH ' ' A' ' 930' ' ' TYR . 9.0 tp -117.1 114.19 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.685 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -89.91 139.66 30.38 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.664 ' HH ' HD22 ' A' ' 928' ' ' LEU . 7.0 m-85 -130.06 130.67 45.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.463 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 8.6 pt-20 -92.73 125.4 37.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.193 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 91.3 m -52.65 143.9 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.402 . . . . 0.0 111.42 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.585 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.9 mtp180 -82.93 155.94 67.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.44 64.75 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.721 2.28 . . . . 0.0 112.753 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.586 ' HA ' HD13 ' A' 1006 ' ' LEU . 39.1 tt0 -174.85 2.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.22 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.568 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 40.1 m-85 -141.24 136.32 31.56 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.402 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.73 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 16.4 p90 -102.73 139.78 37.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.256 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . 150.45 27.68 0.05 OUTLIER Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.58 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 938' ' ' GLY . 16.6 ptm180 45.79 171.04 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 122.971 0.508 . . . . 0.0 112.019 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.481 ' CD ' ' HB2' ' A' ' 939' ' ' ARG . 2.6 Cg_endo -77.86 112.89 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.109 1.873 . . . . 0.0 111.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.406 ' HD1' ' N ' ' A' ' 942' ' ' SER . 23.1 p90 -94.43 -160.52 0.78 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.467 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.406 ' N ' ' HD1' ' A' ' 941' ' ' PHE . 41.9 t -172.89 143.09 1.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.525 HG22 ' HZ ' ' A' ' 908' ' ' PHE . 3.5 pt -94.03 -170.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.986 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.756 HG23 HD22 ' A' ' 946' ' ' LEU . 1.0 OUTLIER -164.63 127.59 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 12.1 t -66.94 112.64 4.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.756 HD22 HG23 ' A' ' 944' ' ' THR . 87.6 mt -82.18 -57.79 3.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -174.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.648 ' HA ' HG22 ' A' ' 924' ' ' ILE . 4.8 t70 172.74 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.948 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -83.5 34.95 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.692 HD22 HD13 ' A' ' 924' ' ' ILE . 30.7 mt 51.9 47.3 25.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.314 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.8 OUTLIER -135.43 -168.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.766 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -146.02 128.77 16.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.088 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 47.7 t -43.96 143.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.085 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.4 t -78.58 115.6 52.9 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.04 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 908' ' ' PHE . 5.1 Cg_exo -75.95 53.49 3.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.372 2.714 . . . . 0.0 112.151 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.39 132.33 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.692 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.434 ' O ' HG11 ' A' ' 957' ' ' VAL . 65.0 t0 56.99 77.89 0.25 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.231 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 956' ' ' ASP . 24.5 m -149.31 -30.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.548 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.778 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 34.8 t -151.6 62.97 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.469 . . . . 0.0 110.913 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.731 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 11.3 mmpt? -55.23 153.77 6.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.646 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.821 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -58.43 132.25 53.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.669 -179.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.73 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 21.4 mmtp -56.37 135.64 53.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.082 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.619 ' HB2' ' HG2' ' A' ' 981' ' ' GLN . 48.3 t -152.66 129.08 10.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.998 0.428 . . . . 0.0 111.018 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 6.1 p -81.58 154.76 26.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.294 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -65.15 137.96 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 0.0 110.92 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 69.4 m -54.17 128.53 57.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 32.6 Cg_endo -63.67 134.41 43.97 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.439 2.092 . . . . 0.0 111.732 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.58 127.89 26.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.104 1.869 . . . . 0.0 111.525 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -57.49 125.46 71.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.95 138.74 41.21 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.5 p -50.89 124.2 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.681 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 59.24 48.04 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.499 ' HA3' ' H ' ' A' ' 991' ' ' THR . . . -156.87 -155.13 7.32 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.534 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 42.8 ttp 173.94 135.74 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.628 HG22 HD13 ' A' ' 986' ' ' ILE . 15.0 p -98.65 123.99 51.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 977' ' ' ILE . 33.3 m-70 -76.98 108.51 10.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 979' ' ' ASP . 89.1 t -62.58 -32.16 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 71.83 -47.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.82 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -148.38 -60.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.596 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.423 ' O ' HG11 ' A' ' 976' ' ' VAL . 2.9 m-20 -155.01 -152.89 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.065 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.416 HG21 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -148.64 22.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.934 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.821 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 84.9 mt-30 -79.36 156.5 27.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.007 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.646 HG12 ' HG ' ' A' 1006 ' ' LEU . 49.2 t -49.95 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.158 0.504 . . . . 0.0 111.065 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 151.8 -40.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.266 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.0 p -76.01 138.54 40.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' 1001 ' ' SER . 76.9 ttt180 -104.19 125.97 50.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.628 HD13 HG22 ' A' ' 974' ' ' VAL . 41.3 pt -98.94 129.22 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.818 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.1 p -96.95 134.2 40.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.563 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 22.9 m-85 -96.13 139.02 32.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.454 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 52.5 m -152.42 116.45 4.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.476 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.8 146.92 41.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.499 ' H ' ' HA3' ' A' ' 972' ' ' GLY . 94.0 m -64.64 142.96 58.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.245 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.406 ' N ' HG21 ' A' ' 991' ' ' THR . 6.0 t -41.94 124.38 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.025 0.441 . . . . 0.0 111.553 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.85 -48.35 0.97 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.742 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -102.33 144.5 30.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.541 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.2 ptt180 -92.63 143.7 26.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 999' ' ' HIS . 7.5 tt -71.81 132.32 44.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.876 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.7 mp -110.05 134.55 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.8 -128.22 9.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.359 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.504 ' O ' HD23 ' A' ' 996' ' ' LEU . 93.8 m-70 -78.3 -132.51 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.437 0.16 . . . . 0.0 111.394 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.8 t -174.25 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.65 0.262 . . . . 0.0 111.191 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.465 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 76.2 p -150.89 150.29 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.893 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.58 130.53 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.0 tt0 -99.08 135.52 40.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 30.5 t -71.44 119.19 15.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.613 HD11 ' H ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -140.78 160.39 23.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.541 0.686 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.646 ' HG ' HG12 ' A' ' 982' ' ' VAL . 93.1 mt -89.22 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.793 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.499 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 68.7 m -149.99 -32.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -157.05 57.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.274 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' 1009 ' ' ASN . 1.9 m120 61.44 27.74 17.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.009 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 8.0 m -149.11 131.99 16.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 128.65 34.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.859 0.362 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.499 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.2 p80 -158.09 145.8 18.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.487 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.416 ' HH2' HG21 ' A' ' 980' ' ' ILE . 58.7 m95 -67.48 137.73 56.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.9 p -54.8 -28.71 51.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.701 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.442 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 81.5 p -139.34 138.9 37.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.957 0.408 . . . . 0.0 111.815 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' 1017 ' ' PRO . 7.5 tmtm? -57.38 134.76 81.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.487 ' N ' ' HD3' ' A' 1016 ' ' LYS . 50.7 Cg_exo -54.56 126.67 23.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 31.8 Cg_exo -59.75 -157.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.832 2.355 . . . . 0.0 112.716 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.538 ' CG2' ' H ' ' A' 1020 ' ' CYS . 1.2 mt -139.75 -161.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.257 0.551 . . . . 0.0 110.964 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.4 m -155.93 138.51 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.876 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.6 tt0 -151.25 134.77 16.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.309 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -46.21 128.46 9.62 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.3 mt -74.87 126.65 88.11 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.765 2.31 . . . . 0.0 112.555 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.715 0.293 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.428 ' N ' HD23 ' A' ' 949' ' ' LEU . 67.2 m80 -153.65 133.64 13.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.5 p -82.27 110.92 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.314 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -83.23 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.88 124.85 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.548 ' HB3' ' CG ' ' A' ' 951' ' ' TRP . 86.8 Cg_endo -82.33 124.09 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.701 2.268 . . . . 0.0 113.395 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 35.8 t0 26.05 -137.09 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.061 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.481 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 35.4 p-80 -161.05 151.43 17.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.168 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -145.51 134.0 21.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.527 ' N ' HD13 ' A' ' 909' ' ' LEU . 4.2 mp -83.04 -49.16 9.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.212 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 933' ' ' ARG . 0.8 OUTLIER -84.97 28.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -156.46 135.11 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' A' ' 912' ' ' LYS . 0.0 OUTLIER -136.44 124.52 22.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.193 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 58.7 tp -49.38 144.67 5.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.137 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.725 ' HD2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -154.75 27.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 0.0 110.986 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.626 HG21 ' HG3' ' A' ' 916' ' ' GLN . 24.2 m -69.96 -111.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.572 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.626 ' HG3' HG21 ' A' ' 915' ' ' THR . 2.5 pp0? -169.13 34.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.452 0.644 . . . . 0.0 110.413 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.1 t -87.35 154.78 20.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.898 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.7 p -136.5 46.54 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.448 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -166.67 159.31 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.015 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.2 p -85.01 -36.95 20.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -84.58 146.03 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 87.6 m-85 -134.75 145.57 55.34 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 111.526 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.5 137.51 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.453 2.769 . . . . 0.0 112.386 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.583 HG21 ' N ' ' A' ' 925' ' ' GLY . 53.3 mt -54.34 154.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.196 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.583 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 74.24 58.14 4.43 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.642 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 3.8 m -175.23 127.26 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.43 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.618 ' HB3' ' OG1' ' A' ' 944' ' ' THR . 79.4 p -105.68 135.42 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.652 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.601 ' HB2' ' HE1' ' A' ' 930' ' ' TYR . 93.5 mt -96.85 128.29 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.363 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.7 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 15.3 tppt? -82.88 121.05 26.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.748 0.309 . . . . 0.0 111.383 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.601 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 9.2 m-85 -111.72 127.95 55.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.725 ' HG3' ' HD2' ' A' ' 914' ' ' LYS . 61.9 mm-40 -92.16 107.0 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 110.637 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 83.1 m -59.62 178.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.856 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.494 ' HD3' ' HA ' ' A' ' 910' ' ' PHE . 78.9 mtp180 -85.67 151.7 55.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.134 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 936' ' ' TYR . 53.2 Cg_exo -52.85 -37.17 76.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.904 2.403 . . . . 0.0 112.872 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.96 12.39 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.662 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 934' ' ' PRO . 33.8 m-85 -139.6 128.75 23.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 19.3 p90 -96.2 137.05 35.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.425 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . 147.33 152.67 5.71 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.72 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.61 142.16 83.44 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.344 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.7 ' HB2' ' HD2' ' A' ' 929' ' ' LYS . 40.9 Cg_exo -56.36 137.02 78.62 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.918 2.412 . . . . 0.0 111.85 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.469 ' HD1' HG22 ' A' ' 943' ' ' ILE . 30.4 p90 -89.71 124.7 34.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.55 0.691 . . . . 0.0 111.336 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 928' ' ' LEU . 75.1 p -75.52 -38.65 59.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.877 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 927' ' ' SER . 47.7 pt 49.32 93.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.618 0.723 . . . . 0.0 111.702 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 927' ' ' SER . 11.9 m -84.29 139.56 32.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.586 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.496 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 98.2 m -73.7 129.06 37.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.732 HD21 HG21 ' A' ' 950' ' ' VAL . 2.2 mm? -82.56 -65.98 0.94 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.558 ' HA ' HD11 ' A' ' 924' ' ' ILE . 24.6 t70 172.82 -41.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.397 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -85.54 41.9 0.93 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.071 0.462 . . . . 0.0 109.89 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 901' ' ' HIS . 63.5 mt 53.28 48.87 21.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.732 HG21 HD21 ' A' ' 946' ' ' LEU . 6.6 m -131.87 177.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.483 0.658 . . . . 0.0 112.005 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.548 ' CG ' ' HB3' ' A' ' 905' ' ' PRO . 46.8 m95 -135.23 126.88 28.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.84 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.471 ' N ' HD22 ' A' ' 946' ' ' LEU . 11.0 m -42.43 148.85 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.274 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 35.4 t -76.98 121.52 84.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.45 ' HG3' HG23 ' A' ' 943' ' ' ILE . 3.0 Cg_exo -76.55 56.44 5.13 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.538 2.826 . . . . 0.0 111.734 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 956' ' ' ASP . 57.8 tttp -75.87 123.61 25.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.431 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' A' ' 955' ' ' LYS . 1.4 m-20 57.76 98.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.384 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 941' ' ' PHE . 16.1 m -151.07 -31.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 92.5 m -152.05 65.4 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.6 mmtt -60.52 137.65 58.13 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.699 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 36.8 ttm180 -59.59 135.56 57.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.652 ' HZ3' HD12 ' A' 1006 ' ' LEU . 98.0 mttt -57.52 145.91 31.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.517 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.7 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 75.6 p -142.47 137.34 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 68.8 m -81.03 154.93 26.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.137 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.81 127.7 33.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.842 0.353 . . . . 0.0 110.667 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 19.4 m -57.15 136.83 80.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.765 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.479 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 5.8 Cg_endo -48.15 140.45 19.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.229 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 968' ' ' ASP . 65.5 Cg_endo -73.62 49.4 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.791 2.327 . . . . 0.0 112.983 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 967' ' ' PRO . 1.7 p30 26.06 67.29 0.47 Allowed Pre-proline 0 N--CA 1.465 0.289 0 O-C-N 123.507 0.505 . . . . 0.0 112.153 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -40.56 134.56 2.18 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.76 2.307 . . . . 0.0 112.635 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.463 HG23 ' ND2' ' A' ' 971' ' ' ASN . 2.6 p -53.1 132.95 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.764 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.463 ' ND2' HG23 ' A' ' 970' ' ' VAL . 76.7 m-20 58.66 53.14 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.332 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -155.66 -153.51 6.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.554 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 38.9 ttm 176.52 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.543 0.211 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . . . . . . . . . 1.9 p -93.83 168.44 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.23 0.538 . . . . 0.0 110.652 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.728 ' NE2' HG13 ' A' ' 977' ' ' ILE . 8.4 t60 -152.83 104.01 2.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.297 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 26.9 m -66.72 -24.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.758 HG23 HG21 ' A' ' 978' ' ' THR . 3.8 mp 76.86 -42.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 0.0 110.435 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.758 HG21 HG23 ' A' ' 977' ' ' ILE . 81.5 p -144.77 -59.76 0.36 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.645 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.8 m-20 -157.39 -145.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.389 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.526 HG22 HG13 ' A' ' 976' ' ' VAL . 4.2 pt -148.25 20.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.068 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.7 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 3.7 mm100 -76.63 177.2 7.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.87 -24.13 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 109.869 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -107.9 53.67 0.59 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.606 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 54.9 m -158.31 127.68 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.014 0.435 . . . . 0.0 110.604 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.447 ' O ' HD12 ' A' ' 977' ' ' ILE . 74.0 ttt180 -104.22 129.13 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.186 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.59 HG21 ' HA ' ' A' ' 976' ' ' VAL . 42.7 pt -103.07 151.77 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.807 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.504 ' OG1' HD13 ' A' ' 977' ' ' ILE . 8.5 p -135.79 138.65 42.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.077 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.479 ' OH ' ' HB3' ' A' ' 966' ' ' PRO . 2.0 m-85 -96.48 151.44 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.399 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 53.6 m -153.61 69.6 0.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.578 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 66.5 m -44.5 151.08 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.776 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 146.2 50.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 77.6 m -40.59 -38.68 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.183 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -55.03 -49.49 62.51 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.826 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.574 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.2 m80 -102.45 141.6 35.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.018 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.615 ' HB3' HG12 ' A' 1023 ' ' ILE . 33.6 ptt85 -90.65 141.43 28.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.32 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 999' ' ' HIS . 5.5 tt -71.87 133.82 45.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.0 mp -104.71 135.07 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.26 -139.19 15.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.572 ' HD1' ' N ' ' A' 1000 ' ' SER . 23.1 p80 -79.58 -135.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.572 ' N ' ' HD1' ' A' ' 999' ' ' HIS . 80.1 p -177.41 16.08 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.594 0.235 . . . . 0.0 111.358 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.473 ' H ' ' HD1' ' A' ' 999' ' ' HIS . 32.1 t -159.43 145.05 15.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.43 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.64 124.02 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.1 tt0 -98.45 137.73 36.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 50.0 t -71.2 124.27 24.1 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' 1006 ' ' LEU . 27.4 pt -133.39 -154.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.952 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.652 HD12 ' HZ3' ' A' ' 961' ' ' LYS . 2.5 tt -154.27 125.36 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.489 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 40.4 t -90.1 42.95 1.12 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.206 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.494 ' N ' HD21 ' A' 1006 ' ' LEU . . . 52.94 26.8 27.82 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.671 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -158.93 -47.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.2 m -147.82 143.53 27.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.054 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -79.83 131.92 36.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.489 ' HE2' ' HB2' ' A' 1007 ' ' SER . 7.6 p80 -160.18 155.95 25.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 80.9 m95 -64.29 144.72 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -54.54 -33.21 59.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 1.7 t -146.75 148.42 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.382 0.611 . . . . 0.0 112.29 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.63 138.04 86.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.985 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.8 138.01 42.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.723 2.282 . . . . 0.0 112.661 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.447 ' HG3' ' CE1' ' A' ' 999' ' ' HIS . 24.1 Cg_exo -63.02 -160.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.29 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 42.3 mt -141.75 136.45 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.0 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.442 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 70.9 m -97.15 125.31 41.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.758 ' HB2' HD12 ' A' ' 997' ' ' ILE . 0.7 OUTLIER -143.14 128.3 18.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -178.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 13.0 ptp180 -47.5 140.36 5.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.588 0.708 . . . . 0.0 111.535 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.9 mt -74.84 130.87 80.3 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.162 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 46.0 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.809 2.34 . . . . 0.0 112.265 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.604 0.24 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -152.69 132.02 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.7 p -82.34 118.51 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.99 173.51 9.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.982 0.42 . . . . 0.0 111.307 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.42 135.55 7.38 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -51.9 136.14 51.46 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.59 2.193 . . . . 0.0 112.068 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 907' ' ' HIS . 35.4 m-20 -64.83 105.1 0.94 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 906' ' ' ASP . 0.4 OUTLIER 11.27 110.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.173 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 3.6 m-85 -90.02 131.47 35.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 110.227 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 909' ' ' LEU . 2.2 mm? -75.19 -68.71 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.685 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.5 OUTLIER -85.29 21.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -149.35 150.75 32.97 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.135 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.462 ' HD3' ' NH1' ' A' ' 933' ' ' ARG . 23.8 pttm -140.51 136.67 33.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.641 HD12 ' H ' ' A' ' 915' ' ' THR . 3.5 tm? -45.27 139.68 3.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.609 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.568 ' N ' HD12 ' A' ' 913' ' ' LEU . 30.7 mmmt -150.82 58.06 0.92 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.731 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.641 ' H ' HD12 ' A' ' 913' ' ' LEU . 15.5 m -167.88 134.95 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.885 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.485 ' NE2' HG22 ' A' ' 915' ' ' THR . 3.4 pm0 -55.74 138.37 47.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.465 ' O ' ' OG1' ' A' ' 918' ' ' THR . 60.0 p -150.75 -57.22 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.396 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 917' ' ' THR . 22.6 p 68.79 -50.11 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.831 0.707 . . . . 0.0 112.255 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.32 148.14 48.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.43 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.7 p -85.8 -48.29 8.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.25 123.27 30.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.182 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 50.1 m-85 -103.86 146.2 32.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.486 . . . . 0.0 112.019 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.6 Cg_endo -83.8 139.9 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.488 2.792 . . . . 0.0 111.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 947' ' ' ASP . 48.1 mt -52.77 152.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.341 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.565 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 89.65 -40.74 3.02 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 38.1 m -56.85 137.69 54.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.345 . . . . 0.0 110.458 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.591 ' HB2' ' OG ' ' A' ' 942' ' ' SER . 82.2 p -120.8 132.33 54.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.113 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 942' ' ' SER . 72.8 mt -106.21 136.41 45.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.04 0.447 . . . . 0.0 111.741 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.527 ' HB2' ' OG1' ' A' ' 915' ' ' THR . 99.3 mttt -86.5 133.41 33.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.723 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.544 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 11.6 m-85 -132.64 125.27 30.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.531 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.43 ' CG ' ' HG3' ' A' ' 914' ' ' LYS . 95.4 mt-10 -95.29 133.18 39.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 72.8 m -58.51 150.31 23.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.018 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.581 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 41.5 mtp85 -82.84 163.36 51.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.518 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.589 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 40.6 Cg_endo -66.75 64.57 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 95.1 mt-10 -165.43 -18.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.232 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 3.0 m-85 -129.38 -168.75 1.99 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 958' ' ' CYS . 16.5 p90 -150.03 138.26 20.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.985 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 167.22 4.84 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.353 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.94 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 6.6 ppt_? 46.06 173.27 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 123.013 0.525 . . . . 0.0 112.286 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.94 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 13.6 Cg_endo -58.93 89.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.41 2.073 . . . . 0.0 113.059 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.501 ' HA ' ' NH1' ' A' ' 939' ' ' ARG . 42.2 p90 -90.17 120.85 31.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.879 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.591 ' OG ' ' HB2' ' A' ' 927' ' ' SER . 23.8 t -74.03 160.21 31.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.809 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 927' ' ' SER . 5.4 pt -137.64 104.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 946' ' ' LEU . 30.3 m -82.33 130.79 35.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 97.9 m -73.71 132.08 42.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 944' ' ' THR . 2.5 mm? -84.54 -60.22 2.14 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.725 ' HA ' HD11 ' A' ' 924' ' ' ILE . 55.1 t0 171.66 -36.81 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.691 0.282 . . . . 0.0 110.953 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.424 ' O ' HG11 ' A' ' 950' ' ' VAL . 73.3 m-80 -82.94 37.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 947' ' ' ASP . 79.6 mt 50.5 42.98 27.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.934 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 948' ' ' ASN . 22.2 m -136.13 147.99 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.796 0.808 . . . . 0.0 112.07 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 952' ' ' SER . 52.2 m95 -91.82 122.16 34.1 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.596 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.516 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -38.68 126.13 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 70.3 m -78.15 107.14 4.96 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 110.909 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 956' ' ' ASP . 60.4 Cg_endo -100.92 55.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 124.013 3.142 . . . . 0.0 112.608 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -77.44 38.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.539 0.685 . . . . 0.0 110.09 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 954' ' ' PRO . 34.3 t70 -159.92 53.78 0.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.692 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.45 HG22 ' CG ' ' A' ' 941' ' ' PHE . 8.8 m -147.05 -17.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.871 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 937' ' ' TYR . 11.1 t -147.57 135.38 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.123 0.487 . . . . 0.0 110.901 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 32.0 mtmt -147.77 149.87 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.252 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 52.2 ttm-85 -53.31 135.38 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 982' ' ' VAL . 30.2 mmtp -56.29 164.73 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.36 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.73 ' HB3' HE22 ' A' ' 981' ' ' GLN . 85.1 p -145.5 132.84 20.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.797 0.332 . . . . 0.0 110.216 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 49.2 m -81.57 36.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.747 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 61.7 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 30.7 m -55.79 129.06 71.06 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.534 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.518 ' HG3' HD11 ' A' ' 986' ' ' ILE . 57.5 Cg_endo -70.71 121.3 7.79 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.462 2.108 . . . . 0.0 112.693 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.76 123.76 10.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.455 2.103 . . . . 0.0 111.364 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.54 120.95 64.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.36 141.27 50.89 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.38 2.053 . . . . 0.0 111.752 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.2 p -45.96 127.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 66.16 49.34 1.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.888 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -163.82 -158.15 9.82 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.867 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 40.0 ttm 176.72 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.536 0.208 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.5 p -100.56 131.47 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.819 0.343 . . . . 0.0 111.52 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.429 ' HB2' HD12 ' A' ' 977' ' ' ILE . 31.3 m-70 -91.87 111.46 23.0 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.618 ' HA ' HG21 ' A' ' 986' ' ' ILE . 30.1 m -64.22 -18.69 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 109.913 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 977' ' ' ILE . 12.4 mm 74.57 -47.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 67.9 p -148.18 -49.97 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.759 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.552 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.4 m-20 -157.49 -149.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.866 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 980' ' ' ILE . 13.2 pt -151.08 25.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 111.143 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.73 HE22 ' HB3' ' A' ' 962' ' ' SER . 3.0 mm100 -80.91 163.7 23.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.143 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 961' ' ' LYS . 54.8 t -55.43 93.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.078 0.466 . . . . 0.0 111.14 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.66 -47.6 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.232 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.5 t -76.4 141.31 41.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 111.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 3.5 ptm85 -104.22 131.86 51.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.546 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 976' ' ' VAL . 26.7 pt -98.13 127.48 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.0 p -97.07 132.69 42.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.977 0.417 . . . . 0.0 110.953 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.506 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 10.8 m-85 -96.6 139.96 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.443 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -152.74 116.43 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.181 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.658 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 83.9 m -73.02 147.21 45.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.454 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.577 ' H ' ' HA3' ' A' ' 972' ' ' GLY . 8.6 t -64.86 149.16 50.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.614 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 84.8 m -46.68 108.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.317 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 152.92 -57.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.265 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.421 ' HB3' ' C ' ' A' 1021 ' ' GLN . 7.6 m80 -102.46 145.92 28.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.763 ' HB3' HG12 ' A' 1023 ' ' ILE . 15.6 ptm180 -90.02 139.16 30.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.166 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 999' ' ' HIS . 6.3 tt -71.84 132.7 44.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.942 0.401 . . . . 0.0 110.734 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.604 HD12 ' HB2' ' A' 1021 ' ' GLN . 3.5 mp -106.07 130.84 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.52 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 96.56 -138.75 14.1 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.085 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.551 ' O ' HD23 ' A' ' 996' ' ' LEU . 83.0 m-70 -81.27 -140.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.414 0.15 . . . . 0.0 111.146 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 42.7 t 178.9 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.416 ' HB2' HH21 ' A' ' 985' ' ' ARG . 66.1 p -158.8 148.95 19.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.045 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.52 ' HB1' ' HB ' ' A' 1015 ' ' THR . . . -156.55 118.16 3.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.2 tt0 -96.33 128.61 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 50.6 t -71.32 119.39 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.4 pt -136.6 143.6 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.244 0.545 . . . . 0.0 111.892 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.423 HD21 ' C ' ' A' ' 934' ' ' PRO . 53.8 tp -84.61 124.48 31.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.998 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.518 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.5 t -95.96 -50.24 4.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' 1010 ' ' THR . . . 169.26 122.16 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.71 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 72.99 -37.14 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.164 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.481 ' H ' ' C ' ' A' 1008 ' ' GLY . 84.6 m -145.72 136.26 24.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.216 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 151.09 26.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.372 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.518 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.7 p80 -153.07 147.59 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.405 ' CH2' HG22 ' A' ' 986' ' ' ILE . 86.9 m95 -64.37 139.13 58.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.162 0.506 . . . . 0.0 111.297 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 m -62.42 -21.75 65.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.282 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.52 ' HB ' ' HB1' ' A' 1002 ' ' ALA . 37.8 m -138.9 135.74 34.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.4 pttm -72.73 148.28 89.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.768 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.448 ' HG3' ' HH ' ' A' ' 988' ' ' TYR . 32.9 Cg_exo -59.85 129.02 28.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.589 2.193 . . . . 0.0 112.397 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.506 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.24 -154.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.735 2.29 . . . . 0.0 112.465 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.49 HG21 ' N ' ' A' 1020 ' ' CYS . 53.1 mt -139.91 141.54 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.49 ' N ' HG21 ' A' 1019 ' ' ILE . 97.5 m -100.85 125.65 47.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.604 ' HB2' HD12 ' A' ' 997' ' ' ILE . 3.3 tt0 -145.51 138.11 25.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.387 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -45.55 135.62 6.33 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 111.703 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.763 HG12 ' HB3' ' A' ' 995' ' ' ARG . 54.8 mt -74.76 126.94 87.92 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' 1023 ' ' ILE . 66.2 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.711 2.274 . . . . 0.0 112.482 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 924' ' ' ILE . . . . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.78 0.324 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.604 ' N ' HD23 ' A' ' 949' ' ' LEU . 8.5 m170 -147.5 120.78 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.52 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 24.9 p -82.25 122.33 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.02 167.69 20.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.476 0.655 . . . . 0.0 112.045 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -47.53 133.23 10.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.509 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.508 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.5 Cg_exo -62.32 154.54 62.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.926 2.418 . . . . 0.0 112.407 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 907' ' ' HIS . 27.1 t70 -62.23 173.08 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.677 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.437 ' N ' ' CG ' ' A' ' 906' ' ' ASP . 42.6 m170 -77.68 121.48 24.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.288 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 1.9 m-85 -86.43 -36.09 19.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 92.0 mt 75.98 -46.03 0.54 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.748 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 6.05 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.66 126.44 5.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.2 124.81 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.309 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.646 HD12 ' HG ' ' A' ' 928' ' ' LEU . 63.2 tp -51.61 156.79 1.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.587 ' H ' HD13 ' A' ' 913' ' ' LEU . 73.9 mmtt -145.29 -66.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 914' ' ' LYS . 17.9 m 19.88 -117.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.687 0.617 . . . . 0.0 111.884 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -175.95 41.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.201 0.524 . . . . 0.0 110.476 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 39.0 p -82.8 -172.82 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 98.0 m -169.1 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.478 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.4 157.76 37.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -84.61 -43.62 14.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.37 124.8 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 80.4 m-85 -103.69 134.55 19.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.56 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 59.9 Cg_endo -71.94 141.92 37.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 112.126 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.675 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 32.7 mt -59.69 156.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.666 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 82.71 -35.6 2.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.716 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.56 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 18.7 m -56.04 127.42 30.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.526 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 48.7 m -101.72 131.42 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.646 ' HG ' HD12 ' A' ' 913' ' ' LEU . 5.2 tp -95.79 -168.07 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.177 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.534 ' O ' HD13 ' A' ' 913' ' ' LEU . 40.6 ttmt -157.44 130.36 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 941' ' ' PHE . 5.4 m-85 -129.09 135.64 49.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.384 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.659 ' OE1' ' HB3' ' A' ' 940' ' ' PRO . 2.9 mm-40 -96.26 134.78 38.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.363 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 86.6 m -55.33 155.35 5.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.545 ' HG2' ' HD2' ' A' ' 934' ' ' PRO . 65.1 ttt180 -82.37 145.13 51.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.545 ' HD2' ' HG2' ' A' ' 933' ' ' ARG . 67.6 Cg_exo -39.35 -41.2 2.15 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.717 2.278 . . . . 0.0 112.884 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 961' ' ' LYS . 50.2 mt-10 -69.14 -34.74 75.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.487 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 933' ' ' ARG . 18.3 m-85 -94.85 142.61 27.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.144 0.497 . . . . 0.0 112.305 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.594 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 8.3 p90 -100.08 141.99 32.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.655 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 153.44 147.65 4.69 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.222 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.677 ' H ' ' HD2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -73.08 158.84 86.47 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.659 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 31.2 Cg_exo -60.03 115.45 2.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.573 2.182 . . . . 0.0 112.208 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 930' ' ' TYR . 49.3 p90 -95.6 -168.21 1.74 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 928' ' ' LEU . 68.8 m -166.93 134.6 2.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.099 0.476 . . . . 0.0 111.33 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.44 HD13 ' HG2' ' A' ' 905' ' ' PRO . 5.1 pt -102.38 125.69 56.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.443 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.552 HG23 ' CD2' ' A' ' 946' ' ' LEU . 18.0 m -82.77 122.09 27.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.28 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.675 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 8.4 t -71.44 103.07 2.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.672 ' HB2' HG21 ' A' ' 950' ' ' VAL . 88.0 mt -82.72 162.02 21.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 949' ' ' LEU . 62.6 t0 -45.44 -34.23 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.135 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.402 ' HB2' HG23 ' A' ' 950' ' ' VAL . 2.6 m120 -81.32 28.89 0.37 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.623 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 901' ' ' HIS . 45.7 mt 47.79 31.78 2.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.323 0.582 . . . . 0.0 109.918 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.672 HG21 ' HB2' ' A' ' 946' ' ' LEU . 29.5 m -107.92 -160.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.62 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 81.9 m95 -150.67 121.41 7.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.817 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.9 p -41.49 142.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.497 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 39.7 t -78.58 115.08 48.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.051 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.8 Cg_exo -74.61 130.81 14.07 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.995 2.463 . . . . 0.0 111.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 955' ' ' LYS . 29.8 mmmt -80.77 -133.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.464 0.65 . . . . 0.0 111.755 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -78.36 60.32 2.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.314 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 941' ' ' PHE . 33.9 m -81.51 -34.09 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.885 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.457 ' O ' ' HE3' ' A' ' 959' ' ' LYS . 30.0 m -150.41 125.7 10.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.12 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.788 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.1 mmpt? -137.48 149.53 46.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.834 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 14.7 mmt85 -53.2 120.7 6.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.594 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 28.8 mtpp -58.29 -171.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 81.1 p -153.14 137.7 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.8 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 58.5 m -81.58 38.85 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt 59.0 130.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 49.6 m -57.74 126.7 76.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.63 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 52.6 Cg_endo -68.6 128.75 17.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.418 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.66 131.18 38.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.365 2.043 . . . . 0.0 111.614 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -61.28 120.63 56.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.954 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 139.22 36.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.072 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' 1020 ' ' CYS . 20.4 t -52.01 130.06 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.436 ' ND2' HG13 ' A' ' 970' ' ' VAL . 72.8 m-20 56.82 52.8 8.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.677 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -158.26 -153.3 6.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.243 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 32.2 ttp 175.01 119.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.607 0.241 . . . . 0.0 111.002 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.02 124.21 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.728 0.775 . . . . 0.0 111.355 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.599 ' CD2' HG12 ' A' ' 977' ' ' ILE . 5.5 t60 -87.28 103.08 15.11 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.829 ' HA ' HG23 ' A' ' 986' ' ' ILE . 27.6 m -53.02 -20.51 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.631 HD13 HG22 ' A' ' 987' ' ' THR . 12.9 mt 66.58 60.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.583 0.706 . . . . 0.0 109.395 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 977' ' ' ILE . 14.1 p 80.79 -48.42 0.29 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.234 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.544 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 55.3 m-20 -156.27 -158.57 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.86 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.453 HG22 HG13 ' A' ' 976' ' ' VAL . 12.8 pt -151.04 23.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.35 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' A' ' 979' ' ' ASP . 7.2 mp0 -76.54 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 961' ' ' LYS . 96.2 t -55.49 84.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.125 0.488 . . . . 0.0 110.736 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.9 -45.94 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.108 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 50.5 m -76.05 138.85 41.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 111.257 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.639 ' HE ' ' HB3' ' A' 1003 ' ' GLU . 38.3 ttm180 -103.37 139.1 39.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.351 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.829 HG23 ' HA ' ' A' ' 976' ' ' VAL . 20.3 pt -98.62 122.45 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.678 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.631 HG22 HD13 ' A' ' 977' ' ' ILE . 6.7 p -101.93 135.56 43.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.095 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.684 ' HB2' HD13 ' A' ' 996' ' ' LEU . 3.1 m-85 -96.49 140.4 31.18 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.747 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 43.9 t -151.75 64.45 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 35.8 m -35.75 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.618 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 9.0 t -174.18 165.87 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' 1023 ' ' ILE . 9.0 t -52.84 -36.28 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.659 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' 1023 ' ' ILE . . . -63.69 -55.14 26.68 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.488 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -101.81 136.73 41.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.413 . . . . 0.0 111.26 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.7 ptt180 -92.57 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.511 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 988' ' ' TYR . 8.7 tt -72.36 132.23 43.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.1 mp -111.25 132.78 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 111.302 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 68.04 131.84 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.217 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.497 ' HE2' ' HZ2' ' A' 1016 ' ' LYS . 76.6 m-70 47.5 -139.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.652 0.263 . . . . 0.0 111.449 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.489 ' HA ' HD23 ' A' ' 996' ' ' LEU . 47.1 t -177.05 -30.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.437 ' HB2' HG21 ' A' ' 987' ' ' THR . 46.8 t -154.56 168.66 26.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.491 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.96 133.65 14.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.045 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.639 ' HB3' ' HE ' ' A' ' 985' ' ' ARG . 19.3 pt-20 -96.15 134.14 39.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.122 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.8 t -76.42 124.76 28.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' 1014 ' ' SER . 41.9 pt -135.94 -154.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.471 . . . . 0.0 112.115 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.537 HD13 ' H ' ' A' 1009 ' ' ASN . 62.3 tp -151.85 138.55 18.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.009 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.697 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 46.6 t -87.91 -48.22 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.17 20.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.13 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.537 ' H ' HD13 ' A' 1006 ' ' LEU . 10.3 p-10 174.94 -53.79 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.408 ' O ' HD11 ' A' 1006 ' ' LEU . 10.3 m -98.88 130.56 45.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.606 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.566 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -81.21 134.8 35.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.697 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.1 p80 -158.82 147.64 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 111.65 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.496 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 60.5 m95 -68.23 134.96 51.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.771 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' 1005 ' ' ILE . 91.4 p -68.37 -12.22 60.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 6.4 m -140.93 139.24 34.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.497 ' HZ2' ' HE2' ' A' ' 999' ' ' HIS . 24.7 pttm -69.76 146.0 95.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.057 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.479 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 23.9 Cg_exo -64.63 135.71 46.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.869 2.379 . . . . 0.0 112.55 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 38.0 Cg_endo -66.28 -156.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.568 2.178 . . . . 0.0 112.449 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.7 mt -142.22 139.95 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.677 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 71.7 m -93.41 124.3 37.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.774 ' HB3' HD12 ' A' ' 997' ' ' ILE . 41.1 tt0 -145.79 133.3 20.84 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.6 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -48.12 133.2 15.38 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.559 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 995' ' ' ARG . 44.8 mt -75.14 124.93 89.6 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.803 2.336 . . . . 0.0 112.253 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.761 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 16.1 m80 67.8 127.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.703 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 2.4 p -82.27 130.03 35.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.453 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -67.22 -177.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.576 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.21 137.9 6.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.551 ' HB2' ' HH ' ' A' ' 930' ' ' TYR . 2.7 Cg_exo -75.07 63.41 6.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.202 2.601 . . . . 0.0 112.167 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.1 t0 36.32 -131.99 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.676 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 17.6 t-160 -160.45 120.21 2.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.848 0.356 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.583 ' HE2' ' HG2' ' A' ' 954' ' ' PRO . 21.9 m-85 -88.15 136.35 33.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.98 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.25 -58.58 3.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.347 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.84 26.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.4 122.33 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.443 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.664 ' HB2' ' HZ3' ' A' ' 912' ' ' LYS . 10.3 mtmp? -100.52 131.49 46.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.432 HD22 ' OG1' ' A' ' 917' ' ' THR . 52.1 tp -48.22 129.71 15.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.491 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.533 ' HD3' ' HD2' ' A' ' 929' ' ' LYS . 51.6 tttp -94.51 -43.08 8.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.433 HG23 HG21 ' A' ' 917' ' ' THR . 42.7 m -64.6 144.43 57.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.853 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -77.54 49.29 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.616 HG23 ' HE2' ' A' ' 922' ' ' PHE . 39.5 p -81.42 146.28 30.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 72.9 p -136.39 -33.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.576 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.47 156.22 39.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 54.6 m -84.78 -38.83 19.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.9 145.29 28.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.616 ' HE2' HG23 ' A' ' 917' ' ' THR . 71.7 m-85 -136.32 137.68 25.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.752 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.5 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -69.74 136.6 33.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.716 2.277 . . . . 0.0 111.764 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.576 HG21 ' H ' ' A' ' 925' ' ' GLY . 39.9 mt -58.04 154.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.205 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 87.02 -34.02 3.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 22.9 m -55.93 122.24 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.659 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.6 m -94.91 120.72 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.885 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 917' ' ' THR . 10.0 tp -99.24 118.85 36.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.316 . . . . 0.0 110.737 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.533 ' HD2' ' HD3' ' A' ' 914' ' ' LYS . 39.9 ttmt -85.34 138.76 32.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.106 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.551 ' HH ' ' HB2' ' A' ' 905' ' ' PRO . 7.2 m-85 -131.65 134.85 46.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.515 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.49 ' HG2' ' HD2' ' A' ' 914' ' ' LYS . 56.6 mm-40 -95.58 130.53 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.607 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.16 156.52 9.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . . . . . . . . . 45.0 mtt-85 -84.8 151.84 58.61 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 936' ' ' TYR . 86.6 Cg_exo -47.48 -46.75 19.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.685 2.257 . . . . 0.0 112.859 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.29 20.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.745 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 934' ' ' PRO . 82.2 m-85 -145.17 137.32 25.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.402 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.71 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 14.3 p90 -97.71 138.0 35.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.423 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 158.57 142.59 3.43 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.082 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -73.06 159.07 86.09 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.258 . . . . 0.0 110.362 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.84 149.17 71.13 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.275 1.983 . . . . 0.0 111.294 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.518 ' CD1' ' HB ' ' A' ' 957' ' ' VAL . 50.7 p90 -140.01 -167.91 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.78 0.324 . . . . 0.0 110.93 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.4 p -172.88 134.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.491 HG23 ' HG3' ' A' ' 954' ' ' PRO . 15.3 pt -97.21 113.55 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 946' ' ' LEU . 47.1 m -78.49 126.67 31.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.2 t -72.96 125.1 26.8 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.155 0.502 . . . . 0.0 109.936 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.763 ' HB2' HG21 ' A' ' 950' ' ' VAL . 1.6 mm? -88.35 167.9 13.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 0.0 113.606 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 949' ' ' LEU . 38.9 t70 -50.6 -38.63 46.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.293 -1.776 . . . . 0.0 112.25 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.509 HD21 HG12 ' A' ' 950' ' ' VAL . 50.9 t30 -81.6 34.25 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 900' ' ' ALA . 21.0 mt 47.93 36.73 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.196 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.763 HG21 ' HB2' ' A' ' 946' ' ' LEU . 29.1 m -112.85 -159.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.241 0.543 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.5 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 85.4 m95 -147.32 124.89 11.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 80.9 p -39.68 141.75 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.803 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 33.7 m -79.51 112.91 32.6 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.583 ' HG2' ' HE2' ' A' ' 908' ' ' PHE . 5.8 Cg_exo -79.63 143.56 16.96 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.456 2.771 . . . . 0.0 112.346 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -159.01 137.22 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.691 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 7.2 m-20 58.95 33.8 23.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.246 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' A' ' 941' ' ' PHE . 29.4 m -94.15 -32.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.209 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 37.4 m -149.82 59.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.205 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.691 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 74.2 mmtt -58.07 152.47 16.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.995 0.426 . . . . 0.0 111.762 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.484 ' HG2' ' HG3' ' A' ' 981' ' ' GLN . 20.8 tpp180 -53.33 116.53 2.48 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.71 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 63.6 tttt -56.26 147.57 20.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.437 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 78.7 p -144.61 139.71 28.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 964' ' ' LYS . 37.4 m -81.56 36.18 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.633 ' HB3' ' HZ2' ' A' ' 964' ' ' LYS . 6.3 ttpm? 56.22 134.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.727 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.4 m -60.31 124.15 76.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.331 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.553 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 59.5 Cg_endo -71.48 130.43 17.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.469 2.112 . . . . 0.0 112.565 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.67 135.04 50.41 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.445 2.097 . . . . 0.0 111.61 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.03 115.13 10.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.655 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 138.92 66.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.712 2.275 . . . . 0.0 112.388 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.3 t -53.86 134.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 971' ' ' ASN . 2.4 m120 56.98 42.56 26.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.873 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -160.28 -155.75 7.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.518 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 35.7 ttp 174.22 131.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.985 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -101.4 128.98 53.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.814 0.34 . . . . 0.0 111.459 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.534 ' O ' HG13 ' A' ' 977' ' ' ILE . 28.3 m-70 -87.85 114.34 24.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.463 ' HA ' HG23 ' A' ' 986' ' ' ILE . 69.9 t -62.13 -33.67 59.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.018 0.437 . . . . 0.0 109.859 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 975' ' ' HIS . 15.0 mt 71.39 -48.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.285 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 977' ' ' ILE . 74.6 p -146.12 -60.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.859 0.362 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.529 ' O ' HG21 ' A' ' 980' ' ' ILE . 2.6 m-20 -152.47 -161.88 1.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.862 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.529 HG21 ' O ' ' A' ' 979' ' ' ASP . 10.0 pt -146.78 19.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.531 . . . . 0.0 110.492 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' 1004 ' ' CYS . 6.7 mm100 -80.82 -178.17 6.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.643 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' A' ' 961' ' ' LYS . 30.0 m -64.9 25.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -157.19 44.16 0.51 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.754 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.4 p -160.54 132.97 6.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.283 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 16.9 ptp180 -100.97 131.06 47.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.044 0.449 . . . . 0.0 111.446 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.63 HD13 ' HH ' ' A' ' 988' ' ' TYR . 23.7 pt -99.35 131.77 46.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.778 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.612 HG21 ' HG ' ' A' 1001 ' ' SER . 6.0 p -95.72 133.43 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.0 111.392 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.63 ' HH ' HD13 ' A' ' 986' ' ' ILE . 5.9 m-85 -98.95 137.86 36.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 55.7 m -153.5 115.01 4.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 74.1 m -75.55 150.93 38.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.809 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 23.8 m -64.07 143.57 57.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.7 t -37.8 139.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.941 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.24 -40.87 2.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' 1021 ' ' GLN . 3.0 m80 -99.37 137.95 37.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.046 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.543 ' HE ' HG12 ' A' 1023 ' ' ILE . 14.2 ptp180 -97.36 147.22 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 999' ' ' HIS . 9.8 tt -69.28 129.52 40.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.571 HD13 ' CD ' ' A' 1021 ' ' GLN . 31.7 mm -102.15 80.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.747 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . 154.93 -131.13 3.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.697 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.581 ' O ' HD23 ' A' ' 996' ' ' LEU . 29.2 m80 -81.48 -116.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.515 0.197 . . . . 0.0 111.454 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.576 ' HA ' HD12 ' A' ' 996' ' ' LEU . 46.9 t -178.61 -30.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.955 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.612 ' HG ' HG21 ' A' ' 987' ' ' THR . 52.6 m -155.58 148.88 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.88 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' 1015 ' ' THR . . . -153.36 133.04 13.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.636 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -100.2 136.9 39.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 13.0 t -71.14 124.22 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.25 -149.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.927 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.518 HD12 ' HZ1' ' A' ' 961' ' ' LYS . 66.2 tp -150.89 139.61 20.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.248 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.725 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 97.6 p -88.62 -52.22 5.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.553 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 158.7 31.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 176.14 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 56.9 m -139.27 134.93 33.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.281 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.25 140.34 36.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.725 ' HE2' ' HB3' ' A' 1007 ' ' SER . 9.9 p80 -158.37 146.19 18.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 78.2 m95 -64.38 146.47 54.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.934 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.6 t -49.91 -34.28 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.723 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.436 ' H ' ' HB1' ' A' 1002 ' ' ALA . 75.8 p -144.74 139.39 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.056 0.455 . . . . 0.0 111.821 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.594 ' HD2' ' N ' ' A' 1017 ' ' PRO . 3.8 tmmm? -62.88 136.21 96.39 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.345 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.594 ' N ' ' HD2' ' A' 1016 ' ' LYS . 10.4 Cg_endo -54.08 124.87 17.03 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.786 2.324 . . . . 0.0 112.801 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.747 ' HB3' ' HA2' ' A' ' 998' ' ' GLY . 44.4 Cg_endo -67.3 -150.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.799 2.332 . . . . 0.0 112.65 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.471 ' CG2' ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -133.18 -158.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.839 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -159.54 135.97 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.566 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.601 ' C ' ' H ' ' A' 1023 ' ' ILE . 3.6 pt20 -151.31 141.89 22.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.521 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' 1022 ' ' ARG . 27.5 ptt85 -64.01 22.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.601 ' H ' ' C ' ' A' 1021 ' ' GLN . 58.0 mt 64.61 132.08 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 52.5 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.836 2.357 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 924' ' ' ILE . . . . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.89 0.376 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.478 ' N ' HD23 ' A' ' 949' ' ' LEU . 45.7 m80 -148.99 140.05 23.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 86.5 m -81.6 131.61 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.701 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -54.6 158.73 2.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 111.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 919' ' ' ALA . . . -48.27 123.32 10.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.846 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.49 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 34.3 Cg_exo -59.17 136.83 75.34 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 122.669 2.246 . . . . 0.0 112.94 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.2 143.79 57.48 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.93 131.92 39.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 911' ' ' ALA . 2.0 m-85 -85.29 150.14 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.987 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -81.17 -57.07 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.047 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.8 OUTLIER -85.47 10.77 11.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -152.14 151.62 31.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.49 136.3 39.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 928' ' ' LEU . 57.5 tp -45.77 130.58 9.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.593 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 914' ' ' LYS . 11.7 tmtt? -94.59 -51.19 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 52.9 m -66.52 136.58 55.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.616 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -64.76 138.54 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.828 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.562 HG23 HD12 ' A' ' 928' ' ' LEU . 81.0 p -154.25 -170.2 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 917' ' ' THR . 40.1 p -156.15 34.28 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.644 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 904' ' ' ALA . . . 41.05 -146.0 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.799 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 920' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' A' ' 919' ' ' ALA . 47.6 t 62.39 44.52 7.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.967 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 902' ' ' CYS . 1.5 m-20 66.61 153.54 0.08 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.503 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.407 ' CE1' ' HA ' ' A' ' 919' ' ' ALA . 63.6 m-85 -136.4 145.97 53.97 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.209 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.492 ' HG2' ' HG1' ' A' ' 926' ' ' THR . 18.1 Cg_endo -59.25 138.24 83.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.729 2.286 . . . . 0.0 111.896 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.633 HG21 ' H ' ' A' ' 925' ' ' GLY . 37.4 mt -58.96 155.73 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.633 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 85.42 -32.36 3.63 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.674 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.492 ' HG1' ' HG2' ' A' ' 923' ' ' PRO . 40.9 m -55.97 126.29 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 47.3 t -96.36 127.87 42.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.781 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.562 HD12 HG23 ' A' ' 917' ' ' THR . 8.6 tp -105.47 120.52 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 0.0 110.903 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 915' ' ' THR . 40.2 ttmt -85.68 140.98 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.556 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 6.3 m-85 -129.15 168.48 16.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.417 ' OE2' ' HG2' ' A' ' 914' ' ' LYS . 16.6 pt-20 -144.47 137.38 26.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.926 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.69 143.26 37.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.02 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.0 mtp180 -85.52 158.69 56.94 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 7.6 Cg_endo -49.64 139.74 30.34 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.579 2.186 . . . . 0.0 111.745 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 50.5 mt-10 81.38 25.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.334 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.483 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 88.2 m-85 -146.87 135.66 22.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.796 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.8 p90 -102.34 137.47 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.885 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 157.62 146.06 4.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.877 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 77.2 mtp180 -72.82 162.72 72.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.662 0.268 . . . . 0.0 110.82 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 73.5 Cg_endo -78.75 114.66 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.384 2.056 . . . . 0.0 112.278 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 48.2 p90 -91.68 -160.17 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.5 p -175.28 132.92 0.3 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.561 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 11.0 pt -93.99 -166.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.188 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.635 ' O ' HD23 ' A' ' 946' ' ' LEU . 26.5 m -166.61 132.6 2.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.5 t -73.79 120.47 19.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.67 ' H ' HD21 ' A' ' 946' ' ' LEU . 1.8 mm? -87.02 174.22 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.219 1.009 . . . . 0.0 112.803 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.05 -42.69 73.01 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.135 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.418 ' O ' HG12 ' A' ' 950' ' ' VAL . 48.7 t30 -84.51 35.09 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.584 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 83.0 mt 46.42 59.66 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.815 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.574 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 16.0 m -138.48 -157.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.117 0.484 . . . . 0.0 111.393 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.49 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 94.3 m95 -149.13 115.98 5.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.478 ' N ' HD22 ' A' ' 946' ' ' LEU . 72.4 m -52.12 147.51 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.4 t -78.16 122.97 86.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.561 ' HG3' ' CG2' ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.09 26.77 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.866 2.377 . . . . 0.0 112.831 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.629 ' NZ ' ' HB2' ' A' ' 955' ' ' LYS . 7.2 mtmp? 39.82 -143.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.01 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.587 ' OD1' ' HE2' ' A' ' 959' ' ' LYS . 60.3 t0 -79.5 134.26 36.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 958' ' ' CYS . 2.5 m -150.68 -98.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.504 ' H ' ' CG2' ' A' ' 957' ' ' VAL . 63.7 m -77.13 147.36 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.014 0.435 . . . . 0.0 111.374 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.587 ' HE2' ' OD1' ' A' ' 956' ' ' ASP . 68.5 mttm -144.93 157.15 44.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.172 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.815 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -59.95 114.98 3.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.851 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.566 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 24.6 ttmm -56.23 150.34 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.653 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 82.8 p -144.51 141.02 29.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.985 0.421 . . . . 0.0 111.38 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 82.0 m -79.9 151.6 30.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.156 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.48 131.06 45.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 29.4 m -55.77 122.94 49.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.58 134.71 29.05 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.428 2.085 . . . . 0.0 111.765 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.84 124.49 15.99 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.047 1.831 . . . . 0.0 111.433 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -58.29 122.86 62.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.788 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.65 138.4 83.09 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.064 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' 1020 ' ' CYS . 21.7 t -52.79 130.47 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.678 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 70.36 36.78 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.837 ' HA3' ' H ' ' A' ' 991' ' ' THR . . . -172.48 -153.16 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.055 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.689 ' HE1' ' HE1' ' A' ' 975' ' ' HIS . 24.1 ptt? 177.41 145.44 0.11 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.491 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 7.7 p -93.81 120.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.689 ' HE1' ' HE1' ' A' ' 973' ' ' MET . 41.4 m-70 -78.87 112.97 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 27.8 m -63.99 -18.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.189 0.519 . . . . 0.0 109.748 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.468 ' O ' HG21 ' A' ' 978' ' ' THR . 8.9 mt 74.07 -44.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.953 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 977' ' ' ILE . 81.3 p -146.77 -54.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.622 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.601 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 45.1 m-20 -159.18 -144.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.514 HG22 HG13 ' A' ' 976' ' ' VAL . 7.0 pt -151.09 31.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.156 0.503 . . . . 0.0 110.944 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.815 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 3.2 mm100 -76.87 156.01 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.504 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.542 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 94.5 t -55.44 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 159.0 -37.99 0.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.278 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.9 p -76.58 139.1 40.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 111.626 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.746 ' HG2' ' HB2' ' A' 1003 ' ' GLU . 87.2 mtm180 -90.64 159.08 16.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.999 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.491 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 41.9 pt -132.72 123.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.9 p -103.85 138.68 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.457 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.469 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.2 m-85 -100.79 138.57 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.266 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 81.9 p -153.48 131.41 11.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 71.5 m -74.17 126.04 29.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.603 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.837 ' H ' ' HA3' ' A' ' 972' ' ' GLY . 6.0 t -76.58 55.1 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.468 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 991' ' ' THR . 99.9 m -177.64 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.405 ' H ' ' HD1' ' A' ' 994' ' ' HIS . . . -168.66 39.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.499 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 3.0 m80 -93.65 159.73 15.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.635 ' HB3' HG12 ' A' 1023 ' ' ILE . 37.3 ptt180 -89.87 135.56 33.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 999' ' ' HIS . 2.1 tm? -71.98 132.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 3.3 mt -118.29 135.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.387 . . . . 0.0 111.487 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.17 -125.57 8.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.533 ' O ' HD13 ' A' ' 996' ' ' LEU . 95.8 m-70 -79.3 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.8 p -174.58 -37.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.9 p -150.85 151.71 32.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.547 ' HB1' ' H ' ' A' 1015 ' ' THR . . . -151.92 133.17 14.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.087 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.746 ' HB2' ' HG2' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.36 136.62 36.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.208 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 35.5 t -71.25 121.8 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.501 ' HA ' HG11 ' A' ' 982' ' ' VAL . 33.5 pt -133.46 -153.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.411 . . . . 0.0 111.934 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.85 136.11 17.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.038 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.745 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.9 t -89.41 -40.88 12.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.713 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.55 -37.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.035 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -140.92 -48.03 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.063 0.458 . . . . 0.0 110.5 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 57.8 m -94.53 135.76 35.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.227 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.488 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -80.78 145.64 31.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.745 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.5 p80 -157.66 144.06 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.371 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 70.7 m95 -66.0 147.05 53.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.4 t -55.81 -35.11 65.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.594 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.547 ' H ' ' HB1' ' A' 1002 ' ' ALA . 82.8 p -143.12 143.78 31.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.462 . . . . 0.0 111.726 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -56.83 137.59 78.71 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.907 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.431 ' HB3' ' HH ' ' A' ' 988' ' ' TYR . 53.1 Cg_exo -52.9 129.89 35.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.379 2.053 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 38.3 Cg_exo -61.44 -158.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 112.683 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.2 mt -142.86 139.37 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.945 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 42.8 t -94.43 129.02 41.34 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 995' ' ' ARG . 2.5 tp-100 -145.74 128.62 16.38 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.664 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -54.39 133.29 45.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.35 0.595 . . . . 0.0 111.311 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.635 HG12 ' HB3' ' A' ' 995' ' ' ARG . 57.5 mt -74.83 122.8 88.29 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.2 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.866 2.378 . . . . 0.0 112.347 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.723 ' HB2' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.113 0.483 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.596 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 41.3 m80 -150.91 136.76 18.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.002 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.41 125.35 29.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.291 0.567 . . . . 0.0 111.213 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -57.7 168.83 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.607 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.5 133.51 13.37 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.567 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.42 145.97 78.84 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.55 2.167 . . . . 0.0 111.729 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.74 148.65 42.2 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.39 0.614 . . . . 0.0 111.332 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -81.19 115.02 20.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.027 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.447 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 9.5 m-85 -89.93 134.39 34.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.762 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.539 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 76.7 mt -76.96 -54.4 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 2.1 p90 -84.59 25.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.201 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.17 120.76 4.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.514 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -103.48 121.14 42.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 930' ' ' TYR . 29.8 tp -49.25 122.05 5.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.004 0.43 . . . . 0.0 111.324 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 0.8 OUTLIER -90.94 -44.77 9.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.321 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 54.3 m -64.65 132.92 51.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.43 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.413 ' O ' HG21 ' A' ' 917' ' ' THR . 3.2 pm0 -65.12 143.64 57.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.267 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.5 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 80.7 p -150.22 -58.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.089 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 82.6 p 46.25 56.16 6.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . 0.425 ' HB2' ' H ' ' A' ' 920' ' ' SER . . . -165.51 -152.43 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.0 111.491 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 920' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 919' ' ' ALA . 60.1 m -146.58 -44.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.866 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.51 135.37 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.113 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.5 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 55.1 m-85 -137.69 141.37 32.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.939 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.488 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 70.0 Cg_endo -73.93 136.98 23.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.634 2.223 . . . . 0.0 111.647 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 947' ' ' ASP . 53.4 mt -52.6 151.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.573 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 91.31 -28.38 8.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.491 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.488 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 31.8 m -55.43 138.99 44.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.994 0.426 . . . . 0.0 111.553 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.7 m -118.0 142.5 47.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.76 120.49 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.519 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -89.83 133.38 34.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.472 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 2.9 m-85 -116.12 134.77 54.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 65.7 mm-40 -94.45 117.25 29.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.801 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 68.7 m -59.41 140.63 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.344 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.0 mtp180 -85.37 158.74 57.31 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 9.2 Cg_endo -52.71 149.47 24.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.519 2.146 . . . . 0.0 110.886 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 49.6 mt-10 83.5 19.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.72 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 960' ' ' ARG . 94.3 m-85 -144.95 125.11 13.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 5.1 p90 -95.96 141.4 29.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.46 147.39 5.46 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.087 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.725 ' HD3' ' H ' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.27 159.03 86.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.83 126.11 16.04 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.585 2.19 . . . . 0.0 112.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 5.2 p90 -90.88 -162.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.712 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 64.1 m -170.12 133.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.2 pt -95.76 168.94 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.277 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.66 ' O ' HD23 ' A' ' 946' ' ' LEU . 20.4 m -162.6 135.26 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 52.8 m -73.8 126.83 31.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 944' ' ' THR . 2.6 mm? -85.19 -53.55 5.18 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.702 ' HA ' HD11 ' A' ' 924' ' ' ILE . 50.9 t0 171.73 -38.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.691 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.07 28.07 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 900' ' ' ALA . 7.0 mp 60.8 43.22 12.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.419 HG21 ' H ' ' A' ' 951' ' ' TRP . 12.2 p -139.32 149.75 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.886 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.419 ' H ' HG21 ' A' ' 950' ' ' VAL . 51.0 m95 -94.02 141.06 28.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.0 p -52.34 138.11 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 44.9 t -79.19 108.61 8.84 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.756 0.312 . . . . 0.0 111.196 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 952' ' ' SER . 6.4 Cg_exo -72.75 136.03 24.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.675 2.25 . . . . 0.0 111.497 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -158.99 143.37 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.373 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.49 36.72 16.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.572 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.462 ' O ' ' HD2' ' A' ' 959' ' ' LYS . 2.8 m -92.4 -111.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.009 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 51.0 m -86.82 87.29 7.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.717 ' HD2' ' H ' ' A' ' 959' ' ' LYS . 8.3 mptt -67.75 154.59 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.469 ' HA ' ' CD1' ' A' ' 936' ' ' TYR . 37.7 ttm180 -54.54 136.52 44.73 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.85 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 16.6 tppt? -53.78 152.32 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.508 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 70.9 p -143.95 124.08 13.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.775 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.508 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.1 p -83.54 37.95 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 965' ' ' THR . 53.4 tptt 60.09 138.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.386 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.489 HG21 ' HD2' ' A' ' 966' ' ' PRO . 9.2 m -57.47 131.86 81.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.734 ' HG3' HD11 ' A' ' 986' ' ' ILE . 37.2 Cg_endo -65.02 125.0 13.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.471 2.114 . . . . 0.0 112.462 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.27 120.57 7.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.305 2.003 . . . . 0.0 111.498 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.455 ' HB3' ' HA ' ' A' ' 973' ' ' MET . 1.5 m-20 -62.55 122.28 72.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.62 144.91 91.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 111.877 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.3 p -48.32 127.44 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.548 ' ND2' HG23 ' A' ' 970' ' ' VAL . 76.8 m-20 63.75 46.4 4.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.907 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.79 -154.07 9.02 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.513 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.455 ' HA ' ' HB3' ' A' ' 968' ' ' ASP . 24.8 ptt? 175.69 143.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.287 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 986' ' ' ILE . 13.5 p -93.79 127.18 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -89.55 110.53 21.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.377 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.551 HG13 HG21 ' A' ' 980' ' ' ILE . 34.8 m -71.99 134.62 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 978' ' ' THR . 47.6 mm -73.45 -38.74 53.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 110.503 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.426 HG22 HG23 ' A' ' 977' ' ' ILE . 76.8 p -144.76 -42.61 0.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 54.3 t0 -160.72 -136.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.197 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.551 HG21 HG13 ' A' ' 976' ' ' VAL . 9.5 pt -151.07 1.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 110.981 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -75.62 164.5 26.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.543 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 53.4 t -50.1 133.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 102.67 -39.03 2.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.566 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 95.8 p -76.06 138.09 40.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -98.87 157.18 16.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.232 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.734 HD11 ' HG3' ' A' ' 966' ' ' PRO . 47.8 pt -141.96 137.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 111.685 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 4.7 p -108.33 133.25 52.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.465 ' CZ ' HD13 ' A' ' 986' ' ' ILE . 5.9 m-85 -94.66 143.2 26.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.789 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.74 123.31 9.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 61.9 m -88.94 146.47 24.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -64.93 147.47 53.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.448 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 86.8 m -45.61 117.1 1.34 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.979 0.419 . . . . 0.0 111.192 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 141.49 -48.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.151 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -113.04 139.2 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.618 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.496 ' HG3' HD13 ' A' ' 997' ' ' ILE . 38.3 ptt180 -93.0 140.9 28.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' 1018 ' ' PRO . 8.9 tt -72.01 126.1 28.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.215 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.714 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.4 mp -102.93 130.92 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.344 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.54 -142.89 15.62 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.617 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.5 ' O ' ' HG3' ' A' 1018 ' ' PRO . 87.5 m-70 -84.03 132.19 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.574 0.226 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.4 t -81.32 -55.87 4.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.5 p -89.2 153.17 21.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.508 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -156.6 123.37 5.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.116 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -104.59 131.25 52.21 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 49.1 t -75.0 131.0 40.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.433 HD11 HG22 ' A' 1005 ' ' ILE . 31.7 pt -135.8 -155.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.581 -0.447 . . . . 0.0 112.007 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' 1010 ' ' THR . 56.3 tp -150.39 131.9 14.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.687 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 26.3 t -90.08 -134.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.395 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -67.65 -49.77 47.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.643 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -152.11 27.56 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.4 ' C ' HD13 ' A' 1006 ' ' LEU . 6.6 m -149.73 130.99 14.58 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.489 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -81.52 137.94 35.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.765 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.687 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.9 p80 -159.76 144.33 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.593 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.508 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 93.1 m95 -64.48 146.74 54.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.704 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.7 t -57.56 -31.5 66.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.508 ' OG1' ' HB1' ' A' 1002 ' ' ALA . 81.6 p -144.35 138.77 28.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.583 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.538 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 1.6 pptp? -62.52 160.7 32.14 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 18.6 Cg_endo -59.57 129.03 29.2 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.499 2.133 . . . . 0.0 112.271 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.5 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 16.8 Cg_exo -67.22 -160.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.581 ' CG2' ' HB ' ' A' ' 997' ' ' ILE . 1.2 tt -144.55 121.3 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.217 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.9 m -78.92 132.91 36.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.714 ' HB3' HD12 ' A' ' 997' ' ' ILE . 36.4 tt0 -146.68 130.93 17.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.406 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -44.29 132.8 5.72 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.524 0.678 . . . . 0.0 111.928 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.668 HG21 ' HD2' ' A' 1024 ' ' PRO . 22.2 mt -76.07 130.44 78.04 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.303 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.668 ' HD2' HG21 ' A' 1023 ' ' ILE . 54.2 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.482 2.122 . . . . 0.0 112.421 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.79 ' HB3' HD13 ' A' ' 924' ' ' ILE . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.912 0.387 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 44.9 m170 -119.87 123.12 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 5.4 p -82.13 127.19 32.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.547 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.2 mm100 -58.34 169.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.12 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -45.86 135.68 6.39 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.544 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 3.0 Cg_exo -74.64 61.86 5.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.063 2.508 . . . . 0.0 111.909 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.565 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 48.4 t0 41.45 -143.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.565 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 70.9 t60 -161.78 116.7 1.98 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.726 0.298 . . . . 0.0 110.974 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 74.3 m-85 -85.93 135.26 33.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.076 0.465 . . . . 0.0 110.779 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.638 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 5.3 mp -74.97 -48.33 24.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.569 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.58 17.7 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.621 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.51 121.88 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 111.788 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 933' ' ' ARG . 59.7 pttt -102.7 128.87 49.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.21 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 930' ' ' TYR . 0.8 OUTLIER -48.61 125.34 9.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.607 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -94.47 -31.47 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.56 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.456 ' HB ' HD23 ' A' ' 913' ' ' LEU . 86.8 m -62.2 135.92 57.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 111.786 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.533 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.1 pm0 -78.34 61.25 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.672 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 918' ' ' THR . 3.4 t -80.62 -53.02 6.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' THR . . . . . 0.439 ' N ' HG22 ' A' ' 917' ' ' THR . 24.9 m 51.81 55.1 9.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.31 155.36 9.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 48.4 t -86.58 -44.83 11.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.21 138.96 32.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.524 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.445 ' HB2' ' SG ' ' A' ' 902' ' ' CYS . 17.0 m-85 -127.67 137.88 31.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.84 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.558 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 60.0 Cg_endo -72.13 131.97 18.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.484 2.123 . . . . 0.0 110.922 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.79 HD13 ' HB3' ' A' ' 900' ' ' ALA . 44.6 mt -57.1 149.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.926 0.393 . . . . 0.0 111.327 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.564 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 91.69 -34.37 4.39 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.663 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 15.8 m -57.19 129.9 43.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 942' ' ' SER . 47.6 t -87.89 151.74 22.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.541 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.625 ' O ' HG12 ' A' ' 943' ' ' ILE . 10.0 tp -140.85 102.18 4.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.51 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 17.8 ptpt -85.37 132.76 34.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.191 0.52 . . . . 0.0 111.99 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.557 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 2.0 m-85 -111.49 133.9 53.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.791 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.466 ' OE2' ' HE3' ' A' ' 912' ' ' LYS . 23.4 pt-20 -95.57 126.47 40.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.3 m -57.87 148.59 24.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 76.9 mtt-85 -85.15 161.95 50.68 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 75.3 Cg_exo -45.64 139.96 9.68 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.234 1.956 . . . . 0.0 112.176 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 95.0 mt-10 82.49 23.43 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.495 ' N ' ' HG3' ' A' ' 961' ' ' LYS . 85.9 m-85 -146.81 145.41 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.558 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.568 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 16.1 p90 -144.07 140.84 29.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 110.942 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.36 21.89 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.651 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.606 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 79.5 mtp180 62.81 164.61 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.85 0.357 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 63.6 Cg_endo -77.65 115.42 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.146 1.897 . . . . 0.0 110.676 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.622 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 42.3 p90 -89.67 108.1 19.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.525 0.678 . . . . 0.0 112.068 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.77 ' HA ' ' HA ' ' A' ' 929' ' ' LYS . 80.3 p -77.21 125.64 29.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.844 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 928' ' ' LEU . 10.0 pt -94.92 -161.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.725 HG23 HD22 ' A' ' 946' ' ' LEU . 4.0 m -161.14 121.42 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -72.08 102.16 2.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.725 HD22 HG23 ' A' ' 944' ' ' THR . 48.9 mt -80.89 161.37 24.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.568 0.699 . . . . 0.0 112.713 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.401 ' HA ' HD12 ' A' ' 924' ' ' ILE . 9.8 t70 -42.55 -38.4 1.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.005 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -83.08 36.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.723 ' HA ' ' HB3' ' A' ' 902' ' ' CYS . 8.2 mp 44.82 46.33 8.76 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.222 0.534 . . . . 0.0 110.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.708 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.4 m -123.61 -162.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.16 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.544 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 90.1 m95 -152.69 122.77 7.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.289 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.9 t -43.43 146.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.531 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 38.9 t -79.39 117.55 67.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.599 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 957' ' ' VAL . 4.0 Cg_exo -76.8 60.93 6.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.55 2.833 . . . . 0.0 111.794 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -77.1 131.77 38.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.017 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.441 ' O ' HG11 ' A' ' 957' ' ' VAL . 21.8 m-20 54.99 81.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.545 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 12.7 m -150.9 -21.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.834 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 12.1 t -151.45 133.37 15.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -143.26 146.86 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.181 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.811 ' HD3' ' HB3' ' A' ' 981' ' ' GLN . 29.9 ttt85 -53.2 143.53 17.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.057 0.456 . . . . 0.0 111.655 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 28.1 mtpp -56.29 152.34 11.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.563 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.582 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 96.3 p -141.61 121.13 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.564 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 4.4 p -81.67 153.68 26.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.596 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.33 132.35 48.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 34.4 m -56.57 134.3 77.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.928 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.71 ' HG2' HG13 ' A' ' 974' ' ' VAL . 9.2 Cg_endo -52.65 150.98 20.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.764 2.309 . . . . 0.0 111.992 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.488 ' HD2' ' HG2' ' A' 1017 ' ' PRO . 64.7 Cg_endo -73.14 45.5 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.678 2.252 . . . . 0.0 112.814 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 967' ' ' PRO . 1.5 m-20 18.02 109.73 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 124.074 0.859 . . . . 0.0 113.165 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.44 142.49 9.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.537 HG23 ' ND2' ' A' ' 971' ' ' ASN . 5.1 p -48.6 131.67 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.638 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.537 ' ND2' HG23 ' A' ' 970' ' ' VAL . 74.2 m-20 75.43 -48.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.634 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.443 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -75.44 -152.62 3.61 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.097 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 1.8 pmm? 177.75 143.48 0.1 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.274 0.23 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.71 HG13 ' HG2' ' A' ' 966' ' ' PRO . 10.1 p -93.62 128.94 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.236 0.541 . . . . 0.0 111.201 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -104.46 118.1 35.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 28.2 m -70.95 141.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 985' ' ' ARG . 24.4 mm -74.92 -36.68 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.476 . . . . 0.0 110.295 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.2 p -144.69 -47.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.186 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 49.0 t0 -160.19 -137.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.559 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.498 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 7.6 pt -151.02 36.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.231 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.811 ' HB3' ' HD3' ' A' ' 960' ' ' ARG . 13.1 mm100 -76.5 166.69 23.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.715 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.547 HG21 ' NE ' ' A' ' 960' ' ' ARG . 15.7 m -64.32 29.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.3 -25.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.3 t -76.1 136.72 39.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.004 0.431 . . . . 0.0 111.256 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 69.0 ttt180 -89.65 158.72 17.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 986' ' ' ILE . 47.4 pt -137.56 129.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.918 0.39 . . . . 0.0 111.025 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.451 HG21 ' HB3' ' A' 1001 ' ' SER . 2.3 p -105.22 139.58 39.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.02 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 7.3 m-85 -103.94 146.99 27.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.677 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -153.48 124.19 7.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.482 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.443 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 96.6 m -72.95 -119.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 993' ' ' GLY . 8.0 t -169.55 158.91 8.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.628 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 61.0 m -52.8 84.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 991' ' ' THR . . . 168.6 -42.22 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.47 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.416 ' HB3' ' N ' ' A' 1021 ' ' GLN . 7.8 m80 -126.13 142.25 51.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.627 ' HG3' HD13 ' A' ' 997' ' ' ILE . 39.3 ptt180 -91.9 145.28 24.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.73 135.42 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.571 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.719 HD12 ' HB3' ' A' 1021 ' ' GLN . 3.9 mp -126.49 139.42 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.94 -124.2 7.99 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.51 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.416 ' CG ' ' H ' ' A' 1000 ' ' SER . 27.0 t60 -80.1 -136.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.416 ' H ' ' CG ' ' A' ' 999' ' ' HIS . 79.4 p -176.76 -43.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 987' ' ' THR . 69.2 p -155.22 141.58 18.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.516 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.434 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -149.49 143.48 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 112.025 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.6 tt0 -95.92 138.24 33.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 47.9 t -71.27 129.62 39.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.1 pt -139.39 146.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 60.8 tp -89.16 137.28 32.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.589 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.685 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 98.8 p -88.97 -40.09 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.372 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -177.72 -36.03 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.415 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -145.29 -44.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.277 0.561 . . . . 0.0 109.707 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 94.2 m -94.5 131.89 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.64 138.8 34.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.01 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.685 ' HE2' ' HB3' ' A' 1007 ' ' SER . 10.8 p80 -155.66 142.61 19.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.083 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 70.7 m95 -66.46 146.35 54.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -51.32 -33.73 30.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.092 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 82.8 p -141.04 -152.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.553 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -126.8 149.75 69.55 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.4 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.488 ' HG2' ' HD2' ' A' ' 967' ' ' PRO . 41.5 Cg_exo -57.46 135.65 71.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.838 2.359 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 27.0 Cg_exo -62.81 -159.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.728 2.286 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.511 ' CG2' ' HB ' ' A' ' 997' ' ' ILE . 3.8 tt -146.57 128.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.868 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 77.3 m -84.29 138.5 32.88 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.719 ' HB3' HD12 ' A' ' 997' ' ' ILE . 7.8 tt0 -149.74 135.7 18.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.081 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.407 ' HG2' HH11 ' A' 1022 ' ' ARG . 42.4 ttp85 -48.63 130.39 17.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.512 0.673 . . . . 0.0 111.695 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.549 HG12 ' HB3' ' A' ' 995' ' ' ARG . 71.2 mt -74.94 127.12 87.44 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.623 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.563 2.175 . . . . 0.0 112.219 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.88 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.849 0.357 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 15.9 m80 67.21 144.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 84.7 m -79.78 122.63 26.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 904' ' ' ALA . 0.0 OUTLIER -65.65 163.99 15.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.78 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.92 125.33 4.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.663 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.614 ' HG2' HD11 ' A' ' 928' ' ' LEU . 16.6 Cg_exo -67.1 135.26 36.75 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.731 2.287 . . . . 0.0 112.509 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.77 152.24 43.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.107 0.48 . . . . 0.0 110.87 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -78.17 134.59 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.091 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.538 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 8.3 m-85 -90.07 1.25 56.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.8 mp 71.61 -63.35 0.43 Allowed 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.602 0.564 . . . . 0.0 111.388 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.463 ' HA ' ' CD ' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -85.35 25.66 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.83 120.86 5.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -103.71 138.77 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.476 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 914' ' ' LYS . 3.1 tm? -46.47 150.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.726 ' H ' HD23 ' A' ' 913' ' ' LEU . 11.8 tmtt? -137.71 -46.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.407 ' O ' HD12 ' A' ' 913' ' ' LEU . 2.7 m -68.76 139.14 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.499 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.651 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -58.21 112.57 1.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 69.8 p -83.34 132.85 34.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 0.0 112.106 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.7 p -89.97 82.71 6.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.135 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 60.32 -152.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 920' ' ' SER . . . . . 0.432 ' HG ' ' H ' ' A' ' 921' ' ' ASP . 80.9 p -86.59 -47.76 8.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . 0.432 ' H ' ' HG ' ' A' ' 920' ' ' SER . 56.7 m-20 -85.43 121.99 28.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 77.7 m-85 -103.87 136.02 19.27 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 112.137 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.698 ' HG2' ' HG1' ' A' ' 926' ' ' THR . 51.3 Cg_endo -68.39 136.09 35.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 111.67 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.711 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 38.6 mt -56.69 143.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.065 0.46 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.472 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 101.87 -41.4 2.14 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.698 ' HG1' ' HG2' ' A' ' 923' ' ' PRO . 17.8 m -57.27 144.43 35.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.267 -0.466 . . . . 0.0 111.056 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 46.6 m -126.61 128.01 46.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.756 0.312 . . . . 0.0 111.235 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.614 HD11 ' HG2' ' A' ' 905' ' ' PRO . 94.3 mt -100.71 122.1 42.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.0 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.692 ' HG2' ' HB3' ' A' ' 942' ' ' SER . 52.0 mtmt -87.58 127.54 35.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.0 111.251 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 940' ' ' PRO . 4.8 m-85 -116.77 120.21 37.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.54 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.11 127.79 41.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.68 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 59.3 m -58.58 -174.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.519 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 43.5 mtp85 -84.42 159.68 58.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.323 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 936' ' ' TYR . 87.4 Cg_exo -45.83 -48.75 11.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.498 2.132 . . . . 0.0 112.466 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -74.44 28.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.304 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.519 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 12.4 m-85 -141.85 150.77 42.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.605 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 23.3 p90 -137.56 136.27 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.349 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.94 11.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 55.4 mtp85 61.41 151.98 0.1 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.348 0.594 . . . . 0.0 111.983 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 930' ' ' TYR . 13.4 Cg_exo -67.46 117.83 5.13 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.795 2.33 . . . . 0.0 111.246 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 957' ' ' VAL . 43.3 p90 -90.35 115.37 27.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.392 0.615 . . . . 0.0 111.768 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.692 ' HB3' ' HG2' ' A' ' 929' ' ' LYS . 80.1 p -78.38 131.36 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.061 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.847 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -101.86 114.24 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 0.0 110.567 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.791 HG23 HD22 ' A' ' 946' ' ' LEU . 2.6 m -83.05 125.96 32.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.711 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 49.7 t -73.7 112.34 9.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.791 HD22 HG23 ' A' ' 944' ' ' THR . 89.1 mt -81.45 -64.51 1.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -174.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 59.9 t0 173.84 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.947 0.403 . . . . 0.0 110.593 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.515 ' HB3' HG11 ' A' ' 950' ' ' VAL . 34.8 t30 -79.16 9.57 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.88 HD12 ' HA ' ' A' ' 900' ' ' ALA . 45.9 mt 69.25 40.42 1.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.44 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.528 HG21 ' H ' ' A' ' 951' ' ' TRP . 3.3 p -137.52 154.94 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.607 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.847 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 29.1 m95 -89.76 145.25 25.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.313 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.542 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 79.5 p -47.2 144.94 2.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 66.1 m -77.71 108.65 7.66 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.459 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 952' ' ' SER . 15.4 Cg_exo -66.65 142.88 65.97 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.643 2.229 . . . . 0.0 111.339 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.37 129.33 8.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.147 0.499 . . . . 0.0 111.832 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 55.4 t0 51.75 33.65 11.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.431 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.783 HG21 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -91.99 -59.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.783 ' H ' HG21 ' A' ' 957' ' ' VAL . 5.9 t -89.31 141.48 28.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 40.1 mtmt -152.37 133.75 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.44 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.836 ' HE ' ' HB3' ' A' ' 981' ' ' GLN . 0.3 OUTLIER -65.88 128.52 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.02 0.438 . . . . 0.0 110.915 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.668 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.2 ttmp? -56.21 161.99 2.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.514 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 73.3 p -149.79 147.81 28.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.472 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.2 m -80.11 147.91 31.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.938 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.619 ' HD3' ' N ' ' A' ' 965' ' ' THR . 6.3 tmtm? -65.96 131.06 45.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.619 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 25.1 m -52.98 124.24 36.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.002 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.56 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 55.2 Cg_endo -68.87 133.66 27.82 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.64 2.227 . . . . 0.0 112.611 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.94 137.55 76.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.351 2.034 . . . . 0.0 111.313 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.71 113.83 7.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.12 151.51 85.02 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.795 2.33 . . . . 0.0 111.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.6 p -49.6 127.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 49.24 46.09 23.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.84 137.97 4.59 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.45 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.414 ' HB2' ' HE1' ' A' ' 973' ' ' MET . 3.3 mpp? -127.95 142.74 51.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 12.6 p -94.23 121.44 44.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.753 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -88.66 128.13 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.51 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.95 123.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.9 -40.49 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.707 0.289 . . . . 0.0 111.154 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 78.6 p -144.68 -50.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.402 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.539 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 37.1 m-20 -158.26 -152.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.994 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.448 HG21 ' O ' ' A' ' 979' ' ' ASP . 14.8 pt -149.9 23.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.836 ' HB3' ' HE ' ' A' ' 960' ' ' ARG . 15.1 mp0 -77.01 154.08 33.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.675 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.532 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 66.6 t -50.85 85.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 111.301 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.98 -41.47 0.29 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' 1003 ' ' GLU . 77.2 p -75.38 -168.83 0.87 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 111.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.454 HH21 ' HB2' ' A' 1001 ' ' SER . 79.2 ttt180 -151.31 131.35 13.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.089 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.56 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 31.2 pt -98.07 142.57 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.539 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.7 p -116.96 135.12 53.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.138 0.494 . . . . 0.0 111.723 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.456 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 1.8 m-85 -103.12 148.66 25.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.5 t -148.74 120.05 7.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.095 0.474 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 71.4 m -83.02 151.55 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.0 p -64.6 149.11 49.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -49.4 92.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 158.51 -46.94 0.44 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.275 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -99.96 148.25 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.596 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.449 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -91.55 148.4 22.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.548 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' 1018 ' ' PRO . 3.4 tm? -65.2 130.19 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.071 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.668 HD13 ' HB2' ' A' 1021 ' ' GLN . 34.6 mm -100.13 73.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.757 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . 156.62 -149.62 20.52 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.126 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.661 ' HD1' HG22 ' A' 1015 ' ' THR . 34.5 m170 -85.91 -9.51 56.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.614 0.245 . . . . 0.0 111.173 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.533 ' N ' HD13 ' A' ' 996' ' ' LEU . 15.3 m 71.8 -5.44 1.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.458 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.454 ' HB2' HH21 ' A' ' 985' ' ' ARG . 57.5 m -156.02 149.55 24.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.465 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -154.58 133.15 12.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.6 tt0 -96.07 132.54 41.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 38.2 t -71.19 121.36 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 35.8 pt -135.52 -151.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 111.617 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' 1008 ' ' GLY . 8.7 tt -155.87 139.77 16.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.498 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.705 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.0 t -87.51 -57.72 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.543 ' N ' HD22 ' A' 1006 ' ' LEU . . . 169.05 35.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.239 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' 1008 ' ' GLY . 0.7 OUTLIER 176.65 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.39 0.614 . . . . 0.0 109.988 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -143.96 143.64 31.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.642 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -78.89 143.87 35.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.705 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.0 p80 -157.72 148.83 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.806 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.455 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.1 m95 -64.38 140.18 58.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -54.26 -30.48 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.811 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.661 HG22 ' HD1' ' A' ' 999' ' ' HIS . 63.0 p -140.82 143.31 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 111.712 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -51.26 146.09 12.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.92 118.8 5.7 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.446 2.097 . . . . 0.0 111.856 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.747 ' HB2' HD23 ' A' ' 996' ' ' LEU . 35.7 Cg_endo -65.99 145.89 80.92 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.544 2.162 . . . . 0.0 112.569 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.605 HG23 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.71 -149.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.247 0.546 . . . . 0.0 110.846 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.605 ' H ' HG23 ' A' 1019 ' ' ILE . 74.7 m -154.76 138.75 16.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.188 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.668 ' HB2' HD13 ' A' ' 997' ' ' ILE . 3.8 tt0 -147.13 129.57 15.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.902 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -48.56 130.1 16.79 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.449 0.642 . . . . 0.0 111.466 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 995' ' ' ARG . 73.8 mt -75.26 128.45 84.53 Favored Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.154 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.776 2.317 . . . . 0.0 112.303 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.729 ' HA ' HD23 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.794 0.33 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 11.0 m80 69.8 134.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 10.9 p -80.79 119.16 23.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.818 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -72.53 -176.81 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.402 . . . . 0.0 111.042 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . 0.438 ' HA ' ' CE1' ' A' ' 922' ' ' PHE . . . -49.02 127.03 14.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.329 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.595 ' HG3' HD21 ' A' ' 928' ' ' LEU . 64.7 Cg_endo -73.33 70.16 3.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.809 2.34 . . . . 0.0 112.162 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.2 t0 35.21 -132.06 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.494 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.447 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 4.7 m170 -156.97 121.82 4.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.661 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.94 139.52 30.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.701 ' H ' HD21 ' A' ' 909' ' ' LEU . 0.6 OUTLIER -102.14 -45.63 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.562 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.417 ' C ' ' HG3' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -80.62 9.66 5.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.969 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.31 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.478 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.62 133.86 40.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.593 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.47 HD13 ' H ' ' A' ' 914' ' ' LYS . 65.0 tp -47.07 161.0 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.686 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.47 ' H ' HD13 ' A' ' 913' ' ' LEU . 31.0 mmmt -144.33 -52.29 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.531 ' CG2' HD13 ' A' ' 928' ' ' LEU . 4.3 m -68.78 137.09 53.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -62.35 123.35 18.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.539 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 49.7 p -83.42 136.06 34.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.029 0.443 . . . . 0.0 111.989 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 70.8 p -90.1 79.5 6.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.547 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 64.57 -154.54 0.3 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.082 0.468 . . . . 0.0 111.96 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.6 p -85.79 -46.07 11.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.38 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.3 120.88 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 54.7 m-85 -102.31 135.47 19.59 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.529 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 74.3 Cg_endo -74.26 133.2 17.44 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.739 2.293 . . . . 0.0 111.446 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.545 ' HA ' ' CB ' ' A' ' 945' ' ' CYS . 50.5 mt -56.89 144.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.933 0.397 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 945' ' ' CYS . . . 101.6 -35.19 5.08 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.529 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 24.0 m -56.17 128.59 36.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.442 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 79.3 p -101.47 123.84 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.595 HD21 ' HG3' ' A' ' 905' ' ' PRO . 8.1 tp -102.74 119.85 39.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.99 140.85 29.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.188 0.518 . . . . 0.0 112.07 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 913' ' ' LEU . 26.7 m-85 -133.95 133.51 41.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 931' ' ' GLU . 14.9 pt-20 -92.84 121.73 34.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.995 0.426 . . . . 0.0 111.279 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.76 153.86 19.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.663 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 78.5 mtp180 -81.35 145.37 55.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.604 0.24 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.554 ' O ' HD23 ' A' 1006 ' ' LEU . 70.9 Cg_exo -49.23 -42.74 39.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.346 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.88 24.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 934' ' ' PRO . 24.3 m-85 -142.04 139.81 32.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.95 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 7.9 p90 -93.26 134.7 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.412 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 133.9 148.44 5.83 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.701 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.673 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.0 ptp180 -72.52 166.24 43.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.478 0.18 . . . . 0.0 110.543 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 42.2 Cg_endo -68.38 122.85 9.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.327 2.018 . . . . 0.0 112.112 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.565 ' CD2' ' HB ' ' A' ' 957' ' ' VAL . 48.8 p90 -91.29 -165.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.9 p -175.29 137.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -91.27 176.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.924 HG23 HD22 ' A' ' 946' ' ' LEU . 1.2 m -161.37 127.54 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.545 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 62.2 m -71.64 117.26 12.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.924 HD22 HG23 ' A' ' 944' ' ' THR . 85.7 mt -87.55 -53.53 4.75 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 53.8 t0 171.06 -39.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.221 0.326 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -83.54 34.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.48 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 900' ' ' ALA . 6.7 mp 50.77 47.39 24.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.345 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.0 148.54 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 111.087 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 94.2 m95 -89.65 46.66 1.39 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.76 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 953' ' ' SER . 37.8 t 49.03 29.73 2.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.2 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 952' ' ' SER . 19.8 m 34.58 100.44 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.611 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 133.98 54.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.371 2.047 . . . . 0.0 112.797 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -159.1 135.94 9.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.459 ' O ' HG11 ' A' ' 957' ' ' VAL . 60.6 t0 56.54 67.09 1.04 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.565 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 19.6 m -147.75 68.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.513 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 957' ' ' VAL . 80.8 m 77.28 144.54 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.322 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.458 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 95.0 mttt -142.17 166.9 23.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 960' ' ' ARG . 0.0 OUTLIER -53.29 119.07 4.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 -179.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 39.8 tptt -56.22 148.69 17.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.744 ' HB3' HE21 ' A' ' 981' ' ' GLN . 54.6 p -149.44 125.04 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.95 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.1 p -82.23 141.07 33.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.851 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.78 137.42 57.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.079 0.466 . . . . 0.0 111.141 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.4 m -53.69 126.61 49.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.647 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 974' ' ' VAL . 28.9 Cg_endo -62.78 125.79 16.77 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.335 2.023 . . . . 0.0 111.878 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.24 134.47 60.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.209 1.939 . . . . 0.0 111.425 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -56.34 117.13 14.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.749 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 970' ' ' VAL . 22.3 Cg_exo -65.28 -146.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.873 2.382 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.849 ' HB ' ' HB2' ' A' 1020 ' ' CYS . 2.5 t -57.75 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.148 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.496 ' H ' ' CG1' ' A' ' 970' ' ' VAL . 76.1 m-20 -72.33 68.53 0.76 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.506 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.4 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -164.96 -160.2 12.12 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.716 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 179.84 144.12 0.17 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.973 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.513 HG22 HD13 ' A' ' 986' ' ' ILE . 9.9 p -94.32 138.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.15 0.5 . . . . 0.0 111.309 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -120.14 117.92 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.909 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 977' ' ' ILE . 35.8 t -70.14 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.503 ' N ' HG11 ' A' ' 976' ' ' VAL . 31.3 mm -75.13 -43.24 44.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 77.6 p -147.03 -53.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.649 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.62 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 48.5 m-20 -157.57 151.01 23.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.102 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.41 HG22 HG23 ' A' ' 976' ' ' VAL . 18.7 pt -88.34 32.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.781 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.744 HE21 ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -78.4 142.11 37.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.061 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.435 HG21 ' SG ' ' A' 1004 ' ' CYS . 80.1 t -50.39 104.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.937 0.398 . . . . 0.0 111.32 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 151.5 -51.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.431 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' 1003 ' ' GLU . 80.5 p -76.27 -152.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 0.0 111.046 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -151.4 178.37 9.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.235 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.513 HD13 HG22 ' A' ' 974' ' ' VAL . 26.9 pt -142.0 129.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.524 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -98.26 138.57 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.587 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.563 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 8.8 m-85 -105.79 151.23 24.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.69 114.18 5.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 111.275 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 75.0 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 971' ' ' ASN . 6.2 t -64.52 146.71 54.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.718 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.3 m -44.26 130.32 6.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.428 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.14 -49.81 0.89 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -102.02 139.67 37.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.683 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.768 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.8 ptt85 -91.45 140.28 29.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.344 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' 1000 ' ' SER . 9.9 tt -71.79 130.44 41.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.529 HD12 ' CB ' ' A' 1021 ' ' GLN . 1.9 mp -100.34 133.64 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.73 -155.41 25.66 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.454 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.645 ' O ' ' HG3' ' A' 1018 ' ' PRO . 14.6 m170 -82.98 125.29 31.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.522 0.201 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.409 ' HA ' HD12 ' A' ' 996' ' ' LEU . 43.8 t -73.6 12.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.1 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.0 p -156.82 150.74 24.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -152.03 135.87 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 984' ' ' SER . 38.4 tt0 -95.15 128.92 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 982' ' ' VAL . 44.8 t -71.28 122.87 21.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.64 -151.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.689 ' HG ' ' H ' ' A' 1008 ' ' GLY . 19.4 tp -151.11 131.38 13.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.395 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.685 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 37.7 t -93.01 31.69 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.689 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 77.22 -48.74 2.84 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.701 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.52 -44.94 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.789 0.328 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 88.7 m -146.63 148.07 31.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.427 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.594 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.4 139.35 38.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.97 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.685 ' HE2' ' HB2' ' A' 1007 ' ' SER . 7.8 p80 -158.11 154.17 27.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.425 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 75.9 m95 -64.21 145.58 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -59.57 -30.45 68.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.433 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 65.7 p -140.59 142.97 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.119 0.485 . . . . 0.0 112.089 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.613 ' HB3' ' NZ ' ' A' 1016 ' ' LYS . 5.8 ttpm? -55.1 139.35 64.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.755 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.11 128.46 22.44 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.524 2.149 . . . . 0.0 112.701 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.645 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 35.7 Cg_exo -57.36 147.02 79.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.019 2.479 . . . . 0.0 112.408 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.419 ' O ' HD11 ' A' ' 997' ' ' ILE . 29.8 mt -103.0 132.89 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.722 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.849 ' HB2' ' HB ' ' A' ' 970' ' ' VAL . 71.4 m -86.37 123.17 31.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.529 ' CB ' HD12 ' A' ' 997' ' ' ILE . 6.0 tt0 -143.81 130.59 20.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.472 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' 1022 ' ' ARG . 41.2 ttp85 -45.19 133.88 6.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 111.832 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.768 HG12 ' HB3' ' A' ' 995' ' ' ARG . 53.6 mt -74.94 129.01 84.13 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.908 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.941 0.4 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.507 ' N ' HD23 ' A' ' 949' ' ' LEU . 66.1 m80 -155.31 141.31 18.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 87.7 m -81.03 128.18 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.5 mm100 -68.12 171.6 6.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.183 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.06 132.38 3.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.772 ' HB3' HD13 ' A' ' 943' ' ' ILE . 15.7 Cg_exo -68.75 63.19 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.17 2.58 . . . . 0.0 112.589 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 50.6 t0 33.95 -135.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.547 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 38.9 m80 -152.54 119.24 5.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.963 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -85.29 136.81 33.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.158 0.504 . . . . 0.0 111.368 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.726 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 1.8 mm? -84.99 -51.65 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.2 OUTLIER -86.13 15.09 5.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.316 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.62 155.77 36.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.343 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.633 ' HE2' ' NE ' ' A' ' 933' ' ' ARG . 68.2 mttm -136.51 134.11 37.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.745 HD11 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -49.43 149.75 2.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.173 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.795 ' HG3' ' HG2' ' A' ' 931' ' ' GLU . 31.2 mmmt -143.22 -35.81 0.39 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 917' ' ' THR . 56.5 m -69.89 65.04 0.22 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 917' ' ' THR . 17.0 pt20 37.2 -148.43 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.516 HG22 ' HE2' ' A' ' 922' ' ' PHE . 15.1 t 50.87 139.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 113.027 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 77.5 p -146.18 15.84 1.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.685 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -74.49 174.96 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t -89.74 -51.47 5.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.3 145.16 27.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.516 ' HE2' HG22 ' A' ' 917' ' ' THR . 31.7 m-85 -136.25 136.72 22.98 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.414 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.401 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.4 Cg_endo -69.3 140.95 45.72 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.737 2.291 . . . . 0.0 111.867 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.662 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.0 mt -56.74 155.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.64 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 87.4 -40.79 3.08 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.401 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 46.9 m -56.37 137.66 52.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.511 -0.345 . . . . 0.0 111.119 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 78.6 p -131.35 134.82 46.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.656 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.532 ' HB3' ' CD2' ' A' ' 913' ' ' LEU . 2.7 mm? -99.08 136.63 38.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.021 0.439 . . . . 0.0 111.786 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 4.4 tppp? -88.18 135.46 33.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.409 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.451 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 13.3 m-85 -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.373 . . . . 0.0 111.227 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.795 ' HG2' ' HG3' ' A' ' 914' ' ' LYS . 5.2 mm-40 -97.38 132.74 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.3 m -59.7 137.53 58.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.726 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.2 mtp180 -87.53 156.89 53.27 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 10.3 Cg_endo -51.24 139.47 44.04 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.539 2.159 . . . . 0.0 111.317 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.674 ' HB3' HG13 ' A' ' 982' ' ' VAL . 90.3 mt-10 83.34 27.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.888 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.578 ' C ' ' HE2' ' A' ' 961' ' ' LYS . 95.7 m-85 -148.23 129.28 14.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 1.4 p90 -101.18 142.0 33.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.066 0.46 . . . . 0.0 111.334 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.56 -130.34 2.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.393 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 939' ' ' ARG . 4.3 ptp85 -166.14 156.75 11.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.507 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 37.5 Cg_exo -59.99 108.62 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.447 2.098 . . . . 0.0 112.434 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.627 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 36.2 p90 -95.51 -168.72 1.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.525 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.04 127.48 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.772 HD13 ' HB3' ' A' ' 905' ' ' PRO . 17.4 pt -97.63 120.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.107 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 946' ' ' LEU . 54.9 m -91.19 134.83 34.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.662 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -73.72 118.23 16.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 109.995 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.844 HD22 ' H ' ' A' ' 952' ' ' SER . 2.1 mm? -87.13 171.61 10.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.255 1.026 . . . . 0.0 113.242 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.72 -43.2 68.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.367 -1.742 . . . . 0.0 111.682 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -83.85 29.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 29.7 mt 48.12 63.13 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.697 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.644 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 9.4 m -135.81 -164.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.408 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 98.1 m95 -144.12 46.69 1.43 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.24 0.543 . . . . 0.0 111.487 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.844 ' H ' HD22 ' A' ' 946' ' ' LEU . 79.4 p 40.08 26.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.289 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 955' ' ' LYS . 45.5 t 35.34 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.002 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.46 137.64 31.91 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.356 2.037 . . . . 0.0 112.751 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.55 ' HD3' ' N ' ' A' ' 955' ' ' LYS . 0.1 OUTLIER -159.09 134.87 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.272 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.563 ' O ' HG11 ' A' ' 957' ' ' VAL . 8.9 t70 59.28 82.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.436 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 941' ' ' PHE . 3.7 m -148.64 -107.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.863 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.557 ' H ' HG22 ' A' ' 957' ' ' VAL . 56.8 m -81.75 57.52 3.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 0.0 110.751 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.5 mmpt? -55.41 155.45 5.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.203 0.525 . . . . 0.0 112.142 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.583 ' CG ' ' HB3' ' A' ' 981' ' ' GLN . 19.6 tpp180 -55.11 116.45 2.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.249 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.927 ' HG3' ' H ' ' A' ' 962' ' ' SER . 15.0 tppt? -61.11 -176.12 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.929 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.927 ' H ' ' HG3' ' A' ' 961' ' ' LYS . 80.6 p -149.75 -155.96 0.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.147 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.848 ' HA ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -154.74 33.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.621 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 60.62 128.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 15.8 m -59.76 135.78 89.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.94 136.49 44.01 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 112.121 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.2 Cg_endo -75.11 47.43 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.697 2.264 . . . . 0.0 112.773 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 967' ' ' PRO . 11.2 p-10 22.77 78.9 0.2 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.67 0.606 . . . . 0.0 112.121 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.439 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 98.2 Cg_exo -43.89 142.16 3.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.719 2.28 . . . . 0.0 112.449 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.422 HG21 ' ND2' ' A' ' 971' ' ' ASN . 2.7 p -48.86 127.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.633 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.422 ' ND2' HG21 ' A' ' 970' ' ' VAL . 74.2 m-20 47.65 48.72 16.99 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.065 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -133.14 -152.5 6.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.388 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 42.4 ttp 176.19 141.87 0.07 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 987' ' ' THR . 10.5 p -136.98 127.85 40.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.972 0.415 . . . . 0.0 111.719 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.534 ' HB2' HD12 ' A' ' 977' ' ' ILE . 33.9 m-70 -87.76 114.86 24.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.66 ' HA ' HG21 ' A' ' 986' ' ' ILE . 81.7 t -65.44 -24.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.138 0.494 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 975' ' ' HIS . 14.0 mm 74.46 -49.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.15 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 977' ' ' ILE . 63.8 p -149.51 -60.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 984' ' ' SER . 11.7 p-10 -159.42 144.71 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.307 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 8.2 pt -85.99 19.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.252 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.583 ' HB3' ' CG ' ' A' ' 960' ' ' ARG . 83.7 mt-30 -80.87 156.48 26.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.788 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 935' ' ' GLU . 57.0 t -55.79 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.48 26.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.643 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.593 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 70.2 m -163.89 139.57 6.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.311 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ptt85 -100.12 131.22 46.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.132 0.491 . . . . 0.0 112.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.66 HG21 ' HA ' ' A' ' 976' ' ' VAL . 40.9 pt -100.3 126.21 53.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.583 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.597 ' O ' HG21 ' A' ' 974' ' ' VAL . 3.3 t -104.56 160.14 15.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.34 0.591 . . . . 0.0 111.583 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.475 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 3.6 m-85 -114.97 153.39 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.5 p -148.61 69.67 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.625 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 84.6 m -44.51 145.6 0.84 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 19.2 p -65.12 149.32 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 82.2 m -44.56 -37.49 3.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.928 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -57.26 -56.39 25.3 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.151 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.812 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 2.3 m80 -95.56 143.23 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.68 HH21 HG21 ' A' 1023 ' ' ILE . 14.3 ptp180 -88.83 138.72 31.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.982 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 999' ' ' HIS . 8.1 tt -71.85 138.07 47.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.312 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.9 mp -117.62 137.32 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.79 -143.39 18.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.019 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.776 ' HD1' HG23 ' A' 1015 ' ' THR . 19.4 m170 -81.47 -134.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.633 0.254 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.489 ' HA ' ' HG2' ' A' 1018 ' ' PRO . 48.3 t -170.9 -54.66 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.84 0.352 . . . . 0.0 110.522 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.9 p -91.3 142.14 28.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.61 122.33 4.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.31 139.86 31.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.529 ' SG ' HG21 ' A' ' 982' ' ' VAL . 15.2 t -69.52 122.83 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' 1006 ' ' LEU . 20.6 pt -139.48 142.29 33.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.665 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 3.4 tm? 45.73 148.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.236 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.781 ' HB2' ' HG2' ' A' ' 961' ' ' LYS . 20.4 m -156.9 -95.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.561 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.686 ' H ' ' HE3' ' A' ' 961' ' ' LYS . . . 60.8 -109.78 2.6 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -66.89 -32.13 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' 1007 ' ' SER . 17.6 m -148.94 119.91 7.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.609 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 963' ' ' CYS . . . -86.88 138.48 31.52 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.665 ' HE2' ' HB3' ' A' 1006 ' ' LEU . 0.3 OUTLIER -152.07 131.52 12.97 Favored 'General case' 0 C--N 1.337 0.057 0 C-N-CA 119.413 -0.915 . . . . 0.0 113.268 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.439 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 80.4 m95 -70.28 165.05 23.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.178 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 88.8 p -63.19 -34.79 78.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.776 HG23 ' HD1' ' A' ' 999' ' ' HIS . 70.2 p -146.27 143.91 29.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.89 144.9 73.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.033 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.19 127.13 20.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.716 2.277 . . . . 0.0 112.75 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.489 ' HG2' ' HA ' ' A' 1000 ' ' SER . 34.4 Cg_exo -61.52 150.39 85.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.466 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.454 ' O ' HD11 ' A' ' 997' ' ' ILE . 51.0 mt -98.92 136.77 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.484 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 73.5 m -99.13 79.58 2.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.674 ' HB3' HD12 ' A' ' 997' ' ' ILE . 41.9 tt0 -90.92 118.9 30.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.616 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 15.1 ptp180 -41.54 142.59 0.59 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.54 0.685 . . . . 0.0 111.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.68 HG21 HH21 ' A' ' 995' ' ' ARG . 70.7 mt -74.4 133.7 77.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' 1023 ' ' ILE . 59.6 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.885 2.39 . . . . 0.0 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.76 ' HB3' HD13 ' A' ' 924' ' ' ILE . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.729 0.299 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 921' ' ' ASP . 52.6 m80 -153.47 144.84 23.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.752 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 99.4 m -80.8 128.92 34.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.489 ' H ' ' CD ' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -68.99 157.13 37.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.648 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -43.19 131.44 3.38 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.041 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.4 -160.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 907' ' ' HIS . 4.2 t0 -173.6 151.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 906' ' ' ASP . 48.1 m80 70.11 68.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.369 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.91 43.63 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.582 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 15.7 mt -70.25 -32.29 70.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.281 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.21 10.67 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.618 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.52 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.669 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.3 120.88 33.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.563 HD21 ' O ' ' A' ' 915' ' ' THR . 1.3 tt -49.17 129.25 17.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.163 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.605 ' HB2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -86.48 -52.29 5.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.563 ' O ' HD21 ' A' ' 913' ' ' LEU . 47.6 m -64.59 138.34 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.253 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -61.94 141.56 57.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.899 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 70.5 p -151.67 149.33 28.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 93.8 m -154.04 -41.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 152.04 44.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.1 p -84.99 -44.41 13.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 901' ' ' HIS . 12.1 p-10 -85.36 132.33 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -118.68 138.89 26.39 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.407 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 926' ' ' THR . 25.4 Cg_endo -61.4 137.32 69.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.603 2.202 . . . . 0.0 112.062 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.76 HD13 ' HB3' ' A' ' 900' ' ' ALA . 20.8 mt -60.97 154.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.347 . . . . 0.0 110.846 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.581 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 83.68 -38.09 2.8 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 923' ' ' PRO . 19.9 m -56.0 131.82 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.02 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 49.7 m -111.3 130.52 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 942' ' ' SER . 94.5 mt -96.53 128.26 43.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 16.3 tppt? -85.16 137.59 32.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.031 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.493 ' CE2' ' HG ' ' A' ' 913' ' ' LEU . 20.5 m-85 -132.31 131.43 41.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 914' ' ' LYS . 45.8 mt-10 -95.18 114.0 25.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.39 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 1.5 t -58.03 144.59 39.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 4.4 ptm180 -82.7 158.88 64.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.93 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 933' ' ' ARG . 39.5 Cg_endo -66.2 68.6 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.203 2.602 . . . . 0.0 113.484 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -172.41 -2.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.091 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.503 ' HB2' ' SG ' ' A' ' 932' ' ' CYS . 44.1 m-85 -142.04 134.91 28.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.264 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 9.4 p90 -102.1 138.61 38.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.562 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.31 8.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.168 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.444 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 71.1 mtt-85 63.62 157.5 0.12 Allowed Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 38.2 Cg_endo -66.68 116.62 4.19 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.2 1.934 . . . . 0.0 111.352 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.575 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 49.5 p90 -93.56 -160.82 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.197 0.522 . . . . 0.0 111.812 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.2 p -172.84 130.05 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.13 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 943' ' ' ILE . 39.6 pt -95.85 117.57 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.876 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.634 ' O ' HD23 ' A' ' 946' ' ' LEU . 52.0 m -84.04 128.96 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.714 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.3 t -73.81 121.6 21.12 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.67 ' H ' HD21 ' A' ' 946' ' ' LEU . 2.1 mm? -85.34 167.92 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 0.0 113.318 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -51.73 -42.66 62.46 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.014 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.405 ' O ' HG12 ' A' ' 950' ' ' VAL . 74.0 m-80 -84.45 32.46 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.707 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.572 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 24.4 mt 48.25 56.29 7.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.0 m -138.43 -157.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 112.38 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.543 ' C ' ' H ' ' A' ' 953' ' ' SER . 50.5 m95 -150.1 125.75 10.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.637 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 953' ' ' SER . 79.8 p -68.54 27.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 951' ' ' TRP . 30.3 t 51.81 129.52 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 14.7 Cg_exo -69.95 69.83 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.086 2.524 . . . . 0.0 111.912 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -79.46 131.59 36.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.075 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.516 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 9.8 t70 55.1 72.66 0.46 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.512 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 18.1 m -150.9 -17.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.856 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 9.0 m -152.18 48.36 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.9 mmtp -56.55 143.81 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.479 ' HA ' ' CD2' ' A' ' 936' ' ' TYR . 38.8 ttm180 -53.23 132.33 38.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.655 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.638 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 0.0 OUTLIER -56.29 154.57 7.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.813 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.691 ' HB3' ' HG3' ' A' ' 981' ' ' GLN . 80.3 p -149.8 136.27 19.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.847 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 66.7 m -81.65 36.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.0 tptt 61.08 133.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.565 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.49 HG21 ' HD2' ' A' ' 966' ' ' PRO . 21.6 m -54.48 127.73 58.87 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.257 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.49 ' HD2' HG21 ' A' ' 965' ' ' THR . 55.1 Cg_endo -68.37 124.87 12.14 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.604 2.203 . . . . 0.0 112.736 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 129.2 16.83 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.189 1.926 . . . . 0.0 111.099 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -57.95 120.68 44.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.878 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.605 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 33.2 Cg_exo -61.28 145.83 98.01 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 112.036 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 25.7 t -49.34 124.65 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.819 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.1 m-80 75.87 -48.65 0.6 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -78.44 -151.78 5.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.5 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.508 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.7 pmm? 177.21 142.81 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.69 0.281 . . . . 0.0 110.818 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 986' ' ' ILE . 14.9 p -93.67 129.57 43.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.868 0.366 . . . . 0.0 110.676 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -91.52 121.73 33.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.81 104.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.629 HD13 HG22 ' A' ' 987' ' ' THR . 3.0 mt -74.38 -38.69 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 79.8 p -144.73 -58.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 984' ' ' SER . 2.8 p30 -159.91 140.97 12.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.143 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.474 HG13 ' NE2' ' A' ' 981' ' ' GLN . 13.2 pt -86.67 -5.4 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.293 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' A' ' 962' ' ' SER . 14.0 mp0 -76.12 156.4 33.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.655 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.539 HG21 ' SG ' ' A' 1004 ' ' CYS . 53.5 t -50.12 97.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.382 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.73 19.26 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.221 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' 1003 ' ' GLU . 26.2 t -165.12 -165.39 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.044 0.422 . . . . 0.0 111.34 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.514 ' HG3' ' C ' ' A' 1002 ' ' ALA . 55.6 ttp180 -147.79 136.74 22.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.544 HD13 HG22 ' A' ' 974' ' ' VAL . 20.3 pt -97.83 138.08 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.629 HG22 HD13 ' A' ' 977' ' ' ILE . 7.6 p -106.23 129.92 54.19 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.691 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 13.3 m-85 -96.48 152.73 18.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.216 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 59.1 m -148.2 129.65 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.68 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.441 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.533 HG21 ' SG ' ' A' 1020 ' ' CYS . 8.8 t -171.01 149.42 2.93 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 991' ' ' THR . 10.7 m 8.81 -118.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.12 0.887 . . . . 0.0 113.218 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1022 ' ' ARG . . . -77.03 48.93 2.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.612 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 6.7 m80 -137.21 134.76 36.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.339 . . . . 0.0 110.19 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.561 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -94.5 135.7 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.665 HD22 ' HB2' ' A' 1018 ' ' PRO . 7.0 tt -68.58 132.26 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.809 HD12 ' HB2' ' A' 1021 ' ' GLN . 3.2 mp -100.11 138.49 24.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 85.61 -131.3 10.38 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.569 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.537 ' O ' HD23 ' A' ' 996' ' ' LEU . 85.9 m-70 -79.07 -131.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.227 0.211 . . . . 0.0 111.484 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.4 p -175.16 -28.43 0.01 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.932 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.7 p -150.91 150.08 30.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.704 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.567 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -152.02 133.71 14.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 984' ' ' SER . 42.3 tt0 -96.23 133.42 40.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.539 ' SG ' HG21 ' A' ' 982' ' ' VAL . 42.7 t -71.18 121.04 17.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.84 -157.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.402 . . . . 0.0 111.767 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 934' ' ' PRO . 58.7 tp -150.85 134.39 16.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.25 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.623 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.2 t -88.8 -48.13 7.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.369 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.98 -51.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.154 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -91.27 -38.36 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.42 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 83.8 m -145.47 145.49 31.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.47 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.11 147.82 32.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.623 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.9 p80 -158.7 148.59 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.435 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 86.2 m95 -64.41 145.15 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.767 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -53.0 -33.07 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.641 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.567 ' OG1' ' HB1' ' A' 1002 ' ' ALA . 69.3 p -145.13 141.65 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.687 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.1 137.55 73.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.482 ' HB3' ' CE2' ' A' ' 988' ' ' TYR . 51.1 Cg_exo -53.68 126.7 22.72 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.533 2.155 . . . . 0.0 112.319 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.665 ' HB2' HD22 ' A' ' 996' ' ' LEU . 39.9 Cg_endo -67.11 -159.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.41 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.605 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 1.2 mt -140.67 -161.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.533 ' SG ' HG21 ' A' ' 991' ' ' THR . 44.5 t -158.69 131.24 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.809 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.0 OUTLIER -153.44 135.24 14.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.66 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 51.1 ttp180 -48.97 134.89 16.48 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 111.532 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.7 mt -74.89 128.82 84.53 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.959 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 42.6 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.709 2.273 . . . . 0.0 112.358 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 949' ' ' LEU . 48.7 m80 -149.66 127.5 11.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.382 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.687 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 7.8 p -82.26 114.5 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 921' ' ' ASP . 2.6 pt20 -66.86 178.39 1.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.13 131.52 12.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.005 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.561 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.4 Cg_exo -62.1 -164.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.547 2.165 . . . . 0.0 112.325 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.12 -14.47 61.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.391 0.615 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 74.2 t60 62.26 114.42 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.57 ' HZ ' ' HG2' ' A' ' 954' ' ' PRO . 49.4 m-85 -90.0 133.56 34.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.254 0.55 . . . . 0.0 111.268 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.534 ' N ' HD13 ' A' ' 909' ' ' LEU . 4.1 mp -70.43 -45.74 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.125 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.698 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 2.3 p90 -82.8 31.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.071 0.462 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 930' ' ' TYR . . . -156.09 121.39 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.879 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -96.54 129.76 43.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -44.85 144.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.728 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 22.8 tptm -135.09 -38.93 0.77 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.459 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.476 ' HB ' HD13 ' A' ' 928' ' ' LEU . 95.9 m -64.56 136.41 57.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.702 0.287 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.634 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -50.94 125.11 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.803 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.594 HG21 HD13 ' A' ' 913' ' ' LEU . 7.0 t -159.43 148.39 18.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 20.7 m -156.85 47.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.387 0.613 . . . . 0.0 110.044 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -169.55 164.03 10.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.717 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 37.0 t -84.56 -39.47 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 903' ' ' GLN . 37.6 p-10 -85.01 118.81 24.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 17.0 m-85 -101.17 139.36 20.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.784 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 38.3 Cg_endo -66.42 139.17 53.16 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.732 2.288 . . . . 0.0 112.104 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.665 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 61.4 mt -61.3 151.91 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.559 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 83.31 -31.25 3.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.886 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 17.1 m -56.01 131.05 46.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.023 0.44 . . . . 0.0 111.982 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.888 ' HB2' ' HB2' ' A' ' 942' ' ' SER . 74.8 p -90.96 116.66 28.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.672 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 942' ' ' SER . 11.7 tp -96.28 97.87 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 38.3 ttpt -82.52 131.03 35.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.31 0.576 . . . . 0.0 112.157 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.73 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 17.9 m-85 -113.78 139.17 49.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.473 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.728 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 5.0 mm-40 -91.41 118.42 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.73 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 75.3 m -57.67 143.2 42.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.6 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.698 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 94.5 mtt180 -84.89 160.78 54.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.092 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 5.9 Cg_endo -47.69 139.18 18.91 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.56 2.173 . . . . 0.0 112.096 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.562 ' HG2' HG13 ' A' ' 982' ' ' VAL . 90.0 mt-10 83.76 26.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.736 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.586 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 62.2 m-85 -145.75 148.19 32.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.302 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -137.56 -155.83 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.045 0.45 . . . . 0.0 111.839 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 78.69 33.16 38.84 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.6 ptp85 47.22 164.95 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.54 0.736 . . . . 0.0 112.962 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.694 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 70.9 Cg_endo -73.96 138.66 26.12 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.925 2.417 . . . . 0.0 112.808 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 43.6 p90 -95.4 120.82 36.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.371 0.605 . . . . 0.0 111.438 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.888 ' HB2' ' HB2' ' A' ' 927' ' ' SER . 78.2 p -75.3 -37.33 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.762 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 943' ' ' ILE . 44.7 pt 49.23 104.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.393 0.616 . . . . 0.0 111.441 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.621 ' O ' HD23 ' A' ' 946' ' ' LEU . 51.6 m -78.62 124.93 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 0.5 OUTLIER -73.74 130.77 40.67 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.085 0.469 . . . . 0.0 110.057 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.676 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 1.6 mm? -90.83 166.96 12.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.333 1.063 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 924' ' ' ILE . 9.4 t70 -50.23 -42.28 51.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.322 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.527 ' ND2' HG12 ' A' ' 950' ' ' VAL . 16.4 p-10 -83.36 43.97 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 902' ' ' CYS . 6.8 mp 44.68 53.52 7.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.089 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.676 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 26.3 m -133.91 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 111.115 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 84.9 m95 -150.95 125.74 9.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.0 t -41.58 152.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.7 t -77.19 118.54 72.64 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.57 ' HG2' ' HZ ' ' A' ' 908' ' ' PHE . 5.9 Cg_exo -79.51 58.24 6.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.468 2.779 . . . . 0.0 112.931 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -80.25 128.6 33.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.761 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 1.5 m-20 55.61 38.41 30.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.876 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 16.7 m -89.31 -35.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.908 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 48.4 t -152.92 60.77 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.761 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.5 mmtt -56.52 148.29 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.243 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 17.4 ttm105 -55.59 137.35 49.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 111.575 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.81 ' HD3' ' N ' ' A' ' 962' ' ' SER . 6.4 tmtt? -56.29 144.25 30.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.618 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.81 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 47.5 t -138.66 137.21 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.492 . . . . 0.0 111.099 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.21 148.45 32.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -65.49 139.01 58.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 111.301 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 60.3 m -58.32 135.95 85.12 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.194 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 974' ' ' VAL . 51.3 Cg_exo -53.31 146.68 39.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.422 2.081 . . . . 0.0 111.938 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 968' ' ' ASP . 10.7 Cg_exo -72.22 46.31 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 0.0 112.687 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 967' ' ' PRO . 8.4 t70 22.03 97.68 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.825 0.703 . . . . 0.0 112.476 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 968' ' ' ASP . 21.9 Cg_endo -60.43 145.25 99.05 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.491 2.128 . . . . 0.0 111.641 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 24.1 t -47.26 122.49 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 73.0 m-80 75.48 -43.11 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.86 151.18 45.54 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.101 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 68.4 mtm -146.76 132.23 18.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.317 . . . . 0.0 110.586 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.589 HG23 ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -98.66 129.93 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.927 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 122.05 38.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.654 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 980' ' ' ILE . 98.0 t -70.62 136.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.302 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.416 ' O ' ' OG1' ' A' ' 978' ' ' THR . 37.1 mm -82.92 64.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.933 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 977' ' ' ILE . 6.6 p 76.4 -43.9 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.096 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -157.5 135.43 10.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.699 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 976' ' ' VAL . 20.3 pt -88.96 26.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 85.0 mt-30 -76.61 146.34 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.562 HG13 ' HG2' ' A' ' 935' ' ' GLU . 69.9 t -50.12 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.144 0.497 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 166.99 -62.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 84.6 p -81.71 -150.07 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.985 0.422 . . . . 0.0 110.225 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.549 ' O ' HG21 ' A' ' 986' ' ' ILE . 5.0 ptp85 -151.38 -165.87 2.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.875 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.589 ' HB ' HG23 ' A' ' 974' ' ' VAL . 26.4 pt -147.7 131.6 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.25 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.474 HG21 ' OG ' ' A' 1001 ' ' SER . 1.3 p -97.8 134.35 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 111.555 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.498 ' CD2' ' HB ' ' A' ' 974' ' ' VAL . 3.7 m-85 -103.03 143.94 31.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.262 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -154.37 127.01 8.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.454 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 15.6 t -63.6 162.35 13.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 992' ' ' THR . 4.2 t -64.83 -53.72 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 991' ' ' THR . 12.2 t 173.84 147.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' 1023 ' ' ILE . . . 84.79 -40.9 3.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.926 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.529 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.1 m80 -100.51 143.51 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.067 0.433 . . . . 0.0 111.194 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -91.89 148.82 21.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.95 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.534 HD13 ' HG3' ' A' 1018 ' ' PRO . 10.2 tt -71.82 128.81 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.433 HD12 ' CB ' ' A' 1021 ' ' GLN . 1.8 mp -113.61 122.43 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 131.32 -57.83 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.908 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.555 ' HD1' ' H ' ' A' 1001 ' ' SER . 40.3 t-80 -162.2 -121.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.503 ' N ' ' HD1' ' A' ' 999' ' ' HIS . 78.8 p 177.31 -22.82 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.537 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.555 ' H ' ' HD1' ' A' ' 999' ' ' HIS . 48.9 m -155.22 159.18 39.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.772 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -151.96 130.14 11.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -94.81 135.11 36.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.204 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 26.2 t -72.67 121.53 19.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.9 pt -134.55 141.93 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 935' ' ' GLU . 49.4 tp -84.52 130.44 34.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.032 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.572 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 42.3 t -96.09 50.38 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 82.19 -37.05 2.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.483 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -147.93 -50.67 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 62.4 m -94.16 125.14 38.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.54 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . . . -82.61 136.19 34.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.561 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.9 p80 -157.73 148.91 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.527 ' CH2' HG22 ' A' ' 986' ' ' ILE . 22.0 m95 -68.59 145.45 53.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.528 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 64.2 m -55.35 -42.96 74.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.268 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 80.9 p -100.15 -148.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.176 0.513 . . . . 0.0 112.114 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -148.66 153.39 39.47 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.563 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.78 130.31 33.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.754 2.303 . . . . 0.0 112.713 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.534 ' HG3' HD13 ' A' ' 996' ' ' LEU . 79.1 Cg_endo -76.9 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.767 2.311 . . . . 0.0 112.696 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.09 142.0 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.379 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 32.9 m -81.49 129.77 34.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.529 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 2.3 tp-100 -143.49 127.14 17.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' 1022 ' ' ARG . 30.7 ptt85 -49.12 142.19 7.23 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.487 0.661 . . . . 0.0 111.38 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 993' ' ' GLY . 23.3 mt -74.75 131.51 79.36 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.182 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.741 2.294 . . . . 0.0 112.407 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.936 0.398 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.588 ' N ' HD23 ' A' ' 949' ' ' LEU . 21.2 m80 68.88 129.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.856 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.8 p -82.21 124.19 29.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.629 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.417 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.0 mm100 -69.65 166.75 18.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.142 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.44 127.79 10.15 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.122 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 928' ' ' LEU . 53.9 Cg_endo -69.47 133.13 25.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.389 2.06 . . . . 0.0 112.018 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.19 153.2 35.26 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.216 0.532 . . . . 0.0 111.161 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -78.29 139.29 38.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.92 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -89.48 -140.32 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.955 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.441 ' HA ' HD21 ' A' ' 909' ' ' LEU . 63.1 mt -154.03 -38.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.438 ' HD1' ' HB2' ' A' ' 911' ' ' ALA . 0.7 OUTLIER -82.23 -6.3 59.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.438 ' HB2' ' HD1' ' A' ' 910' ' ' PHE . . . -157.85 128.81 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.324 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -98.81 135.06 40.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.839 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.435 HD11 ' CE1' ' A' ' 930' ' ' TYR . 36.8 tp -48.86 125.35 10.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.372 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -94.52 -43.34 8.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.501 HG21 ' NE2' ' A' ' 916' ' ' GLN . 38.1 m -64.84 135.44 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.806 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 915' ' ' THR . 3.2 pm0 -64.08 144.55 57.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.046 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.67 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 46.5 p -150.53 -86.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.419 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 918' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 917' ' ' THR . 91.3 m 73.26 -38.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.4 136.49 51.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.365 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.5 p -89.67 34.51 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.389 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.53 135.85 11.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.885 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.67 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 72.8 m-85 -143.4 138.36 15.43 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.46 140.48 12.01 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.913 2.409 . . . . 0.0 111.414 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 945' ' ' CYS . 29.8 mt -51.59 141.18 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 110.583 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 105.8 -29.09 11.87 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.491 HG22 ' HD2' ' A' ' 922' ' ' PHE . 30.4 m -55.45 140.08 41.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.0 m -121.19 140.39 52.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.498 HD12 HG23 ' A' ' 917' ' ' THR . 90.3 mt -132.36 118.94 20.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 39.4 ttmt -89.18 128.43 35.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.409 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.454 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 2.5 m-85 -110.99 129.18 55.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -97.58 129.41 44.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 911' ' ' ALA . 61.5 m -56.75 160.01 3.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.542 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 67.6 mtt-85 -81.47 158.33 68.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.485 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 936' ' ' TYR . 68.9 Cg_exo -39.17 -55.64 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.922 2.415 . . . . 0.0 113.26 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 960' ' ' ARG . 14.4 pt-20 -75.23 36.51 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 935' ' ' GLU . 56.4 m-85 -142.7 150.87 40.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.727 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 35.9 p90 -145.43 135.46 23.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.326 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 957' ' ' VAL . . . 153.16 28.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.17 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 80.6 mtp180 61.05 148.0 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.451 0.643 . . . . 0.0 112.239 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 939' ' ' ARG . 4.4 Cg_exo -75.18 123.04 7.49 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.263 2.642 . . . . 0.0 111.989 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.52 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 46.3 p90 -90.37 -161.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.615 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 135.93 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.425 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 4.6 pt -92.61 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.895 HG23 HD22 ' A' ' 946' ' ' LEU . 1.1 m -164.0 132.12 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 59.5 m -72.12 110.88 6.89 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.895 HD22 HG23 ' A' ' 944' ' ' THR . 97.5 mt -83.41 -52.85 6.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.6 t70 174.32 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 110.905 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.43 ' O ' HG11 ' A' ' 950' ' ' VAL . 74.5 m-80 -83.13 31.78 0.44 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 900' ' ' ALA . 78.3 mt 50.75 42.38 27.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 948' ' ' ASN . 19.9 m -137.44 150.91 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 121.632 0.73 . . . . 0.0 112.343 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 68.6 m95 -91.49 124.71 35.87 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.323 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.2 t -43.37 142.07 1.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t -79.86 113.08 34.91 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.702 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.07 67.12 6.05 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.49 2.793 . . . . 0.0 111.766 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -76.42 131.68 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.296 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.504 ' O ' HG11 ' A' ' 957' ' ' VAL . 8.3 t70 57.87 96.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.638 HG21 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -152.85 -70.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.638 ' H ' HG21 ' A' ' 957' ' ' VAL . 80.9 m -88.44 140.62 29.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -143.12 127.21 17.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.188 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.554 ' NE ' ' HB3' ' A' ' 981' ' ' GLN . 53.8 ttp180 -53.24 137.3 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.165 0.507 . . . . 0.0 112.042 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.727 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 32.1 mmmt -56.34 170.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.127 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.616 ' HB3' HE21 ' A' ' 981' ' ' GLN . 69.5 p -150.24 134.69 17.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.075 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.0 m -81.58 144.26 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.085 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -65.89 134.84 53.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.45 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.7 m -54.48 117.31 12.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.31 129.98 15.67 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.402 2.068 . . . . 0.0 111.835 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.04 125.15 18.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.098 1.866 . . . . 0.0 111.507 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.25 126.55 82.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.81 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.01 142.68 82.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.549 2.166 . . . . 0.0 112.076 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.3 p -46.97 129.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.549 ' ND2' HG23 ' A' ' 970' ' ' VAL . 77.3 m-20 63.74 47.2 3.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.796 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -166.96 -155.38 8.99 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.447 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 23.7 ptp 175.23 140.33 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.63 0.252 . . . . 0.0 111.013 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.693 HG22 HD13 ' A' ' 986' ' ' ILE . 8.4 p -93.84 135.41 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.769 0.318 . . . . 0.0 111.029 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -94.29 108.96 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.179 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.777 ' HA ' HG23 ' A' ' 986' ' ' ILE . 57.3 t -65.41 -22.83 31.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 985' ' ' ARG . 7.2 mm 73.88 -52.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.748 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 73.3 p -150.25 -56.68 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.46 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 31.0 m-20 -157.13 157.69 34.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.595 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 14.6 pt -95.51 32.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.664 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.616 HE21 ' HB3' ' A' ' 962' ' ' SER . 5.4 mp0 -79.22 151.15 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 961' ' ' LYS . 73.7 t -53.93 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.079 0.466 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 160.56 -46.52 0.4 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.7 m -78.72 135.91 37.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 55.6 ttp180 -98.24 132.32 43.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 976' ' ' VAL . 28.6 pt -93.97 130.09 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.316 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.481 HG21 ' OG ' ' A' 1001 ' ' SER . 7.8 p -102.52 130.99 49.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.452 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.7 m-85 -95.15 145.35 25.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.195 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 88.9 p -148.64 121.44 8.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.744 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.99 149.27 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.7 t -64.32 146.02 55.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.491 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 88.5 m -46.42 125.14 6.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.257 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.433 ' O ' HG13 ' A' 1023 ' ' ILE . . . 127.72 -46.81 1.06 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.464 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.9 m80 -100.19 140.24 34.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.648 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.5 ptm180 -92.36 144.13 25.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.371 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 999' ' ' HIS . 6.8 tt -72.81 135.39 45.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.0 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -115.07 139.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 90.47 -125.71 8.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.262 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.539 ' CD2' ' HB ' ' A' 1015 ' ' THR . 85.0 m-70 -78.33 -134.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.463 0.173 . . . . 0.0 111.314 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.5 p -177.9 -27.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.481 ' OG ' HG21 ' A' ' 987' ' ' THR . 50.0 m -151.63 153.0 33.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.561 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.58 128.9 11.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 20.5 pt-20 -95.66 137.85 34.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.805 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.26 95.89 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.41 HG22 HD11 ' A' 1005 ' ' ILE . 32.1 pt -103.56 -157.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.869 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' 1010 ' ' THR . 57.3 tp -153.68 137.73 16.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.474 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.794 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.8 t -90.03 -40.09 12.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.777 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -169.92 -34.08 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.45 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.461 ' C ' HD13 ' A' 1006 ' ' LEU . 14.4 p-10 -152.95 -40.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.498 ' O ' HD11 ' A' 1006 ' ' LEU . 70.5 m -91.2 130.08 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.608 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.98 141.02 37.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.106 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.794 ' HE2' ' HB2' ' A' 1007 ' ' SER . 10.0 p80 -157.01 145.95 20.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.33 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.4 m95 -68.27 141.89 55.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -57.74 -32.32 67.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.38 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.539 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 71.5 p -142.88 139.07 30.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.958 0.409 . . . . 0.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' 1017 ' ' PRO . 4.7 tmmm? -64.82 138.37 97.45 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.554 ' N ' ' HD2' ' A' 1016 ' ' LYS . 97.8 Cg_exo -44.75 134.74 10.15 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.964 2.443 . . . . 0.0 113.207 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 40.3 Cg_endo -66.54 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.861 2.374 . . . . 0.0 112.844 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 55.9 mt -141.09 144.85 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.837 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 74.2 m -103.89 123.97 48.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.563 ' HB2' HD12 ' A' ' 997' ' ' ILE . 0.6 OUTLIER -142.84 127.48 18.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.669 0.271 . . . . 0.0 110.754 -178.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 0.0 OUTLIER -49.66 136.95 16.46 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.447 0.642 . . . . 0.0 111.168 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.648 HG12 ' HB3' ' A' ' 995' ' ' ARG . 16.0 mt -75.96 132.46 74.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.188 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.469 ' N ' HD23 ' A' ' 949' ' ' LEU . 74.0 m80 -156.04 141.08 17.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.276 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 92.1 m -81.05 128.6 33.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -76.14 172.14 13.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.397 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.1 126.06 7.15 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.984 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.432 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 50.5 Cg_exo -56.75 138.08 83.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.623 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.22 157.21 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -78.11 123.74 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 911' ' ' ALA . 2.8 m-85 -85.22 24.1 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.25 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 911' ' ' ALA . 14.1 mt 61.33 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.17 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.6 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -82.49 35.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.392 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.698 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.48 143.12 20.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.228 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.28 144.61 32.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.03 152.49 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.394 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.848 ' HA ' ' HE3' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -147.9 48.1 1.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.036 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.485 ' O ' HG21 ' A' ' 917' ' ' THR . 16.2 m -170.72 137.32 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -52.91 132.09 36.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.808 0.337 . . . . 0.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.819 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 82.7 p -152.88 57.9 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 85.0 m -51.5 -44.74 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.6 51.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 49.4 m -86.78 -41.57 14.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.87 145.98 27.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.382 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.819 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 37.9 m-85 -134.95 138.51 29.69 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 0.0 112.037 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.476 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 58.0 Cg_endo -70.59 141.1 41.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.367 . . . . 0.0 111.67 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.74 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.7 mt -56.53 143.05 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.994 0.425 . . . . 0.0 111.312 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 99.12 -28.2 16.44 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.492 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 19.5 m -55.88 132.76 50.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 143.19 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.835 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.519 HD22 ' HE1' ' A' ' 930' ' ' TYR . 8.6 tp -135.18 125.19 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.452 ' HB2' ' HG1' ' A' ' 915' ' ' THR . 63.6 mttp -85.29 134.22 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.519 ' HE1' HD22 ' A' ' 928' ' ' LEU . 8.5 m-85 -132.13 122.79 25.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.392 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -95.62 130.46 42.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.346 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 36.0 m -56.79 -173.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.401 . . . . 0.0 111.363 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.6 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 93.7 mtt180 -82.46 152.72 67.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.758 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 936' ' ' TYR . 91.9 Cg_exo -44.51 -40.01 13.28 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.78 2.32 . . . . 0.0 112.547 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 982' ' ' VAL . 47.9 mt-10 -73.04 21.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 111.082 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.3 m-85 -142.75 137.22 29.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.486 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.458 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 3.7 p90 -102.12 36.56 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.215 0.531 . . . . 0.0 110.962 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . -83.87 139.74 18.81 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.79 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.637 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 37.1 ptt85 -72.89 163.52 67.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -63.63 112.69 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.352 2.035 . . . . 0.0 112.017 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -91.04 114.85 27.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.46 0.648 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.2 p -79.58 122.09 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.955 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 943' ' ' ILE . 9.4 pt -97.46 -174.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.845 HG23 HD22 ' A' ' 946' ' ' LEU . 0.7 OUTLIER -166.82 134.42 2.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 52.7 t -66.53 116.16 7.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.845 HD22 HG23 ' A' ' 944' ' ' THR . 77.4 mt -80.96 -55.56 4.71 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 49.8 t0 173.21 -48.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.53 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -83.87 33.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.278 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.515 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 40.4 mt 60.92 56.77 2.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.637 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 2.1 m -139.4 -163.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.219 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 944' ' ' THR . 74.7 m95 -145.41 125.03 13.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.766 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.647 ' HA ' HD13 ' A' ' 946' ' ' LEU . 47.5 t -38.59 135.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 79.9 p -76.97 111.38 16.04 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 952' ' ' SER . 18.6 Cg_exo -65.85 132.64 31.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.601 ' HG2' ' H ' ' A' ' 956' ' ' ASP . 79.2 tttt -78.23 -134.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.601 ' H ' ' HG2' ' A' ' 955' ' ' LYS . 38.9 p-10 -78.98 127.0 31.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.847 0.356 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 956' ' ' ASP . 21.0 m -150.36 -48.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.456 ' N ' HG22 ' A' ' 957' ' ' VAL . 71.3 m -84.18 138.17 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -143.88 131.47 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 20.5 mmt180 -58.96 113.95 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.052 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.856 ' HE3' ' HB1' ' A' 1011 ' ' ALA . 38.3 ttpt -58.33 166.06 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.449 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 90.1 p -144.46 141.61 29.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.965 0.412 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 49.2 m -81.54 36.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.979 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 60.18 128.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 14.6 m -61.17 132.81 92.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.484 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 11.6 Cg_endo -55.37 135.68 70.2 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 112.384 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 968' ' ' ASP . 72.2 Cg_endo -76.23 52.31 3.47 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 967' ' ' PRO . 8.1 t70 29.59 102.03 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.24 0.616 . . . . 0.0 112.423 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.485 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 52.1 Cg_exo -52.62 143.97 44.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.743 2.295 . . . . 0.0 112.322 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' 1020 ' ' CYS . 6.4 p -53.04 133.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.484 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 52.65 47.3 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.415 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.51 -158.77 16.21 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.631 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 176.29 140.42 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.151 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 987' ' ' THR . 7.2 p -99.82 128.77 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.463 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.5 OUTLIER -89.76 124.31 34.52 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.4 124.55 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 977' ' ' ILE . 3.5 mm -75.49 -41.65 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.9 p -144.71 -52.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.317 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -153.33 -156.57 0.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 15.8 pt -151.08 22.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 960' ' ' ARG . 4.8 mm100 -80.88 174.86 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.454 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 88.0 t -58.83 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.91 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 146.99 -34.44 1.32 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.4 m -75.06 140.4 43.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.631 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' 1002 ' ' ALA . 38.8 ttm180 -104.16 150.63 24.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 974' ' ' VAL . 40.8 pt -131.21 135.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.638 HG21 ' HB3' ' A' 1001 ' ' SER . 11.6 p -103.61 132.7 49.63 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.559 ' HH ' ' HB3' ' A' 1017 ' ' PRO . 5.2 m-85 -98.7 145.63 26.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 989' ' ' SER . . . . . 0.463 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 46.8 t -152.32 119.13 5.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.028 0.442 . . . . 0.0 110.984 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 62.6 m -80.92 144.85 31.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.854 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.8 t -65.0 158.37 25.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.4 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.0 t -46.47 134.57 9.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.624 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 113.83 -51.01 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.979 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -101.88 141.3 34.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.509 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.6 ptp180 -93.33 146.44 23.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.354 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.744 HD22 ' HB3' ' A' 1018 ' ' PRO . 10.0 tt -69.64 129.78 40.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.775 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.1 mp -98.34 142.26 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.72 -133.57 11.89 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.945 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.497 ' CD2' ' HB ' ' A' 1015 ' ' THR . 96.0 m-70 -78.63 -121.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.44 ' HA ' HD23 ' A' ' 996' ' ' LEU . 20.3 m -164.67 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.574 0.226 . . . . 0.0 111.177 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.638 ' HB3' HG21 ' A' ' 987' ' ' THR . 80.0 p -155.17 117.87 4.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.973 0.415 . . . . 0.0 111.274 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -91.09 179.45 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.478 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -145.41 132.13 19.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.339 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.3 t -71.19 122.35 20.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.38 148.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.179 0.514 . . . . 0.0 111.911 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.465 ' HG ' ' NZ ' ' A' ' 961' ' ' LYS . 1.2 tt -88.47 129.86 35.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.496 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.639 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -89.98 -44.92 9.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -173.5 -32.27 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.993 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.63 -49.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 26.2 m -94.46 133.01 38.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.802 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.856 ' HB1' ' HE3' ' A' ' 961' ' ' LYS . . . -82.01 139.29 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.243 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.639 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -157.67 144.61 18.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 62.3 m95 -68.56 138.35 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.599 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.5 p -52.9 -28.42 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.674 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.497 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 53.2 p -141.54 142.43 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.639 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -56.63 153.97 19.32 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.751 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.559 ' HB3' ' HH ' ' A' ' 988' ' ' TYR . 44.8 Cg_endo -69.19 122.15 8.97 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.302 2.001 . . . . 0.0 112.597 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.744 ' HB3' HD22 ' A' ' 996' ' ' LEU . 51.3 Cg_exo -54.42 148.8 40.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.779 2.319 . . . . 0.0 112.225 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.664 HG23 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.86 -159.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.664 ' H ' HG23 ' A' 1019 ' ' ILE . 84.5 m -153.31 134.69 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.011 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.845 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.0 OUTLIER -151.85 136.85 17.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.26 -178.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -48.02 133.59 14.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.374 0.607 . . . . 0.0 111.018 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.53 HG21 ' HD2' ' A' 1024 ' ' PRO . 60.0 mt -74.79 129.48 83.34 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.976 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' 1023 ' ' ILE . 76.4 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 112.501 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.578 ' N ' HD13 ' A' ' 949' ' ' LEU . 36.3 m80 -151.6 138.51 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.525 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.597 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 83.3 m -81.1 124.94 29.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.706 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -69.38 173.14 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.0 134.86 6.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.226 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.07 149.4 35.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.525 2.15 . . . . 0.0 111.942 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 29.2 t0 -63.23 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.751 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.506 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 26.3 m80 -77.77 134.36 38.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.03 47.07 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.217 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.63 ' C ' HD11 ' A' ' 909' ' ' LEU . 4.2 pp -53.26 -34.44 57.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.4 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.558 ' N ' HD11 ' A' ' 909' ' ' LEU . 0.2 OUTLIER -87.11 26.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.485 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -155.09 129.98 9.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.196 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -101.62 126.2 48.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.382 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.49 119.89 6.34 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.536 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.631 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 74.4 mmtt -95.4 -39.04 10.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.651 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 18.5 m -64.55 -119.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.142 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.06 134.05 0.92 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.4 t -160.35 159.44 31.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.566 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.2 m -155.95 -31.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.403 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.3 158.74 35.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.03 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.3 p -84.67 -50.68 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.35 126.19 33.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.328 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 20.0 m-85 -102.0 134.13 20.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.439 . . . . 0.0 111.906 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.48 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 71.5 Cg_endo -73.36 137.36 25.58 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.833 2.355 . . . . 0.0 112.003 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.586 HG12 ' SG ' ' A' ' 945' ' ' CYS . 25.9 mt -59.99 151.58 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.531 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 93.94 -36.2 3.85 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.9 m -56.12 133.53 52.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.271 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 42.6 t -114.08 121.72 44.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.435 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.562 ' HB3' ' HE1' ' A' ' 930' ' ' TYR . 92.9 mt -103.38 124.82 49.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 17.1 tppt? -87.39 132.52 33.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.562 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 15.0 m-85 -135.27 123.03 22.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.544 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.95 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 90.4 mt-10 -103.29 129.59 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.691 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 74.2 m -54.09 168.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.548 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 77.6 mtp180 -79.03 148.46 71.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.53 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 936' ' ' TYR . 83.3 Cg_exo -45.45 -42.64 17.98 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.831 2.354 . . . . 0.0 112.682 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.33 20.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.227 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.6 m-85 -144.6 135.12 24.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.746 0.308 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.552 ' CD2' ' HD2' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -102.67 37.35 1.95 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 110.922 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.998 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . -77.03 0.12 67.88 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.764 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 939' ' ' ARG . 62.0 mtt85 64.58 144.12 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.429 . . . . 0.0 111.353 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.95 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 19.6 Cg_exo -66.36 110.43 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.796 2.331 . . . . 0.0 112.505 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.407 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 52.3 p90 -95.54 -164.3 1.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.496 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.502 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 80.5 p -172.83 135.98 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 10.8 pt -97.01 166.26 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.838 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 1.029 HG23 HD22 ' A' ' 946' ' ' LEU . 2.9 m -161.41 120.48 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.814 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 34.8 t -68.6 112.87 5.65 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 1.029 HD22 HG23 ' A' ' 944' ' ' THR . 82.2 mt -83.79 -52.5 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 50.0 t0 173.49 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.787 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.504 ' OD1' HG23 ' A' ' 950' ' ' VAL . 16.3 p30 -85.9 36.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.471 0.653 . . . . 0.0 109.84 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.597 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 2.3 mm? 54.88 63.69 2.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.384 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 19.0 m -141.64 146.19 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 111.891 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.72 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 97.7 m95 -93.8 47.88 1.25 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.051 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 89.3 p 53.03 26.85 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t 38.23 75.16 0.57 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.23 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 951' ' ' TRP . 92.5 Cg_endo -79.84 53.71 4.86 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.429 2.086 . . . . 0.0 112.376 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.36 129.07 35.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.916 0.389 . . . . 0.0 110.71 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.3 t0 60.88 106.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.86 -56.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.998 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 72.6 m -83.55 141.53 31.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.042 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -143.03 148.12 36.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.268 0.556 . . . . 0.0 112.08 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 981' ' ' GLN . 10.8 tpt180 -53.48 113.9 1.32 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.366 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.646 ' HZ3' ' H ' ' A' 1011 ' ' ALA . 27.8 tptp -56.99 158.33 5.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.371 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 77.4 p -150.81 138.36 19.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.581 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 964' ' ' LYS . 65.4 m -81.6 35.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 963' ' ' CYS . 87.4 tttt 55.45 131.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.416 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.3 m -54.11 129.05 58.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.526 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.433 ' HG3' HD11 ' A' ' 986' ' ' ILE . 72.8 Cg_endo -74.87 124.94 9.06 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.511 2.141 . . . . 0.0 112.67 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 15.5 Cg_exo -67.99 125.76 13.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.456 2.104 . . . . 0.0 111.533 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.24 128.53 91.21 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.243 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.26 -152.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.685 2.256 . . . . 0.0 111.979 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' 1020 ' ' CYS . 12.7 t -53.94 116.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.596 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 18.3 p30 39.53 32.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -67.02 177.56 19.05 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.111 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 50.6 ttm -175.45 73.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.323 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.7 p -90.35 122.05 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 111.328 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 975' ' ' HIS . 0.7 OUTLIER -95.62 131.61 41.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.166 0.507 . . . . 0.0 109.902 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.703 HG13 HG22 ' A' ' 980' ' ' ILE . 2.1 m -75.4 135.63 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.626 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.568 ' N ' HD11 ' A' ' 977' ' ' ILE . 2.5 mp -76.46 -32.14 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.475 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 977' ' ' ILE . 64.8 p -140.4 -66.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.557 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 53.0 t0 -162.16 14.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.703 HG22 HG13 ' A' ' 976' ' ' VAL . 29.3 pt 51.77 24.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.361 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.557 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 7.3 mm100 -80.93 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.64 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 14.7 t -55.51 130.31 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.333 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 96.26 -23.05 36.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.852 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' 1003 ' ' GLU . 52.3 m -74.61 -165.45 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' A' 1001 ' ' SER . 74.1 ttt180 -151.35 161.51 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.406 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.509 ' N ' ' HG2' ' A' ' 985' ' ' ARG . 20.3 pt -136.42 132.05 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.692 HG21 ' HB3' ' A' 1001 ' ' SER . 2.5 p -124.59 136.11 53.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 111.575 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -94.04 156.51 16.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.443 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 57.7 m -147.84 69.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.41 ' SG ' HD21 ' A' ' 996' ' ' LEU . 85.7 m -44.93 151.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.368 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 21.0 p -64.04 150.68 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -48.32 137.74 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.134 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' 1023 ' ' ILE . . . 106.02 -40.14 2.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.656 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 4.2 m80 -96.38 138.68 33.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.598 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.4 ptt180 -94.91 151.04 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.552 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' 1018 ' ' PRO . 0.4 OUTLIER -73.48 125.05 27.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.0 mp -103.05 138.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.707 0.289 . . . . 0.0 110.78 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 81.09 -125.13 6.72 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.428 ' O ' HD13 ' A' ' 996' ' ' LEU . 89.7 m-70 -78.57 -132.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.1 p -177.21 -30.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.606 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.692 ' HB3' HG21 ' A' ' 987' ' ' THR . 83.3 p -150.93 167.51 27.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.56 ' HB1' ' HG1' ' A' 1015 ' ' THR . . . -156.56 139.03 14.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.5 tt0 -96.25 134.94 38.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 40.5 t -71.96 125.83 28.21 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' 1011 ' ' ALA . 30.8 pt -135.24 -155.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.805 0.336 . . . . 0.0 111.537 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 36.8 tp -152.05 124.75 8.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.673 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.3 t -91.35 -48.37 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' 1010 ' ' THR . . . 168.85 124.15 0.71 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.867 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.6 m120 71.38 -28.82 0.19 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' 1008 ' ' GLY . 96.7 m -145.43 135.43 23.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.774 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.646 ' H ' ' HZ3' ' A' ' 961' ' ' LYS . . . -82.25 149.07 28.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.673 ' HE2' ' HB2' ' A' 1007 ' ' SER . 7.4 p80 -157.93 151.37 23.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.54 ' CZ2' ' HB ' ' A' ' 980' ' ' ILE . 81.2 m95 -68.46 144.05 54.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.253 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -56.8 -31.06 64.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.673 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.56 ' HG1' ' HB1' ' A' 1002 ' ' ALA . 80.8 p -144.06 138.41 28.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 111.923 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.561 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -66.45 155.74 87.61 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.182 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.16 135.31 52.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.759 2.306 . . . . 0.0 112.782 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.441 ' HB2' HD12 ' A' ' 996' ' ' LEU . 53.6 Cg_endo -68.81 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.818 2.346 . . . . 0.0 112.605 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.747 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 54.4 mt -140.16 137.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -98.75 123.37 42.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.806 ' HB3' HD12 ' A' ' 997' ' ' ILE . 36.3 tt0 -145.74 129.12 16.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.692 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 36.5 ttm180 -51.16 135.45 25.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.439 0.638 . . . . 0.0 111.475 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 995' ' ' ARG . 48.4 mt -74.92 125.78 89.0 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.422 ' HD2' HG21 ' A' 1023 ' ' ILE . 81.2 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.627 2.218 . . . . 0.0 112.475 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.535 ' HB3' HD23 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.861 0.362 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.519 ' N ' HD23 ' A' ' 949' ' ' LEU . 50.9 m80 -153.86 143.93 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 66.1 m -80.47 122.95 27.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.596 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -68.14 170.68 8.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.687 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.35 133.18 5.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.945 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.467 ' HG3' ' OH ' ' A' ' 930' ' ' TYR . 26.6 Cg_endo -61.7 -168.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.642 2.228 . . . . 0.0 112.333 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 8.3 t70 -174.96 161.04 2.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.053 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.417 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 78.0 t60 72.11 62.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.587 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.434 ' CZ ' HD12 ' A' ' 943' ' ' ILE . 45.1 m-85 -146.01 120.15 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.084 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 0.0 OUTLIER -132.58 -45.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.012 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.97 13.87 3.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.126 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.81 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.534 ' HG3' ' HZ2' ' A' ' 914' ' ' LYS . 20.8 pttp -107.92 123.85 49.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.684 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -51.13 146.81 6.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.086 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.739 ' N ' HD12 ' A' ' 913' ' ' LEU . 42.6 mmtm -147.88 11.89 0.97 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.692 HG23 HD22 ' A' ' 913' ' ' LEU . 14.3 t -70.88 -151.18 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.879 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' A' ' 916' ' ' GLN . 0.7 OUTLIER -86.55 -44.45 11.91 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-O 121.221 0.534 . . . . 0.0 110.978 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.738 HG22 HD13 ' A' ' 913' ' ' LEU . 21.4 p 50.67 -121.12 1.7 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.187 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 68.8 p 55.7 33.14 20.74 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.47 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.557 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.0 t -85.72 -49.37 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.744 0.306 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.74 126.01 33.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.593 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.455 ' CD2' HD22 ' A' ' 928' ' ' LEU . 36.0 m-85 -108.46 138.18 20.15 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.922 0.391 . . . . 0.0 111.756 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.511 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.1 Cg_endo -69.39 143.25 51.98 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.923 2.415 . . . . 0.0 112.302 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.719 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.1 mt -57.66 154.79 2.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.845 0.355 . . . . 0.0 110.914 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.647 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 83.81 -40.37 2.89 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.4 m -57.11 132.1 51.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.865 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 22.6 t -115.44 133.41 56.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.495 HD23 ' CG2' ' A' ' 915' ' ' THR . 78.3 mt -95.47 125.81 40.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.956 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -85.35 136.82 33.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.467 ' OH ' ' HG3' ' A' ' 905' ' ' PRO . 11.1 m-85 -128.75 131.28 47.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.61 123.03 44.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 80.5 m -57.25 163.54 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 73.9 mtp180 -81.89 151.55 67.55 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 936' ' ' TYR . 6.7 Cg_endo -49.44 -44.23 35.48 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.972 2.448 . . . . 0.0 112.609 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 982' ' ' VAL . 55.4 mt-10 -73.27 20.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.73 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 45.4 m-85 -143.08 134.99 26.86 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.825 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 13.2 p90 -96.17 135.82 37.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.631 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 164.95 141.17 3.05 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.87 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 939' ' ' ARG . 0.6 OUTLIER -72.75 157.12 89.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.931 0.396 . . . . 0.0 110.505 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 19.2 Cg_endo -60.75 147.27 95.55 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.986 2.457 . . . . 0.0 112.092 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 957' ' ' VAL . 53.1 p90 -144.44 -171.27 3.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 44.9 t -172.92 142.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.434 HD12 ' CZ ' ' A' ' 908' ' ' PHE . 10.7 pt -100.46 116.93 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.857 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.662 ' O ' HD23 ' A' ' 946' ' ' LEU . 36.9 m -81.45 131.68 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.38 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.719 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.6 t -73.74 123.22 23.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 109.903 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.671 ' H ' HD21 ' A' ' 946' ' ' LEU . 1.9 mm? -87.44 169.03 12.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.338 1.066 . . . . 0.0 113.622 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.4 -40.4 62.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.146 -1.843 . . . . 0.0 112.043 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -83.33 32.89 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 900' ' ' ALA . 56.7 mt 46.39 57.99 4.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.237 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.629 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 16.0 m -135.59 -159.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.385 0.612 . . . . 0.0 111.697 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -144.72 122.31 11.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.1 p -42.16 136.29 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.818 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 34.0 t -77.93 112.35 24.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 955' ' ' LYS . 15.4 Cg_exo -68.64 -153.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.713 2.275 . . . . 0.0 111.885 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 954' ' ' PRO . 32.4 mtmt -159.84 -147.37 0.16 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.69 0.757 . . . . 0.0 111.6 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 56.5 m-20 -81.28 58.63 3.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.406 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.794 HG21 ' H ' ' A' ' 958' ' ' CYS . 29.5 m -81.6 -50.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.409 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.794 ' H ' HG21 ' A' ' 957' ' ' VAL . 97.5 m -89.0 52.3 2.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.422 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -57.64 138.7 55.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.735 ' HD2' ' HB2' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -55.37 120.56 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.844 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.825 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 35.6 ttmt -56.45 142.36 38.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 78.5 p -144.44 141.23 29.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.492 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.1 m -81.63 23.79 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 965' ' ' THR . 13.8 tmtt? 55.6 136.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.414 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.474 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 4.4 m -51.12 118.19 10.1 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.316 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.626 ' HG3' HD13 ' A' ' 986' ' ' ILE . 43.9 Cg_endo -64.5 141.73 75.07 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 122.664 2.243 . . . . 0.0 111.694 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.35 115.87 2.75 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.124 1.883 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -62.54 134.98 95.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 17.7 Cg_endo -59.6 138.1 81.48 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.433 2.089 . . . . 0.0 111.872 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.4 p -50.7 129.29 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.424 ' ND2' HG21 ' A' ' 970' ' ' VAL . 74.9 m-20 64.04 48.24 3.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -170.82 -145.54 4.81 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.725 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER -178.83 156.6 0.85 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.68 HG23 HD11 ' A' ' 986' ' ' ILE . 14.2 p -87.55 128.07 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.466 0.65 . . . . 0.0 110.851 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.608 ' HB3' HG22 ' A' ' 987' ' ' THR . 12.3 t-160 -75.05 70.97 2.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.341 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.06 122.84 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.97 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 987' ' ' THR . 32.0 mm -78.44 -40.64 24.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.29 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 59.0 p -144.67 -50.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -154.45 -142.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.496 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 17.0 pt -145.56 -3.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.436 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.735 ' HB2' ' HD2' ' A' ' 960' ' ' ARG . 3.2 pt20 -75.56 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 935' ' ' GLU . 5.9 m -47.92 150.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 111.366 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 85.17 -40.75 3.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.257 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 40.6 t -77.63 131.28 37.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 111.436 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ttm180 -100.33 150.15 22.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.157 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.68 HD11 HG23 ' A' ' 974' ' ' VAL . 48.2 pt -141.73 127.58 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.381 . . . . 0.0 111.51 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' 1001 ' ' SER . 1.6 t -98.62 -168.31 1.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.549 ' HA ' ' H ' ' A' ' 975' ' ' HIS . 22.0 m-85 -136.87 154.15 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 0.0 111.176 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.4 t -148.44 125.21 11.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 72.6 m -100.04 147.39 25.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -65.03 146.85 54.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.525 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 87.0 m -45.87 126.48 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' 1023 ' ' ILE . . . 126.09 -46.93 1.05 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -102.23 137.48 40.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.065 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.716 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.8 ptm85 -93.33 146.59 23.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.196 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 999' ' ' HIS . 8.4 tt -71.77 133.2 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.984 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.2 mp -110.22 133.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 98.5 -128.9 9.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.306 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.527 ' CD2' ' HB ' ' A' 1015 ' ' THR . 94.2 m-70 -79.04 -129.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.0 p -172.24 -31.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.319 . . . . 0.0 111.247 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 47.2 t -150.84 159.82 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.6 133.77 12.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.989 0.424 . . . . 0.0 111.83 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 4.6 pm0 -104.05 138.24 40.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.451 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.9 t -76.9 125.82 29.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' 1011 ' ' ALA . 29.9 pt -131.56 -151.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.669 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.557 HD12 ' HZ1' ' A' ' 961' ' ' LYS . 28.8 tp -147.18 -26.57 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.335 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.6 t 69.42 -42.94 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' 1006 ' ' LEU . . . -175.83 -45.66 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.265 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -156.18 21.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.418 0.151 . . . . 0.0 111.025 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.481 ' N ' HD13 ' A' 1006 ' ' LEU . 3.3 m -150.58 121.04 7.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.283 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' 1005 ' ' ILE . . . -76.15 129.13 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 0.0 110.888 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.562 ' HE2' ' HB2' ' A' 1007 ' ' SER . 20.7 p80 -160.15 144.16 14.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 96.3 m95 -68.63 136.28 52.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.063 0.458 . . . . 0.0 110.453 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.402 ' OG ' ' HG2' ' A' 1003 ' ' GLU . 73.7 m -56.36 -27.25 55.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.888 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.527 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 72.8 p -145.86 143.9 29.9 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.176 0.512 . . . . 0.0 112.324 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' A' 1017 ' ' PRO . 26.0 ttpp -65.79 140.9 97.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.778 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.459 ' HD2' ' HG3' ' A' 1016 ' ' LYS . 18.2 Cg_endo -58.15 131.25 42.2 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.524 2.149 . . . . 0.0 112.277 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -65.02 -160.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.746 2.297 . . . . 0.0 113.01 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.402 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 58.3 mt -143.16 139.65 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.814 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 71.9 m -92.58 124.66 36.77 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 997' ' ' ILE . 5.7 tt0 -145.62 134.67 22.68 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.199 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -45.7 135.5 6.7 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 111.851 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.716 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.1 mt -74.88 128.41 85.27 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 40.2 Cg_exo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.851 2.367 . . . . 0.0 112.253 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.437 ' C ' HD13 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.946 0.403 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.551 ' N ' HD13 ' A' ' 949' ' ' LEU . 61.1 m80 -152.58 139.8 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.267 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 76.5 m -81.08 132.48 35.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.987 0.422 . . . . 0.0 111.491 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.54 171.57 14.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.652 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.01 149.75 1.52 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.535 ' HB2' ' CD1' ' A' ' 908' ' ' PHE . 10.1 Cg_endo -50.84 135.17 42.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.961 2.441 . . . . 0.0 112.341 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.451 ' O ' ' HD1' ' A' ' 908' ' ' PHE . 46.6 m-20 -67.51 116.3 8.09 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.481 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 23.9 p80 38.0 46.67 0.84 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 905' ' ' PRO . 5.5 m-85 -81.64 137.47 35.45 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.652 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.948 HD11 ' N ' ' A' ' 909' ' ' LEU . 0.0 OUTLIER -159.63 -27.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.0 0.63 30.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.45 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.517 ' HB3' ' SG ' ' A' ' 958' ' ' CYS . . . -153.05 134.37 14.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.347 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.21 126.35 39.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.651 HD12 HG22 ' A' ' 917' ' ' THR . 1.2 tt -51.19 131.94 28.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.62 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.787 ' HD3' ' HG2' ' A' ' 929' ' ' LYS . 7.0 mtpm? -85.22 -49.61 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.795 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 60.2 m -64.77 136.72 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.219 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.469 ' C ' HG21 ' A' ' 917' ' ' THR . 3.0 pm0 -60.37 130.48 46.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.31 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 913' ' ' LEU . 82.0 p -152.08 147.36 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.325 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.4 p -143.66 -42.87 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 141.76 52.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 40.0 t -86.97 39.18 0.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -157.23 138.72 13.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.545 ' HE2' HG23 ' A' ' 917' ' ' THR . 71.7 m-85 -136.36 139.31 29.33 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.48 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.6 Cg_endo -69.33 146.95 64.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.559 . . . . 0.0 112.227 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.749 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 18.3 mt -59.55 158.18 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.892 0.377 . . . . 0.0 111.386 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.663 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 81.23 -35.43 2.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.938 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 39.7 m -56.02 129.25 39.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 111.364 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 66.3 p -108.9 125.77 52.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 91.5 mt -105.02 122.76 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.889 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.787 ' HG2' ' HD3' ' A' ' 914' ' ' LYS . 37.6 ttmt -90.01 133.35 34.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.546 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 1.5 m-85 -120.65 168.78 11.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.374 . . . . 0.0 111.075 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 914' ' ' LYS . 11.8 pt-20 -140.95 125.43 17.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.822 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 79.2 m -57.51 154.88 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.011 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.628 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 99.7 mtt180 -82.77 165.0 44.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 54.7 Cg_endo -69.94 56.08 1.42 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.892 2.395 . . . . 0.0 112.868 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.731 ' O ' ' HD2' ' A' ' 961' ' ' LYS . 55.3 mt-10 -164.94 9.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -149.18 135.31 19.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 10.8 p90 -95.02 136.38 35.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 0.0 111.221 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 167.73 141.25 3.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.52 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.35 156.0 92.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.744 0.307 . . . . 0.0 110.435 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -60.99 109.15 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.411 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.499 ' HB3' ' NH1' ' A' ' 939' ' ' ARG . 52.6 p90 -96.08 -164.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.91 132.09 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.565 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.764 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 5.1 pt -97.34 120.31 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 111.643 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 946' ' ' LEU . 17.5 m -84.08 122.72 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.83 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.749 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.8 t -73.7 102.84 4.07 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.681 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 83.9 mt -84.01 162.2 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -43.09 -38.4 2.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.869 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -82.29 33.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.164 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.576 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 1.7 mm? 44.82 52.28 8.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.681 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 29.6 m -127.64 -160.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.537 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.764 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 75.5 m95 -149.01 121.81 8.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.67 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 87.8 p -42.72 143.85 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.918 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 41.8 t -77.08 117.29 64.12 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 17.0 Cg_exo -66.4 -8.74 21.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.596 2.198 . . . . 0.0 111.289 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 46.97 57.26 5.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.865 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 59.9 t0 61.19 126.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.966 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 5.1 m -150.94 -48.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.756 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 911' ' ' ALA . 99.5 m -83.51 54.37 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 0.0 110.648 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 93.5 mttt -61.39 151.83 31.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.7 ' HD2' ' NZ ' ' A' ' 961' ' ' LYS . 15.1 tpp85 -53.37 125.22 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.731 ' HD2' ' O ' ' A' ' 935' ' ' GLU . 0.0 OUTLIER -56.38 125.67 22.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.38 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.521 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 91.9 p -144.45 127.9 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.107 0.48 . . . . 0.0 111.083 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.9 p -82.0 44.19 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.189 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.7 tptt 62.86 135.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.073 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.592 HG21 ' HD2' ' A' ' 966' ' ' PRO . 14.0 m -59.85 131.32 88.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.704 ' HG3' HD11 ' A' ' 986' ' ' ILE . 37.6 Cg_endo -65.21 132.64 32.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.596 2.197 . . . . 0.0 112.459 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.35 138.9 52.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.4 2.067 . . . . 0.0 111.793 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -57.94 116.87 15.9 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.77 141.82 55.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.211 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' 1020 ' ' CYS . 11.3 p -53.74 129.13 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 44.97 46.66 9.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.992 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.467 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -168.01 135.05 3.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.58 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.412 ' HB2' ' HE1' ' A' ' 973' ' ' MET . 54.4 mtm -103.68 136.65 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.511 HG22 HD13 ' A' ' 986' ' ' ILE . 12.1 p -99.75 132.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -95.9 115.66 27.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.871 HG12 HG21 ' A' ' 980' ' ' ILE . 94.7 t -66.01 -25.34 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.094 0.473 . . . . 0.0 109.993 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.527 HD13 ' OG1' ' A' ' 987' ' ' THR . 14.6 mm 74.21 -51.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.988 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.447 HG21 ' C ' ' A' ' 977' ' ' ILE . 70.9 p -148.92 -59.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.485 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.616 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 34.4 m-20 -157.41 143.84 17.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.168 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.871 HG21 HG12 ' A' ' 976' ' ' VAL . 6.0 pt -84.64 21.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.616 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 75.8 mm-40 -78.95 159.94 27.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.219 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' A' ' 961' ' ' LYS . 2.2 m -56.45 -7.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.836 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -95.64 22.46 38.97 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.465 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 67.5 m -163.95 -160.89 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.778 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' 1002 ' ' ALA . 17.2 ptp180 -151.39 -168.19 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.223 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.828 HG23 ' HA ' ' A' ' 976' ' ' VAL . 33.3 pt -146.37 129.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.527 ' OG1' HD13 ' A' ' 977' ' ' ILE . 11.0 p -103.28 134.52 46.54 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.129 0.49 . . . . 0.0 111.134 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.507 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 1.5 m-85 -95.44 145.2 25.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.2 t -146.46 74.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.514 ' SG ' HD21 ' A' ' 996' ' ' LEU . 59.4 m -51.64 147.34 6.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.4 p -64.3 150.48 46.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 62.2 m -47.78 112.45 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.163 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 144.72 -50.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -102.3 142.98 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.544 HH21 HG22 ' A' 1023 ' ' ILE . 13.3 ptp180 -92.92 145.0 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.504 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.546 HD13 ' C ' ' A' ' 999' ' ' HIS . 2.5 tm? -72.45 129.53 38.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.696 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' 1021 ' ' GLN . 4.6 mp -118.41 123.52 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.64 0.257 . . . . 0.0 110.72 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.28 43.22 3.04 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.723 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.546 ' C ' HD13 ' A' ' 996' ' ' LEU . 93.2 m-70 60.86 125.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 0.0 111.672 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.518 ' HB3' ' HG ' ' A' ' 996' ' ' LEU . 79.9 p -81.39 32.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 50.2 m -158.59 145.72 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.671 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -155.8 125.5 6.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.645 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.47 130.13 40.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.227 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 120.97 17.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.06 137.71 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.414 0.625 . . . . 0.0 112.082 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' 1010 ' ' THR . 22.5 tp -84.51 120.4 26.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.014 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.2 t -96.08 52.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 81.43 -124.51 6.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.773 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.9 m120 -55.62 -46.96 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.501 ' O ' HD13 ' A' 1006 ' ' LEU . 0.4 OUTLIER -94.52 -164.02 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.972 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.467 ' H ' ' CG2' ' A' 1010 ' ' THR . . . -158.25 147.38 19.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.054 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.26 152.04 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.465 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 85.1 m95 -68.69 146.1 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.385 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -56.52 -30.78 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.723 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 8.1 t -146.97 145.69 29.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.93 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -53.81 137.46 54.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.093 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 73.8 Cg_exo -49.53 113.1 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.197 1.931 . . . . 0.0 112.668 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.542 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 11.0 Cg_endo -54.27 142.28 68.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.927 2.418 . . . . 0.0 112.138 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 970' ' ' VAL . 0.1 OUTLIER -107.11 143.7 17.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.031 0.443 . . . . 0.0 111.9 -179.405 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 57.8 m -83.49 141.09 31.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.813 ' HB2' HD12 ' A' ' 997' ' ' ILE . 0.5 OUTLIER -145.8 131.24 18.68 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.862 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -49.75 130.92 21.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.405 0.622 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.544 HG22 HH21 ' A' ' 995' ' ' ARG . 64.9 mt -74.86 126.32 88.48 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.066 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.831 2.354 . . . . 0.0 112.314 -179.92 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.794 0.331 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.521 ' N ' HD23 ' A' ' 949' ' ' LEU . 26.8 m80 -148.17 131.46 16.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 8.9 p -82.3 127.8 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -64.17 159.26 20.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.48 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.21 131.7 5.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.676 ' HG3' HD13 ' A' ' 928' ' ' LEU . 31.3 Cg_endo -63.89 149.57 90.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.829 2.353 . . . . 0.0 112.48 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -62.37 162.94 9.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.06 124.77 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.508 ' HZ ' HG22 ' A' ' 943' ' ' ILE . 4.6 m-30 -85.28 129.06 34.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.56 25.63 4.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.443 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 8.5 p90 -154.01 1.63 0.23 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.066 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.43 131.38 8.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.402 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -102.01 136.16 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.991 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 66.0 tp -47.8 157.0 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.389 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.695 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 3.9 mmmp? -145.36 -36.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 19.5 m -64.4 139.45 58.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.46 136.13 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.542 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 77.1 p -152.18 140.33 20.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 25.5 m -158.4 53.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.197 0.522 . . . . 0.0 110.548 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.31 154.27 7.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.787 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.3 p -84.08 -49.44 8.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.535 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -85.32 124.59 32.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.227 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 928' ' ' LEU . 25.8 m-85 -103.71 136.49 19.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.014 0.435 . . . . 0.0 111.819 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.48 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 61.2 Cg_endo -72.24 139.33 32.01 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 0.0 112.071 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.647 HG21 ' H ' ' A' ' 925' ' ' GLY . 26.4 mt -57.54 158.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.647 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 83.66 -40.91 2.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 30.7 m -56.01 136.64 51.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.003 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.2 m -123.63 131.86 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 905' ' ' PRO . 88.7 mt -97.92 129.26 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.695 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 40.0 ttmt -85.25 136.81 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.767 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.644 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 17.2 m-85 -134.44 125.3 27.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.734 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.695 ' HG3' ' HG3' ' A' ' 914' ' ' LYS . 96.1 mt-10 -95.63 136.11 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 80.7 m -51.69 158.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 0.0 110.91 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.513 ' HG3' ' C ' ' A' ' 910' ' ' PHE . 44.1 mtp85 -80.09 160.26 68.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.279 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 38.2 Cg_endo -66.51 62.4 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.831 2.354 . . . . 0.0 112.452 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.0 mt-10 -163.73 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.392 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 936' ' ' TYR . 2.6 m-85 -104.48 -176.96 3.23 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.458 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 4.9 p90 -150.51 32.77 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.966 0.412 . . . . 0.0 111.336 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.898 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . -76.68 27.42 1.6 Allowed Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.294 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.723 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.9 ptp180 46.02 166.14 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.356 0.662 . . . . 0.0 112.633 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 41.8 Cg_endo -67.72 145.6 69.95 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.341 2.027 . . . . 0.0 112.427 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.546 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 45.3 p90 -144.46 -162.07 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.299 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 57.5 m -169.78 136.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.508 HG22 ' HZ ' ' A' ' 908' ' ' PHE . 7.8 pt -93.0 120.85 43.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.002 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.56 HG23 ' CD2' ' A' ' 946' ' ' LEU . 16.6 m -81.52 123.48 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.76 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 10.7 t -73.72 104.23 4.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.686 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 74.4 mt -81.76 161.55 23.26 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -42.09 -47.5 4.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.381 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . 0.666 ' ND2' HG23 ' A' ' 950' ' ' VAL . 0.0 OUTLIER -82.27 40.96 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.975 -178.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 901' ' ' HIS . 43.7 mt 45.85 59.18 3.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.247 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.686 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 34.9 m -135.98 -161.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.425 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 76.5 m95 -151.02 122.94 8.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.975 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.5 p -41.87 137.64 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 39.7 t -79.4 110.95 17.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 0.0 112.073 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 952' ' ' SER . 57.9 Cg_endo -90.96 54.07 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.471 2.781 . . . . 0.0 110.828 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.601 ' NZ ' ' HB2' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -75.63 132.82 40.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.422 -178.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 52.95 44.95 29.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.3 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.565 HG11 ' N ' ' A' ' 958' ' ' CYS . 0.5 OUTLIER -87.83 -50.95 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.247 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.898 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 93.1 m -89.13 111.77 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 72.7 mmtt -83.78 124.84 31.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.524 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 40.4 ttm180 -61.96 133.69 55.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.277 0.561 . . . . 0.0 112.386 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.882 ' HB3' HG22 ' A' ' 982' ' ' VAL . 20.3 tptm -56.35 168.48 0.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.809 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.503 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 51.0 m -149.85 134.81 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.005 0.431 . . . . 0.0 111.235 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.92 141.77 35.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.804 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -65.54 136.09 55.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 66.5 m -52.62 121.86 23.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.735 ' HG2' HG13 ' A' ' 974' ' ' VAL . 30.9 Cg_endo -62.46 135.02 51.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 0.0 112.088 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.09 121.2 9.65 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.988 1.792 . . . . 0.0 110.94 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . 0.47 ' HB3' ' HG3' ' A' ' 973' ' ' MET . 14.2 m-20 -57.96 118.66 28.17 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.06 148.7 91.41 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.654 2.236 . . . . 0.0 111.873 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . . . . . . . . . 19.3 t -45.25 122.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.959 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 60.71 45.61 9.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.528 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -179.71 139.71 3.95 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.956 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 968' ' ' ASP . 3.5 mpp? -133.54 150.03 51.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.735 HG13 ' HG2' ' A' ' 966' ' ' PRO . 8.4 p -89.92 121.77 40.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.17 0.509 . . . . 0.0 111.051 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 121.84 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.83 135.1 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.764 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.488 HD13 ' HG1' ' A' ' 987' ' ' THR . 26.7 mm -74.47 -53.27 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.787 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 82.0 p -147.66 -52.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.312 0.577 . . . . 0.0 110.87 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.73 139.35 18.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.02 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.6 pt -88.33 34.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.897 0.379 . . . . 0.0 111.656 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.524 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 80.6 mt-30 -80.81 151.19 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.882 HG22 ' HB3' ' A' ' 961' ' ' LYS . 76.2 t -54.48 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 165.63 -48.35 0.28 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' 1003 ' ' GLU . 93.9 p -80.04 -160.38 0.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -151.39 134.97 16.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.524 HD13 HG22 ' A' ' 974' ' ' VAL . 34.6 pt -97.72 136.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.488 ' HG1' HD13 ' A' ' 977' ' ' ILE . 3.0 p -102.47 135.25 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.1 m-85 -96.24 143.69 27.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -148.71 120.72 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 60.9 m -83.58 119.71 25.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.463 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 992' ' ' THR . 7.6 t -72.57 137.4 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.547 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 991' ' ' THR . 96.6 m 111.23 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.309 1.005 . . . . 0.0 111.168 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -170.66 32.45 0.15 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.215 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -95.74 144.36 26.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.697 ' HB3' HG12 ' A' 1023 ' ' ILE . 7.6 ptm180 -89.28 136.23 33.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.23 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' 1000 ' ' SER . 10.3 tt -72.26 132.28 43.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.3 mp -99.73 125.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.031 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.2 -139.87 14.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.389 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -85.86 135.02 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.544 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.676 ' HA ' HD12 ' A' ' 996' ' ' LEU . 80.5 p -102.96 20.31 17.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.58 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 47.4 t -159.19 146.84 17.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -153.68 134.31 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.062 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 984' ' ' SER . 39.3 tt0 -95.0 129.08 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.199 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.28 120.34 16.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.417 ' HB ' ' H ' ' A' 1006 ' ' LEU . 33.3 pt -129.9 -159.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.889 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.417 ' H ' ' HB ' ' A' 1005 ' ' ILE . 41.6 tp -150.78 136.84 18.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.3 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.728 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.6 t -90.0 -40.31 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.828 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.68 -32.02 0.03 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.292 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 49.7 t30 -150.04 -44.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 110.511 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 37.4 m -92.66 131.44 37.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.979 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.461 ' H ' ' HZ2' ' A' ' 961' ' ' LYS . . . -80.97 143.59 32.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.819 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.728 ' HE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -155.76 144.06 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.307 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 49.1 m95 -68.29 144.09 54.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -53.55 -29.05 35.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.61 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 68.4 p -140.91 138.8 34.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.713 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.559 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.5 pptp? -62.31 152.47 79.16 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.014 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.76 132.36 41.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.635 2.224 . . . . 0.0 112.643 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' 1019 ' ' ILE . 56.1 Cg_endo -69.88 -153.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.783 2.322 . . . . 0.0 112.578 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.669 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.7 mt -139.01 141.97 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.015 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.528 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 97.9 m -99.66 124.18 44.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.732 ' HB2' HD12 ' A' ' 997' ' ' ILE . 10.1 tt0 -142.23 129.52 21.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.184 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -50.45 133.89 24.22 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.68 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.697 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.2 mt -74.83 123.91 89.27 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.797 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.813 2.342 . . . . 0.0 112.343 -179.892 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.771 0.32 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 11.7 m80 66.92 140.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.928 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 47.8 m -80.11 129.07 34.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.419 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.1 mm100 -64.65 168.19 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.69 125.32 6.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.38 123.64 8.34 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 122.457 2.105 . . . . 0.0 112.82 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 136.11 54.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.011 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -77.25 138.55 39.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.503 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 14.5 m-85 -89.09 24.02 2.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.503 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.716 HD11 ' N ' ' A' ' 909' ' ' LEU . 6.5 mp 68.74 -59.01 0.47 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 5.4 p90 -81.82 31.03 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -152.63 122.36 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 111.589 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -99.68 124.29 44.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.311 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -48.97 118.51 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.267 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.65 ' HE2' ' HD2' ' A' ' 929' ' ' LYS . 0.7 OUTLIER -95.89 -47.96 5.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.159 -179.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.443 ' O ' HG21 ' A' ' 917' ' ' THR . 31.7 m -64.59 128.39 35.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.613 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -52.36 135.14 33.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.875 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 915' ' ' THR . 79.4 p -152.02 144.67 24.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 24.9 m -156.46 53.36 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.73 156.2 9.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.5 t -86.4 -46.87 9.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.99 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.28 141.94 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -129.9 133.79 25.41 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.514 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -70.52 141.89 43.23 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.656 2.237 . . . . 0.0 112.229 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.657 ' HA ' ' HB3' ' A' ' 945' ' ' CYS . 34.2 mt -55.44 152.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.537 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 88.47 -29.54 5.67 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.452 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.4 m -55.05 137.74 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 51.1 m -115.99 142.6 46.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.733 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.21 119.09 19.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.625 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.65 ' HD2' ' HE2' ' A' ' 914' ' ' LYS . 40.0 ttmt -89.4 138.52 31.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.395 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.551 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 5.9 m-85 -129.03 134.45 48.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -95.18 121.57 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 64.2 m -59.92 149.98 30.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.0 mtp180 -84.13 162.89 50.39 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 10.0 Cg_endo -51.88 146.23 29.46 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.241 1.961 . . . . 0.0 110.966 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.964 ' HB3' HG22 ' A' ' 982' ' ' VAL . 95.6 mt-10 83.23 25.89 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.888 0.742 . . . . 0.0 109.968 -178.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.766 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 78.8 m-85 -143.91 142.35 30.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.839 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.616 ' HB3' ' NZ ' ' A' ' 961' ' ' LYS . 36.2 p90 -144.06 134.73 24.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 111.439 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.811 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . 155.75 28.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.41 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 63.09 144.43 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.0 111.784 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.57 124.93 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.524 2.15 . . . . 0.0 110.703 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 6.5 p90 -90.17 -166.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.66 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 59.2 m -170.21 132.27 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.01 168.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.596 ' O ' HD23 ' A' ' 946' ' ' LEU . 20.5 m -162.62 136.09 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 38.7 t -73.82 125.78 28.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.616 ' H ' HD21 ' A' ' 946' ' ' LEU . 2.8 mm? -84.86 -57.03 3.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -176.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.52 ' HA ' HD12 ' A' ' 924' ' ' ILE . 23.7 t70 171.67 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.218 0.324 . . . . 0.0 111.031 -178.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -82.77 32.1 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 109.636 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' A' ' 900' ' ' ALA . 22.2 mt 51.67 43.25 30.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.762 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.475 ' O ' HD21 ' A' ' 946' ' ' LEU . 7.9 m -143.41 154.41 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.644 0.735 . . . . 0.0 112.467 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' A' ' 953' ' ' SER . 72.9 m95 -91.51 130.85 37.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.381 -1.282 . . . . 0.0 109.128 177.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 946' ' ' LEU . 45.3 t -51.47 -10.22 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.372 0.606 . . . . 0.0 111.524 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 951' ' ' TRP . 48.0 t 61.93 121.55 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.744 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 11.5 Cg_exo -71.08 141.31 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.978 2.452 . . . . 0.0 110.74 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.672 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 11.0 tmtt? -154.59 134.64 13.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.212 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.672 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 38.7 t70 60.82 41.01 15.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.123 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.79 -111.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.089 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.811 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 26.8 p -87.97 103.29 15.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.4 mmtt -82.05 134.68 35.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.799 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.766 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 35.7 ptt180 -56.76 143.56 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.592 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.616 ' NZ ' ' HB3' ' A' ' 937' ' ' TYR . 5.3 mptp? -47.12 150.47 0.8 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.528 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.73 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.2 p -142.65 127.19 17.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 70.5 m -79.48 138.21 37.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.302 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.57 135.28 55.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.895 0.379 . . . . 0.0 110.757 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.551 ' HG1' HD11 ' A' ' 980' ' ' ILE . 83.2 m -48.59 114.45 3.61 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.538 ' HG2' HG13 ' A' ' 974' ' ' VAL . 20.0 Cg_endo -60.57 135.42 60.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.489 2.126 . . . . 0.0 112.013 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.12 117.18 3.34 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.068 1.845 . . . . 0.0 111.327 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.14 125.11 80.41 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 144.54 99.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.681 2.254 . . . . 0.0 112.076 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.4 t -46.42 129.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.446 ' ND2' HG13 ' A' ' 970' ' ' VAL . 75.3 m-20 61.76 45.65 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.9 -162.94 23.08 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.585 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 178.63 147.44 0.17 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 110.993 -179.641 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 986' ' ' ILE . 8.6 p -91.08 102.79 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.773 0.797 . . . . 0.0 110.845 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -68.17 107.9 2.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.307 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.46 133.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 985' ' ' ARG . 44.9 mm -74.28 -36.07 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.088 0.47 . . . . 0.0 110.263 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.9 p -144.71 -49.54 0.26 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.88 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.1 t70 -161.57 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.822 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.551 HD11 ' HG1' ' A' ' 965' ' ' THR . 6.2 pt -151.03 9.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 110.849 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.73 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 21.2 mt-30 -75.75 161.16 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.964 HG22 ' HB3' ' A' ' 935' ' ' GLU . 10.4 m -49.27 149.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.695 0.283 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 82.94 -32.76 2.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.976 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.0 m -75.84 131.71 39.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.153 0.501 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 977' ' ' ILE . 78.7 ttt180 -93.38 155.82 17.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.717 HD13 HG22 ' A' ' 974' ' ' VAL . 43.9 pt -141.78 123.81 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.255 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.3 p -107.61 136.9 46.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.466 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.476 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 5.2 m-85 -94.06 146.58 23.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.418 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -148.65 109.83 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.997 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 79.8 m -79.96 147.87 31.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 5.6 t -64.31 146.39 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.7 m -44.02 123.69 3.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.49 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 134.73 -51.23 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.331 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.438 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.5 m80 -102.54 141.12 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.356 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.601 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.6 ptm180 -92.38 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.348 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' 1000 ' ' SER . 9.7 tt -71.77 132.73 44.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.623 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.2 mp -108.91 132.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 83.94 -144.25 21.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.15 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.623 ' HD1' ' HB ' ' A' 1015 ' ' THR . 39.5 m170 -81.34 130.24 34.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.767 0.317 . . . . 0.0 111.278 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.64 ' HA ' HD12 ' A' ' 996' ' ' LEU . 47.6 t -85.04 -51.84 6.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.665 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 33.1 t -90.37 155.02 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.509 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.707 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.477 ' H ' ' HB3' ' A' 1014 ' ' SER . 88.3 tt0 -111.56 129.94 55.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.766 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.512 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 43.2 t -71.25 125.62 27.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.476 HG13 ' CD2' ' A' 1012 ' ' HIS . 26.7 pt -129.42 -155.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.615 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 45.3 tp -150.62 -21.86 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.832 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 36.8 t 53.27 26.96 5.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 35.54 48.52 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.522 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -163.21 -49.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 40.2 m -145.54 136.45 24.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.843 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.02 124.94 28.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.873 0.368 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.476 ' CD2' HG13 ' A' 1005 ' ' ILE . 0.3 OUTLIER -161.2 152.91 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.761 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.512 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 93.7 m95 -64.92 144.38 57.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.985 0.422 . . . . 0.0 110.784 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.477 ' HB3' ' H ' ' A' 1003 ' ' GLU . 45.4 t -64.18 -31.59 72.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.623 ' HB ' ' HD1' ' A' ' 999' ' ' HIS . 40.9 p -144.19 138.67 28.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.871 0.367 . . . . 0.0 111.266 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.03 148.63 83.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.798 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.3 130.3 37.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.613 2.209 . . . . 0.0 112.338 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.29 -160.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.758 2.306 . . . . 0.0 112.665 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.4 mt -142.33 138.59 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.885 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.543 ' N ' HG21 ' A' 1019 ' ' ILE . 82.1 m -92.66 124.42 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.623 ' HB3' HD12 ' A' ' 997' ' ' ILE . 34.0 tt0 -143.75 135.39 26.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.464 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.419 ' HG2' HH11 ' A' 1022 ' ' ARG . 15.1 tpp85 -49.04 131.92 18.99 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.398 0.618 . . . . 0.0 111.621 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.2 mt -76.89 124.96 87.57 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.878 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.809 2.34 . . . . 0.0 112.363 -179.926 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.451 ' HB1' HD22 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.147 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.559 ' N ' HD23 ' A' ' 949' ' ' LEU . 58.1 m80 -150.4 127.41 11.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.403 178.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 11.3 p -82.9 128.15 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . 0.408 ' H ' ' HG3' ' A' ' 903' ' ' GLN . 2.0 pp0? -73.15 175.45 6.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.43 129.1 10.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 906' ' ' ASP . 50.8 Cg_endo -68.46 91.5 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.483 2.122 . . . . 0.0 112.421 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 905' ' ' PRO . 6.5 t0 29.75 -133.02 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 O-C-N 123.606 0.566 . . . . 0.0 111.123 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 31.7 t-80 -161.8 109.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -86.5 137.15 32.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.448 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.525 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 62.5 mt -80.08 -52.96 7.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.18 29.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -155.91 139.98 16.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -136.47 130.9 33.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 917' ' ' THR . 66.0 tp -48.42 156.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.332 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.847 ' HE2' ' HA ' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -145.49 -39.82 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.411 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 4.4 m -64.52 141.87 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.583 ' O ' HG21 ' A' ' 917' ' ' THR . 13.9 pt20 -52.92 133.54 37.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.318 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 916' ' ' GLN . 62.7 p -150.92 -65.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 918' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 917' ' ' THR . 32.1 p 66.28 -50.96 0.43 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.892 0.745 . . . . 0.0 112.555 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.36 151.93 44.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.1 p -85.04 -42.92 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 901' ' ' HIS . 63.9 t0 -85.02 126.26 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.483 ' HE2' HG23 ' A' ' 917' ' ' THR . 92.0 m-85 -106.78 136.13 19.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.63 140.6 18.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.106 2.538 . . . . 0.0 111.829 178.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.758 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 46.7 mt -55.88 148.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.059 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.608 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 73.55 77.57 0.61 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 2.2 m -176.72 122.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 54.9 m -83.43 129.69 35.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.981 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 6.0 tp -106.87 118.55 36.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.568 ' NZ ' ' HB2' ' A' ' 929' ' ' LYS . 0.1 OUTLIER -85.63 135.15 33.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.785 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -135.4 129.34 33.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.258 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 940' ' ' PRO . 90.0 mt-10 -95.48 123.09 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 6.1 t -58.77 153.38 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.548 ' HG3' HH11 ' A' ' 933' ' ' ARG . 38.9 mtt85 -81.35 155.48 71.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.507 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 51.6 Cg_endo -68.45 66.4 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.024 2.483 . . . . 0.0 112.543 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.6 mt-10 -163.15 -9.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 959' ' ' LYS . 33.9 m-85 -134.79 140.6 46.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.402 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.1 p90 -99.91 137.7 38.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 148.13 21.38 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.456 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 938' ' ' GLY . 18.9 ptp180 46.72 164.28 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.654 0.782 . . . . 0.0 112.59 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.727 ' HB3' ' HA ' ' A' ' 931' ' ' GLU . 18.5 Cg_exo -66.39 127.32 17.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.782 2.322 . . . . 0.0 112.386 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.505 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 43.6 p90 -93.01 -161.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.5 p -172.86 134.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.066 0.46 . . . . 0.0 111.25 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 943' ' ' ILE . 4.9 pt -95.05 -168.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.933 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.632 HG23 HD22 ' A' ' 946' ' ' LEU . 1.4 m -167.28 127.13 1.43 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.758 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 17.0 t -69.99 110.64 5.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 944' ' ' THR . 92.1 mt -82.75 -57.3 3.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 56.0 t0 173.01 -43.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.013 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -82.88 36.65 0.51 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 901' ' ' HIS . 31.0 mt 51.67 46.15 26.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.5 OUTLIER -128.57 -173.6 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.988 -179.357 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.422 ' CE3' HD13 ' A' ' 943' ' ' ILE . 73.5 m95 -144.71 130.73 19.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.161 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 45.6 t -44.05 146.25 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 953' ' ' SER . . . . . 0.482 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -79.59 115.88 56.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.6 Cg_exo -76.31 61.05 6.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.496 2.797 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -76.43 139.27 40.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.486 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.599 ' HA ' ' HZ3' ' A' ' 959' ' ' LYS . 9.9 t70 58.11 82.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.041 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.428 HG11 ' C ' ' A' ' 956' ' ' ASP . 30.9 m -149.69 -24.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.653 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 936' ' ' TYR . 72.6 m -150.47 133.19 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.599 ' HZ3' ' HA ' ' A' ' 956' ' ' ASP . 45.6 mmtm -140.72 150.53 43.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.303 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.597 ' HG3' ' NE2' ' A' ' 981' ' ' GLN . 12.2 tpt180 -53.34 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.971 0.415 . . . . 0.0 111.311 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.497 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 40.4 ttmt -56.32 149.63 16.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.501 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.656 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 60.4 p -141.14 140.36 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.257 0.551 . . . . 0.0 111.506 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.87 154.69 28.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.06 134.21 53.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.323 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 32.5 m -54.28 126.67 54.58 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.497 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 80.1 Cg_endo -76.3 134.25 15.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.778 2.319 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.51 128.58 28.89 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.221 1.948 . . . . 0.0 111.511 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.86 129.52 85.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.87 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.07 142.67 88.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.864 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 39.5 t -47.5 124.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.244 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 73.1 m-20 76.42 -46.39 0.53 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.826 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -71.29 -151.61 0.95 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.438 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 178.79 140.33 0.1 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 986' ' ' ILE . 11.1 p -96.51 143.1 12.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.684 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.476 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.5 m-70 -102.7 114.5 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.751 HG12 HG22 ' A' ' 980' ' ' ILE . 77.9 t -63.78 -39.01 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.22 0.533 . . . . 0.0 110.021 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.503 ' O ' HG21 ' A' ' 978' ' ' THR . 9.3 mt 71.64 -33.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.409 178.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.503 HG21 ' O ' ' A' ' 977' ' ' ILE . 48.1 p -144.84 -86.14 0.12 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 980' ' ' ILE . 2.8 m-20 -154.59 13.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.312 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.751 HG22 HG12 ' A' ' 976' ' ' VAL . 36.9 pt 50.65 34.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.366 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.656 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 3.8 mm100 -76.64 151.13 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.81 88.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.068 0.461 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 160.09 -42.67 0.44 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.217 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' 1003 ' ' GLU . 49.2 m -76.09 -168.64 0.96 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.653 ' HD3' ' HB2' ' A' 1001 ' ' SER . 38.1 ttm180 -151.35 134.9 16.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.689 HG21 ' HA ' ' A' ' 976' ' ' VAL . 25.7 pt -95.26 131.75 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.761 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -99.3 129.27 45.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 111.797 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' 1000 ' ' SER . 7.1 m-85 -96.58 139.73 32.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.0 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.1 t -153.69 112.14 3.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.684 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.508 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 3.2 t -81.38 142.13 33.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.602 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.2 t -65.01 154.09 38.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.0 t -45.64 109.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 111.246 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 159.57 -44.42 0.44 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.429 ' HB3' ' N ' ' A' 1021 ' ' GLN . 15.3 m80 -126.87 147.58 50.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.206 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.409 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.9 ptm180 -90.04 138.98 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.706 HD23 ' HB2' ' A' 1000 ' ' SER . 9.8 tt -71.89 130.84 42.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.987 -178.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.706 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.0 mp -109.73 93.39 2.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.464 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . 158.31 -153.53 24.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.594 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -85.93 -35.43 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.706 ' HB2' HD23 ' A' ' 996' ' ' LEU . 48.2 t 67.27 16.39 10.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.653 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.3 p -157.6 59.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.764 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.779 ' HB1' HG21 ' A' 1015 ' ' THR . . . -79.77 126.51 31.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.8 tt0 -96.09 131.48 42.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.923 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1004 ' ' CYS . . . . . 0.427 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 45.0 t -71.77 119.93 16.64 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.28 -156.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 112.131 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 56.4 tp -152.24 135.06 15.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.02 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1007 ' ' SER . . . . . 0.669 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.0 t -88.39 -45.39 10.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.29 -49.74 0.26 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.038 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.16 -37.19 12.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -145.45 144.91 30.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.696 -178.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.22 144.58 34.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.704 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.669 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.0 p80 -158.15 154.62 27.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.883 0.373 . . . . 0.0 111.514 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 72.3 m95 -68.63 149.49 49.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.9 m -58.92 -34.6 71.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.81 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.779 HG21 ' HB1' ' A' 1002 ' ' ALA . 6.4 t -143.08 149.33 38.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.228 0.537 . . . . 0.0 112.357 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' A' 1017 ' ' PRO . 1.0 OUTLIER -59.54 136.86 89.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.939 179.052 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.507 ' N ' ' HD3' ' A' 1016 ' ' LYS . 77.7 Cg_exo -50.75 119.86 5.78 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.541 2.161 . . . . 0.0 112.971 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.604 ' HB3' ' HA2' ' A' ' 998' ' ' GLY . 14.6 Cg_endo -57.28 147.72 75.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.822 2.348 . . . . 0.0 112.447 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.18 147.13 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 95.3 m -81.39 136.34 35.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.706 ' HB3' HD12 ' A' ' 997' ' ' ILE . 6.2 tt0 -145.72 132.31 19.85 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.353 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -44.03 136.04 3.95 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.5 0.667 . . . . 0.0 111.779 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.6 mt -74.86 127.04 87.68 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.012 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.848 2.365 . . . . 0.0 112.356 -179.852 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.125 0 CA-C-O 121.017 0.437 . . . . 0.0 111.661 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . 0.6 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 53.4 m80 -149.86 135.46 18.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 922' ' ' PHE . 10.0 p -80.72 121.43 25.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -69.23 172.36 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.539 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.08 8.46 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.567 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.486 ' HG2' ' OH ' ' A' ' 930' ' ' TYR . 51.1 Cg_exo -53.71 127.08 24.03 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.89 2.393 . . . . 0.0 112.624 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.74 119.61 14.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.854 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 38.7 m170 42.77 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.075 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -145.93 47.51 1.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.987 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 38.9 mt -75.08 -7.2 53.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.736 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -12.12 54.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.806 179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.02 137.22 16.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.321 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . 0.493 ' HB2' ' HZ3' ' A' ' 912' ' ' LYS . 0.0 OUTLIER -91.61 123.79 35.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.083 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.683 HD13 HG22 ' A' ' 917' ' ' THR . 3.4 tm? -47.18 129.51 12.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.107 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.562 ' O ' ' HD2' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -94.56 -31.26 13.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.93 -178.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.572 HG21 ' N ' ' A' ' 916' ' ' GLN . 86.4 m -57.19 154.02 10.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.609 -179.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.572 ' N ' HG21 ' A' ' 915' ' ' THR . 3.0 pp0? -57.49 -47.91 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.533 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.683 HG22 HD13 ' A' ' 913' ' ' LEU . 52.8 p 51.76 138.77 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.802 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 918' ' ' THR . . . . . 0.496 ' O ' HG21 ' A' ' 918' ' ' THR . 16.3 m -161.31 32.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.232 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.78 140.51 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 45.6 m -86.74 37.86 0.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.456 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -154.68 127.72 8.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.862 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . 0.421 ' O ' ' SG ' ' A' ' 902' ' ' CYS . 36.4 m-85 -119.12 142.29 31.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.929 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.21 136.73 10.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.949 2.433 . . . . 0.0 111.9 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 947' ' ' ASP . 61.6 mt -52.02 150.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.575 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 72.83 74.79 0.76 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.738 -178.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 944' ' ' THR . 3.6 m -174.82 130.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.856 -178.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 927' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 75.5 p -99.99 155.35 17.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.114 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 942' ' ' SER . 95.4 mt -141.05 128.37 21.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.117 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.839 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 43.4 mmtm -85.07 141.5 30.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.486 ' OH ' ' HG2' ' A' ' 905' ' ' PRO . 11.4 m-85 -129.12 133.19 47.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 912' ' ' LYS . 50.1 mt-10 -92.53 118.39 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.138 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.68 148.94 18.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.728 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.2 mtt85 -83.01 155.96 67.29 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.893 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 936' ' ' TYR . 62.6 Cg_exo -38.56 -53.75 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.881 2.388 . . . . 0.0 113.613 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.92 31.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 72.2 m-85 -145.19 133.78 22.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.677 0.275 . . . . 0.0 111.184 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.568 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 2.2 p90 -103.89 138.88 39.84 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 137.24 143.57 4.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.863 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -73.02 170.69 12.66 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.547 0.213 . . . . 0.0 110.769 179.703 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.863 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 9.2 Cg_endo -59.39 114.71 2.15 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.399 2.066 . . . . 0.0 112.958 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 27.2 p90 -90.24 -164.62 1.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 942' ' ' SER . . . . . 0.839 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 79.7 p -171.95 130.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.289 0.566 . . . . 0.0 112.352 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 927' ' ' SER . 8.1 pt -96.14 -174.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.632 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.669 ' O ' HD23 ' A' ' 946' ' ' LEU . 15.9 m -165.9 136.74 3.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 73.5 m -73.29 126.64 30.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 944' ' ' THR . 2.5 mm? -83.61 -60.51 2.1 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.645 ' HA ' HG22 ' A' ' 924' ' ' ILE . 4.7 t70 171.84 -40.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.262 0.352 . . . . 0.0 110.814 -178.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -86.38 39.67 0.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.691 HD12 ' HB1' ' A' ' 900' ' ' ALA . 6.2 mp 53.5 46.12 26.81 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.481 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 3.2 m -125.68 -179.98 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.798 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.414 ' CE3' HD13 ' A' ' 943' ' ' ILE . 41.3 m95 -142.04 131.8 24.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.756 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 80.4 p -40.83 143.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.3 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 40.7 t -78.7 114.45 43.67 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.33 -178.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.52 57.6 6.37 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.473 2.782 . . . . 0.0 111.994 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 1.2 tmtp? -78.6 127.04 31.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . 0.779 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 38.8 t70 53.34 41.59 32.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.25 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.14 -41.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.424 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 17.2 t -157.64 68.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.478 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.779 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.4 mmtp -56.43 144.55 30.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 12.8 ptt-85 -55.43 147.39 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.151 0.5 . . . . 0.0 111.986 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.568 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 26.9 tptp -47.64 155.77 0.36 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.56 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.785 ' HB2' ' HG3' ' A' ' 981' ' ' GLN . 48.2 t -144.47 139.88 28.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.473 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 59.3 m -81.57 37.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.293 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 59.52 135.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.066 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 11.8 m -56.1 128.4 71.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.496 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.445 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 39.6 Cg_endo -66.4 127.14 16.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.489 2.126 . . . . 0.0 112.64 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 16.7 Cg_exo -67.0 132.85 29.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.499 2.133 . . . . 0.0 111.515 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.68 114.22 8.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.745 0.307 . . . . 0.0 110.781 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 144.15 29.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.685 2.257 . . . . 0.0 112.224 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.457 HG13 ' ND2' ' A' ' 971' ' ' ASN . 21.5 t -50.63 129.01 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.457 ' ND2' HG13 ' A' ' 970' ' ' VAL . 71.9 m-20 54.47 44.64 28.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.475 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -170.9 147.99 10.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.939 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.2 136.98 40.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.571 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 986' ' ' ILE . 10.1 p -98.18 127.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.913 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -86.45 114.74 23.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.757 ' HA ' HG23 ' A' ' 986' ' ' ILE . 27.8 m -63.11 -28.14 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.017 0.436 . . . . 0.0 110.203 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 10.0 mt 73.07 -43.54 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.134 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 976' ' ' VAL . 71.0 p -146.11 -51.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.577 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.535 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 8.2 p-10 -160.26 -143.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.146 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 979' ' ' ASP . 4.6 pt -151.0 6.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.785 ' HG3' ' HB2' ' A' ' 962' ' ' SER . 14.5 mp0 -76.65 177.32 7.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.601 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.55 132.66 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.233 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 106.83 -46.27 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.278 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.0 m -76.09 134.36 40.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 77.5 ttt180 -104.12 124.09 48.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.154 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.757 HG23 ' HA ' ' A' ' 976' ' ' VAL . 34.4 pt -97.1 136.51 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 0.0 111.535 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.4 p -103.84 136.38 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.542 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 14.9 m-85 -103.19 142.57 33.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.231 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.9 t -153.57 127.56 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.589 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 99.8 m -58.37 135.84 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.258 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 992' ' ' THR . 10.2 t -73.41 43.59 0.14 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.433 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 991' ' ' THR . 8.5 t 175.41 -130.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' ' 992' ' ' THR . . . -133.69 51.25 0.85 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.499 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.585 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 3.8 m80 -94.49 -137.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.618 ' HB3' ' O ' ' A' 1021 ' ' GLN . 13.5 ttt85 -140.88 112.06 7.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.921 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' 1000 ' ' SER . 6.3 tt -68.83 131.86 45.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.818 0.342 . . . . 0.0 110.702 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.628 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -97.27 136.21 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 84.33 -152.25 27.78 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.383 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -81.55 129.74 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.688 0.244 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1000 ' ' SER . . . . . 0.634 ' HA ' HD23 ' A' ' 996' ' ' LEU . 50.2 m -74.79 10.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.338 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.46 ' HG ' ' HE ' ' A' ' 985' ' ' ARG . 30.7 t -159.29 151.42 20.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.533 ' HB1' ' HG1' ' A' 1015 ' ' THR . . . -155.07 128.86 8.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.383 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 12.7 pt-20 -96.48 134.24 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.539 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.2 t -71.83 123.17 22.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.67 139.18 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.262 0.553 . . . . 0.0 112.139 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 60.8 tp -84.5 120.57 26.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 94.1 p -96.03 36.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.053 179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.485 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 67.19 123.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.058 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 73.17 -37.38 0.38 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 122.373 0.269 . . . . 0.0 111.671 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' 1008 ' ' GLY . 98.6 m -145.48 129.09 17.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 111.632 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -87.36 147.32 25.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.66 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.9 p80 -157.64 149.1 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.384 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.458 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 91.7 m95 -65.79 139.21 58.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -51.39 -27.68 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.886 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.533 ' HG1' ' HB1' ' A' 1002 ' ' ALA . 75.4 p -141.02 141.57 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.963 0.411 . . . . 0.0 111.611 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.579 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -53.82 153.15 8.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.09 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.17 123.78 14.66 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.446 2.097 . . . . 0.0 112.733 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.542 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 14.0 Cg_exo -69.0 148.71 70.62 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.185 2.59 . . . . 0.0 112.243 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.636 HG23 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -100.35 -153.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.636 ' H ' HG23 ' A' 1019 ' ' ILE . 35.5 t -161.64 141.24 10.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.819 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.628 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.4 tt0 -151.36 127.98 10.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.563 -178.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -51.42 131.9 29.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 111.658 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 995' ' ' ARG . 62.9 mt -74.82 129.16 83.97 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.974 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.889 2.392 . . . . 0.0 112.287 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 900' ' ' ALA . . . . . 0.819 ' HB1' HD12 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.912 0.387 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -110.52 124.45 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.998 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 902' ' ' CYS . . . . . 0.846 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 1.8 p -82.11 124.0 29.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -60.02 172.01 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.63 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 904' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -44.78 134.4 4.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 905' ' ' PRO . . . . . 0.615 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 3.5 Cg_exo -73.79 44.06 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.738 2.292 . . . . 0.0 112.582 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 4.0 t70 57.93 153.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.472 0.653 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -82.42 122.31 27.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.704 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 908' ' ' PHE . . . . . 0.418 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 8.3 m-85 -85.88 141.98 29.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 909' ' ' LEU . . . . . 0.629 ' N ' HD21 ' A' ' 909' ' ' LEU . 2.0 mm? -87.53 -65.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.688 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.59 ' O ' ' HG3' ' A' ' 933' ' ' ARG . 2.5 p90 -82.77 -22.12 34.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.469 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 911' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -87.04 142.94 27.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.54 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -129.81 123.41 30.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.17 116.56 1.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.428 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 914' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -93.07 -42.28 9.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 915' ' ' THR . . . . . 0.531 HG21 ' NE2' ' A' ' 916' ' ' GLN . 5.0 m -66.16 -127.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 916' ' ' GLN . . . . . 0.531 ' NE2' HG21 ' A' ' 915' ' ' THR . 3.0 pm0 -173.5 139.43 0.74 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.676 0.274 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 917' ' ' THR . . . . . 0.652 HG21 ' H ' ' A' ' 918' ' ' THR . 1.8 t -157.18 -54.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 918' ' ' THR . . . . . 0.652 ' H ' HG21 ' A' ' 917' ' ' THR . 27.9 m 53.9 57.77 5.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.044 0.45 . . . . 0.0 110.599 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.44 156.66 14.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.4 t -87.9 -44.99 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.72 141.8 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.35 137.84 27.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 923' ' ' PRO . . . . . 0.594 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 65.3 Cg_endo -73.12 132.01 17.47 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.569 2.179 . . . . 0.0 111.427 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 924' ' ' ILE . . . . . 0.682 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.5 mt -56.78 147.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . 0.607 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 95.7 -32.97 5.82 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 926' ' ' THR . . . . . 0.594 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 20.6 m -56.21 135.68 53.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.426 . . . . 0.0 112.145 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 61.6 p -107.2 142.99 36.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.388 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 928' ' ' LEU . . . . . 0.433 ' HA ' HD21 ' A' ' 928' ' ' LEU . 94.1 mt -133.3 117.82 17.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.063 0.459 . . . . 0.0 110.974 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 38.1 ttmt -90.04 132.4 35.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.035 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 930' ' ' TYR . . . . . 0.424 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 4.2 m-85 -122.33 125.75 46.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.037 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 931' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 95.4 mt-10 -96.51 117.32 30.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.543 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 932' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 81.0 m -59.27 169.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.451 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 933' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 910' ' ' PHE . 46.5 mtp85 -84.36 151.16 58.92 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.142 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 19.7 Cg_exo -66.48 66.0 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.303 2.669 . . . . 0.0 112.994 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 935' ' ' GLU . . . . . 0.506 ' HG2' HG13 ' A' ' 982' ' ' VAL . 54.4 mt-10 -163.39 -29.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 109.925 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 936' ' ' TYR . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 910' ' ' PHE . 1.6 m-85 -94.96 147.26 23.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 937' ' ' TYR . . . . . 0.773 ' HB3' ' HD2' ' A' ' 961' ' ' LYS . 1.7 p90 -89.18 132.94 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.241 0.543 . . . . 0.0 111.152 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.37 139.48 4.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.382 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 939' ' ' ARG . . . . . 0.87 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -71.88 171.11 10.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.513 0.197 . . . . 0.0 110.549 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 940' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 40.4 Cg_endo -67.89 121.61 8.66 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.385 2.057 . . . . 0.0 112.26 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.502 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 36.8 p90 -90.15 -161.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.73 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 82.5 p -172.79 134.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.16 -172.6 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.822 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 944' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 946' ' ' LEU . 1.1 m -167.09 123.61 1.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 945' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 33.7 t -63.91 112.09 2.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 946' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 950' ' ' VAL . 87.6 mt -81.25 -53.11 6.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 947' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 19.2 t70 172.54 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.202 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -84.49 37.35 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 949' ' ' LEU . . . . . 0.846 ' HA ' ' HB3' ' A' ' 902' ' ' CYS . 6.4 mp 53.5 48.96 20.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.994 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 6.7 m -120.63 179.97 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.327 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 951' ' ' TRP . . . . . 0.615 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 97.2 m95 -145.13 49.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.231 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 23.5 t 49.5 -141.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 29.7 t -155.44 109.66 2.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.56 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.05 53.99 3.53 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.121 2.547 . . . . 0.0 111.348 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 955' ' ' LYS . . . . . 0.6 ' HB3' ' NZ ' ' A' ' 955' ' ' LYS . 5.8 ttpm? -78.79 133.14 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.666 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 58.4 t0 57.42 40.59 27.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.281 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 957' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 958' ' ' CYS . 27.8 m -90.44 -42.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.511 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 958' ' ' CYS . . . . . 0.487 ' N ' HG21 ' A' ' 957' ' ' VAL . 84.6 m -155.0 141.63 18.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.164 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.5 mmtt -146.21 145.16 30.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.706 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 960' ' ' ARG . . . . . 0.614 ' HD2' ' HB ' ' A' ' 982' ' ' VAL . 14.8 tpp85 -53.24 103.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.141 0.496 . . . . 0.0 110.726 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 961' ' ' LYS . . . . . 0.773 ' HD2' ' HB3' ' A' ' 937' ' ' TYR . 51.5 tttp -59.3 -179.06 0.07 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.566 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 962' ' ' SER . . . . . 0.689 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 83.9 p -149.66 142.58 24.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.625 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . 0.503 ' HA ' ' HB3' ' A' 1011 ' ' ALA . 77.2 m -79.51 164.69 23.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.16 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.9 133.16 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.363 . . . . 0.0 110.554 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 965' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 56.8 m -55.12 131.99 68.58 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 3.0 Cg_exo -74.15 125.12 9.54 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.736 2.291 . . . . 0.0 112.056 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.0 122.46 11.76 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.122 1.882 . . . . 0.0 111.305 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.05 116.07 17.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 969' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 64.5 Cg_endo -73.49 133.96 19.83 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.614 2.209 . . . . 0.0 111.993 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 970' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 971' ' ' ASN . 1.1 p -53.77 -57.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.202 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 971' ' ' ASN . . . . . 0.599 ' H ' HG11 ' A' ' 970' ' ' VAL . 75.9 m-20 -79.01 34.23 0.23 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.356 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . 0.502 ' HA3' ' H ' ' A' ' 991' ' ' THR . . . 177.04 -147.77 8.53 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.953 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 973' ' ' MET . . . . . 0.491 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 22.5 ptt? 174.49 139.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 974' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 15.0 p -95.69 138.87 20.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.324 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 975' ' ' HIS . . . . . 0.464 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.9 m-70 -94.82 113.11 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 976' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 980' ' ' ILE . 92.2 t -65.63 -27.64 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 977' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 975' ' ' HIS . 4.8 mt 56.22 59.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.094 179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 978' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 977' ' ' ILE . 12.3 p 76.61 -49.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.931 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 979' ' ' ASP . . . . . 0.559 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 2.6 p30 -159.88 138.52 10.57 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.459 -178.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 976' ' ' VAL . 15.3 pt -91.46 32.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.974 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 981' ' ' GLN . . . . . 0.689 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -75.5 156.64 34.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.319 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 982' ' ' VAL . . . . . 0.614 ' HB ' ' HD2' ' A' ' 960' ' ' ARG . 57.4 t -54.4 86.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.3 -49.25 0.3 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.922 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 984' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 979' ' ' ASP . 48.0 t -80.44 141.69 35.02 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.972 0.415 . . . . 0.0 110.691 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 985' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 13.9 ptm180 -101.08 137.39 39.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 986' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 16.6 pt -89.07 126.45 42.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.152 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 987' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' 1001 ' ' SER . 7.0 p -103.84 128.63 51.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.346 0.593 . . . . 0.0 112.017 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 988' ' ' TYR . . . . . 0.54 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 2.0 m-85 -96.4 143.75 27.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.164 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 86.1 p -148.67 117.05 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 990' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 994' ' ' HIS . 57.6 m -66.71 133.7 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.823 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 991' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 992' ' ' THR . 13.3 t -68.15 -147.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 992' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 991' ' ' THR . 49.5 m 8.75 -91.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.66 0.784 . . . . 0.0 113.044 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -158.38 44.93 0.47 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.294 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 15.1 m80 -93.76 155.36 17.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . 0.648 ' HB2' HG12 ' A' 1023 ' ' ILE . 7.6 tpt180 -90.04 130.73 36.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.609 -179.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 996' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 995' ' ' ARG . 8.5 tt -67.58 134.54 51.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.699 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 997' ' ' ILE . . . . . 0.96 HD13 ' HG2' ' A' 1021 ' ' GLN . 14.8 mm -107.36 123.31 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 998' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 59.94 134.51 0.01 OUTLIER Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.197 178.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 999' ' ' HIS . . . . . 0.691 ' ND1' ' HB ' ' A' 1015 ' ' THR . 47.0 m170 48.32 -141.98 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.9 p -177.95 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.79 0.329 . . . . 0.0 111.231 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1001 ' ' SER . . . . . 0.465 ' HB3' HG21 ' A' ' 987' ' ' THR . 70.9 p -152.27 157.2 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1002 ' ' ALA . . . . . 0.536 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -151.99 133.42 14.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 111.391 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1003 ' ' GLU . . . . . 0.764 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 18.9 pt-20 -96.22 141.91 29.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -70.95 126.46 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1005 ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' 1014 ' ' SER . 30.9 pt -138.98 162.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1006 ' ' LEU . . . . . 0.642 HD11 ' N ' ' A' 1007 ' ' SER . 3.2 tm? 58.82 -77.76 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.459 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1007 ' ' SER . . . . . 1.017 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 97.1 p 59.59 -111.36 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.458 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1008 ' ' GLY . . . . . 0.578 ' H ' ' HG ' ' A' 1007 ' ' SER . . . 64.43 -112.32 4.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.428 -178.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1009 ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' 1009 ' ' ASN . 2.7 m120 -65.82 -32.55 74.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1010 ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' 1007 ' ' SER . 77.2 m -150.06 122.53 8.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.493 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1011 ' ' ALA . . . . . 1.017 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -83.58 137.97 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.365 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1012 ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.4 OUTLIER -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.178 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A 1013 ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' 1002 ' ' ALA . 67.0 m95 -68.86 150.92 47.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1014 ' ' SER . . . . . 0.588 ' HA ' HD12 ' A' 1005 ' ' ILE . 40.5 t -60.22 -34.6 73.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.476 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1015 ' ' THR . . . . . 0.691 ' HB ' ' ND1' ' A' ' 999' ' ' HIS . 74.8 p -141.78 149.38 40.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.775 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1016 ' ' LYS . . . . . 0.657 ' HD3' ' O ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -56.85 147.72 52.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.56 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A 1017 ' ' PRO . . . . . 0.54 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 25.2 Cg_exo -64.8 123.38 11.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.906 2.404 . . . . 0.0 113.032 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1018 ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 23.6 Cg_exo -64.37 149.43 90.12 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 112.262 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1019 ' ' ILE . . . . . 0.63 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 2.7 mt -98.12 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.486 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1020 ' ' CYS . . . . . 0.557 ' H ' ' CG2' ' A' 1019 ' ' ILE . 23.1 m -163.29 128.58 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.433 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1021 ' ' GLN . . . . . 0.96 ' HG2' HD13 ' A' ' 997' ' ' ILE . 22.8 pt20 -153.21 130.98 11.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1022 ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 32.4 tpt85 -28.19 134.67 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1023 ' ' ILE . . . . . 0.648 HG12 ' HB2' ' A' ' 995' ' ' ARG . 33.6 mt -73.07 124.79 91.04 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.783 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1024 ' ' PRO . . . . . 0.463 ' HD2' HG21 ' A' 1023 ' ' ILE . 74.5 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.543 2.162 . . . . 0.0 112.468 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.778 0.323 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -174.13 45.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.23 143.88 51.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.107 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 949' ' ' LEU . . . 70.47 143.32 0.05 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.653 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.629 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 30.4 m80 -149.08 144.16 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.509 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.29 119.09 19.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.24 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.415 HE21 ' HA ' ' A' ' 903' ' ' GLN . 2.8 mm100 -55.88 166.21 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.628 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.97 131.58 8.86 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.127 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.438 ' HB3' HD13 ' A' ' 943' ' ' ILE . 29.9 Cg_endo -63.27 138.32 65.76 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.415 2.077 . . . . 0.0 111.937 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.71 156.99 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -78.43 126.98 31.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.306 0.574 . . . . 0.0 111.542 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.57 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 2.0 m-85 -90.81 -33.36 15.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.614 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.9 mp 75.72 -48.44 0.6 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.8 OUTLIER -85.72 18.41 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.021 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.32 126.39 6.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 914' ' ' LYS . 52.2 mtmt -96.74 132.94 41.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.092 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 915' ' ' THR . 3.3 tm? -48.71 141.65 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.585 ' H ' HD23 ' A' ' 913' ' ' LEU . 74.7 mmtt -147.14 64.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.61 ' H ' HD12 ' A' ' 913' ' ' LEU . 17.6 m -167.46 139.55 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.066 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.457 ' O ' HG21 ' A' ' 917' ' ' THR . 13.8 pt20 -51.33 124.81 12.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.586 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 916' ' ' GLN . 75.1 p -152.06 135.42 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.6 p -148.59 44.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.491 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.64 156.09 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.0 m -84.1 -44.91 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.819 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.34 120.34 26.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.404 ' HE2' HD12 ' A' ' 928' ' ' LEU . 14.3 m-85 -96.81 141.32 22.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.02 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.58 132.43 14.67 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.581 2.188 . . . . 0.0 112.382 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 947' ' ' ASP . 65.7 mt -54.15 147.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.527 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 78.27 67.25 1.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 1.8 m -174.83 121.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.4 m -90.3 128.43 36.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.645 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 942' ' ' SER . 8.5 tp -97.64 127.51 43.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -80.64 133.59 35.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.495 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 19.7 m-85 -138.5 124.09 19.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.616 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.744 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 55.5 mt-10 -102.03 125.34 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.991 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 99.0 m -57.95 166.09 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.325 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 44.8 mtp85 -82.75 158.94 64.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 936' ' ' TYR . 90.1 Cg_exo -44.07 -46.44 11.13 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.635 2.223 . . . . 0.0 112.697 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.534 ' HA ' HD23 ' A' 1006 ' ' LEU . 56.1 mt-10 -73.77 26.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.43 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.503 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 67.3 m-85 -145.15 157.64 44.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.616 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 31.6 p90 -144.09 137.08 27.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 155.94 29.69 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.636 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.8 ptp85 46.71 164.36 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.497 0.719 . . . . 0.0 112.464 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.744 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 74.2 Cg_endo -75.2 116.44 4.55 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.294 1.996 . . . . 0.0 112.515 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.538 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 16.1 p90 -95.57 -159.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 81.1 p -171.86 136.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.719 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 3.3 pt -96.27 117.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.976 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.899 HG23 HD22 ' A' ' 946' ' ' LEU . 2.8 m -84.23 126.27 32.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 85.2 m -73.48 115.18 12.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.899 HD22 HG23 ' A' ' 944' ' ' THR . 94.5 mt -83.19 -59.93 2.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 55.5 t0 172.91 -37.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.874 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.438 ' HB2' HG13 ' A' ' 950' ' ' VAL . 74.5 m-80 -81.85 26.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.312 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.632 HD12 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 61.3 40.43 14.36 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 948' ' ' ASN . 7.1 p -136.43 152.71 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.341 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.639 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 46.7 m95 -93.72 141.46 28.47 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.907 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 88.5 p -48.14 140.96 6.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 59.9 p -79.02 108.53 8.48 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.919 0.39 . . . . 0.0 111.387 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 952' ' ' SER . 2.9 Cg_exo -76.29 129.59 11.33 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.054 2.503 . . . . 0.0 111.974 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.597 ' NZ ' ' HB2' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -80.65 -145.11 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.466 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -80.71 60.97 4.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.622 HG21 ' N ' ' A' ' 958' ' ' CYS . 26.0 m -80.53 -56.36 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.585 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.622 ' N ' HG21 ' A' ' 957' ' ' VAL . 6.2 t -89.87 135.03 33.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -150.36 130.12 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.871 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 935' ' ' GLU . 40.6 ttm180 -53.91 142.67 23.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.008 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.616 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 13.3 mmmm -54.51 149.28 10.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.161 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.703 ' HB3' HE21 ' A' ' 981' ' ' GLN . 63.7 p -142.49 131.57 23.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -81.53 146.74 30.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.64 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.654 ' HD3' ' N ' ' A' ' 965' ' ' THR . 2.0 tmtp? -66.77 133.41 50.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.047 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.654 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 47.4 m -53.22 130.77 51.56 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.332 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 60.1 Cg_endo -70.9 136.13 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.744 2.296 . . . . 0.0 112.384 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.54 134.58 64.25 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.151 1.901 . . . . 0.0 111.296 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -57.3 122.62 55.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 0.0 111.054 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.21 143.25 58.32 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.111 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' 1020 ' ' CYS . 22.0 t -49.21 129.2 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.23 45.77 16.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.031 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -174.54 -166.75 32.98 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.528 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -178.88 146.71 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.226 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.796 HG22 HD13 ' A' ' 986' ' ' ILE . 7.1 p -98.66 133.54 40.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.823 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.0 OUTLIER -109.89 117.77 34.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.625 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.531 ' O ' HG21 ' A' ' 976' ' ' VAL . 33.9 m -74.46 131.03 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.83 -30.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.875 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.8 p -144.72 -54.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.415 ' O ' HG21 ' A' ' 980' ' ' ILE . 54.7 m-20 -158.64 -142.18 0.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.415 HG21 ' O ' ' A' ' 979' ' ' ASP . 11.5 pt -151.05 37.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.703 HE21 ' HB3' ' A' ' 962' ' ' SER . 7.9 mp0 -76.99 174.17 10.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.198 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 961' ' ' LYS . 28.1 m -63.91 30.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.62 -32.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.272 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 47.7 t -75.97 134.63 40.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 39.1 ptt180 -104.14 134.95 46.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 974' ' ' VAL . 37.3 pt -97.94 137.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.0 p -96.98 135.48 38.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 0.0 111.697 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.412 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 6.7 m-85 -101.68 138.19 39.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.457 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 51.1 m -153.54 121.61 6.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.966 0.412 . . . . 0.0 111.146 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 64.4 m -80.87 157.67 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.3 t -63.93 146.23 54.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.38 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 89.3 m -44.46 122.07 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 128.91 -54.11 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -102.99 138.56 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.663 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.462 ' HB3' HD12 ' A' 1023 ' ' ILE . 39.0 ptt180 -95.13 147.24 23.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.314 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' 1019 ' ' ILE . 4.7 pp -71.63 139.74 49.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.593 ' CD1' ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -122.17 111.15 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 151.76 -60.36 0.41 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.246 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.465 ' CD2' ' HB ' ' A' 1015 ' ' THR . 98.1 m-70 -154.08 -122.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.518 0.199 . . . . 0.0 110.827 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 77.7 p -168.31 -46.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.4 p -156.0 107.62 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.443 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -88.02 132.63 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.409 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 7.4 pm0 -96.27 133.1 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.126 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 42.4 t -77.43 126.9 31.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.8 pt -135.75 -159.73 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.096 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 935' ' ' GLU . 28.0 tp -150.9 138.05 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.914 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 70.4 m -88.17 -44.21 11.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.34 -45.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.001 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.6 m120 -105.15 -31.48 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 98.5 m -142.69 138.53 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.051 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.416 ' HA ' HD11 ' A' 1006 ' ' LEU . . . -82.68 145.71 29.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.102 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.8 p80 -158.55 151.37 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' A' ' 966' ' ' PRO . 66.1 m95 -66.16 141.7 57.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 t -60.92 -30.78 70.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.465 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 61.8 p -144.06 139.29 28.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.52 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.524 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.7 pptp? -63.32 155.22 75.52 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.411 ' HB3' ' HE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -66.01 130.09 23.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.523 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_exo -64.88 -150.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.901 2.401 . . . . 0.0 112.628 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 996' ' ' LEU . 1.5 mt -136.91 -158.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.511 ' H ' ' CG2' ' A' 1019 ' ' ILE . 73.7 m -155.07 132.01 10.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.312 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' A' ' 997' ' ' ILE . 3.0 pt20 -152.42 142.26 22.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -48.51 128.92 15.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.359 0.599 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.622 HG21 ' HD2' ' A' 1024 ' ' PRO . 37.8 mt -74.83 128.98 84.34 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.039 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.622 ' HD2' HG21 ' A' 1023 ' ' ILE . 59.2 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.742 2.295 . . . . 0.0 112.34 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.64 138.7 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.061 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -56.18 136.72 52.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -166.16 131.94 2.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.408 ' N ' HD23 ' A' ' 949' ' ' LEU . 41.9 m80 -150.75 132.23 14.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.672 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 6.1 p -82.15 128.96 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.409 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.3 mm100 -69.85 170.63 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.291 0.567 . . . . 0.0 111.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.42 134.3 12.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.41 149.96 84.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.4 ' OD2' ' HD2' ' A' ' 907' ' ' HIS . 27.5 t70 -61.64 172.72 1.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.4 ' HD2' ' OD2' ' A' ' 906' ' ' ASP . 0.5 OUTLIER -77.96 130.4 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.242 0.544 . . . . 0.0 111.553 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.525 ' HZ ' HG22 ' A' ' 943' ' ' ILE . 1.5 m-85 -89.98 -43.46 10.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.585 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 82.2 mt 75.0 -43.01 0.5 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.929 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 908' ' ' PHE . 0.1 OUTLIER -83.55 -1.03 52.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -153.65 128.96 9.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.48 132.65 40.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 914' ' ' LYS . 3.3 tm? -44.65 144.89 0.99 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.995 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 38.5 ttpt -138.54 -36.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.514 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 917' ' ' THR . 4.6 m -64.63 143.64 57.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.618 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -49.4 125.29 10.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.221 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.468 HG23 HD12 ' A' ' 928' ' ' LEU . 81.0 p -152.04 143.77 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.239 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.3 m -159.48 -47.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.558 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.25 160.32 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.4 p -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -85.37 145.38 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -132.03 136.0 27.51 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.488 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.411 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.9 Cg_endo -69.54 141.86 47.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.838 2.358 . . . . 0.0 112.198 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.703 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 15.9 mm -54.63 151.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.489 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 90.09 -30.74 5.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.174 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.0 m -55.9 125.25 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 112.015 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 34.9 t -95.94 135.14 38.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.855 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.664 HD22 ' HH ' ' A' ' 930' ' ' TYR . 9.0 tp -117.1 114.19 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.685 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -89.91 139.66 30.38 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.664 ' HH ' HD22 ' A' ' 928' ' ' LEU . 7.0 m-85 -130.06 130.67 45.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.463 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 8.6 pt-20 -92.73 125.4 37.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.193 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 91.3 m -52.65 143.9 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.402 . . . . 0.0 111.42 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.585 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.9 mtp180 -82.93 155.94 67.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.44 64.75 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.721 2.28 . . . . 0.0 112.753 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.586 ' HA ' HD13 ' A' 1006 ' ' LEU . 39.1 tt0 -174.85 2.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.22 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.568 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 40.1 m-85 -141.24 136.32 31.56 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.402 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.73 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 16.4 p90 -102.73 139.78 37.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.256 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . 150.45 27.68 0.05 OUTLIER Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.58 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 938' ' ' GLY . 16.6 ptm180 45.79 171.04 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 122.971 0.508 . . . . 0.0 112.019 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.481 ' CD ' ' HB2' ' A' ' 939' ' ' ARG . 2.6 Cg_endo -77.86 112.89 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.109 1.873 . . . . 0.0 111.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.406 ' HD1' ' N ' ' A' ' 942' ' ' SER . 23.1 p90 -94.43 -160.52 0.78 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.467 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.406 ' N ' ' HD1' ' A' ' 941' ' ' PHE . 41.9 t -172.89 143.09 1.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.525 HG22 ' HZ ' ' A' ' 908' ' ' PHE . 3.5 pt -94.03 -170.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.986 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.756 HG23 HD22 ' A' ' 946' ' ' LEU . 1.0 OUTLIER -164.63 127.59 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 12.1 t -66.94 112.64 4.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.756 HD22 HG23 ' A' ' 944' ' ' THR . 87.6 mt -82.18 -57.79 3.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -174.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.648 ' HA ' HG22 ' A' ' 924' ' ' ILE . 4.8 t70 172.74 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.948 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -83.5 34.95 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.692 HD22 HD13 ' A' ' 924' ' ' ILE . 30.7 mt 51.9 47.3 25.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.314 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.8 OUTLIER -135.43 -168.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.766 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -146.02 128.77 16.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.088 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 47.7 t -43.96 143.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.085 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.4 t -78.58 115.6 52.9 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.04 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 908' ' ' PHE . 5.1 Cg_exo -75.95 53.49 3.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.372 2.714 . . . . 0.0 112.151 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.39 132.33 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.692 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.434 ' O ' HG11 ' A' ' 957' ' ' VAL . 65.0 t0 56.99 77.89 0.25 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.231 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 956' ' ' ASP . 24.5 m -149.31 -30.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.548 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.778 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 34.8 t -151.6 62.97 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.469 . . . . 0.0 110.913 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.731 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 11.3 mmpt? -55.23 153.77 6.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.646 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.821 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -58.43 132.25 53.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.669 -179.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.73 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 21.4 mmtp -56.37 135.64 53.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.082 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.619 ' HB2' ' HG2' ' A' ' 981' ' ' GLN . 48.3 t -152.66 129.08 10.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.998 0.428 . . . . 0.0 111.018 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 6.1 p -81.58 154.76 26.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.294 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -65.15 137.96 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 0.0 110.92 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 69.4 m -54.17 128.53 57.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 32.6 Cg_endo -63.67 134.41 43.97 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.439 2.092 . . . . 0.0 111.732 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.58 127.89 26.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.104 1.869 . . . . 0.0 111.525 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -57.49 125.46 71.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.95 138.74 41.21 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.5 p -50.89 124.2 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.681 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 59.24 48.04 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.499 ' HA3' ' H ' ' A' ' 991' ' ' THR . . . -156.87 -155.13 7.32 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.534 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 42.8 ttp 173.94 135.74 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.628 HG22 HD13 ' A' ' 986' ' ' ILE . 15.0 p -98.65 123.99 51.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 977' ' ' ILE . 33.3 m-70 -76.98 108.51 10.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 979' ' ' ASP . 89.1 t -62.58 -32.16 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 71.83 -47.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.82 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -148.38 -60.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.596 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.423 ' O ' HG11 ' A' ' 976' ' ' VAL . 2.9 m-20 -155.01 -152.89 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.065 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.416 HG21 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -148.64 22.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.934 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.821 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 84.9 mt-30 -79.36 156.5 27.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.007 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.646 HG12 ' HG ' ' A' 1006 ' ' LEU . 49.2 t -49.95 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.158 0.504 . . . . 0.0 111.065 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 151.8 -40.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.266 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.0 p -76.01 138.54 40.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' 1001 ' ' SER . 76.9 ttt180 -104.19 125.97 50.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.628 HD13 HG22 ' A' ' 974' ' ' VAL . 41.3 pt -98.94 129.22 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.818 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.1 p -96.95 134.2 40.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.563 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 22.9 m-85 -96.13 139.02 32.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.454 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 52.5 m -152.42 116.45 4.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.476 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.8 146.92 41.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.499 ' H ' ' HA3' ' A' ' 972' ' ' GLY . 94.0 m -64.64 142.96 58.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.245 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.406 ' N ' HG21 ' A' ' 991' ' ' THR . 6.0 t -41.94 124.38 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.025 0.441 . . . . 0.0 111.553 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.85 -48.35 0.97 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.742 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -102.33 144.5 30.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.541 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.2 ptt180 -92.63 143.7 26.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 999' ' ' HIS . 7.5 tt -71.81 132.32 44.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.876 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.7 mp -110.05 134.55 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.8 -128.22 9.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.359 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.504 ' O ' HD23 ' A' ' 996' ' ' LEU . 93.8 m-70 -78.3 -132.51 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.437 0.16 . . . . 0.0 111.394 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.8 t -174.25 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.65 0.262 . . . . 0.0 111.191 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.465 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 76.2 p -150.89 150.29 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.893 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.58 130.53 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.0 tt0 -99.08 135.52 40.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 30.5 t -71.44 119.19 15.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.613 HD11 ' H ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -140.78 160.39 23.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.541 0.686 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.646 ' HG ' HG12 ' A' ' 982' ' ' VAL . 93.1 mt -89.22 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.793 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.499 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 68.7 m -149.99 -32.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -157.05 57.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.274 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' 1009 ' ' ASN . 1.9 m120 61.44 27.74 17.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.009 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 8.0 m -149.11 131.99 16.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 128.65 34.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.859 0.362 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.499 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.2 p80 -158.09 145.8 18.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.487 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.416 ' HH2' HG21 ' A' ' 980' ' ' ILE . 58.7 m95 -67.48 137.73 56.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.9 p -54.8 -28.71 51.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.701 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.442 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 81.5 p -139.34 138.9 37.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.957 0.408 . . . . 0.0 111.815 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' 1017 ' ' PRO . 7.5 tmtm? -57.38 134.76 81.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.487 ' N ' ' HD3' ' A' 1016 ' ' LYS . 50.7 Cg_exo -54.56 126.67 23.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 31.8 Cg_exo -59.75 -157.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.832 2.355 . . . . 0.0 112.716 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.538 ' CG2' ' H ' ' A' 1020 ' ' CYS . 1.2 mt -139.75 -161.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.257 0.551 . . . . 0.0 110.964 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.4 m -155.93 138.51 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.876 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.6 tt0 -151.25 134.77 16.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.309 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -46.21 128.46 9.62 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.3 mt -74.87 126.65 88.11 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.765 2.31 . . . . 0.0 112.555 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.812 0.339 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -170.27 134.29 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.46 -154.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.327 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -74.12 130.12 39.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.406 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.428 ' N ' HD23 ' A' ' 949' ' ' LEU . 67.2 m80 -153.65 133.64 13.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.5 p -82.27 110.92 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.314 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -83.23 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.88 124.85 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.548 ' HB3' ' CG ' ' A' ' 951' ' ' TRP . 86.8 Cg_endo -82.33 124.09 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.701 2.268 . . . . 0.0 113.395 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 35.8 t0 26.05 -137.09 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.061 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.481 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 35.4 p-80 -161.05 151.43 17.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.168 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -145.51 134.0 21.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.527 ' N ' HD13 ' A' ' 909' ' ' LEU . 4.2 mp -83.04 -49.16 9.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.212 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 933' ' ' ARG . 0.8 OUTLIER -84.97 28.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -156.46 135.11 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' A' ' 912' ' ' LYS . 0.0 OUTLIER -136.44 124.52 22.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.193 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 58.7 tp -49.38 144.67 5.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.137 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.725 ' HD2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -154.75 27.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 0.0 110.986 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.626 HG21 ' HG3' ' A' ' 916' ' ' GLN . 24.2 m -69.96 -111.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.572 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.626 ' HG3' HG21 ' A' ' 915' ' ' THR . 2.5 pp0? -169.13 34.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.452 0.644 . . . . 0.0 110.413 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.1 t -87.35 154.78 20.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.898 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.7 p -136.5 46.54 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.448 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -166.67 159.31 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.015 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.2 p -85.01 -36.95 20.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -84.58 146.03 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 87.6 m-85 -134.75 145.57 55.34 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 111.526 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.5 137.51 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.453 2.769 . . . . 0.0 112.386 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.583 HG21 ' N ' ' A' ' 925' ' ' GLY . 53.3 mt -54.34 154.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.196 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.583 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 74.24 58.14 4.43 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.642 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 3.8 m -175.23 127.26 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.43 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.618 ' HB3' ' OG1' ' A' ' 944' ' ' THR . 79.4 p -105.68 135.42 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.652 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.601 ' HB2' ' HE1' ' A' ' 930' ' ' TYR . 93.5 mt -96.85 128.29 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.363 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.7 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 15.3 tppt? -82.88 121.05 26.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.748 0.309 . . . . 0.0 111.383 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.601 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 9.2 m-85 -111.72 127.95 55.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.725 ' HG3' ' HD2' ' A' ' 914' ' ' LYS . 61.9 mm-40 -92.16 107.0 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 110.637 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 83.1 m -59.62 178.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.856 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.494 ' HD3' ' HA ' ' A' ' 910' ' ' PHE . 78.9 mtp180 -85.67 151.7 55.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.134 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 936' ' ' TYR . 53.2 Cg_exo -52.85 -37.17 76.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.904 2.403 . . . . 0.0 112.872 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.96 12.39 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.662 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 934' ' ' PRO . 33.8 m-85 -139.6 128.75 23.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 19.3 p90 -96.2 137.05 35.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.425 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . 147.33 152.67 5.71 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.72 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.61 142.16 83.44 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.344 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.7 ' HB2' ' HD2' ' A' ' 929' ' ' LYS . 40.9 Cg_exo -56.36 137.02 78.62 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.918 2.412 . . . . 0.0 111.85 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.469 ' HD1' HG22 ' A' ' 943' ' ' ILE . 30.4 p90 -89.71 124.7 34.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.55 0.691 . . . . 0.0 111.336 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 928' ' ' LEU . 75.1 p -75.52 -38.65 59.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.877 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 927' ' ' SER . 47.7 pt 49.32 93.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.618 0.723 . . . . 0.0 111.702 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 927' ' ' SER . 11.9 m -84.29 139.56 32.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.586 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.496 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 98.2 m -73.7 129.06 37.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.732 HD21 HG21 ' A' ' 950' ' ' VAL . 2.2 mm? -82.56 -65.98 0.94 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.558 ' HA ' HD11 ' A' ' 924' ' ' ILE . 24.6 t70 172.82 -41.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.397 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -85.54 41.9 0.93 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.071 0.462 . . . . 0.0 109.89 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 901' ' ' HIS . 63.5 mt 53.28 48.87 21.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.732 HG21 HD21 ' A' ' 946' ' ' LEU . 6.6 m -131.87 177.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.483 0.658 . . . . 0.0 112.005 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.548 ' CG ' ' HB3' ' A' ' 905' ' ' PRO . 46.8 m95 -135.23 126.88 28.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.84 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.471 ' N ' HD22 ' A' ' 946' ' ' LEU . 11.0 m -42.43 148.85 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.274 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 35.4 t -76.98 121.52 84.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.45 ' HG3' HG23 ' A' ' 943' ' ' ILE . 3.0 Cg_exo -76.55 56.44 5.13 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.538 2.826 . . . . 0.0 111.734 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 956' ' ' ASP . 57.8 tttp -75.87 123.61 25.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.431 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' A' ' 955' ' ' LYS . 1.4 m-20 57.76 98.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.384 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 941' ' ' PHE . 16.1 m -151.07 -31.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 92.5 m -152.05 65.4 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.6 mmtt -60.52 137.65 58.13 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.699 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 36.8 ttm180 -59.59 135.56 57.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.652 ' HZ3' HD12 ' A' 1006 ' ' LEU . 98.0 mttt -57.52 145.91 31.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.517 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.7 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 75.6 p -142.47 137.34 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 68.8 m -81.03 154.93 26.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.137 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.81 127.7 33.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.842 0.353 . . . . 0.0 110.667 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 19.4 m -57.15 136.83 80.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.765 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.479 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 5.8 Cg_endo -48.15 140.45 19.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.229 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 968' ' ' ASP . 65.5 Cg_endo -73.62 49.4 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.791 2.327 . . . . 0.0 112.983 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 967' ' ' PRO . 1.7 p30 26.06 67.29 0.47 Allowed Pre-proline 0 N--CA 1.465 0.289 0 O-C-N 123.507 0.505 . . . . 0.0 112.153 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -40.56 134.56 2.18 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.76 2.307 . . . . 0.0 112.635 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.463 HG23 ' ND2' ' A' ' 971' ' ' ASN . 2.6 p -53.1 132.95 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.764 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.463 ' ND2' HG23 ' A' ' 970' ' ' VAL . 76.7 m-20 58.66 53.14 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.332 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -155.66 -153.51 6.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.554 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 38.9 ttm 176.52 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.543 0.211 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . . . . . . . . . 1.9 p -93.83 168.44 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.23 0.538 . . . . 0.0 110.652 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.728 ' NE2' HG13 ' A' ' 977' ' ' ILE . 8.4 t60 -152.83 104.01 2.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.297 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 26.9 m -66.72 -24.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.758 HG23 HG21 ' A' ' 978' ' ' THR . 3.8 mp 76.86 -42.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 0.0 110.435 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.758 HG21 HG23 ' A' ' 977' ' ' ILE . 81.5 p -144.77 -59.76 0.36 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.645 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.8 m-20 -157.39 -145.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.389 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.526 HG22 HG13 ' A' ' 976' ' ' VAL . 4.2 pt -148.25 20.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.068 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.7 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 3.7 mm100 -76.63 177.2 7.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.87 -24.13 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 109.869 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -107.9 53.67 0.59 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.606 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 54.9 m -158.31 127.68 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.014 0.435 . . . . 0.0 110.604 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.447 ' O ' HD12 ' A' ' 977' ' ' ILE . 74.0 ttt180 -104.22 129.13 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.186 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.59 HG21 ' HA ' ' A' ' 976' ' ' VAL . 42.7 pt -103.07 151.77 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.807 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.504 ' OG1' HD13 ' A' ' 977' ' ' ILE . 8.5 p -135.79 138.65 42.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.077 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.479 ' OH ' ' HB3' ' A' ' 966' ' ' PRO . 2.0 m-85 -96.48 151.44 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.399 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 53.6 m -153.61 69.6 0.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.578 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 66.5 m -44.5 151.08 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.776 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 146.2 50.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 77.6 m -40.59 -38.68 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.183 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -55.03 -49.49 62.51 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.826 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.574 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.2 m80 -102.45 141.6 35.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.018 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.615 ' HB3' HG12 ' A' 1023 ' ' ILE . 33.6 ptt85 -90.65 141.43 28.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.32 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 999' ' ' HIS . 5.5 tt -71.87 133.82 45.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.0 mp -104.71 135.07 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.26 -139.19 15.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.572 ' HD1' ' N ' ' A' 1000 ' ' SER . 23.1 p80 -79.58 -135.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.572 ' N ' ' HD1' ' A' ' 999' ' ' HIS . 80.1 p -177.41 16.08 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.594 0.235 . . . . 0.0 111.358 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.473 ' H ' ' HD1' ' A' ' 999' ' ' HIS . 32.1 t -159.43 145.05 15.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.43 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.64 124.02 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.1 tt0 -98.45 137.73 36.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 50.0 t -71.2 124.27 24.1 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' 1006 ' ' LEU . 27.4 pt -133.39 -154.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.952 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.652 HD12 ' HZ3' ' A' ' 961' ' ' LYS . 2.5 tt -154.27 125.36 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.489 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 40.4 t -90.1 42.95 1.12 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.206 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.494 ' N ' HD21 ' A' 1006 ' ' LEU . . . 52.94 26.8 27.82 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.671 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -158.93 -47.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.2 m -147.82 143.53 27.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.054 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -79.83 131.92 36.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.489 ' HE2' ' HB2' ' A' 1007 ' ' SER . 7.6 p80 -160.18 155.95 25.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 80.9 m95 -64.29 144.72 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -54.54 -33.21 59.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 1.7 t -146.75 148.42 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.382 0.611 . . . . 0.0 112.29 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.63 138.04 86.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.985 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.8 138.01 42.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.723 2.282 . . . . 0.0 112.661 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.447 ' HG3' ' CE1' ' A' ' 999' ' ' HIS . 24.1 Cg_exo -63.02 -160.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.29 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 42.3 mt -141.75 136.45 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.0 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.442 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 70.9 m -97.15 125.31 41.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.758 ' HB2' HD12 ' A' ' 997' ' ' ILE . 0.7 OUTLIER -143.14 128.3 18.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -178.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 13.0 ptp180 -47.5 140.36 5.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.588 0.708 . . . . 0.0 111.535 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.615 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.9 mt -74.84 130.87 80.3 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.162 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 46.0 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.809 2.34 . . . . 0.0 112.265 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 897' ' ' GLU . 53.0 mp0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.823 0.344 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -81.39 48.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.059 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 59.66 46.03 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.818 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -74.65 135.74 41.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -152.69 132.02 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.7 p -82.34 118.51 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.99 173.51 9.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.982 0.42 . . . . 0.0 111.307 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.42 135.55 7.38 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -51.9 136.14 51.46 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.59 2.193 . . . . 0.0 112.068 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 907' ' ' HIS . 35.4 m-20 -64.83 105.1 0.94 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 906' ' ' ASP . 0.4 OUTLIER 11.27 110.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.173 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 3.6 m-85 -90.02 131.47 35.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 110.227 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 909' ' ' LEU . 2.2 mm? -75.19 -68.71 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.685 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.5 OUTLIER -85.29 21.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -149.35 150.75 32.97 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.135 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.462 ' HD3' ' NH1' ' A' ' 933' ' ' ARG . 23.8 pttm -140.51 136.67 33.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.641 HD12 ' H ' ' A' ' 915' ' ' THR . 3.5 tm? -45.27 139.68 3.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.609 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.568 ' N ' HD12 ' A' ' 913' ' ' LEU . 30.7 mmmt -150.82 58.06 0.92 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.731 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.641 ' H ' HD12 ' A' ' 913' ' ' LEU . 15.5 m -167.88 134.95 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.885 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.485 ' NE2' HG22 ' A' ' 915' ' ' THR . 3.4 pm0 -55.74 138.37 47.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.465 ' O ' ' OG1' ' A' ' 918' ' ' THR . 60.0 p -150.75 -57.22 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.396 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 917' ' ' THR . 22.6 p 68.79 -50.11 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.831 0.707 . . . . 0.0 112.255 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.32 148.14 48.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.43 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.7 p -85.8 -48.29 8.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.25 123.27 30.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.182 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 50.1 m-85 -103.86 146.2 32.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.486 . . . . 0.0 112.019 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.6 Cg_endo -83.8 139.9 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.488 2.792 . . . . 0.0 111.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 947' ' ' ASP . 48.1 mt -52.77 152.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.341 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.565 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 89.65 -40.74 3.02 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 38.1 m -56.85 137.69 54.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.345 . . . . 0.0 110.458 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.591 ' HB2' ' OG ' ' A' ' 942' ' ' SER . 82.2 p -120.8 132.33 54.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.113 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 942' ' ' SER . 72.8 mt -106.21 136.41 45.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.04 0.447 . . . . 0.0 111.741 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.527 ' HB2' ' OG1' ' A' ' 915' ' ' THR . 99.3 mttt -86.5 133.41 33.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.723 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.544 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 11.6 m-85 -132.64 125.27 30.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.531 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.43 ' CG ' ' HG3' ' A' ' 914' ' ' LYS . 95.4 mt-10 -95.29 133.18 39.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 72.8 m -58.51 150.31 23.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.018 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.581 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 41.5 mtp85 -82.84 163.36 51.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.518 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.589 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 40.6 Cg_endo -66.75 64.57 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 95.1 mt-10 -165.43 -18.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.232 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 3.0 m-85 -129.38 -168.75 1.99 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 958' ' ' CYS . 16.5 p90 -150.03 138.26 20.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.985 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 167.22 4.84 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.353 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.94 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 6.6 ppt_? 46.06 173.27 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 123.013 0.525 . . . . 0.0 112.286 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.94 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 13.6 Cg_endo -58.93 89.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.41 2.073 . . . . 0.0 113.059 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.501 ' HA ' ' NH1' ' A' ' 939' ' ' ARG . 42.2 p90 -90.17 120.85 31.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.879 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.591 ' OG ' ' HB2' ' A' ' 927' ' ' SER . 23.8 t -74.03 160.21 31.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.809 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 927' ' ' SER . 5.4 pt -137.64 104.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 946' ' ' LEU . 30.3 m -82.33 130.79 35.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 97.9 m -73.71 132.08 42.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 944' ' ' THR . 2.5 mm? -84.54 -60.22 2.14 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.725 ' HA ' HD11 ' A' ' 924' ' ' ILE . 55.1 t0 171.66 -36.81 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.691 0.282 . . . . 0.0 110.953 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.424 ' O ' HG11 ' A' ' 950' ' ' VAL . 73.3 m-80 -82.94 37.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 947' ' ' ASP . 79.6 mt 50.5 42.98 27.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.934 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 948' ' ' ASN . 22.2 m -136.13 147.99 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.796 0.808 . . . . 0.0 112.07 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 952' ' ' SER . 52.2 m95 -91.82 122.16 34.1 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.596 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.516 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -38.68 126.13 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 70.3 m -78.15 107.14 4.96 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 110.909 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 956' ' ' ASP . 60.4 Cg_endo -100.92 55.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 124.013 3.142 . . . . 0.0 112.608 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -77.44 38.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.539 0.685 . . . . 0.0 110.09 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 954' ' ' PRO . 34.3 t70 -159.92 53.78 0.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.692 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.45 HG22 ' CG ' ' A' ' 941' ' ' PHE . 8.8 m -147.05 -17.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.871 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 937' ' ' TYR . 11.1 t -147.57 135.38 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.123 0.487 . . . . 0.0 110.901 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 32.0 mtmt -147.77 149.87 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.252 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 52.2 ttm-85 -53.31 135.38 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 982' ' ' VAL . 30.2 mmtp -56.29 164.73 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.36 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.73 ' HB3' HE22 ' A' ' 981' ' ' GLN . 85.1 p -145.5 132.84 20.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.797 0.332 . . . . 0.0 110.216 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 49.2 m -81.57 36.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.747 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 61.7 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 30.7 m -55.79 129.06 71.06 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.534 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.518 ' HG3' HD11 ' A' ' 986' ' ' ILE . 57.5 Cg_endo -70.71 121.3 7.79 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.462 2.108 . . . . 0.0 112.693 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.76 123.76 10.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.455 2.103 . . . . 0.0 111.364 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.54 120.95 64.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.36 141.27 50.89 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.38 2.053 . . . . 0.0 111.752 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.2 p -45.96 127.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 66.16 49.34 1.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.888 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -163.82 -158.15 9.82 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.867 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 40.0 ttm 176.72 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.536 0.208 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.5 p -100.56 131.47 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.819 0.343 . . . . 0.0 111.52 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.429 ' HB2' HD12 ' A' ' 977' ' ' ILE . 31.3 m-70 -91.87 111.46 23.0 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.618 ' HA ' HG21 ' A' ' 986' ' ' ILE . 30.1 m -64.22 -18.69 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 109.913 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 977' ' ' ILE . 12.4 mm 74.57 -47.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 67.9 p -148.18 -49.97 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.759 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.552 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.4 m-20 -157.49 -149.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.866 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 980' ' ' ILE . 13.2 pt -151.08 25.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 111.143 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.73 HE22 ' HB3' ' A' ' 962' ' ' SER . 3.0 mm100 -80.91 163.7 23.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.143 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 961' ' ' LYS . 54.8 t -55.43 93.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.078 0.466 . . . . 0.0 111.14 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.66 -47.6 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.232 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.5 t -76.4 141.31 41.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 111.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 3.5 ptm85 -104.22 131.86 51.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.546 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 976' ' ' VAL . 26.7 pt -98.13 127.48 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.0 p -97.07 132.69 42.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.977 0.417 . . . . 0.0 110.953 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.506 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 10.8 m-85 -96.6 139.96 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.443 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -152.74 116.43 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.181 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.658 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 83.9 m -73.02 147.21 45.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.454 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.577 ' H ' ' HA3' ' A' ' 972' ' ' GLY . 8.6 t -64.86 149.16 50.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.614 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 84.8 m -46.68 108.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.317 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 152.92 -57.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.265 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.421 ' HB3' ' C ' ' A' 1021 ' ' GLN . 7.6 m80 -102.46 145.92 28.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.763 ' HB3' HG12 ' A' 1023 ' ' ILE . 15.6 ptm180 -90.02 139.16 30.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.166 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 999' ' ' HIS . 6.3 tt -71.84 132.7 44.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.942 0.401 . . . . 0.0 110.734 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.604 HD12 ' HB2' ' A' 1021 ' ' GLN . 3.5 mp -106.07 130.84 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.52 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 96.56 -138.75 14.1 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.085 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.551 ' O ' HD23 ' A' ' 996' ' ' LEU . 83.0 m-70 -81.27 -140.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.414 0.15 . . . . 0.0 111.146 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 42.7 t 178.9 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.416 ' HB2' HH21 ' A' ' 985' ' ' ARG . 66.1 p -158.8 148.95 19.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.045 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.52 ' HB1' ' HB ' ' A' 1015 ' ' THR . . . -156.55 118.16 3.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.2 tt0 -96.33 128.61 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 50.6 t -71.32 119.39 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.4 pt -136.6 143.6 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.244 0.545 . . . . 0.0 111.892 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.423 HD21 ' C ' ' A' ' 934' ' ' PRO . 53.8 tp -84.61 124.48 31.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.998 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.518 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.5 t -95.96 -50.24 4.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' 1010 ' ' THR . . . 169.26 122.16 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.71 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 72.99 -37.14 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.164 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.481 ' H ' ' C ' ' A' 1008 ' ' GLY . 84.6 m -145.72 136.26 24.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.216 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 151.09 26.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.372 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.518 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.7 p80 -153.07 147.59 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.405 ' CH2' HG22 ' A' ' 986' ' ' ILE . 86.9 m95 -64.37 139.13 58.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.162 0.506 . . . . 0.0 111.297 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 m -62.42 -21.75 65.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.282 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.52 ' HB ' ' HB1' ' A' 1002 ' ' ALA . 37.8 m -138.9 135.74 34.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.4 pttm -72.73 148.28 89.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.768 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.448 ' HG3' ' HH ' ' A' ' 988' ' ' TYR . 32.9 Cg_exo -59.85 129.02 28.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.589 2.193 . . . . 0.0 112.397 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.506 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.24 -154.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.735 2.29 . . . . 0.0 112.465 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.49 HG21 ' N ' ' A' 1020 ' ' CYS . 53.1 mt -139.91 141.54 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.49 ' N ' HG21 ' A' 1019 ' ' ILE . 97.5 m -100.85 125.65 47.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.604 ' HB2' HD12 ' A' ' 997' ' ' ILE . 3.3 tt0 -145.51 138.11 25.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.387 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -45.55 135.62 6.33 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 111.703 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.763 HG12 ' HB3' ' A' ' 995' ' ' ARG . 54.8 mt -74.76 126.94 87.92 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' 1023 ' ' ILE . 66.2 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.711 2.274 . . . . 0.0 112.482 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.732 0.301 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -178.67 136.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -151.39 130.38 12.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.776 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 924' ' ' ILE . . . 64.65 136.3 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.52 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.604 ' N ' HD23 ' A' ' 949' ' ' LEU . 8.5 m170 -147.5 120.78 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.52 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 24.9 p -82.25 122.33 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.02 167.69 20.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.476 0.655 . . . . 0.0 112.045 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -47.53 133.23 10.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.509 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.508 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.5 Cg_exo -62.32 154.54 62.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.926 2.418 . . . . 0.0 112.407 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 907' ' ' HIS . 27.1 t70 -62.23 173.08 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.677 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.437 ' N ' ' CG ' ' A' ' 906' ' ' ASP . 42.6 m170 -77.68 121.48 24.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.288 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 1.9 m-85 -86.43 -36.09 19.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 92.0 mt 75.98 -46.03 0.54 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.748 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 6.05 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.66 126.44 5.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.2 124.81 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.309 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.646 HD12 ' HG ' ' A' ' 928' ' ' LEU . 63.2 tp -51.61 156.79 1.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.587 ' H ' HD13 ' A' ' 913' ' ' LEU . 73.9 mmtt -145.29 -66.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 914' ' ' LYS . 17.9 m 19.88 -117.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.687 0.617 . . . . 0.0 111.884 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -175.95 41.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.201 0.524 . . . . 0.0 110.476 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 39.0 p -82.8 -172.82 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 98.0 m -169.1 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.478 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.4 157.76 37.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -84.61 -43.62 14.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.37 124.8 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 80.4 m-85 -103.69 134.55 19.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.56 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 59.9 Cg_endo -71.94 141.92 37.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 112.126 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.675 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 32.7 mt -59.69 156.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.666 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 82.71 -35.6 2.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.716 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.56 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 18.7 m -56.04 127.42 30.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.526 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 48.7 m -101.72 131.42 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.646 ' HG ' HD12 ' A' ' 913' ' ' LEU . 5.2 tp -95.79 -168.07 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.177 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.534 ' O ' HD13 ' A' ' 913' ' ' LEU . 40.6 ttmt -157.44 130.36 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 941' ' ' PHE . 5.4 m-85 -129.09 135.64 49.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.384 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.659 ' OE1' ' HB3' ' A' ' 940' ' ' PRO . 2.9 mm-40 -96.26 134.78 38.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.363 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 86.6 m -55.33 155.35 5.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.545 ' HG2' ' HD2' ' A' ' 934' ' ' PRO . 65.1 ttt180 -82.37 145.13 51.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.545 ' HD2' ' HG2' ' A' ' 933' ' ' ARG . 67.6 Cg_exo -39.35 -41.2 2.15 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.717 2.278 . . . . 0.0 112.884 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 961' ' ' LYS . 50.2 mt-10 -69.14 -34.74 75.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.487 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 933' ' ' ARG . 18.3 m-85 -94.85 142.61 27.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.144 0.497 . . . . 0.0 112.305 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.594 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 8.3 p90 -100.08 141.99 32.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.655 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 153.44 147.65 4.69 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.222 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.677 ' H ' ' HD2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -73.08 158.84 86.47 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.659 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 31.2 Cg_exo -60.03 115.45 2.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.573 2.182 . . . . 0.0 112.208 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 930' ' ' TYR . 49.3 p90 -95.6 -168.21 1.74 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 928' ' ' LEU . 68.8 m -166.93 134.6 2.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.099 0.476 . . . . 0.0 111.33 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.44 HD13 ' HG2' ' A' ' 905' ' ' PRO . 5.1 pt -102.38 125.69 56.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.443 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.552 HG23 ' CD2' ' A' ' 946' ' ' LEU . 18.0 m -82.77 122.09 27.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.28 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.675 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 8.4 t -71.44 103.07 2.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.672 ' HB2' HG21 ' A' ' 950' ' ' VAL . 88.0 mt -82.72 162.02 21.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 949' ' ' LEU . 62.6 t0 -45.44 -34.23 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.135 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.402 ' HB2' HG23 ' A' ' 950' ' ' VAL . 2.6 m120 -81.32 28.89 0.37 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.623 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 901' ' ' HIS . 45.7 mt 47.79 31.78 2.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.323 0.582 . . . . 0.0 109.918 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.672 HG21 ' HB2' ' A' ' 946' ' ' LEU . 29.5 m -107.92 -160.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.62 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 81.9 m95 -150.67 121.41 7.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.817 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.9 p -41.49 142.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.497 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 39.7 t -78.58 115.08 48.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.051 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.8 Cg_exo -74.61 130.81 14.07 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.995 2.463 . . . . 0.0 111.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 955' ' ' LYS . 29.8 mmmt -80.77 -133.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.464 0.65 . . . . 0.0 111.755 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -78.36 60.32 2.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.314 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 941' ' ' PHE . 33.9 m -81.51 -34.09 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.885 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.457 ' O ' ' HE3' ' A' ' 959' ' ' LYS . 30.0 m -150.41 125.7 10.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.12 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.788 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.1 mmpt? -137.48 149.53 46.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.834 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 14.7 mmt85 -53.2 120.7 6.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.594 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 28.8 mtpp -58.29 -171.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 81.1 p -153.14 137.7 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.8 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 58.5 m -81.58 38.85 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt 59.0 130.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 49.6 m -57.74 126.7 76.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.63 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 52.6 Cg_endo -68.6 128.75 17.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.418 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.66 131.18 38.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.365 2.043 . . . . 0.0 111.614 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -61.28 120.63 56.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.954 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 139.22 36.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.072 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' 1020 ' ' CYS . 20.4 t -52.01 130.06 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.436 ' ND2' HG13 ' A' ' 970' ' ' VAL . 72.8 m-20 56.82 52.8 8.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.677 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -158.26 -153.3 6.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.243 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 32.2 ttp 175.01 119.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.607 0.241 . . . . 0.0 111.002 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.02 124.21 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.728 0.775 . . . . 0.0 111.355 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.599 ' CD2' HG12 ' A' ' 977' ' ' ILE . 5.5 t60 -87.28 103.08 15.11 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.829 ' HA ' HG23 ' A' ' 986' ' ' ILE . 27.6 m -53.02 -20.51 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.631 HD13 HG22 ' A' ' 987' ' ' THR . 12.9 mt 66.58 60.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.583 0.706 . . . . 0.0 109.395 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 977' ' ' ILE . 14.1 p 80.79 -48.42 0.29 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.234 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.544 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 55.3 m-20 -156.27 -158.57 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.86 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.453 HG22 HG13 ' A' ' 976' ' ' VAL . 12.8 pt -151.04 23.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.35 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' A' ' 979' ' ' ASP . 7.2 mp0 -76.54 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 961' ' ' LYS . 96.2 t -55.49 84.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.125 0.488 . . . . 0.0 110.736 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.9 -45.94 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.108 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 50.5 m -76.05 138.85 41.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 111.257 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.639 ' HE ' ' HB3' ' A' 1003 ' ' GLU . 38.3 ttm180 -103.37 139.1 39.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.351 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.829 HG23 ' HA ' ' A' ' 976' ' ' VAL . 20.3 pt -98.62 122.45 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.678 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.631 HG22 HD13 ' A' ' 977' ' ' ILE . 6.7 p -101.93 135.56 43.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.095 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.684 ' HB2' HD13 ' A' ' 996' ' ' LEU . 3.1 m-85 -96.49 140.4 31.18 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.747 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 43.9 t -151.75 64.45 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 35.8 m -35.75 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.618 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 9.0 t -174.18 165.87 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' 1023 ' ' ILE . 9.0 t -52.84 -36.28 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.659 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' 1023 ' ' ILE . . . -63.69 -55.14 26.68 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.488 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -101.81 136.73 41.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.413 . . . . 0.0 111.26 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.7 ptt180 -92.57 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.511 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 988' ' ' TYR . 8.7 tt -72.36 132.23 43.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.1 mp -111.25 132.78 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 111.302 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 68.04 131.84 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.217 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.497 ' HE2' ' HZ2' ' A' 1016 ' ' LYS . 76.6 m-70 47.5 -139.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.652 0.263 . . . . 0.0 111.449 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.489 ' HA ' HD23 ' A' ' 996' ' ' LEU . 47.1 t -177.05 -30.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.437 ' HB2' HG21 ' A' ' 987' ' ' THR . 46.8 t -154.56 168.66 26.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.491 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.96 133.65 14.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.045 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.639 ' HB3' ' HE ' ' A' ' 985' ' ' ARG . 19.3 pt-20 -96.15 134.14 39.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.122 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.8 t -76.42 124.76 28.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' 1014 ' ' SER . 41.9 pt -135.94 -154.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.471 . . . . 0.0 112.115 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.537 HD13 ' H ' ' A' 1009 ' ' ASN . 62.3 tp -151.85 138.55 18.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.009 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.697 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 46.6 t -87.91 -48.22 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.17 20.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.13 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.537 ' H ' HD13 ' A' 1006 ' ' LEU . 10.3 p-10 174.94 -53.79 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.408 ' O ' HD11 ' A' 1006 ' ' LEU . 10.3 m -98.88 130.56 45.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.606 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.566 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -81.21 134.8 35.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.697 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.1 p80 -158.82 147.64 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 111.65 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.496 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 60.5 m95 -68.23 134.96 51.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.771 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' 1005 ' ' ILE . 91.4 p -68.37 -12.22 60.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 6.4 m -140.93 139.24 34.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.497 ' HZ2' ' HE2' ' A' ' 999' ' ' HIS . 24.7 pttm -69.76 146.0 95.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.057 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.479 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 23.9 Cg_exo -64.63 135.71 46.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.869 2.379 . . . . 0.0 112.55 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 38.0 Cg_endo -66.28 -156.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.568 2.178 . . . . 0.0 112.449 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.7 mt -142.22 139.95 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.677 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 71.7 m -93.41 124.3 37.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.774 ' HB3' HD12 ' A' ' 997' ' ' ILE . 41.1 tt0 -145.79 133.3 20.84 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.6 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -48.12 133.2 15.38 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.559 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 995' ' ' ARG . 44.8 mt -75.14 124.93 89.6 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.803 2.336 . . . . 0.0 112.253 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.75 0.31 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -171.41 135.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -152.58 -155.33 0.6 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.71 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.761 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . 59.69 -145.4 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 16.1 m80 67.8 127.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.703 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 2.4 p -82.27 130.03 35.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.453 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -67.22 -177.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.576 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.21 137.9 6.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.551 ' HB2' ' HH ' ' A' ' 930' ' ' TYR . 2.7 Cg_exo -75.07 63.41 6.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.202 2.601 . . . . 0.0 112.167 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.1 t0 36.32 -131.99 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.676 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 17.6 t-160 -160.45 120.21 2.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.848 0.356 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.583 ' HE2' ' HG2' ' A' ' 954' ' ' PRO . 21.9 m-85 -88.15 136.35 33.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.98 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.25 -58.58 3.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.347 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.84 26.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.4 122.33 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.443 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.664 ' HB2' ' HZ3' ' A' ' 912' ' ' LYS . 10.3 mtmp? -100.52 131.49 46.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.432 HD22 ' OG1' ' A' ' 917' ' ' THR . 52.1 tp -48.22 129.71 15.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.491 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.533 ' HD3' ' HD2' ' A' ' 929' ' ' LYS . 51.6 tttp -94.51 -43.08 8.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.433 HG23 HG21 ' A' ' 917' ' ' THR . 42.7 m -64.6 144.43 57.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.853 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -77.54 49.29 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.616 HG23 ' HE2' ' A' ' 922' ' ' PHE . 39.5 p -81.42 146.28 30.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 72.9 p -136.39 -33.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.576 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.47 156.22 39.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 54.6 m -84.78 -38.83 19.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.9 145.29 28.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.616 ' HE2' HG23 ' A' ' 917' ' ' THR . 71.7 m-85 -136.32 137.68 25.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.752 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.5 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -69.74 136.6 33.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.716 2.277 . . . . 0.0 111.764 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.576 HG21 ' H ' ' A' ' 925' ' ' GLY . 39.9 mt -58.04 154.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.205 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 87.02 -34.02 3.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 22.9 m -55.93 122.24 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.659 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.6 m -94.91 120.72 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.885 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 917' ' ' THR . 10.0 tp -99.24 118.85 36.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.316 . . . . 0.0 110.737 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.533 ' HD2' ' HD3' ' A' ' 914' ' ' LYS . 39.9 ttmt -85.34 138.76 32.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.106 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.551 ' HH ' ' HB2' ' A' ' 905' ' ' PRO . 7.2 m-85 -131.65 134.85 46.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.515 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.49 ' HG2' ' HD2' ' A' ' 914' ' ' LYS . 56.6 mm-40 -95.58 130.53 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.607 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.16 156.52 9.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . . . . . . . . . 45.0 mtt-85 -84.8 151.84 58.61 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 936' ' ' TYR . 86.6 Cg_exo -47.48 -46.75 19.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.685 2.257 . . . . 0.0 112.859 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.29 20.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.745 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 934' ' ' PRO . 82.2 m-85 -145.17 137.32 25.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.402 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.71 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 14.3 p90 -97.71 138.0 35.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.423 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 158.57 142.59 3.43 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.082 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -73.06 159.07 86.09 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.258 . . . . 0.0 110.362 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.84 149.17 71.13 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.275 1.983 . . . . 0.0 111.294 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.518 ' CD1' ' HB ' ' A' ' 957' ' ' VAL . 50.7 p90 -140.01 -167.91 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.78 0.324 . . . . 0.0 110.93 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.4 p -172.88 134.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.491 HG23 ' HG3' ' A' ' 954' ' ' PRO . 15.3 pt -97.21 113.55 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 946' ' ' LEU . 47.1 m -78.49 126.67 31.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.2 t -72.96 125.1 26.8 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.155 0.502 . . . . 0.0 109.936 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.763 ' HB2' HG21 ' A' ' 950' ' ' VAL . 1.6 mm? -88.35 167.9 13.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 0.0 113.606 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 949' ' ' LEU . 38.9 t70 -50.6 -38.63 46.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.293 -1.776 . . . . 0.0 112.25 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.509 HD21 HG12 ' A' ' 950' ' ' VAL . 50.9 t30 -81.6 34.25 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 900' ' ' ALA . 21.0 mt 47.93 36.73 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.196 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.763 HG21 ' HB2' ' A' ' 946' ' ' LEU . 29.1 m -112.85 -159.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.241 0.543 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.5 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 85.4 m95 -147.32 124.89 11.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 80.9 p -39.68 141.75 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.803 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 33.7 m -79.51 112.91 32.6 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.583 ' HG2' ' HE2' ' A' ' 908' ' ' PHE . 5.8 Cg_exo -79.63 143.56 16.96 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.456 2.771 . . . . 0.0 112.346 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -159.01 137.22 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.691 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 7.2 m-20 58.95 33.8 23.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.246 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' A' ' 941' ' ' PHE . 29.4 m -94.15 -32.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.209 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 37.4 m -149.82 59.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.205 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.691 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 74.2 mmtt -58.07 152.47 16.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.995 0.426 . . . . 0.0 111.762 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.484 ' HG2' ' HG3' ' A' ' 981' ' ' GLN . 20.8 tpp180 -53.33 116.53 2.48 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.71 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 63.6 tttt -56.26 147.57 20.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.437 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 78.7 p -144.61 139.71 28.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 964' ' ' LYS . 37.4 m -81.56 36.18 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.633 ' HB3' ' HZ2' ' A' ' 964' ' ' LYS . 6.3 ttpm? 56.22 134.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.727 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.4 m -60.31 124.15 76.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.331 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.553 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 59.5 Cg_endo -71.48 130.43 17.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.469 2.112 . . . . 0.0 112.565 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.67 135.04 50.41 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.445 2.097 . . . . 0.0 111.61 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.03 115.13 10.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.655 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 138.92 66.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.712 2.275 . . . . 0.0 112.388 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.3 t -53.86 134.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 971' ' ' ASN . 2.4 m120 56.98 42.56 26.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.873 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -160.28 -155.75 7.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.518 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 35.7 ttp 174.22 131.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.985 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -101.4 128.98 53.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.814 0.34 . . . . 0.0 111.459 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.534 ' O ' HG13 ' A' ' 977' ' ' ILE . 28.3 m-70 -87.85 114.34 24.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.463 ' HA ' HG23 ' A' ' 986' ' ' ILE . 69.9 t -62.13 -33.67 59.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.018 0.437 . . . . 0.0 109.859 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 975' ' ' HIS . 15.0 mt 71.39 -48.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.285 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 977' ' ' ILE . 74.6 p -146.12 -60.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.859 0.362 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.529 ' O ' HG21 ' A' ' 980' ' ' ILE . 2.6 m-20 -152.47 -161.88 1.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.862 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.529 HG21 ' O ' ' A' ' 979' ' ' ASP . 10.0 pt -146.78 19.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.531 . . . . 0.0 110.492 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' 1004 ' ' CYS . 6.7 mm100 -80.82 -178.17 6.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.643 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' A' ' 961' ' ' LYS . 30.0 m -64.9 25.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -157.19 44.16 0.51 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.754 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.4 p -160.54 132.97 6.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.283 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 16.9 ptp180 -100.97 131.06 47.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.044 0.449 . . . . 0.0 111.446 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.63 HD13 ' HH ' ' A' ' 988' ' ' TYR . 23.7 pt -99.35 131.77 46.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.778 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.612 HG21 ' HG ' ' A' 1001 ' ' SER . 6.0 p -95.72 133.43 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.0 111.392 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.63 ' HH ' HD13 ' A' ' 986' ' ' ILE . 5.9 m-85 -98.95 137.86 36.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 55.7 m -153.5 115.01 4.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 74.1 m -75.55 150.93 38.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.809 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 23.8 m -64.07 143.57 57.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.7 t -37.8 139.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.941 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.24 -40.87 2.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' 1021 ' ' GLN . 3.0 m80 -99.37 137.95 37.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.046 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.543 ' HE ' HG12 ' A' 1023 ' ' ILE . 14.2 ptp180 -97.36 147.22 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 999' ' ' HIS . 9.8 tt -69.28 129.52 40.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.571 HD13 ' CD ' ' A' 1021 ' ' GLN . 31.7 mm -102.15 80.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.747 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . 154.93 -131.13 3.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.697 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.581 ' O ' HD23 ' A' ' 996' ' ' LEU . 29.2 m80 -81.48 -116.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.515 0.197 . . . . 0.0 111.454 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.576 ' HA ' HD12 ' A' ' 996' ' ' LEU . 46.9 t -178.61 -30.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.955 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.612 ' HG ' HG21 ' A' ' 987' ' ' THR . 52.6 m -155.58 148.88 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.88 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' 1015 ' ' THR . . . -153.36 133.04 13.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.636 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -100.2 136.9 39.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 13.0 t -71.14 124.22 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.25 -149.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.927 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.518 HD12 ' HZ1' ' A' ' 961' ' ' LYS . 66.2 tp -150.89 139.61 20.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.248 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.725 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 97.6 p -88.62 -52.22 5.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.553 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 158.7 31.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 176.14 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 56.9 m -139.27 134.93 33.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.281 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.25 140.34 36.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.725 ' HE2' ' HB3' ' A' 1007 ' ' SER . 9.9 p80 -158.37 146.19 18.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 78.2 m95 -64.38 146.47 54.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.934 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.6 t -49.91 -34.28 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.723 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.436 ' H ' ' HB1' ' A' 1002 ' ' ALA . 75.8 p -144.74 139.39 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.056 0.455 . . . . 0.0 111.821 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.594 ' HD2' ' N ' ' A' 1017 ' ' PRO . 3.8 tmmm? -62.88 136.21 96.39 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.345 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.594 ' N ' ' HD2' ' A' 1016 ' ' LYS . 10.4 Cg_endo -54.08 124.87 17.03 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.786 2.324 . . . . 0.0 112.801 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.747 ' HB3' ' HA2' ' A' ' 998' ' ' GLY . 44.4 Cg_endo -67.3 -150.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.799 2.332 . . . . 0.0 112.65 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.471 ' CG2' ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -133.18 -158.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.839 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -159.54 135.97 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.566 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.601 ' C ' ' H ' ' A' 1023 ' ' ILE . 3.6 pt20 -151.31 141.89 22.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.521 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' 1022 ' ' ARG . 27.5 ptt85 -64.01 22.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.601 ' H ' ' C ' ' A' 1021 ' ' GLN . 58.0 mt 64.61 132.08 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 52.5 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.836 2.357 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -66.12 -165.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.279 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.44 139.28 0.19 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 924' ' ' ILE . . . 66.69 143.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.478 ' N ' HD23 ' A' ' 949' ' ' LEU . 45.7 m80 -148.99 140.05 23.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 86.5 m -81.6 131.61 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.701 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -54.6 158.73 2.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 111.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 919' ' ' ALA . . . -48.27 123.32 10.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.846 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.49 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 34.3 Cg_exo -59.17 136.83 75.34 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 122.669 2.246 . . . . 0.0 112.94 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.2 143.79 57.48 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.93 131.92 39.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 911' ' ' ALA . 2.0 m-85 -85.29 150.14 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.987 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -81.17 -57.07 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.047 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.8 OUTLIER -85.47 10.77 11.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -152.14 151.62 31.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.49 136.3 39.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 928' ' ' LEU . 57.5 tp -45.77 130.58 9.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.593 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 914' ' ' LYS . 11.7 tmtt? -94.59 -51.19 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 52.9 m -66.52 136.58 55.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.616 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -64.76 138.54 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.828 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.562 HG23 HD12 ' A' ' 928' ' ' LEU . 81.0 p -154.25 -170.2 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 917' ' ' THR . 40.1 p -156.15 34.28 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.644 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 904' ' ' ALA . . . 41.05 -146.0 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.799 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' A' ' 919' ' ' ALA . 47.6 t 62.39 44.52 7.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.967 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 902' ' ' CYS . 1.5 m-20 66.61 153.54 0.08 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.503 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.407 ' CE1' ' HA ' ' A' ' 919' ' ' ALA . 63.6 m-85 -136.4 145.97 53.97 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.209 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.492 ' HG2' ' HG1' ' A' ' 926' ' ' THR . 18.1 Cg_endo -59.25 138.24 83.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.729 2.286 . . . . 0.0 111.896 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.633 HG21 ' H ' ' A' ' 925' ' ' GLY . 37.4 mt -58.96 155.73 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.633 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 85.42 -32.36 3.63 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.674 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.492 ' HG1' ' HG2' ' A' ' 923' ' ' PRO . 40.9 m -55.97 126.29 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 47.3 t -96.36 127.87 42.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.781 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.562 HD12 HG23 ' A' ' 917' ' ' THR . 8.6 tp -105.47 120.52 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 0.0 110.903 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 915' ' ' THR . 40.2 ttmt -85.68 140.98 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.556 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 6.3 m-85 -129.15 168.48 16.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.417 ' OE2' ' HG2' ' A' ' 914' ' ' LYS . 16.6 pt-20 -144.47 137.38 26.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.926 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.69 143.26 37.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.02 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.0 mtp180 -85.52 158.69 56.94 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 7.6 Cg_endo -49.64 139.74 30.34 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.579 2.186 . . . . 0.0 111.745 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 50.5 mt-10 81.38 25.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.334 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.483 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 88.2 m-85 -146.87 135.66 22.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.796 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.8 p90 -102.34 137.47 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.885 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 157.62 146.06 4.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.877 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 77.2 mtp180 -72.82 162.72 72.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.662 0.268 . . . . 0.0 110.82 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 73.5 Cg_endo -78.75 114.66 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.384 2.056 . . . . 0.0 112.278 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 48.2 p90 -91.68 -160.17 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.5 p -175.28 132.92 0.3 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.561 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 11.0 pt -93.99 -166.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.188 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.635 ' O ' HD23 ' A' ' 946' ' ' LEU . 26.5 m -166.61 132.6 2.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.5 t -73.79 120.47 19.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.67 ' H ' HD21 ' A' ' 946' ' ' LEU . 1.8 mm? -87.02 174.22 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.219 1.009 . . . . 0.0 112.803 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.05 -42.69 73.01 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.135 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.418 ' O ' HG12 ' A' ' 950' ' ' VAL . 48.7 t30 -84.51 35.09 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.584 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 83.0 mt 46.42 59.66 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.815 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.574 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 16.0 m -138.48 -157.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.117 0.484 . . . . 0.0 111.393 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.49 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 94.3 m95 -149.13 115.98 5.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.478 ' N ' HD22 ' A' ' 946' ' ' LEU . 72.4 m -52.12 147.51 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.4 t -78.16 122.97 86.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.561 ' HG3' ' CG2' ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.09 26.77 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.866 2.377 . . . . 0.0 112.831 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.629 ' NZ ' ' HB2' ' A' ' 955' ' ' LYS . 7.2 mtmp? 39.82 -143.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.01 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.587 ' OD1' ' HE2' ' A' ' 959' ' ' LYS . 60.3 t0 -79.5 134.26 36.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 958' ' ' CYS . 2.5 m -150.68 -98.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.504 ' H ' ' CG2' ' A' ' 957' ' ' VAL . 63.7 m -77.13 147.36 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.014 0.435 . . . . 0.0 111.374 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.587 ' HE2' ' OD1' ' A' ' 956' ' ' ASP . 68.5 mttm -144.93 157.15 44.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.172 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.815 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -59.95 114.98 3.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.851 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.566 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 24.6 ttmm -56.23 150.34 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.653 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 82.8 p -144.51 141.02 29.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.985 0.421 . . . . 0.0 111.38 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 82.0 m -79.9 151.6 30.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.156 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.48 131.06 45.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 29.4 m -55.77 122.94 49.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.58 134.71 29.05 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.428 2.085 . . . . 0.0 111.765 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.84 124.49 15.99 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.047 1.831 . . . . 0.0 111.433 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -58.29 122.86 62.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.788 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.65 138.4 83.09 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.064 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' 1020 ' ' CYS . 21.7 t -52.79 130.47 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.678 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 70.36 36.78 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.837 ' HA3' ' H ' ' A' ' 991' ' ' THR . . . -172.48 -153.16 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.055 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.689 ' HE1' ' HE1' ' A' ' 975' ' ' HIS . 24.1 ptt? 177.41 145.44 0.11 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.491 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 7.7 p -93.81 120.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.689 ' HE1' ' HE1' ' A' ' 973' ' ' MET . 41.4 m-70 -78.87 112.97 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 27.8 m -63.99 -18.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.189 0.519 . . . . 0.0 109.748 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.468 ' O ' HG21 ' A' ' 978' ' ' THR . 8.9 mt 74.07 -44.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.953 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 977' ' ' ILE . 81.3 p -146.77 -54.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.622 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.601 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 45.1 m-20 -159.18 -144.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.514 HG22 HG13 ' A' ' 976' ' ' VAL . 7.0 pt -151.09 31.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.156 0.503 . . . . 0.0 110.944 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.815 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 3.2 mm100 -76.87 156.01 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.504 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.542 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 94.5 t -55.44 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 159.0 -37.99 0.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.278 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.9 p -76.58 139.1 40.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 111.626 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.746 ' HG2' ' HB2' ' A' 1003 ' ' GLU . 87.2 mtm180 -90.64 159.08 16.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.999 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.491 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 41.9 pt -132.72 123.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.9 p -103.85 138.68 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.457 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.469 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.2 m-85 -100.79 138.57 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.266 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 81.9 p -153.48 131.41 11.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 71.5 m -74.17 126.04 29.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.603 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.837 ' H ' ' HA3' ' A' ' 972' ' ' GLY . 6.0 t -76.58 55.1 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.468 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 991' ' ' THR . 99.9 m -177.64 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.405 ' H ' ' HD1' ' A' ' 994' ' ' HIS . . . -168.66 39.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.499 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 3.0 m80 -93.65 159.73 15.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.635 ' HB3' HG12 ' A' 1023 ' ' ILE . 37.3 ptt180 -89.87 135.56 33.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 999' ' ' HIS . 2.1 tm? -71.98 132.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 3.3 mt -118.29 135.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.387 . . . . 0.0 111.487 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.17 -125.57 8.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.533 ' O ' HD13 ' A' ' 996' ' ' LEU . 95.8 m-70 -79.3 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.8 p -174.58 -37.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.9 p -150.85 151.71 32.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.547 ' HB1' ' H ' ' A' 1015 ' ' THR . . . -151.92 133.17 14.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.087 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.746 ' HB2' ' HG2' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.36 136.62 36.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.208 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 35.5 t -71.25 121.8 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.501 ' HA ' HG11 ' A' ' 982' ' ' VAL . 33.5 pt -133.46 -153.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.411 . . . . 0.0 111.934 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.85 136.11 17.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.038 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.745 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.9 t -89.41 -40.88 12.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.713 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.55 -37.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.035 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.5 m120 -140.92 -48.03 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.063 0.458 . . . . 0.0 110.5 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 57.8 m -94.53 135.76 35.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.227 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.488 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -80.78 145.64 31.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.745 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.5 p80 -157.66 144.06 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.371 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 70.7 m95 -66.0 147.05 53.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.4 t -55.81 -35.11 65.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.594 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.547 ' H ' ' HB1' ' A' 1002 ' ' ALA . 82.8 p -143.12 143.78 31.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.462 . . . . 0.0 111.726 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -56.83 137.59 78.71 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.907 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.431 ' HB3' ' HH ' ' A' ' 988' ' ' TYR . 53.1 Cg_exo -52.9 129.89 35.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.379 2.053 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 38.3 Cg_exo -61.44 -158.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 112.683 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.2 mt -142.86 139.37 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.945 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 42.8 t -94.43 129.02 41.34 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 995' ' ' ARG . 2.5 tp-100 -145.74 128.62 16.38 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.664 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -54.39 133.29 45.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.35 0.595 . . . . 0.0 111.311 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.635 HG12 ' HB3' ' A' ' 995' ' ' ARG . 57.5 mt -74.83 122.8 88.29 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.2 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.866 2.378 . . . . 0.0 112.347 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.596 0.236 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 63.91 131.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.204 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 62.62 122.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.723 ' HB2' HD12 ' A' ' 949' ' ' LEU . . . 62.67 130.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.454 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.596 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 41.3 m80 -150.91 136.76 18.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.002 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.41 125.35 29.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.291 0.567 . . . . 0.0 111.213 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -57.7 168.83 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.607 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.5 133.51 13.37 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.567 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.42 145.97 78.84 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.55 2.167 . . . . 0.0 111.729 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.74 148.65 42.2 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.39 0.614 . . . . 0.0 111.332 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -81.19 115.02 20.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.027 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.447 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 9.5 m-85 -89.93 134.39 34.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.762 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.539 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 76.7 mt -76.96 -54.4 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 2.1 p90 -84.59 25.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.201 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.17 120.76 4.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.514 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -103.48 121.14 42.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 930' ' ' TYR . 29.8 tp -49.25 122.05 5.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.004 0.43 . . . . 0.0 111.324 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 0.8 OUTLIER -90.94 -44.77 9.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.321 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 54.3 m -64.65 132.92 51.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.43 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.413 ' O ' HG21 ' A' ' 917' ' ' THR . 3.2 pm0 -65.12 143.64 57.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.267 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.5 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 80.7 p -150.22 -58.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.089 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 82.6 p 46.25 56.16 6.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . 0.425 ' HB2' ' H ' ' A' ' 920' ' ' SER . . . -165.51 -152.43 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.0 111.491 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 919' ' ' ALA . 60.1 m -146.58 -44.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.866 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.51 135.37 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.113 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.5 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 55.1 m-85 -137.69 141.37 32.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.939 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.488 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 70.0 Cg_endo -73.93 136.98 23.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.634 2.223 . . . . 0.0 111.647 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 947' ' ' ASP . 53.4 mt -52.6 151.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.573 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 91.31 -28.38 8.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.491 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.488 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 31.8 m -55.43 138.99 44.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.994 0.426 . . . . 0.0 111.553 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.7 m -118.0 142.5 47.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.76 120.49 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.519 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -89.83 133.38 34.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.472 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 2.9 m-85 -116.12 134.77 54.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 65.7 mm-40 -94.45 117.25 29.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.801 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 68.7 m -59.41 140.63 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.344 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.0 mtp180 -85.37 158.74 57.31 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 9.2 Cg_endo -52.71 149.47 24.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.519 2.146 . . . . 0.0 110.886 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 49.6 mt-10 83.5 19.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.72 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 960' ' ' ARG . 94.3 m-85 -144.95 125.11 13.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 5.1 p90 -95.96 141.4 29.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.46 147.39 5.46 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.087 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.725 ' HD3' ' H ' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.27 159.03 86.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.83 126.11 16.04 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.585 2.19 . . . . 0.0 112.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 5.2 p90 -90.88 -162.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.712 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 64.1 m -170.12 133.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.2 pt -95.76 168.94 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.277 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.66 ' O ' HD23 ' A' ' 946' ' ' LEU . 20.4 m -162.6 135.26 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 52.8 m -73.8 126.83 31.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 944' ' ' THR . 2.6 mm? -85.19 -53.55 5.18 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.702 ' HA ' HD11 ' A' ' 924' ' ' ILE . 50.9 t0 171.73 -38.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.691 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.07 28.07 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 900' ' ' ALA . 7.0 mp 60.8 43.22 12.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.419 HG21 ' H ' ' A' ' 951' ' ' TRP . 12.2 p -139.32 149.75 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.886 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.419 ' H ' HG21 ' A' ' 950' ' ' VAL . 51.0 m95 -94.02 141.06 28.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.0 p -52.34 138.11 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 44.9 t -79.19 108.61 8.84 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.756 0.312 . . . . 0.0 111.196 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 952' ' ' SER . 6.4 Cg_exo -72.75 136.03 24.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.675 2.25 . . . . 0.0 111.497 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -158.99 143.37 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.373 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.49 36.72 16.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.572 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.462 ' O ' ' HD2' ' A' ' 959' ' ' LYS . 2.8 m -92.4 -111.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.009 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 51.0 m -86.82 87.29 7.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.717 ' HD2' ' H ' ' A' ' 959' ' ' LYS . 8.3 mptt -67.75 154.59 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.469 ' HA ' ' CD1' ' A' ' 936' ' ' TYR . 37.7 ttm180 -54.54 136.52 44.73 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.85 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 16.6 tppt? -53.78 152.32 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.508 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 70.9 p -143.95 124.08 13.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.775 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.508 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.1 p -83.54 37.95 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 965' ' ' THR . 53.4 tptt 60.09 138.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.386 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.489 HG21 ' HD2' ' A' ' 966' ' ' PRO . 9.2 m -57.47 131.86 81.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.734 ' HG3' HD11 ' A' ' 986' ' ' ILE . 37.2 Cg_endo -65.02 125.0 13.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.471 2.114 . . . . 0.0 112.462 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.27 120.57 7.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.305 2.003 . . . . 0.0 111.498 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.455 ' HB3' ' HA ' ' A' ' 973' ' ' MET . 1.5 m-20 -62.55 122.28 72.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.62 144.91 91.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 111.877 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.3 p -48.32 127.44 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.548 ' ND2' HG23 ' A' ' 970' ' ' VAL . 76.8 m-20 63.75 46.4 4.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.907 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.79 -154.07 9.02 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.513 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.455 ' HA ' ' HB3' ' A' ' 968' ' ' ASP . 24.8 ptt? 175.69 143.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.287 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 986' ' ' ILE . 13.5 p -93.79 127.18 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -89.55 110.53 21.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.377 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.551 HG13 HG21 ' A' ' 980' ' ' ILE . 34.8 m -71.99 134.62 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 978' ' ' THR . 47.6 mm -73.45 -38.74 53.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 110.503 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.426 HG22 HG23 ' A' ' 977' ' ' ILE . 76.8 p -144.76 -42.61 0.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 54.3 t0 -160.72 -136.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.197 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.551 HG21 HG13 ' A' ' 976' ' ' VAL . 9.5 pt -151.07 1.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 110.981 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -75.62 164.5 26.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.543 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 53.4 t -50.1 133.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 102.67 -39.03 2.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.566 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 95.8 p -76.06 138.09 40.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -98.87 157.18 16.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.232 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.734 HD11 ' HG3' ' A' ' 966' ' ' PRO . 47.8 pt -141.96 137.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 111.685 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 4.7 p -108.33 133.25 52.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.465 ' CZ ' HD13 ' A' ' 986' ' ' ILE . 5.9 m-85 -94.66 143.2 26.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.789 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.74 123.31 9.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 61.9 m -88.94 146.47 24.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -64.93 147.47 53.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.448 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 86.8 m -45.61 117.1 1.34 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.979 0.419 . . . . 0.0 111.192 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 141.49 -48.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.151 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -113.04 139.2 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.618 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.496 ' HG3' HD13 ' A' ' 997' ' ' ILE . 38.3 ptt180 -93.0 140.9 28.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' 1018 ' ' PRO . 8.9 tt -72.01 126.1 28.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.215 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.714 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.4 mp -102.93 130.92 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.344 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.54 -142.89 15.62 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.617 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.5 ' O ' ' HG3' ' A' 1018 ' ' PRO . 87.5 m-70 -84.03 132.19 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.574 0.226 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.4 t -81.32 -55.87 4.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.5 p -89.2 153.17 21.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.508 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -156.6 123.37 5.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.116 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -104.59 131.25 52.21 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 49.1 t -75.0 131.0 40.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.433 HD11 HG22 ' A' 1005 ' ' ILE . 31.7 pt -135.8 -155.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.581 -0.447 . . . . 0.0 112.007 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' 1010 ' ' THR . 56.3 tp -150.39 131.9 14.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.687 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 26.3 t -90.08 -134.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.395 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -67.65 -49.77 47.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.643 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -152.11 27.56 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.4 ' C ' HD13 ' A' 1006 ' ' LEU . 6.6 m -149.73 130.99 14.58 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.489 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -81.52 137.94 35.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.765 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.687 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.9 p80 -159.76 144.33 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.593 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.508 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 93.1 m95 -64.48 146.74 54.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.704 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.7 t -57.56 -31.5 66.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.508 ' OG1' ' HB1' ' A' 1002 ' ' ALA . 81.6 p -144.35 138.77 28.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.583 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.538 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 1.6 pptp? -62.52 160.7 32.14 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 18.6 Cg_endo -59.57 129.03 29.2 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.499 2.133 . . . . 0.0 112.271 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.5 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 16.8 Cg_exo -67.22 -160.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.581 ' CG2' ' HB ' ' A' ' 997' ' ' ILE . 1.2 tt -144.55 121.3 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.217 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.9 m -78.92 132.91 36.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.714 ' HB3' HD12 ' A' ' 997' ' ' ILE . 36.4 tt0 -146.68 130.93 17.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.406 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -44.29 132.8 5.72 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.524 0.678 . . . . 0.0 111.928 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.668 HG21 ' HD2' ' A' 1024 ' ' PRO . 22.2 mt -76.07 130.44 78.04 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.303 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.668 ' HD2' HG21 ' A' 1023 ' ' ILE . 54.2 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.482 2.122 . . . . 0.0 112.421 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.788 0.327 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -66.3 135.51 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 64.77 141.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.79 ' HB3' HD13 ' A' ' 924' ' ' ILE . . . -165.19 127.29 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 44.9 m170 -119.87 123.12 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 5.4 p -82.13 127.19 32.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.547 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.2 mm100 -58.34 169.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.12 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -45.86 135.68 6.39 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.544 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 3.0 Cg_exo -74.64 61.86 5.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.063 2.508 . . . . 0.0 111.909 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.565 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 48.4 t0 41.45 -143.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.565 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 70.9 t60 -161.78 116.7 1.98 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.726 0.298 . . . . 0.0 110.974 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 74.3 m-85 -85.93 135.26 33.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.076 0.465 . . . . 0.0 110.779 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.638 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 5.3 mp -74.97 -48.33 24.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.569 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.58 17.7 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.621 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.51 121.88 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 111.788 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 933' ' ' ARG . 59.7 pttt -102.7 128.87 49.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.21 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 930' ' ' TYR . 0.8 OUTLIER -48.61 125.34 9.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.607 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -94.47 -31.47 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.56 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.456 ' HB ' HD23 ' A' ' 913' ' ' LEU . 86.8 m -62.2 135.92 57.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 111.786 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.533 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.1 pm0 -78.34 61.25 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.672 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 918' ' ' THR . 3.4 t -80.62 -53.02 6.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' THR . . . . . 0.439 ' N ' HG22 ' A' ' 917' ' ' THR . 24.9 m 51.81 55.1 9.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.31 155.36 9.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 48.4 t -86.58 -44.83 11.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.21 138.96 32.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.524 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.445 ' HB2' ' SG ' ' A' ' 902' ' ' CYS . 17.0 m-85 -127.67 137.88 31.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.84 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.558 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 60.0 Cg_endo -72.13 131.97 18.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.484 2.123 . . . . 0.0 110.922 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.79 HD13 ' HB3' ' A' ' 900' ' ' ALA . 44.6 mt -57.1 149.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.926 0.393 . . . . 0.0 111.327 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.564 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 91.69 -34.37 4.39 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.663 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 15.8 m -57.19 129.9 43.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 942' ' ' SER . 47.6 t -87.89 151.74 22.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.541 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.625 ' O ' HG12 ' A' ' 943' ' ' ILE . 10.0 tp -140.85 102.18 4.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.51 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 17.8 ptpt -85.37 132.76 34.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.191 0.52 . . . . 0.0 111.99 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.557 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 2.0 m-85 -111.49 133.9 53.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.791 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.466 ' OE2' ' HE3' ' A' ' 912' ' ' LYS . 23.4 pt-20 -95.57 126.47 40.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.3 m -57.87 148.59 24.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 76.9 mtt-85 -85.15 161.95 50.68 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 75.3 Cg_exo -45.64 139.96 9.68 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.234 1.956 . . . . 0.0 112.176 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 95.0 mt-10 82.49 23.43 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.495 ' N ' ' HG3' ' A' ' 961' ' ' LYS . 85.9 m-85 -146.81 145.41 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.558 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.568 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 16.1 p90 -144.07 140.84 29.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 110.942 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.36 21.89 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.651 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.606 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 79.5 mtp180 62.81 164.61 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.85 0.357 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 63.6 Cg_endo -77.65 115.42 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.146 1.897 . . . . 0.0 110.676 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.622 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 42.3 p90 -89.67 108.1 19.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.525 0.678 . . . . 0.0 112.068 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.77 ' HA ' ' HA ' ' A' ' 929' ' ' LYS . 80.3 p -77.21 125.64 29.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.844 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 928' ' ' LEU . 10.0 pt -94.92 -161.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.725 HG23 HD22 ' A' ' 946' ' ' LEU . 4.0 m -161.14 121.42 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -72.08 102.16 2.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.725 HD22 HG23 ' A' ' 944' ' ' THR . 48.9 mt -80.89 161.37 24.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.568 0.699 . . . . 0.0 112.713 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.401 ' HA ' HD12 ' A' ' 924' ' ' ILE . 9.8 t70 -42.55 -38.4 1.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.005 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -83.08 36.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.723 ' HA ' ' HB3' ' A' ' 902' ' ' CYS . 8.2 mp 44.82 46.33 8.76 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.222 0.534 . . . . 0.0 110.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.708 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.4 m -123.61 -162.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.16 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.544 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 90.1 m95 -152.69 122.77 7.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.289 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.9 t -43.43 146.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.531 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 38.9 t -79.39 117.55 67.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.599 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 957' ' ' VAL . 4.0 Cg_exo -76.8 60.93 6.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.55 2.833 . . . . 0.0 111.794 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -77.1 131.77 38.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.017 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.441 ' O ' HG11 ' A' ' 957' ' ' VAL . 21.8 m-20 54.99 81.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.545 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 12.7 m -150.9 -21.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.834 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 12.1 t -151.45 133.37 15.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -143.26 146.86 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.181 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.811 ' HD3' ' HB3' ' A' ' 981' ' ' GLN . 29.9 ttt85 -53.2 143.53 17.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.057 0.456 . . . . 0.0 111.655 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 28.1 mtpp -56.29 152.34 11.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.563 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.582 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 96.3 p -141.61 121.13 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.564 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 4.4 p -81.67 153.68 26.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.596 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.33 132.35 48.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 34.4 m -56.57 134.3 77.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.928 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.71 ' HG2' HG13 ' A' ' 974' ' ' VAL . 9.2 Cg_endo -52.65 150.98 20.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.764 2.309 . . . . 0.0 111.992 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.488 ' HD2' ' HG2' ' A' 1017 ' ' PRO . 64.7 Cg_endo -73.14 45.5 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.678 2.252 . . . . 0.0 112.814 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 967' ' ' PRO . 1.5 m-20 18.02 109.73 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 124.074 0.859 . . . . 0.0 113.165 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.44 142.49 9.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.537 HG23 ' ND2' ' A' ' 971' ' ' ASN . 5.1 p -48.6 131.67 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.638 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.537 ' ND2' HG23 ' A' ' 970' ' ' VAL . 74.2 m-20 75.43 -48.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.634 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.443 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -75.44 -152.62 3.61 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.097 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 1.8 pmm? 177.75 143.48 0.1 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.274 0.23 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.71 HG13 ' HG2' ' A' ' 966' ' ' PRO . 10.1 p -93.62 128.94 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.236 0.541 . . . . 0.0 111.201 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -104.46 118.1 35.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 28.2 m -70.95 141.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 985' ' ' ARG . 24.4 mm -74.92 -36.68 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.476 . . . . 0.0 110.295 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.2 p -144.69 -47.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.186 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 49.0 t0 -160.19 -137.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.559 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.498 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 7.6 pt -151.02 36.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.231 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.811 ' HB3' ' HD3' ' A' ' 960' ' ' ARG . 13.1 mm100 -76.5 166.69 23.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.715 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.547 HG21 ' NE ' ' A' ' 960' ' ' ARG . 15.7 m -64.32 29.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.3 -25.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.3 t -76.1 136.72 39.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.004 0.431 . . . . 0.0 111.256 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 69.0 ttt180 -89.65 158.72 17.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 986' ' ' ILE . 47.4 pt -137.56 129.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.918 0.39 . . . . 0.0 111.025 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.451 HG21 ' HB3' ' A' 1001 ' ' SER . 2.3 p -105.22 139.58 39.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.02 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 7.3 m-85 -103.94 146.99 27.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.677 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -153.48 124.19 7.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.482 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.443 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 96.6 m -72.95 -119.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 993' ' ' GLY . 8.0 t -169.55 158.91 8.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.628 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 61.0 m -52.8 84.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 991' ' ' THR . . . 168.6 -42.22 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.47 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.416 ' HB3' ' N ' ' A' 1021 ' ' GLN . 7.8 m80 -126.13 142.25 51.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.627 ' HG3' HD13 ' A' ' 997' ' ' ILE . 39.3 ptt180 -91.9 145.28 24.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.73 135.42 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.571 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.719 HD12 ' HB3' ' A' 1021 ' ' GLN . 3.9 mp -126.49 139.42 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.94 -124.2 7.99 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.51 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.416 ' CG ' ' H ' ' A' 1000 ' ' SER . 27.0 t60 -80.1 -136.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.416 ' H ' ' CG ' ' A' ' 999' ' ' HIS . 79.4 p -176.76 -43.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 987' ' ' THR . 69.2 p -155.22 141.58 18.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.516 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.434 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -149.49 143.48 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 112.025 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.6 tt0 -95.92 138.24 33.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 47.9 t -71.27 129.62 39.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.1 pt -139.39 146.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 60.8 tp -89.16 137.28 32.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.589 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.685 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 98.8 p -88.97 -40.09 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.372 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -177.72 -36.03 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.415 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -145.29 -44.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.277 0.561 . . . . 0.0 109.707 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 94.2 m -94.5 131.89 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.64 138.8 34.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.01 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.685 ' HE2' ' HB3' ' A' 1007 ' ' SER . 10.8 p80 -155.66 142.61 19.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.083 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 70.7 m95 -66.46 146.35 54.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -51.32 -33.73 30.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.092 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 82.8 p -141.04 -152.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.553 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -126.8 149.75 69.55 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.4 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.488 ' HG2' ' HD2' ' A' ' 967' ' ' PRO . 41.5 Cg_exo -57.46 135.65 71.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.838 2.359 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 27.0 Cg_exo -62.81 -159.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.728 2.286 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.511 ' CG2' ' HB ' ' A' ' 997' ' ' ILE . 3.8 tt -146.57 128.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.868 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 77.3 m -84.29 138.5 32.88 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.719 ' HB3' HD12 ' A' ' 997' ' ' ILE . 7.8 tt0 -149.74 135.7 18.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.081 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.407 ' HG2' HH11 ' A' 1022 ' ' ARG . 42.4 ttp85 -48.63 130.39 17.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.512 0.673 . . . . 0.0 111.695 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.549 HG12 ' HB3' ' A' ' 995' ' ' ARG . 71.2 mt -74.94 127.12 87.44 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.623 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.563 2.175 . . . . 0.0 112.219 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -171.23 135.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.01 140.08 57.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.037 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.88 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . 62.8 -150.76 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 15.9 m80 67.21 144.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 84.7 m -79.78 122.63 26.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 904' ' ' ALA . 0.0 OUTLIER -65.65 163.99 15.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.78 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.92 125.33 4.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.663 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.614 ' HG2' HD11 ' A' ' 928' ' ' LEU . 16.6 Cg_exo -67.1 135.26 36.75 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.731 2.287 . . . . 0.0 112.509 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.77 152.24 43.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.107 0.48 . . . . 0.0 110.87 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -78.17 134.59 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.091 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.538 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 8.3 m-85 -90.07 1.25 56.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.8 mp 71.61 -63.35 0.43 Allowed 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.602 0.564 . . . . 0.0 111.388 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.463 ' HA ' ' CD ' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -85.35 25.66 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.83 120.86 5.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -103.71 138.77 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.476 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 914' ' ' LYS . 3.1 tm? -46.47 150.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.726 ' H ' HD23 ' A' ' 913' ' ' LEU . 11.8 tmtt? -137.71 -46.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.407 ' O ' HD12 ' A' ' 913' ' ' LEU . 2.7 m -68.76 139.14 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.499 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.651 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -58.21 112.57 1.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 69.8 p -83.34 132.85 34.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 0.0 112.106 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.7 p -89.97 82.71 6.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.135 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 60.32 -152.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' SER . . . . . 0.432 ' HG ' ' H ' ' A' ' 921' ' ' ASP . 80.9 p -86.59 -47.76 8.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.432 ' H ' ' HG ' ' A' ' 920' ' ' SER . 56.7 m-20 -85.43 121.99 28.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 77.7 m-85 -103.87 136.02 19.27 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 112.137 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.698 ' HG2' ' HG1' ' A' ' 926' ' ' THR . 51.3 Cg_endo -68.39 136.09 35.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 111.67 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.711 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 38.6 mt -56.69 143.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.065 0.46 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.472 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 101.87 -41.4 2.14 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.698 ' HG1' ' HG2' ' A' ' 923' ' ' PRO . 17.8 m -57.27 144.43 35.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.267 -0.466 . . . . 0.0 111.056 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 46.6 m -126.61 128.01 46.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.756 0.312 . . . . 0.0 111.235 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.614 HD11 ' HG2' ' A' ' 905' ' ' PRO . 94.3 mt -100.71 122.1 42.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.0 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.692 ' HG2' ' HB3' ' A' ' 942' ' ' SER . 52.0 mtmt -87.58 127.54 35.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.0 111.251 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 940' ' ' PRO . 4.8 m-85 -116.77 120.21 37.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.54 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.11 127.79 41.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.68 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 59.3 m -58.58 -174.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.519 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 43.5 mtp85 -84.42 159.68 58.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.323 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 936' ' ' TYR . 87.4 Cg_exo -45.83 -48.75 11.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.498 2.132 . . . . 0.0 112.466 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -74.44 28.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.304 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.519 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 12.4 m-85 -141.85 150.77 42.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.605 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 23.3 p90 -137.56 136.27 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.349 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.94 11.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 55.4 mtp85 61.41 151.98 0.1 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.348 0.594 . . . . 0.0 111.983 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 930' ' ' TYR . 13.4 Cg_exo -67.46 117.83 5.13 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.795 2.33 . . . . 0.0 111.246 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 957' ' ' VAL . 43.3 p90 -90.35 115.37 27.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.392 0.615 . . . . 0.0 111.768 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.692 ' HB3' ' HG2' ' A' ' 929' ' ' LYS . 80.1 p -78.38 131.36 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.061 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.847 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -101.86 114.24 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 0.0 110.567 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.791 HG23 HD22 ' A' ' 946' ' ' LEU . 2.6 m -83.05 125.96 32.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.711 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 49.7 t -73.7 112.34 9.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.791 HD22 HG23 ' A' ' 944' ' ' THR . 89.1 mt -81.45 -64.51 1.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -174.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 59.9 t0 173.84 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.947 0.403 . . . . 0.0 110.593 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.515 ' HB3' HG11 ' A' ' 950' ' ' VAL . 34.8 t30 -79.16 9.57 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.88 HD12 ' HA ' ' A' ' 900' ' ' ALA . 45.9 mt 69.25 40.42 1.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.44 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.528 HG21 ' H ' ' A' ' 951' ' ' TRP . 3.3 p -137.52 154.94 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.607 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.847 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 29.1 m95 -89.76 145.25 25.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.313 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.542 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 79.5 p -47.2 144.94 2.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 66.1 m -77.71 108.65 7.66 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.459 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 952' ' ' SER . 15.4 Cg_exo -66.65 142.88 65.97 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.643 2.229 . . . . 0.0 111.339 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.37 129.33 8.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.147 0.499 . . . . 0.0 111.832 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 55.4 t0 51.75 33.65 11.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.431 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.783 HG21 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -91.99 -59.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.783 ' H ' HG21 ' A' ' 957' ' ' VAL . 5.9 t -89.31 141.48 28.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 40.1 mtmt -152.37 133.75 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.44 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.836 ' HE ' ' HB3' ' A' ' 981' ' ' GLN . 0.3 OUTLIER -65.88 128.52 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.02 0.438 . . . . 0.0 110.915 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.668 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.2 ttmp? -56.21 161.99 2.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.514 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 73.3 p -149.79 147.81 28.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.472 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.2 m -80.11 147.91 31.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.938 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.619 ' HD3' ' N ' ' A' ' 965' ' ' THR . 6.3 tmtm? -65.96 131.06 45.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.619 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 25.1 m -52.98 124.24 36.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.002 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.56 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 55.2 Cg_endo -68.87 133.66 27.82 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.64 2.227 . . . . 0.0 112.611 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.94 137.55 76.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.351 2.034 . . . . 0.0 111.313 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.71 113.83 7.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.12 151.51 85.02 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.795 2.33 . . . . 0.0 111.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.6 p -49.6 127.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 49.24 46.09 23.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.84 137.97 4.59 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.45 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.414 ' HB2' ' HE1' ' A' ' 973' ' ' MET . 3.3 mpp? -127.95 142.74 51.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 12.6 p -94.23 121.44 44.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.753 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -88.66 128.13 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.51 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 95.3 t -83.95 123.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.9 -40.49 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.707 0.289 . . . . 0.0 111.154 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 78.6 p -144.68 -50.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.402 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.539 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 37.1 m-20 -158.26 -152.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.994 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.448 HG21 ' O ' ' A' ' 979' ' ' ASP . 14.8 pt -149.9 23.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.836 ' HB3' ' HE ' ' A' ' 960' ' ' ARG . 15.1 mp0 -77.01 154.08 33.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.675 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.532 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 66.6 t -50.85 85.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 111.301 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.98 -41.47 0.29 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' 1003 ' ' GLU . 77.2 p -75.38 -168.83 0.87 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 111.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.454 HH21 ' HB2' ' A' 1001 ' ' SER . 79.2 ttt180 -151.31 131.35 13.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.089 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.56 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 31.2 pt -98.07 142.57 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.539 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.7 p -116.96 135.12 53.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.138 0.494 . . . . 0.0 111.723 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.456 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 1.8 m-85 -103.12 148.66 25.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.5 t -148.74 120.05 7.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.095 0.474 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 71.4 m -83.02 151.55 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.0 p -64.6 149.11 49.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -49.4 92.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 158.51 -46.94 0.44 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.275 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -99.96 148.25 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.596 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.449 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -91.55 148.4 22.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.548 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' 1018 ' ' PRO . 3.4 tm? -65.2 130.19 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.071 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.668 HD13 ' HB2' ' A' 1021 ' ' GLN . 34.6 mm -100.13 73.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.757 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . 156.62 -149.62 20.52 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.126 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.661 ' HD1' HG22 ' A' 1015 ' ' THR . 34.5 m170 -85.91 -9.51 56.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.614 0.245 . . . . 0.0 111.173 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.533 ' N ' HD13 ' A' ' 996' ' ' LEU . 15.3 m 71.8 -5.44 1.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.458 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.454 ' HB2' HH21 ' A' ' 985' ' ' ARG . 57.5 m -156.02 149.55 24.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.465 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -154.58 133.15 12.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.6 tt0 -96.07 132.54 41.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 38.2 t -71.19 121.36 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 35.8 pt -135.52 -151.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 111.617 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' 1008 ' ' GLY . 8.7 tt -155.87 139.77 16.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.498 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.705 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.0 t -87.51 -57.72 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.543 ' N ' HD22 ' A' 1006 ' ' LEU . . . 169.05 35.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.239 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' 1008 ' ' GLY . 0.7 OUTLIER 176.65 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.39 0.614 . . . . 0.0 109.988 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -143.96 143.64 31.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.642 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -78.89 143.87 35.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.705 ' HE2' ' HB2' ' A' 1007 ' ' SER . 9.0 p80 -157.72 148.83 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.806 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.455 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.1 m95 -64.38 140.18 58.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -54.26 -30.48 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.811 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.661 HG22 ' HD1' ' A' ' 999' ' ' HIS . 63.0 p -140.82 143.31 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 111.712 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -51.26 146.09 12.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.92 118.8 5.7 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.446 2.097 . . . . 0.0 111.856 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.747 ' HB2' HD23 ' A' ' 996' ' ' LEU . 35.7 Cg_endo -65.99 145.89 80.92 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.544 2.162 . . . . 0.0 112.569 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.605 HG23 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.71 -149.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.247 0.546 . . . . 0.0 110.846 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.605 ' H ' HG23 ' A' 1019 ' ' ILE . 74.7 m -154.76 138.75 16.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.188 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.668 ' HB2' HD13 ' A' ' 997' ' ' ILE . 3.8 tt0 -147.13 129.57 15.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.902 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -48.56 130.1 16.79 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.449 0.642 . . . . 0.0 111.466 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 995' ' ' ARG . 73.8 mt -75.26 128.45 84.53 Favored Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.154 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.776 2.317 . . . . 0.0 112.303 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.43 136.01 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.007 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -58.93 125.99 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.052 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.729 ' HA ' HD23 ' A' ' 949' ' ' LEU . . . -167.32 -136.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.81 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 11.0 m80 69.8 134.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 10.9 p -80.79 119.16 23.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.818 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -72.53 -176.81 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.402 . . . . 0.0 111.042 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . 0.438 ' HA ' ' CE1' ' A' ' 922' ' ' PHE . . . -49.02 127.03 14.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.329 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.595 ' HG3' HD21 ' A' ' 928' ' ' LEU . 64.7 Cg_endo -73.33 70.16 3.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.809 2.34 . . . . 0.0 112.162 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.2 t0 35.21 -132.06 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.494 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.447 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 4.7 m170 -156.97 121.82 4.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.661 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.94 139.52 30.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.701 ' H ' HD21 ' A' ' 909' ' ' LEU . 0.6 OUTLIER -102.14 -45.63 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.562 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.417 ' C ' ' HG3' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -80.62 9.66 5.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.969 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.31 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.478 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.62 133.86 40.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.593 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.47 HD13 ' H ' ' A' ' 914' ' ' LYS . 65.0 tp -47.07 161.0 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.686 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.47 ' H ' HD13 ' A' ' 913' ' ' LEU . 31.0 mmmt -144.33 -52.29 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.531 ' CG2' HD13 ' A' ' 928' ' ' LEU . 4.3 m -68.78 137.09 53.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -62.35 123.35 18.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.539 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 49.7 p -83.42 136.06 34.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.029 0.443 . . . . 0.0 111.989 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 70.8 p -90.1 79.5 6.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.547 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 64.57 -154.54 0.3 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.082 0.468 . . . . 0.0 111.96 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.6 p -85.79 -46.07 11.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.38 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.3 120.88 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 54.7 m-85 -102.31 135.47 19.59 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.529 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 74.3 Cg_endo -74.26 133.2 17.44 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.739 2.293 . . . . 0.0 111.446 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.545 ' HA ' ' CB ' ' A' ' 945' ' ' CYS . 50.5 mt -56.89 144.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.933 0.397 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 945' ' ' CYS . . . 101.6 -35.19 5.08 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.529 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 24.0 m -56.17 128.59 36.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.442 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 79.3 p -101.47 123.84 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.595 HD21 ' HG3' ' A' ' 905' ' ' PRO . 8.1 tp -102.74 119.85 39.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.99 140.85 29.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.188 0.518 . . . . 0.0 112.07 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 913' ' ' LEU . 26.7 m-85 -133.95 133.51 41.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 931' ' ' GLU . 14.9 pt-20 -92.84 121.73 34.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.995 0.426 . . . . 0.0 111.279 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.76 153.86 19.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.663 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 78.5 mtp180 -81.35 145.37 55.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.604 0.24 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.554 ' O ' HD23 ' A' 1006 ' ' LEU . 70.9 Cg_exo -49.23 -42.74 39.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.346 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.88 24.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 934' ' ' PRO . 24.3 m-85 -142.04 139.81 32.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.95 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 7.9 p90 -93.26 134.7 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.412 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 133.9 148.44 5.83 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.701 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.673 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.0 ptp180 -72.52 166.24 43.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.478 0.18 . . . . 0.0 110.543 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 42.2 Cg_endo -68.38 122.85 9.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.327 2.018 . . . . 0.0 112.112 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.565 ' CD2' ' HB ' ' A' ' 957' ' ' VAL . 48.8 p90 -91.29 -165.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.9 p -175.29 137.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -91.27 176.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.924 HG23 HD22 ' A' ' 946' ' ' LEU . 1.2 m -161.37 127.54 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.545 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 62.2 m -71.64 117.26 12.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.924 HD22 HG23 ' A' ' 944' ' ' THR . 85.7 mt -87.55 -53.53 4.75 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 53.8 t0 171.06 -39.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.221 0.326 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -83.54 34.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.48 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 900' ' ' ALA . 6.7 mp 50.77 47.39 24.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.345 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.0 148.54 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 111.087 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 94.2 m95 -89.65 46.66 1.39 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.76 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 953' ' ' SER . 37.8 t 49.03 29.73 2.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.2 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 952' ' ' SER . 19.8 m 34.58 100.44 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.611 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 133.98 54.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.371 2.047 . . . . 0.0 112.797 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -159.1 135.94 9.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.459 ' O ' HG11 ' A' ' 957' ' ' VAL . 60.6 t0 56.54 67.09 1.04 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.565 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 19.6 m -147.75 68.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.513 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 957' ' ' VAL . 80.8 m 77.28 144.54 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.322 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.458 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 95.0 mttt -142.17 166.9 23.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 960' ' ' ARG . 0.0 OUTLIER -53.29 119.07 4.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 -179.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 39.8 tptt -56.22 148.69 17.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.744 ' HB3' HE21 ' A' ' 981' ' ' GLN . 54.6 p -149.44 125.04 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.95 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 2.1 p -82.23 141.07 33.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.851 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.78 137.42 57.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.079 0.466 . . . . 0.0 111.141 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.4 m -53.69 126.61 49.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.647 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 974' ' ' VAL . 28.9 Cg_endo -62.78 125.79 16.77 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.335 2.023 . . . . 0.0 111.878 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.24 134.47 60.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.209 1.939 . . . . 0.0 111.425 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -56.34 117.13 14.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.749 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 970' ' ' VAL . 22.3 Cg_exo -65.28 -146.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.873 2.382 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.849 ' HB ' ' HB2' ' A' 1020 ' ' CYS . 2.5 t -57.75 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.148 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.496 ' H ' ' CG1' ' A' ' 970' ' ' VAL . 76.1 m-20 -72.33 68.53 0.76 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.506 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.4 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -164.96 -160.2 12.12 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.716 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 179.84 144.12 0.17 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.973 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.513 HG22 HD13 ' A' ' 986' ' ' ILE . 9.9 p -94.32 138.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.15 0.5 . . . . 0.0 111.309 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -120.14 117.92 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.909 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 977' ' ' ILE . 35.8 t -70.14 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.503 ' N ' HG11 ' A' ' 976' ' ' VAL . 31.3 mm -75.13 -43.24 44.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 77.6 p -147.03 -53.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.649 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.62 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 48.5 m-20 -157.57 151.01 23.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.102 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.41 HG22 HG23 ' A' ' 976' ' ' VAL . 18.7 pt -88.34 32.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.781 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.744 HE21 ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -78.4 142.11 37.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.061 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.435 HG21 ' SG ' ' A' 1004 ' ' CYS . 80.1 t -50.39 104.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.937 0.398 . . . . 0.0 111.32 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 151.5 -51.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.431 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' 1003 ' ' GLU . 80.5 p -76.27 -152.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 0.0 111.046 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -151.4 178.37 9.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.235 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.513 HD13 HG22 ' A' ' 974' ' ' VAL . 26.9 pt -142.0 129.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.524 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -98.26 138.57 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.587 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.563 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 8.8 m-85 -105.79 151.23 24.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.69 114.18 5.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 111.275 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 75.0 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 971' ' ' ASN . 6.2 t -64.52 146.71 54.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.718 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.3 m -44.26 130.32 6.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.428 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.14 -49.81 0.89 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -102.02 139.67 37.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.683 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.768 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.8 ptt85 -91.45 140.28 29.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.344 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' 1000 ' ' SER . 9.9 tt -71.79 130.44 41.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.529 HD12 ' CB ' ' A' 1021 ' ' GLN . 1.9 mp -100.34 133.64 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.73 -155.41 25.66 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.454 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.645 ' O ' ' HG3' ' A' 1018 ' ' PRO . 14.6 m170 -82.98 125.29 31.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.522 0.201 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.409 ' HA ' HD12 ' A' ' 996' ' ' LEU . 43.8 t -73.6 12.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.1 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.0 p -156.82 150.74 24.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -152.03 135.87 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 984' ' ' SER . 38.4 tt0 -95.15 128.92 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 982' ' ' VAL . 44.8 t -71.28 122.87 21.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.64 -151.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.689 ' HG ' ' H ' ' A' 1008 ' ' GLY . 19.4 tp -151.11 131.38 13.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.395 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.685 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 37.7 t -93.01 31.69 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.689 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 77.22 -48.74 2.84 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.701 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.52 -44.94 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.789 0.328 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 88.7 m -146.63 148.07 31.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.427 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.594 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.4 139.35 38.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.97 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.685 ' HE2' ' HB2' ' A' 1007 ' ' SER . 7.8 p80 -158.11 154.17 27.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.425 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 75.9 m95 -64.21 145.58 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -59.57 -30.45 68.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.433 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 65.7 p -140.59 142.97 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.119 0.485 . . . . 0.0 112.089 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.613 ' HB3' ' NZ ' ' A' 1016 ' ' LYS . 5.8 ttpm? -55.1 139.35 64.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.755 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.11 128.46 22.44 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.524 2.149 . . . . 0.0 112.701 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.645 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 35.7 Cg_exo -57.36 147.02 79.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.019 2.479 . . . . 0.0 112.408 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.419 ' O ' HD11 ' A' ' 997' ' ' ILE . 29.8 mt -103.0 132.89 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.722 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.849 ' HB2' ' HB ' ' A' ' 970' ' ' VAL . 71.4 m -86.37 123.17 31.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.529 ' CB ' HD12 ' A' ' 997' ' ' ILE . 6.0 tt0 -143.81 130.59 20.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.472 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' 1022 ' ' ARG . 41.2 ttp85 -45.19 133.88 6.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 111.832 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.768 HG12 ' HB3' ' A' ' 995' ' ' ARG . 53.6 mt -74.94 129.01 84.13 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.908 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.695 0.283 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . 0.449 ' HB2' ' H ' ' A' ' 899' ' ' GLU . . . 61.29 -153.56 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.234 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . 0.449 ' H ' ' HB2' ' A' ' 898' ' ' ALA . 56.4 mt-10 65.02 133.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.334 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . 64.39 121.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.671 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.507 ' N ' HD23 ' A' ' 949' ' ' LEU . 66.1 m80 -155.31 141.31 18.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 87.7 m -81.03 128.18 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.5 mm100 -68.12 171.6 6.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.183 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.06 132.38 3.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.772 ' HB3' HD13 ' A' ' 943' ' ' ILE . 15.7 Cg_exo -68.75 63.19 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.17 2.58 . . . . 0.0 112.589 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 50.6 t0 33.95 -135.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.547 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 38.9 m80 -152.54 119.24 5.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.963 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -85.29 136.81 33.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.158 0.504 . . . . 0.0 111.368 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.726 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 1.8 mm? -84.99 -51.65 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.2 OUTLIER -86.13 15.09 5.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.316 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.62 155.77 36.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.343 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.633 ' HE2' ' NE ' ' A' ' 933' ' ' ARG . 68.2 mttm -136.51 134.11 37.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.745 HD11 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -49.43 149.75 2.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.173 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.795 ' HG3' ' HG2' ' A' ' 931' ' ' GLU . 31.2 mmmt -143.22 -35.81 0.39 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 917' ' ' THR . 56.5 m -69.89 65.04 0.22 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 917' ' ' THR . 17.0 pt20 37.2 -148.43 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.516 HG22 ' HE2' ' A' ' 922' ' ' PHE . 15.1 t 50.87 139.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 113.027 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 77.5 p -146.18 15.84 1.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.685 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -74.49 174.96 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t -89.74 -51.47 5.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.3 145.16 27.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.516 ' HE2' HG22 ' A' ' 917' ' ' THR . 31.7 m-85 -136.25 136.72 22.98 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.414 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.401 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.4 Cg_endo -69.3 140.95 45.72 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.737 2.291 . . . . 0.0 111.867 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.662 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.0 mt -56.74 155.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.64 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 87.4 -40.79 3.08 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.401 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 46.9 m -56.37 137.66 52.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.511 -0.345 . . . . 0.0 111.119 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 78.6 p -131.35 134.82 46.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.656 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.532 ' HB3' ' CD2' ' A' ' 913' ' ' LEU . 2.7 mm? -99.08 136.63 38.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.021 0.439 . . . . 0.0 111.786 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 4.4 tppp? -88.18 135.46 33.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.409 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.451 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 13.3 m-85 -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.373 . . . . 0.0 111.227 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.795 ' HG2' ' HG3' ' A' ' 914' ' ' LYS . 5.2 mm-40 -97.38 132.74 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.3 m -59.7 137.53 58.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.726 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.2 mtp180 -87.53 156.89 53.27 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 10.3 Cg_endo -51.24 139.47 44.04 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.539 2.159 . . . . 0.0 111.317 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.674 ' HB3' HG13 ' A' ' 982' ' ' VAL . 90.3 mt-10 83.34 27.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.888 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.578 ' C ' ' HE2' ' A' ' 961' ' ' LYS . 95.7 m-85 -148.23 129.28 14.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 1.4 p90 -101.18 142.0 33.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.066 0.46 . . . . 0.0 111.334 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.56 -130.34 2.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.393 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 939' ' ' ARG . 4.3 ptp85 -166.14 156.75 11.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.507 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 37.5 Cg_exo -59.99 108.62 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.447 2.098 . . . . 0.0 112.434 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.627 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 36.2 p90 -95.51 -168.72 1.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.525 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.04 127.48 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.772 HD13 ' HB3' ' A' ' 905' ' ' PRO . 17.4 pt -97.63 120.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.107 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 946' ' ' LEU . 54.9 m -91.19 134.83 34.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.662 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -73.72 118.23 16.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 109.995 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.844 HD22 ' H ' ' A' ' 952' ' ' SER . 2.1 mm? -87.13 171.61 10.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.255 1.026 . . . . 0.0 113.242 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.72 -43.2 68.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.367 -1.742 . . . . 0.0 111.682 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -83.85 29.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 29.7 mt 48.12 63.13 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.697 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.644 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 9.4 m -135.81 -164.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.408 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 98.1 m95 -144.12 46.69 1.43 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.24 0.543 . . . . 0.0 111.487 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.844 ' H ' HD22 ' A' ' 946' ' ' LEU . 79.4 p 40.08 26.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.289 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 955' ' ' LYS . 45.5 t 35.34 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.002 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.46 137.64 31.91 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.356 2.037 . . . . 0.0 112.751 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.55 ' HD3' ' N ' ' A' ' 955' ' ' LYS . 0.1 OUTLIER -159.09 134.87 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.272 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.563 ' O ' HG11 ' A' ' 957' ' ' VAL . 8.9 t70 59.28 82.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.436 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 941' ' ' PHE . 3.7 m -148.64 -107.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.863 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.557 ' H ' HG22 ' A' ' 957' ' ' VAL . 56.8 m -81.75 57.52 3.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 0.0 110.751 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.5 mmpt? -55.41 155.45 5.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.203 0.525 . . . . 0.0 112.142 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.583 ' CG ' ' HB3' ' A' ' 981' ' ' GLN . 19.6 tpp180 -55.11 116.45 2.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.249 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.927 ' HG3' ' H ' ' A' ' 962' ' ' SER . 15.0 tppt? -61.11 -176.12 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.929 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.927 ' H ' ' HG3' ' A' ' 961' ' ' LYS . 80.6 p -149.75 -155.96 0.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.147 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.848 ' HA ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -154.74 33.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.621 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 60.62 128.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 15.8 m -59.76 135.78 89.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.94 136.49 44.01 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 112.121 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.2 Cg_endo -75.11 47.43 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.697 2.264 . . . . 0.0 112.773 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 967' ' ' PRO . 11.2 p-10 22.77 78.9 0.2 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.67 0.606 . . . . 0.0 112.121 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.439 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 98.2 Cg_exo -43.89 142.16 3.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.719 2.28 . . . . 0.0 112.449 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.422 HG21 ' ND2' ' A' ' 971' ' ' ASN . 2.7 p -48.86 127.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.633 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.422 ' ND2' HG21 ' A' ' 970' ' ' VAL . 74.2 m-20 47.65 48.72 16.99 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.065 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -133.14 -152.5 6.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.388 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 42.4 ttp 176.19 141.87 0.07 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 987' ' ' THR . 10.5 p -136.98 127.85 40.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.972 0.415 . . . . 0.0 111.719 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.534 ' HB2' HD12 ' A' ' 977' ' ' ILE . 33.9 m-70 -87.76 114.86 24.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.66 ' HA ' HG21 ' A' ' 986' ' ' ILE . 81.7 t -65.44 -24.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.138 0.494 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 975' ' ' HIS . 14.0 mm 74.46 -49.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.15 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 977' ' ' ILE . 63.8 p -149.51 -60.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 984' ' ' SER . 11.7 p-10 -159.42 144.71 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.307 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 8.2 pt -85.99 19.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.252 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.583 ' HB3' ' CG ' ' A' ' 960' ' ' ARG . 83.7 mt-30 -80.87 156.48 26.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.788 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 935' ' ' GLU . 57.0 t -55.79 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.48 26.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.643 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.593 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 70.2 m -163.89 139.57 6.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.311 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ptt85 -100.12 131.22 46.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.132 0.491 . . . . 0.0 112.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.66 HG21 ' HA ' ' A' ' 976' ' ' VAL . 40.9 pt -100.3 126.21 53.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.583 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.597 ' O ' HG21 ' A' ' 974' ' ' VAL . 3.3 t -104.56 160.14 15.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.34 0.591 . . . . 0.0 111.583 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.475 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 3.6 m-85 -114.97 153.39 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.5 p -148.61 69.67 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.625 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 84.6 m -44.51 145.6 0.84 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 19.2 p -65.12 149.32 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 82.2 m -44.56 -37.49 3.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.928 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -57.26 -56.39 25.3 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.151 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.812 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 2.3 m80 -95.56 143.23 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.68 HH21 HG21 ' A' 1023 ' ' ILE . 14.3 ptp180 -88.83 138.72 31.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.982 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 999' ' ' HIS . 8.1 tt -71.85 138.07 47.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.312 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.9 mp -117.62 137.32 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.79 -143.39 18.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.019 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.776 ' HD1' HG23 ' A' 1015 ' ' THR . 19.4 m170 -81.47 -134.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.633 0.254 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.489 ' HA ' ' HG2' ' A' 1018 ' ' PRO . 48.3 t -170.9 -54.66 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.84 0.352 . . . . 0.0 110.522 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.9 p -91.3 142.14 28.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.61 122.33 4.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.31 139.86 31.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.529 ' SG ' HG21 ' A' ' 982' ' ' VAL . 15.2 t -69.52 122.83 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' 1006 ' ' LEU . 20.6 pt -139.48 142.29 33.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.665 ' HB3' ' HE2' ' A' 1012 ' ' HIS . 3.4 tm? 45.73 148.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.236 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.781 ' HB2' ' HG2' ' A' ' 961' ' ' LYS . 20.4 m -156.9 -95.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.561 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.686 ' H ' ' HE3' ' A' ' 961' ' ' LYS . . . 60.8 -109.78 2.6 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -66.89 -32.13 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' 1007 ' ' SER . 17.6 m -148.94 119.91 7.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.609 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 963' ' ' CYS . . . -86.88 138.48 31.52 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.665 ' HE2' ' HB3' ' A' 1006 ' ' LEU . 0.3 OUTLIER -152.07 131.52 12.97 Favored 'General case' 0 C--N 1.337 0.057 0 C-N-CA 119.413 -0.915 . . . . 0.0 113.268 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.439 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 80.4 m95 -70.28 165.05 23.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.178 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 88.8 p -63.19 -34.79 78.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.776 HG23 ' HD1' ' A' ' 999' ' ' HIS . 70.2 p -146.27 143.91 29.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.89 144.9 73.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.033 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.19 127.13 20.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.716 2.277 . . . . 0.0 112.75 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.489 ' HG2' ' HA ' ' A' 1000 ' ' SER . 34.4 Cg_exo -61.52 150.39 85.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.466 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.454 ' O ' HD11 ' A' ' 997' ' ' ILE . 51.0 mt -98.92 136.77 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.484 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 73.5 m -99.13 79.58 2.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.674 ' HB3' HD12 ' A' ' 997' ' ' ILE . 41.9 tt0 -90.92 118.9 30.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.616 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 15.1 ptp180 -41.54 142.59 0.59 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.54 0.685 . . . . 0.0 111.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.68 HG21 HH21 ' A' ' 995' ' ' ARG . 70.7 mt -74.4 133.7 77.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' 1023 ' ' ILE . 59.6 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.885 2.39 . . . . 0.0 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 897' ' ' GLU . 17.5 tp10 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.18 133.21 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 63.79 133.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.252 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.76 ' HB3' HD13 ' A' ' 924' ' ' ILE . . . -166.08 128.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 921' ' ' ASP . 52.6 m80 -153.47 144.84 23.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.752 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 99.4 m -80.8 128.92 34.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.489 ' H ' ' CD ' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -68.99 157.13 37.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.648 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -43.19 131.44 3.38 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.041 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.4 -160.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 907' ' ' HIS . 4.2 t0 -173.6 151.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 906' ' ' ASP . 48.1 m80 70.11 68.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.369 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.91 43.63 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.582 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 15.7 mt -70.25 -32.29 70.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.281 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.21 10.67 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.618 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.52 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.669 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.3 120.88 33.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.563 HD21 ' O ' ' A' ' 915' ' ' THR . 1.3 tt -49.17 129.25 17.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.163 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.605 ' HB2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -86.48 -52.29 5.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.563 ' O ' HD21 ' A' ' 913' ' ' LEU . 47.6 m -64.59 138.34 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.253 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -61.94 141.56 57.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.899 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 70.5 p -151.67 149.33 28.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 93.8 m -154.04 -41.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 152.04 44.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.1 p -84.99 -44.41 13.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 901' ' ' HIS . 12.1 p-10 -85.36 132.33 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -118.68 138.89 26.39 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.407 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 926' ' ' THR . 25.4 Cg_endo -61.4 137.32 69.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.603 2.202 . . . . 0.0 112.062 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.76 HD13 ' HB3' ' A' ' 900' ' ' ALA . 20.8 mt -60.97 154.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.347 . . . . 0.0 110.846 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.581 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 83.68 -38.09 2.8 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 923' ' ' PRO . 19.9 m -56.0 131.82 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.02 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 49.7 m -111.3 130.52 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 942' ' ' SER . 94.5 mt -96.53 128.26 43.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 16.3 tppt? -85.16 137.59 32.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.031 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.493 ' CE2' ' HG ' ' A' ' 913' ' ' LEU . 20.5 m-85 -132.31 131.43 41.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 914' ' ' LYS . 45.8 mt-10 -95.18 114.0 25.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.39 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 1.5 t -58.03 144.59 39.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 4.4 ptm180 -82.7 158.88 64.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.93 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 933' ' ' ARG . 39.5 Cg_endo -66.2 68.6 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.203 2.602 . . . . 0.0 113.484 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -172.41 -2.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.091 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.503 ' HB2' ' SG ' ' A' ' 932' ' ' CYS . 44.1 m-85 -142.04 134.91 28.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.264 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.638 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 9.4 p90 -102.1 138.61 38.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.562 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.31 8.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.168 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.444 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 71.1 mtt-85 63.62 157.5 0.12 Allowed Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 38.2 Cg_endo -66.68 116.62 4.19 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.2 1.934 . . . . 0.0 111.352 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.575 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 49.5 p90 -93.56 -160.82 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.197 0.522 . . . . 0.0 111.812 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.2 p -172.84 130.05 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.13 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 943' ' ' ILE . 39.6 pt -95.85 117.57 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.876 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.634 ' O ' HD23 ' A' ' 946' ' ' LEU . 52.0 m -84.04 128.96 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.714 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.3 t -73.81 121.6 21.12 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.67 ' H ' HD21 ' A' ' 946' ' ' LEU . 2.1 mm? -85.34 167.92 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 0.0 113.318 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -51.73 -42.66 62.46 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.014 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.405 ' O ' HG12 ' A' ' 950' ' ' VAL . 74.0 m-80 -84.45 32.46 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.707 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.572 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 24.4 mt 48.25 56.29 7.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.0 m -138.43 -157.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 112.38 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.543 ' C ' ' H ' ' A' ' 953' ' ' SER . 50.5 m95 -150.1 125.75 10.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.637 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 953' ' ' SER . 79.8 p -68.54 27.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 951' ' ' TRP . 30.3 t 51.81 129.52 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 14.7 Cg_exo -69.95 69.83 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.086 2.524 . . . . 0.0 111.912 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -79.46 131.59 36.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.075 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.516 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 9.8 t70 55.1 72.66 0.46 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.512 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 18.1 m -150.9 -17.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.856 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 9.0 m -152.18 48.36 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.9 mmtp -56.55 143.81 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.479 ' HA ' ' CD2' ' A' ' 936' ' ' TYR . 38.8 ttm180 -53.23 132.33 38.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.655 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.638 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 0.0 OUTLIER -56.29 154.57 7.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.813 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.691 ' HB3' ' HG3' ' A' ' 981' ' ' GLN . 80.3 p -149.8 136.27 19.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.847 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 66.7 m -81.65 36.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.0 tptt 61.08 133.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.565 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.49 HG21 ' HD2' ' A' ' 966' ' ' PRO . 21.6 m -54.48 127.73 58.87 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.257 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.49 ' HD2' HG21 ' A' ' 965' ' ' THR . 55.1 Cg_endo -68.37 124.87 12.14 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.604 2.203 . . . . 0.0 112.736 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 129.2 16.83 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.189 1.926 . . . . 0.0 111.099 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -57.95 120.68 44.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.878 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.605 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 33.2 Cg_exo -61.28 145.83 98.01 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 112.036 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 25.7 t -49.34 124.65 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.819 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.1 m-80 75.87 -48.65 0.6 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -78.44 -151.78 5.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.5 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.508 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.7 pmm? 177.21 142.81 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.69 0.281 . . . . 0.0 110.818 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 986' ' ' ILE . 14.9 p -93.67 129.57 43.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.868 0.366 . . . . 0.0 110.676 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -91.52 121.73 33.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.81 104.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.629 HD13 HG22 ' A' ' 987' ' ' THR . 3.0 mt -74.38 -38.69 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 79.8 p -144.73 -58.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 984' ' ' SER . 2.8 p30 -159.91 140.97 12.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.143 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.474 HG13 ' NE2' ' A' ' 981' ' ' GLN . 13.2 pt -86.67 -5.4 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.293 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' A' ' 962' ' ' SER . 14.0 mp0 -76.12 156.4 33.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.655 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.539 HG21 ' SG ' ' A' 1004 ' ' CYS . 53.5 t -50.12 97.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.382 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.73 19.26 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.221 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' 1003 ' ' GLU . 26.2 t -165.12 -165.39 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.044 0.422 . . . . 0.0 111.34 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.514 ' HG3' ' C ' ' A' 1002 ' ' ALA . 55.6 ttp180 -147.79 136.74 22.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.544 HD13 HG22 ' A' ' 974' ' ' VAL . 20.3 pt -97.83 138.08 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.629 HG22 HD13 ' A' ' 977' ' ' ILE . 7.6 p -106.23 129.92 54.19 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.691 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 13.3 m-85 -96.48 152.73 18.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.216 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 59.1 m -148.2 129.65 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.68 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.441 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.533 HG21 ' SG ' ' A' 1020 ' ' CYS . 8.8 t -171.01 149.42 2.93 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 991' ' ' THR . 10.7 m 8.81 -118.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.12 0.887 . . . . 0.0 113.218 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1022 ' ' ARG . . . -77.03 48.93 2.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.612 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 6.7 m80 -137.21 134.76 36.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.339 . . . . 0.0 110.19 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.561 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -94.5 135.7 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.665 HD22 ' HB2' ' A' 1018 ' ' PRO . 7.0 tt -68.58 132.26 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.809 HD12 ' HB2' ' A' 1021 ' ' GLN . 3.2 mp -100.11 138.49 24.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 85.61 -131.3 10.38 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.569 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.537 ' O ' HD23 ' A' ' 996' ' ' LEU . 85.9 m-70 -79.07 -131.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.227 0.211 . . . . 0.0 111.484 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.4 p -175.16 -28.43 0.01 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.932 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.7 p -150.91 150.08 30.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.704 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.567 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -152.02 133.71 14.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 984' ' ' SER . 42.3 tt0 -96.23 133.42 40.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.539 ' SG ' HG21 ' A' ' 982' ' ' VAL . 42.7 t -71.18 121.04 17.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.84 -157.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.402 . . . . 0.0 111.767 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 934' ' ' PRO . 58.7 tp -150.85 134.39 16.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.25 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.623 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.2 t -88.8 -48.13 7.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.369 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.98 -51.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.154 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -91.27 -38.36 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.42 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 83.8 m -145.47 145.49 31.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.47 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.11 147.82 32.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.623 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.9 p80 -158.7 148.59 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.435 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 86.2 m95 -64.41 145.15 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.767 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -53.0 -33.07 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.641 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.567 ' OG1' ' HB1' ' A' 1002 ' ' ALA . 69.3 p -145.13 141.65 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.687 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.1 137.55 73.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.482 ' HB3' ' CE2' ' A' ' 988' ' ' TYR . 51.1 Cg_exo -53.68 126.7 22.72 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.533 2.155 . . . . 0.0 112.319 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.665 ' HB2' HD22 ' A' ' 996' ' ' LEU . 39.9 Cg_endo -67.11 -159.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.41 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.605 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 1.2 mt -140.67 -161.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.533 ' SG ' HG21 ' A' ' 991' ' ' THR . 44.5 t -158.69 131.24 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.809 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.0 OUTLIER -153.44 135.24 14.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.66 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 51.1 ttp180 -48.97 134.89 16.48 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 111.532 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.7 mt -74.89 128.82 84.53 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.959 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 42.6 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.709 2.273 . . . . 0.0 112.358 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 898' ' ' ALA . 15.5 tp10 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . 0.521 ' H ' ' HG3' ' A' ' 897' ' ' GLU . . . -63.62 133.08 53.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -175.5 135.1 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.71 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -166.07 136.74 3.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.413 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 949' ' ' LEU . 48.7 m80 -149.66 127.5 11.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.382 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.687 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 7.8 p -82.26 114.5 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 921' ' ' ASP . 2.6 pt20 -66.86 178.39 1.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.13 131.52 12.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.005 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.561 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.4 Cg_exo -62.1 -164.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.547 2.165 . . . . 0.0 112.325 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.12 -14.47 61.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.391 0.615 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 74.2 t60 62.26 114.42 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.57 ' HZ ' ' HG2' ' A' ' 954' ' ' PRO . 49.4 m-85 -90.0 133.56 34.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.254 0.55 . . . . 0.0 111.268 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.534 ' N ' HD13 ' A' ' 909' ' ' LEU . 4.1 mp -70.43 -45.74 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.125 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.698 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 2.3 p90 -82.8 31.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.071 0.462 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 930' ' ' TYR . . . -156.09 121.39 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.879 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -96.54 129.76 43.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -44.85 144.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.728 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 22.8 tptm -135.09 -38.93 0.77 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.459 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.476 ' HB ' HD13 ' A' ' 928' ' ' LEU . 95.9 m -64.56 136.41 57.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.702 0.287 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.634 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -50.94 125.11 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.803 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.594 HG21 HD13 ' A' ' 913' ' ' LEU . 7.0 t -159.43 148.39 18.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 20.7 m -156.85 47.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.387 0.613 . . . . 0.0 110.044 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -169.55 164.03 10.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.717 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 37.0 t -84.56 -39.47 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 903' ' ' GLN . 37.6 p-10 -85.01 118.81 24.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 17.0 m-85 -101.17 139.36 20.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.784 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 38.3 Cg_endo -66.42 139.17 53.16 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.732 2.288 . . . . 0.0 112.104 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.665 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 61.4 mt -61.3 151.91 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.559 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 83.31 -31.25 3.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.886 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 17.1 m -56.01 131.05 46.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.023 0.44 . . . . 0.0 111.982 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.888 ' HB2' ' HB2' ' A' ' 942' ' ' SER . 74.8 p -90.96 116.66 28.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.672 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 942' ' ' SER . 11.7 tp -96.28 97.87 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 38.3 ttpt -82.52 131.03 35.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.31 0.576 . . . . 0.0 112.157 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.73 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 17.9 m-85 -113.78 139.17 49.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.473 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.728 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 5.0 mm-40 -91.41 118.42 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.73 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 75.3 m -57.67 143.2 42.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.6 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.698 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 94.5 mtt180 -84.89 160.78 54.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.092 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 5.9 Cg_endo -47.69 139.18 18.91 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.56 2.173 . . . . 0.0 112.096 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.562 ' HG2' HG13 ' A' ' 982' ' ' VAL . 90.0 mt-10 83.76 26.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.736 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.586 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 62.2 m-85 -145.75 148.19 32.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.302 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -137.56 -155.83 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.045 0.45 . . . . 0.0 111.839 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 78.69 33.16 38.84 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.6 ptp85 47.22 164.95 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.54 0.736 . . . . 0.0 112.962 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.694 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 70.9 Cg_endo -73.96 138.66 26.12 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.925 2.417 . . . . 0.0 112.808 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 43.6 p90 -95.4 120.82 36.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.371 0.605 . . . . 0.0 111.438 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.888 ' HB2' ' HB2' ' A' ' 927' ' ' SER . 78.2 p -75.3 -37.33 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.762 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 943' ' ' ILE . 44.7 pt 49.23 104.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.393 0.616 . . . . 0.0 111.441 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.621 ' O ' HD23 ' A' ' 946' ' ' LEU . 51.6 m -78.62 124.93 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 0.5 OUTLIER -73.74 130.77 40.67 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.085 0.469 . . . . 0.0 110.057 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.676 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 1.6 mm? -90.83 166.96 12.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.333 1.063 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 924' ' ' ILE . 9.4 t70 -50.23 -42.28 51.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.322 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.527 ' ND2' HG12 ' A' ' 950' ' ' VAL . 16.4 p-10 -83.36 43.97 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 902' ' ' CYS . 6.8 mp 44.68 53.52 7.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.089 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.676 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 26.3 m -133.91 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 111.115 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 84.9 m95 -150.95 125.74 9.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.0 t -41.58 152.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.7 t -77.19 118.54 72.64 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.57 ' HG2' ' HZ ' ' A' ' 908' ' ' PHE . 5.9 Cg_exo -79.51 58.24 6.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.468 2.779 . . . . 0.0 112.931 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -80.25 128.6 33.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.761 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 1.5 m-20 55.61 38.41 30.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.876 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 16.7 m -89.31 -35.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.908 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 48.4 t -152.92 60.77 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.761 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.5 mmtt -56.52 148.29 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.243 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 17.4 ttm105 -55.59 137.35 49.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 111.575 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.81 ' HD3' ' N ' ' A' ' 962' ' ' SER . 6.4 tmtt? -56.29 144.25 30.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.618 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.81 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 47.5 t -138.66 137.21 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.492 . . . . 0.0 111.099 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.21 148.45 32.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -65.49 139.01 58.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 111.301 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 60.3 m -58.32 135.95 85.12 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.194 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 974' ' ' VAL . 51.3 Cg_exo -53.31 146.68 39.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.422 2.081 . . . . 0.0 111.938 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 968' ' ' ASP . 10.7 Cg_exo -72.22 46.31 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 0.0 112.687 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 967' ' ' PRO . 8.4 t70 22.03 97.68 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.825 0.703 . . . . 0.0 112.476 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 968' ' ' ASP . 21.9 Cg_endo -60.43 145.25 99.05 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.491 2.128 . . . . 0.0 111.641 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 24.1 t -47.26 122.49 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 73.0 m-80 75.48 -43.11 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.86 151.18 45.54 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.101 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 68.4 mtm -146.76 132.23 18.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.317 . . . . 0.0 110.586 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.589 HG23 ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -98.66 129.93 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.927 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 122.05 38.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.654 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 980' ' ' ILE . 98.0 t -70.62 136.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.302 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.416 ' O ' ' OG1' ' A' ' 978' ' ' THR . 37.1 mm -82.92 64.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.933 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 977' ' ' ILE . 6.6 p 76.4 -43.9 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.096 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -157.5 135.43 10.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.699 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 976' ' ' VAL . 20.3 pt -88.96 26.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 85.0 mt-30 -76.61 146.34 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.562 HG13 ' HG2' ' A' ' 935' ' ' GLU . 69.9 t -50.12 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.144 0.497 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 166.99 -62.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 84.6 p -81.71 -150.07 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.985 0.422 . . . . 0.0 110.225 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.549 ' O ' HG21 ' A' ' 986' ' ' ILE . 5.0 ptp85 -151.38 -165.87 2.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.875 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.589 ' HB ' HG23 ' A' ' 974' ' ' VAL . 26.4 pt -147.7 131.6 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.25 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.474 HG21 ' OG ' ' A' 1001 ' ' SER . 1.3 p -97.8 134.35 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 111.555 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.498 ' CD2' ' HB ' ' A' ' 974' ' ' VAL . 3.7 m-85 -103.03 143.94 31.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.262 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -154.37 127.01 8.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.454 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 15.6 t -63.6 162.35 13.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 992' ' ' THR . 4.2 t -64.83 -53.72 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 991' ' ' THR . 12.2 t 173.84 147.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' 1023 ' ' ILE . . . 84.79 -40.9 3.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.926 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.529 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.1 m80 -100.51 143.51 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.067 0.433 . . . . 0.0 111.194 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -91.89 148.82 21.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.95 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.534 HD13 ' HG3' ' A' 1018 ' ' PRO . 10.2 tt -71.82 128.81 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.433 HD12 ' CB ' ' A' 1021 ' ' GLN . 1.8 mp -113.61 122.43 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 131.32 -57.83 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.908 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.555 ' HD1' ' H ' ' A' 1001 ' ' SER . 40.3 t-80 -162.2 -121.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.503 ' N ' ' HD1' ' A' ' 999' ' ' HIS . 78.8 p 177.31 -22.82 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.537 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.555 ' H ' ' HD1' ' A' ' 999' ' ' HIS . 48.9 m -155.22 159.18 39.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.772 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -151.96 130.14 11.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -94.81 135.11 36.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.204 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 26.2 t -72.67 121.53 19.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.9 pt -134.55 141.93 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 935' ' ' GLU . 49.4 tp -84.52 130.44 34.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.032 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.572 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 42.3 t -96.09 50.38 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 82.19 -37.05 2.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.483 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -147.93 -50.67 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 62.4 m -94.16 125.14 38.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.54 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . . . -82.61 136.19 34.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.561 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.9 p80 -157.73 148.91 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.527 ' CH2' HG22 ' A' ' 986' ' ' ILE . 22.0 m95 -68.59 145.45 53.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.528 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 64.2 m -55.35 -42.96 74.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.268 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 80.9 p -100.15 -148.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.176 0.513 . . . . 0.0 112.114 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -148.66 153.39 39.47 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.563 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.78 130.31 33.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.754 2.303 . . . . 0.0 112.713 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.534 ' HG3' HD13 ' A' ' 996' ' ' LEU . 79.1 Cg_endo -76.9 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.767 2.311 . . . . 0.0 112.696 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.09 142.0 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.379 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 32.9 m -81.49 129.77 34.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.529 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 2.3 tp-100 -143.49 127.14 17.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' 1022 ' ' ARG . 30.7 ptt85 -49.12 142.19 7.23 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.487 0.661 . . . . 0.0 111.38 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 993' ' ' GLY . 23.3 mt -74.75 131.51 79.36 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.182 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.741 2.294 . . . . 0.0 112.407 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.856 0.36 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.38 136.23 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.981 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 899' ' ' GLU . 0.4 OUTLIER -58.86 132.02 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . -166.27 -141.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.315 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.588 ' N ' HD23 ' A' ' 949' ' ' LEU . 21.2 m80 68.88 129.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.856 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.8 p -82.21 124.19 29.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.629 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.417 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.0 mm100 -69.65 166.75 18.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.142 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.44 127.79 10.15 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.122 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 928' ' ' LEU . 53.9 Cg_endo -69.47 133.13 25.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.389 2.06 . . . . 0.0 112.018 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.19 153.2 35.26 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.216 0.532 . . . . 0.0 111.161 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -78.29 139.29 38.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.92 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -89.48 -140.32 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.955 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.441 ' HA ' HD21 ' A' ' 909' ' ' LEU . 63.1 mt -154.03 -38.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.438 ' HD1' ' HB2' ' A' ' 911' ' ' ALA . 0.7 OUTLIER -82.23 -6.3 59.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.438 ' HB2' ' HD1' ' A' ' 910' ' ' PHE . . . -157.85 128.81 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.324 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -98.81 135.06 40.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.839 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.435 HD11 ' CE1' ' A' ' 930' ' ' TYR . 36.8 tp -48.86 125.35 10.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.372 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -94.52 -43.34 8.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.501 HG21 ' NE2' ' A' ' 916' ' ' GLN . 38.1 m -64.84 135.44 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.806 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 915' ' ' THR . 3.2 pm0 -64.08 144.55 57.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.046 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.67 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 46.5 p -150.53 -86.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.419 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 918' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 917' ' ' THR . 91.3 m 73.26 -38.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.4 136.49 51.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.365 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.5 p -89.67 34.51 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.389 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.53 135.85 11.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.885 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.67 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 72.8 m-85 -143.4 138.36 15.43 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.46 140.48 12.01 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.913 2.409 . . . . 0.0 111.414 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 945' ' ' CYS . 29.8 mt -51.59 141.18 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 110.583 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 105.8 -29.09 11.87 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.491 HG22 ' HD2' ' A' ' 922' ' ' PHE . 30.4 m -55.45 140.08 41.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.0 m -121.19 140.39 52.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.498 HD12 HG23 ' A' ' 917' ' ' THR . 90.3 mt -132.36 118.94 20.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 39.4 ttmt -89.18 128.43 35.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.409 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.454 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 2.5 m-85 -110.99 129.18 55.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -97.58 129.41 44.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 911' ' ' ALA . 61.5 m -56.75 160.01 3.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.542 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 67.6 mtt-85 -81.47 158.33 68.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.485 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 936' ' ' TYR . 68.9 Cg_exo -39.17 -55.64 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.922 2.415 . . . . 0.0 113.26 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 960' ' ' ARG . 14.4 pt-20 -75.23 36.51 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 935' ' ' GLU . 56.4 m-85 -142.7 150.87 40.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.727 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 35.9 p90 -145.43 135.46 23.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.326 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 957' ' ' VAL . . . 153.16 28.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.17 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 80.6 mtp180 61.05 148.0 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.451 0.643 . . . . 0.0 112.239 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 939' ' ' ARG . 4.4 Cg_exo -75.18 123.04 7.49 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.263 2.642 . . . . 0.0 111.989 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.52 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 46.3 p90 -90.37 -161.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.615 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 135.93 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.425 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 4.6 pt -92.61 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.895 HG23 HD22 ' A' ' 946' ' ' LEU . 1.1 m -164.0 132.12 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 59.5 m -72.12 110.88 6.89 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.895 HD22 HG23 ' A' ' 944' ' ' THR . 97.5 mt -83.41 -52.85 6.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.6 t70 174.32 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 110.905 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.43 ' O ' HG11 ' A' ' 950' ' ' VAL . 74.5 m-80 -83.13 31.78 0.44 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 900' ' ' ALA . 78.3 mt 50.75 42.38 27.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 948' ' ' ASN . 19.9 m -137.44 150.91 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 121.632 0.73 . . . . 0.0 112.343 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 68.6 m95 -91.49 124.71 35.87 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.323 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.2 t -43.37 142.07 1.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t -79.86 113.08 34.91 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.702 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.07 67.12 6.05 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.49 2.793 . . . . 0.0 111.766 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -76.42 131.68 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.296 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.504 ' O ' HG11 ' A' ' 957' ' ' VAL . 8.3 t70 57.87 96.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.638 HG21 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -152.85 -70.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.638 ' H ' HG21 ' A' ' 957' ' ' VAL . 80.9 m -88.44 140.62 29.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -143.12 127.21 17.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.188 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.554 ' NE ' ' HB3' ' A' ' 981' ' ' GLN . 53.8 ttp180 -53.24 137.3 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.165 0.507 . . . . 0.0 112.042 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.727 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 32.1 mmmt -56.34 170.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.127 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.616 ' HB3' HE21 ' A' ' 981' ' ' GLN . 69.5 p -150.24 134.69 17.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.075 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.0 m -81.58 144.26 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.085 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -65.89 134.84 53.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.45 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.7 m -54.48 117.31 12.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.31 129.98 15.67 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.402 2.068 . . . . 0.0 111.835 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.04 125.15 18.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.098 1.866 . . . . 0.0 111.507 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.25 126.55 82.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.81 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.01 142.68 82.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.549 2.166 . . . . 0.0 112.076 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.3 p -46.97 129.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.549 ' ND2' HG23 ' A' ' 970' ' ' VAL . 77.3 m-20 63.74 47.2 3.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.796 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -166.96 -155.38 8.99 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.447 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 23.7 ptp 175.23 140.33 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.63 0.252 . . . . 0.0 111.013 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.693 HG22 HD13 ' A' ' 986' ' ' ILE . 8.4 p -93.84 135.41 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.769 0.318 . . . . 0.0 111.029 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -94.29 108.96 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.179 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.777 ' HA ' HG23 ' A' ' 986' ' ' ILE . 57.3 t -65.41 -22.83 31.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 985' ' ' ARG . 7.2 mm 73.88 -52.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.748 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 73.3 p -150.25 -56.68 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.46 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 31.0 m-20 -157.13 157.69 34.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.595 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 14.6 pt -95.51 32.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.664 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.616 HE21 ' HB3' ' A' ' 962' ' ' SER . 5.4 mp0 -79.22 151.15 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 961' ' ' LYS . 73.7 t -53.93 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.079 0.466 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 160.56 -46.52 0.4 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.7 m -78.72 135.91 37.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 55.6 ttp180 -98.24 132.32 43.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 976' ' ' VAL . 28.6 pt -93.97 130.09 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.316 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.481 HG21 ' OG ' ' A' 1001 ' ' SER . 7.8 p -102.52 130.99 49.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.452 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.7 m-85 -95.15 145.35 25.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.195 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 88.9 p -148.64 121.44 8.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.744 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.99 149.27 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.7 t -64.32 146.02 55.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.491 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 88.5 m -46.42 125.14 6.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.257 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.433 ' O ' HG13 ' A' 1023 ' ' ILE . . . 127.72 -46.81 1.06 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.464 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.9 m80 -100.19 140.24 34.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.648 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.5 ptm180 -92.36 144.13 25.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.371 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 999' ' ' HIS . 6.8 tt -72.81 135.39 45.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.0 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -115.07 139.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 90.47 -125.71 8.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.262 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.539 ' CD2' ' HB ' ' A' 1015 ' ' THR . 85.0 m-70 -78.33 -134.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.463 0.173 . . . . 0.0 111.314 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.5 p -177.9 -27.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.481 ' OG ' HG21 ' A' ' 987' ' ' THR . 50.0 m -151.63 153.0 33.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.561 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.58 128.9 11.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 20.5 pt-20 -95.66 137.85 34.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.805 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.26 95.89 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.41 HG22 HD11 ' A' 1005 ' ' ILE . 32.1 pt -103.56 -157.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.869 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' 1010 ' ' THR . 57.3 tp -153.68 137.73 16.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.474 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.794 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.8 t -90.03 -40.09 12.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.777 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -169.92 -34.08 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.45 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.461 ' C ' HD13 ' A' 1006 ' ' LEU . 14.4 p-10 -152.95 -40.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.498 ' O ' HD11 ' A' 1006 ' ' LEU . 70.5 m -91.2 130.08 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.608 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.98 141.02 37.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.106 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.794 ' HE2' ' HB2' ' A' 1007 ' ' SER . 10.0 p80 -157.01 145.95 20.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.33 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.4 m95 -68.27 141.89 55.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -57.74 -32.32 67.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.38 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.539 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 71.5 p -142.88 139.07 30.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.958 0.409 . . . . 0.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' 1017 ' ' PRO . 4.7 tmmm? -64.82 138.37 97.45 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.554 ' N ' ' HD2' ' A' 1016 ' ' LYS . 97.8 Cg_exo -44.75 134.74 10.15 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.964 2.443 . . . . 0.0 113.207 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 40.3 Cg_endo -66.54 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.861 2.374 . . . . 0.0 112.844 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 55.9 mt -141.09 144.85 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.837 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 74.2 m -103.89 123.97 48.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.563 ' HB2' HD12 ' A' ' 997' ' ' ILE . 0.6 OUTLIER -142.84 127.48 18.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.669 0.271 . . . . 0.0 110.754 -178.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 0.0 OUTLIER -49.66 136.95 16.46 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.447 0.642 . . . . 0.0 111.168 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.648 HG12 ' HB3' ' A' ' 995' ' ' ARG . 16.0 mt -75.96 132.46 74.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.188 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.733 0.301 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 57.22 -153.17 0.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . 0.427 ' HB3' ' HE1' ' A' ' 901' ' ' HIS . 95.1 mt-10 -57.99 134.38 56.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -73.9 128.68 36.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.054 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.469 ' N ' HD23 ' A' ' 949' ' ' LEU . 74.0 m80 -156.04 141.08 17.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.276 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 92.1 m -81.05 128.6 33.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -76.14 172.14 13.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.397 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.1 126.06 7.15 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.984 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.432 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 50.5 Cg_exo -56.75 138.08 83.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.623 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.22 157.21 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -78.11 123.74 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 911' ' ' ALA . 2.8 m-85 -85.22 24.1 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.25 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 911' ' ' ALA . 14.1 mt 61.33 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.17 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.6 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -82.49 35.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.392 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.698 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.48 143.12 20.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.228 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.28 144.61 32.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.03 152.49 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.394 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.848 ' HA ' ' HE3' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -147.9 48.1 1.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.036 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.485 ' O ' HG21 ' A' ' 917' ' ' THR . 16.2 m -170.72 137.32 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -52.91 132.09 36.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.808 0.337 . . . . 0.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.819 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 82.7 p -152.88 57.9 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 85.0 m -51.5 -44.74 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.6 51.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 49.4 m -86.78 -41.57 14.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.87 145.98 27.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.382 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.819 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 37.9 m-85 -134.95 138.51 29.69 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 0.0 112.037 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.476 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 58.0 Cg_endo -70.59 141.1 41.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.367 . . . . 0.0 111.67 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.74 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.7 mt -56.53 143.05 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.994 0.425 . . . . 0.0 111.312 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 99.12 -28.2 16.44 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.492 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 19.5 m -55.88 132.76 50.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 143.19 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.835 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.519 HD22 ' HE1' ' A' ' 930' ' ' TYR . 8.6 tp -135.18 125.19 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.452 ' HB2' ' HG1' ' A' ' 915' ' ' THR . 63.6 mttp -85.29 134.22 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.519 ' HE1' HD22 ' A' ' 928' ' ' LEU . 8.5 m-85 -132.13 122.79 25.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.392 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -95.62 130.46 42.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.346 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 36.0 m -56.79 -173.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.401 . . . . 0.0 111.363 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.6 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 93.7 mtt180 -82.46 152.72 67.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.758 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 936' ' ' TYR . 91.9 Cg_exo -44.51 -40.01 13.28 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.78 2.32 . . . . 0.0 112.547 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 982' ' ' VAL . 47.9 mt-10 -73.04 21.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 111.082 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.3 m-85 -142.75 137.22 29.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.486 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.458 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 3.7 p90 -102.12 36.56 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.215 0.531 . . . . 0.0 110.962 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . -83.87 139.74 18.81 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.79 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.637 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 37.1 ptt85 -72.89 163.52 67.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -63.63 112.69 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.352 2.035 . . . . 0.0 112.017 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -91.04 114.85 27.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.46 0.648 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.2 p -79.58 122.09 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.955 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 943' ' ' ILE . 9.4 pt -97.46 -174.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.845 HG23 HD22 ' A' ' 946' ' ' LEU . 0.7 OUTLIER -166.82 134.42 2.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 52.7 t -66.53 116.16 7.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.845 HD22 HG23 ' A' ' 944' ' ' THR . 77.4 mt -80.96 -55.56 4.71 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 49.8 t0 173.21 -48.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.53 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -83.87 33.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.278 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.515 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 40.4 mt 60.92 56.77 2.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.637 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 2.1 m -139.4 -163.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.219 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 944' ' ' THR . 74.7 m95 -145.41 125.03 13.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.766 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.647 ' HA ' HD13 ' A' ' 946' ' ' LEU . 47.5 t -38.59 135.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 79.9 p -76.97 111.38 16.04 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 952' ' ' SER . 18.6 Cg_exo -65.85 132.64 31.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.601 ' HG2' ' H ' ' A' ' 956' ' ' ASP . 79.2 tttt -78.23 -134.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.601 ' H ' ' HG2' ' A' ' 955' ' ' LYS . 38.9 p-10 -78.98 127.0 31.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.847 0.356 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 956' ' ' ASP . 21.0 m -150.36 -48.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.456 ' N ' HG22 ' A' ' 957' ' ' VAL . 71.3 m -84.18 138.17 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -143.88 131.47 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 20.5 mmt180 -58.96 113.95 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.052 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.856 ' HE3' ' HB1' ' A' 1011 ' ' ALA . 38.3 ttpt -58.33 166.06 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.449 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 90.1 p -144.46 141.61 29.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.965 0.412 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' 1011 ' ' ALA . 49.2 m -81.54 36.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.979 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 60.18 128.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 14.6 m -61.17 132.81 92.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.484 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 11.6 Cg_endo -55.37 135.68 70.2 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 112.384 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 968' ' ' ASP . 72.2 Cg_endo -76.23 52.31 3.47 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 967' ' ' PRO . 8.1 t70 29.59 102.03 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.24 0.616 . . . . 0.0 112.423 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.485 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 52.1 Cg_exo -52.62 143.97 44.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.743 2.295 . . . . 0.0 112.322 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' 1020 ' ' CYS . 6.4 p -53.04 133.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.484 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 52.65 47.3 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.415 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.51 -158.77 16.21 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.631 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 176.29 140.42 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.151 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 987' ' ' THR . 7.2 p -99.82 128.77 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.463 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.5 OUTLIER -89.76 124.31 34.52 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.4 124.55 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 977' ' ' ILE . 3.5 mm -75.49 -41.65 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.9 p -144.71 -52.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.317 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -153.33 -156.57 0.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 15.8 pt -151.08 22.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 960' ' ' ARG . 4.8 mm100 -80.88 174.86 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.454 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 88.0 t -58.83 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.91 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 146.99 -34.44 1.32 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.4 m -75.06 140.4 43.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.631 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' 1002 ' ' ALA . 38.8 ttm180 -104.16 150.63 24.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 974' ' ' VAL . 40.8 pt -131.21 135.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.638 HG21 ' HB3' ' A' 1001 ' ' SER . 11.6 p -103.61 132.7 49.63 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.559 ' HH ' ' HB3' ' A' 1017 ' ' PRO . 5.2 m-85 -98.7 145.63 26.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 989' ' ' SER . . . . . 0.463 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 46.8 t -152.32 119.13 5.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.028 0.442 . . . . 0.0 110.984 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 62.6 m -80.92 144.85 31.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.854 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.8 t -65.0 158.37 25.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.4 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.0 t -46.47 134.57 9.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.624 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 113.83 -51.01 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.979 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -101.88 141.3 34.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.509 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.6 ptp180 -93.33 146.44 23.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.354 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.744 HD22 ' HB3' ' A' 1018 ' ' PRO . 10.0 tt -69.64 129.78 40.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.775 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.1 mp -98.34 142.26 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.72 -133.57 11.89 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.945 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.497 ' CD2' ' HB ' ' A' 1015 ' ' THR . 96.0 m-70 -78.63 -121.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.44 ' HA ' HD23 ' A' ' 996' ' ' LEU . 20.3 m -164.67 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.574 0.226 . . . . 0.0 111.177 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.638 ' HB3' HG21 ' A' ' 987' ' ' THR . 80.0 p -155.17 117.87 4.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.973 0.415 . . . . 0.0 111.274 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -91.09 179.45 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.478 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -145.41 132.13 19.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.339 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.3 t -71.19 122.35 20.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.38 148.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.179 0.514 . . . . 0.0 111.911 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.465 ' HG ' ' NZ ' ' A' ' 961' ' ' LYS . 1.2 tt -88.47 129.86 35.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.496 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.639 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -89.98 -44.92 9.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -173.5 -32.27 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.993 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.63 -49.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 26.2 m -94.46 133.01 38.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.802 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.856 ' HB1' ' HE3' ' A' ' 961' ' ' LYS . . . -82.01 139.29 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.243 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.639 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -157.67 144.61 18.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 62.3 m95 -68.56 138.35 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.599 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.5 p -52.9 -28.42 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.674 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.497 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 53.2 p -141.54 142.43 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.639 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -56.63 153.97 19.32 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.751 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.559 ' HB3' ' HH ' ' A' ' 988' ' ' TYR . 44.8 Cg_endo -69.19 122.15 8.97 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.302 2.001 . . . . 0.0 112.597 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.744 ' HB3' HD22 ' A' ' 996' ' ' LEU . 51.3 Cg_exo -54.42 148.8 40.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.779 2.319 . . . . 0.0 112.225 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.664 HG23 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.86 -159.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.664 ' H ' HG23 ' A' 1019 ' ' ILE . 84.5 m -153.31 134.69 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.011 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.845 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.0 OUTLIER -151.85 136.85 17.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.26 -178.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -48.02 133.59 14.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.374 0.607 . . . . 0.0 111.018 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.53 HG21 ' HD2' ' A' 1024 ' ' PRO . 60.0 mt -74.79 129.48 83.34 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.976 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' 1023 ' ' ILE . 76.4 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 112.501 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 897' ' ' GLU . 54.5 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.786 0.327 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 65.63 130.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -152.03 139.41 19.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -166.18 126.89 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.578 ' N ' HD13 ' A' ' 949' ' ' LEU . 36.3 m80 -151.6 138.51 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.525 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.597 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 83.3 m -81.1 124.94 29.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.706 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -69.38 173.14 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.0 134.86 6.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.226 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.07 149.4 35.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.525 2.15 . . . . 0.0 111.942 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 29.2 t0 -63.23 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.751 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.506 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 26.3 m80 -77.77 134.36 38.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.03 47.07 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.217 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.63 ' C ' HD11 ' A' ' 909' ' ' LEU . 4.2 pp -53.26 -34.44 57.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.4 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.558 ' N ' HD11 ' A' ' 909' ' ' LEU . 0.2 OUTLIER -87.11 26.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.485 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -155.09 129.98 9.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.196 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -101.62 126.2 48.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.382 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.49 119.89 6.34 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.536 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.631 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 74.4 mmtt -95.4 -39.04 10.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.651 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 18.5 m -64.55 -119.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.142 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.06 134.05 0.92 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.4 t -160.35 159.44 31.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.566 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.2 m -155.95 -31.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.403 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.3 158.74 35.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.03 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.3 p -84.67 -50.68 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.35 126.19 33.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.328 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 20.0 m-85 -102.0 134.13 20.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.439 . . . . 0.0 111.906 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.48 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 71.5 Cg_endo -73.36 137.36 25.58 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.833 2.355 . . . . 0.0 112.003 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.586 HG12 ' SG ' ' A' ' 945' ' ' CYS . 25.9 mt -59.99 151.58 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.531 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 93.94 -36.2 3.85 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.9 m -56.12 133.53 52.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.271 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 42.6 t -114.08 121.72 44.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.435 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.562 ' HB3' ' HE1' ' A' ' 930' ' ' TYR . 92.9 mt -103.38 124.82 49.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 17.1 tppt? -87.39 132.52 33.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.562 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 15.0 m-85 -135.27 123.03 22.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.544 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.95 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 90.4 mt-10 -103.29 129.59 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.691 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 74.2 m -54.09 168.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.548 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 77.6 mtp180 -79.03 148.46 71.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.53 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 936' ' ' TYR . 83.3 Cg_exo -45.45 -42.64 17.98 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.831 2.354 . . . . 0.0 112.682 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.33 20.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.227 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.6 m-85 -144.6 135.12 24.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.746 0.308 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.552 ' CD2' ' HD2' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -102.67 37.35 1.95 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 110.922 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.998 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . -77.03 0.12 67.88 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.764 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 939' ' ' ARG . 62.0 mtt85 64.58 144.12 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.429 . . . . 0.0 111.353 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.95 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 19.6 Cg_exo -66.36 110.43 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.796 2.331 . . . . 0.0 112.505 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.407 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 52.3 p90 -95.54 -164.3 1.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.496 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.502 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 80.5 p -172.83 135.98 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 10.8 pt -97.01 166.26 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.838 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 1.029 HG23 HD22 ' A' ' 946' ' ' LEU . 2.9 m -161.41 120.48 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.814 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 34.8 t -68.6 112.87 5.65 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 1.029 HD22 HG23 ' A' ' 944' ' ' THR . 82.2 mt -83.79 -52.5 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 50.0 t0 173.49 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.787 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.504 ' OD1' HG23 ' A' ' 950' ' ' VAL . 16.3 p30 -85.9 36.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.471 0.653 . . . . 0.0 109.84 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.597 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 2.3 mm? 54.88 63.69 2.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.384 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 19.0 m -141.64 146.19 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 111.891 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.72 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 97.7 m95 -93.8 47.88 1.25 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.051 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 89.3 p 53.03 26.85 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t 38.23 75.16 0.57 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.23 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 951' ' ' TRP . 92.5 Cg_endo -79.84 53.71 4.86 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.429 2.086 . . . . 0.0 112.376 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.36 129.07 35.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.916 0.389 . . . . 0.0 110.71 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.3 t0 60.88 106.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.86 -56.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.998 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 72.6 m -83.55 141.53 31.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.042 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -143.03 148.12 36.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.268 0.556 . . . . 0.0 112.08 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 981' ' ' GLN . 10.8 tpt180 -53.48 113.9 1.32 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.366 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.646 ' HZ3' ' H ' ' A' 1011 ' ' ALA . 27.8 tptp -56.99 158.33 5.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.371 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 77.4 p -150.81 138.36 19.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.581 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 964' ' ' LYS . 65.4 m -81.6 35.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 963' ' ' CYS . 87.4 tttt 55.45 131.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.416 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.3 m -54.11 129.05 58.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.526 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.433 ' HG3' HD11 ' A' ' 986' ' ' ILE . 72.8 Cg_endo -74.87 124.94 9.06 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.511 2.141 . . . . 0.0 112.67 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 15.5 Cg_exo -67.99 125.76 13.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.456 2.104 . . . . 0.0 111.533 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.24 128.53 91.21 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.243 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.26 -152.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.685 2.256 . . . . 0.0 111.979 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' 1020 ' ' CYS . 12.7 t -53.94 116.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.596 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 18.3 p30 39.53 32.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -67.02 177.56 19.05 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.111 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 50.6 ttm -175.45 73.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.323 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.7 p -90.35 122.05 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 111.328 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 975' ' ' HIS . 0.7 OUTLIER -95.62 131.61 41.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.166 0.507 . . . . 0.0 109.902 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.703 HG13 HG22 ' A' ' 980' ' ' ILE . 2.1 m -75.4 135.63 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.626 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.568 ' N ' HD11 ' A' ' 977' ' ' ILE . 2.5 mp -76.46 -32.14 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.475 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 977' ' ' ILE . 64.8 p -140.4 -66.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.557 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 53.0 t0 -162.16 14.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.703 HG22 HG13 ' A' ' 976' ' ' VAL . 29.3 pt 51.77 24.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.361 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.557 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 7.3 mm100 -80.93 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.64 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 14.7 t -55.51 130.31 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.333 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 96.26 -23.05 36.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.852 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' 1003 ' ' GLU . 52.3 m -74.61 -165.45 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' A' 1001 ' ' SER . 74.1 ttt180 -151.35 161.51 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.406 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.509 ' N ' ' HG2' ' A' ' 985' ' ' ARG . 20.3 pt -136.42 132.05 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.692 HG21 ' HB3' ' A' 1001 ' ' SER . 2.5 p -124.59 136.11 53.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 111.575 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -94.04 156.51 16.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.443 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 57.7 m -147.84 69.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.41 ' SG ' HD21 ' A' ' 996' ' ' LEU . 85.7 m -44.93 151.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.368 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 21.0 p -64.04 150.68 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -48.32 137.74 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.134 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' 1023 ' ' ILE . . . 106.02 -40.14 2.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.656 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 4.2 m80 -96.38 138.68 33.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.598 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.4 ptt180 -94.91 151.04 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.552 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' 1018 ' ' PRO . 0.4 OUTLIER -73.48 125.05 27.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.0 mp -103.05 138.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.707 0.289 . . . . 0.0 110.78 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 81.09 -125.13 6.72 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.428 ' O ' HD13 ' A' ' 996' ' ' LEU . 89.7 m-70 -78.57 -132.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.1 p -177.21 -30.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.606 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.692 ' HB3' HG21 ' A' ' 987' ' ' THR . 83.3 p -150.93 167.51 27.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.56 ' HB1' ' HG1' ' A' 1015 ' ' THR . . . -156.56 139.03 14.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.5 tt0 -96.25 134.94 38.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 40.5 t -71.96 125.83 28.21 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' 1011 ' ' ALA . 30.8 pt -135.24 -155.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.805 0.336 . . . . 0.0 111.537 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 36.8 tp -152.05 124.75 8.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.673 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.3 t -91.35 -48.37 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' 1010 ' ' THR . . . 168.85 124.15 0.71 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.867 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.6 m120 71.38 -28.82 0.19 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' 1008 ' ' GLY . 96.7 m -145.43 135.43 23.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.774 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.646 ' H ' ' HZ3' ' A' ' 961' ' ' LYS . . . -82.25 149.07 28.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.673 ' HE2' ' HB2' ' A' 1007 ' ' SER . 7.4 p80 -157.93 151.37 23.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.54 ' CZ2' ' HB ' ' A' ' 980' ' ' ILE . 81.2 m95 -68.46 144.05 54.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.253 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -56.8 -31.06 64.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.673 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.56 ' HG1' ' HB1' ' A' 1002 ' ' ALA . 80.8 p -144.06 138.41 28.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 111.923 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.561 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -66.45 155.74 87.61 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.182 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.16 135.31 52.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.759 2.306 . . . . 0.0 112.782 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.441 ' HB2' HD12 ' A' ' 996' ' ' LEU . 53.6 Cg_endo -68.81 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.818 2.346 . . . . 0.0 112.605 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.747 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 54.4 mt -140.16 137.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -98.75 123.37 42.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.806 ' HB3' HD12 ' A' ' 997' ' ' ILE . 36.3 tt0 -145.74 129.12 16.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.692 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 36.5 ttm180 -51.16 135.45 25.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.439 0.638 . . . . 0.0 111.475 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 995' ' ' ARG . 48.4 mt -74.92 125.78 89.0 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.422 ' HD2' HG21 ' A' 1023 ' ' ILE . 81.2 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.627 2.218 . . . . 0.0 112.475 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.879 0.371 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -64.83 136.35 56.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.045 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -173.74 138.33 0.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.535 ' HB3' HD23 ' A' ' 949' ' ' LEU . . . 65.99 128.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.427 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.519 ' N ' HD23 ' A' ' 949' ' ' LEU . 50.9 m80 -153.86 143.93 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 66.1 m -80.47 122.95 27.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.596 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -68.14 170.68 8.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.687 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.35 133.18 5.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.945 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.467 ' HG3' ' OH ' ' A' ' 930' ' ' TYR . 26.6 Cg_endo -61.7 -168.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.642 2.228 . . . . 0.0 112.333 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 8.3 t70 -174.96 161.04 2.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.053 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.417 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 78.0 t60 72.11 62.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.587 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.434 ' CZ ' HD12 ' A' ' 943' ' ' ILE . 45.1 m-85 -146.01 120.15 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.084 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 0.0 OUTLIER -132.58 -45.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.012 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.97 13.87 3.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.126 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.81 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.534 ' HG3' ' HZ2' ' A' ' 914' ' ' LYS . 20.8 pttp -107.92 123.85 49.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.684 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -51.13 146.81 6.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.086 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.739 ' N ' HD12 ' A' ' 913' ' ' LEU . 42.6 mmtm -147.88 11.89 0.97 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.692 HG23 HD22 ' A' ' 913' ' ' LEU . 14.3 t -70.88 -151.18 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.879 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' A' ' 916' ' ' GLN . 0.7 OUTLIER -86.55 -44.45 11.91 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-O 121.221 0.534 . . . . 0.0 110.978 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.738 HG22 HD13 ' A' ' 913' ' ' LEU . 21.4 p 50.67 -121.12 1.7 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.187 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 68.8 p 55.7 33.14 20.74 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.47 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.557 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.0 t -85.72 -49.37 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.744 0.306 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.74 126.01 33.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.593 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.455 ' CD2' HD22 ' A' ' 928' ' ' LEU . 36.0 m-85 -108.46 138.18 20.15 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.922 0.391 . . . . 0.0 111.756 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.511 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.1 Cg_endo -69.39 143.25 51.98 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.923 2.415 . . . . 0.0 112.302 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.719 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.1 mt -57.66 154.79 2.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.845 0.355 . . . . 0.0 110.914 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.647 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 83.81 -40.37 2.89 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.4 m -57.11 132.1 51.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.865 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 22.6 t -115.44 133.41 56.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.495 HD23 ' CG2' ' A' ' 915' ' ' THR . 78.3 mt -95.47 125.81 40.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.956 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -85.35 136.82 33.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.467 ' OH ' ' HG3' ' A' ' 905' ' ' PRO . 11.1 m-85 -128.75 131.28 47.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.61 123.03 44.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 80.5 m -57.25 163.54 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 73.9 mtp180 -81.89 151.55 67.55 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 936' ' ' TYR . 6.7 Cg_endo -49.44 -44.23 35.48 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.972 2.448 . . . . 0.0 112.609 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 982' ' ' VAL . 55.4 mt-10 -73.27 20.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.73 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 45.4 m-85 -143.08 134.99 26.86 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.825 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 13.2 p90 -96.17 135.82 37.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.631 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 164.95 141.17 3.05 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.87 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 939' ' ' ARG . 0.6 OUTLIER -72.75 157.12 89.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.931 0.396 . . . . 0.0 110.505 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 19.2 Cg_endo -60.75 147.27 95.55 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.986 2.457 . . . . 0.0 112.092 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 957' ' ' VAL . 53.1 p90 -144.44 -171.27 3.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 44.9 t -172.92 142.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.434 HD12 ' CZ ' ' A' ' 908' ' ' PHE . 10.7 pt -100.46 116.93 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.857 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.662 ' O ' HD23 ' A' ' 946' ' ' LEU . 36.9 m -81.45 131.68 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.38 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.719 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.6 t -73.74 123.22 23.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 109.903 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.671 ' H ' HD21 ' A' ' 946' ' ' LEU . 1.9 mm? -87.44 169.03 12.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.338 1.066 . . . . 0.0 113.622 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.4 -40.4 62.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.146 -1.843 . . . . 0.0 112.043 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -83.33 32.89 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 900' ' ' ALA . 56.7 mt 46.39 57.99 4.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.237 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.629 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 16.0 m -135.59 -159.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.385 0.612 . . . . 0.0 111.697 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -144.72 122.31 11.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.1 p -42.16 136.29 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.818 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 34.0 t -77.93 112.35 24.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 955' ' ' LYS . 15.4 Cg_exo -68.64 -153.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.713 2.275 . . . . 0.0 111.885 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 954' ' ' PRO . 32.4 mtmt -159.84 -147.37 0.16 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.69 0.757 . . . . 0.0 111.6 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 56.5 m-20 -81.28 58.63 3.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.406 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.794 HG21 ' H ' ' A' ' 958' ' ' CYS . 29.5 m -81.6 -50.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.409 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.794 ' H ' HG21 ' A' ' 957' ' ' VAL . 97.5 m -89.0 52.3 2.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.422 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -57.64 138.7 55.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.735 ' HD2' ' HB2' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -55.37 120.56 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.844 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.825 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 35.6 ttmt -56.45 142.36 38.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 78.5 p -144.44 141.23 29.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.492 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.1 m -81.63 23.79 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 965' ' ' THR . 13.8 tmtt? 55.6 136.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.414 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.474 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 4.4 m -51.12 118.19 10.1 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.316 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.626 ' HG3' HD13 ' A' ' 986' ' ' ILE . 43.9 Cg_endo -64.5 141.73 75.07 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 122.664 2.243 . . . . 0.0 111.694 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.35 115.87 2.75 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.124 1.883 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -62.54 134.98 95.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 17.7 Cg_endo -59.6 138.1 81.48 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.433 2.089 . . . . 0.0 111.872 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.4 p -50.7 129.29 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.424 ' ND2' HG21 ' A' ' 970' ' ' VAL . 74.9 m-20 64.04 48.24 3.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -170.82 -145.54 4.81 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.725 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER -178.83 156.6 0.85 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.68 HG23 HD11 ' A' ' 986' ' ' ILE . 14.2 p -87.55 128.07 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.466 0.65 . . . . 0.0 110.851 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.608 ' HB3' HG22 ' A' ' 987' ' ' THR . 12.3 t-160 -75.05 70.97 2.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.341 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.06 122.84 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.97 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 987' ' ' THR . 32.0 mm -78.44 -40.64 24.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.29 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 59.0 p -144.67 -50.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -154.45 -142.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.496 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 17.0 pt -145.56 -3.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.436 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.735 ' HB2' ' HD2' ' A' ' 960' ' ' ARG . 3.2 pt20 -75.56 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 935' ' ' GLU . 5.9 m -47.92 150.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 111.366 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 85.17 -40.75 3.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.257 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 40.6 t -77.63 131.28 37.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 111.436 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ttm180 -100.33 150.15 22.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.157 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.68 HD11 HG23 ' A' ' 974' ' ' VAL . 48.2 pt -141.73 127.58 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.381 . . . . 0.0 111.51 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' 1001 ' ' SER . 1.6 t -98.62 -168.31 1.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.549 ' HA ' ' H ' ' A' ' 975' ' ' HIS . 22.0 m-85 -136.87 154.15 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 0.0 111.176 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.4 t -148.44 125.21 11.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 72.6 m -100.04 147.39 25.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -65.03 146.85 54.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.525 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 87.0 m -45.87 126.48 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' 1023 ' ' ILE . . . 126.09 -46.93 1.05 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -102.23 137.48 40.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.065 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.716 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.8 ptm85 -93.33 146.59 23.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.196 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 999' ' ' HIS . 8.4 tt -71.77 133.2 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.984 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.2 mp -110.22 133.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 98.5 -128.9 9.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.306 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.527 ' CD2' ' HB ' ' A' 1015 ' ' THR . 94.2 m-70 -79.04 -129.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.0 p -172.24 -31.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.319 . . . . 0.0 111.247 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 47.2 t -150.84 159.82 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -154.6 133.77 12.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.989 0.424 . . . . 0.0 111.83 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 4.6 pm0 -104.05 138.24 40.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.451 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.9 t -76.9 125.82 29.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' 1011 ' ' ALA . 29.9 pt -131.56 -151.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.669 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.557 HD12 ' HZ1' ' A' ' 961' ' ' LYS . 28.8 tp -147.18 -26.57 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.335 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.6 t 69.42 -42.94 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' 1006 ' ' LEU . . . -175.83 -45.66 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.265 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -156.18 21.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.418 0.151 . . . . 0.0 111.025 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.481 ' N ' HD13 ' A' 1006 ' ' LEU . 3.3 m -150.58 121.04 7.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.283 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' 1005 ' ' ILE . . . -76.15 129.13 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 0.0 110.888 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.562 ' HE2' ' HB2' ' A' 1007 ' ' SER . 20.7 p80 -160.15 144.16 14.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 96.3 m95 -68.63 136.28 52.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.063 0.458 . . . . 0.0 110.453 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.402 ' OG ' ' HG2' ' A' 1003 ' ' GLU . 73.7 m -56.36 -27.25 55.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.888 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.527 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 72.8 p -145.86 143.9 29.9 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.176 0.512 . . . . 0.0 112.324 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' A' 1017 ' ' PRO . 26.0 ttpp -65.79 140.9 97.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.778 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.459 ' HD2' ' HG3' ' A' 1016 ' ' LYS . 18.2 Cg_endo -58.15 131.25 42.2 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.524 2.149 . . . . 0.0 112.277 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -65.02 -160.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.746 2.297 . . . . 0.0 113.01 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.402 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 58.3 mt -143.16 139.65 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.814 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 71.9 m -92.58 124.66 36.77 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 997' ' ' ILE . 5.7 tt0 -145.62 134.67 22.68 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.199 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -45.7 135.5 6.7 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 111.851 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.716 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.1 mt -74.88 128.41 85.27 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 40.2 Cg_exo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.851 2.367 . . . . 0.0 112.253 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.866 0.365 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.88 135.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -175.19 54.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.437 ' C ' HD13 ' A' ' 949' ' ' LEU . . . -166.14 127.53 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.621 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.551 ' N ' HD13 ' A' ' 949' ' ' LEU . 61.1 m80 -152.58 139.8 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.267 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 76.5 m -81.08 132.48 35.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.987 0.422 . . . . 0.0 111.491 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.54 171.57 14.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.652 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.01 149.75 1.52 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.535 ' HB2' ' CD1' ' A' ' 908' ' ' PHE . 10.1 Cg_endo -50.84 135.17 42.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.961 2.441 . . . . 0.0 112.341 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.451 ' O ' ' HD1' ' A' ' 908' ' ' PHE . 46.6 m-20 -67.51 116.3 8.09 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.481 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 23.9 p80 38.0 46.67 0.84 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 905' ' ' PRO . 5.5 m-85 -81.64 137.47 35.45 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.652 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.948 HD11 ' N ' ' A' ' 909' ' ' LEU . 0.0 OUTLIER -159.63 -27.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.0 0.63 30.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.45 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.517 ' HB3' ' SG ' ' A' ' 958' ' ' CYS . . . -153.05 134.37 14.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.347 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.21 126.35 39.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.651 HD12 HG22 ' A' ' 917' ' ' THR . 1.2 tt -51.19 131.94 28.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.62 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.787 ' HD3' ' HG2' ' A' ' 929' ' ' LYS . 7.0 mtpm? -85.22 -49.61 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.795 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 60.2 m -64.77 136.72 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.219 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.469 ' C ' HG21 ' A' ' 917' ' ' THR . 3.0 pm0 -60.37 130.48 46.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.31 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 913' ' ' LEU . 82.0 p -152.08 147.36 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.325 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.4 p -143.66 -42.87 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 141.76 52.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 40.0 t -86.97 39.18 0.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -157.23 138.72 13.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.545 ' HE2' HG23 ' A' ' 917' ' ' THR . 71.7 m-85 -136.36 139.31 29.33 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.48 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.6 Cg_endo -69.33 146.95 64.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.559 . . . . 0.0 112.227 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.749 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 18.3 mt -59.55 158.18 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.892 0.377 . . . . 0.0 111.386 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.663 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 81.23 -35.43 2.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.938 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 39.7 m -56.02 129.25 39.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 111.364 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 66.3 p -108.9 125.77 52.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 91.5 mt -105.02 122.76 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.889 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.787 ' HG2' ' HD3' ' A' ' 914' ' ' LYS . 37.6 ttmt -90.01 133.35 34.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.546 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 1.5 m-85 -120.65 168.78 11.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.374 . . . . 0.0 111.075 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 914' ' ' LYS . 11.8 pt-20 -140.95 125.43 17.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.822 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 79.2 m -57.51 154.88 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.011 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.628 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 99.7 mtt180 -82.77 165.0 44.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 54.7 Cg_endo -69.94 56.08 1.42 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.892 2.395 . . . . 0.0 112.868 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.731 ' O ' ' HD2' ' A' ' 961' ' ' LYS . 55.3 mt-10 -164.94 9.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -149.18 135.31 19.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 10.8 p90 -95.02 136.38 35.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 0.0 111.221 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 167.73 141.25 3.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.52 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.35 156.0 92.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.744 0.307 . . . . 0.0 110.435 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -60.99 109.15 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.411 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.499 ' HB3' ' NH1' ' A' ' 939' ' ' ARG . 52.6 p90 -96.08 -164.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.91 132.09 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.565 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.764 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 5.1 pt -97.34 120.31 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 111.643 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 946' ' ' LEU . 17.5 m -84.08 122.72 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.83 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.749 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.8 t -73.7 102.84 4.07 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.681 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 83.9 mt -84.01 162.2 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -43.09 -38.4 2.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.869 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -82.29 33.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.164 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.576 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 1.7 mm? 44.82 52.28 8.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.681 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 29.6 m -127.64 -160.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.537 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.764 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 75.5 m95 -149.01 121.81 8.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.67 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 87.8 p -42.72 143.85 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.918 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 41.8 t -77.08 117.29 64.12 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 17.0 Cg_exo -66.4 -8.74 21.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.596 2.198 . . . . 0.0 111.289 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 46.97 57.26 5.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.865 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 59.9 t0 61.19 126.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.966 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 5.1 m -150.94 -48.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.756 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 911' ' ' ALA . 99.5 m -83.51 54.37 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 0.0 110.648 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 93.5 mttt -61.39 151.83 31.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.7 ' HD2' ' NZ ' ' A' ' 961' ' ' LYS . 15.1 tpp85 -53.37 125.22 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.731 ' HD2' ' O ' ' A' ' 935' ' ' GLU . 0.0 OUTLIER -56.38 125.67 22.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.38 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.521 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 91.9 p -144.45 127.9 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.107 0.48 . . . . 0.0 111.083 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.9 p -82.0 44.19 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.189 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.7 tptt 62.86 135.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.073 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.592 HG21 ' HD2' ' A' ' 966' ' ' PRO . 14.0 m -59.85 131.32 88.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.704 ' HG3' HD11 ' A' ' 986' ' ' ILE . 37.6 Cg_endo -65.21 132.64 32.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.596 2.197 . . . . 0.0 112.459 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.35 138.9 52.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.4 2.067 . . . . 0.0 111.793 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -57.94 116.87 15.9 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.77 141.82 55.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.211 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' 1020 ' ' CYS . 11.3 p -53.74 129.13 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 44.97 46.66 9.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.992 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.467 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -168.01 135.05 3.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.58 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.412 ' HB2' ' HE1' ' A' ' 973' ' ' MET . 54.4 mtm -103.68 136.65 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.511 HG22 HD13 ' A' ' 986' ' ' ILE . 12.1 p -99.75 132.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -95.9 115.66 27.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.871 HG12 HG21 ' A' ' 980' ' ' ILE . 94.7 t -66.01 -25.34 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.094 0.473 . . . . 0.0 109.993 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.527 HD13 ' OG1' ' A' ' 987' ' ' THR . 14.6 mm 74.21 -51.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.988 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.447 HG21 ' C ' ' A' ' 977' ' ' ILE . 70.9 p -148.92 -59.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.485 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.616 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 34.4 m-20 -157.41 143.84 17.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.168 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.871 HG21 HG12 ' A' ' 976' ' ' VAL . 6.0 pt -84.64 21.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.616 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 75.8 mm-40 -78.95 159.94 27.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.219 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' A' ' 961' ' ' LYS . 2.2 m -56.45 -7.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.836 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -95.64 22.46 38.97 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.465 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 67.5 m -163.95 -160.89 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.778 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' 1002 ' ' ALA . 17.2 ptp180 -151.39 -168.19 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.223 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.828 HG23 ' HA ' ' A' ' 976' ' ' VAL . 33.3 pt -146.37 129.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.527 ' OG1' HD13 ' A' ' 977' ' ' ILE . 11.0 p -103.28 134.52 46.54 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.129 0.49 . . . . 0.0 111.134 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.507 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 1.5 m-85 -95.44 145.2 25.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.2 t -146.46 74.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.514 ' SG ' HD21 ' A' ' 996' ' ' LEU . 59.4 m -51.64 147.34 6.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.4 p -64.3 150.48 46.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 62.2 m -47.78 112.45 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.163 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 144.72 -50.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -102.3 142.98 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.544 HH21 HG22 ' A' 1023 ' ' ILE . 13.3 ptp180 -92.92 145.0 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.504 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.546 HD13 ' C ' ' A' ' 999' ' ' HIS . 2.5 tm? -72.45 129.53 38.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.696 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' 1021 ' ' GLN . 4.6 mp -118.41 123.52 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.64 0.257 . . . . 0.0 110.72 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.28 43.22 3.04 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.723 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.546 ' C ' HD13 ' A' ' 996' ' ' LEU . 93.2 m-70 60.86 125.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 0.0 111.672 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.518 ' HB3' ' HG ' ' A' ' 996' ' ' LEU . 79.9 p -81.39 32.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 50.2 m -158.59 145.72 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.671 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -155.8 125.5 6.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.645 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.47 130.13 40.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.227 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 120.97 17.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.06 137.71 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.414 0.625 . . . . 0.0 112.082 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' 1010 ' ' THR . 22.5 tp -84.51 120.4 26.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.014 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.2 t -96.08 52.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 81.43 -124.51 6.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.773 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.9 m120 -55.62 -46.96 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.501 ' O ' HD13 ' A' 1006 ' ' LEU . 0.4 OUTLIER -94.52 -164.02 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.972 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.467 ' H ' ' CG2' ' A' 1010 ' ' THR . . . -158.25 147.38 19.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.054 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.26 152.04 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.465 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 85.1 m95 -68.69 146.1 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.385 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -56.52 -30.78 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.723 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 8.1 t -146.97 145.69 29.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.93 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -53.81 137.46 54.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.093 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 73.8 Cg_exo -49.53 113.1 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.197 1.931 . . . . 0.0 112.668 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.542 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 11.0 Cg_endo -54.27 142.28 68.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.927 2.418 . . . . 0.0 112.138 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 970' ' ' VAL . 0.1 OUTLIER -107.11 143.7 17.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.031 0.443 . . . . 0.0 111.9 -179.405 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 57.8 m -83.49 141.09 31.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.813 ' HB2' HD12 ' A' ' 997' ' ' ILE . 0.5 OUTLIER -145.8 131.24 18.68 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.862 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -49.75 130.92 21.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.405 0.622 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.544 HG22 HH21 ' A' ' 995' ' ' ARG . 64.9 mt -74.86 126.32 88.48 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.066 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.831 2.354 . . . . 0.0 112.314 -179.92 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.82 0.343 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -78.8 44.41 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.314 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.13 140.54 58.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.768 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -165.98 137.05 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.521 ' N ' HD23 ' A' ' 949' ' ' LEU . 26.8 m80 -148.17 131.46 16.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 8.9 p -82.3 127.8 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -64.17 159.26 20.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.48 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.21 131.7 5.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.676 ' HG3' HD13 ' A' ' 928' ' ' LEU . 31.3 Cg_endo -63.89 149.57 90.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.829 2.353 . . . . 0.0 112.48 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -62.37 162.94 9.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.06 124.77 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.508 ' HZ ' HG22 ' A' ' 943' ' ' ILE . 4.6 m-30 -85.28 129.06 34.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.56 25.63 4.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.443 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 8.5 p90 -154.01 1.63 0.23 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.066 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.43 131.38 8.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.402 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -102.01 136.16 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.991 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 66.0 tp -47.8 157.0 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.389 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.695 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 3.9 mmmp? -145.36 -36.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 19.5 m -64.4 139.45 58.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.46 136.13 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.542 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 77.1 p -152.18 140.33 20.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 25.5 m -158.4 53.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.197 0.522 . . . . 0.0 110.548 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.31 154.27 7.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.787 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.3 p -84.08 -49.44 8.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.535 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -85.32 124.59 32.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.227 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 928' ' ' LEU . 25.8 m-85 -103.71 136.49 19.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.014 0.435 . . . . 0.0 111.819 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.48 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 61.2 Cg_endo -72.24 139.33 32.01 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 0.0 112.071 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.647 HG21 ' H ' ' A' ' 925' ' ' GLY . 26.4 mt -57.54 158.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.647 ' H ' HG21 ' A' ' 924' ' ' ILE . . . 83.66 -40.91 2.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 30.7 m -56.01 136.64 51.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.003 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.2 m -123.63 131.86 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 905' ' ' PRO . 88.7 mt -97.92 129.26 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.695 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 40.0 ttmt -85.25 136.81 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.767 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.644 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 17.2 m-85 -134.44 125.3 27.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.734 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.695 ' HG3' ' HG3' ' A' ' 914' ' ' LYS . 96.1 mt-10 -95.63 136.11 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 80.7 m -51.69 158.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 0.0 110.91 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.513 ' HG3' ' C ' ' A' ' 910' ' ' PHE . 44.1 mtp85 -80.09 160.26 68.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.279 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 38.2 Cg_endo -66.51 62.4 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.831 2.354 . . . . 0.0 112.452 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.0 mt-10 -163.73 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.392 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 936' ' ' TYR . 2.6 m-85 -104.48 -176.96 3.23 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.458 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 4.9 p90 -150.51 32.77 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.966 0.412 . . . . 0.0 111.336 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.898 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . -76.68 27.42 1.6 Allowed Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.294 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.723 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.9 ptp180 46.02 166.14 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.356 0.662 . . . . 0.0 112.633 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 41.8 Cg_endo -67.72 145.6 69.95 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.341 2.027 . . . . 0.0 112.427 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.546 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 45.3 p90 -144.46 -162.07 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.299 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 57.5 m -169.78 136.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.508 HG22 ' HZ ' ' A' ' 908' ' ' PHE . 7.8 pt -93.0 120.85 43.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.002 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.56 HG23 ' CD2' ' A' ' 946' ' ' LEU . 16.6 m -81.52 123.48 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.76 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 10.7 t -73.72 104.23 4.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.686 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 74.4 mt -81.76 161.55 23.26 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -42.09 -47.5 4.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.381 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . 0.666 ' ND2' HG23 ' A' ' 950' ' ' VAL . 0.0 OUTLIER -82.27 40.96 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.975 -178.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 901' ' ' HIS . 43.7 mt 45.85 59.18 3.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.247 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.686 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 34.9 m -135.98 -161.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.425 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 76.5 m95 -151.02 122.94 8.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.975 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.5 p -41.87 137.64 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 39.7 t -79.4 110.95 17.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 0.0 112.073 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 952' ' ' SER . 57.9 Cg_endo -90.96 54.07 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.471 2.781 . . . . 0.0 110.828 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.601 ' NZ ' ' HB2' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -75.63 132.82 40.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.422 -178.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 52.95 44.95 29.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.3 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.565 HG11 ' N ' ' A' ' 958' ' ' CYS . 0.5 OUTLIER -87.83 -50.95 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.247 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.898 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 93.1 m -89.13 111.77 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 72.7 mmtt -83.78 124.84 31.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.524 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 40.4 ttm180 -61.96 133.69 55.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.277 0.561 . . . . 0.0 112.386 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.882 ' HB3' HG22 ' A' ' 982' ' ' VAL . 20.3 tptm -56.35 168.48 0.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.809 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.503 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 51.0 m -149.85 134.81 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.005 0.431 . . . . 0.0 111.235 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.92 141.77 35.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.804 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -65.54 136.09 55.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 66.5 m -52.62 121.86 23.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.735 ' HG2' HG13 ' A' ' 974' ' ' VAL . 30.9 Cg_endo -62.46 135.02 51.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 0.0 112.088 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.09 121.2 9.65 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.988 1.792 . . . . 0.0 110.94 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . 0.47 ' HB3' ' HG3' ' A' ' 973' ' ' MET . 14.2 m-20 -57.96 118.66 28.17 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.06 148.7 91.41 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.654 2.236 . . . . 0.0 111.873 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . . . . . . . . . 19.3 t -45.25 122.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.959 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 60.71 45.61 9.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.528 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -179.71 139.71 3.95 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.956 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 968' ' ' ASP . 3.5 mpp? -133.54 150.03 51.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.735 HG13 ' HG2' ' A' ' 966' ' ' PRO . 8.4 p -89.92 121.77 40.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.17 0.509 . . . . 0.0 111.051 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 121.84 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.83 135.1 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.764 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.488 HD13 ' HG1' ' A' ' 987' ' ' THR . 26.7 mm -74.47 -53.27 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.787 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 82.0 p -147.66 -52.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.312 0.577 . . . . 0.0 110.87 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.73 139.35 18.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.02 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.6 pt -88.33 34.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.897 0.379 . . . . 0.0 111.656 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.524 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 80.6 mt-30 -80.81 151.19 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.882 HG22 ' HB3' ' A' ' 961' ' ' LYS . 76.2 t -54.48 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 165.63 -48.35 0.28 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' 1003 ' ' GLU . 93.9 p -80.04 -160.38 0.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -151.39 134.97 16.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.524 HD13 HG22 ' A' ' 974' ' ' VAL . 34.6 pt -97.72 136.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.488 ' HG1' HD13 ' A' ' 977' ' ' ILE . 3.0 p -102.47 135.25 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.1 m-85 -96.24 143.69 27.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -148.71 120.72 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 60.9 m -83.58 119.71 25.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.463 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 992' ' ' THR . 7.6 t -72.57 137.4 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.547 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 991' ' ' THR . 96.6 m 111.23 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.309 1.005 . . . . 0.0 111.168 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -170.66 32.45 0.15 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.215 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -95.74 144.36 26.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.697 ' HB3' HG12 ' A' 1023 ' ' ILE . 7.6 ptm180 -89.28 136.23 33.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.23 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' 1000 ' ' SER . 10.3 tt -72.26 132.28 43.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.3 mp -99.73 125.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.031 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.2 -139.87 14.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.389 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -85.86 135.02 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.544 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.676 ' HA ' HD12 ' A' ' 996' ' ' LEU . 80.5 p -102.96 20.31 17.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.58 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 47.4 t -159.19 146.84 17.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -153.68 134.31 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.062 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 984' ' ' SER . 39.3 tt0 -95.0 129.08 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.199 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.28 120.34 16.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.417 ' HB ' ' H ' ' A' 1006 ' ' LEU . 33.3 pt -129.9 -159.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.889 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.417 ' H ' ' HB ' ' A' 1005 ' ' ILE . 41.6 tp -150.78 136.84 18.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.3 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.728 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 47.6 t -90.0 -40.31 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.828 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.68 -32.02 0.03 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.292 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 49.7 t30 -150.04 -44.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 110.511 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 37.4 m -92.66 131.44 37.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.979 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.461 ' H ' ' HZ2' ' A' ' 961' ' ' LYS . . . -80.97 143.59 32.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.819 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.728 ' HE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -155.76 144.06 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.307 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 49.1 m95 -68.29 144.09 54.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -53.55 -29.05 35.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.61 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 68.4 p -140.91 138.8 34.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.713 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.559 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.5 pptp? -62.31 152.47 79.16 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.014 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.76 132.36 41.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.635 2.224 . . . . 0.0 112.643 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' 1019 ' ' ILE . 56.1 Cg_endo -69.88 -153.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.783 2.322 . . . . 0.0 112.578 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.669 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.7 mt -139.01 141.97 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.015 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.528 ' SG ' ' HA2' ' A' ' 972' ' ' GLY . 97.9 m -99.66 124.18 44.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.732 ' HB2' HD12 ' A' ' 997' ' ' ILE . 10.1 tt0 -142.23 129.52 21.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.184 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -50.45 133.89 24.22 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.68 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.697 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.2 mt -74.83 123.91 89.27 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.797 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.813 2.342 . . . . 0.0 112.343 -179.892 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.768 0.318 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.82 139.51 0.69 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 66.07 132.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 949' ' ' LEU . . . 51.54 -150.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 11.7 m80 66.92 140.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.928 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 47.8 m -80.11 129.07 34.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.419 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.1 mm100 -64.65 168.19 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.69 125.32 6.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.38 123.64 8.34 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 122.457 2.105 . . . . 0.0 112.82 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 136.11 54.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.011 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -77.25 138.55 39.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.503 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 14.5 m-85 -89.09 24.02 2.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.503 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.716 HD11 ' N ' ' A' ' 909' ' ' LEU . 6.5 mp 68.74 -59.01 0.47 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 5.4 p90 -81.82 31.03 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -152.63 122.36 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 111.589 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -99.68 124.29 44.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.311 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -48.97 118.51 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.267 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.65 ' HE2' ' HD2' ' A' ' 929' ' ' LYS . 0.7 OUTLIER -95.89 -47.96 5.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.159 -179.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.443 ' O ' HG21 ' A' ' 917' ' ' THR . 31.7 m -64.59 128.39 35.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.613 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -52.36 135.14 33.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.875 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 915' ' ' THR . 79.4 p -152.02 144.67 24.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 24.9 m -156.46 53.36 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.73 156.2 9.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.5 t -86.4 -46.87 9.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.99 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.28 141.94 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -129.9 133.79 25.41 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.514 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -70.52 141.89 43.23 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.656 2.237 . . . . 0.0 112.229 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.657 ' HA ' ' HB3' ' A' ' 945' ' ' CYS . 34.2 mt -55.44 152.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.537 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 88.47 -29.54 5.67 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.452 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.4 m -55.05 137.74 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 51.1 m -115.99 142.6 46.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.733 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.21 119.09 19.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.625 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.65 ' HD2' ' HE2' ' A' ' 914' ' ' LYS . 40.0 ttmt -89.4 138.52 31.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.395 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.551 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 5.9 m-85 -129.03 134.45 48.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -95.18 121.57 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 64.2 m -59.92 149.98 30.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.0 mtp180 -84.13 162.89 50.39 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 10.0 Cg_endo -51.88 146.23 29.46 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.241 1.961 . . . . 0.0 110.966 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.964 ' HB3' HG22 ' A' ' 982' ' ' VAL . 95.6 mt-10 83.23 25.89 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.888 0.742 . . . . 0.0 109.968 -178.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.766 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 78.8 m-85 -143.91 142.35 30.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.839 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.616 ' HB3' ' NZ ' ' A' ' 961' ' ' LYS . 36.2 p90 -144.06 134.73 24.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 111.439 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.811 ' HA2' ' HA ' ' A' ' 958' ' ' CYS . . . 155.75 28.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.41 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 63.09 144.43 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.0 111.784 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.57 124.93 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.524 2.15 . . . . 0.0 110.703 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 6.5 p90 -90.17 -166.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.66 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 59.2 m -170.21 132.27 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.01 168.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.596 ' O ' HD23 ' A' ' 946' ' ' LEU . 20.5 m -162.62 136.09 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 38.7 t -73.82 125.78 28.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.616 ' H ' HD21 ' A' ' 946' ' ' LEU . 2.8 mm? -84.86 -57.03 3.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -176.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.52 ' HA ' HD12 ' A' ' 924' ' ' ILE . 23.7 t70 171.67 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.218 0.324 . . . . 0.0 111.031 -178.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -82.77 32.1 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 109.636 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' A' ' 900' ' ' ALA . 22.2 mt 51.67 43.25 30.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.762 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.475 ' O ' HD21 ' A' ' 946' ' ' LEU . 7.9 m -143.41 154.41 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.644 0.735 . . . . 0.0 112.467 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' A' ' 953' ' ' SER . 72.9 m95 -91.51 130.85 37.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.381 -1.282 . . . . 0.0 109.128 177.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 946' ' ' LEU . 45.3 t -51.47 -10.22 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.372 0.606 . . . . 0.0 111.524 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 951' ' ' TRP . 48.0 t 61.93 121.55 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.744 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 11.5 Cg_exo -71.08 141.31 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.978 2.452 . . . . 0.0 110.74 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.672 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 11.0 tmtt? -154.59 134.64 13.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.212 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.672 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 38.7 t70 60.82 41.01 15.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.123 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.79 -111.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.089 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.811 ' HA ' ' HA2' ' A' ' 938' ' ' GLY . 26.8 p -87.97 103.29 15.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.4 mmtt -82.05 134.68 35.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.799 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.766 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 35.7 ptt180 -56.76 143.56 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.592 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.616 ' NZ ' ' HB3' ' A' ' 937' ' ' TYR . 5.3 mptp? -47.12 150.47 0.8 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.528 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.73 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.2 p -142.65 127.19 17.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 70.5 m -79.48 138.21 37.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.302 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.57 135.28 55.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.895 0.379 . . . . 0.0 110.757 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.551 ' HG1' HD11 ' A' ' 980' ' ' ILE . 83.2 m -48.59 114.45 3.61 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.538 ' HG2' HG13 ' A' ' 974' ' ' VAL . 20.0 Cg_endo -60.57 135.42 60.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.489 2.126 . . . . 0.0 112.013 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.12 117.18 3.34 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.068 1.845 . . . . 0.0 111.327 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.14 125.11 80.41 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 144.54 99.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.681 2.254 . . . . 0.0 112.076 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.4 t -46.42 129.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.446 ' ND2' HG13 ' A' ' 970' ' ' VAL . 75.3 m-20 61.76 45.65 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.9 -162.94 23.08 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.585 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 178.63 147.44 0.17 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 110.993 -179.641 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 986' ' ' ILE . 8.6 p -91.08 102.79 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.773 0.797 . . . . 0.0 110.845 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -68.17 107.9 2.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.307 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.46 133.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 985' ' ' ARG . 44.9 mm -74.28 -36.07 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.088 0.47 . . . . 0.0 110.263 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.9 p -144.71 -49.54 0.26 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.88 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.1 t70 -161.57 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.822 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.551 HD11 ' HG1' ' A' ' 965' ' ' THR . 6.2 pt -151.03 9.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 110.849 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.73 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 21.2 mt-30 -75.75 161.16 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.964 HG22 ' HB3' ' A' ' 935' ' ' GLU . 10.4 m -49.27 149.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.695 0.283 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 82.94 -32.76 2.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.976 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.0 m -75.84 131.71 39.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.153 0.501 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 977' ' ' ILE . 78.7 ttt180 -93.38 155.82 17.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.717 HD13 HG22 ' A' ' 974' ' ' VAL . 43.9 pt -141.78 123.81 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.255 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.3 p -107.61 136.9 46.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.466 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.476 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 5.2 m-85 -94.06 146.58 23.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.418 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -148.65 109.83 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.997 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 79.8 m -79.96 147.87 31.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 5.6 t -64.31 146.39 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.7 m -44.02 123.69 3.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.49 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 134.73 -51.23 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.331 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.438 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.5 m80 -102.54 141.12 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.356 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.601 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.6 ptm180 -92.38 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.348 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' 1000 ' ' SER . 9.7 tt -71.77 132.73 44.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.623 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.2 mp -108.91 132.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 83.94 -144.25 21.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.15 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.623 ' HD1' ' HB ' ' A' 1015 ' ' THR . 39.5 m170 -81.34 130.24 34.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.767 0.317 . . . . 0.0 111.278 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.64 ' HA ' HD12 ' A' ' 996' ' ' LEU . 47.6 t -85.04 -51.84 6.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.665 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 33.1 t -90.37 155.02 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.509 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.707 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.477 ' H ' ' HB3' ' A' 1014 ' ' SER . 88.3 tt0 -111.56 129.94 55.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.766 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.512 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 43.2 t -71.25 125.62 27.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.476 HG13 ' CD2' ' A' 1012 ' ' HIS . 26.7 pt -129.42 -155.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.615 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 45.3 tp -150.62 -21.86 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.832 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 36.8 t 53.27 26.96 5.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 35.54 48.52 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.522 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -163.21 -49.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 40.2 m -145.54 136.45 24.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.843 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.02 124.94 28.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.873 0.368 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.476 ' CD2' HG13 ' A' 1005 ' ' ILE . 0.3 OUTLIER -161.2 152.91 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.761 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.512 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 93.7 m95 -64.92 144.38 57.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.985 0.422 . . . . 0.0 110.784 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.477 ' HB3' ' H ' ' A' 1003 ' ' GLU . 45.4 t -64.18 -31.59 72.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.623 ' HB ' ' HD1' ' A' ' 999' ' ' HIS . 40.9 p -144.19 138.67 28.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.871 0.367 . . . . 0.0 111.266 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.03 148.63 83.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.798 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.3 130.3 37.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.613 2.209 . . . . 0.0 112.338 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.29 -160.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.758 2.306 . . . . 0.0 112.665 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.4 mt -142.33 138.59 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.885 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.543 ' N ' HG21 ' A' 1019 ' ' ILE . 82.1 m -92.66 124.42 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.623 ' HB3' HD12 ' A' ' 997' ' ' ILE . 34.0 tt0 -143.75 135.39 26.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.464 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.419 ' HG2' HH11 ' A' 1022 ' ' ARG . 15.1 tpp85 -49.04 131.92 18.99 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.398 0.618 . . . . 0.0 111.621 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.2 mt -76.89 124.96 87.57 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.878 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.809 2.34 . . . . 0.0 112.363 -179.926 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.829 0.347 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -63.0 135.99 57.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . 0.569 ' HB2' ' HE1' ' A' ' 901' ' ' HIS . 56.1 mt-10 -60.27 138.5 57.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.675 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.451 ' HB1' HD22 ' A' ' 949' ' ' LEU . . . -75.03 143.32 43.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.229 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.569 ' HE1' ' HB2' ' A' ' 899' ' ' GLU . 58.1 m80 -150.4 127.41 11.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.403 178.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 11.3 p -82.9 128.15 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . 0.408 ' H ' ' HG3' ' A' ' 903' ' ' GLN . 2.0 pp0? -73.15 175.45 6.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.43 129.1 10.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 906' ' ' ASP . 50.8 Cg_endo -68.46 91.5 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.483 2.122 . . . . 0.0 112.421 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 905' ' ' PRO . 6.5 t0 29.75 -133.02 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 O-C-N 123.606 0.566 . . . . 0.0 111.123 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 31.7 t-80 -161.8 109.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -86.5 137.15 32.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.448 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.525 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 62.5 mt -80.08 -52.96 7.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.18 29.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -155.91 139.98 16.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -136.47 130.9 33.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 917' ' ' THR . 66.0 tp -48.42 156.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.332 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.847 ' HE2' ' HA ' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -145.49 -39.82 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.411 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 4.4 m -64.52 141.87 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.583 ' O ' HG21 ' A' ' 917' ' ' THR . 13.9 pt20 -52.92 133.54 37.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.318 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 916' ' ' GLN . 62.7 p -150.92 -65.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 918' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 917' ' ' THR . 32.1 p 66.28 -50.96 0.43 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.892 0.745 . . . . 0.0 112.555 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.36 151.93 44.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.1 p -85.04 -42.92 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 901' ' ' HIS . 63.9 t0 -85.02 126.26 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.483 ' HE2' HG23 ' A' ' 917' ' ' THR . 92.0 m-85 -106.78 136.13 19.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.63 140.6 18.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.106 2.538 . . . . 0.0 111.829 178.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.758 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 46.7 mt -55.88 148.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.059 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.608 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 73.55 77.57 0.61 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 2.2 m -176.72 122.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 54.9 m -83.43 129.69 35.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.981 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 6.0 tp -106.87 118.55 36.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.568 ' NZ ' ' HB2' ' A' ' 929' ' ' LYS . 0.1 OUTLIER -85.63 135.15 33.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.785 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -135.4 129.34 33.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.258 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 940' ' ' PRO . 90.0 mt-10 -95.48 123.09 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 6.1 t -58.77 153.38 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.548 ' HG3' HH11 ' A' ' 933' ' ' ARG . 38.9 mtt85 -81.35 155.48 71.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.507 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 51.6 Cg_endo -68.45 66.4 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.024 2.483 . . . . 0.0 112.543 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.6 mt-10 -163.15 -9.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 959' ' ' LYS . 33.9 m-85 -134.79 140.6 46.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.402 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.1 p90 -99.91 137.7 38.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 148.13 21.38 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.456 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 938' ' ' GLY . 18.9 ptp180 46.72 164.28 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.654 0.782 . . . . 0.0 112.59 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.727 ' HB3' ' HA ' ' A' ' 931' ' ' GLU . 18.5 Cg_exo -66.39 127.32 17.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.782 2.322 . . . . 0.0 112.386 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.505 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 43.6 p90 -93.01 -161.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.5 p -172.86 134.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.066 0.46 . . . . 0.0 111.25 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 943' ' ' ILE . 4.9 pt -95.05 -168.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.933 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.632 HG23 HD22 ' A' ' 946' ' ' LEU . 1.4 m -167.28 127.13 1.43 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.758 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 17.0 t -69.99 110.64 5.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 944' ' ' THR . 92.1 mt -82.75 -57.3 3.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 56.0 t0 173.01 -43.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.013 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -82.88 36.65 0.51 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 901' ' ' HIS . 31.0 mt 51.67 46.15 26.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.5 OUTLIER -128.57 -173.6 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.988 -179.357 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.422 ' CE3' HD13 ' A' ' 943' ' ' ILE . 73.5 m95 -144.71 130.73 19.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.161 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 45.6 t -44.05 146.25 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 953' ' ' SER . . . . . 0.482 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -79.59 115.88 56.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.6 Cg_exo -76.31 61.05 6.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.496 2.797 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -76.43 139.27 40.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.486 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.599 ' HA ' ' HZ3' ' A' ' 959' ' ' LYS . 9.9 t70 58.11 82.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.041 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.428 HG11 ' C ' ' A' ' 956' ' ' ASP . 30.9 m -149.69 -24.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.653 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 936' ' ' TYR . 72.6 m -150.47 133.19 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.599 ' HZ3' ' HA ' ' A' ' 956' ' ' ASP . 45.6 mmtm -140.72 150.53 43.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.303 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.597 ' HG3' ' NE2' ' A' ' 981' ' ' GLN . 12.2 tpt180 -53.34 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.971 0.415 . . . . 0.0 111.311 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.497 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 40.4 ttmt -56.32 149.63 16.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.501 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.656 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 60.4 p -141.14 140.36 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.257 0.551 . . . . 0.0 111.506 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.87 154.69 28.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.06 134.21 53.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.323 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 32.5 m -54.28 126.67 54.58 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.497 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 80.1 Cg_endo -76.3 134.25 15.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.778 2.319 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.51 128.58 28.89 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.221 1.948 . . . . 0.0 111.511 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.86 129.52 85.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.87 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.07 142.67 88.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.864 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 39.5 t -47.5 124.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.244 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 73.1 m-20 76.42 -46.39 0.53 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.826 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -71.29 -151.61 0.95 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.438 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 178.79 140.33 0.1 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 986' ' ' ILE . 11.1 p -96.51 143.1 12.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.684 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.476 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.5 m-70 -102.7 114.5 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.751 HG12 HG22 ' A' ' 980' ' ' ILE . 77.9 t -63.78 -39.01 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.22 0.533 . . . . 0.0 110.021 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.503 ' O ' HG21 ' A' ' 978' ' ' THR . 9.3 mt 71.64 -33.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.409 178.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.503 HG21 ' O ' ' A' ' 977' ' ' ILE . 48.1 p -144.84 -86.14 0.12 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 980' ' ' ILE . 2.8 m-20 -154.59 13.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.312 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.751 HG22 HG12 ' A' ' 976' ' ' VAL . 36.9 pt 50.65 34.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.366 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.656 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 3.8 mm100 -76.64 151.13 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.81 88.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.068 0.461 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 160.09 -42.67 0.44 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.217 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' 1003 ' ' GLU . 49.2 m -76.09 -168.64 0.96 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.653 ' HD3' ' HB2' ' A' 1001 ' ' SER . 38.1 ttm180 -151.35 134.9 16.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.689 HG21 ' HA ' ' A' ' 976' ' ' VAL . 25.7 pt -95.26 131.75 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.761 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -99.3 129.27 45.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 111.797 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' 1000 ' ' SER . 7.1 m-85 -96.58 139.73 32.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.0 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.1 t -153.69 112.14 3.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.684 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.508 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 3.2 t -81.38 142.13 33.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.602 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.2 t -65.01 154.09 38.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.0 t -45.64 109.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 111.246 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 159.57 -44.42 0.44 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.429 ' HB3' ' N ' ' A' 1021 ' ' GLN . 15.3 m80 -126.87 147.58 50.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.206 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.409 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.9 ptm180 -90.04 138.98 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.706 HD23 ' HB2' ' A' 1000 ' ' SER . 9.8 tt -71.89 130.84 42.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.987 -178.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.706 HD12 ' HB3' ' A' 1021 ' ' GLN . 2.0 mp -109.73 93.39 2.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.464 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' A' 1018 ' ' PRO . . . 158.31 -153.53 24.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.594 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -85.93 -35.43 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.706 ' HB2' HD23 ' A' ' 996' ' ' LEU . 48.2 t 67.27 16.39 10.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.653 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.3 p -157.6 59.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.764 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.779 ' HB1' HG21 ' A' 1015 ' ' THR . . . -79.77 126.51 31.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.8 tt0 -96.09 131.48 42.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.923 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1004 ' ' CYS . . . . . 0.427 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 45.0 t -71.77 119.93 16.64 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.28 -156.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 112.131 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 56.4 tp -152.24 135.06 15.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.02 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.669 ' HB2' ' HE2' ' A' 1012 ' ' HIS . 48.0 t -88.39 -45.39 10.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.29 -49.74 0.26 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.038 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.16 -37.19 12.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -145.45 144.91 30.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.696 -178.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.22 144.58 34.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.704 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.669 ' HE2' ' HB2' ' A' 1007 ' ' SER . 8.0 p80 -158.15 154.62 27.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.883 0.373 . . . . 0.0 111.514 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 72.3 m95 -68.63 149.49 49.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.9 m -58.92 -34.6 71.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.81 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.779 HG21 ' HB1' ' A' 1002 ' ' ALA . 6.4 t -143.08 149.33 38.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.228 0.537 . . . . 0.0 112.357 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' A' 1017 ' ' PRO . 1.0 OUTLIER -59.54 136.86 89.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.939 179.052 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.507 ' N ' ' HD3' ' A' 1016 ' ' LYS . 77.7 Cg_exo -50.75 119.86 5.78 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.541 2.161 . . . . 0.0 112.971 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.604 ' HB3' ' HA2' ' A' ' 998' ' ' GLY . 14.6 Cg_endo -57.28 147.72 75.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.822 2.348 . . . . 0.0 112.447 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.18 147.13 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 95.3 m -81.39 136.34 35.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.706 ' HB3' HD12 ' A' ' 997' ' ' ILE . 6.2 tt0 -145.72 132.31 19.85 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.353 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -44.03 136.04 3.95 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.5 0.667 . . . . 0.0 111.779 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.6 mt -74.86 127.04 87.68 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.012 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.848 2.365 . . . . 0.0 112.356 -179.852 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.81 0.338 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 57.1 -157.18 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.23 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 64.01 132.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.305 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 949' ' ' LEU . . . 65.52 137.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.661 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . 0.6 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 53.4 m80 -149.86 135.46 18.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 922' ' ' PHE . 10.0 p -80.72 121.43 25.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -69.23 172.36 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.539 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.08 8.46 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.567 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.486 ' HG2' ' OH ' ' A' ' 930' ' ' TYR . 51.1 Cg_exo -53.71 127.08 24.03 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.89 2.393 . . . . 0.0 112.624 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.74 119.61 14.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.854 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 38.7 m170 42.77 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.075 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -145.93 47.51 1.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.987 178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 38.9 mt -75.08 -7.2 53.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.736 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -12.12 54.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.806 179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.02 137.22 16.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.321 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . 0.493 ' HB2' ' HZ3' ' A' ' 912' ' ' LYS . 0.0 OUTLIER -91.61 123.79 35.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.083 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.683 HD13 HG22 ' A' ' 917' ' ' THR . 3.4 tm? -47.18 129.51 12.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.107 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.562 ' O ' ' HD2' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -94.56 -31.26 13.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.93 -178.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.572 HG21 ' N ' ' A' ' 916' ' ' GLN . 86.4 m -57.19 154.02 10.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.609 -179.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.572 ' N ' HG21 ' A' ' 915' ' ' THR . 3.0 pp0? -57.49 -47.91 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.533 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.683 HG22 HD13 ' A' ' 913' ' ' LEU . 52.8 p 51.76 138.77 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.802 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 918' ' ' THR . . . . . 0.496 ' O ' HG21 ' A' ' 918' ' ' THR . 16.3 m -161.31 32.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.232 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.78 140.51 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 45.6 m -86.74 37.86 0.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.456 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -154.68 127.72 8.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.862 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . 0.421 ' O ' ' SG ' ' A' ' 902' ' ' CYS . 36.4 m-85 -119.12 142.29 31.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.929 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.21 136.73 10.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.949 2.433 . . . . 0.0 111.9 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 947' ' ' ASP . 61.6 mt -52.02 150.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.575 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 72.83 74.79 0.76 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.738 -178.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 944' ' ' THR . 3.6 m -174.82 130.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.856 -178.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 927' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 75.5 p -99.99 155.35 17.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.114 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 942' ' ' SER . 95.4 mt -141.05 128.37 21.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.117 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.839 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 43.4 mmtm -85.07 141.5 30.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.486 ' OH ' ' HG2' ' A' ' 905' ' ' PRO . 11.4 m-85 -129.12 133.19 47.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 912' ' ' LYS . 50.1 mt-10 -92.53 118.39 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.138 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.68 148.94 18.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.728 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.2 mtt85 -83.01 155.96 67.29 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.893 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 936' ' ' TYR . 62.6 Cg_exo -38.56 -53.75 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.881 2.388 . . . . 0.0 113.613 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.92 31.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 72.2 m-85 -145.19 133.78 22.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.677 0.275 . . . . 0.0 111.184 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.568 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 2.2 p90 -103.89 138.88 39.84 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 137.24 143.57 4.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.863 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -73.02 170.69 12.66 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.547 0.213 . . . . 0.0 110.769 179.703 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.863 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 9.2 Cg_endo -59.39 114.71 2.15 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.399 2.066 . . . . 0.0 112.958 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 27.2 p90 -90.24 -164.62 1.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 942' ' ' SER . . . . . 0.839 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 79.7 p -171.95 130.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.289 0.566 . . . . 0.0 112.352 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 927' ' ' SER . 8.1 pt -96.14 -174.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.632 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.669 ' O ' HD23 ' A' ' 946' ' ' LEU . 15.9 m -165.9 136.74 3.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 73.5 m -73.29 126.64 30.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 944' ' ' THR . 2.5 mm? -83.61 -60.51 2.1 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.645 ' HA ' HG22 ' A' ' 924' ' ' ILE . 4.7 t70 171.84 -40.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.262 0.352 . . . . 0.0 110.814 -178.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -86.38 39.67 0.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.691 HD12 ' HB1' ' A' ' 900' ' ' ALA . 6.2 mp 53.5 46.12 26.81 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.481 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 3.2 m -125.68 -179.98 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.798 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.414 ' CE3' HD13 ' A' ' 943' ' ' ILE . 41.3 m95 -142.04 131.8 24.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.756 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 80.4 p -40.83 143.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.3 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 40.7 t -78.7 114.45 43.67 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.33 -178.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.52 57.6 6.37 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.473 2.782 . . . . 0.0 111.994 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 1.2 tmtp? -78.6 127.04 31.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . 0.779 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 38.8 t70 53.34 41.59 32.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.25 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.14 -41.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.424 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 17.2 t -157.64 68.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.478 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.779 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.4 mmtp -56.43 144.55 30.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 12.8 ptt-85 -55.43 147.39 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.151 0.5 . . . . 0.0 111.986 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.568 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 26.9 tptp -47.64 155.77 0.36 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.56 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.785 ' HB2' ' HG3' ' A' ' 981' ' ' GLN . 48.2 t -144.47 139.88 28.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.473 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 59.3 m -81.57 37.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.293 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 59.52 135.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.066 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 11.8 m -56.1 128.4 71.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.496 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.445 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 39.6 Cg_endo -66.4 127.14 16.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.489 2.126 . . . . 0.0 112.64 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 16.7 Cg_exo -67.0 132.85 29.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.499 2.133 . . . . 0.0 111.515 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.68 114.22 8.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.745 0.307 . . . . 0.0 110.781 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 144.15 29.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.685 2.257 . . . . 0.0 112.224 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.457 HG13 ' ND2' ' A' ' 971' ' ' ASN . 21.5 t -50.63 129.01 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.457 ' ND2' HG13 ' A' ' 970' ' ' VAL . 71.9 m-20 54.47 44.64 28.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.475 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 990' ' ' CYS . . . -170.9 147.99 10.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.939 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.2 136.98 40.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.571 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 986' ' ' ILE . 10.1 p -98.18 127.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.913 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -86.45 114.74 23.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.757 ' HA ' HG23 ' A' ' 986' ' ' ILE . 27.8 m -63.11 -28.14 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.017 0.436 . . . . 0.0 110.203 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 10.0 mt 73.07 -43.54 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.134 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 976' ' ' VAL . 71.0 p -146.11 -51.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.577 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.535 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 8.2 p-10 -160.26 -143.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.146 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 979' ' ' ASP . 4.6 pt -151.0 6.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.785 ' HG3' ' HB2' ' A' ' 962' ' ' SER . 14.5 mp0 -76.65 177.32 7.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.601 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.55 132.66 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.233 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 106.83 -46.27 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.278 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.0 m -76.09 134.36 40.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 77.5 ttt180 -104.12 124.09 48.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.154 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.757 HG23 ' HA ' ' A' ' 976' ' ' VAL . 34.4 pt -97.1 136.51 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 0.0 111.535 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.4 p -103.84 136.38 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.542 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 14.9 m-85 -103.19 142.57 33.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.231 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.9 t -153.57 127.56 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.589 ' HA ' ' HA3' ' A' ' 972' ' ' GLY . 99.8 m -58.37 135.84 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.258 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 992' ' ' THR . 10.2 t -73.41 43.59 0.14 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.433 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 991' ' ' THR . 8.5 t 175.41 -130.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' ' 992' ' ' THR . . . -133.69 51.25 0.85 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.499 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.585 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 3.8 m80 -94.49 -137.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.618 ' HB3' ' O ' ' A' 1021 ' ' GLN . 13.5 ttt85 -140.88 112.06 7.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.921 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' 1000 ' ' SER . 6.3 tt -68.83 131.86 45.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.818 0.342 . . . . 0.0 110.702 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.628 HD12 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -97.27 136.21 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 84.33 -152.25 27.78 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.383 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -81.55 129.74 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.688 0.244 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1000 ' ' SER . . . . . 0.634 ' HA ' HD23 ' A' ' 996' ' ' LEU . 50.2 m -74.79 10.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.338 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.46 ' HG ' ' HE ' ' A' ' 985' ' ' ARG . 30.7 t -159.29 151.42 20.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.533 ' HB1' ' HG1' ' A' 1015 ' ' THR . . . -155.07 128.86 8.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.383 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 12.7 pt-20 -96.48 134.24 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.539 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.2 t -71.83 123.17 22.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.67 139.18 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.262 0.553 . . . . 0.0 112.139 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 60.8 tp -84.5 120.57 26.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 94.1 p -96.03 36.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.053 179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.485 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 67.19 123.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.058 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 73.17 -37.38 0.38 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 122.373 0.269 . . . . 0.0 111.671 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' 1008 ' ' GLY . 98.6 m -145.48 129.09 17.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 111.632 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -87.36 147.32 25.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.66 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.9 p80 -157.64 149.1 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.384 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.458 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 91.7 m95 -65.79 139.21 58.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -51.39 -27.68 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.886 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.533 ' HG1' ' HB1' ' A' 1002 ' ' ALA . 75.4 p -141.02 141.57 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.963 0.411 . . . . 0.0 111.611 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.579 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -53.82 153.15 8.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.09 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.17 123.78 14.66 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.446 2.097 . . . . 0.0 112.733 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.542 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 14.0 Cg_exo -69.0 148.71 70.62 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.185 2.59 . . . . 0.0 112.243 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.636 HG23 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -100.35 -153.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.636 ' H ' HG23 ' A' 1019 ' ' ILE . 35.5 t -161.64 141.24 10.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.819 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.628 ' HB2' HD12 ' A' ' 997' ' ' ILE . 1.4 tt0 -151.36 127.98 10.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.563 -178.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -51.42 131.9 29.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 111.658 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 995' ' ' ARG . 62.9 mt -74.82 129.16 83.97 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.974 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.889 2.392 . . . . 0.0 112.287 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.522 0.201 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -174.84 44.41 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.794 0.33 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 63.73 135.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.1 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 900' ' ' ALA . . . . . 0.819 ' HB1' HD12 ' A' ' 949' ' ' LEU . . . -73.78 121.92 21.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.119 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -110.52 124.45 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.998 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 902' ' ' CYS . . . . . 0.846 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 1.8 p -82.11 124.0 29.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -60.02 172.01 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.63 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 904' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -44.78 134.4 4.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 905' ' ' PRO . . . . . 0.615 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 3.5 Cg_exo -73.79 44.06 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.738 2.292 . . . . 0.0 112.582 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 4.0 t70 57.93 153.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.472 0.653 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -82.42 122.31 27.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.704 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.418 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 8.3 m-85 -85.88 141.98 29.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 909' ' ' LEU . . . . . 0.629 ' N ' HD21 ' A' ' 909' ' ' LEU . 2.0 mm? -87.53 -65.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.688 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.59 ' O ' ' HG3' ' A' ' 933' ' ' ARG . 2.5 p90 -82.77 -22.12 34.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.469 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 911' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -87.04 142.94 27.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.54 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -129.81 123.41 30.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.17 116.56 1.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.428 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 914' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -93.07 -42.28 9.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 915' ' ' THR . . . . . 0.531 HG21 ' NE2' ' A' ' 916' ' ' GLN . 5.0 m -66.16 -127.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 916' ' ' GLN . . . . . 0.531 ' NE2' HG21 ' A' ' 915' ' ' THR . 3.0 pm0 -173.5 139.43 0.74 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.676 0.274 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 917' ' ' THR . . . . . 0.652 HG21 ' H ' ' A' ' 918' ' ' THR . 1.8 t -157.18 -54.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 918' ' ' THR . . . . . 0.652 ' H ' HG21 ' A' ' 917' ' ' THR . 27.9 m 53.9 57.77 5.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.044 0.45 . . . . 0.0 110.599 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.44 156.66 14.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.4 t -87.9 -44.99 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.72 141.8 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.35 137.84 27.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . 0.594 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 65.3 Cg_endo -73.12 132.01 17.47 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.569 2.179 . . . . 0.0 111.427 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 924' ' ' ILE . . . . . 0.682 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.5 mt -56.78 147.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . 0.607 ' N ' HG21 ' A' ' 924' ' ' ILE . . . 95.7 -32.97 5.82 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 926' ' ' THR . . . . . 0.594 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 20.6 m -56.21 135.68 53.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.426 . . . . 0.0 112.145 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 61.6 p -107.2 142.99 36.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.388 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 928' ' ' LEU . . . . . 0.433 ' HA ' HD21 ' A' ' 928' ' ' LEU . 94.1 mt -133.3 117.82 17.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.063 0.459 . . . . 0.0 110.974 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 38.1 ttmt -90.04 132.4 35.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.035 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 930' ' ' TYR . . . . . 0.424 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 4.2 m-85 -122.33 125.75 46.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.037 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 931' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 95.4 mt-10 -96.51 117.32 30.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.543 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 932' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 81.0 m -59.27 169.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.451 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 933' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 910' ' ' PHE . 46.5 mtp85 -84.36 151.16 58.92 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.142 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 19.7 Cg_exo -66.48 66.0 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.303 2.669 . . . . 0.0 112.994 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 935' ' ' GLU . . . . . 0.506 ' HG2' HG13 ' A' ' 982' ' ' VAL . 54.4 mt-10 -163.39 -29.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 109.925 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 936' ' ' TYR . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 910' ' ' PHE . 1.6 m-85 -94.96 147.26 23.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 937' ' ' TYR . . . . . 0.773 ' HB3' ' HD2' ' A' ' 961' ' ' LYS . 1.7 p90 -89.18 132.94 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.241 0.543 . . . . 0.0 111.152 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.37 139.48 4.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.382 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 939' ' ' ARG . . . . . 0.87 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -71.88 171.11 10.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.513 0.197 . . . . 0.0 110.549 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 940' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 40.4 Cg_endo -67.89 121.61 8.66 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.385 2.057 . . . . 0.0 112.26 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.502 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 36.8 p90 -90.15 -161.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.73 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 82.5 p -172.79 134.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.16 -172.6 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.822 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 944' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 946' ' ' LEU . 1.1 m -167.09 123.61 1.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 945' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 33.7 t -63.91 112.09 2.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 946' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 950' ' ' VAL . 87.6 mt -81.25 -53.11 6.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 947' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 19.2 t70 172.54 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.202 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -84.49 37.35 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 949' ' ' LEU . . . . . 0.846 ' HA ' ' HB3' ' A' ' 902' ' ' CYS . 6.4 mp 53.5 48.96 20.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.994 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 6.7 m -120.63 179.97 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.327 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 951' ' ' TRP . . . . . 0.615 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 97.2 m95 -145.13 49.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.231 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 23.5 t 49.5 -141.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 29.7 t -155.44 109.66 2.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.56 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.05 53.99 3.53 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.121 2.547 . . . . 0.0 111.348 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 955' ' ' LYS . . . . . 0.6 ' HB3' ' NZ ' ' A' ' 955' ' ' LYS . 5.8 ttpm? -78.79 133.14 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.666 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 58.4 t0 57.42 40.59 27.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.281 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 957' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 958' ' ' CYS . 27.8 m -90.44 -42.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.511 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 958' ' ' CYS . . . . . 0.487 ' N ' HG21 ' A' ' 957' ' ' VAL . 84.6 m -155.0 141.63 18.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.164 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.5 mmtt -146.21 145.16 30.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.706 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 960' ' ' ARG . . . . . 0.614 ' HD2' ' HB ' ' A' ' 982' ' ' VAL . 14.8 tpp85 -53.24 103.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.141 0.496 . . . . 0.0 110.726 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 961' ' ' LYS . . . . . 0.773 ' HD2' ' HB3' ' A' ' 937' ' ' TYR . 51.5 tttp -59.3 -179.06 0.07 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.566 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 962' ' ' SER . . . . . 0.689 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 83.9 p -149.66 142.58 24.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.625 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.503 ' HA ' ' HB3' ' A' 1011 ' ' ALA . 77.2 m -79.51 164.69 23.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.16 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.9 133.16 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.363 . . . . 0.0 110.554 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 965' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 56.8 m -55.12 131.99 68.58 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 3.0 Cg_exo -74.15 125.12 9.54 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.736 2.291 . . . . 0.0 112.056 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.0 122.46 11.76 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.122 1.882 . . . . 0.0 111.305 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.05 116.07 17.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 969' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 64.5 Cg_endo -73.49 133.96 19.83 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.614 2.209 . . . . 0.0 111.993 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 970' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 971' ' ' ASN . 1.1 p -53.77 -57.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.202 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 971' ' ' ASN . . . . . 0.599 ' H ' HG11 ' A' ' 970' ' ' VAL . 75.9 m-20 -79.01 34.23 0.23 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.356 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . 0.502 ' HA3' ' H ' ' A' ' 991' ' ' THR . . . 177.04 -147.77 8.53 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.953 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 973' ' ' MET . . . . . 0.491 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 22.5 ptt? 174.49 139.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 974' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 15.0 p -95.69 138.87 20.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.324 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 975' ' ' HIS . . . . . 0.464 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.9 m-70 -94.82 113.11 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 976' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 980' ' ' ILE . 92.2 t -65.63 -27.64 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 977' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 975' ' ' HIS . 4.8 mt 56.22 59.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.094 179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 978' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 977' ' ' ILE . 12.3 p 76.61 -49.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.931 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 979' ' ' ASP . . . . . 0.559 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 2.6 p30 -159.88 138.52 10.57 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.459 -178.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 976' ' ' VAL . 15.3 pt -91.46 32.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.974 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 981' ' ' GLN . . . . . 0.689 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -75.5 156.64 34.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.319 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 982' ' ' VAL . . . . . 0.614 ' HB ' ' HD2' ' A' ' 960' ' ' ARG . 57.4 t -54.4 86.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.3 -49.25 0.3 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.922 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 984' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 979' ' ' ASP . 48.0 t -80.44 141.69 35.02 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.972 0.415 . . . . 0.0 110.691 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 985' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 13.9 ptm180 -101.08 137.39 39.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 986' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 16.6 pt -89.07 126.45 42.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.152 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 987' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' 1001 ' ' SER . 7.0 p -103.84 128.63 51.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.346 0.593 . . . . 0.0 112.017 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 988' ' ' TYR . . . . . 0.54 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 2.0 m-85 -96.4 143.75 27.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.164 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 86.1 p -148.67 117.05 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 990' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 994' ' ' HIS . 57.6 m -66.71 133.7 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.823 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 991' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 992' ' ' THR . 13.3 t -68.15 -147.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 992' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 991' ' ' THR . 49.5 m 8.75 -91.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.66 0.784 . . . . 0.0 113.044 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -158.38 44.93 0.47 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.294 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 15.1 m80 -93.76 155.36 17.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.648 ' HB2' HG12 ' A' 1023 ' ' ILE . 7.6 tpt180 -90.04 130.73 36.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.609 -179.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 996' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 995' ' ' ARG . 8.5 tt -67.58 134.54 51.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.699 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 997' ' ' ILE . . . . . 0.96 HD13 ' HG2' ' A' 1021 ' ' GLN . 14.8 mm -107.36 123.31 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 998' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 59.94 134.51 0.01 OUTLIER Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.197 178.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 999' ' ' HIS . . . . . 0.691 ' ND1' ' HB ' ' A' 1015 ' ' THR . 47.0 m170 48.32 -141.98 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.9 p -177.95 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.79 0.329 . . . . 0.0 111.231 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1001 ' ' SER . . . . . 0.465 ' HB3' HG21 ' A' ' 987' ' ' THR . 70.9 p -152.27 157.2 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1002 ' ' ALA . . . . . 0.536 ' HB1' ' OG1' ' A' 1015 ' ' THR . . . -151.99 133.42 14.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 111.391 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1003 ' ' GLU . . . . . 0.764 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 18.9 pt-20 -96.22 141.91 29.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -70.95 126.46 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1005 ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' 1014 ' ' SER . 30.9 pt -138.98 162.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1006 ' ' LEU . . . . . 0.642 HD11 ' N ' ' A' 1007 ' ' SER . 3.2 tm? 58.82 -77.76 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.459 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1007 ' ' SER . . . . . 1.017 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 97.1 p 59.59 -111.36 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.458 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.578 ' H ' ' HG ' ' A' 1007 ' ' SER . . . 64.43 -112.32 4.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.428 -178.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1009 ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' 1009 ' ' ASN . 2.7 m120 -65.82 -32.55 74.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1010 ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' 1007 ' ' SER . 77.2 m -150.06 122.53 8.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.493 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1011 ' ' ALA . . . . . 1.017 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -83.58 137.97 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.365 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1012 ' ' HIS . . . . . 0.58 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.4 OUTLIER -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.178 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A 1013 ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' 1002 ' ' ALA . 67.0 m95 -68.86 150.92 47.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1014 ' ' SER . . . . . 0.588 ' HA ' HD12 ' A' 1005 ' ' ILE . 40.5 t -60.22 -34.6 73.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.476 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1015 ' ' THR . . . . . 0.691 ' HB ' ' ND1' ' A' ' 999' ' ' HIS . 74.8 p -141.78 149.38 40.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.775 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1016 ' ' LYS . . . . . 0.657 ' HD3' ' O ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -56.85 147.72 52.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.56 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A 1017 ' ' PRO . . . . . 0.54 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 25.2 Cg_exo -64.8 123.38 11.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.906 2.404 . . . . 0.0 113.032 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1018 ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 23.6 Cg_exo -64.37 149.43 90.12 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 112.262 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1019 ' ' ILE . . . . . 0.63 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 2.7 mt -98.12 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.486 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1020 ' ' CYS . . . . . 0.557 ' H ' ' CG2' ' A' 1019 ' ' ILE . 23.1 m -163.29 128.58 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.433 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1021 ' ' GLN . . . . . 0.96 ' HG2' HD13 ' A' ' 997' ' ' ILE . 22.8 pt20 -153.21 130.98 11.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1022 ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 32.4 tpt85 -28.19 134.67 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1023 ' ' ILE . . . . . 0.648 HG12 ' HB2' ' A' ' 995' ' ' ARG . 33.6 mt -73.07 124.79 91.04 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.783 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1024 ' ' PRO . . . . . 0.463 ' HD2' HG21 ' A' 1023 ' ' ILE . 74.5 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.543 2.162 . . . . 0.0 112.468 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.965 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.921 0.391 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.643 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 30.4 m80 -149.08 144.16 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.509 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.29 119.09 19.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.24 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -55.88 166.21 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.628 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.97 131.58 8.86 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.127 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.27 138.32 65.76 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.415 2.077 . . . . 0.0 111.937 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.71 156.99 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -78.43 126.98 31.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.306 0.574 . . . . 0.0 111.542 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.57 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 2.0 m-85 -90.81 -33.36 15.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.614 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.9 mp 75.72 -48.44 0.6 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.8 OUTLIER -85.72 18.41 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.021 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.32 126.39 6.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 914' ' ' LYS . 52.2 mtmt -96.74 132.94 41.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.092 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.3 tm? -48.71 141.65 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.587 ' H ' HD22 ' A' ' 913' ' ' LEU . 74.7 mmtt -147.14 64.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.453 ' H ' HD13 ' A' ' 913' ' ' LEU . 17.6 m -167.46 139.55 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.066 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -51.33 124.81 12.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.586 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 915' ' ' THR . 75.1 p -152.06 135.42 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.6 p -148.59 44.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.491 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.64 156.09 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.0 m -84.1 -44.91 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.819 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.34 120.34 26.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -96.81 141.32 22.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.02 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.58 132.43 14.67 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.581 2.188 . . . . 0.0 112.382 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.743 HD13 ' HA ' ' A' ' 947' ' ' ASP . 65.7 mt -54.15 147.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 78.27 67.25 1.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 1.8 m -174.83 121.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.4 m -90.3 128.43 36.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.645 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 942' ' ' SER . 8.5 tp -97.64 127.51 43.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -80.64 133.59 35.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.49 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 19.7 m-85 -138.5 124.09 19.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.616 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.776 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 55.5 mt-10 -102.03 125.34 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.991 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 99.0 m -57.95 166.09 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.325 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 44.8 mtp85 -82.75 158.94 64.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 936' ' ' TYR . 90.1 Cg_exo -44.07 -46.44 11.13 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.635 2.223 . . . . 0.0 112.697 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.547 ' HA ' HD22 ' A' 1006 ' ' LEU . 56.1 mt-10 -73.77 26.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.43 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 67.3 m-85 -145.15 157.64 44.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.618 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 31.6 p90 -144.09 137.08 27.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 155.94 29.69 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.8 ptp85 46.71 164.36 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.497 0.719 . . . . 0.0 112.464 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.776 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 74.2 Cg_endo -75.2 116.44 4.55 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.294 1.996 . . . . 0.0 112.515 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.557 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 16.1 p90 -95.57 -159.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 81.1 p -171.86 136.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.719 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 3.3 pt -96.27 117.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.976 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.421 HG22 HD23 ' A' ' 946' ' ' LEU . 2.8 m -84.23 126.27 32.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 85.2 m -73.48 115.18 12.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 94.5 mt -83.19 -59.93 2.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.743 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.5 t0 172.91 -37.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.874 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -81.85 26.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.312 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.965 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 61.3 40.43 14.36 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 951' ' ' TRP . 7.1 p -136.43 152.71 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.341 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.657 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 46.7 m95 -93.72 141.46 28.47 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.907 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 88.5 p -48.14 140.96 6.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 59.9 p -79.02 108.53 8.48 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.919 0.39 . . . . 0.0 111.387 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 952' ' ' SER . 2.9 Cg_exo -76.29 129.59 11.33 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.054 2.503 . . . . 0.0 111.974 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.601 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -80.65 -145.11 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.466 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -80.71 60.97 4.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 958' ' ' CYS . 26.0 m -80.53 -56.36 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.585 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.615 ' N ' HG23 ' A' ' 957' ' ' VAL . 6.2 t -89.87 135.03 33.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 44.0 mtmt -150.36 130.12 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.871 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 935' ' ' GLU . 40.6 ttm180 -53.91 142.67 23.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.008 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.618 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 13.3 mmmm -54.51 149.28 10.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.161 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.759 ' HB3' HE21 ' A' ' 981' ' ' GLN . 63.7 p -142.49 131.57 23.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -81.53 146.74 30.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.64 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 965' ' ' THR . 2.0 tmtp? -66.77 133.41 50.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.047 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.663 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 47.4 m -53.22 130.77 51.56 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.332 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.556 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 60.1 Cg_endo -70.9 136.13 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.744 2.296 . . . . 0.0 112.384 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.54 134.58 64.25 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.151 1.901 . . . . 0.0 111.296 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -57.3 122.62 55.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 0.0 111.054 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.21 143.25 58.32 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.111 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' 1020 ' ' CYS . 22.0 t -49.21 129.2 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 33.9 m120 58.23 45.77 16.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.031 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -174.54 -166.75 32.98 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.528 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -178.88 146.71 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.226 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 986' ' ' ILE . 7.1 p -98.66 133.54 40.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.823 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.0 OUTLIER -109.89 117.77 34.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.625 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 986' ' ' ILE . 33.9 m -74.46 131.03 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.83 -30.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.875 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.8 p -144.72 -54.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -158.64 -142.18 0.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.488 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -151.05 37.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.759 HE21 ' HB3' ' A' ' 962' ' ' SER . 7.9 mp0 -76.99 174.17 10.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.198 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 961' ' ' LYS . 28.1 m -63.91 30.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.62 -32.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.272 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 47.7 t -75.97 134.63 40.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 39.1 ptt180 -104.14 134.95 46.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 974' ' ' VAL . 37.3 pt -97.94 137.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.0 p -96.98 135.48 38.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 0.0 111.697 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.442 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 6.7 m-85 -101.68 138.19 39.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 51.1 m -153.54 121.61 6.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.966 0.412 . . . . 0.0 111.146 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 64.4 m -80.87 157.67 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.3 t -63.93 146.23 54.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.38 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 89.3 m -44.46 122.07 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 128.91 -54.11 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -102.99 138.56 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.663 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -95.13 147.24 23.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.314 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 997' ' ' ILE . 4.7 pp -71.63 139.74 49.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.601 ' CD1' ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -122.17 111.15 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 151.76 -60.36 0.41 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.246 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.464 ' CD2' ' HB ' ' A' 1015 ' ' THR . 98.1 m-70 -154.08 -122.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.518 0.199 . . . . 0.0 110.827 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 77.7 p -168.31 -46.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.4 p -156.0 107.62 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.63 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.409 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' 1003 ' ' GLU . 7.4 pm0 -96.27 133.1 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.126 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 42.4 t -77.43 126.9 31.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.8 pt -135.75 -159.73 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.096 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.547 HD22 ' HA ' ' A' ' 935' ' ' GLU . 28.0 tp -150.9 138.05 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.914 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 70.4 m -88.17 -44.21 11.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.34 -45.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.001 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.6 m120 -105.15 -31.48 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.43 ' C ' HD12 ' A' 1006 ' ' LEU . 98.5 m -142.69 138.53 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.051 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -82.68 145.71 29.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.102 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.8 p80 -158.55 151.37 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.537 ' CZ2' ' HD3' ' A' ' 966' ' ' PRO . 66.1 m95 -66.16 141.7 57.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 t -60.92 -30.78 70.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.464 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 61.8 p -144.06 139.29 28.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.52 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.7 pptp? -63.32 155.22 75.52 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.413 ' HB3' ' HE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -66.01 130.09 23.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.523 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.442 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_exo -64.88 -150.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.901 2.401 . . . . 0.0 112.628 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.772 HG22 ' H ' ' A' 1020 ' ' CYS . 1.5 mt -136.91 -158.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.772 ' H ' HG22 ' A' 1019 ' ' ILE . 73.7 m -155.07 132.01 10.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.312 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.601 ' HG2' ' CD1' ' A' ' 997' ' ' ILE . 20.5 pt20 -152.42 142.26 22.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -48.51 128.92 15.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.359 0.599 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 37.8 mt -74.83 128.98 84.34 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.039 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.742 2.295 . . . . 0.0 112.34 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.912 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.55 ' C ' HD22 ' A' ' 949' ' ' LEU . 41.9 m80 -150.75 132.23 14.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.672 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 6.1 p -82.15 128.96 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -69.85 170.63 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.291 0.567 . . . . 0.0 111.302 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.42 134.3 12.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.41 149.96 84.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.64 172.72 1.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.96 130.4 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.242 0.544 . . . . 0.0 111.553 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 943' ' ' ILE . 1.5 m-85 -89.98 -43.46 10.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.6 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 82.2 mt 75.0 -43.01 0.5 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.929 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 908' ' ' PHE . 0.1 OUTLIER -83.55 -1.03 52.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -153.65 128.96 9.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.48 132.65 40.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -44.65 144.89 0.99 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.995 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 913' ' ' LEU . 38.5 ttpt -138.54 -36.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.514 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 917' ' ' THR . 4.6 m -64.63 143.64 57.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.49 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 17.8 mp0 -49.4 125.29 10.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 915' ' ' THR . 81.0 p -152.04 143.77 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.239 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.3 m -159.48 -47.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.558 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.25 160.32 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.4 p -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -85.37 145.38 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -132.03 136.0 27.51 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.488 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.417 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.9 Cg_endo -69.54 141.86 47.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.838 2.358 . . . . 0.0 112.198 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 949' ' ' LEU . 15.9 mm -54.63 151.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 90.09 -30.74 5.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.0 m -55.9 125.25 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 112.015 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 34.9 t -95.94 135.14 38.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.855 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' A' ' 917' ' ' THR . 9.0 tp -117.1 114.19 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.685 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 24.9 ttmm -89.91 139.66 30.38 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.426 ' CZ ' HD23 ' A' ' 913' ' ' LEU . 7.0 m-85 -130.06 130.67 45.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.463 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 8.6 pt-20 -92.73 125.4 37.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.193 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 91.3 m -52.65 143.9 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.402 . . . . 0.0 111.42 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.9 mtp180 -82.93 155.94 67.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' 1006 ' ' LEU . 27.5 Cg_endo -63.44 64.75 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.721 2.28 . . . . 0.0 112.753 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.463 ' HG2' ' HE ' ' A' ' 960' ' ' ARG . 39.1 tt0 -174.85 2.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.22 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 40.1 m-85 -141.24 136.32 31.56 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.402 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.747 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 16.4 p90 -102.73 139.78 37.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.256 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.803 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 150.45 27.68 0.05 OUTLIER Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.58 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 938' ' ' GLY . 16.6 ptm180 45.79 171.04 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 122.971 0.508 . . . . 0.0 112.019 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.481 ' CD ' ' HB2' ' A' ' 939' ' ' ARG . 2.6 Cg_endo -77.86 112.89 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.109 1.873 . . . . 0.0 111.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.403 ' HD1' ' N ' ' A' ' 942' ' ' SER . 23.1 p90 -94.43 -160.52 0.78 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.467 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.403 ' N ' ' HD1' ' A' ' 941' ' ' PHE . 41.9 t -172.89 143.09 1.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.568 HD13 ' HZ ' ' A' ' 908' ' ' PHE . 3.5 pt -94.03 -170.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.986 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.42 HG22 HD23 ' A' ' 946' ' ' LEU . 1.0 OUTLIER -164.63 127.59 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.721 ' SG ' HD13 ' A' ' 924' ' ' ILE . 12.1 t -66.94 112.64 4.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 87.6 mt -82.18 -57.79 3.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -174.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.8 t70 172.74 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.948 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -83.5 34.95 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.912 HD21 ' HB1' ' A' ' 900' ' ' ALA . 30.7 mt 51.9 47.3 25.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.314 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.8 OUTLIER -135.43 -168.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.766 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.425 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 47.9 m95 -146.02 128.77 16.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 47.7 t -43.96 143.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.085 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.4 t -78.58 115.6 52.9 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.04 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.471 ' HG2' ' CE2' ' A' ' 908' ' ' PHE . 5.1 Cg_exo -75.95 53.49 3.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.372 2.714 . . . . 0.0 112.151 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.39 132.33 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.692 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.0 t0 56.99 77.89 0.25 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.231 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 24.5 m -149.31 -30.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.548 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.803 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 34.8 t -151.6 62.97 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.469 . . . . 0.0 110.913 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 11.3 mmpt? -55.23 153.77 6.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.646 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.824 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -58.43 132.25 53.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.669 -179.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.747 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 21.4 mmtp -56.37 135.64 53.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.082 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.629 ' HB2' ' HG2' ' A' ' 981' ' ' GLN . 48.3 t -152.66 129.08 10.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.998 0.428 . . . . 0.0 111.018 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 6.1 p -81.58 154.76 26.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.294 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -65.15 137.96 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 0.0 110.92 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 69.4 m -54.17 128.53 57.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 32.6 Cg_endo -63.67 134.41 43.97 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.439 2.092 . . . . 0.0 111.732 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 52.2 Cg_exo -52.58 127.89 26.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.104 1.869 . . . . 0.0 111.525 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -57.49 125.46 71.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.95 138.74 41.21 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.5 p -50.89 124.2 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.681 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 33.9 m120 59.24 48.04 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.521 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -156.87 -155.13 7.32 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.534 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 42.8 ttp 173.94 135.74 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.867 HG21 HD12 ' A' ' 986' ' ' ILE . 15.0 p -98.65 123.99 51.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 977' ' ' ILE . 33.3 m-70 -76.98 108.51 10.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 979' ' ' ASP . 89.1 t -62.58 -32.16 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 71.83 -47.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.82 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -148.38 -60.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.596 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.9 m-20 -155.01 -152.89 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.065 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.585 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -148.64 22.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.934 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 84.9 mt-30 -79.36 156.5 27.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.007 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.596 HG11 ' HG ' ' A' 1006 ' ' LEU . 49.2 t -49.95 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.158 0.504 . . . . 0.0 111.065 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 151.8 -40.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.266 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.0 p -76.01 138.54 40.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.517 ' HE ' ' HB2' ' A' 1001 ' ' SER . 76.9 ttt180 -104.19 125.97 50.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.867 HD12 HG21 ' A' ' 974' ' ' VAL . 41.3 pt -98.94 129.22 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.818 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.1 p -96.95 134.2 40.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 22.9 m-85 -96.13 139.02 32.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.454 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 52.5 m -152.42 116.45 4.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.476 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.8 146.92 41.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.521 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 94.0 m -64.64 142.96 58.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.245 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.0 t -41.94 124.38 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.025 0.441 . . . . 0.0 111.553 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.85 -48.35 0.97 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.742 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -102.33 144.5 30.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.545 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.2 ptt180 -92.63 143.7 26.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 997' ' ' ILE . 7.5 tt -71.81 132.32 44.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.555 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.7 mp -110.05 134.55 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.8 -128.22 9.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.359 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.439 ' HB2' ' HG3' ' A' 1018 ' ' PRO . 40.9 m80 -78.3 -132.51 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.437 0.16 . . . . 0.0 111.394 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.8 t -174.25 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.65 0.262 . . . . 0.0 111.191 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.517 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 76.2 p -150.89 150.29 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.893 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.496 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.58 130.53 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.0 tt0 -99.08 135.52 40.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 30.5 t -71.44 119.19 15.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.649 HD13 ' H ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -140.78 160.39 23.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.541 0.686 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.596 ' HG ' HG11 ' A' ' 982' ' ' VAL . 93.1 mt -89.22 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.793 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 68.7 m -149.99 -32.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -157.05 57.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.274 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 14.2 m-20 61.44 27.74 17.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.009 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 8.0 m -149.11 131.99 16.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 128.65 34.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.859 0.362 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.465 ' O ' HD13 ' A' 1005 ' ' ILE . 8.2 p80 -158.09 145.8 18.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.487 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' HG22 ' A' ' 980' ' ' ILE . 58.7 m95 -67.48 137.73 56.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.9 p -54.8 -28.71 51.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.701 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 81.5 p -139.34 138.9 37.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.957 0.408 . . . . 0.0 111.815 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1017 ' ' PRO . 7.5 tmtm? -57.38 134.76 81.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.499 ' O ' ' HD3' ' A' 1016 ' ' LYS . 50.7 Cg_exo -54.56 126.67 23.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 31.8 Cg_exo -59.75 -157.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.832 2.355 . . . . 0.0 112.716 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.783 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -139.75 -161.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.257 0.551 . . . . 0.0 110.964 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.783 ' H ' HG22 ' A' 1019 ' ' ILE . 84.4 m -155.93 138.51 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 8.4 tt0 -151.25 134.77 16.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.309 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -46.21 128.46 9.62 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.3 mt -74.87 126.65 88.11 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.765 2.31 . . . . 0.0 112.555 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.715 0.293 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -153.65 133.64 13.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.5 p -82.27 110.92 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.314 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -83.23 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.88 124.85 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.568 ' HB3' ' CG ' ' A' ' 951' ' ' TRP . 86.8 Cg_endo -82.33 124.09 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.701 2.268 . . . . 0.0 113.395 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 35.8 t0 26.05 -137.09 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.061 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 35.4 p-80 -161.05 151.43 17.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.168 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -145.51 134.0 21.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.2 mp -83.04 -49.16 9.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.212 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.515 ' HA ' ' HD3' ' A' ' 933' ' ' ARG . 0.8 OUTLIER -84.97 28.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -156.46 135.11 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.509 ' HD3' ' C ' ' A' ' 911' ' ' ALA . 0.0 OUTLIER -136.44 124.52 22.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.193 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 58.7 tp -49.38 144.67 5.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.137 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.735 ' HD2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -154.75 27.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 0.0 110.986 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.578 HG22 ' HG3' ' A' ' 916' ' ' GLN . 24.2 m -69.96 -111.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.572 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -169.13 34.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.452 0.644 . . . . 0.0 110.413 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.1 t -87.35 154.78 20.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.898 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.7 p -136.5 46.54 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.448 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -166.67 159.31 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.015 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.2 p -85.01 -36.95 20.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -84.58 146.03 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.6 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 87.6 m-85 -134.75 145.57 55.34 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 111.526 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.1 Cg_endo -84.5 137.51 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.453 2.769 . . . . 0.0 112.386 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.803 HG21 ' HA ' ' A' ' 947' ' ' ASP . 53.3 mt -54.34 154.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.196 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 74.24 58.14 4.43 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.642 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 3.8 m -175.23 127.26 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.43 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.627 ' HB3' ' OG1' ' A' ' 944' ' ' THR . 79.4 p -105.68 135.42 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.652 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.619 ' HB2' ' HE1' ' A' ' 930' ' ' TYR . 93.5 mt -96.85 128.29 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.363 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 15.3 tppt? -82.88 121.05 26.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.748 0.309 . . . . 0.0 111.383 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 9.2 m-85 -111.72 127.95 55.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.735 ' HG3' ' HD2' ' A' ' 914' ' ' LYS . 61.9 mm-40 -92.16 107.0 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 110.637 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 83.1 m -59.62 178.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.856 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 910' ' ' PHE . 78.9 mtp180 -85.67 151.7 55.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.134 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 936' ' ' TYR . 53.2 Cg_exo -52.85 -37.17 76.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.904 2.403 . . . . 0.0 112.872 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.96 12.39 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.662 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 934' ' ' PRO . 33.8 m-85 -139.6 128.75 23.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 19.3 p90 -96.2 137.05 35.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.425 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 147.33 152.67 5.71 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.72 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.61 142.16 83.44 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.344 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.746 ' HB2' ' HD2' ' A' ' 929' ' ' LYS . 40.9 Cg_exo -56.36 137.02 78.62 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.918 2.412 . . . . 0.0 111.85 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.727 ' HB3' HG11 ' A' ' 957' ' ' VAL . 30.4 p90 -89.71 124.7 34.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.55 0.691 . . . . 0.0 111.336 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 928' ' ' LEU . 75.1 p -75.52 -38.65 59.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.877 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' A' ' 930' ' ' TYR . 47.7 pt 49.32 93.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.618 0.723 . . . . 0.0 111.702 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 927' ' ' SER . 11.9 m -84.29 139.56 32.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.586 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 98.2 m -73.7 129.06 37.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 950' ' ' VAL . 2.2 mm? -82.56 -65.98 0.94 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.803 ' HA ' HG21 ' A' ' 924' ' ' ILE . 24.6 t70 172.82 -41.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.397 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -85.54 41.9 0.93 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.071 0.462 . . . . 0.0 109.89 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 900' ' ' ALA . 63.5 mt 53.28 48.87 21.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.783 HG23 HD23 ' A' ' 946' ' ' LEU . 6.6 m -131.87 177.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.483 0.658 . . . . 0.0 112.005 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.568 ' CG ' ' HB3' ' A' ' 905' ' ' PRO . 46.8 m95 -135.23 126.88 28.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.84 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.741 ' N ' HD21 ' A' ' 946' ' ' LEU . 11.0 m -42.43 148.85 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.274 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 35.4 t -76.98 121.52 84.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.0 Cg_exo -76.55 56.44 5.13 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.538 2.826 . . . . 0.0 111.734 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.525 ' HG2' ' OD1' ' A' ' 956' ' ' ASP . 57.8 tttp -75.87 123.61 25.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.431 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.525 ' OD1' ' HG2' ' A' ' 955' ' ' LYS . 1.4 m-20 57.76 98.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.384 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 941' ' ' PHE . 16.1 m -151.07 -31.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 92.5 m -152.05 65.4 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.6 mmtt -60.52 137.65 58.13 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 36.8 ttm180 -59.59 135.56 57.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.649 ' NZ ' HD11 ' A' 1006 ' ' LEU . 98.0 mttt -57.52 145.91 31.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.517 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.558 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 75.6 p -142.47 137.34 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 68.8 m -81.03 154.93 26.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.137 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.81 127.7 33.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.842 0.353 . . . . 0.0 110.667 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 19.4 m -57.15 136.83 80.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.765 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 974' ' ' VAL . 5.8 Cg_endo -48.15 140.45 19.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.229 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 968' ' ' ASP . 65.5 Cg_endo -73.62 49.4 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.791 2.327 . . . . 0.0 112.983 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 967' ' ' PRO . 1.7 p30 26.06 67.29 0.47 Allowed Pre-proline 0 N--CA 1.465 0.289 0 O-C-N 123.507 0.505 . . . . 0.0 112.153 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -40.56 134.56 2.18 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.76 2.307 . . . . 0.0 112.635 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 971' ' ' ASN . 2.6 p -53.1 132.95 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.764 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.435 ' OD1' HG22 ' A' ' 970' ' ' VAL . 32.9 m120 58.66 53.14 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.332 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -155.66 -153.51 6.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.554 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 38.9 ttm 176.52 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.543 0.211 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.616 HG21 ' HG3' ' A' ' 966' ' ' PRO . 1.9 p -93.83 168.44 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.23 0.538 . . . . 0.0 110.652 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.932 ' CE1' HG13 ' A' ' 977' ' ' ILE . 3.0 t-80 -152.83 104.01 2.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.297 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 26.9 m -66.72 -24.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.932 HG13 ' CE1' ' A' ' 975' ' ' HIS . 3.8 mp 76.86 -42.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 0.0 110.435 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 977' ' ' ILE . 81.5 p -144.77 -59.76 0.36 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.664 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.8 m-20 -157.39 -145.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.389 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.491 HG22 ' HH2' ' A' 1013 ' ' TRP . 4.2 pt -148.25 20.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.068 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.729 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 53.8 mm-40 -76.63 177.2 7.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.87 -24.13 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 109.869 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -107.9 53.67 0.59 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.606 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 54.9 m -158.31 127.68 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.014 0.435 . . . . 0.0 110.604 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.595 ' O ' HD13 ' A' ' 977' ' ' ILE . 74.0 ttt180 -104.22 129.13 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.186 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 976' ' ' VAL . 42.7 pt -103.07 151.77 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.807 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.467 ' OG1' HD11 ' A' ' 977' ' ' ILE . 8.5 p -135.79 138.65 42.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.077 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 966' ' ' PRO . 2.0 m-85 -96.48 151.44 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.399 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 53.6 m -153.61 69.6 0.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.601 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 66.5 m -44.5 151.08 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.776 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 146.2 50.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 77.6 m -40.59 -38.68 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.183 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -55.03 -49.49 62.51 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.826 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.2 m80 -102.45 141.6 35.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.018 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.606 ' HB3' HG12 ' A' 1023 ' ' ILE . 33.6 ptt85 -90.65 141.43 28.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.32 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 997' ' ' ILE . 5.5 tt -71.87 133.82 45.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.719 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.0 mp -104.71 135.07 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.26 -139.19 15.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.453 ' CE1' ' HG3' ' A' 1018 ' ' PRO . 23.1 p80 -79.58 -135.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.436 ' N ' ' ND1' ' A' ' 999' ' ' HIS . 80.1 p -177.41 16.08 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.594 0.235 . . . . 0.0 111.358 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 32.1 t -159.43 145.05 15.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.43 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.519 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.64 124.02 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.1 tt0 -98.45 137.73 36.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 50.0 t -71.2 124.27 24.1 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 27.4 pt -133.39 -154.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.952 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.649 HD11 ' NZ ' ' A' ' 961' ' ' LYS . 2.5 tt -154.27 125.36 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.476 ' N ' HD23 ' A' 1006 ' ' LEU . 40.4 t -90.1 42.95 1.12 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.206 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 26.8 27.82 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.671 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -158.93 -47.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.2 m -147.82 143.53 27.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.054 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -79.83 131.92 36.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.6 p80 -160.18 155.95 25.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.491 ' HH2' HG22 ' A' ' 980' ' ' ILE . 80.9 m95 -64.29 144.72 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -54.54 -33.21 59.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 1.7 t -146.75 148.42 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.382 0.611 . . . . 0.0 112.29 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.63 138.04 86.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.985 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 77.5 Cg_exo -50.8 138.01 42.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.723 2.282 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 999' ' ' HIS . 24.1 Cg_exo -63.02 -160.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.29 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 42.3 mt -141.75 136.45 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.0 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 70.9 m -97.15 125.31 41.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.14 128.3 18.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 13.0 ptp180 -47.5 140.36 5.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.588 0.708 . . . . 0.0 111.535 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.9 mt -74.84 130.87 80.3 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.162 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 46.0 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.809 2.34 . . . . 0.0 112.265 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.604 0.24 . . . . 0.0 111.479 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -152.69 132.02 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.7 p -82.34 118.51 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.99 173.51 9.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.982 0.42 . . . . 0.0 111.307 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.42 135.55 7.38 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.272 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 54.7 Cg_exo -51.9 136.14 51.46 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.59 2.193 . . . . 0.0 112.068 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 907' ' ' HIS . 35.4 m-20 -64.83 105.1 0.94 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 906' ' ' ASP . 0.0 OUTLIER 11.27 110.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.173 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.671 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 3.6 m-85 -90.02 131.47 35.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 110.227 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.2 mm? -75.19 -68.71 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.685 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.5 OUTLIER -85.29 21.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -149.35 150.75 32.97 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.135 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.472 ' HD3' ' NH1' ' A' ' 933' ' ' ARG . 23.8 pttm -140.51 136.67 33.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.5 tm? -45.27 139.68 3.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.609 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.606 ' N ' HD13 ' A' ' 913' ' ' LEU . 30.7 mmmt -150.82 58.06 0.92 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.731 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 917' ' ' THR . 15.5 m -167.88 134.95 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.885 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.74 138.37 47.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 915' ' ' THR . 60.0 p -150.75 -57.22 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.396 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 22.6 p 68.79 -50.11 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.831 0.707 . . . . 0.0 112.255 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.32 148.14 48.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.43 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.7 p -85.8 -48.29 8.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.25 123.27 30.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.182 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 50.1 m-85 -103.86 146.2 32.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.486 . . . . 0.0 112.019 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.6 Cg_endo -83.8 139.9 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.488 2.792 . . . . 0.0 111.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.768 HD13 ' HA ' ' A' ' 947' ' ' ASP . 48.1 mt -52.77 152.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.341 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 944' ' ' THR . . . 89.65 -40.74 3.02 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 38.1 m -56.85 137.69 54.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.345 . . . . 0.0 110.458 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.582 ' HB2' ' OG ' ' A' ' 942' ' ' SER . 82.2 p -120.8 132.33 54.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.113 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 942' ' ' SER . 72.8 mt -106.21 136.41 45.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.04 0.447 . . . . 0.0 111.741 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.525 ' HB2' ' OG1' ' A' ' 915' ' ' THR . 99.3 mttt -86.5 133.41 33.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.723 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 11.6 m-85 -132.64 125.27 30.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.531 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 914' ' ' LYS . 95.4 mt-10 -95.29 133.18 39.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 72.8 m -58.51 150.31 23.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.018 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 41.5 mtp85 -82.84 163.36 51.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.518 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 40.6 Cg_endo -66.75 64.57 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 95.1 mt-10 -165.43 -18.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.232 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 3.0 m-85 -129.38 -168.75 1.99 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 958' ' ' CYS . 16.5 p90 -150.03 138.26 20.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.985 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 167.22 4.84 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.353 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.935 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 6.6 ppt_? 46.06 173.27 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 123.013 0.525 . . . . 0.0 112.286 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 13.6 Cg_endo -58.93 89.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.41 2.073 . . . . 0.0 113.059 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.503 ' HA ' ' NH1' ' A' ' 939' ' ' ARG . 42.2 p90 -90.17 120.85 31.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.879 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 927' ' ' SER . 23.8 t -74.03 160.21 31.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.809 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.533 HG22 ' HG3' ' A' ' 954' ' ' PRO . 5.4 pt -137.64 104.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 925' ' ' GLY . 30.3 m -82.33 130.79 35.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 97.9 m -73.71 132.08 42.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.5 mm? -84.54 -60.22 2.14 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.768 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.1 t0 171.66 -36.81 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.691 0.282 . . . . 0.0 110.953 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 950' ' ' VAL . 73.3 m-80 -82.94 37.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 900' ' ' ALA . 79.6 mt 50.5 42.98 27.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.934 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 948' ' ' ASN . 22.2 m -136.13 147.99 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.796 0.808 . . . . 0.0 112.07 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 952' ' ' SER . 52.2 m95 -91.82 122.16 34.1 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.596 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -38.68 126.13 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 70.3 m -78.15 107.14 4.96 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 110.909 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 943' ' ' ILE . 60.4 Cg_endo -100.92 55.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 124.013 3.142 . . . . 0.0 112.608 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -77.44 38.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.539 0.685 . . . . 0.0 110.09 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 954' ' ' PRO . 34.3 t70 -159.92 53.78 0.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.692 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 941' ' ' PHE . 8.8 m -147.05 -17.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.871 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 937' ' ' TYR . 11.1 t -147.57 135.38 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.123 0.487 . . . . 0.0 110.901 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 32.0 mtmt -147.77 149.87 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.252 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 52.2 ttm-85 -53.31 135.38 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 937' ' ' TYR . 30.2 mmtp -56.29 164.73 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.36 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.509 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 85.1 p -145.5 132.84 20.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.797 0.332 . . . . 0.0 110.216 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 49.2 m -81.57 36.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 61.7 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 980' ' ' ILE . 30.7 m -55.79 129.06 71.06 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 57.5 Cg_endo -70.71 121.3 7.79 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.462 2.108 . . . . 0.0 112.693 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 11.8 Cg_exo -69.76 123.76 10.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.455 2.103 . . . . 0.0 111.364 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.54 120.95 64.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.36 141.27 50.89 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.38 2.053 . . . . 0.0 111.752 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.452 HG22 ' OD1' ' A' ' 971' ' ' ASN . 2.2 p -45.96 127.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.452 ' OD1' HG22 ' A' ' 970' ' ' VAL . 33.3 m120 66.16 49.34 1.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.888 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -163.82 -158.15 9.82 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.867 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 40.0 ttm 176.72 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.536 0.208 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.5 p -100.56 131.47 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.819 0.343 . . . . 0.0 111.52 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -91.87 111.46 23.0 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 30.1 m -64.22 -18.69 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 109.913 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 987' ' ' THR . 12.4 mm 74.57 -47.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 67.9 p -148.18 -49.97 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.759 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.4 m-20 -157.49 -149.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.866 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -151.08 25.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 111.143 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 962' ' ' SER . 44.7 mm-40 -80.91 163.7 23.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.143 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 961' ' ' LYS . 54.8 t -55.43 93.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.078 0.466 . . . . 0.0 111.14 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.66 -47.6 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.232 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.5 t -76.4 141.31 41.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 111.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 3.5 ptm85 -104.22 131.86 51.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.546 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.7 pt -98.13 127.48 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.569 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -97.07 132.69 42.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.977 0.417 . . . . 0.0 110.953 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.516 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 10.8 m-85 -96.6 139.96 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.443 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -152.74 116.43 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.181 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 83.9 m -73.02 147.21 45.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.454 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.56 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 8.6 t -64.86 149.16 50.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.614 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 84.8 m -46.68 108.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.317 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 152.92 -57.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.265 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.415 ' HB3' ' C ' ' A' 1021 ' ' GLN . 7.6 m80 -102.46 145.92 28.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.77 ' HB3' HG12 ' A' 1023 ' ' ILE . 15.6 ptm180 -90.02 139.16 30.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.166 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.689 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.3 tt -71.84 132.7 44.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.942 0.401 . . . . 0.0 110.734 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.689 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.5 mp -106.07 130.84 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.52 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 96.56 -138.75 14.1 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.085 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -81.27 -140.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.414 0.15 . . . . 0.0 111.146 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 42.7 t 178.9 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.424 ' HB2' HH21 ' A' ' 985' ' ' ARG . 66.1 p -158.8 148.95 19.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.045 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.55 118.16 3.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.2 tt0 -96.33 128.61 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 50.6 t -71.32 119.39 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.404 ' HA ' HG13 ' A' ' 982' ' ' VAL . 37.4 pt -136.6 143.6 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.244 0.545 . . . . 0.0 111.892 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 53.8 tp -84.61 124.48 31.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.998 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.5 t -95.96 -50.24 4.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' 1010 ' ' THR . . . 169.26 122.16 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.71 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 72.99 -37.14 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.164 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' 1008 ' ' GLY . 84.6 m -145.72 136.26 24.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.216 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 151.09 26.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.372 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.7 p80 -153.07 147.59 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 86.9 m95 -64.37 139.13 58.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.162 0.506 . . . . 0.0 111.297 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 m -62.42 -21.75 65.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.282 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.8 m -138.9 135.74 34.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.4 pttm -72.73 148.28 89.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.768 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.85 129.02 28.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.589 2.193 . . . . 0.0 112.397 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.24 -154.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.735 2.29 . . . . 0.0 112.465 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 53.1 mt -139.91 141.54 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 97.5 m -100.85 125.65 47.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.415 ' C ' ' HB3' ' A' ' 994' ' ' HIS . 19.8 tt0 -145.51 138.11 25.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.387 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -45.55 135.62 6.33 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 111.703 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.77 HG12 ' HB3' ' A' ' 995' ' ' ARG . 54.8 mt -74.76 126.94 87.92 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.711 2.274 . . . . 0.0 112.482 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.78 0.324 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.501 ' C ' HD22 ' A' ' 949' ' ' LEU . 1.7 m-70 -147.5 120.78 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.52 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 24.9 p -82.25 122.33 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -73.02 167.69 20.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.476 0.655 . . . . 0.0 112.045 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -47.53 133.23 10.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.509 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.5 Cg_exo -62.32 154.54 62.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.926 2.418 . . . . 0.0 112.407 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 907' ' ' HIS . 27.1 t70 -62.23 173.08 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.677 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.437 ' N ' ' CG ' ' A' ' 906' ' ' ASP . 42.6 m170 -77.68 121.48 24.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.288 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 1.9 m-85 -86.43 -36.09 19.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.48 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 92.0 mt 75.98 -46.03 0.54 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.748 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 6.05 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.66 126.44 5.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.2 124.81 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.309 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 929' ' ' LYS . 63.2 tp -51.61 156.79 1.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.503 ' H ' HD12 ' A' ' 913' ' ' LEU . 73.9 mmtt -145.29 -66.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 914' ' ' LYS . 17.9 m 19.88 -117.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.687 0.617 . . . . 0.0 111.884 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.499 ' N ' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -175.95 41.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.201 0.524 . . . . 0.0 110.476 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.669 HG21 HD11 ' A' ' 928' ' ' LEU . 39.0 p -82.8 -172.82 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 98.0 m -169.1 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.478 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.4 157.76 37.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -84.61 -43.62 14.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.37 124.8 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.53 ' HE2' HG21 ' A' ' 917' ' ' THR . 80.4 m-85 -103.69 134.55 19.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.574 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 59.9 Cg_endo -71.94 141.92 37.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 112.126 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.689 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 32.7 mt -59.69 156.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 82.71 -35.6 2.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.716 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.574 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 18.7 m -56.04 127.42 30.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.526 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 48.7 m -101.72 131.42 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 917' ' ' THR . 5.2 tp -95.79 -168.07 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.177 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.695 ' O ' HD12 ' A' ' 913' ' ' LEU . 40.6 ttmt -157.44 130.36 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.591 ' CE1' HD23 ' A' ' 928' ' ' LEU . 5.4 m-85 -129.09 135.64 49.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.384 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.653 ' OE1' ' HB3' ' A' ' 940' ' ' PRO . 2.9 mm-40 -96.26 134.78 38.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.363 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 86.6 m -55.33 155.35 5.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.566 ' HG2' ' HD2' ' A' ' 934' ' ' PRO . 65.1 ttt180 -82.37 145.13 51.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 933' ' ' ARG . 67.6 Cg_exo -39.35 -41.2 2.15 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.717 2.278 . . . . 0.0 112.884 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 961' ' ' LYS . 50.2 mt-10 -69.14 -34.74 75.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.487 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.43 ' HD1' ' HB3' ' A' ' 933' ' ' ARG . 18.3 m-85 -94.85 142.61 27.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.144 0.497 . . . . 0.0 112.305 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 8.3 p90 -100.08 141.99 32.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.655 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 153.44 147.65 4.69 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.222 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.688 ' H ' ' HD2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -73.08 158.84 86.47 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.653 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 31.2 Cg_exo -60.03 115.45 2.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.573 2.182 . . . . 0.0 112.208 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 930' ' ' TYR . 49.3 p90 -95.6 -168.21 1.74 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 928' ' ' LEU . 68.8 m -166.93 134.6 2.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.099 0.476 . . . . 0.0 111.33 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.412 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 5.1 pt -102.38 125.69 56.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.443 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 18.0 m -82.77 122.09 27.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.28 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 8.4 t -71.44 103.07 2.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 88.0 mt -82.72 162.02 21.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.437 ' HA ' HG21 ' A' ' 924' ' ' ILE . 62.6 t0 -45.44 -34.23 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.135 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.663 ' O ' HG13 ' A' ' 950' ' ' VAL . 2.6 m120 -81.32 28.89 0.37 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.623 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 900' ' ' ALA . 45.7 mt 47.79 31.78 2.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.323 0.582 . . . . 0.0 109.918 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 948' ' ' ASN . 29.5 m -107.92 -160.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.62 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.511 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 81.9 m95 -150.67 121.41 7.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.817 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.9 p -41.49 142.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.497 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.479 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 39.7 t -78.58 115.08 48.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.051 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.8 Cg_exo -74.61 130.81 14.07 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.995 2.463 . . . . 0.0 111.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.484 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 29.8 mmmt -80.77 -133.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.464 0.65 . . . . 0.0 111.755 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 6.7 t70 -78.36 60.32 2.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.314 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 33.9 m -81.51 -34.09 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.885 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.48 ' O ' ' HE3' ' A' ' 959' ' ' LYS . 30.0 m -150.41 125.7 10.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.12 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.1 mmpt? -137.48 149.53 46.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.834 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 14.7 mmt85 -53.2 120.7 6.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 28.8 mtpp -58.29 -171.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.417 ' HB3' HE21 ' A' ' 981' ' ' GLN . 81.1 p -153.14 137.7 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.8 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.411 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 58.5 m -81.58 38.85 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt 59.0 130.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.433 ' HA ' HD12 ' A' ' 980' ' ' ILE . 49.6 m -57.74 126.7 76.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 986' ' ' ILE . 52.6 Cg_endo -68.6 128.75 17.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.418 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 34.9 Cg_exo -59.66 131.18 38.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.365 2.043 . . . . 0.0 111.614 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -61.28 120.63 56.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.954 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 139.22 36.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.072 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' 1020 ' ' CYS . 20.4 t -52.01 130.06 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 30.6 m120 56.82 52.8 8.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.694 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -158.26 -153.3 6.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.243 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 32.2 ttp 175.01 119.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.607 0.241 . . . . 0.0 111.002 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 974' ' ' VAL . 12.0 p -101.02 124.21 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.728 0.775 . . . . 0.0 111.355 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.789 ' CE1' HG12 ' A' ' 977' ' ' ILE . 1.9 t-80 -87.28 103.08 15.11 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.6 m -53.02 -20.51 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.789 HG12 ' CE1' ' A' ' 975' ' ' HIS . 12.9 mt 66.58 60.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.583 0.706 . . . . 0.0 109.395 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 14.1 p 80.79 -48.42 0.29 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.234 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.562 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 55.3 m-20 -156.27 -158.57 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.86 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.485 HG22 ' CG2' ' A' ' 986' ' ' ILE . 12.8 pt -151.04 23.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.35 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.562 ' OE1' ' HB3' ' A' ' 979' ' ' ASP . 7.2 mp0 -76.54 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 96.2 t -55.49 84.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.125 0.488 . . . . 0.0 110.736 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.9 -45.94 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.108 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 50.5 m -76.05 138.85 41.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 111.257 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.686 ' HE ' ' HB3' ' A' 1003 ' ' GLU . 38.3 ttm180 -103.37 139.1 39.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.351 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 20.3 pt -98.62 122.45 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.678 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.483 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.7 p -101.93 135.56 43.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.095 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 3.1 m-85 -96.49 140.4 31.18 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.747 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 43.9 t -151.75 64.45 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 35.8 m -35.75 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.618 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 9.0 t -174.18 165.87 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 9.0 t -52.84 -36.28 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.659 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' 1023 ' ' ILE . . . -63.69 -55.14 26.68 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.488 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -101.81 136.73 41.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.413 . . . . 0.0 111.26 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.7 ptt180 -92.57 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.511 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.7 tt -72.36 132.23 43.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -111.25 132.78 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 111.302 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 68.04 131.84 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.217 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 47.5 -139.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.652 0.263 . . . . 0.0 111.449 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.1 t -177.05 -30.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 46.8 t -154.56 168.66 26.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.511 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.96 133.65 14.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.045 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.686 ' HB3' ' HE ' ' A' ' 985' ' ' ARG . 19.3 pt-20 -96.15 134.14 39.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.122 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.453 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.8 t -76.42 124.76 28.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' 1014 ' ' SER . 41.9 pt -135.94 -154.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.471 . . . . 0.0 112.115 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' 1010 ' ' THR . 62.3 tp -151.85 138.55 18.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.009 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.507 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.6 t -87.91 -48.22 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.17 20.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.13 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 10.3 p-10 174.94 -53.79 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.782 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.488 ' O ' HD12 ' A' 1006 ' ' LEU . 10.3 m -98.88 130.56 45.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.606 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -81.21 134.8 35.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.507 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.1 p80 -158.82 147.64 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 111.65 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.493 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 60.5 m95 -68.23 134.96 51.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.771 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' 1005 ' ' ILE . 91.4 p -68.37 -12.22 60.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 6.4 m -140.93 139.24 34.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 pttm -69.76 146.0 95.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.057 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.468 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 23.9 Cg_exo -64.63 135.71 46.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.869 2.379 . . . . 0.0 112.55 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 38.0 Cg_endo -66.28 -156.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.568 2.178 . . . . 0.0 112.449 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.7 mt -142.22 139.95 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.694 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 71.7 m -93.41 124.3 37.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -145.79 133.3 20.84 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.6 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -48.12 133.2 15.38 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.559 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.645 HG12 ' HB3' ' A' ' 995' ' ' ARG . 44.8 mt -75.14 124.93 89.6 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.803 2.336 . . . . 0.0 112.253 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.612 ' N ' HD22 ' A' ' 949' ' ' LEU . 16.1 m80 67.8 127.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.703 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 2.4 p -82.27 130.03 35.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.453 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -67.22 -177.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.576 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.21 137.9 6.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 2.7 Cg_exo -75.07 63.41 6.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.202 2.601 . . . . 0.0 112.167 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.1 t0 36.32 -131.99 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.676 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 17.6 t-160 -160.45 120.21 2.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.848 0.356 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.595 ' HE2' ' HG2' ' A' ' 954' ' ' PRO . 21.9 m-85 -88.15 136.35 33.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.98 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.25 -58.58 3.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.347 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -84.84 26.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.4 122.33 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.443 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 912' ' ' LYS . 10.3 mtmp? -100.52 131.49 46.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.548 HD21 ' OG1' ' A' ' 917' ' ' THR . 52.1 tp -48.22 129.71 15.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.491 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.564 ' HD3' ' HD2' ' A' ' 929' ' ' LYS . 51.6 tttp -94.51 -43.08 8.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 42.7 m -64.6 144.43 57.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.853 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 916' ' ' GLN . 1.3 pp0? -77.54 49.29 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.548 ' OG1' HD21 ' A' ' 913' ' ' LEU . 39.5 p -81.42 146.28 30.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 72.9 p -136.39 -33.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.576 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.47 156.22 39.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 54.6 m -84.78 -38.83 19.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.9 145.29 28.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.32 137.68 25.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.511 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -69.74 136.6 33.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.716 2.277 . . . . 0.0 111.764 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 39.9 mt -58.04 154.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.205 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.02 -34.02 3.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 22.9 m -55.93 122.24 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.659 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.6 m -94.91 120.72 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.885 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 942' ' ' SER . 10.0 tp -99.24 118.85 36.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.316 . . . . 0.0 110.737 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.564 ' HD2' ' HD3' ' A' ' 914' ' ' LYS . 39.9 ttmt -85.34 138.76 32.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.106 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 941' ' ' PHE . 7.2 m-85 -131.65 134.85 46.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.515 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.495 ' HG2' ' HD2' ' A' ' 914' ' ' LYS . 56.6 mm-40 -95.58 130.53 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.607 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.16 156.52 9.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 45.0 mtt-85 -84.8 151.84 58.61 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 936' ' ' TYR . 86.6 Cg_exo -47.48 -46.75 19.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.685 2.257 . . . . 0.0 112.859 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.587 ' HB3' HG21 ' A' ' 982' ' ' VAL . 4.8 mm-40 -73.29 20.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.745 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 82.2 m-85 -145.17 137.32 25.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.402 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.721 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 14.3 p90 -97.71 138.0 35.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.423 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 158.57 142.59 3.43 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.082 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -73.06 159.07 86.09 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.258 . . . . 0.0 110.362 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.84 149.17 71.13 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.275 1.983 . . . . 0.0 111.294 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 957' ' ' VAL . 50.7 p90 -140.01 -167.91 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.78 0.324 . . . . 0.0 110.93 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.4 p -172.88 134.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.483 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 15.3 pt -97.21 113.55 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 47.1 m -78.49 126.67 31.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.828 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.2 t -72.96 125.1 26.8 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.155 0.502 . . . . 0.0 109.936 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.915 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -88.35 167.9 13.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 0.0 113.606 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -50.6 -38.63 46.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.293 -1.776 . . . . 0.0 112.25 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.549 ' O ' HG13 ' A' ' 950' ' ' VAL . 15.0 t-20 -81.6 34.25 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 900' ' ' ALA . 21.0 mt 47.93 36.73 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.196 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.915 HG23 HD23 ' A' ' 946' ' ' LEU . 29.1 m -112.85 -159.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.241 0.543 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 85.4 m95 -147.32 124.89 11.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.473 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.9 p -39.68 141.75 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.803 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 33.7 m -79.51 112.91 32.6 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.595 ' HG2' ' HE2' ' A' ' 908' ' ' PHE . 5.8 Cg_exo -79.63 143.56 16.96 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.456 2.771 . . . . 0.0 112.346 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -159.01 137.22 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 7.2 m-20 58.95 33.8 23.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.246 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 941' ' ' PHE . 29.4 m -94.15 -32.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.209 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 37.4 m -149.82 59.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.205 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 74.2 mmtt -58.07 152.47 16.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.995 0.426 . . . . 0.0 111.762 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 981' ' ' GLN . 20.8 tpp180 -53.33 116.53 2.48 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.721 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 63.6 tttt -56.26 147.57 20.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 78.7 p -144.61 139.71 28.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 964' ' ' LYS . 37.4 m -81.56 36.18 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.563 ' NZ ' ' HB3' ' A' ' 964' ' ' LYS . 6.3 ttpm? 56.22 134.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.727 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.4 m -60.31 124.15 76.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.331 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.568 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 59.5 Cg_endo -71.48 130.43 17.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.469 2.112 . . . . 0.0 112.565 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 24.9 Cg_exo -62.67 135.04 50.41 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.445 2.097 . . . . 0.0 111.61 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.03 115.13 10.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.655 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 138.92 66.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.712 2.275 . . . . 0.0 112.388 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.3 t -53.86 134.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 56.98 42.56 26.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.873 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -160.28 -155.75 7.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.518 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 35.7 ttp 174.22 131.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.985 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -101.4 128.98 53.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.814 0.34 . . . . 0.0 111.459 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.549 ' O ' HG13 ' A' ' 977' ' ' ILE . 28.3 m-70 -87.85 114.34 24.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 980' ' ' ILE . 69.9 t -62.13 -33.67 59.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.018 0.437 . . . . 0.0 109.859 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 975' ' ' HIS . 15.0 mt 71.39 -48.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.285 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 977' ' ' ILE . 74.6 p -146.12 -60.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.859 0.362 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.6 m-20 -152.47 -161.88 1.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.862 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 976' ' ' VAL . 10.0 pt -146.78 19.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.531 . . . . 0.0 110.492 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' A' 1004 ' ' CYS . 6.7 mm100 -80.82 -178.17 6.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.643 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 935' ' ' GLU . 30.0 m -64.9 25.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -157.19 44.16 0.51 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.754 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.4 p -160.54 132.97 6.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.283 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 16.9 ptp180 -100.97 131.06 47.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.044 0.449 . . . . 0.0 111.446 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 23.7 pt -99.35 131.77 46.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.778 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.463 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -95.72 133.43 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.0 111.392 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.495 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 5.9 m-85 -98.95 137.86 36.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 55.7 m -153.5 115.01 4.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 74.1 m -75.55 150.93 38.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.809 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 23.8 m -64.07 143.57 57.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.7 t -37.8 139.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.941 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.24 -40.87 2.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.548 ' HA ' ' O ' ' A' 1021 ' ' GLN . 6.4 m-70 -99.37 137.95 37.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.046 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.552 ' HE ' HG12 ' A' 1023 ' ' ILE . 14.2 ptp180 -97.36 147.22 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.533 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 9.8 tt -69.28 129.52 40.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.796 HD11 ' HG2' ' A' 1021 ' ' GLN . 31.7 mm -102.15 80.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 154.93 -131.13 3.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.697 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.435 ' O ' HD22 ' A' ' 996' ' ' LEU . 29.2 m80 -81.48 -116.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.515 0.197 . . . . 0.0 111.454 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 46.9 t -178.61 -30.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.955 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 52.6 m -155.58 148.88 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.88 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.601 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -153.36 133.04 13.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.636 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -100.2 136.9 39.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 13.0 t -71.14 124.22 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.25 -149.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.927 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' 1010 ' ' THR . 66.2 tp -150.89 139.61 20.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.248 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.552 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 97.6 p -88.62 -52.22 5.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.553 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 158.7 31.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.649 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' 1008 ' ' GLY . 25.4 t-20 176.14 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.418 ' O ' HD12 ' A' 1006 ' ' LEU . 56.9 m -139.27 134.93 33.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.281 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.25 140.34 36.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.552 ' NE2' ' HB3' ' A' 1007 ' ' SER . 9.9 p80 -158.37 146.19 18.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 78.2 m95 -64.38 146.47 54.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.934 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.6 t -49.91 -34.28 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.723 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.8 p -144.74 139.39 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.056 0.455 . . . . 0.0 111.821 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.597 ' HD2' ' N ' ' A' 1017 ' ' PRO . 3.8 tmmm? -62.88 136.21 96.39 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.345 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.597 ' N ' ' HD2' ' A' 1016 ' ' LYS . 10.4 Cg_endo -54.08 124.87 17.03 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.786 2.324 . . . . 0.0 112.801 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.737 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 44.4 Cg_endo -67.3 -150.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.799 2.332 . . . . 0.0 112.65 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -133.18 -158.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.839 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.695 ' H ' HG22 ' A' 1019 ' ' ILE . 78.6 m -159.54 135.97 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.566 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.796 ' HG2' HD11 ' A' ' 997' ' ' ILE . 19.0 pt20 -151.31 141.89 22.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.521 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' 1022 ' ' ARG . 27.5 ptt85 -64.01 22.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.574 ' H ' ' C ' ' A' 1021 ' ' GLN . 58.0 mt 64.61 132.08 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 52.5 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.836 2.357 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.998 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.89 0.376 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.508 ' C ' HD22 ' A' ' 949' ' ' LEU . 45.7 m80 -148.99 140.05 23.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 86.5 m -81.6 131.61 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.701 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -54.6 158.73 2.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 111.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 919' ' ' ALA . . . -48.27 123.32 10.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.846 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.506 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 34.3 Cg_exo -59.17 136.83 75.34 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 122.669 2.246 . . . . 0.0 112.94 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.2 143.79 57.48 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 131.92 39.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 911' ' ' ALA . 2.0 m-85 -85.29 150.14 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.987 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -81.17 -57.07 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.047 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.8 OUTLIER -85.47 10.77 11.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -152.14 151.62 31.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.49 136.3 39.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.526 HD11 ' HG ' ' A' ' 928' ' ' LEU . 57.5 tp -45.77 130.58 9.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.593 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 930' ' ' TYR . 11.7 tmtt? -94.59 -51.19 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 52.9 m -66.52 136.58 55.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.616 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -64.76 138.54 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.828 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.627 HG21 HD11 ' A' ' 928' ' ' LEU . 81.0 p -154.25 -170.2 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 40.1 p -156.15 34.28 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.644 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 919' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 904' ' ' ALA . . . 41.05 -146.0 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.799 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t 62.39 44.52 7.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 921' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 902' ' ' CYS . 1.5 m-20 66.61 153.54 0.08 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.503 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 919' ' ' ALA . 63.6 m-85 -136.4 145.97 53.97 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.209 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 138.24 83.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.729 2.286 . . . . 0.0 111.896 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.623 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.4 mt -58.96 155.73 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.47 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 85.42 -32.36 3.63 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.674 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 40.9 m -55.97 126.29 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 47.3 t -96.36 127.87 42.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.781 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.627 HD11 HG21 ' A' ' 917' ' ' THR . 8.6 tp -105.47 120.52 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 0.0 110.903 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 915' ' ' THR . 40.2 ttmt -85.68 140.98 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.561 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 6.3 m-85 -129.15 168.48 16.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 914' ' ' LYS . 16.6 pt-20 -144.47 137.38 26.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.926 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.69 143.26 37.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.02 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.0 mtp180 -85.52 158.69 56.94 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 7.6 Cg_endo -49.64 139.74 30.34 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.579 2.186 . . . . 0.0 111.745 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 50.5 mt-10 81.38 25.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.334 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 88.2 m-85 -146.87 135.66 22.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.796 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.8 p90 -102.34 137.47 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.885 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 157.62 146.06 4.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.877 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.519 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 77.2 mtp180 -72.82 162.72 72.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.662 0.268 . . . . 0.0 110.82 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 73.5 Cg_endo -78.75 114.66 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.384 2.056 . . . . 0.0 112.278 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 48.2 p90 -91.68 -160.17 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.5 p -175.28 132.92 0.3 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' A' ' 954' ' ' PRO . 11.0 pt -93.99 -166.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.188 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.491 ' O ' HD22 ' A' ' 946' ' ' LEU . 26.5 m -166.61 132.6 2.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.5 t -73.79 120.47 19.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 950' ' ' VAL . 1.8 mm? -87.02 174.22 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.219 1.009 . . . . 0.0 112.803 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.05 -42.69 73.01 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.135 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 950' ' ' VAL . 48.7 t30 -84.51 35.09 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.998 HD21 ' HB1' ' A' ' 900' ' ' ALA . 83.0 mt 46.42 59.66 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.815 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -138.48 -157.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.117 0.484 . . . . 0.0 111.393 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.506 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 94.3 m95 -149.13 115.98 5.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.731 ' N ' HD21 ' A' ' 946' ' ' LEU . 72.4 m -52.12 147.51 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.4 t -78.16 122.97 86.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.578 ' HG3' HG22 ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.09 26.77 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.866 2.377 . . . . 0.0 112.831 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.635 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 7.2 mtmp? 39.82 -143.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.01 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.594 ' OD1' ' HE2' ' A' ' 959' ' ' LYS . 60.3 t0 -79.5 134.26 36.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -150.68 -98.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.719 ' H ' HG23 ' A' ' 957' ' ' VAL . 63.7 m -77.13 147.36 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.014 0.435 . . . . 0.0 111.374 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.594 ' HE2' ' OD1' ' A' ' 956' ' ' ASP . 68.5 mttm -144.93 157.15 44.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.172 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.832 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -59.95 114.98 3.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.851 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' 1011 ' ' ALA . 24.6 ttmm -56.23 150.34 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.513 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 82.8 p -144.51 141.02 29.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.985 0.421 . . . . 0.0 111.38 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 82.0 m -79.9 151.6 30.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.156 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.48 131.06 45.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 29.4 m -55.77 122.94 49.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.462 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.9 Cg_endo -69.58 134.71 29.05 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.428 2.085 . . . . 0.0 111.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.84 124.49 15.99 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.047 1.831 . . . . 0.0 111.433 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -58.29 122.86 62.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.788 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.65 138.4 83.09 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.064 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' 1020 ' ' CYS . 21.7 t -52.79 130.47 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.678 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 25.9 m120 70.36 36.78 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.888 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -172.48 -153.16 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.055 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 177.41 145.44 0.11 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 110.636 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 7.7 p -93.81 120.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -78.87 112.97 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.62 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.99 -18.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.189 0.519 . . . . 0.0 109.748 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 8.9 mt 74.07 -44.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.953 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.3 p -146.77 -54.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.622 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 45.1 m-20 -159.18 -144.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.505 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 7.0 pt -151.09 31.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.156 0.503 . . . . 0.0 110.944 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.832 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 47.6 mm-40 -76.87 156.01 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.504 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' 1005 ' ' ILE . 94.5 t -55.44 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 159.0 -37.99 0.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.278 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.9 p -76.58 139.1 40.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 111.626 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.769 ' HG2' ' HB2' ' A' 1003 ' ' GLU . 87.2 mtm180 -90.64 159.08 16.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.999 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.9 pt -132.72 123.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.9 p -103.85 138.68 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.457 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.482 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.2 m-85 -100.79 138.57 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.266 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 81.9 p -153.48 131.41 11.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 71.5 m -74.17 126.04 29.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.603 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.888 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 6.0 t -76.58 55.1 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.468 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 991' ' ' THR . 99.9 m -177.64 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 992' ' ' THR . . . -168.66 39.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.499 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.743 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 3.0 m80 -93.65 159.73 15.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.641 ' HB3' HG12 ' A' 1023 ' ' ILE . 37.3 ptt180 -89.87 135.56 33.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.1 tm? -71.98 132.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 3.3 mt -118.29 135.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.387 . . . . 0.0 111.487 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.17 -125.57 8.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -79.3 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.8 p -174.58 -37.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.9 p -150.85 151.71 32.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.537 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -151.92 133.17 14.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.087 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.769 ' HB2' ' HG2' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.36 136.62 36.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.208 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 35.5 t -71.25 121.8 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.639 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.5 pt -133.46 -153.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.411 . . . . 0.0 111.934 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' 1010 ' ' THR . 57.7 tp -150.85 136.11 17.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.038 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.604 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.9 t -89.41 -40.88 12.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.713 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.55 -37.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.035 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.401 ' C ' HD11 ' A' 1006 ' ' LEU . 5.5 m120 -140.92 -48.03 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.063 0.458 . . . . 0.0 110.5 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.456 ' O ' HD12 ' A' 1006 ' ' LEU . 57.8 m -94.53 135.76 35.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.227 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.583 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -80.78 145.64 31.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.604 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.5 p80 -157.66 144.06 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.371 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 70.7 m95 -66.0 147.05 53.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.4 t -55.81 -35.11 65.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.594 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -143.12 143.78 31.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.462 . . . . 0.0 111.726 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -56.83 137.59 78.71 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.907 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 53.1 Cg_exo -52.9 129.89 35.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.379 2.053 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1017 ' ' PRO . 38.3 Cg_exo -61.44 -158.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 112.683 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.2 mt -142.86 139.37 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.945 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 42.8 t -94.43 129.02 41.34 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 995' ' ' ARG . 2.5 tp-100 -145.74 128.62 16.38 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.664 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -54.39 133.29 45.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.35 0.595 . . . . 0.0 111.311 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 995' ' ' ARG . 57.5 mt -74.83 122.8 88.29 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.2 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.866 2.378 . . . . 0.0 112.347 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.113 0.483 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.603 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 41.3 m80 -150.91 136.76 18.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.002 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.41 125.35 29.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.291 0.567 . . . . 0.0 111.213 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -57.7 168.83 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.607 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.5 133.51 13.37 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.567 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.42 145.97 78.84 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.55 2.167 . . . . 0.0 111.729 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.74 148.65 42.2 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.39 0.614 . . . . 0.0 111.332 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -81.19 115.02 20.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.027 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 9.5 m-85 -89.93 134.39 34.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.762 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 76.7 mt -76.96 -54.4 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 2.1 p90 -84.59 25.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.201 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.17 120.76 4.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.514 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -103.48 121.14 42.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.485 HD13 ' CE1' ' A' ' 930' ' ' TYR . 29.8 tp -49.25 122.05 5.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.004 0.43 . . . . 0.0 111.324 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.702 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 0.8 OUTLIER -90.94 -44.77 9.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.321 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 54.3 m -64.65 132.92 51.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.43 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.432 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.2 pm0 -65.12 143.64 57.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.267 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 80.7 p -150.22 -58.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.089 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 82.6 p 46.25 56.16 6.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.51 -152.43 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.0 111.491 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 60.1 m -146.58 -44.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.51 135.37 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.113 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 55.1 m-85 -137.69 141.37 32.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.939 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.491 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 70.0 Cg_endo -73.93 136.98 23.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.634 2.223 . . . . 0.0 111.647 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 947' ' ' ASP . 53.4 mt -52.6 151.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 91.31 -28.38 8.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.491 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 31.8 m -55.43 138.99 44.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.994 0.426 . . . . 0.0 111.553 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.7 m -118.0 142.5 47.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.76 120.49 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.519 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -89.83 133.38 34.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.567 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 2.9 m-85 -116.12 134.77 54.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.702 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 65.7 mm-40 -94.45 117.25 29.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.801 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 68.7 m -59.41 140.63 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.344 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.0 mtp180 -85.37 158.74 57.31 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 9.2 Cg_endo -52.71 149.47 24.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.519 2.146 . . . . 0.0 110.886 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 49.6 mt-10 83.5 19.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.72 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 960' ' ' ARG . 94.3 m-85 -144.95 125.11 13.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 5.1 p90 -95.96 141.4 29.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.46 147.39 5.46 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.087 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.27 159.03 86.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.83 126.11 16.04 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.585 2.19 . . . . 0.0 112.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 5.2 p90 -90.88 -162.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.712 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 941' ' ' PHE . 64.1 m -170.12 133.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.2 pt -95.76 168.94 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.277 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.419 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.4 m -162.6 135.26 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 52.8 m -73.8 126.83 31.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.6 mm? -85.19 -53.55 5.18 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.841 ' HA ' HD13 ' A' ' 924' ' ' ILE . 50.9 t0 171.73 -38.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.691 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.07 28.07 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 60.8 43.22 12.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.32 149.75 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.886 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -94.02 141.06 28.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.166 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.0 p -52.34 138.11 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.9 t -79.19 108.61 8.84 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.756 0.312 . . . . 0.0 111.196 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 952' ' ' SER . 6.4 Cg_exo -72.75 136.03 24.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.675 2.25 . . . . 0.0 111.497 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -158.99 143.37 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.373 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.49 36.72 16.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.572 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.8 m -92.4 -111.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.009 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.467 ' H ' HG23 ' A' ' 957' ' ' VAL . 51.0 m -86.82 87.29 7.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.78 ' HD2' ' H ' ' A' ' 959' ' ' LYS . 8.3 mptt -67.75 154.59 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 936' ' ' TYR . 37.7 ttm180 -54.54 136.52 44.73 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.85 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.514 ' HG2' ' HB2' ' A' 1011 ' ' ALA . 16.6 tppt? -53.78 152.32 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.508 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 70.9 p -143.95 124.08 13.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.775 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.508 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.1 p -83.54 37.95 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 53.4 tptt 60.09 138.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.386 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 9.2 m -57.47 131.86 81.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.137 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.709 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.2 Cg_endo -65.02 125.0 13.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.471 2.114 . . . . 0.0 112.462 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 17.3 Cg_exo -66.27 120.57 7.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.305 2.003 . . . . 0.0 111.498 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 973' ' ' MET . 1.5 m-20 -62.55 122.28 72.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 968' ' ' ASP . 37.4 Cg_exo -57.62 144.91 91.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 111.877 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.3 p -48.32 127.44 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 970' ' ' VAL . 34.0 m120 63.75 46.4 4.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.907 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.79 -154.07 9.02 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.513 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.447 ' HA ' ' HB3' ' A' ' 968' ' ' ASP . 24.8 ptt? 175.69 143.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.287 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 986' ' ' ILE . 13.5 p -93.79 127.18 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -89.55 110.53 21.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.377 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 34.8 m -71.99 134.62 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 978' ' ' THR . 47.6 mm -73.45 -38.74 53.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 110.503 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 977' ' ' ILE . 76.8 p -144.76 -42.61 0.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 54.3 t0 -160.72 -136.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.197 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.524 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 9.5 pt -151.07 1.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 110.981 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -75.62 164.5 26.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.558 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 53.4 t -50.1 133.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 102.67 -39.03 2.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.566 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 95.8 p -76.06 138.09 40.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -98.87 157.18 16.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.232 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 974' ' ' VAL . 47.8 pt -141.96 137.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 111.685 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 4.7 p -108.33 133.25 52.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 988' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.66 143.2 26.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.789 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.74 123.31 9.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 61.9 m -88.94 146.47 24.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -64.93 147.47 53.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.448 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 86.8 m -45.61 117.1 1.34 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.979 0.419 . . . . 0.0 111.192 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 141.49 -48.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.151 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -113.04 139.2 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.618 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.3 ptt180 -93.0 140.9 28.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.9 tt -72.01 126.1 28.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.215 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.988 ' HB ' HG23 ' A' 1019 ' ' ILE . 2.4 mp -102.93 130.92 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.344 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.54 -142.89 15.62 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.617 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.527 ' O ' ' HG3' ' A' 1018 ' ' PRO . 87.5 m-70 -84.03 132.19 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.574 0.226 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.4 t -81.32 -55.87 4.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.5 p -89.2 153.17 21.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.6 123.37 5.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.116 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -104.59 131.25 52.21 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 49.1 t -75.0 131.0 40.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.7 pt -135.8 -155.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.581 -0.447 . . . . 0.0 112.007 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' 1010 ' ' THR . 56.3 tp -150.39 131.9 14.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.564 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 26.3 t -90.08 -134.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.395 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -67.65 -49.77 47.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.643 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -152.11 27.56 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.449 ' C ' HD12 ' A' 1006 ' ' LEU . 6.6 m -149.73 130.99 14.58 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.489 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 961' ' ' LYS . . . -81.52 137.94 35.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.765 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.564 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.9 p80 -159.76 144.33 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.593 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.508 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 93.1 m95 -64.48 146.74 54.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.704 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.7 t -57.56 -31.5 66.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.6 p -144.35 138.77 28.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.583 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.547 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 1.6 pptp? -62.52 160.7 32.14 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 18.6 Cg_endo -59.57 129.03 29.2 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.499 2.133 . . . . 0.0 112.271 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.527 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 16.8 Cg_exo -67.22 -160.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.988 HG23 ' HB ' ' A' ' 997' ' ' ILE . 1.2 tt -144.55 121.3 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.217 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.9 m -78.92 132.91 36.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -146.68 130.93 17.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.406 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -44.29 132.8 5.72 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.524 0.678 . . . . 0.0 111.928 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 22.2 mt -76.07 130.44 78.04 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.303 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.482 2.122 . . . . 0.0 112.421 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.992 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.912 0.387 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 44.9 m170 -119.87 123.12 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.757 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 5.4 p -82.13 127.19 32.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.547 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -58.34 169.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.12 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -45.86 135.68 6.39 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.554 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 3.0 Cg_exo -74.64 61.86 5.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.063 2.508 . . . . 0.0 111.909 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 48.4 t0 41.45 -143.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.55 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 70.9 t60 -161.78 116.7 1.98 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.726 0.298 . . . . 0.0 110.974 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.47 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 74.3 m-85 -85.93 135.26 33.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.076 0.465 . . . . 0.0 110.779 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.633 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 5.3 mp -74.97 -48.33 24.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.569 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.58 17.7 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.621 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.51 121.88 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 111.788 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 933' ' ' ARG . 59.7 pttt -102.7 128.87 49.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.21 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 928' ' ' LEU . 0.8 OUTLIER -48.61 125.34 9.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.607 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -94.47 -31.47 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.56 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 86.8 m -62.2 135.92 57.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 111.786 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.622 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.1 pm0 -78.34 61.25 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.672 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 918' ' ' THR . 3.4 t -80.62 -53.02 6.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 917' ' ' THR . 24.9 m 51.81 55.1 9.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.31 155.36 9.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 48.4 t -86.58 -44.83 11.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.21 138.96 32.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.524 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.467 ' HB2' ' SG ' ' A' ' 902' ' ' CYS . 17.0 m-85 -127.67 137.88 31.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.84 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 60.0 Cg_endo -72.13 131.97 18.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.484 2.123 . . . . 0.0 110.922 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.64 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.6 mt -57.1 149.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.926 0.393 . . . . 0.0 111.327 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 91.69 -34.37 4.39 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.663 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 15.8 m -57.19 129.9 43.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 942' ' ' SER . 47.6 t -87.89 151.74 22.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.541 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 913' ' ' LEU . 10.0 tp -140.85 102.18 4.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.51 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.775 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 17.8 ptpt -85.37 132.76 34.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.191 0.52 . . . . 0.0 111.99 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.564 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 2.0 m-85 -111.49 133.9 53.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.791 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 912' ' ' LYS . 23.4 pt-20 -95.57 126.47 40.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.3 m -57.87 148.59 24.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 76.9 mtt-85 -85.15 161.95 50.68 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 75.3 Cg_exo -45.64 139.96 9.68 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.234 1.956 . . . . 0.0 112.176 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 95.0 mt-10 82.49 23.43 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.507 ' N ' ' HG3' ' A' ' 961' ' ' LYS . 85.9 m-85 -146.81 145.41 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.558 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 16.1 p90 -144.07 140.84 29.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 110.942 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.36 21.89 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.651 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.621 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 79.5 mtp180 62.81 164.61 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.85 0.357 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 63.6 Cg_endo -77.65 115.42 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.146 1.897 . . . . 0.0 110.676 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 42.3 p90 -89.67 108.1 19.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.525 0.678 . . . . 0.0 112.068 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.775 ' HA ' ' HA ' ' A' ' 929' ' ' LYS . 80.3 p -77.21 125.64 29.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.844 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 928' ' ' LEU . 10.0 pt -94.92 -161.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 4.0 m -161.14 121.42 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -72.08 102.16 2.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.719 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 48.9 mt -80.89 161.37 24.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.568 0.699 . . . . 0.0 112.713 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' A' ' 924' ' ' ILE . 9.8 t70 -42.55 -38.4 1.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.005 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 950' ' ' VAL . 75.2 m-20 -83.08 36.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.992 HD11 ' HB1' ' A' ' 900' ' ' ALA . 8.2 mp 44.82 46.33 8.76 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.222 0.534 . . . . 0.0 110.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.719 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.4 m -123.61 -162.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.16 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.554 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 90.1 m95 -152.69 122.77 7.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.289 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.9 t -43.43 146.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.531 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 38.9 t -79.39 117.55 67.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.599 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 908' ' ' PHE . 4.0 Cg_exo -76.8 60.93 6.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.55 2.833 . . . . 0.0 111.794 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -77.1 131.77 38.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.017 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 54.99 81.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.545 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 12.7 m -150.9 -21.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.834 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 12.1 t -151.45 133.37 15.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -143.26 146.86 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.181 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.805 ' HD3' ' HB3' ' A' ' 981' ' ' GLN . 29.9 ttt85 -53.2 143.53 17.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.057 0.456 . . . . 0.0 111.655 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 28.1 mtpp -56.29 152.34 11.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.563 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.605 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 96.3 p -141.61 121.13 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.564 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 4.4 p -81.67 153.68 26.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.596 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.33 132.35 48.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 34.4 m -56.57 134.3 77.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.928 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.788 ' HG2' HG11 ' A' ' 974' ' ' VAL . 9.2 Cg_endo -52.65 150.98 20.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.764 2.309 . . . . 0.0 111.992 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' 1017 ' ' PRO . 64.7 Cg_endo -73.14 45.5 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.678 2.252 . . . . 0.0 112.814 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 967' ' ' PRO . 1.5 m-20 18.02 109.73 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 124.074 0.859 . . . . 0.0 113.165 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.44 142.49 9.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 5.1 p -48.6 131.67 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.638 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.9 m120 75.43 -48.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.634 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -75.44 -152.62 3.61 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.097 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 1.8 pmm? 177.75 143.48 0.1 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.274 0.23 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.788 HG11 ' HG2' ' A' ' 966' ' ' PRO . 10.1 p -93.62 128.94 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.236 0.541 . . . . 0.0 111.201 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -104.46 118.1 35.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.403 HG11 HG23 ' A' ' 980' ' ' ILE . 28.2 m -70.95 141.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.925 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 985' ' ' ARG . 24.4 mm -74.92 -36.68 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.476 . . . . 0.0 110.295 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.2 p -144.69 -47.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.186 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 49.0 t0 -160.19 -137.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.559 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.479 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 7.6 pt -151.02 36.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.231 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' A' ' 960' ' ' ARG . 13.1 mm100 -76.5 166.69 23.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.715 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.32 29.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.3 -25.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.3 t -76.1 136.72 39.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.004 0.431 . . . . 0.0 111.256 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 69.0 ttt180 -89.65 158.72 17.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.602 HD12 HG21 ' A' ' 974' ' ' VAL . 47.4 pt -137.56 129.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.918 0.39 . . . . 0.0 111.025 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' 1001 ' ' SER . 2.3 p -105.22 139.58 39.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.02 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.3 m-85 -103.94 146.99 27.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.677 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -153.48 124.19 7.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.482 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 96.6 m -72.95 -119.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 993' ' ' GLY . 8.0 t -169.55 158.91 8.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.628 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 61.0 m -52.8 84.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 991' ' ' THR . . . 168.6 -42.22 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.47 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.432 ' HB3' ' N ' ' A' 1021 ' ' GLN . 7.8 m80 -126.13 142.25 51.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.653 ' O ' HD12 ' A' ' 997' ' ' ILE . 39.3 ptt180 -91.9 145.28 24.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.6 tt -72.73 135.42 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.571 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.874 ' HB ' HG23 ' A' 1019 ' ' ILE . 3.9 mp -126.49 139.42 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.94 -124.2 7.99 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.51 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -80.1 -136.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.4 p -176.76 -43.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.465 ' HB3' HG22 ' A' ' 987' ' ' THR . 69.2 p -155.22 141.58 18.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.516 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -149.49 143.48 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 112.025 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.6 tt0 -95.92 138.24 33.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 47.9 t -71.27 129.62 39.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.1 pt -139.39 146.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 961' ' ' LYS . 60.8 tp -89.16 137.28 32.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.589 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.664 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 98.8 p -88.97 -40.09 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.372 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -177.72 -36.03 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.415 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -145.29 -44.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.277 0.561 . . . . 0.0 109.707 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 94.2 m -94.5 131.89 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.53 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.64 138.8 34.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.01 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.664 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.8 p80 -155.66 142.61 19.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.083 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 70.7 m95 -66.46 146.35 54.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -51.32 -33.73 30.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.092 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -141.04 -152.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.557 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -126.8 149.75 69.55 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.4 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 966' ' ' PRO . 41.5 Cg_exo -57.46 135.65 71.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.838 2.359 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.457 ' HG2' HD11 ' A' ' 996' ' ' LEU . 27.0 Cg_exo -62.81 -159.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.728 2.286 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.874 HG23 ' HB ' ' A' ' 997' ' ' ILE . 3.8 tt -146.57 128.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.868 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 77.3 m -84.29 138.5 32.88 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 997' ' ' ILE . 62.1 tt0 -149.74 135.7 18.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.081 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' 1022 ' ' ARG . 42.4 ttp85 -48.63 130.39 17.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.512 0.673 . . . . 0.0 111.695 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 995' ' ' ARG . 71.2 mt -74.94 127.12 87.44 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.623 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.563 2.175 . . . . 0.0 112.219 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.849 0.357 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.572 ' N ' HD22 ' A' ' 949' ' ' LEU . 15.9 m80 67.21 144.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 84.7 m -79.78 122.63 26.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 903' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 903' ' ' GLN . 0.8 OUTLIER -65.65 163.99 15.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.78 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.92 125.33 4.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.663 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 16.6 Cg_exo -67.1 135.26 36.75 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.731 2.287 . . . . 0.0 112.509 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.77 152.24 43.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.107 0.48 . . . . 0.0 110.87 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -78.17 134.59 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.091 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 8.3 m-85 -90.07 1.25 56.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.8 mp 71.61 -63.35 0.43 Allowed 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.602 0.564 . . . . 0.0 111.388 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.477 ' HA ' ' CD ' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -85.35 25.66 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.83 120.86 5.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -103.71 138.77 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.476 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.751 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.1 tm? -46.47 150.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.751 ' H ' HD22 ' A' ' 913' ' ' LEU . 11.8 tmtt? -137.71 -46.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 913' ' ' LEU . 2.7 m -68.76 139.14 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.499 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 17.6 mp0 -58.21 112.57 1.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 69.8 p -83.34 132.85 34.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 0.0 112.106 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.7 p -89.97 82.71 6.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.135 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 60.32 -152.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.9 p -86.59 -47.76 8.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -85.43 121.99 28.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.158 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 928' ' ' LEU . 77.7 m-85 -103.87 136.02 19.27 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 112.137 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.39 136.09 35.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 111.67 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.723 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 38.6 mt -56.69 143.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.065 0.46 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 101.87 -41.4 2.14 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.8 m -57.27 144.43 35.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.267 -0.466 . . . . 0.0 111.056 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 46.6 m -126.61 128.01 46.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.756 0.312 . . . . 0.0 111.235 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.3 mt -100.71 122.1 42.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.0 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.726 ' HG2' ' HB3' ' A' ' 942' ' ' SER . 52.0 mtmt -87.58 127.54 35.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.0 111.251 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 940' ' ' PRO . 4.8 m-85 -116.77 120.21 37.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.54 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.11 127.79 41.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.68 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 59.3 m -58.58 -174.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.531 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 43.5 mtp85 -84.42 159.68 58.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.323 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 936' ' ' TYR . 87.4 Cg_exo -45.83 -48.75 11.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.498 2.132 . . . . 0.0 112.466 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -74.44 28.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.304 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 12.4 m-85 -141.85 150.77 42.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 23.3 p90 -137.56 136.27 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.349 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.94 11.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 55.4 mtp85 61.41 151.98 0.1 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.348 0.594 . . . . 0.0 111.983 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 930' ' ' TYR . 13.4 Cg_exo -67.46 117.83 5.13 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.795 2.33 . . . . 0.0 111.246 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -90.35 115.37 27.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.392 0.615 . . . . 0.0 111.768 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.726 ' HB3' ' HG2' ' A' ' 929' ' ' LYS . 80.1 p -78.38 131.36 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.061 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -101.86 114.24 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 0.0 110.567 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 2.6 m -83.05 125.96 32.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.723 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 49.7 t -73.7 112.34 9.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 89.1 mt -81.45 -64.51 1.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -174.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 59.9 t0 173.84 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.947 0.403 . . . . 0.0 110.593 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.534 ' HB3' HG12 ' A' ' 950' ' ' VAL . 34.8 t30 -79.16 9.57 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 901' ' ' HIS . 45.9 mt 69.25 40.42 1.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.44 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 948' ' ' ASN . 3.3 p -137.52 154.94 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.607 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.863 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 29.1 m95 -89.76 145.25 25.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.313 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 79.5 p -47.2 144.94 2.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 66.1 m -77.71 108.65 7.66 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.459 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 952' ' ' SER . 15.4 Cg_exo -66.65 142.88 65.97 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.643 2.229 . . . . 0.0 111.339 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.37 129.33 8.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.147 0.499 . . . . 0.0 111.832 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 55.4 t0 51.75 33.65 11.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.431 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.647 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -91.99 -59.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.647 ' H ' HG23 ' A' ' 957' ' ' VAL . 5.9 t -89.31 141.48 28.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 40.1 mtmt -152.37 133.75 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.44 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.885 ' HE ' ' HB3' ' A' ' 981' ' ' GLN . 0.3 OUTLIER -65.88 128.52 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.02 0.438 . . . . 0.0 110.915 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.671 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.2 ttmp? -56.21 161.99 2.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.514 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 73.3 p -149.79 147.81 28.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.472 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.2 m -80.11 147.91 31.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.938 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 965' ' ' THR . 6.3 tmtm? -65.96 131.06 45.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.635 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 25.1 m -52.98 124.24 36.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.002 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.2 Cg_endo -68.87 133.66 27.82 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.64 2.227 . . . . 0.0 112.611 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 38.0 Cg_exo -59.94 137.55 76.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.351 2.034 . . . . 0.0 111.313 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.71 113.83 7.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.12 151.51 85.02 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.795 2.33 . . . . 0.0 111.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.6 p -49.6 127.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.24 46.09 23.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.84 137.97 4.59 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.45 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -127.95 142.74 51.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 966' ' ' PRO . 12.6 p -94.23 121.44 44.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.753 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.9 OUTLIER -88.66 128.13 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.51 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 979' ' ' ASP . 95.3 t -83.95 123.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.9 -40.49 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.707 0.289 . . . . 0.0 111.154 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 78.6 p -144.68 -50.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.402 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.543 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 37.1 m-20 -158.26 -152.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.994 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.458 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 14.8 pt -149.9 23.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.885 ' HB3' ' HE ' ' A' ' 960' ' ' ARG . 15.1 mp0 -77.01 154.08 33.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.675 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' 1005 ' ' ILE . 66.6 t -50.85 85.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 111.301 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.98 -41.47 0.29 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 77.2 p -75.38 -168.83 0.87 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 111.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.489 HH21 ' HB2' ' A' 1001 ' ' SER . 79.2 ttt180 -151.31 131.35 13.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.089 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.575 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 31.2 pt -98.07 142.57 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.539 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.7 p -116.96 135.12 53.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.138 0.494 . . . . 0.0 111.723 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.472 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 1.8 m-85 -103.12 148.66 25.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 47.5 t -148.74 120.05 7.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.095 0.474 . . . . 0.0 110.974 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 71.4 m -83.02 151.55 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.0 p -64.6 149.11 49.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -49.4 92.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 158.51 -46.94 0.44 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.275 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -99.96 148.25 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.596 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.442 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -91.55 148.4 22.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.548 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.496 ' C ' HD13 ' A' ' 996' ' ' LEU . 3.4 tm? -65.2 130.19 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.071 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' 1021 ' ' GLN . 34.6 mm -100.13 73.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.757 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 156.62 -149.62 20.52 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.126 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.603 ' ND1' HG21 ' A' 1015 ' ' THR . 34.5 m170 -85.91 -9.51 56.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.614 0.245 . . . . 0.0 111.173 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m 71.8 -5.44 1.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.458 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.489 ' HB2' HH21 ' A' ' 985' ' ' ARG . 57.5 m -156.02 149.55 24.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.435 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -154.58 133.15 12.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.6 tt0 -96.07 132.54 41.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 38.2 t -71.19 121.36 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.595 ' HA ' HG13 ' A' ' 982' ' ' VAL . 35.8 pt -135.52 -151.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 111.617 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.503 HD23 ' C ' ' A' 1006 ' ' LEU . 8.7 tt -155.87 139.77 16.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.498 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -87.51 -57.72 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 169.05 35.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.239 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' 1008 ' ' GLY . 49.5 t-20 176.65 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.39 0.614 . . . . 0.0 109.988 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -143.96 143.64 31.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.89 143.87 35.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.0 p80 -157.72 148.83 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.806 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.469 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.1 m95 -64.38 140.18 58.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -54.26 -30.48 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.811 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' ND1' ' A' ' 999' ' ' HIS . 63.0 p -140.82 143.31 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 111.712 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 58.0 mtpt -51.26 146.09 12.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 28.0 Cg_exo -61.92 118.8 5.7 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.446 2.097 . . . . 0.0 111.856 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.472 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 35.7 Cg_endo -65.99 145.89 80.92 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.544 2.162 . . . . 0.0 112.569 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.71 -149.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.247 0.546 . . . . 0.0 110.846 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' 1019 ' ' ILE . 74.7 m -154.76 138.75 16.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.188 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 997' ' ' ILE . 3.8 tt0 -147.13 129.57 15.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.902 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -48.56 130.1 16.79 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.449 0.642 . . . . 0.0 111.466 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.442 HG12 ' HB3' ' A' ' 995' ' ' ARG . 73.8 mt -75.26 128.45 84.53 Favored Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.154 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.776 2.317 . . . . 0.0 112.303 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.794 0.33 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 11.0 m80 69.8 134.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 10.9 p -80.79 119.16 23.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.818 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.53 -176.81 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.402 . . . . 0.0 111.042 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 922' ' ' PHE . . . -49.02 127.03 14.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.329 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.518 ' HG3' HD22 ' A' ' 928' ' ' LEU . 64.7 Cg_endo -73.33 70.16 3.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.809 2.34 . . . . 0.0 112.162 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.2 t0 35.21 -132.06 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.494 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.447 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 1.4 m-70 -156.97 121.82 4.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.661 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.94 139.52 30.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.714 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.6 OUTLIER -102.14 -45.63 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.562 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.422 ' C ' ' HG3' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -80.62 9.66 5.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.969 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.31 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.478 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.62 133.86 40.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.593 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.702 HD21 HG23 ' A' ' 917' ' ' THR . 65.0 tp -47.07 161.0 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.686 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.447 ' N ' ' HG ' ' A' ' 913' ' ' LEU . 31.0 mmmt -144.33 -52.29 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 928' ' ' LEU . 4.3 m -68.78 137.09 53.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -62.35 123.35 18.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 913' ' ' LEU . 49.7 p -83.42 136.06 34.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.029 0.443 . . . . 0.0 111.989 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 70.8 p -90.1 79.5 6.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.547 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 64.57 -154.54 0.3 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.082 0.468 . . . . 0.0 111.96 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.6 p -85.79 -46.07 11.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.38 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.3 120.88 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 54.7 m-85 -102.31 135.47 19.59 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.54 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 74.3 Cg_endo -74.26 133.2 17.44 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.739 2.293 . . . . 0.0 111.446 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 947' ' ' ASP . 50.5 mt -56.89 144.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.933 0.397 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' ' 945' ' ' CYS . . . 101.6 -35.19 5.08 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.54 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 24.0 m -56.17 128.59 36.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.442 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 79.3 p -101.47 123.84 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.518 HD22 ' HG3' ' A' ' 905' ' ' PRO . 8.1 tp -102.74 119.85 39.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.99 140.85 29.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.188 0.518 . . . . 0.0 112.07 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.44 ' CE1' HD23 ' A' ' 928' ' ' LEU . 26.7 m-85 -133.95 133.51 41.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 931' ' ' GLU . 14.9 pt-20 -92.84 121.73 34.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.995 0.426 . . . . 0.0 111.279 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.76 153.86 19.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 78.5 mtp180 -81.35 145.37 55.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.604 0.24 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 936' ' ' TYR . 70.9 Cg_exo -49.23 -42.74 39.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.346 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.88 24.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 24.3 m-85 -142.04 139.81 32.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.95 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.501 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 7.9 p90 -93.26 134.7 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.412 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 133.9 148.44 5.83 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.701 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.0 ptp180 -72.52 166.24 43.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.478 0.18 . . . . 0.0 110.543 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 42.2 Cg_endo -68.38 122.85 9.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.327 2.018 . . . . 0.0 112.112 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.573 ' CD2' ' HB ' ' A' ' 957' ' ' VAL . 48.8 p90 -91.29 -165.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.9 p -175.29 137.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -91.27 176.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.2 m -161.37 127.54 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 62.2 m -71.64 117.26 12.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 85.7 mt -87.55 -53.53 4.75 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.657 ' HA ' HD13 ' A' ' 924' ' ' ILE . 53.8 t0 171.06 -39.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.221 0.326 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -83.54 34.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.48 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.7 mp 50.77 47.39 24.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.345 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.0 148.54 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 111.087 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 94.2 m95 -89.65 46.66 1.39 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.76 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 953' ' ' SER . 37.8 t 49.03 29.73 2.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.2 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 952' ' ' SER . 19.8 m 34.58 100.44 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.611 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 133.98 54.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.371 2.047 . . . . 0.0 112.797 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -159.1 135.94 9.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 60.6 t0 56.54 67.09 1.04 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 19.6 m -147.75 68.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.513 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 957' ' ' VAL . 80.8 m 77.28 144.54 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.322 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 95.0 mttt -142.17 166.9 23.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -53.29 119.07 4.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 -179.053 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 39.8 tptt -56.22 148.69 17.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.433 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 54.6 p -149.44 125.04 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.95 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.428 ' O ' HD12 ' A' ' 980' ' ' ILE . 2.1 p -82.23 141.07 33.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.851 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.78 137.42 57.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.079 0.466 . . . . 0.0 111.141 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.4 m -53.69 126.61 49.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.647 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.626 ' HG2' HG11 ' A' ' 974' ' ' VAL . 28.9 Cg_endo -62.78 125.79 16.77 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.335 2.023 . . . . 0.0 111.878 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.24 134.47 60.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.209 1.939 . . . . 0.0 111.425 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -56.34 117.13 14.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.749 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 970' ' ' VAL . 22.3 Cg_exo -65.28 -146.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.873 2.382 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.87 ' HB ' ' HB2' ' A' 1020 ' ' CYS . 2.5 t -57.75 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.148 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.591 ' H ' HG12 ' A' ' 970' ' ' VAL . 34.8 m120 -72.33 68.53 0.76 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.506 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.408 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -164.96 -160.2 12.12 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.716 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 179.84 144.12 0.17 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.973 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.673 HG21 HD12 ' A' ' 986' ' ' ILE . 9.9 p -94.32 138.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.15 0.5 . . . . 0.0 111.309 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -120.14 117.92 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.909 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.8 t -70.14 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 31.3 mm -75.13 -43.24 44.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 77.6 p -147.03 -53.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.649 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.788 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 48.5 m-20 -157.57 151.01 23.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.102 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.46 HG22 ' HH2' ' A' 1013 ' ' TRP . 18.7 pt -88.34 32.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.781 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.788 ' NE2' ' HB3' ' A' ' 979' ' ' ASP . 2.1 mp0 -78.4 142.11 37.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.061 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' 1005 ' ' ILE . 80.1 t -50.39 104.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.937 0.398 . . . . 0.0 111.32 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 151.5 -51.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.431 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' 1003 ' ' GLU . 80.5 p -76.27 -152.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 0.0 111.046 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -151.4 178.37 9.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.235 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 974' ' ' VAL . 26.9 pt -142.0 129.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.524 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -98.26 138.57 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.587 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.572 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 8.8 m-85 -105.79 151.23 24.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.69 114.18 5.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 111.275 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 75.0 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 971' ' ' ASN . 6.2 t -64.52 146.71 54.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.718 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.3 m -44.26 130.32 6.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.428 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.14 -49.81 0.89 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -102.02 139.67 37.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.683 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.756 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.8 ptt85 -91.45 140.28 29.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.344 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.9 tt -71.79 130.44 41.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.9 mp -100.34 133.64 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.73 -155.41 25.66 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.454 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.676 ' O ' ' HG3' ' A' 1018 ' ' PRO . 14.6 m170 -82.98 125.29 31.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.522 0.201 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 43.8 t -73.6 12.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.0 p -156.82 150.74 24.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.407 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -152.03 135.87 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 984' ' ' SER . 38.4 tt0 -95.15 128.92 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.434 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 44.8 t -71.28 122.87 21.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.504 ' HA ' HG13 ' A' ' 982' ' ' VAL . 32.4 pt -133.64 -151.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.728 ' HG ' ' H ' ' A' 1008 ' ' GLY . 19.4 tp -151.11 131.38 13.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.395 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.671 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 37.7 t -93.01 31.69 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.728 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 77.22 -48.74 2.84 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.701 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.52 -44.94 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.789 0.328 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.581 ' C ' HD12 ' A' 1006 ' ' LEU . 88.7 m -146.63 148.07 31.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.427 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.4 139.35 38.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.97 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.671 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.8 p80 -158.11 154.17 27.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.46 ' HH2' HG22 ' A' ' 980' ' ' ILE . 75.9 m95 -64.21 145.58 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -59.57 -30.45 68.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.433 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.506 HG21 ' ND1' ' A' ' 999' ' ' HIS . 65.7 p -140.59 142.97 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.119 0.485 . . . . 0.0 112.089 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 5.8 ttpm? -55.1 139.35 64.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.755 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.11 128.46 22.44 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.524 2.149 . . . . 0.0 112.701 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.676 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 35.7 Cg_exo -57.36 147.02 79.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.019 2.479 . . . . 0.0 112.408 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 29.8 mt -103.0 132.89 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.722 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.87 ' HB2' ' HB ' ' A' ' 970' ' ' VAL . 71.4 m -86.37 123.17 31.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -143.81 130.59 20.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.472 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' 1022 ' ' ARG . 41.2 ttp85 -45.19 133.88 6.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 111.832 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.756 HG12 ' HB3' ' A' ' 995' ' ' ARG . 53.6 mt -74.94 129.01 84.13 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.908 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.73 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.941 0.4 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.461 ' C ' HD22 ' A' ' 949' ' ' LEU . 66.1 m80 -155.31 141.31 18.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 87.7 m -81.03 128.18 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -68.12 171.6 6.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.183 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.06 132.38 3.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 943' ' ' ILE . 15.7 Cg_exo -68.75 63.19 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.17 2.58 . . . . 0.0 112.589 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 50.6 t0 33.95 -135.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 38.9 m80 -152.54 119.24 5.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.963 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 9.6 m-85 -85.29 136.81 33.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.158 0.504 . . . . 0.0 111.368 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.739 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 1.8 mm? -84.99 -51.65 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.2 OUTLIER -86.13 15.09 5.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.316 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -153.62 155.77 36.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.343 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.639 ' HE2' ' NE ' ' A' ' 933' ' ' ARG . 68.2 mttm -136.51 134.11 37.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -49.43 149.75 2.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.173 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.834 ' HG3' ' HG2' ' A' ' 931' ' ' GLU . 31.2 mmmt -143.22 -35.81 0.39 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 915' ' ' THR . 56.5 m -69.89 65.04 0.22 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 917' ' ' THR . 17.0 pt20 37.2 -148.43 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 916' ' ' GLN . 15.1 t 50.87 139.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 113.027 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 77.5 p -146.18 15.84 1.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.685 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -74.49 174.96 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t -89.74 -51.47 5.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.3 145.16 27.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 917' ' ' THR . 31.7 m-85 -136.25 136.72 22.98 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.414 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.407 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.4 Cg_endo -69.3 140.95 45.72 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.737 2.291 . . . . 0.0 111.867 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.675 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.0 mt -56.74 155.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.4 -40.79 3.08 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.407 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 46.9 m -56.37 137.66 52.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.511 -0.345 . . . . 0.0 111.119 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 78.6 p -131.35 134.82 46.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.656 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 913' ' ' LEU . 2.7 mm? -99.08 136.63 38.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.021 0.439 . . . . 0.0 111.786 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.642 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 4.4 tppp? -88.18 135.46 33.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.409 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 13.3 m-85 -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.373 . . . . 0.0 111.227 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.834 ' HG2' ' HG3' ' A' ' 914' ' ' LYS . 5.2 mm-40 -97.38 132.74 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.3 m -59.7 137.53 58.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.739 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.2 mtp180 -87.53 156.89 53.27 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 10.3 Cg_endo -51.24 139.47 44.04 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.539 2.159 . . . . 0.0 111.317 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.642 ' HB3' HG11 ' A' ' 982' ' ' VAL . 90.3 mt-10 83.34 27.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.888 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.585 ' C ' ' HE2' ' A' ' 961' ' ' LYS . 95.7 m-85 -148.23 129.28 14.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.74 ' HB3' ' HZ3' ' A' ' 961' ' ' LYS . 1.4 p90 -101.18 142.0 33.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.066 0.46 . . . . 0.0 111.334 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.56 -130.34 2.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.393 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.439 HH11 ' HG2' ' A' ' 939' ' ' ARG . 4.3 ptp85 -166.14 156.75 11.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.506 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 37.5 Cg_exo -59.99 108.62 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.447 2.098 . . . . 0.0 112.434 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.642 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 36.2 p90 -95.51 -168.72 1.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.525 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.04 127.48 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 905' ' ' PRO . 17.4 pt -97.63 120.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.107 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 946' ' ' LEU . 54.9 m -91.19 134.83 34.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.675 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -73.72 118.23 16.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 109.995 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.903 HD23 HG23 ' A' ' 950' ' ' VAL . 2.1 mm? -87.13 171.61 10.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.255 1.026 . . . . 0.0 113.242 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.72 -43.2 68.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.367 -1.742 . . . . 0.0 111.682 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -83.85 29.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.73 HD21 ' HB1' ' A' ' 900' ' ' ALA . 29.7 mt 48.12 63.13 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.697 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.903 HG23 HD23 ' A' ' 946' ' ' LEU . 9.4 m -135.81 -164.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.408 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 98.1 m95 -144.12 46.69 1.43 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.24 0.543 . . . . 0.0 111.487 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.427 ' H ' HD23 ' A' ' 946' ' ' LEU . 79.4 p 40.08 26.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.289 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 955' ' ' LYS . 45.5 t 35.34 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.002 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.46 137.64 31.91 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.356 2.037 . . . . 0.0 112.751 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 0.1 OUTLIER -159.09 134.87 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.272 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.9 t70 59.28 82.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.436 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -148.64 -107.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.863 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.625 ' H ' HG23 ' A' ' 957' ' ' VAL . 56.8 m -81.75 57.52 3.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 0.0 110.751 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.884 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.5 mmpt? -55.41 155.45 5.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.203 0.525 . . . . 0.0 112.142 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.592 ' CG ' ' HB3' ' A' ' 981' ' ' GLN . 19.6 tpp180 -55.11 116.45 2.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.249 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.931 ' HG3' ' H ' ' A' ' 962' ' ' SER . 15.0 tppt? -61.11 -176.12 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.929 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.931 ' H ' ' HG3' ' A' ' 961' ' ' LYS . 80.6 p -149.75 -155.96 0.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.147 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.689 ' HA ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -154.74 33.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.621 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 60.62 128.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 15.8 m -59.76 135.78 89.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.432 ' CG ' HG11 ' A' ' 974' ' ' VAL . 9.6 Cg_endo -50.94 136.49 44.01 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 112.121 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.2 Cg_endo -75.11 47.43 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.697 2.264 . . . . 0.0 112.773 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 967' ' ' PRO . 11.2 p-10 22.77 78.9 0.2 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.67 0.606 . . . . 0.0 112.121 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.46 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 98.2 Cg_exo -43.89 142.16 3.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.719 2.28 . . . . 0.0 112.449 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 970' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.86 127.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.633 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 32.3 m120 47.65 48.72 16.99 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.065 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -133.14 -152.5 6.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.388 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.412 ' HB3' ' HE2' ' A' ' 973' ' ' MET . 42.4 ttp 176.19 141.87 0.07 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 987' ' ' THR . 10.5 p -136.98 127.85 40.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.972 0.415 . . . . 0.0 111.719 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -87.76 114.86 24.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.878 ' HA ' HG22 ' A' ' 986' ' ' ILE . 81.7 t -65.44 -24.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.138 0.494 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.568 HD11 HG22 ' A' ' 987' ' ' THR . 14.0 mm 74.46 -49.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.15 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 63.8 p -149.51 -60.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 984' ' ' SER . 11.7 p-10 -159.42 144.71 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.307 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.623 HG23 HG13 ' A' ' 976' ' ' VAL . 8.2 pt -85.99 19.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.252 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.592 ' HB3' ' CG ' ' A' ' 960' ' ' ARG . 29.1 mt-30 -80.87 156.48 26.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.788 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 935' ' ' GLU . 57.0 t -55.79 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.48 26.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.643 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 70.2 m -163.89 139.57 6.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.311 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ptt85 -100.12 131.22 46.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.132 0.491 . . . . 0.0 112.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 976' ' ' VAL . 40.9 pt -100.3 126.21 53.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.583 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.568 HG22 HD11 ' A' ' 977' ' ' ILE . 3.3 t -104.56 160.14 15.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.34 0.591 . . . . 0.0 111.583 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.478 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 3.6 m-85 -114.97 153.39 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.5 p -148.61 69.67 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.625 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 84.6 m -44.51 145.6 0.84 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 19.2 p -65.12 149.32 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 82.2 m -44.56 -37.49 3.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.928 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -57.26 -56.39 25.3 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.151 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.832 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 2.3 m80 -95.56 143.23 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.748 HH21 HG23 ' A' 1023 ' ' ILE . 14.3 ptp180 -88.83 138.72 31.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.982 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 997' ' ' ILE . 8.1 tt -71.85 138.07 47.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.312 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.616 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.9 mp -117.62 137.32 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.79 -143.39 18.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.019 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 996' ' ' LEU . 19.4 m170 -81.47 -134.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.633 0.254 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.529 ' HA ' ' HG2' ' A' 1018 ' ' PRO . 48.3 t -170.9 -54.66 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.84 0.352 . . . . 0.0 110.522 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.9 p -91.3 142.14 28.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.438 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -156.61 122.33 4.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.791 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.31 139.86 31.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 982' ' ' VAL . 15.2 t -69.52 122.83 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' 1006 ' ' LEU . 20.6 pt -139.48 142.29 33.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.91 HD13 ' N ' ' A' 1007 ' ' SER . 3.4 tm? 45.73 148.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.236 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.91 ' N ' HD13 ' A' 1006 ' ' LEU . 20.4 m -156.9 -95.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.561 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.73 ' H ' ' HE3' ' A' ' 961' ' ' LYS . . . 60.8 -109.78 2.6 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -66.89 -32.13 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.637 ' O ' ' HA ' ' A' 1007 ' ' SER . 17.6 m -148.94 119.91 7.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.609 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -86.88 138.48 31.52 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.646 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.3 OUTLIER -152.07 131.52 12.97 Favored 'General case' 0 C--N 1.337 0.057 0 C-N-CA 119.413 -0.915 . . . . 0.0 113.268 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 80.4 m95 -70.28 165.05 23.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.178 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.519 ' HA ' HD11 ' A' 1005 ' ' ILE . 88.8 p -63.19 -34.79 78.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.43 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 70.2 p -146.27 143.91 29.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.89 144.9 73.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.033 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 28.2 Cg_exo -62.19 127.13 20.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.716 2.277 . . . . 0.0 112.75 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.529 ' HG2' ' HA ' ' A' 1000 ' ' SER . 34.4 Cg_exo -61.52 150.39 85.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.466 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 51.0 mt -98.92 136.77 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.484 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 73.5 m -99.13 79.58 2.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 997' ' ' ILE . 41.9 tt0 -90.92 118.9 30.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.616 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 15.1 ptp180 -41.54 142.59 0.59 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.54 0.685 . . . . 0.0 111.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.748 HG23 HH21 ' A' ' 995' ' ' ARG . 70.7 mt -74.4 133.7 77.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.885 2.39 . . . . 0.0 112.489 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.887 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.729 0.299 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 921' ' ' ASP . 52.6 m80 -153.47 144.84 23.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.752 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 99.4 m -80.8 128.92 34.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 903' ' ' GLN . . . . . 0.579 ' CD ' ' H ' ' A' ' 903' ' ' GLN . 0.4 OUTLIER -68.99 157.13 37.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.648 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -43.19 131.44 3.38 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.041 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.4 -160.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 907' ' ' HIS . 4.2 t0 -173.6 151.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 906' ' ' ASP . 48.1 m80 70.11 68.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.369 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.485 ' CZ ' HD13 ' A' ' 943' ' ' ILE . 11.4 m-85 -139.91 43.63 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.582 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.532 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 15.7 mt -70.25 -32.29 70.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.281 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.21 10.67 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.618 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.52 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.669 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.3 120.88 33.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 915' ' ' THR . 1.3 tt -49.17 129.25 17.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.163 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.622 ' HB2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -86.48 -52.29 5.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.636 ' O ' HD22 ' A' ' 913' ' ' LEU . 47.6 m -64.59 138.34 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.253 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 916' ' ' GLN . 2.7 pp0? -61.94 141.56 57.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.899 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 70.5 p -151.67 149.33 28.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 93.8 m -154.04 -41.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 152.04 44.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.1 p -84.99 -44.41 13.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 921' ' ' ASP . . . . . 0.585 ' HB2' ' HB2' ' A' ' 901' ' ' HIS . 12.1 p-10 -85.36 132.33 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -118.68 138.89 26.39 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.407 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.469 ' O ' ' HB ' ' A' ' 926' ' ' THR . 25.4 Cg_endo -61.4 137.32 69.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.603 2.202 . . . . 0.0 112.062 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 20.8 mt -60.97 154.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.347 . . . . 0.0 110.846 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.68 -38.09 2.8 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 923' ' ' PRO . 19.9 m -56.0 131.82 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.02 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 49.7 m -111.3 130.52 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 942' ' ' SER . 94.5 mt -96.53 128.26 43.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 16.3 tppt? -85.16 137.59 32.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.031 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.505 ' CE2' ' HG ' ' A' ' 913' ' ' LEU . 20.5 m-85 -132.31 131.43 41.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.622 ' HG3' ' HB2' ' A' ' 914' ' ' LYS . 45.8 mt-10 -95.18 114.0 25.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.39 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 1.5 t -58.03 144.59 39.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 4.4 ptm180 -82.7 158.88 64.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.93 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 933' ' ' ARG . 39.5 Cg_endo -66.2 68.6 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.203 2.602 . . . . 0.0 113.484 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -172.41 -2.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.091 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.523 ' HB2' ' SG ' ' A' ' 932' ' ' CYS . 44.1 m-85 -142.04 134.91 28.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.264 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.651 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 9.4 p90 -102.1 138.61 38.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.562 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.31 8.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.168 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.434 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 71.1 mtt-85 63.62 157.5 0.12 Allowed Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 38.2 Cg_endo -66.68 116.62 4.19 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.2 1.934 . . . . 0.0 111.352 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.593 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 49.5 p90 -93.56 -160.82 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.197 0.522 . . . . 0.0 111.812 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.2 p -172.84 130.05 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.13 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.485 HD13 ' CZ ' ' A' ' 908' ' ' PHE . 39.6 pt -95.85 117.57 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.876 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 946' ' ' LEU . 52.0 m -84.04 128.96 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.3 t -73.81 121.6 21.12 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.1 mm? -85.34 167.92 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 0.0 113.318 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -51.73 -42.66 62.46 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.014 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.569 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.0 m-80 -84.45 32.46 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.707 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.887 HD21 ' HB1' ' A' ' 900' ' ' ALA . 24.4 mt 48.25 56.29 7.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.669 HG23 HD23 ' A' ' 946' ' ' LEU . 30.0 m -138.43 -157.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 112.38 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' A' ' 953' ' ' SER . 50.5 m95 -150.1 125.75 10.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.637 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.488 ' H ' HD21 ' A' ' 946' ' ' LEU . 79.8 p -68.54 27.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 951' ' ' TRP . 30.3 t 51.81 129.52 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 14.7 Cg_exo -69.95 69.83 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.086 2.524 . . . . 0.0 111.912 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -79.46 131.59 36.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.075 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 9.8 t70 55.1 72.66 0.46 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.512 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 18.1 m -150.9 -17.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.856 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 9.0 m -152.18 48.36 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.9 mmtp -56.55 143.81 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.495 ' HA ' ' CD2' ' A' ' 936' ' ' TYR . 38.8 ttm180 -53.23 132.33 38.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.655 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.651 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 0.0 OUTLIER -56.29 154.57 7.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.813 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 981' ' ' GLN . 80.3 p -149.8 136.27 19.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.847 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 66.7 m -81.65 36.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.0 tptt 61.08 133.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.565 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.629 ' HA ' HD12 ' A' ' 980' ' ' ILE . 21.6 m -54.48 127.73 58.87 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.257 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.405 ' HG3' HD13 ' A' ' 986' ' ' ILE . 55.1 Cg_endo -68.37 124.87 12.14 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.604 2.203 . . . . 0.0 112.736 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 129.2 16.83 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.189 1.926 . . . . 0.0 111.099 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 37.8 m-20 -57.95 120.68 44.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.878 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 33.2 Cg_exo -61.28 145.83 98.01 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 112.036 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 25.7 t -49.34 124.65 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.819 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 34.6 m120 75.87 -48.65 0.6 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -78.44 -151.78 5.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.5 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.533 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.7 pmm? 177.21 142.81 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.69 0.281 . . . . 0.0 110.818 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.684 HG21 HD12 ' A' ' 986' ' ' ILE . 14.9 p -93.67 129.57 43.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.868 0.366 . . . . 0.0 110.676 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -91.52 121.73 33.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.81 104.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.435 HD11 ' OG1' ' A' ' 987' ' ' THR . 3.0 mt -74.38 -38.69 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 79.8 p -144.73 -58.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 984' ' ' SER . 2.8 p30 -159.91 140.97 12.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.143 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -86.67 -5.4 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.293 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.709 ' HG3' ' HB3' ' A' ' 962' ' ' SER . 3.9 mp0 -76.12 156.4 33.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.655 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.12 97.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.382 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.73 19.26 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.221 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' 1003 ' ' GLU . 26.2 t -165.12 -165.39 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.044 0.422 . . . . 0.0 111.34 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.527 ' HG3' ' C ' ' A' 1002 ' ' ALA . 55.6 ttp180 -147.79 136.74 22.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.684 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -97.83 138.08 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.435 ' OG1' HD11 ' A' ' 977' ' ' ILE . 7.6 p -106.23 129.92 54.19 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.691 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 13.3 m-85 -96.48 152.73 18.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.216 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 59.1 m -148.2 129.65 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.68 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.441 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.751 HG22 ' SG ' ' A' 1020 ' ' CYS . 8.8 t -171.01 149.42 2.93 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 993' ' ' GLY . 10.7 m 8.81 -118.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.12 0.887 . . . . 0.0 113.218 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1022 ' ' ARG . . . -77.03 48.93 2.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.612 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.594 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 6.7 m80 -137.21 134.76 36.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.339 . . . . 0.0 110.19 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.561 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.3 ptm180 -94.5 135.7 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' 1018 ' ' PRO . 7.0 tt -68.58 132.26 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.2 mp -100.11 138.49 24.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 85.61 -131.3 10.38 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.569 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -79.07 -131.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.227 0.211 . . . . 0.0 111.484 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.4 p -175.16 -28.43 0.01 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.932 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.7 p -150.91 150.08 30.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.704 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.527 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.02 133.71 14.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 984' ' ' SER . 42.3 tt0 -96.23 133.42 40.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.403 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.7 t -71.18 121.04 17.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.84 -157.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.402 . . . . 0.0 111.767 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 58.7 tp -150.85 134.39 16.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.25 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.2 t -88.8 -48.13 7.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.369 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.98 -51.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.154 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -91.27 -38.36 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.42 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 83.8 m -145.47 145.49 31.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.47 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.11 147.82 32.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.9 p80 -158.7 148.59 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.425 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 86.2 m95 -64.41 145.15 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.767 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -53.0 -33.07 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.641 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 69.3 p -145.13 141.65 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.687 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.1 137.55 73.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 988' ' ' TYR . 51.1 Cg_exo -53.68 126.7 22.72 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.533 2.155 . . . . 0.0 112.319 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.629 ' HB2' HD21 ' A' ' 996' ' ' LEU . 39.9 Cg_endo -67.11 -159.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.41 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.768 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -140.67 -161.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.768 ' H ' HG22 ' A' 1019 ' ' ILE . 44.5 t -158.69 131.24 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 4.5 tt0 -153.44 135.24 14.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.66 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 51.1 ttp180 -48.97 134.89 16.48 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 111.532 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.7 mt -74.89 128.82 84.53 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.959 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 42.6 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.709 2.273 . . . . 0.0 112.358 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 949' ' ' LEU . 48.7 m80 -149.66 127.5 11.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.382 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 7.8 p -82.26 114.5 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 903' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 921' ' ' ASP . 18.3 pt20 -66.86 178.39 1.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -48.13 131.52 12.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.005 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.4 Cg_exo -62.1 -164.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.547 2.165 . . . . 0.0 112.325 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.12 -14.47 61.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.391 0.615 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 74.2 t60 62.26 114.42 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.582 ' HZ ' ' HG2' ' A' ' 954' ' ' PRO . 49.4 m-85 -90.0 133.56 34.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.254 0.55 . . . . 0.0 111.268 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.1 mp -70.43 -45.74 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.125 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.698 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 2.3 p90 -82.8 31.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.071 0.462 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.09 121.39 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.879 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -96.54 129.76 43.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -44.85 144.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 22.8 tptm -135.09 -38.93 0.77 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.459 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.575 ' O ' HD11 ' A' ' 913' ' ' LEU . 95.9 m -64.56 136.41 57.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.702 0.287 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.455 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 19.4 mp0 -50.94 125.11 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.803 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.464 HG22 HD11 ' A' ' 913' ' ' LEU . 7.0 t -159.43 148.39 18.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 918' ' ' THR . 20.7 m -156.85 47.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.387 0.613 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -169.55 164.03 10.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.717 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 37.0 t -84.56 -39.47 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 921' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 903' ' ' GLN . 37.6 p-10 -85.01 118.81 24.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 17.0 m-85 -101.17 139.36 20.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.784 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.589 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 38.3 Cg_endo -66.42 139.17 53.16 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.732 2.288 . . . . 0.0 112.104 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.673 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 61.4 mt -61.3 151.91 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.31 -31.25 3.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.886 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.589 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 17.1 m -56.01 131.05 46.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.023 0.44 . . . . 0.0 111.982 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 942' ' ' SER . 74.8 p -90.96 116.66 28.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.672 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.638 HD23 ' OH ' ' A' ' 930' ' ' TYR . 11.7 tp -96.28 97.87 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 38.3 ttpt -82.52 131.03 35.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.31 0.576 . . . . 0.0 112.157 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.842 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 17.9 m-85 -113.78 139.17 49.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.473 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 5.0 mm-40 -91.41 118.42 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.73 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 75.3 m -57.67 143.2 42.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.6 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.698 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 94.5 mtt180 -84.89 160.78 54.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.092 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 5.9 Cg_endo -47.69 139.18 18.91 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.56 2.173 . . . . 0.0 112.096 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.551 ' HG2' HG11 ' A' ' 982' ' ' VAL . 90.0 mt-10 83.76 26.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.736 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.619 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 62.2 m-85 -145.75 148.19 32.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.302 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -137.56 -155.83 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.045 0.45 . . . . 0.0 111.839 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 78.69 33.16 38.84 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.713 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.6 ptp85 47.22 164.95 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.54 0.736 . . . . 0.0 112.962 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.713 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 70.9 Cg_endo -73.96 138.66 26.12 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.925 2.417 . . . . 0.0 112.808 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.893 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 43.6 p90 -95.4 120.82 36.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.371 0.605 . . . . 0.0 111.438 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 927' ' ' SER . 78.2 p -75.3 -37.33 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.762 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.506 ' O ' HG13 ' A' ' 943' ' ' ILE . 44.7 pt 49.23 104.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.393 0.616 . . . . 0.0 111.441 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 51.6 m -78.62 124.93 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.486 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 0.5 OUTLIER -73.74 130.77 40.67 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.085 0.469 . . . . 0.0 110.057 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.776 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -90.83 166.96 12.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.333 1.063 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 924' ' ' ILE . 9.4 t70 -50.23 -42.28 51.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.322 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.56 ' O ' HG13 ' A' ' 950' ' ' VAL . 16.4 p-10 -83.36 43.97 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.8 mp 44.68 53.52 7.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.089 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.776 HG23 HD23 ' A' ' 946' ' ' LEU . 26.3 m -133.91 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 111.115 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.57 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 84.9 m95 -150.95 125.74 9.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.0 t -41.58 152.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.7 t -77.19 118.54 72.64 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.582 ' HG2' ' HZ ' ' A' ' 908' ' ' PHE . 5.9 Cg_exo -79.51 58.24 6.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.468 2.779 . . . . 0.0 112.931 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -80.25 128.6 33.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.778 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 1.5 m-20 55.61 38.41 30.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.893 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 16.7 m -89.31 -35.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.908 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 48.4 t -152.92 60.77 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.5 mmtt -56.52 148.29 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.243 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 17.4 ttm105 -55.59 137.35 49.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 111.575 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.823 ' HD3' ' N ' ' A' ' 962' ' ' SER . 6.4 tmtt? -56.29 144.25 30.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.618 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.823 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 47.5 t -138.66 137.21 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.492 . . . . 0.0 111.099 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.21 148.45 32.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -65.49 139.01 58.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 111.301 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 60.3 m -58.32 135.95 85.12 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.194 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 974' ' ' VAL . 51.3 Cg_exo -53.31 146.68 39.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.422 2.081 . . . . 0.0 111.938 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 10.7 Cg_exo -72.22 46.31 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 0.0 112.687 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 8.4 t70 22.03 97.68 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.825 0.703 . . . . 0.0 112.476 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 968' ' ' ASP . 21.9 Cg_endo -60.43 145.25 99.05 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.491 2.128 . . . . 0.0 111.641 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 24.1 t -47.26 122.49 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' 1020 ' ' CYS . 33.0 m120 75.48 -43.11 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.86 151.18 45.54 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.101 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 68.4 mtm -146.76 132.23 18.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.317 . . . . 0.0 110.586 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 986' ' ' ILE . 14.8 p -98.66 129.93 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.927 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 122.05 38.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.654 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.644 ' HA ' HG22 ' A' ' 986' ' ' ILE . 98.0 t -70.62 136.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.302 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 986' ' ' ILE . 37.1 mm -82.92 64.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.933 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 6.6 p 76.4 -43.9 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -157.5 135.43 10.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.699 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 976' ' ' VAL . 20.3 pt -88.96 26.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.591 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 85.0 mt-30 -76.61 146.34 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.551 HG11 ' HG2' ' A' ' 935' ' ' GLU . 69.9 t -50.12 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.144 0.497 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 166.99 -62.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 84.6 p -81.71 -150.07 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.985 0.422 . . . . 0.0 110.225 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' 1002 ' ' ALA . 5.0 ptp85 -151.38 -165.87 2.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.875 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.644 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.4 pt -147.7 131.6 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.25 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' 1001 ' ' SER . 1.3 p -97.8 134.35 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 111.555 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 974' ' ' VAL . 3.7 m-85 -103.03 143.94 31.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.262 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -154.37 127.01 8.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.454 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 15.6 t -63.6 162.35 13.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 992' ' ' THR . 4.2 t -64.83 -53.72 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 991' ' ' THR . 12.2 t 173.84 147.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' 1023 ' ' ILE . . . 84.79 -40.9 3.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.926 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.541 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.1 m80 -100.51 143.51 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.067 0.433 . . . . 0.0 111.194 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -91.89 148.82 21.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.95 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 999' ' ' HIS . 10.2 tt -71.82 128.81 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 997' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.61 122.43 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 131.32 -57.83 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.908 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.574 ' O ' HD22 ' A' ' 996' ' ' LEU . 40.3 t-80 -162.2 -121.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.8 p 177.31 -22.82 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.537 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 987' ' ' THR . 48.9 m -155.22 159.18 39.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.772 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -151.96 130.14 11.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -94.81 135.11 36.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.204 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 26.2 t -72.67 121.53 19.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.9 pt -134.55 141.93 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.506 HD22 ' H ' ' A' ' 935' ' ' GLU . 49.4 tp -84.52 130.44 34.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.032 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.582 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 42.3 t -96.09 50.38 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 82.19 -37.05 2.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.483 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -147.93 -50.67 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 62.4 m -94.16 125.14 38.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 961' ' ' LYS . . . -82.61 136.19 34.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.561 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.582 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.9 p80 -157.73 148.91 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 22.0 m95 -68.59 145.45 53.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 64.2 m -55.35 -42.96 74.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.268 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.502 HG21 ' CD2' ' A' ' 999' ' ' HIS . 80.9 p -100.15 -148.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.176 0.513 . . . . 0.0 112.114 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.573 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -148.66 153.39 39.47 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.563 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.78 130.31 33.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.754 2.303 . . . . 0.0 112.713 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.511 ' HG3' HD11 ' A' ' 996' ' ' LEU . 79.1 Cg_endo -76.9 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.767 2.311 . . . . 0.0 112.696 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.09 142.0 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.379 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 32.9 m -81.49 129.77 34.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.541 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 18.2 tp60 -143.49 127.14 17.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 30.7 ptt85 -49.12 142.19 7.23 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.487 0.661 . . . . 0.0 111.38 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 993' ' ' GLY . 23.3 mt -74.75 131.51 79.36 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.182 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.741 2.294 . . . . 0.0 112.407 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.936 0.398 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 900' ' ' ALA . 21.2 m80 68.88 129.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.856 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.8 p -82.21 124.19 29.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.629 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -69.65 166.75 18.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.142 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 920' ' ' SER . . . -47.44 127.79 10.15 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.122 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.579 ' HG3' HD12 ' A' ' 928' ' ' LEU . 53.9 Cg_endo -69.47 133.13 25.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.389 2.06 . . . . 0.0 112.018 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.19 153.2 35.26 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.216 0.532 . . . . 0.0 111.161 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -78.29 139.29 38.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.92 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.417 ' O ' HD23 ' A' ' 909' ' ' LEU . 2.9 m-85 -89.48 -140.32 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.955 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 908' ' ' PHE . 63.1 mt -154.03 -38.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -6.3 59.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.683 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -157.85 128.81 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.324 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -98.81 135.06 40.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.839 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 930' ' ' TYR . 36.8 tp -48.86 125.35 10.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.372 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -94.52 -43.34 8.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 38.1 m -64.84 135.44 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.806 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.421 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -64.08 144.55 57.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.046 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.685 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 46.5 p -150.53 -86.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.419 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 917' ' ' THR . 91.3 m 73.26 -38.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.4 136.49 51.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.365 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 920' ' ' SER . . . . . 0.571 ' HA ' ' HB2' ' A' ' 904' ' ' ALA . 79.5 p -89.67 34.51 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.389 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.53 135.85 11.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.885 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.685 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 72.8 m-85 -143.4 138.36 15.43 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.46 140.48 12.01 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.913 2.409 . . . . 0.0 111.414 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.545 ' HA ' ' HB2' ' A' ' 945' ' ' CYS . 29.8 mt -51.59 141.18 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 110.583 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 105.8 -29.09 11.87 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.523 HG21 ' HD2' ' A' ' 922' ' ' PHE . 30.4 m -55.45 140.08 41.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.0 m -121.19 140.39 52.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.579 HD12 ' HG3' ' A' ' 905' ' ' PRO . 90.3 mt -132.36 118.94 20.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 39.4 ttmt -89.18 128.43 35.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.409 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.596 ' CE1' HD13 ' A' ' 913' ' ' LEU . 2.5 m-85 -110.99 129.18 55.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -97.58 129.41 44.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.5 m -56.75 160.01 3.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.558 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 67.6 mtt-85 -81.47 158.33 68.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.485 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 936' ' ' TYR . 68.9 Cg_exo -39.17 -55.64 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.922 2.415 . . . . 0.0 113.26 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 936' ' ' TYR . 14.4 pt-20 -75.23 36.51 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.56 ' CE1' ' HG3' ' A' ' 935' ' ' GLU . 56.4 m-85 -142.7 150.87 40.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.739 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 35.9 p90 -145.43 135.46 23.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.326 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 957' ' ' VAL . . . 153.16 28.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.17 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 80.6 mtp180 61.05 148.0 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.451 0.643 . . . . 0.0 112.239 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 939' ' ' ARG . 4.4 Cg_exo -75.18 123.04 7.49 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.263 2.642 . . . . 0.0 111.989 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.537 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 46.3 p90 -90.37 -161.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.615 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 135.93 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.425 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 4.6 pt -92.61 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -164.0 132.12 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 59.5 m -72.12 110.88 6.89 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 97.5 mt -83.41 -52.85 6.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.6 t70 174.32 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 110.905 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.449 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.5 m-80 -83.13 31.78 0.44 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 900' ' ' ALA . 78.3 mt 50.75 42.38 27.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 948' ' ' ASN . 19.9 m -137.44 150.91 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 121.632 0.73 . . . . 0.0 112.343 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 68.6 m95 -91.49 124.71 35.87 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.323 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.2 t -43.37 142.07 1.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t -79.86 113.08 34.91 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.702 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.07 67.12 6.05 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.49 2.793 . . . . 0.0 111.766 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -76.42 131.68 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.296 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.3 t70 57.87 96.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.802 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -152.85 -70.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.802 ' H ' HG23 ' A' ' 957' ' ' VAL . 80.9 m -88.44 140.62 29.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -143.12 127.21 17.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.188 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 981' ' ' GLN . 53.8 ttp180 -53.24 137.3 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.165 0.507 . . . . 0.0 112.042 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.739 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 32.1 mmmt -56.34 170.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.127 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.658 ' HB3' HE21 ' A' ' 981' ' ' GLN . 69.5 p -150.24 134.69 17.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.075 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 980' ' ' ILE . 83.0 m -81.58 144.26 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.085 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -65.89 134.84 53.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.45 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.7 m -54.48 117.31 12.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.31 129.98 15.67 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.402 2.068 . . . . 0.0 111.835 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.04 125.15 18.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.098 1.866 . . . . 0.0 111.507 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.25 126.55 82.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.81 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.01 142.68 82.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.549 2.166 . . . . 0.0 112.076 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.3 p -46.97 129.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.425 ' OD1' HG22 ' A' ' 970' ' ' VAL . 33.7 m120 63.74 47.2 3.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.796 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -166.96 -155.38 8.99 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.447 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 23.7 ptp 175.23 140.33 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.63 0.252 . . . . 0.0 111.013 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.875 HG21 HD12 ' A' ' 986' ' ' ILE . 8.4 p -93.84 135.41 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.769 0.318 . . . . 0.0 111.029 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -94.29 108.96 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.179 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -65.41 -22.83 31.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 985' ' ' ARG . 7.2 mm 73.88 -52.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.748 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 73.3 p -150.25 -56.68 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.484 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 31.0 m-20 -157.13 157.69 34.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.595 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.647 HG23 HG13 ' A' ' 976' ' ' VAL . 14.6 pt -95.51 32.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.664 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' A' ' 962' ' ' SER . 5.4 mp0 -79.22 151.15 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 961' ' ' LYS . 73.7 t -53.93 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.079 0.466 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 160.56 -46.52 0.4 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.7 m -78.72 135.91 37.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.742 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 55.6 ttp180 -98.24 132.32 43.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.875 HD12 HG21 ' A' ' 974' ' ' VAL . 28.6 pt -93.97 130.09 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.316 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.519 HG22 ' OG ' ' A' 1001 ' ' SER . 7.8 p -102.52 130.99 49.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.461 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.7 m-85 -95.15 145.35 25.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.195 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 88.9 p -148.64 121.44 8.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.744 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.99 149.27 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.7 t -64.32 146.02 55.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.491 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 88.5 m -46.42 125.14 6.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.257 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' 1023 ' ' ILE . . . 127.72 -46.81 1.06 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.464 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.9 m80 -100.19 140.24 34.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.618 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.5 ptm180 -92.36 144.13 25.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.371 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.8 tt -72.81 135.39 45.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.0 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.656 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.6 mp -115.07 139.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 90.47 -125.71 8.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.262 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -78.33 -134.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.463 0.173 . . . . 0.0 111.314 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.5 p -177.9 -27.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 987' ' ' THR . 50.0 m -151.63 153.0 33.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.577 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.58 128.9 11.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.742 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 20.5 pt-20 -95.66 137.85 34.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.805 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.26 95.89 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.604 HG23 ' HG3' ' A' 1003 ' ' GLU . 32.1 pt -103.56 -157.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.869 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' 1010 ' ' THR . 57.3 tp -153.68 137.73 16.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.474 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.509 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.8 t -90.03 -40.09 12.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.777 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -169.92 -34.08 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.45 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.485 ' C ' HD11 ' A' 1006 ' ' LEU . 14.4 p-10 -152.95 -40.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.528 ' O ' HD12 ' A' 1006 ' ' LEU . 70.5 m -91.2 130.08 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.608 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.98 141.02 37.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.106 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.0 p80 -157.01 145.95 20.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.33 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.4 m95 -68.27 141.89 55.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -57.74 -32.32 67.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.38 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 71.5 p -142.88 139.07 30.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.958 0.409 . . . . 0.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' 1017 ' ' PRO . 4.7 tmmm? -64.82 138.37 97.45 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.558 ' N ' ' HD2' ' A' 1016 ' ' LYS . 97.8 Cg_exo -44.75 134.74 10.15 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.964 2.443 . . . . 0.0 113.207 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 40.3 Cg_endo -66.54 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.861 2.374 . . . . 0.0 112.844 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 55.9 mt -141.09 144.85 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.837 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 74.2 m -103.89 123.97 48.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 0.6 OUTLIER -142.84 127.48 18.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.669 0.271 . . . . 0.0 110.754 -178.363 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 0.0 OUTLIER -49.66 136.95 16.46 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.447 0.642 . . . . 0.0 111.168 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 995' ' ' ARG . 16.0 mt -75.96 132.46 74.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.188 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.14 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.447 ' C ' HD22 ' A' ' 949' ' ' LEU . 74.0 m80 -156.04 141.08 17.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.276 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 92.1 m -81.05 128.6 33.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -76.14 172.14 13.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.397 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.1 126.06 7.15 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.984 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.693 ' HG2' HD23 ' A' ' 928' ' ' LEU . 50.5 Cg_exo -56.75 138.08 83.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.623 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.22 157.21 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -78.11 123.74 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.87 ' HB2' ' HB3' ' A' ' 911' ' ' ALA . 2.8 m-85 -85.22 24.1 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.25 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 14.1 mt 61.33 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.17 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.592 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -82.49 35.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.392 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 908' ' ' PHE . . . -154.48 143.12 20.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.228 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.28 144.61 32.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 915' ' ' THR . 59.3 tp -43.03 152.49 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.394 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.875 ' HA ' ' HE3' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -147.9 48.1 1.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.036 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 917' ' ' THR . 16.2 m -170.72 137.32 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -52.91 132.09 36.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.808 0.337 . . . . 0.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.833 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 82.7 p -152.88 57.9 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 85.0 m -51.5 -44.74 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.6 51.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 49.4 m -86.78 -41.57 14.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.87 145.98 27.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.382 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.833 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 37.9 m-85 -134.95 138.51 29.69 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 0.0 112.037 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.478 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 58.0 Cg_endo -70.59 141.1 41.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.367 . . . . 0.0 111.67 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.75 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.7 mt -56.53 143.05 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.994 0.425 . . . . 0.0 111.312 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.2 16.44 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.492 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 19.5 m -55.88 132.76 50.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 143.19 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.835 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.693 HD23 ' HG2' ' A' ' 905' ' ' PRO . 8.6 tp -135.18 125.19 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.29 134.22 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.515 ' HE1' HD23 ' A' ' 928' ' ' LEU . 8.5 m-85 -132.13 122.79 25.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.392 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -95.62 130.46 42.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.346 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 36.0 m -56.79 -173.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.401 . . . . 0.0 111.363 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.592 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 93.7 mtt180 -82.46 152.72 67.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.758 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 936' ' ' TYR . 91.9 Cg_exo -44.51 -40.01 13.28 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.78 2.32 . . . . 0.0 112.547 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.04 21.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 111.082 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.3 m-85 -142.75 137.22 29.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.486 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.473 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 3.7 p90 -102.12 36.56 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.215 0.531 . . . . 0.0 110.962 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . -83.87 139.74 18.81 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.79 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 37.1 ptt85 -72.89 163.52 67.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -63.63 112.69 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.352 2.035 . . . . 0.0 112.017 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.636 ' HB3' HG11 ' A' ' 957' ' ' VAL . 53.1 p90 -91.04 114.85 27.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.46 0.648 . . . . 0.0 110.612 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.2 p -79.58 122.09 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.955 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 954' ' ' PRO . 9.4 pt -97.46 -174.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 0.7 OUTLIER -166.82 134.42 2.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.75 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 52.7 t -66.53 116.16 7.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.648 HD11 ' HA ' ' A' ' 952' ' ' SER . 77.4 mt -80.96 -55.56 4.71 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.571 ' HA ' HD13 ' A' ' 924' ' ' ILE . 49.8 t0 173.21 -48.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.53 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -83.87 33.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.278 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 900' ' ' ALA . 40.4 mt 60.92 56.77 2.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.637 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 2.1 m -139.4 -163.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.219 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.554 ' HA ' ' O ' ' A' ' 944' ' ' THR . 74.7 m95 -145.41 125.03 13.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.766 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.648 ' HA ' HD11 ' A' ' 946' ' ' LEU . 47.5 t -38.59 135.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 79.9 p -76.97 111.38 16.04 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 943' ' ' ILE . 18.6 Cg_exo -65.85 132.64 31.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.576 ' HG2' ' H ' ' A' ' 956' ' ' ASP . 79.2 tttt -78.23 -134.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.576 ' H ' ' HG2' ' A' ' 955' ' ' LYS . 38.9 p-10 -78.98 127.0 31.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.847 0.356 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.636 HG11 ' HB3' ' A' ' 941' ' ' PHE . 21.0 m -150.36 -48.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.5 ' N ' HG23 ' A' ' 957' ' ' VAL . 71.3 m -84.18 138.17 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.4 mmtt -143.88 131.47 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 20.5 mmt180 -58.96 113.95 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.052 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.962 ' HE3' ' HB2' ' A' 1011 ' ' ALA . 38.3 ttpt -58.33 166.06 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.473 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 90.1 p -144.46 141.61 29.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.965 0.412 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.408 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 49.2 m -81.54 36.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.979 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 60.18 128.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 14.6 m -61.17 132.81 92.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.484 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.456 ' CG ' HG11 ' A' ' 974' ' ' VAL . 11.6 Cg_endo -55.37 135.68 70.2 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 112.384 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 968' ' ' ASP . 72.2 Cg_endo -76.23 52.31 3.47 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 967' ' ' PRO . 8.1 t70 29.59 102.03 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.24 0.616 . . . . 0.0 112.423 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.509 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 52.1 Cg_exo -52.62 143.97 44.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.743 2.295 . . . . 0.0 112.322 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' 1020 ' ' CYS . 6.4 p -53.04 133.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.484 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 34.3 m120 52.65 47.3 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.415 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.51 -158.77 16.21 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.631 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 176.29 140.42 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.151 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.576 HG21 HD12 ' A' ' 986' ' ' ILE . 7.2 p -99.82 128.77 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.483 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.5 OUTLIER -89.76 124.31 34.52 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 979' ' ' ASP . 87.3 t -76.4 124.55 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.5 mm -75.49 -41.65 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.9 p -144.71 -52.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.317 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.7 m-20 -153.33 -156.57 0.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 986' ' ' ILE . 15.8 pt -151.08 22.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 960' ' ' ARG . 4.8 mm100 -80.88 174.86 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' 1006 ' ' LEU . 88.0 t -58.83 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.91 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 146.99 -34.44 1.32 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.4 m -75.06 140.4 43.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.631 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' 1002 ' ' ALA . 38.8 ttm180 -104.16 150.63 24.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.576 HD12 HG21 ' A' ' 974' ' ' VAL . 40.8 pt -131.21 135.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' 1001 ' ' SER . 11.6 p -103.61 132.7 49.63 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.509 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 5.2 m-85 -98.7 145.63 26.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 989' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 46.8 t -152.32 119.13 5.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.028 0.442 . . . . 0.0 110.984 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 62.6 m -80.92 144.85 31.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.854 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.8 t -65.0 158.37 25.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.4 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.0 t -46.47 134.57 9.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.624 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 113.83 -51.01 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.979 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -101.88 141.3 34.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.524 ' O ' HD12 ' A' ' 997' ' ' ILE . 2.6 ptp180 -93.33 146.44 23.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.354 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' 1018 ' ' PRO . 10.0 tt -69.64 129.78 40.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.775 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -98.34 142.26 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.72 -133.57 11.89 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.945 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -78.63 -121.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 20.3 m -164.67 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.574 0.226 . . . . 0.0 111.177 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.575 ' HB3' HG22 ' A' ' 987' ' ' THR . 80.0 p -155.17 117.87 4.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.973 0.415 . . . . 0.0 111.274 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -91.09 179.45 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.478 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -145.41 132.13 19.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.339 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.3 t -71.19 122.35 20.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 982' ' ' VAL . 29.8 pt -138.38 148.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.179 0.514 . . . . 0.0 111.911 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' 1007 ' ' SER . 1.2 tt -88.47 129.86 35.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.496 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.651 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -89.98 -44.92 9.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -173.5 -32.27 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.993 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.63 -49.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 26.2 m -94.46 133.01 38.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.802 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.962 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.01 139.29 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.243 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.651 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -157.67 144.61 18.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 62.3 m95 -68.56 138.35 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.599 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.5 p -52.9 -28.42 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.674 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 53.2 p -141.54 142.43 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.639 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -56.63 153.97 19.32 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.751 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.19 122.15 8.97 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.302 2.001 . . . . 0.0 112.597 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.568 ' HB3' HD21 ' A' ' 996' ' ' LEU . 51.3 Cg_exo -54.42 148.8 40.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.779 2.319 . . . . 0.0 112.225 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.86 -159.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.752 ' H ' HG22 ' A' 1019 ' ' ILE . 84.5 m -153.31 134.69 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.011 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 997' ' ' ILE . 4.4 tt0 -151.85 136.85 17.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.26 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -48.02 133.59 14.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.374 0.607 . . . . 0.0 111.018 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 995' ' ' ARG . 60.0 mt -74.79 129.48 83.34 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.976 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 112.501 -179.868 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.559 ' C ' HD12 ' A' ' 949' ' ' LEU . 36.3 m80 -151.6 138.51 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.525 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 83.3 m -81.1 124.94 29.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.706 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -69.38 173.14 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.0 134.86 6.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.226 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 52.5 Cg_exo -54.07 149.4 35.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.525 2.15 . . . . 0.0 111.942 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 29.2 t0 -63.23 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.751 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.475 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 26.3 m80 -77.77 134.36 38.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.03 47.07 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.217 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.935 HD12 ' N ' ' A' ' 910' ' ' PHE . 4.2 pp -53.26 -34.44 57.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.4 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.935 ' N ' HD12 ' A' ' 909' ' ' LEU . 0.2 OUTLIER -87.11 26.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.485 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -155.09 129.98 9.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -101.62 126.2 48.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.382 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -55.49 119.89 6.34 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.536 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.645 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 74.4 mmtt -95.4 -39.04 10.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.651 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 916' ' ' GLN . 18.5 m -64.55 -119.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.142 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.505 ' N ' HG22 ' A' ' 915' ' ' THR . 12.0 tm0? -171.06 134.05 0.92 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.4 t -160.35 159.44 31.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.566 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.2 m -155.95 -31.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.403 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.3 158.74 35.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.03 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.3 p -84.67 -50.68 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.35 126.19 33.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.328 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 20.0 m-85 -102.0 134.13 20.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.439 . . . . 0.0 111.906 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.487 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 71.5 Cg_endo -73.36 137.36 25.58 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.833 2.355 . . . . 0.0 112.003 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.596 HG12 ' SG ' ' A' ' 945' ' ' CYS . 25.9 mt -59.99 151.58 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 93.94 -36.2 3.85 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.9 m -56.12 133.53 52.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.271 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 42.6 t -114.08 121.72 44.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.435 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.579 ' HB3' ' HE1' ' A' ' 930' ' ' TYR . 92.9 mt -103.38 124.82 49.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 17.1 tppt? -87.39 132.52 33.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.579 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 15.0 m-85 -135.27 123.03 22.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.544 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.979 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 90.4 mt-10 -103.29 129.59 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.691 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 74.2 m -54.09 168.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.548 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 77.6 mtp180 -79.03 148.46 71.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.53 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 936' ' ' TYR . 83.3 Cg_exo -45.45 -42.64 17.98 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.831 2.354 . . . . 0.0 112.682 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.431 ' CD ' HG11 ' A' ' 982' ' ' VAL . 4.2 mm-40 -73.33 20.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.227 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.6 m-85 -144.6 135.12 24.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.746 0.308 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -102.67 37.35 1.95 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 110.922 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -77.03 0.12 67.88 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.764 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 939' ' ' ARG . 62.0 mtt85 64.58 144.12 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.429 . . . . 0.0 111.353 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.979 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 19.6 Cg_exo -66.36 110.43 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.796 2.331 . . . . 0.0 112.505 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.431 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 52.3 p90 -95.54 -164.3 1.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.496 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.524 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 80.5 p -172.83 135.98 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 10.8 pt -97.01 166.26 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.838 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 946' ' ' LEU . 2.9 m -161.41 120.48 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.814 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 34.8 t -68.6 112.87 5.65 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 82.2 mt -83.79 -52.5 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 50.0 t0 173.49 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.787 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -85.9 36.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.471 0.653 . . . . 0.0 109.84 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 2.3 mm? 54.88 63.69 2.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.384 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 19.0 m -141.64 146.19 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 111.891 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.716 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 97.7 m95 -93.8 47.88 1.25 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.051 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 89.3 p 53.03 26.85 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t 38.23 75.16 0.57 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.23 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 951' ' ' TRP . 92.5 Cg_endo -79.84 53.71 4.86 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.429 2.086 . . . . 0.0 112.376 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.36 129.07 35.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.916 0.389 . . . . 0.0 110.71 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.3 t0 60.88 106.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.3 m -153.86 -56.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 1.035 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 72.6 m -83.55 141.53 31.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.042 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -143.03 148.12 36.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.268 0.556 . . . . 0.0 112.08 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 981' ' ' GLN . 10.8 tpt180 -53.48 113.9 1.32 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.366 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.711 ' HZ1' ' H ' ' A' 1011 ' ' ALA . 27.8 tptp -56.99 158.33 5.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.371 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.423 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 77.4 p -150.81 138.36 19.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.581 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 964' ' ' LYS . 65.4 m -81.6 35.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 963' ' ' CYS . 87.4 tttt 55.45 131.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.416 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 980' ' ' ILE . 24.3 m -54.11 129.05 58.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.526 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 72.8 Cg_endo -74.87 124.94 9.06 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.511 2.141 . . . . 0.0 112.67 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 15.5 Cg_exo -67.99 125.76 13.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.456 2.104 . . . . 0.0 111.533 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.24 128.53 91.21 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.243 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 970' ' ' VAL . 72.6 Cg_endo -76.26 -152.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.685 2.256 . . . . 0.0 111.979 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' 1020 ' ' CYS . 12.7 t -53.94 116.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.596 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 18.3 p30 39.53 32.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -67.02 177.56 19.05 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.111 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 50.6 ttm -175.45 73.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.323 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.7 p -90.35 122.05 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 111.328 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.62 131.61 41.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.166 0.507 . . . . 0.0 109.902 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.573 ' HB ' HG23 ' A' ' 980' ' ' ILE . 2.1 m -75.4 135.63 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.626 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.557 ' N ' HD12 ' A' ' 977' ' ' ILE . 2.5 mp -76.46 -32.14 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.475 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 977' ' ' ILE . 64.8 p -140.4 -66.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.0 t0 -162.16 14.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 965' ' ' THR . 29.3 pt 51.77 24.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.361 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 7.3 mm100 -80.93 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.654 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 14.7 t -55.51 130.31 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.333 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 96.26 -23.05 36.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.852 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' 1003 ' ' GLU . 52.3 m -74.61 -165.45 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.587 ' HE ' ' HB2' ' A' 1001 ' ' SER . 74.1 ttt180 -151.35 161.51 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.406 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 980' ' ' ILE . 20.3 pt -136.42 132.05 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' 1001 ' ' SER . 2.5 p -124.59 136.11 53.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 111.575 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -94.04 156.51 16.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.443 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 57.7 m -147.84 69.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 85.7 m -44.93 151.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.368 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 21.0 p -64.04 150.68 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -48.32 137.74 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.134 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' 1023 ' ' ILE . . . 106.02 -40.14 2.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.656 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 4.2 m80 -96.38 138.68 33.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.4 ptt180 -94.91 151.04 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.552 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 997' ' ' ILE . 0.4 OUTLIER -73.48 125.05 27.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.0 mp -103.05 138.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.707 0.289 . . . . 0.0 110.78 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 81.09 -125.13 6.72 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -78.57 -132.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.1 p -177.21 -30.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.606 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 987' ' ' THR . 83.3 p -150.93 167.51 27.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.56 139.03 14.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.5 tt0 -96.25 134.94 38.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.654 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 40.5 t -71.96 125.83 28.21 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.24 -155.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.805 0.336 . . . . 0.0 111.537 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 36.8 tp -152.05 124.75 8.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.643 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.3 t -91.35 -48.37 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' 1010 ' ' THR . . . 168.85 124.15 0.71 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.867 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.6 m120 71.38 -28.82 0.19 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' 1008 ' ' GLY . 96.7 m -145.43 135.43 23.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.774 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.711 ' H ' ' HZ1' ' A' ' 961' ' ' LYS . . . -82.25 149.07 28.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.643 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.4 p80 -157.93 151.37 23.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.538 ' CZ2' ' HB ' ' A' ' 980' ' ' ILE . 81.2 m95 -68.46 144.05 54.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.253 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -56.8 -31.06 64.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.673 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 80.8 p -144.06 138.41 28.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 111.923 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.57 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -66.45 155.74 87.61 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.182 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.16 135.31 52.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.759 2.306 . . . . 0.0 112.782 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 988' ' ' TYR . 53.6 Cg_endo -68.81 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.818 2.346 . . . . 0.0 112.605 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 54.4 mt -140.16 137.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -98.75 123.37 42.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 997' ' ' ILE . 36.3 tt0 -145.74 129.12 16.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.692 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 36.5 ttm180 -51.16 135.45 25.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.439 0.638 . . . . 0.0 111.475 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 995' ' ' ARG . 48.4 mt -74.92 125.78 89.0 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.627 2.218 . . . . 0.0 112.475 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.861 0.362 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.455 ' C ' HD22 ' A' ' 949' ' ' LEU . 50.9 m80 -153.86 143.93 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 66.1 m -80.47 122.95 27.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.596 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -68.14 170.68 8.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.687 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.35 133.18 5.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.945 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.48 ' HG3' ' OH ' ' A' ' 930' ' ' TYR . 26.6 Cg_endo -61.7 -168.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.642 2.228 . . . . 0.0 112.333 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 8.3 t70 -174.96 161.04 2.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.053 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.417 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 78.0 t60 72.11 62.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.587 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.695 ' O ' HD13 ' A' ' 909' ' ' LEU . 45.1 m-85 -146.01 120.15 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.084 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.0 OUTLIER -132.58 -45.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.012 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.97 13.87 3.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.126 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.475 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -152.0 126.81 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.115 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.546 ' HG3' ' HZ3' ' A' ' 914' ' ' LYS . 20.8 pttp -107.92 123.85 49.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.684 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -51.13 146.81 6.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.086 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.748 ' N ' HD13 ' A' ' 913' ' ' LEU . 42.6 mmtm -147.88 11.89 0.97 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 915' ' ' THR . . . . . 1.041 HG21 HD22 ' A' ' 928' ' ' LEU . 14.3 t -70.88 -151.18 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.879 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 915' ' ' THR . 0.7 OUTLIER -86.55 -44.45 11.91 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-O 121.221 0.534 . . . . 0.0 110.978 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 915' ' ' THR . 21.4 p 50.67 -121.12 1.7 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.187 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 916' ' ' GLN . 68.8 p 55.7 33.14 20.74 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.47 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.557 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.0 t -85.72 -49.37 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.744 0.306 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.74 126.01 33.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.593 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.482 ' CD2' HD21 ' A' ' 928' ' ' LEU . 36.0 m-85 -108.46 138.18 20.15 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.922 0.391 . . . . 0.0 111.756 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.526 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.1 Cg_endo -69.39 143.25 51.98 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.923 2.415 . . . . 0.0 112.302 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.1 mt -57.66 154.79 2.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.845 0.355 . . . . 0.0 110.914 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.81 -40.37 2.89 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.526 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.4 m -57.11 132.1 51.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.865 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 22.6 t -115.44 133.41 56.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 1.041 HD22 HG21 ' A' ' 915' ' ' THR . 78.3 mt -95.47 125.81 40.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.956 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.441 ' O ' HD22 ' A' ' 913' ' ' LEU . 40.4 ttmt -85.35 136.82 33.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.48 ' OH ' ' HG3' ' A' ' 905' ' ' PRO . 11.1 m-85 -128.75 131.28 47.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.61 123.03 44.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 80.5 m -57.25 163.54 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 73.9 mtp180 -81.89 151.55 67.55 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 936' ' ' TYR . 6.7 Cg_endo -49.44 -44.23 35.48 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.972 2.448 . . . . 0.0 112.609 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.416 ' HB3' HG21 ' A' ' 982' ' ' VAL . 55.4 mt-10 -73.27 20.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.77 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 45.4 m-85 -143.08 134.99 26.86 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.837 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 13.2 p90 -96.17 135.82 37.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.631 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 164.95 141.17 3.05 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.87 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 939' ' ' ARG . 0.6 OUTLIER -72.75 157.12 89.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.931 0.396 . . . . 0.0 110.505 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 19.2 Cg_endo -60.75 147.27 95.55 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.986 2.457 . . . . 0.0 112.092 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 53.1 p90 -144.44 -171.27 3.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 44.9 t -172.92 142.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 10.7 pt -100.46 116.93 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.445 ' O ' HD22 ' A' ' 946' ' ' LEU . 36.9 m -81.45 131.68 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.38 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.6 t -73.74 123.22 23.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 109.903 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 950' ' ' VAL . 1.9 mm? -87.44 169.03 12.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.338 1.066 . . . . 0.0 113.622 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.4 -40.4 62.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.146 -1.843 . . . . 0.0 112.043 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 950' ' ' VAL . 50.0 t30 -83.33 32.89 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 900' ' ' ALA . 56.7 mt 46.39 57.99 4.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.237 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.872 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -135.59 -159.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.385 0.612 . . . . 0.0 111.697 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.417 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 91.8 m95 -144.72 122.31 11.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.137 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.45 ' N ' HD21 ' A' ' 946' ' ' LEU . 79.1 p -42.16 136.29 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.818 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 34.0 t -77.93 112.35 24.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 955' ' ' LYS . 15.4 Cg_exo -68.64 -153.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.713 2.275 . . . . 0.0 111.885 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.533 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 32.4 mtmt -159.84 -147.37 0.16 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.69 0.757 . . . . 0.0 111.6 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.533 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 56.5 m-20 -81.28 58.63 3.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.406 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 958' ' ' CYS . 29.5 m -81.6 -50.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.409 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.535 ' N ' HG23 ' A' ' 957' ' ' VAL . 97.5 m -89.0 52.3 2.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.422 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -57.64 138.7 55.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.754 ' HD2' ' HB2' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -55.37 120.56 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.844 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.837 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 35.6 ttmt -56.45 142.36 38.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 78.5 p -144.44 141.23 29.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.512 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.1 m -81.63 23.79 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 964' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 965' ' ' THR . 13.8 tmtt? 55.6 136.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.414 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 4.4 m -51.12 118.19 10.1 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.316 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG3' HD11 ' A' ' 986' ' ' ILE . 43.9 Cg_endo -64.5 141.73 75.07 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 122.664 2.243 . . . . 0.0 111.694 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.35 115.87 2.75 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.124 1.883 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -62.54 134.98 95.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 17.7 Cg_endo -59.6 138.1 81.48 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.433 2.089 . . . . 0.0 111.872 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.4 p -50.7 129.29 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.481 ' OD1' HG22 ' A' ' 970' ' ' VAL . 33.3 m120 64.04 48.24 3.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -170.82 -145.54 4.81 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.725 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER -178.83 156.6 0.85 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 986' ' ' ILE . 14.2 p -87.55 128.07 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.466 0.65 . . . . 0.0 110.851 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.977 ' HB3' HG23 ' A' ' 987' ' ' THR . 12.3 t-160 -75.05 70.97 2.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.341 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.593 HG23 HG13 ' A' ' 974' ' ' VAL . 99.3 t -59.06 122.84 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.97 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 987' ' ' THR . 32.0 mm -78.44 -40.64 24.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.29 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 59.0 p -144.67 -50.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 976' ' ' VAL . 56.5 m-20 -154.45 -142.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.495 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 17.0 pt -145.56 -3.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.436 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HB2' ' HD2' ' A' ' 960' ' ' ARG . 15.8 pt20 -75.56 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 5.9 m -47.92 150.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 111.366 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 85.17 -40.75 3.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.257 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 40.6 t -77.63 131.28 37.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 111.436 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ttm180 -100.33 150.15 22.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.157 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.709 HD12 HG21 ' A' ' 974' ' ' VAL . 48.2 pt -141.73 127.58 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.381 . . . . 0.0 111.51 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.977 HG23 ' HB3' ' A' ' 975' ' ' HIS . 1.6 t -98.62 -168.31 1.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.578 ' HA ' ' H ' ' A' ' 975' ' ' HIS . 22.0 m-85 -136.87 154.15 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 0.0 111.176 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.4 t -148.44 125.21 11.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 72.6 m -100.04 147.39 25.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -65.03 146.85 54.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.525 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 87.0 m -45.87 126.48 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' 1023 ' ' ILE . . . 126.09 -46.93 1.05 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -102.23 137.48 40.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.065 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.701 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.8 ptm85 -93.33 146.59 23.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.196 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.4 tt -71.77 133.2 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.984 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.513 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.2 mp -110.22 133.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 98.5 -128.9 9.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.306 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -79.04 -129.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.0 p -172.24 -31.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.319 . . . . 0.0 111.247 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 47.2 t -150.84 159.82 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.529 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.6 133.77 12.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.989 0.424 . . . . 0.0 111.83 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 4.6 pm0 -104.05 138.24 40.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.451 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.9 t -76.9 125.82 29.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' 1011 ' ' ALA . 29.9 pt -131.56 -151.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.669 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' 1010 ' ' THR . 28.8 tp -147.18 -26.57 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.335 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' 1006 ' ' LEU . 47.6 t 69.42 -42.94 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -175.83 -45.66 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -156.18 21.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.418 0.151 . . . . 0.0 111.025 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.667 ' C ' HD12 ' A' 1006 ' ' LEU . 3.3 m -150.58 121.04 7.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.283 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -76.15 129.13 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 0.0 110.888 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.468 ' CE1' HD11 ' A' 1005 ' ' ILE . 20.7 p80 -160.15 144.16 14.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 96.3 m95 -68.63 136.28 52.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.063 0.458 . . . . 0.0 110.453 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' 1003 ' ' GLU . 73.7 m -56.36 -27.25 55.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.888 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 72.8 p -145.86 143.9 29.9 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.176 0.512 . . . . 0.0 112.324 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.468 ' HG3' ' HD2' ' A' 1017 ' ' PRO . 26.0 ttpp -65.79 140.9 97.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.778 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' 1016 ' ' LYS . 18.2 Cg_endo -58.15 131.25 42.2 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.524 2.149 . . . . 0.0 112.277 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.448 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -65.02 -160.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.746 2.297 . . . . 0.0 113.01 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 58.3 mt -143.16 139.65 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.814 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 71.9 m -92.58 124.66 36.77 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.62 134.67 22.68 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.199 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -45.7 135.5 6.7 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 111.851 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.701 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.1 mt -74.88 128.41 85.27 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 40.2 Cg_exo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.851 2.367 . . . . 0.0 112.253 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.834 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.946 0.403 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.556 ' C ' HD12 ' A' ' 949' ' ' LEU . 61.1 m80 -152.58 139.8 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.267 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 76.5 m -81.08 132.48 35.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.987 0.422 . . . . 0.0 111.491 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -76.54 171.57 14.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.652 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.01 149.75 1.52 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.544 ' HB2' ' CD1' ' A' ' 908' ' ' PHE . 10.1 Cg_endo -50.84 135.17 42.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.961 2.441 . . . . 0.0 112.341 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.455 ' O ' ' HD1' ' A' ' 908' ' ' PHE . 46.6 m-20 -67.51 116.3 8.09 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.481 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.437 ' O ' HD12 ' A' ' 909' ' ' LEU . 23.9 p80 38.0 46.67 0.84 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 905' ' ' PRO . 5.5 m-85 -81.64 137.47 35.45 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.652 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.691 HD22 ' N ' ' A' ' 910' ' ' PHE . 0.0 OUTLIER -159.63 -27.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.691 ' N ' HD22 ' A' ' 909' ' ' LEU . 0.1 OUTLIER -80.0 0.63 30.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.45 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.577 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -153.05 134.37 14.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.347 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.21 126.35 39.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.554 ' HG ' ' CZ ' ' A' ' 930' ' ' TYR . 1.2 tt -51.19 131.94 28.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.62 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.806 ' HD3' ' HG2' ' A' ' 929' ' ' LYS . 7.0 mtpm? -85.22 -49.61 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.795 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.54 ' O ' HD22 ' A' ' 913' ' ' LEU . 60.2 m -64.77 136.72 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.219 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -60.37 130.48 46.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.31 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 82.0 p -152.08 147.36 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.325 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.4 p -143.66 -42.87 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 141.76 52.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 40.0 t -86.97 39.18 0.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -157.23 138.72 13.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.36 139.31 29.33 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.493 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.6 Cg_endo -69.33 146.95 64.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.559 . . . . 0.0 112.227 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.762 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 18.3 mt -59.55 158.18 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.892 0.377 . . . . 0.0 111.386 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 81.23 -35.43 2.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.938 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 39.7 m -56.02 129.25 39.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 111.364 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 66.3 p -108.9 125.77 52.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 913' ' ' LEU . 91.5 mt -105.02 122.76 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.889 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.806 ' HG2' ' HD3' ' A' ' 914' ' ' LYS . 37.6 ttmt -90.01 133.35 34.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.554 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 1.5 m-85 -120.65 168.78 11.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.374 . . . . 0.0 111.075 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 914' ' ' LYS . 11.8 pt-20 -140.95 125.43 17.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.822 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 79.2 m -57.51 154.88 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.011 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 99.7 mtt180 -82.77 165.0 44.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 54.7 Cg_endo -69.94 56.08 1.42 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.892 2.395 . . . . 0.0 112.868 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.743 ' O ' ' HD2' ' A' ' 961' ' ' LYS . 55.3 mt-10 -164.94 9.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 936' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -149.18 135.31 19.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 10.8 p90 -95.02 136.38 35.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 0.0 111.221 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 167.73 141.25 3.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.52 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.35 156.0 92.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.744 0.307 . . . . 0.0 110.435 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -60.99 109.15 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.411 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.518 ' HB3' ' NH1' ' A' ' 939' ' ' ARG . 52.6 p90 -96.08 -164.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.91 132.09 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.565 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 5.1 pt -97.34 120.31 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 111.643 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 17.5 m -84.08 122.72 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.83 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.762 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.8 t -73.7 102.84 4.07 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 83.9 mt -84.01 162.2 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -43.09 -38.4 2.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.869 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.6 m-80 -82.29 33.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.164 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.834 HD11 ' HB1' ' A' ' 900' ' ' ALA . 1.7 mm? 44.82 52.28 8.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 29.6 m -127.64 -160.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.537 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.767 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 75.5 m95 -149.01 121.81 8.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.67 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 87.8 p -42.72 143.85 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.918 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 41.8 t -77.08 117.29 64.12 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 17.0 Cg_exo -66.4 -8.74 21.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.596 2.198 . . . . 0.0 111.289 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 46.97 57.26 5.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.865 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 59.9 t0 61.19 126.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.966 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 941' ' ' PHE . 5.1 m -150.94 -48.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.756 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 911' ' ' ALA . 99.5 m -83.51 54.37 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 0.0 110.648 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 93.5 mttt -61.39 151.83 31.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.719 ' HD2' ' NZ ' ' A' ' 961' ' ' LYS . 15.1 tpp85 -53.37 125.22 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.861 ' HG2' HG13 ' A' ' 982' ' ' VAL . 0.0 OUTLIER -56.38 125.67 22.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.38 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 91.9 p -144.45 127.9 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.107 0.48 . . . . 0.0 111.083 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.9 p -82.0 44.19 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.189 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.7 tptt 62.86 135.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.073 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.802 ' HA ' HD12 ' A' ' 980' ' ' ILE . 14.0 m -59.85 131.32 88.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.558 ' HG3' HD13 ' A' ' 986' ' ' ILE . 37.6 Cg_endo -65.21 132.64 32.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.596 2.197 . . . . 0.0 112.459 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.35 138.9 52.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.4 2.067 . . . . 0.0 111.793 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -57.94 116.87 15.9 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.77 141.82 55.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.211 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' 1020 ' ' CYS . 11.3 p -53.74 129.13 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 33.3 m120 44.97 46.66 9.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.992 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -168.01 135.05 3.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.58 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 54.4 mtm -103.68 136.65 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 986' ' ' ILE . 12.1 p -99.75 132.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -95.9 115.66 27.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 986' ' ' ILE . 94.7 t -66.01 -25.34 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.094 0.473 . . . . 0.0 109.993 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.596 HD11 ' OG1' ' A' ' 987' ' ' THR . 14.6 mm 74.21 -51.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.988 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 70.9 p -148.92 -59.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 34.4 m-20 -157.41 143.84 17.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.168 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 965' ' ' THR . 6.0 pt -84.64 21.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.651 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 75.8 mm-40 -78.95 159.94 27.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.219 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 961' ' ' LYS . 2.2 m -56.45 -7.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.836 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -95.64 22.46 38.97 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 67.5 m -163.95 -160.89 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.778 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' 1002 ' ' ALA . 17.2 ptp180 -151.39 -168.19 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.223 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 976' ' ' VAL . 33.3 pt -146.37 129.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.596 ' OG1' HD11 ' A' ' 977' ' ' ILE . 11.0 p -103.28 134.52 46.54 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.129 0.49 . . . . 0.0 111.134 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.521 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 1.5 m-85 -95.44 145.2 25.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.2 t -146.46 74.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 59.4 m -51.64 147.34 6.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.4 p -64.3 150.48 46.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 62.2 m -47.78 112.45 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.163 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 144.72 -50.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -102.3 142.98 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.622 ' O ' HD12 ' A' ' 997' ' ' ILE . 13.3 ptp180 -92.92 145.0 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.504 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.5 tm? -72.45 129.53 38.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.696 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' 1021 ' ' GLN . 4.6 mp -118.41 123.52 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.64 0.257 . . . . 0.0 110.72 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.28 43.22 3.04 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.723 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.538 ' O ' ' HG3' ' A' 1018 ' ' PRO . 93.2 m-70 60.86 125.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 0.0 111.672 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.543 ' HB3' ' HG ' ' A' ' 996' ' ' LEU . 79.9 p -81.39 32.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 50.2 m -158.59 145.72 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.671 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -155.8 125.5 6.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.645 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.47 130.13 40.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.227 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 120.97 17.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.06 137.71 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.414 0.625 . . . . 0.0 112.082 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' 1011 ' ' ALA . 22.5 tp -84.51 120.4 26.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.014 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.2 t -96.08 52.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 81.43 -124.51 6.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.773 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.9 m120 -55.62 -46.96 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.764 HG22 ' H ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -94.52 -164.02 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.972 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.778 ' HB2' HD12 ' A' 1006 ' ' LEU . . . -158.25 147.38 19.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.054 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.26 152.04 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.478 ' HZ2' ' HD3' ' A' ' 966' ' ' PRO . 85.1 m95 -68.69 146.1 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.385 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -56.52 -30.78 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.723 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 8.1 t -146.97 145.69 29.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.93 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -53.81 137.46 54.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.093 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.515 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 73.8 Cg_exo -49.53 113.1 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.197 1.931 . . . . 0.0 112.668 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.538 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 11.0 Cg_endo -54.27 142.28 68.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.927 2.418 . . . . 0.0 112.138 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.686 ' H ' HD12 ' A' 1019 ' ' ILE . 0.1 OUTLIER -107.11 143.7 17.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.031 0.443 . . . . 0.0 111.9 -179.405 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 57.8 m -83.49 141.09 31.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.667 ' HB2' HD13 ' A' ' 997' ' ' ILE . 2.8 tt0 -145.8 131.24 18.68 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.862 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -49.75 130.92 21.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.405 0.622 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.533 HG23 HH21 ' A' ' 995' ' ' ARG . 64.9 mt -74.86 126.32 88.48 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.066 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.831 2.354 . . . . 0.0 112.314 -179.92 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.86 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.794 0.331 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.632 ' C ' HD22 ' A' ' 949' ' ' LEU . 26.8 m80 -148.17 131.46 16.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 8.9 p -82.3 127.8 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 903' ' ' GLN . . . . . 0.569 ' CD ' ' H ' ' A' ' 903' ' ' GLN . 1.5 pm0 -64.17 159.26 20.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.48 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.21 131.7 5.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.708 ' HG3' HD12 ' A' ' 928' ' ' LEU . 31.3 Cg_endo -63.89 149.57 90.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.829 2.353 . . . . 0.0 112.48 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -62.37 162.94 9.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.06 124.77 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.501 ' HZ ' HG21 ' A' ' 943' ' ' ILE . 4.6 m-30 -85.28 129.06 34.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.56 25.63 4.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.443 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 8.5 p90 -154.01 1.63 0.23 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.066 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -157.43 131.38 8.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.402 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -102.01 136.16 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.991 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 66.0 tp -47.8 157.0 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.389 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.703 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 3.9 mmmp? -145.36 -36.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 19.5 m -64.4 139.45 58.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -58.46 136.13 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.542 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 77.1 p -152.18 140.33 20.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 918' ' ' THR . 25.5 m -158.4 53.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.197 0.522 . . . . 0.0 110.548 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.31 154.27 7.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.787 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.3 p -84.08 -49.44 8.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.535 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -85.32 124.59 32.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.227 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.44 ' CE2' HD11 ' A' ' 928' ' ' LEU . 25.8 m-85 -103.71 136.49 19.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.014 0.435 . . . . 0.0 111.819 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.49 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 61.2 Cg_endo -72.24 139.33 32.01 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 0.0 112.071 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.639 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 26.4 mt -57.54 158.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.66 -40.91 2.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.49 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 30.7 m -56.01 136.64 51.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.003 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.2 m -123.63 131.86 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.708 HD12 ' HG3' ' A' ' 905' ' ' PRO . 88.7 mt -97.92 129.26 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.695 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 40.0 ttmt -85.25 136.81 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.767 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 17.2 m-85 -134.44 125.3 27.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.734 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.703 ' HG3' ' HG3' ' A' ' 914' ' ' LYS . 96.1 mt-10 -95.63 136.11 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 80.7 m -51.69 158.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 0.0 110.91 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.521 ' HG3' ' C ' ' A' ' 910' ' ' PHE . 44.1 mtp85 -80.09 160.26 68.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.279 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 38.2 Cg_endo -66.51 62.4 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.831 2.354 . . . . 0.0 112.452 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.0 mt-10 -163.73 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.392 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 2.6 m-85 -104.48 -176.96 3.23 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.458 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 4.9 p90 -150.51 32.77 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.966 0.412 . . . . 0.0 111.336 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.918 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -76.68 27.42 1.6 Allowed Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.294 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.74 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.9 ptp180 46.02 166.14 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.356 0.662 . . . . 0.0 112.633 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 41.8 Cg_endo -67.72 145.6 69.95 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.341 2.027 . . . . 0.0 112.427 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.562 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 45.3 p90 -144.46 -162.07 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.299 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.534 ' HG ' ' HA ' ' A' ' 929' ' ' LYS . 57.5 m -169.78 136.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.501 HG21 ' HZ ' ' A' ' 908' ' ' PHE . 7.8 pt -93.0 120.85 43.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.002 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 946' ' ' LEU . 16.6 m -81.52 123.48 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.76 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 10.7 t -73.72 104.23 4.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 74.4 mt -81.76 161.55 23.26 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.503 ' HA ' HG21 ' A' ' 924' ' ' ILE . 64.2 t0 -42.09 -47.5 4.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.381 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 948' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 950' ' ' VAL . 24.2 p-10 -82.27 40.96 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.975 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.86 HD21 ' HB1' ' A' ' 900' ' ' ALA . 43.7 mt 45.85 59.18 3.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.247 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.696 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 34.9 m -135.98 -161.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -151.02 122.94 8.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.975 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.5 p -41.87 137.64 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 39.7 t -79.4 110.95 17.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 0.0 112.073 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 952' ' ' SER . 57.9 Cg_endo -90.96 54.07 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.471 2.781 . . . . 0.0 110.828 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.593 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -75.63 132.82 40.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.422 -178.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 52.95 44.95 29.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.3 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 958' ' ' CYS . 0.5 OUTLIER -87.83 -50.95 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.247 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.918 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 93.1 m -89.13 111.77 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 72.7 mmtt -83.78 124.84 31.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 40.4 ttm180 -61.96 133.69 55.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.277 0.561 . . . . 0.0 112.386 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.509 ' HA ' ' CE2' ' A' ' 937' ' ' TYR . 20.3 tptm -56.35 168.48 0.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.809 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.518 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 51.0 m -149.85 134.81 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.005 0.431 . . . . 0.0 111.235 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.92 141.77 35.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.804 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -65.54 136.09 55.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 66.5 m -52.62 121.86 23.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.809 ' HG2' HG11 ' A' ' 974' ' ' VAL . 30.9 Cg_endo -62.46 135.02 51.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 0.0 112.088 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.09 121.2 9.65 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.988 1.792 . . . . 0.0 110.94 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 968' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 973' ' ' MET . 14.2 m-20 -57.96 118.66 28.17 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.06 148.7 91.41 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.654 2.236 . . . . 0.0 111.873 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 970' ' ' VAL . 19.3 t -45.25 122.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.959 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 32.7 m120 60.71 45.61 9.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.537 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -179.71 139.71 3.95 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.956 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 968' ' ' ASP . 3.5 mpp? -133.54 150.03 51.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.809 HG11 ' HG2' ' A' ' 966' ' ' PRO . 8.4 p -89.92 121.77 40.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.17 0.509 . . . . 0.0 111.051 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 121.84 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.83 135.1 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.764 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 978' ' ' THR . 26.7 mm -74.47 -53.27 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.787 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 978' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 977' ' ' ILE . 82.0 p -147.66 -52.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.312 0.577 . . . . 0.0 110.87 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.73 139.35 18.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.02 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.6 pt -88.33 34.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.897 0.379 . . . . 0.0 111.656 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.554 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 33.0 mt-30 -80.81 151.19 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' A' 1005 ' ' ILE . 76.2 t -54.48 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 165.63 -48.35 0.28 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HG3' ' A' 1003 ' ' GLU . 93.9 p -80.04 -160.38 0.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 985' ' ' ARG . 4.0 ptp85 -151.39 134.97 16.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.705 HD12 HG21 ' A' ' 974' ' ' VAL . 34.6 pt -97.72 136.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.0 p -102.47 135.25 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.1 m-85 -96.24 143.69 27.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -148.71 120.72 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 60.9 m -83.58 119.71 25.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.463 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 992' ' ' THR . 7.6 t -72.57 137.4 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.547 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 991' ' ' THR . 96.6 m 111.23 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.309 1.005 . . . . 0.0 111.168 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 992' ' ' THR . . . -170.66 32.45 0.15 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.215 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -95.74 144.36 26.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.69 ' HB3' HG12 ' A' 1023 ' ' ILE . 7.6 ptm180 -89.28 136.23 33.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.23 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.414 HD11 ' HG3' ' A' 1018 ' ' PRO . 10.3 tt -72.26 132.28 43.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.3 mp -99.73 125.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.031 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.2 -139.87 14.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.389 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -85.86 135.02 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.544 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.5 p -102.96 20.31 17.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.58 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 47.4 t -159.19 146.84 17.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -153.68 134.31 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.062 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 984' ' ' SER . 39.3 tt0 -95.0 129.08 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.199 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.28 120.34 16.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.664 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.3 pt -129.9 -159.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.889 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' 1009 ' ' ASN . 41.6 tp -150.78 136.84 18.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.3 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.506 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -90.0 -40.31 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.828 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.68 -32.02 0.03 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.292 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.434 ' C ' HD11 ' A' 1006 ' ' LEU . 49.7 t30 -150.04 -44.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 110.511 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.421 ' O ' HD12 ' A' 1006 ' ' LEU . 37.4 m -92.66 131.44 37.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.979 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.97 143.59 32.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.819 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.506 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -155.76 144.06 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.307 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.494 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 49.1 m95 -68.29 144.09 54.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -53.55 -29.05 35.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.61 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 68.4 p -140.91 138.8 34.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.713 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.571 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.5 pptp? -62.31 152.47 79.16 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.014 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.76 132.36 41.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.635 2.224 . . . . 0.0 112.643 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.414 ' HG3' HD11 ' A' ' 996' ' ' LEU . 56.1 Cg_endo -69.88 -153.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.783 2.322 . . . . 0.0 112.578 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.7 mt -139.01 141.97 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.015 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 97.9 m -99.66 124.18 44.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -142.23 129.52 21.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.184 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -50.45 133.89 24.22 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.68 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.2 mt -74.83 123.91 89.27 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.797 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.813 2.342 . . . . 0.0 112.343 -179.892 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.454 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.771 0.32 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.567 ' N ' HD22 ' A' ' 949' ' ' LEU . 11.7 m80 66.92 140.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.928 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 47.8 m -80.11 129.07 34.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -64.65 168.19 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.23 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.69 125.32 6.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.38 123.64 8.34 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 122.457 2.105 . . . . 0.0 112.82 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 136.11 54.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.011 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -77.25 138.55 39.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.503 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 14.5 m-85 -89.09 24.02 2.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.503 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.666 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 6.5 mp 68.74 -59.01 0.47 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 5.4 p90 -81.82 31.03 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -152.63 122.36 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 111.589 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -99.68 124.29 44.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.311 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.708 HD11 ' O ' ' A' ' 915' ' ' THR . 2.1 tm? -48.97 118.51 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.267 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.673 ' HE2' ' HD2' ' A' ' 929' ' ' LYS . 0.7 OUTLIER -95.89 -47.96 5.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.159 -179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.708 ' O ' HD11 ' A' ' 913' ' ' LEU . 31.7 m -64.59 128.39 35.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.613 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -52.36 135.14 33.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.875 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 915' ' ' THR . 79.4 p -152.02 144.67 24.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 918' ' ' THR . 24.9 m -156.46 53.36 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.73 156.2 9.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.5 t -86.4 -46.87 9.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.99 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.28 141.94 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -129.9 133.79 25.41 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.516 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -70.52 141.89 43.23 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.656 2.237 . . . . 0.0 112.229 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 947' ' ' ASP . 34.2 mt -55.44 152.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 925' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 88.47 -29.54 5.67 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.452 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.516 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.4 m -55.05 137.74 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 51.1 m -115.99 142.6 46.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.733 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.21 119.09 19.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.625 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.673 ' HD2' ' HE2' ' A' ' 914' ' ' LYS . 40.0 ttmt -89.4 138.52 31.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.395 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.582 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 5.9 m-85 -129.03 134.45 48.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -95.18 121.57 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 64.2 m -59.92 149.98 30.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.0 mtp180 -84.13 162.89 50.39 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.617 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 10.0 Cg_endo -51.88 146.23 29.46 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.241 1.961 . . . . 0.0 110.966 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 1.045 ' HB3' HG21 ' A' ' 982' ' ' VAL . 95.6 mt-10 83.23 25.89 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.888 0.742 . . . . 0.0 109.968 -178.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.794 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 78.8 m-85 -143.91 142.35 30.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.839 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.624 ' HB3' ' NZ ' ' A' ' 961' ' ' LYS . 36.2 p90 -144.06 134.73 24.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 111.439 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.811 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 155.75 28.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.41 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 63.09 144.43 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.0 111.784 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.57 124.93 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.524 2.15 . . . . 0.0 110.703 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 6.5 p90 -90.17 -166.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.66 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 59.2 m -170.21 132.27 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.414 ' HB ' ' CE3' ' A' ' 951' ' ' TRP . 13.5 pt -94.01 168.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.676 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.497 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.5 m -162.62 136.09 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 38.7 t -73.82 125.78 28.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.621 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.8 mm? -84.86 -57.03 3.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -176.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.709 ' HA ' HD13 ' A' ' 924' ' ' ILE . 23.7 t70 171.67 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.218 0.324 . . . . 0.0 111.031 -178.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -82.77 32.1 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 109.636 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 901' ' ' HIS . 22.2 mt 51.67 43.25 30.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.762 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.9 m -143.41 154.41 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.644 0.735 . . . . 0.0 112.467 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.495 ' C ' ' H ' ' A' ' 953' ' ' SER . 72.9 m95 -91.51 130.85 37.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.381 -1.282 . . . . 0.0 109.128 177.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.561 ' HB2' HD21 ' A' ' 946' ' ' LEU . 45.3 t -51.47 -10.22 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.372 0.606 . . . . 0.0 111.524 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 951' ' ' TRP . 48.0 t 61.93 121.55 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.744 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 11.5 Cg_exo -71.08 141.31 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.978 2.452 . . . . 0.0 110.74 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 11.0 tmtt? -154.59 134.64 13.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.212 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.68 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 38.7 t70 60.82 41.01 15.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.123 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.79 -111.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.089 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.811 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 26.8 p -87.97 103.29 15.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.4 mmtt -82.05 134.68 35.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.799 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 35.7 ptt180 -56.76 143.56 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.592 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.624 ' NZ ' ' HB3' ' A' ' 937' ' ' TYR . 5.3 mptp? -47.12 150.47 0.8 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.528 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.2 p -142.65 127.19 17.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 70.5 m -79.48 138.21 37.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.302 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.57 135.28 55.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.895 0.379 . . . . 0.0 110.757 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 83.2 m -48.59 114.45 3.61 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.548 ' HG2' HG11 ' A' ' 974' ' ' VAL . 20.0 Cg_endo -60.57 135.42 60.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.489 2.126 . . . . 0.0 112.013 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.12 117.18 3.34 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.068 1.845 . . . . 0.0 111.327 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.14 125.11 80.41 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 144.54 99.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.681 2.254 . . . . 0.0 112.076 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.4 t -46.42 129.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 991' ' ' THR . 33.7 m120 61.76 45.65 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.9 -162.94 23.08 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.585 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 178.63 147.44 0.17 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 110.993 -179.641 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.906 HG21 HD12 ' A' ' 986' ' ' ILE . 8.6 p -91.08 102.79 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.773 0.797 . . . . 0.0 110.845 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.17 107.9 2.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.307 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.46 133.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 985' ' ' ARG . 44.9 mm -74.28 -36.07 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.088 0.47 . . . . 0.0 110.263 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.9 p -144.71 -49.54 0.26 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.88 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.1 t70 -161.57 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.822 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.465 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 6.2 pt -151.03 9.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 110.849 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 3.7 mt-30 -75.75 161.16 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 1.045 HG21 ' HB3' ' A' ' 935' ' ' GLU . 10.4 m -49.27 149.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.695 0.283 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 82.94 -32.76 2.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.976 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.0 m -75.84 131.71 39.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.153 0.501 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 977' ' ' ILE . 78.7 ttt180 -93.38 155.82 17.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.906 HD12 HG21 ' A' ' 974' ' ' VAL . 43.9 pt -141.78 123.81 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.255 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.3 p -107.61 136.9 46.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.466 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.483 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 5.2 m-85 -94.06 146.58 23.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.418 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -148.65 109.83 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.997 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 79.8 m -79.96 147.87 31.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 971' ' ' ASN . 5.6 t -64.31 146.39 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.7 m -44.02 123.69 3.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.49 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 134.73 -51.23 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.331 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.452 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.5 m80 -102.54 141.12 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.356 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.583 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.6 ptm180 -92.38 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.348 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.7 tt -71.77 132.73 44.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.2 mp -108.91 132.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 83.94 -144.25 21.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.15 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -81.34 130.24 34.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.767 0.317 . . . . 0.0 111.278 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.421 ' HA ' HD11 ' A' ' 996' ' ' LEU . 47.6 t -85.04 -51.84 6.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.665 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 33.1 t -90.37 155.02 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.707 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.545 ' H ' ' HB3' ' A' 1014 ' ' SER . 88.3 tt0 -111.56 129.94 55.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.766 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.531 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 43.2 t -71.25 125.62 27.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' 1012 ' ' HIS . 26.7 pt -129.42 -155.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.615 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 45.3 tp -150.62 -21.86 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.832 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 36.8 t 53.27 26.96 5.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 35.54 48.52 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.522 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -163.21 -49.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.539 ' C ' HD12 ' A' 1006 ' ' LEU . 40.2 m -145.54 136.45 24.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.843 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.02 124.94 28.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.873 0.368 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.485 ' CD2' HG13 ' A' 1005 ' ' ILE . 0.3 OUTLIER -161.2 152.91 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.761 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.531 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 93.7 m95 -64.92 144.38 57.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.985 0.422 . . . . 0.0 110.784 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1014 ' ' SER . . . . . 0.545 ' HB3' ' H ' ' A' 1003 ' ' GLU . 45.4 t -64.18 -31.59 72.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 40.9 p -144.19 138.67 28.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.871 0.367 . . . . 0.0 111.266 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 22.5 pttp -61.03 148.63 83.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 33.0 Cg_exo -58.3 130.3 37.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.613 2.209 . . . . 0.0 112.338 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.483 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.29 -160.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.758 2.306 . . . . 0.0 112.665 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.4 mt -142.33 138.59 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.885 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 82.1 m -92.66 124.42 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.452 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 34.0 tt0 -143.75 135.39 26.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.464 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' 1022 ' ' ARG . 15.1 tpp85 -49.04 131.92 18.99 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.398 0.618 . . . . 0.0 111.621 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.2 mt -76.89 124.96 87.57 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.878 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 32.8 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.809 2.34 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.946 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.147 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.623 ' C ' HD22 ' A' ' 949' ' ' LEU . 58.1 m80 -150.4 127.41 11.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.403 178.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 11.3 p -82.9 128.15 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -73.15 175.45 6.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.43 129.1 10.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 906' ' ' ASP . 50.8 Cg_endo -68.46 91.5 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.483 2.122 . . . . 0.0 112.421 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 906' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 905' ' ' PRO . 6.5 t0 29.75 -133.02 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 O-C-N 123.606 0.566 . . . . 0.0 111.123 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 907' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 31.7 t-80 -161.8 109.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 911' ' ' ALA . 22.7 m-85 -86.5 137.15 32.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 62.5 mt -80.08 -52.96 7.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.18 29.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 908' ' ' PHE . . . -155.91 139.98 16.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.402 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -136.47 130.9 33.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 929' ' ' LYS . 66.0 tp -48.42 156.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.332 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.857 ' HA ' ' HE2' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -145.49 -39.82 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.411 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 917' ' ' THR . 4.4 m -64.52 141.87 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.92 133.54 37.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.318 179.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 915' ' ' THR . 62.7 p -150.92 -65.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 917' ' ' THR . 32.1 p 66.28 -50.96 0.43 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.892 0.745 . . . . 0.0 112.555 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.36 151.93 44.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.1 p -85.04 -42.92 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 921' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 901' ' ' HIS . 63.9 t0 -85.02 126.26 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -106.78 136.13 19.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.63 140.6 18.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.106 2.538 . . . . 0.0 111.829 178.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.772 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 46.7 mt -55.88 148.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.059 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 73.55 77.57 0.61 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 2.2 m -176.72 122.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 54.9 m -83.43 129.69 35.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.981 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 917' ' ' THR . 6.0 tp -106.87 118.55 36.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.994 179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 929' ' ' LYS . 0.1 OUTLIER -85.63 135.15 33.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.785 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 930' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -135.4 129.34 33.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.258 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 940' ' ' PRO . 90.0 mt-10 -95.48 123.09 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 6.1 t -58.77 153.38 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.559 HH11 ' HG3' ' A' ' 933' ' ' ARG . 38.9 mtt85 -81.35 155.48 71.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 51.6 Cg_endo -68.45 66.4 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.024 2.483 . . . . 0.0 112.543 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.6 mt-10 -163.15 -9.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 959' ' ' LYS . 33.9 m-85 -134.79 140.6 46.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.402 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.1 p90 -99.91 137.7 38.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 938' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 148.13 21.38 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.456 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 938' ' ' GLY . 18.9 ptp180 46.72 164.28 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.654 0.782 . . . . 0.0 112.59 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.737 ' HB3' ' HA ' ' A' ' 931' ' ' GLU . 18.5 Cg_exo -66.39 127.32 17.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.782 2.322 . . . . 0.0 112.386 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.526 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 43.6 p90 -93.01 -161.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.5 p -172.86 134.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.066 0.46 . . . . 0.0 111.25 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.416 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 4.9 pt -95.05 -168.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.933 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 1.4 m -167.28 127.13 1.43 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.772 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 17.0 t -69.99 110.64 5.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 92.1 mt -82.75 -57.3 3.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.251 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.654 ' HA ' HD13 ' A' ' 924' ' ' ILE . 56.0 t0 173.01 -43.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.013 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -82.88 36.65 0.51 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.946 HD21 ' HB1' ' A' ' 900' ' ' ALA . 31.0 mt 51.67 46.15 26.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.5 OUTLIER -128.57 -173.6 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.988 -179.357 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 944' ' ' THR . 73.5 m95 -144.71 130.73 19.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.161 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 45.6 t -44.05 146.25 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -79.59 115.88 56.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.6 Cg_exo -76.31 61.05 6.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.496 2.797 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -76.43 139.27 40.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.486 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.569 ' HA ' ' NZ ' ' A' ' 959' ' ' LYS . 9.9 t70 58.11 82.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.041 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 30.9 m -149.69 -24.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.653 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 936' ' ' TYR . 72.6 m -150.47 133.19 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.569 ' NZ ' ' HA ' ' A' ' 956' ' ' ASP . 45.6 mmtm -140.72 150.53 43.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.303 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.463 ' HG3' ' OE1' ' A' ' 981' ' ' GLN . 12.2 tpt180 -53.34 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.971 0.415 . . . . 0.0 111.311 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.506 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 40.4 ttmt -56.32 149.63 16.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.501 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.515 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 60.4 p -141.14 140.36 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.257 0.551 . . . . 0.0 111.506 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.87 154.69 28.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.06 134.21 53.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.323 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 32.5 m -54.28 126.67 54.58 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 80.1 Cg_endo -76.3 134.25 15.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.778 2.319 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 31.7 Cg_exo -58.51 128.58 28.89 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.221 1.948 . . . . 0.0 111.511 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.86 129.52 85.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.87 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.07 142.67 88.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.864 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 39.5 t -47.5 124.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.244 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.6 m120 76.42 -46.39 0.53 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.826 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -71.29 -151.61 0.95 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.438 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 178.79 140.33 0.1 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.934 HG21 HD12 ' A' ' 986' ' ' ILE . 11.1 p -96.51 143.1 12.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.684 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.489 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.5 m-70 -102.7 114.5 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 77.9 t -63.78 -39.01 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.22 0.533 . . . . 0.0 110.021 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 975' ' ' HIS . 9.3 mt 71.64 -33.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.409 178.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 48.1 p -144.84 -86.14 0.12 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 980' ' ' ILE . 2.8 m-20 -154.59 13.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.312 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 36.9 pt 50.65 34.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.366 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.515 ' OE1' ' HB3' ' A' ' 962' ' ' SER . 50.0 mm-40 -76.64 151.13 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.81 88.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.068 0.461 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 160.09 -42.67 0.44 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.217 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 49.2 m -76.09 -168.64 0.96 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.668 ' HD3' ' HB2' ' A' 1001 ' ' SER . 38.1 ttm180 -151.35 134.9 16.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.934 HD12 HG21 ' A' ' 974' ' ' VAL . 25.7 pt -95.26 131.75 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.761 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -99.3 129.27 45.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 111.797 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' 1000 ' ' SER . 7.1 m-85 -96.58 139.73 32.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.0 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.1 t -153.69 112.14 3.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.684 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.535 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t -81.38 142.13 33.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.602 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.2 t -65.01 154.09 38.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 992' ' ' THR . 6.0 t -45.64 109.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 111.246 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 159.57 -44.42 0.44 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.438 ' HB3' ' N ' ' A' 1021 ' ' GLN . 15.3 m80 -126.87 147.58 50.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.206 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.9 ptm180 -90.04 138.98 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' 1018 ' ' PRO . 9.8 tt -71.89 130.84 42.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.987 -178.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 997' ' ' ILE . 2.0 mp -109.73 93.39 2.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.464 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 158.31 -153.53 24.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.594 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.598 ' HB2' HG21 ' A' 1015 ' ' THR . 38.7 m170 -85.93 -35.43 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1000 ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 996' ' ' LEU . 48.2 t 67.27 16.39 10.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.668 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.3 p -157.6 59.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.764 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -79.77 126.51 31.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.8 tt0 -96.09 131.48 42.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.923 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1004 ' ' CYS . . . . . 0.437 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 45.0 t -71.77 119.93 16.64 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' 1006 ' ' LEU . 41.2 pt -133.28 -156.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 112.131 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 56.4 tp -152.24 135.06 15.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.02 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1007 ' ' SER . . . . . 0.587 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -88.39 -45.39 10.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.29 -49.74 0.26 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.038 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.16 -37.19 12.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -145.45 144.91 30.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.696 -178.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.22 144.58 34.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.704 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.587 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.0 p80 -158.15 154.62 27.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.883 0.373 . . . . 0.0 111.514 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 72.3 m95 -68.63 149.49 49.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.9 m -58.92 -34.6 71.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.81 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 999' ' ' HIS . 6.4 t -143.08 149.33 38.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.228 0.537 . . . . 0.0 112.357 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.508 ' HD3' ' N ' ' A' 1017 ' ' PRO . 1.0 OUTLIER -59.54 136.86 89.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.939 179.052 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' 1016 ' ' LYS . 77.7 Cg_exo -50.75 119.86 5.78 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.541 2.161 . . . . 0.0 112.971 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.597 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 14.6 Cg_endo -57.28 147.72 75.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.822 2.348 . . . . 0.0 112.447 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.18 147.13 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 95.3 m -81.39 136.34 35.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.438 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 44.2 tt0 -145.72 132.31 19.85 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.353 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -44.03 136.04 3.95 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.5 0.667 . . . . 0.0 111.779 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' 1024 ' ' PRO . 59.6 mt -74.86 127.04 87.68 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.012 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1024 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.848 2.365 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.125 0 CA-C-O 121.017 0.437 . . . . 0.0 111.661 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 901' ' ' HIS . . . . . 0.6 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 53.4 m80 -149.86 135.46 18.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 922' ' ' PHE . 10.0 p -80.72 121.43 25.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -69.23 172.36 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.539 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.08 8.46 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.567 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.509 ' HG2' ' OH ' ' A' ' 930' ' ' TYR . 51.1 Cg_exo -53.71 127.08 24.03 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.89 2.393 . . . . 0.0 112.624 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.74 119.61 14.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.854 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 38.7 m170 42.77 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.075 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 943' ' ' ILE . 21.8 m-85 -145.93 47.51 1.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.987 178.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 38.9 mt -75.08 -7.2 53.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.736 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -12.12 54.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.806 179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.02 137.22 16.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.321 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 912' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 931' ' ' GLU . 0.0 OUTLIER -91.61 123.79 35.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.083 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.584 HD11 ' HB ' ' A' ' 915' ' ' THR . 3.4 tm? -47.18 129.51 12.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.107 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -94.56 -31.26 13.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.93 -178.962 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.584 ' HB ' HD11 ' A' ' 913' ' ' LEU . 86.4 m -57.19 154.02 10.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.609 -179.012 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 917' ' ' THR . 0.0 OUTLIER -57.49 -47.91 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.533 -179.41 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 916' ' ' GLN . 52.8 p 51.76 138.77 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.802 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 918' ' ' THR . 16.3 m -161.31 32.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.232 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.78 140.51 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 45.6 m -86.74 37.86 0.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.456 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -154.68 127.72 8.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.862 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.421 ' O ' ' SG ' ' A' ' 902' ' ' CYS . 36.4 m-85 -119.12 142.29 31.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.929 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.21 136.73 10.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.949 2.433 . . . . 0.0 111.9 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.749 HG21 ' HA ' ' A' ' 947' ' ' ASP . 61.6 mt -52.02 150.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 72.83 74.79 0.76 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.738 -178.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 944' ' ' THR . 3.6 m -174.82 130.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.856 -178.371 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 927' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 75.5 p -99.99 155.35 17.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.114 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 942' ' ' SER . 95.4 mt -141.05 128.37 21.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.117 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.84 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 43.4 mmtm -85.07 141.5 30.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.509 ' OH ' ' HG2' ' A' ' 905' ' ' PRO . 11.4 m-85 -129.12 133.19 47.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 912' ' ' LYS . 50.1 mt-10 -92.53 118.39 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.138 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.68 148.94 18.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.728 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.438 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 59.2 mtt85 -83.01 155.96 67.29 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.893 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 936' ' ' TYR . 62.6 Cg_exo -38.56 -53.75 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.881 2.388 . . . . 0.0 113.613 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.92 31.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 72.2 m-85 -145.19 133.78 22.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.677 0.275 . . . . 0.0 111.184 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.59 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 2.2 p90 -103.89 138.88 39.84 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 137.24 143.57 4.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.868 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -73.02 170.69 12.66 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.547 0.213 . . . . 0.0 110.769 179.703 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.868 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 9.2 Cg_endo -59.39 114.71 2.15 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.399 2.066 . . . . 0.0 112.958 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 27.2 p90 -90.24 -164.62 1.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.036 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 942' ' ' SER . . . . . 0.84 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 79.7 p -171.95 130.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.289 0.566 . . . . 0.0 112.352 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 943' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 908' ' ' PHE . 8.1 pt -96.14 -174.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.632 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 944' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 926' ' ' THR . 15.9 m -165.9 136.74 3.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 73.5 m -73.29 126.64 30.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.708 HD23 HG23 ' A' ' 950' ' ' VAL . 2.5 mm? -83.61 -60.51 2.1 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.749 ' HA ' HG21 ' A' ' 924' ' ' ILE . 4.7 t70 171.84 -40.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.262 0.352 . . . . 0.0 110.814 -178.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -86.38 39.67 0.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.819 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.2 mp 53.5 46.12 26.81 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.481 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.708 HG23 HD23 ' A' ' 946' ' ' LEU . 3.2 m -125.68 -179.98 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.798 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 943' ' ' ILE . 41.3 m95 -142.04 131.8 24.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.756 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.475 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.4 p -40.83 143.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.3 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 40.7 t -78.7 114.45 43.67 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.52 57.6 6.37 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.473 2.782 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 1.2 tmtp? -78.6 127.04 31.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 956' ' ' ASP . . . . . 0.775 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 38.8 t70 53.34 41.59 32.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.25 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.14 -41.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.424 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 17.2 t -157.64 68.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.478 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.775 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.4 mmtp -56.43 144.55 30.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.697 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 12.8 ptt-85 -55.43 147.39 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.151 0.5 . . . . 0.0 111.986 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.59 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 26.9 tptp -47.64 155.77 0.36 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.56 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.783 ' HB2' ' HG3' ' A' ' 981' ' ' GLN . 48.2 t -144.47 139.88 28.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.473 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 963' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.3 m -81.57 37.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.293 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 59.52 135.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.066 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.591 ' HA ' HD12 ' A' ' 980' ' ' ILE . 11.8 m -56.1 128.4 71.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.496 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 39.6 Cg_endo -66.4 127.14 16.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.489 2.126 . . . . 0.0 112.64 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 16.7 Cg_exo -67.0 132.85 29.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.499 2.133 . . . . 0.0 111.515 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.68 114.22 8.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.745 0.307 . . . . 0.0 110.781 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 144.15 29.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.685 2.257 . . . . 0.0 112.224 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 970' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.63 129.01 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.411 ' C ' HG22 ' A' ' 991' ' ' THR . 30.5 m120 54.47 44.64 28.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.475 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -170.9 147.99 10.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.939 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.2 136.98 40.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.571 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.712 HG21 HD12 ' A' ' 986' ' ' ILE . 10.1 p -98.18 127.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.913 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 977' ' ' ILE . 25.1 m-70 -86.45 114.74 23.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 0.623 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.11 -28.14 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.017 0.436 . . . . 0.0 110.203 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 73.07 -43.54 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.134 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.0 p -146.11 -51.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.577 179.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.54 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 8.2 p-10 -160.26 -143.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.146 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 965' ' ' THR . 4.6 pt -151.0 6.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.783 ' HG3' ' HB2' ' A' ' 962' ' ' SER . 14.5 mp0 -76.65 177.32 7.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.601 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.55 132.66 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.233 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 106.83 -46.27 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.278 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.0 m -76.09 134.36 40.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 77.5 ttt180 -104.12 124.09 48.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.154 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.712 HD12 HG21 ' A' ' 974' ' ' VAL . 34.4 pt -97.1 136.51 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 0.0 111.535 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.4 p -103.84 136.38 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.566 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 14.9 m-85 -103.19 142.57 33.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.231 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.9 t -153.57 127.56 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.617 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 99.8 m -58.37 135.84 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.258 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 992' ' ' THR . 10.2 t -73.41 43.59 0.14 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.433 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 991' ' ' THR . 8.5 t 175.41 -130.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 992' ' ' THR . . . -133.69 51.25 0.85 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.499 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.604 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 3.8 m80 -94.49 -137.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' 1021 ' ' GLN . 13.5 ttt85 -140.88 112.06 7.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.921 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 996' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.83 131.86 45.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.818 0.342 . . . . 0.0 110.702 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -97.27 136.21 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 84.33 -152.25 27.78 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.383 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.72 ' ND1' HG21 ' A' 1015 ' ' THR . 22.4 m170 -81.55 129.74 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.688 0.244 . . . . 0.0 110.731 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 50.2 m -74.79 10.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.338 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 30.7 t -159.29 151.42 20.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.07 128.86 8.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.383 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 12.7 pt-20 -96.48 134.24 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.539 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.2 t -71.83 123.17 22.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.67 139.18 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.262 0.553 . . . . 0.0 112.139 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 60.8 tp -84.5 120.57 26.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 94.1 p -96.03 36.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.053 179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.556 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 67.19 123.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.058 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1009 ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 73.17 -37.38 0.38 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 122.373 0.269 . . . . 0.0 111.671 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' 1008 ' ' GLY . 98.6 m -145.48 129.09 17.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 111.632 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1011 ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -87.36 147.32 25.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.66 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.9 p80 -157.64 149.1 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.384 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1013 ' ' TRP . . . . . 0.453 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 91.7 m95 -65.79 139.21 58.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -51.39 -27.68 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.886 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.72 HG21 ' ND1' ' A' ' 999' ' ' HIS . 75.4 p -141.02 141.57 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.963 0.411 . . . . 0.0 111.611 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -53.82 153.15 8.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.09 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 44.9 Cg_exo -56.17 123.78 14.66 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.446 2.097 . . . . 0.0 112.733 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.566 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 14.0 Cg_exo -69.0 148.71 70.62 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.185 2.59 . . . . 0.0 112.243 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -100.35 -153.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.616 ' H ' HG22 ' A' 1019 ' ' ILE . 35.5 t -161.64 141.24 10.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.819 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.856 ' HB2' HD11 ' A' ' 997' ' ' ILE . 7.2 tt0 -151.36 127.98 10.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.563 -178.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -51.42 131.9 29.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 111.658 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 995' ' ' ARG . 62.9 mt -74.82 129.16 83.97 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.974 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.889 2.392 . . . . 0.0 112.287 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 900' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.912 0.387 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -110.52 124.45 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.998 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 902' ' ' CYS . . . . . 0.895 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 1.8 p -82.11 124.0 29.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -60.02 172.01 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.63 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 904' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -44.78 134.4 4.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 905' ' ' PRO . . . . . 0.615 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 3.5 Cg_exo -73.79 44.06 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.738 2.292 . . . . 0.0 112.582 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 4.0 t70 57.93 153.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.472 0.653 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -82.42 122.31 27.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.704 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 908' ' ' PHE . . . . . 0.791 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 8.3 m-85 -85.88 141.98 29.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 909' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -87.53 -65.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.688 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.595 ' O ' ' HG3' ' A' ' 933' ' ' ARG . 2.5 p90 -82.77 -22.12 34.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.469 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 911' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -87.04 142.94 27.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.54 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -129.81 123.41 30.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -49.17 116.56 1.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.428 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 914' ' ' LYS . . . . . 0.494 ' HD2' ' C ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -93.07 -42.28 9.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 915' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 916' ' ' GLN . 5.0 m -66.16 -127.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 916' ' ' GLN . . . . . 0.451 ' H ' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -173.5 139.43 0.74 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.676 0.274 . . . . 0.0 110.44 179.589 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 917' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 918' ' ' THR . 1.8 t -157.18 -54.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 918' ' ' THR . . . . . 0.498 ' H ' HG23 ' A' ' 917' ' ' THR . 27.9 m 53.9 57.77 5.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.044 0.45 . . . . 0.0 110.599 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.44 156.66 14.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.4 t -87.9 -44.99 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.72 141.8 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 922' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 928' ' ' LEU . 46.2 m-85 -135.35 137.84 27.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 923' ' ' PRO . . . . . 0.603 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 65.3 Cg_endo -73.12 132.01 17.47 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.569 2.179 . . . . 0.0 111.427 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 924' ' ' ILE . . . . . 0.697 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.5 mt -56.78 147.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 95.7 -32.97 5.82 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 926' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 20.6 m -56.21 135.68 53.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.426 . . . . 0.0 112.145 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 61.6 p -107.2 142.99 36.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.388 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 928' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.1 mt -133.3 117.82 17.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.063 0.459 . . . . 0.0 110.974 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 38.1 ttmt -90.04 132.4 35.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.035 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 930' ' ' TYR . . . . . 0.43 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 4.2 m-85 -122.33 125.75 46.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.037 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 931' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 95.4 mt-10 -96.51 117.32 30.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.543 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 932' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 81.0 m -59.27 169.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.451 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 910' ' ' PHE . 46.5 mtp85 -84.36 151.16 58.92 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.142 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.507 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 19.7 Cg_exo -66.48 66.0 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.303 2.669 . . . . 0.0 112.994 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 935' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' 1006 ' ' LEU . 54.4 mt-10 -163.39 -29.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 109.925 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 936' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 910' ' ' PHE . 1.6 m-85 -94.96 147.26 23.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 937' ' ' TYR . . . . . 0.793 ' HB3' ' HD2' ' A' ' 961' ' ' LYS . 1.7 p90 -89.18 132.94 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.241 0.543 . . . . 0.0 111.152 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.37 139.48 4.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.382 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 939' ' ' ARG . . . . . 0.88 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -71.88 171.11 10.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.513 0.197 . . . . 0.0 110.549 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 940' ' ' PRO . . . . . 0.88 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 40.4 Cg_endo -67.89 121.61 8.66 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.385 2.057 . . . . 0.0 112.26 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.521 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 36.8 p90 -90.15 -161.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.73 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 82.5 p -172.79 134.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.16 -172.6 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.822 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -167.09 123.61 1.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 945' ' ' CYS . . . . . 0.697 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 33.7 t -63.91 112.09 2.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 946' ' ' LEU . . . . . 0.631 ' HB2' HG23 ' A' ' 950' ' ' VAL . 87.6 mt -81.25 -53.11 6.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.134 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 947' ' ' ASP . . . . . 0.679 ' HA ' HD13 ' A' ' 924' ' ' ILE . 19.2 t70 172.54 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.202 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -84.49 37.35 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 949' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.4 mp 53.5 48.96 20.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.994 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 946' ' ' LEU . 6.7 m -120.63 179.97 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.327 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 951' ' ' TRP . . . . . 0.615 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 97.2 m95 -145.13 49.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.231 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 23.5 t 49.5 -141.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 953' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 29.7 t -155.44 109.66 2.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.56 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 954' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.3 Cg_exo -75.05 53.99 3.53 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.121 2.547 . . . . 0.0 111.348 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 955' ' ' LYS . . . . . 0.606 ' HB3' ' NZ ' ' A' ' 955' ' ' LYS . 5.8 ttpm? -78.79 133.14 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.666 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 58.4 t0 57.42 40.59 27.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.281 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 957' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 958' ' ' CYS . 27.8 m -90.44 -42.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.511 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 958' ' ' CYS . . . . . 0.408 ' N ' HG23 ' A' ' 957' ' ' VAL . 84.6 m -155.0 141.63 18.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.164 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 959' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.5 mmtt -146.21 145.16 30.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.706 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 960' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 982' ' ' VAL . 14.8 tpp85 -53.24 103.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.141 0.496 . . . . 0.0 110.726 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 961' ' ' LYS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 937' ' ' TYR . 51.5 tttp -59.3 -179.06 0.07 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.566 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 962' ' ' SER . . . . . 0.705 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 83.9 p -149.66 142.58 24.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.625 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 77.2 m -79.51 164.69 23.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.16 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.9 133.16 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.363 . . . . 0.0 110.554 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 56.8 m -55.12 131.99 68.58 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 966' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 3.0 Cg_exo -74.15 125.12 9.54 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.736 2.291 . . . . 0.0 112.056 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.0 122.46 11.76 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.122 1.882 . . . . 0.0 111.305 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.05 116.07 17.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 969' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 64.5 Cg_endo -73.49 133.96 19.83 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.614 2.209 . . . . 0.0 111.993 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 970' ' ' VAL . . . . . 0.581 HG13 ' H ' ' A' ' 971' ' ' ASN . 1.1 p -53.77 -57.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.202 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 971' ' ' ASN . . . . . 0.581 ' H ' HG13 ' A' ' 970' ' ' VAL . 75.9 m-20 -79.01 34.23 0.23 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.356 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . 177.04 -147.77 8.53 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.953 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 973' ' ' MET . . . . . 0.498 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 22.5 ptt? 174.49 139.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 974' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 15.0 p -95.69 138.87 20.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.324 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 975' ' ' HIS . . . . . 0.477 ' O ' HG13 ' A' ' 977' ' ' ILE . 24.1 m170 -94.82 113.11 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 976' ' ' VAL . . . . . 1.029 HG13 HG23 ' A' ' 980' ' ' ILE . 92.2 t -65.63 -27.64 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 977' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 985' ' ' ARG . 4.8 mt 56.22 59.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.094 179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 12.3 p 76.61 -49.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.931 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 979' ' ' ASP . . . . . 0.58 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 2.6 p30 -159.88 138.52 10.57 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.459 -178.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 1.029 HG23 HG13 ' A' ' 976' ' ' VAL . 15.3 pt -91.46 32.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.974 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 981' ' ' GLN . . . . . 0.705 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -75.5 156.64 34.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.319 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 982' ' ' VAL . . . . . 0.803 HG13 ' HA ' ' A' 1005 ' ' ILE . 57.4 t -54.4 86.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.3 -49.25 0.3 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.922 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 984' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 979' ' ' ASP . 48.0 t -80.44 141.69 35.02 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.972 0.415 . . . . 0.0 110.691 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 985' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 13.9 ptm180 -101.08 137.39 39.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 986' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 16.6 pt -89.07 126.45 42.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.152 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 987' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' 1001 ' ' SER . 7.0 p -103.84 128.63 51.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.346 0.593 . . . . 0.0 112.017 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 988' ' ' TYR . . . . . 0.535 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 2.0 m-85 -96.4 143.75 27.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.164 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 86.1 p -148.67 117.05 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 990' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 994' ' ' HIS . 57.6 m -66.71 133.7 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.823 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 991' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 992' ' ' THR . 13.3 t -68.15 -147.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 992' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 991' ' ' THR . 49.5 m 8.75 -91.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.66 0.784 . . . . 0.0 113.044 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -158.38 44.93 0.47 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.294 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 994' ' ' HIS . . . . . 0.544 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 15.1 m80 -93.76 155.36 17.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 995' ' ' ARG . . . . . 0.675 ' HB2' HG12 ' A' 1023 ' ' ILE . 7.6 tpt180 -90.04 130.73 36.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.609 -179.134 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 996' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' 1018 ' ' PRO . 8.5 tt -67.58 134.54 51.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.699 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 997' ' ' ILE . . . . . 0.932 HD11 ' HG2' ' A' 1021 ' ' GLN . 14.8 mm -107.36 123.31 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 998' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 59.94 134.51 0.01 OUTLIER Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.197 178.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 999' ' ' HIS . . . . . 0.698 ' ND1' ' HB ' ' A' 1015 ' ' THR . 47.0 m170 48.32 -141.98 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.9 p -177.95 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.79 0.329 . . . . 0.0 111.231 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1001 ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 987' ' ' THR . 70.9 p -152.27 157.2 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1002 ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -151.99 133.42 14.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 111.391 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1003 ' ' GLU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 18.9 pt-20 -96.22 141.91 29.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -70.95 126.46 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1005 ' ' ILE . . . . . 0.803 ' HA ' HG13 ' A' ' 982' ' ' VAL . 30.9 pt -138.98 162.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1006 ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' 1007 ' ' SER . 3.2 tm? 58.82 -77.76 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.459 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1007 ' ' SER . . . . . 1.035 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 97.1 p 59.59 -111.36 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.458 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1008 ' ' GLY . . . . . 0.494 ' N ' ' HD3' ' A' ' 961' ' ' LYS . . . 64.43 -112.32 4.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.428 -178.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -65.82 -32.55 74.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1010 ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' 1007 ' ' SER . 77.2 m -150.06 122.53 8.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.493 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1011 ' ' ALA . . . . . 1.035 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -83.58 137.97 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.365 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1012 ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.4 OUTLIER -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.178 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 67.0 m95 -68.86 150.92 47.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 40.5 t -60.22 -34.6 73.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.476 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1015 ' ' THR . . . . . 0.698 ' HB ' ' ND1' ' A' ' 999' ' ' HIS . 74.8 p -141.78 149.38 40.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.775 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1016 ' ' LYS . . . . . 0.655 ' O ' ' HD3' ' A' 1016 ' ' LYS . 0.0 OUTLIER -56.85 147.72 52.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.56 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A 1017 ' ' PRO . . . . . 0.535 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 25.2 Cg_exo -64.8 123.38 11.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.906 2.404 . . . . 0.0 113.032 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1018 ' ' PRO . . . . . 0.636 ' HB3' HD21 ' A' ' 996' ' ' LEU . 23.6 Cg_exo -64.37 149.43 90.12 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 112.262 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1019 ' ' ILE . . . . . 0.877 HG22 ' H ' ' A' 1020 ' ' CYS . 2.7 mt -98.12 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.486 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1020 ' ' CYS . . . . . 0.877 ' H ' HG22 ' A' 1019 ' ' ILE . 23.1 m -163.29 128.58 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.433 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1021 ' ' GLN . . . . . 0.932 ' HG2' HD11 ' A' ' 997' ' ' ILE . 10.6 pt20 -153.21 130.98 11.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1022 ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 32.4 tpt85 -28.19 134.67 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1023 ' ' ILE . . . . . 0.675 HG12 ' HB2' ' A' ' 995' ' ' ARG . 33.6 mt -73.07 124.79 91.04 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.783 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.543 2.162 . . . . 0.0 112.468 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.778 0.323 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -174.13 45.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 899' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 900' ' ' ALA . 39.4 tt0 -60.23 143.88 51.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.107 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.965 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . 70.47 143.32 0.05 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.653 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.643 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 30.4 m80 -149.08 144.16 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.509 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.29 119.09 19.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.24 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -55.88 166.21 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.628 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.97 131.58 8.86 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.127 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.27 138.32 65.76 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.415 2.077 . . . . 0.0 111.937 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.71 156.99 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -78.43 126.98 31.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.306 0.574 . . . . 0.0 111.542 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.57 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 2.0 m-85 -90.81 -33.36 15.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.614 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.9 mp 75.72 -48.44 0.6 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.8 OUTLIER -85.72 18.41 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.021 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.32 126.39 6.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 914' ' ' LYS . 52.2 mtmt -96.74 132.94 41.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.092 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.3 tm? -48.71 141.65 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.587 ' H ' HD22 ' A' ' 913' ' ' LEU . 74.7 mmtt -147.14 64.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.453 ' H ' HD13 ' A' ' 913' ' ' LEU . 17.6 m -167.46 139.55 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.066 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -51.33 124.81 12.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.586 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 915' ' ' THR . 75.1 p -152.06 135.42 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.6 p -148.59 44.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.491 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.64 156.09 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.0 m -84.1 -44.91 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.819 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.34 120.34 26.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -96.81 141.32 22.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.02 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.58 132.43 14.67 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.581 2.188 . . . . 0.0 112.382 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.743 HD13 ' HA ' ' A' ' 947' ' ' ASP . 65.7 mt -54.15 147.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 78.27 67.25 1.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 1.8 m -174.83 121.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.4 m -90.3 128.43 36.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.645 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 942' ' ' SER . 8.5 tp -97.64 127.51 43.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -80.64 133.59 35.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.49 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 19.7 m-85 -138.5 124.09 19.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.616 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.776 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 55.5 mt-10 -102.03 125.34 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.991 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 99.0 m -57.95 166.09 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.325 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 44.8 mtp85 -82.75 158.94 64.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 936' ' ' TYR . 90.1 Cg_exo -44.07 -46.44 11.13 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.635 2.223 . . . . 0.0 112.697 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.547 ' HA ' HD22 ' A' 1006 ' ' LEU . 56.1 mt-10 -73.77 26.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.43 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 67.3 m-85 -145.15 157.64 44.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.618 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 31.6 p90 -144.09 137.08 27.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 155.94 29.69 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.8 ptp85 46.71 164.36 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.497 0.719 . . . . 0.0 112.464 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.776 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 74.2 Cg_endo -75.2 116.44 4.55 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.294 1.996 . . . . 0.0 112.515 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.557 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 16.1 p90 -95.57 -159.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 81.1 p -171.86 136.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.719 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 3.3 pt -96.27 117.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.976 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.421 HG22 HD23 ' A' ' 946' ' ' LEU . 2.8 m -84.23 126.27 32.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 85.2 m -73.48 115.18 12.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 94.5 mt -83.19 -59.93 2.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.743 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.5 t0 172.91 -37.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.874 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -81.85 26.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.312 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.965 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 61.3 40.43 14.36 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 951' ' ' TRP . 7.1 p -136.43 152.71 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.341 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.657 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 46.7 m95 -93.72 141.46 28.47 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.907 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 88.5 p -48.14 140.96 6.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 59.9 p -79.02 108.53 8.48 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.919 0.39 . . . . 0.0 111.387 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 952' ' ' SER . 2.9 Cg_exo -76.29 129.59 11.33 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.054 2.503 . . . . 0.0 111.974 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.601 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -80.65 -145.11 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.466 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -80.71 60.97 4.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 958' ' ' CYS . 26.0 m -80.53 -56.36 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.585 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.615 ' N ' HG23 ' A' ' 957' ' ' VAL . 6.2 t -89.87 135.03 33.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 44.0 mtmt -150.36 130.12 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.871 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 935' ' ' GLU . 40.6 ttm180 -53.91 142.67 23.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.008 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.618 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 13.3 mmmm -54.51 149.28 10.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.161 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.759 ' HB3' HE21 ' A' ' 981' ' ' GLN . 63.7 p -142.49 131.57 23.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -81.53 146.74 30.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.64 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 965' ' ' THR . 2.0 tmtp? -66.77 133.41 50.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.047 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.663 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 47.4 m -53.22 130.77 51.56 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.332 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.556 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 60.1 Cg_endo -70.9 136.13 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.744 2.296 . . . . 0.0 112.384 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.54 134.58 64.25 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.151 1.901 . . . . 0.0 111.296 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -57.3 122.62 55.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 0.0 111.054 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.21 143.25 58.32 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.111 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' 1020 ' ' CYS . 22.0 t -49.21 129.2 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 33.9 m120 58.23 45.77 16.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.031 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -174.54 -166.75 32.98 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.528 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -178.88 146.71 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.226 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 986' ' ' ILE . 7.1 p -98.66 133.54 40.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.823 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.0 OUTLIER -109.89 117.77 34.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.625 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 986' ' ' ILE . 33.9 m -74.46 131.03 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.83 -30.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.875 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.8 p -144.72 -54.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -158.64 -142.18 0.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.488 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -151.05 37.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.759 HE21 ' HB3' ' A' ' 962' ' ' SER . 7.9 mp0 -76.99 174.17 10.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.198 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 961' ' ' LYS . 28.1 m -63.91 30.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.62 -32.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.272 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 47.7 t -75.97 134.63 40.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 39.1 ptt180 -104.14 134.95 46.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 974' ' ' VAL . 37.3 pt -97.94 137.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.0 p -96.98 135.48 38.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 0.0 111.697 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.442 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 6.7 m-85 -101.68 138.19 39.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 51.1 m -153.54 121.61 6.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.966 0.412 . . . . 0.0 111.146 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 64.4 m -80.87 157.67 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.3 t -63.93 146.23 54.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.38 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 89.3 m -44.46 122.07 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 128.91 -54.11 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -102.99 138.56 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.663 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -95.13 147.24 23.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.314 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 997' ' ' ILE . 4.7 pp -71.63 139.74 49.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.601 ' CD1' ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -122.17 111.15 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 151.76 -60.36 0.41 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.246 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.464 ' CD2' ' HB ' ' A' 1015 ' ' THR . 98.1 m-70 -154.08 -122.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.518 0.199 . . . . 0.0 110.827 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 77.7 p -168.31 -46.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.4 p -156.0 107.62 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.63 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.409 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' 1003 ' ' GLU . 7.4 pm0 -96.27 133.1 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.126 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 42.4 t -77.43 126.9 31.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.8 pt -135.75 -159.73 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.096 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.547 HD22 ' HA ' ' A' ' 935' ' ' GLU . 28.0 tp -150.9 138.05 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.914 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 70.4 m -88.17 -44.21 11.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.34 -45.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.001 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.6 m120 -105.15 -31.48 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.43 ' C ' HD12 ' A' 1006 ' ' LEU . 98.5 m -142.69 138.53 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.051 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -82.68 145.71 29.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.102 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.8 p80 -158.55 151.37 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.537 ' CZ2' ' HD3' ' A' ' 966' ' ' PRO . 66.1 m95 -66.16 141.7 57.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 t -60.92 -30.78 70.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.464 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 61.8 p -144.06 139.29 28.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.52 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.7 pptp? -63.32 155.22 75.52 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.413 ' HB3' ' HE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -66.01 130.09 23.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.523 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.442 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_exo -64.88 -150.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.901 2.401 . . . . 0.0 112.628 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.772 HG22 ' H ' ' A' 1020 ' ' CYS . 1.5 mt -136.91 -158.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.772 ' H ' HG22 ' A' 1019 ' ' ILE . 73.7 m -155.07 132.01 10.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.312 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.601 ' HG2' ' CD1' ' A' ' 997' ' ' ILE . 20.5 pt20 -152.42 142.26 22.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -48.51 128.92 15.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.359 0.599 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 37.8 mt -74.83 128.98 84.34 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.039 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.742 2.295 . . . . 0.0 112.34 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.64 138.7 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.061 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -56.18 136.72 52.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.912 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -166.16 131.94 2.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.55 ' C ' HD22 ' A' ' 949' ' ' LEU . 41.9 m80 -150.75 132.23 14.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.672 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 6.1 p -82.15 128.96 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -69.85 170.63 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.291 0.567 . . . . 0.0 111.302 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.42 134.3 12.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.41 149.96 84.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.64 172.72 1.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.96 130.4 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.242 0.544 . . . . 0.0 111.553 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 943' ' ' ILE . 1.5 m-85 -89.98 -43.46 10.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.6 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 82.2 mt 75.0 -43.01 0.5 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.929 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 908' ' ' PHE . 0.1 OUTLIER -83.55 -1.03 52.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -153.65 128.96 9.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.48 132.65 40.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -44.65 144.89 0.99 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.995 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 913' ' ' LEU . 38.5 ttpt -138.54 -36.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.514 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 917' ' ' THR . 4.6 m -64.63 143.64 57.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.49 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 17.8 mp0 -49.4 125.29 10.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 915' ' ' THR . 81.0 p -152.04 143.77 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.239 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.3 m -159.48 -47.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.558 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.25 160.32 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.4 p -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -85.37 145.38 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -132.03 136.0 27.51 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.488 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.417 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.9 Cg_endo -69.54 141.86 47.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.838 2.358 . . . . 0.0 112.198 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 949' ' ' LEU . 15.9 mm -54.63 151.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 90.09 -30.74 5.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.0 m -55.9 125.25 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 112.015 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 34.9 t -95.94 135.14 38.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.855 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' A' ' 917' ' ' THR . 9.0 tp -117.1 114.19 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.685 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 24.9 ttmm -89.91 139.66 30.38 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.426 ' CZ ' HD23 ' A' ' 913' ' ' LEU . 7.0 m-85 -130.06 130.67 45.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.463 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 8.6 pt-20 -92.73 125.4 37.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.193 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 91.3 m -52.65 143.9 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.402 . . . . 0.0 111.42 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.9 mtp180 -82.93 155.94 67.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' 1006 ' ' LEU . 27.5 Cg_endo -63.44 64.75 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.721 2.28 . . . . 0.0 112.753 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.463 ' HG2' ' HE ' ' A' ' 960' ' ' ARG . 39.1 tt0 -174.85 2.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.22 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 40.1 m-85 -141.24 136.32 31.56 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.402 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.747 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 16.4 p90 -102.73 139.78 37.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.256 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.803 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 150.45 27.68 0.05 OUTLIER Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.58 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 938' ' ' GLY . 16.6 ptm180 45.79 171.04 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 122.971 0.508 . . . . 0.0 112.019 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.481 ' CD ' ' HB2' ' A' ' 939' ' ' ARG . 2.6 Cg_endo -77.86 112.89 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.109 1.873 . . . . 0.0 111.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.403 ' HD1' ' N ' ' A' ' 942' ' ' SER . 23.1 p90 -94.43 -160.52 0.78 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.467 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.403 ' N ' ' HD1' ' A' ' 941' ' ' PHE . 41.9 t -172.89 143.09 1.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.568 HD13 ' HZ ' ' A' ' 908' ' ' PHE . 3.5 pt -94.03 -170.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.986 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.42 HG22 HD23 ' A' ' 946' ' ' LEU . 1.0 OUTLIER -164.63 127.59 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.721 ' SG ' HD13 ' A' ' 924' ' ' ILE . 12.1 t -66.94 112.64 4.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 87.6 mt -82.18 -57.79 3.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -174.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.8 t70 172.74 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.948 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -83.5 34.95 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.912 HD21 ' HB1' ' A' ' 900' ' ' ALA . 30.7 mt 51.9 47.3 25.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.314 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.8 OUTLIER -135.43 -168.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.766 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.425 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 47.9 m95 -146.02 128.77 16.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 47.7 t -43.96 143.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.085 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.4 t -78.58 115.6 52.9 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.04 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.471 ' HG2' ' CE2' ' A' ' 908' ' ' PHE . 5.1 Cg_exo -75.95 53.49 3.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.372 2.714 . . . . 0.0 112.151 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.39 132.33 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.692 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.0 t0 56.99 77.89 0.25 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.231 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 24.5 m -149.31 -30.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.548 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.803 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 34.8 t -151.6 62.97 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.469 . . . . 0.0 110.913 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 11.3 mmpt? -55.23 153.77 6.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.646 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.824 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -58.43 132.25 53.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.669 -179.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.747 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 21.4 mmtp -56.37 135.64 53.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.082 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.629 ' HB2' ' HG2' ' A' ' 981' ' ' GLN . 48.3 t -152.66 129.08 10.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.998 0.428 . . . . 0.0 111.018 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 6.1 p -81.58 154.76 26.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.294 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -65.15 137.96 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 0.0 110.92 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 69.4 m -54.17 128.53 57.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 32.6 Cg_endo -63.67 134.41 43.97 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.439 2.092 . . . . 0.0 111.732 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 52.2 Cg_exo -52.58 127.89 26.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.104 1.869 . . . . 0.0 111.525 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -57.49 125.46 71.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.95 138.74 41.21 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.5 p -50.89 124.2 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.681 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 33.9 m120 59.24 48.04 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.521 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -156.87 -155.13 7.32 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.534 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 42.8 ttp 173.94 135.74 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.867 HG21 HD12 ' A' ' 986' ' ' ILE . 15.0 p -98.65 123.99 51.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 977' ' ' ILE . 33.3 m-70 -76.98 108.51 10.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 979' ' ' ASP . 89.1 t -62.58 -32.16 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 71.83 -47.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.82 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -148.38 -60.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.596 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.9 m-20 -155.01 -152.89 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.065 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.585 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -148.64 22.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.934 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 84.9 mt-30 -79.36 156.5 27.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.007 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.596 HG11 ' HG ' ' A' 1006 ' ' LEU . 49.2 t -49.95 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.158 0.504 . . . . 0.0 111.065 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 151.8 -40.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.266 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.0 p -76.01 138.54 40.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.517 ' HE ' ' HB2' ' A' 1001 ' ' SER . 76.9 ttt180 -104.19 125.97 50.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.867 HD12 HG21 ' A' ' 974' ' ' VAL . 41.3 pt -98.94 129.22 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.818 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.1 p -96.95 134.2 40.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 22.9 m-85 -96.13 139.02 32.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.454 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 52.5 m -152.42 116.45 4.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.476 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.8 146.92 41.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.521 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 94.0 m -64.64 142.96 58.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.245 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.0 t -41.94 124.38 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.025 0.441 . . . . 0.0 111.553 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.85 -48.35 0.97 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.742 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -102.33 144.5 30.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.545 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.2 ptt180 -92.63 143.7 26.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 997' ' ' ILE . 7.5 tt -71.81 132.32 44.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.555 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.7 mp -110.05 134.55 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.8 -128.22 9.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.359 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.439 ' HB2' ' HG3' ' A' 1018 ' ' PRO . 40.9 m80 -78.3 -132.51 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.437 0.16 . . . . 0.0 111.394 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.8 t -174.25 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.65 0.262 . . . . 0.0 111.191 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.517 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 76.2 p -150.89 150.29 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.893 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.496 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.58 130.53 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.0 tt0 -99.08 135.52 40.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 30.5 t -71.44 119.19 15.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.649 HD13 ' H ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -140.78 160.39 23.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.541 0.686 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.596 ' HG ' HG11 ' A' ' 982' ' ' VAL . 93.1 mt -89.22 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.793 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 68.7 m -149.99 -32.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -157.05 57.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.274 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 14.2 m-20 61.44 27.74 17.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.009 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 8.0 m -149.11 131.99 16.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 128.65 34.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.859 0.362 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.465 ' O ' HD13 ' A' 1005 ' ' ILE . 8.2 p80 -158.09 145.8 18.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.487 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' HG22 ' A' ' 980' ' ' ILE . 58.7 m95 -67.48 137.73 56.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.9 p -54.8 -28.71 51.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.701 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 81.5 p -139.34 138.9 37.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.957 0.408 . . . . 0.0 111.815 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1017 ' ' PRO . 7.5 tmtm? -57.38 134.76 81.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.499 ' O ' ' HD3' ' A' 1016 ' ' LYS . 50.7 Cg_exo -54.56 126.67 23.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 31.8 Cg_exo -59.75 -157.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.832 2.355 . . . . 0.0 112.716 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.783 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -139.75 -161.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.257 0.551 . . . . 0.0 110.964 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.783 ' H ' HG22 ' A' 1019 ' ' ILE . 84.4 m -155.93 138.51 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 8.4 tt0 -151.25 134.77 16.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.309 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -46.21 128.46 9.62 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.3 mt -74.87 126.65 88.11 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.765 2.31 . . . . 0.0 112.555 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.812 0.339 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -170.27 134.29 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.46 -154.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.327 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -74.12 130.12 39.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.406 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -153.65 133.64 13.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.5 p -82.27 110.92 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.314 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -83.23 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.88 124.85 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.568 ' HB3' ' CG ' ' A' ' 951' ' ' TRP . 86.8 Cg_endo -82.33 124.09 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.701 2.268 . . . . 0.0 113.395 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 35.8 t0 26.05 -137.09 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.061 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 35.4 p-80 -161.05 151.43 17.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.168 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -145.51 134.0 21.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.2 mp -83.04 -49.16 9.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.212 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.515 ' HA ' ' HD3' ' A' ' 933' ' ' ARG . 0.8 OUTLIER -84.97 28.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -156.46 135.11 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.509 ' HD3' ' C ' ' A' ' 911' ' ' ALA . 0.0 OUTLIER -136.44 124.52 22.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.193 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 58.7 tp -49.38 144.67 5.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.137 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.735 ' HD2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -154.75 27.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 0.0 110.986 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.578 HG22 ' HG3' ' A' ' 916' ' ' GLN . 24.2 m -69.96 -111.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.572 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -169.13 34.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.452 0.644 . . . . 0.0 110.413 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.1 t -87.35 154.78 20.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.898 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.7 p -136.5 46.54 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.448 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -166.67 159.31 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.015 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.2 p -85.01 -36.95 20.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -84.58 146.03 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.6 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 87.6 m-85 -134.75 145.57 55.34 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 111.526 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.1 Cg_endo -84.5 137.51 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.453 2.769 . . . . 0.0 112.386 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.803 HG21 ' HA ' ' A' ' 947' ' ' ASP . 53.3 mt -54.34 154.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.196 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 74.24 58.14 4.43 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.642 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 3.8 m -175.23 127.26 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.43 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.627 ' HB3' ' OG1' ' A' ' 944' ' ' THR . 79.4 p -105.68 135.42 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.652 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.619 ' HB2' ' HE1' ' A' ' 930' ' ' TYR . 93.5 mt -96.85 128.29 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.363 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 15.3 tppt? -82.88 121.05 26.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.748 0.309 . . . . 0.0 111.383 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 9.2 m-85 -111.72 127.95 55.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.735 ' HG3' ' HD2' ' A' ' 914' ' ' LYS . 61.9 mm-40 -92.16 107.0 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 110.637 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 83.1 m -59.62 178.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.856 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 910' ' ' PHE . 78.9 mtp180 -85.67 151.7 55.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.134 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 936' ' ' TYR . 53.2 Cg_exo -52.85 -37.17 76.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.904 2.403 . . . . 0.0 112.872 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.96 12.39 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.662 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 934' ' ' PRO . 33.8 m-85 -139.6 128.75 23.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 19.3 p90 -96.2 137.05 35.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.425 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 147.33 152.67 5.71 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.72 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.61 142.16 83.44 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.344 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.746 ' HB2' ' HD2' ' A' ' 929' ' ' LYS . 40.9 Cg_exo -56.36 137.02 78.62 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.918 2.412 . . . . 0.0 111.85 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.727 ' HB3' HG11 ' A' ' 957' ' ' VAL . 30.4 p90 -89.71 124.7 34.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.55 0.691 . . . . 0.0 111.336 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 928' ' ' LEU . 75.1 p -75.52 -38.65 59.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.877 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' A' ' 930' ' ' TYR . 47.7 pt 49.32 93.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.618 0.723 . . . . 0.0 111.702 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 927' ' ' SER . 11.9 m -84.29 139.56 32.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.586 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 98.2 m -73.7 129.06 37.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 950' ' ' VAL . 2.2 mm? -82.56 -65.98 0.94 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.803 ' HA ' HG21 ' A' ' 924' ' ' ILE . 24.6 t70 172.82 -41.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.397 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -85.54 41.9 0.93 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.071 0.462 . . . . 0.0 109.89 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 900' ' ' ALA . 63.5 mt 53.28 48.87 21.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.783 HG23 HD23 ' A' ' 946' ' ' LEU . 6.6 m -131.87 177.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.483 0.658 . . . . 0.0 112.005 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.568 ' CG ' ' HB3' ' A' ' 905' ' ' PRO . 46.8 m95 -135.23 126.88 28.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.84 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.741 ' N ' HD21 ' A' ' 946' ' ' LEU . 11.0 m -42.43 148.85 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.274 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 35.4 t -76.98 121.52 84.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.0 Cg_exo -76.55 56.44 5.13 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.538 2.826 . . . . 0.0 111.734 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.525 ' HG2' ' OD1' ' A' ' 956' ' ' ASP . 57.8 tttp -75.87 123.61 25.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.431 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.525 ' OD1' ' HG2' ' A' ' 955' ' ' LYS . 1.4 m-20 57.76 98.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.384 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 941' ' ' PHE . 16.1 m -151.07 -31.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 92.5 m -152.05 65.4 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.6 mmtt -60.52 137.65 58.13 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 36.8 ttm180 -59.59 135.56 57.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.649 ' NZ ' HD11 ' A' 1006 ' ' LEU . 98.0 mttt -57.52 145.91 31.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.517 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.558 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 75.6 p -142.47 137.34 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 68.8 m -81.03 154.93 26.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.137 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.81 127.7 33.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.842 0.353 . . . . 0.0 110.667 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 19.4 m -57.15 136.83 80.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.765 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 974' ' ' VAL . 5.8 Cg_endo -48.15 140.45 19.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.229 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 968' ' ' ASP . 65.5 Cg_endo -73.62 49.4 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.791 2.327 . . . . 0.0 112.983 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 967' ' ' PRO . 1.7 p30 26.06 67.29 0.47 Allowed Pre-proline 0 N--CA 1.465 0.289 0 O-C-N 123.507 0.505 . . . . 0.0 112.153 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -40.56 134.56 2.18 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.76 2.307 . . . . 0.0 112.635 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 971' ' ' ASN . 2.6 p -53.1 132.95 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.764 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.435 ' OD1' HG22 ' A' ' 970' ' ' VAL . 32.9 m120 58.66 53.14 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.332 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -155.66 -153.51 6.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.554 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 38.9 ttm 176.52 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.543 0.211 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.616 HG21 ' HG3' ' A' ' 966' ' ' PRO . 1.9 p -93.83 168.44 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.23 0.538 . . . . 0.0 110.652 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.932 ' CE1' HG13 ' A' ' 977' ' ' ILE . 3.0 t-80 -152.83 104.01 2.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.297 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 26.9 m -66.72 -24.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.932 HG13 ' CE1' ' A' ' 975' ' ' HIS . 3.8 mp 76.86 -42.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 0.0 110.435 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 977' ' ' ILE . 81.5 p -144.77 -59.76 0.36 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.664 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.8 m-20 -157.39 -145.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.389 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.491 HG22 ' HH2' ' A' 1013 ' ' TRP . 4.2 pt -148.25 20.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.068 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.729 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 53.8 mm-40 -76.63 177.2 7.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.87 -24.13 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 109.869 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -107.9 53.67 0.59 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.606 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 54.9 m -158.31 127.68 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.014 0.435 . . . . 0.0 110.604 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.595 ' O ' HD13 ' A' ' 977' ' ' ILE . 74.0 ttt180 -104.22 129.13 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.186 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 976' ' ' VAL . 42.7 pt -103.07 151.77 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.807 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.467 ' OG1' HD11 ' A' ' 977' ' ' ILE . 8.5 p -135.79 138.65 42.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.077 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 966' ' ' PRO . 2.0 m-85 -96.48 151.44 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.399 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 53.6 m -153.61 69.6 0.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.601 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 66.5 m -44.5 151.08 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.776 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 146.2 50.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 77.6 m -40.59 -38.68 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.183 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -55.03 -49.49 62.51 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.826 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.2 m80 -102.45 141.6 35.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.018 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.606 ' HB3' HG12 ' A' 1023 ' ' ILE . 33.6 ptt85 -90.65 141.43 28.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.32 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 997' ' ' ILE . 5.5 tt -71.87 133.82 45.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.719 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.0 mp -104.71 135.07 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.26 -139.19 15.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.453 ' CE1' ' HG3' ' A' 1018 ' ' PRO . 23.1 p80 -79.58 -135.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.436 ' N ' ' ND1' ' A' ' 999' ' ' HIS . 80.1 p -177.41 16.08 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.594 0.235 . . . . 0.0 111.358 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 32.1 t -159.43 145.05 15.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.43 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.519 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.64 124.02 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.1 tt0 -98.45 137.73 36.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 50.0 t -71.2 124.27 24.1 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 27.4 pt -133.39 -154.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.952 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.649 HD11 ' NZ ' ' A' ' 961' ' ' LYS . 2.5 tt -154.27 125.36 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.476 ' N ' HD23 ' A' 1006 ' ' LEU . 40.4 t -90.1 42.95 1.12 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.206 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 26.8 27.82 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.671 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -158.93 -47.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.2 m -147.82 143.53 27.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.054 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -79.83 131.92 36.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.6 p80 -160.18 155.95 25.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.491 ' HH2' HG22 ' A' ' 980' ' ' ILE . 80.9 m95 -64.29 144.72 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -54.54 -33.21 59.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 1.7 t -146.75 148.42 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.382 0.611 . . . . 0.0 112.29 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.63 138.04 86.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.985 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 77.5 Cg_exo -50.8 138.01 42.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.723 2.282 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 999' ' ' HIS . 24.1 Cg_exo -63.02 -160.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.29 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 42.3 mt -141.75 136.45 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.0 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 70.9 m -97.15 125.31 41.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.14 128.3 18.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 13.0 ptp180 -47.5 140.36 5.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.588 0.708 . . . . 0.0 111.535 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.9 mt -74.84 130.87 80.3 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.162 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 46.0 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.809 2.34 . . . . 0.0 112.265 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 897' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 897' ' ' GLU . 53.0 mp0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.823 0.344 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -81.39 48.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.059 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 59.66 46.03 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.818 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -74.65 135.74 41.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -152.69 132.02 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.7 p -82.34 118.51 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.99 173.51 9.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.982 0.42 . . . . 0.0 111.307 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.42 135.55 7.38 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.272 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 54.7 Cg_exo -51.9 136.14 51.46 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.59 2.193 . . . . 0.0 112.068 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 907' ' ' HIS . 35.4 m-20 -64.83 105.1 0.94 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 906' ' ' ASP . 0.0 OUTLIER 11.27 110.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.173 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.671 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 3.6 m-85 -90.02 131.47 35.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 110.227 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.2 mm? -75.19 -68.71 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.685 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.5 OUTLIER -85.29 21.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -149.35 150.75 32.97 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.135 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.472 ' HD3' ' NH1' ' A' ' 933' ' ' ARG . 23.8 pttm -140.51 136.67 33.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.5 tm? -45.27 139.68 3.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.609 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.606 ' N ' HD13 ' A' ' 913' ' ' LEU . 30.7 mmmt -150.82 58.06 0.92 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.731 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 917' ' ' THR . 15.5 m -167.88 134.95 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.885 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.74 138.37 47.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 915' ' ' THR . 60.0 p -150.75 -57.22 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.396 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 22.6 p 68.79 -50.11 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.831 0.707 . . . . 0.0 112.255 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.32 148.14 48.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.43 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.7 p -85.8 -48.29 8.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.25 123.27 30.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.182 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 50.1 m-85 -103.86 146.2 32.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.486 . . . . 0.0 112.019 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.6 Cg_endo -83.8 139.9 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.488 2.792 . . . . 0.0 111.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.768 HD13 ' HA ' ' A' ' 947' ' ' ASP . 48.1 mt -52.77 152.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.341 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 944' ' ' THR . . . 89.65 -40.74 3.02 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 38.1 m -56.85 137.69 54.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.345 . . . . 0.0 110.458 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.582 ' HB2' ' OG ' ' A' ' 942' ' ' SER . 82.2 p -120.8 132.33 54.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.113 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 942' ' ' SER . 72.8 mt -106.21 136.41 45.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.04 0.447 . . . . 0.0 111.741 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.525 ' HB2' ' OG1' ' A' ' 915' ' ' THR . 99.3 mttt -86.5 133.41 33.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.723 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 11.6 m-85 -132.64 125.27 30.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.531 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 914' ' ' LYS . 95.4 mt-10 -95.29 133.18 39.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 72.8 m -58.51 150.31 23.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.018 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 41.5 mtp85 -82.84 163.36 51.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.518 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 40.6 Cg_endo -66.75 64.57 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 95.1 mt-10 -165.43 -18.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.232 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 3.0 m-85 -129.38 -168.75 1.99 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 958' ' ' CYS . 16.5 p90 -150.03 138.26 20.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.985 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 167.22 4.84 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.353 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.935 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 6.6 ppt_? 46.06 173.27 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 123.013 0.525 . . . . 0.0 112.286 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 13.6 Cg_endo -58.93 89.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.41 2.073 . . . . 0.0 113.059 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.503 ' HA ' ' NH1' ' A' ' 939' ' ' ARG . 42.2 p90 -90.17 120.85 31.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.879 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 927' ' ' SER . 23.8 t -74.03 160.21 31.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.809 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.533 HG22 ' HG3' ' A' ' 954' ' ' PRO . 5.4 pt -137.64 104.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 925' ' ' GLY . 30.3 m -82.33 130.79 35.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 97.9 m -73.71 132.08 42.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.5 mm? -84.54 -60.22 2.14 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.768 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.1 t0 171.66 -36.81 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.691 0.282 . . . . 0.0 110.953 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 950' ' ' VAL . 73.3 m-80 -82.94 37.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 900' ' ' ALA . 79.6 mt 50.5 42.98 27.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.934 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 948' ' ' ASN . 22.2 m -136.13 147.99 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.796 0.808 . . . . 0.0 112.07 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 952' ' ' SER . 52.2 m95 -91.82 122.16 34.1 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.596 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -38.68 126.13 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 70.3 m -78.15 107.14 4.96 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 110.909 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 943' ' ' ILE . 60.4 Cg_endo -100.92 55.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 124.013 3.142 . . . . 0.0 112.608 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -77.44 38.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.539 0.685 . . . . 0.0 110.09 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 954' ' ' PRO . 34.3 t70 -159.92 53.78 0.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.692 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 941' ' ' PHE . 8.8 m -147.05 -17.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.871 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 937' ' ' TYR . 11.1 t -147.57 135.38 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.123 0.487 . . . . 0.0 110.901 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 32.0 mtmt -147.77 149.87 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.252 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 52.2 ttm-85 -53.31 135.38 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 937' ' ' TYR . 30.2 mmtp -56.29 164.73 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.36 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.509 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 85.1 p -145.5 132.84 20.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.797 0.332 . . . . 0.0 110.216 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 49.2 m -81.57 36.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 61.7 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 980' ' ' ILE . 30.7 m -55.79 129.06 71.06 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 57.5 Cg_endo -70.71 121.3 7.79 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.462 2.108 . . . . 0.0 112.693 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 11.8 Cg_exo -69.76 123.76 10.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.455 2.103 . . . . 0.0 111.364 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.54 120.95 64.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.36 141.27 50.89 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.38 2.053 . . . . 0.0 111.752 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.452 HG22 ' OD1' ' A' ' 971' ' ' ASN . 2.2 p -45.96 127.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.452 ' OD1' HG22 ' A' ' 970' ' ' VAL . 33.3 m120 66.16 49.34 1.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.888 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -163.82 -158.15 9.82 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.867 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 40.0 ttm 176.72 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.536 0.208 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.5 p -100.56 131.47 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.819 0.343 . . . . 0.0 111.52 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -91.87 111.46 23.0 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 30.1 m -64.22 -18.69 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 109.913 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 987' ' ' THR . 12.4 mm 74.57 -47.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 67.9 p -148.18 -49.97 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.759 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.4 m-20 -157.49 -149.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.866 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -151.08 25.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 111.143 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 962' ' ' SER . 44.7 mm-40 -80.91 163.7 23.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.143 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 961' ' ' LYS . 54.8 t -55.43 93.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.078 0.466 . . . . 0.0 111.14 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.66 -47.6 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.232 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.5 t -76.4 141.31 41.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 111.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 3.5 ptm85 -104.22 131.86 51.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.546 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.7 pt -98.13 127.48 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.569 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -97.07 132.69 42.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.977 0.417 . . . . 0.0 110.953 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.516 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 10.8 m-85 -96.6 139.96 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.443 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -152.74 116.43 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.181 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 83.9 m -73.02 147.21 45.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.454 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.56 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 8.6 t -64.86 149.16 50.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.614 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 84.8 m -46.68 108.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.317 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 152.92 -57.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.265 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.415 ' HB3' ' C ' ' A' 1021 ' ' GLN . 7.6 m80 -102.46 145.92 28.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.77 ' HB3' HG12 ' A' 1023 ' ' ILE . 15.6 ptm180 -90.02 139.16 30.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.166 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.689 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.3 tt -71.84 132.7 44.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.942 0.401 . . . . 0.0 110.734 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.689 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.5 mp -106.07 130.84 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.52 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 96.56 -138.75 14.1 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.085 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -81.27 -140.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.414 0.15 . . . . 0.0 111.146 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 42.7 t 178.9 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.424 ' HB2' HH21 ' A' ' 985' ' ' ARG . 66.1 p -158.8 148.95 19.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.045 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.55 118.16 3.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.2 tt0 -96.33 128.61 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 50.6 t -71.32 119.39 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.404 ' HA ' HG13 ' A' ' 982' ' ' VAL . 37.4 pt -136.6 143.6 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.244 0.545 . . . . 0.0 111.892 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 53.8 tp -84.61 124.48 31.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.998 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.5 t -95.96 -50.24 4.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' 1010 ' ' THR . . . 169.26 122.16 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.71 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 72.99 -37.14 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.164 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' 1008 ' ' GLY . 84.6 m -145.72 136.26 24.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.216 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 151.09 26.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.372 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.7 p80 -153.07 147.59 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 86.9 m95 -64.37 139.13 58.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.162 0.506 . . . . 0.0 111.297 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 m -62.42 -21.75 65.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.282 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.8 m -138.9 135.74 34.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.4 pttm -72.73 148.28 89.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.768 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.85 129.02 28.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.589 2.193 . . . . 0.0 112.397 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.24 -154.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.735 2.29 . . . . 0.0 112.465 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 53.1 mt -139.91 141.54 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 97.5 m -100.85 125.65 47.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.415 ' C ' ' HB3' ' A' ' 994' ' ' HIS . 19.8 tt0 -145.51 138.11 25.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.387 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -45.55 135.62 6.33 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 111.703 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.77 HG12 ' HB3' ' A' ' 995' ' ' ARG . 54.8 mt -74.76 126.94 87.92 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.711 2.274 . . . . 0.0 112.482 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.732 0.301 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -178.67 136.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -151.39 130.38 12.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.776 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 64.65 136.3 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.52 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.501 ' C ' HD22 ' A' ' 949' ' ' LEU . 1.7 m-70 -147.5 120.78 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.52 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 24.9 p -82.25 122.33 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -73.02 167.69 20.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.476 0.655 . . . . 0.0 112.045 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -47.53 133.23 10.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.509 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.5 Cg_exo -62.32 154.54 62.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.926 2.418 . . . . 0.0 112.407 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 907' ' ' HIS . 27.1 t70 -62.23 173.08 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.677 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.437 ' N ' ' CG ' ' A' ' 906' ' ' ASP . 42.6 m170 -77.68 121.48 24.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.288 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 1.9 m-85 -86.43 -36.09 19.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.48 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 92.0 mt 75.98 -46.03 0.54 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.748 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 6.05 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.66 126.44 5.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.2 124.81 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.309 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 929' ' ' LYS . 63.2 tp -51.61 156.79 1.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.503 ' H ' HD12 ' A' ' 913' ' ' LEU . 73.9 mmtt -145.29 -66.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 914' ' ' LYS . 17.9 m 19.88 -117.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.687 0.617 . . . . 0.0 111.884 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.499 ' N ' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -175.95 41.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.201 0.524 . . . . 0.0 110.476 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.669 HG21 HD11 ' A' ' 928' ' ' LEU . 39.0 p -82.8 -172.82 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 98.0 m -169.1 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.478 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.4 157.76 37.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -84.61 -43.62 14.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.37 124.8 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.53 ' HE2' HG21 ' A' ' 917' ' ' THR . 80.4 m-85 -103.69 134.55 19.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.574 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 59.9 Cg_endo -71.94 141.92 37.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 112.126 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.689 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 32.7 mt -59.69 156.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 82.71 -35.6 2.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.716 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.574 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 18.7 m -56.04 127.42 30.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.526 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 48.7 m -101.72 131.42 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 917' ' ' THR . 5.2 tp -95.79 -168.07 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.177 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.695 ' O ' HD12 ' A' ' 913' ' ' LEU . 40.6 ttmt -157.44 130.36 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.591 ' CE1' HD23 ' A' ' 928' ' ' LEU . 5.4 m-85 -129.09 135.64 49.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.384 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.653 ' OE1' ' HB3' ' A' ' 940' ' ' PRO . 2.9 mm-40 -96.26 134.78 38.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.363 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 86.6 m -55.33 155.35 5.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.566 ' HG2' ' HD2' ' A' ' 934' ' ' PRO . 65.1 ttt180 -82.37 145.13 51.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 933' ' ' ARG . 67.6 Cg_exo -39.35 -41.2 2.15 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.717 2.278 . . . . 0.0 112.884 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 961' ' ' LYS . 50.2 mt-10 -69.14 -34.74 75.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.487 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.43 ' HD1' ' HB3' ' A' ' 933' ' ' ARG . 18.3 m-85 -94.85 142.61 27.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.144 0.497 . . . . 0.0 112.305 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 8.3 p90 -100.08 141.99 32.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.655 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 153.44 147.65 4.69 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.222 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.688 ' H ' ' HD2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -73.08 158.84 86.47 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.653 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 31.2 Cg_exo -60.03 115.45 2.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.573 2.182 . . . . 0.0 112.208 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 930' ' ' TYR . 49.3 p90 -95.6 -168.21 1.74 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 928' ' ' LEU . 68.8 m -166.93 134.6 2.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.099 0.476 . . . . 0.0 111.33 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.412 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 5.1 pt -102.38 125.69 56.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.443 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 18.0 m -82.77 122.09 27.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.28 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 8.4 t -71.44 103.07 2.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 88.0 mt -82.72 162.02 21.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.437 ' HA ' HG21 ' A' ' 924' ' ' ILE . 62.6 t0 -45.44 -34.23 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.135 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.663 ' O ' HG13 ' A' ' 950' ' ' VAL . 2.6 m120 -81.32 28.89 0.37 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.623 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 900' ' ' ALA . 45.7 mt 47.79 31.78 2.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.323 0.582 . . . . 0.0 109.918 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 948' ' ' ASN . 29.5 m -107.92 -160.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.62 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.511 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 81.9 m95 -150.67 121.41 7.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.817 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.9 p -41.49 142.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.497 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.479 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 39.7 t -78.58 115.08 48.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.051 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.8 Cg_exo -74.61 130.81 14.07 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.995 2.463 . . . . 0.0 111.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.484 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 29.8 mmmt -80.77 -133.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.464 0.65 . . . . 0.0 111.755 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 6.7 t70 -78.36 60.32 2.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.314 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 33.9 m -81.51 -34.09 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.885 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.48 ' O ' ' HE3' ' A' ' 959' ' ' LYS . 30.0 m -150.41 125.7 10.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.12 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.1 mmpt? -137.48 149.53 46.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.834 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 14.7 mmt85 -53.2 120.7 6.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 28.8 mtpp -58.29 -171.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.417 ' HB3' HE21 ' A' ' 981' ' ' GLN . 81.1 p -153.14 137.7 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.8 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.411 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 58.5 m -81.58 38.85 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt 59.0 130.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.433 ' HA ' HD12 ' A' ' 980' ' ' ILE . 49.6 m -57.74 126.7 76.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 986' ' ' ILE . 52.6 Cg_endo -68.6 128.75 17.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.418 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 34.9 Cg_exo -59.66 131.18 38.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.365 2.043 . . . . 0.0 111.614 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -61.28 120.63 56.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.954 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 139.22 36.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.072 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' 1020 ' ' CYS . 20.4 t -52.01 130.06 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 30.6 m120 56.82 52.8 8.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.694 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -158.26 -153.3 6.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.243 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 32.2 ttp 175.01 119.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.607 0.241 . . . . 0.0 111.002 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 974' ' ' VAL . 12.0 p -101.02 124.21 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.728 0.775 . . . . 0.0 111.355 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.789 ' CE1' HG12 ' A' ' 977' ' ' ILE . 1.9 t-80 -87.28 103.08 15.11 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.6 m -53.02 -20.51 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.789 HG12 ' CE1' ' A' ' 975' ' ' HIS . 12.9 mt 66.58 60.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.583 0.706 . . . . 0.0 109.395 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 14.1 p 80.79 -48.42 0.29 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.234 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.562 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 55.3 m-20 -156.27 -158.57 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.86 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.485 HG22 ' CG2' ' A' ' 986' ' ' ILE . 12.8 pt -151.04 23.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.35 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.562 ' OE1' ' HB3' ' A' ' 979' ' ' ASP . 7.2 mp0 -76.54 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 96.2 t -55.49 84.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.125 0.488 . . . . 0.0 110.736 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.9 -45.94 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.108 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 50.5 m -76.05 138.85 41.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 111.257 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.686 ' HE ' ' HB3' ' A' 1003 ' ' GLU . 38.3 ttm180 -103.37 139.1 39.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.351 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 20.3 pt -98.62 122.45 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.678 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.483 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.7 p -101.93 135.56 43.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.095 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 3.1 m-85 -96.49 140.4 31.18 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.747 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 43.9 t -151.75 64.45 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 35.8 m -35.75 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.618 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 9.0 t -174.18 165.87 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 9.0 t -52.84 -36.28 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.659 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' 1023 ' ' ILE . . . -63.69 -55.14 26.68 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.488 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -101.81 136.73 41.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.413 . . . . 0.0 111.26 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.7 ptt180 -92.57 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.511 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.7 tt -72.36 132.23 43.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -111.25 132.78 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 111.302 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 68.04 131.84 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.217 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 47.5 -139.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.652 0.263 . . . . 0.0 111.449 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.1 t -177.05 -30.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 46.8 t -154.56 168.66 26.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.511 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.96 133.65 14.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.045 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.686 ' HB3' ' HE ' ' A' ' 985' ' ' ARG . 19.3 pt-20 -96.15 134.14 39.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.122 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.453 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.8 t -76.42 124.76 28.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' 1014 ' ' SER . 41.9 pt -135.94 -154.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.471 . . . . 0.0 112.115 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' 1010 ' ' THR . 62.3 tp -151.85 138.55 18.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.009 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.507 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.6 t -87.91 -48.22 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.17 20.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.13 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 10.3 p-10 174.94 -53.79 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.782 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.488 ' O ' HD12 ' A' 1006 ' ' LEU . 10.3 m -98.88 130.56 45.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.606 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -81.21 134.8 35.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.507 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.1 p80 -158.82 147.64 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 111.65 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.493 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 60.5 m95 -68.23 134.96 51.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.771 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' 1005 ' ' ILE . 91.4 p -68.37 -12.22 60.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 6.4 m -140.93 139.24 34.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 pttm -69.76 146.0 95.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.057 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.468 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 23.9 Cg_exo -64.63 135.71 46.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.869 2.379 . . . . 0.0 112.55 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 38.0 Cg_endo -66.28 -156.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.568 2.178 . . . . 0.0 112.449 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.7 mt -142.22 139.95 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.694 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 71.7 m -93.41 124.3 37.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -145.79 133.3 20.84 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.6 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -48.12 133.2 15.38 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.559 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.645 HG12 ' HB3' ' A' ' 995' ' ' ARG . 44.8 mt -75.14 124.93 89.6 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.803 2.336 . . . . 0.0 112.253 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.75 0.31 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -171.41 135.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 899' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 900' ' ' ALA . 5.5 mm-40 -152.58 -155.33 0.6 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . 59.69 -145.4 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.612 ' N ' HD22 ' A' ' 949' ' ' LEU . 16.1 m80 67.8 127.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.703 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 2.4 p -82.27 130.03 35.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.453 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -67.22 -177.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.576 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.21 137.9 6.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 2.7 Cg_exo -75.07 63.41 6.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.202 2.601 . . . . 0.0 112.167 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.1 t0 36.32 -131.99 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.676 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 17.6 t-160 -160.45 120.21 2.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.848 0.356 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.595 ' HE2' ' HG2' ' A' ' 954' ' ' PRO . 21.9 m-85 -88.15 136.35 33.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.98 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.25 -58.58 3.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.347 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -84.84 26.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.4 122.33 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.443 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 912' ' ' LYS . 10.3 mtmp? -100.52 131.49 46.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.548 HD21 ' OG1' ' A' ' 917' ' ' THR . 52.1 tp -48.22 129.71 15.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.491 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.564 ' HD3' ' HD2' ' A' ' 929' ' ' LYS . 51.6 tttp -94.51 -43.08 8.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 42.7 m -64.6 144.43 57.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.853 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 916' ' ' GLN . 1.3 pp0? -77.54 49.29 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.548 ' OG1' HD21 ' A' ' 913' ' ' LEU . 39.5 p -81.42 146.28 30.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 72.9 p -136.39 -33.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.576 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.47 156.22 39.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 54.6 m -84.78 -38.83 19.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.9 145.29 28.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.32 137.68 25.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.511 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -69.74 136.6 33.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.716 2.277 . . . . 0.0 111.764 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 39.9 mt -58.04 154.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.205 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.02 -34.02 3.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 22.9 m -55.93 122.24 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.659 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.6 m -94.91 120.72 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.885 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 942' ' ' SER . 10.0 tp -99.24 118.85 36.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.316 . . . . 0.0 110.737 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.564 ' HD2' ' HD3' ' A' ' 914' ' ' LYS . 39.9 ttmt -85.34 138.76 32.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.106 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 941' ' ' PHE . 7.2 m-85 -131.65 134.85 46.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.515 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.495 ' HG2' ' HD2' ' A' ' 914' ' ' LYS . 56.6 mm-40 -95.58 130.53 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.607 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.16 156.52 9.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 45.0 mtt-85 -84.8 151.84 58.61 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 936' ' ' TYR . 86.6 Cg_exo -47.48 -46.75 19.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.685 2.257 . . . . 0.0 112.859 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.587 ' HB3' HG21 ' A' ' 982' ' ' VAL . 4.8 mm-40 -73.29 20.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.745 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 82.2 m-85 -145.17 137.32 25.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.402 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.721 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 14.3 p90 -97.71 138.0 35.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.423 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 158.57 142.59 3.43 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.082 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -73.06 159.07 86.09 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.258 . . . . 0.0 110.362 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.84 149.17 71.13 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.275 1.983 . . . . 0.0 111.294 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 957' ' ' VAL . 50.7 p90 -140.01 -167.91 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.78 0.324 . . . . 0.0 110.93 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.4 p -172.88 134.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.483 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 15.3 pt -97.21 113.55 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 47.1 m -78.49 126.67 31.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.828 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.2 t -72.96 125.1 26.8 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.155 0.502 . . . . 0.0 109.936 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.915 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -88.35 167.9 13.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 0.0 113.606 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -50.6 -38.63 46.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.293 -1.776 . . . . 0.0 112.25 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.549 ' O ' HG13 ' A' ' 950' ' ' VAL . 15.0 t-20 -81.6 34.25 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 900' ' ' ALA . 21.0 mt 47.93 36.73 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.196 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.915 HG23 HD23 ' A' ' 946' ' ' LEU . 29.1 m -112.85 -159.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.241 0.543 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 85.4 m95 -147.32 124.89 11.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.473 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.9 p -39.68 141.75 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.803 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 33.7 m -79.51 112.91 32.6 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.595 ' HG2' ' HE2' ' A' ' 908' ' ' PHE . 5.8 Cg_exo -79.63 143.56 16.96 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.456 2.771 . . . . 0.0 112.346 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -159.01 137.22 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 7.2 m-20 58.95 33.8 23.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.246 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 941' ' ' PHE . 29.4 m -94.15 -32.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.209 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 37.4 m -149.82 59.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.205 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 74.2 mmtt -58.07 152.47 16.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.995 0.426 . . . . 0.0 111.762 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 981' ' ' GLN . 20.8 tpp180 -53.33 116.53 2.48 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.721 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 63.6 tttt -56.26 147.57 20.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 78.7 p -144.61 139.71 28.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 964' ' ' LYS . 37.4 m -81.56 36.18 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.563 ' NZ ' ' HB3' ' A' ' 964' ' ' LYS . 6.3 ttpm? 56.22 134.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.727 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.4 m -60.31 124.15 76.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.331 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.568 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 59.5 Cg_endo -71.48 130.43 17.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.469 2.112 . . . . 0.0 112.565 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 24.9 Cg_exo -62.67 135.04 50.41 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.445 2.097 . . . . 0.0 111.61 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.03 115.13 10.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.655 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 138.92 66.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.712 2.275 . . . . 0.0 112.388 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.3 t -53.86 134.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 56.98 42.56 26.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.873 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -160.28 -155.75 7.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.518 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 35.7 ttp 174.22 131.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.985 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -101.4 128.98 53.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.814 0.34 . . . . 0.0 111.459 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.549 ' O ' HG13 ' A' ' 977' ' ' ILE . 28.3 m-70 -87.85 114.34 24.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 980' ' ' ILE . 69.9 t -62.13 -33.67 59.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.018 0.437 . . . . 0.0 109.859 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 975' ' ' HIS . 15.0 mt 71.39 -48.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.285 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 977' ' ' ILE . 74.6 p -146.12 -60.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.859 0.362 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.6 m-20 -152.47 -161.88 1.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.862 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 976' ' ' VAL . 10.0 pt -146.78 19.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.531 . . . . 0.0 110.492 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' A' 1004 ' ' CYS . 6.7 mm100 -80.82 -178.17 6.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.643 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 935' ' ' GLU . 30.0 m -64.9 25.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -157.19 44.16 0.51 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.754 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.4 p -160.54 132.97 6.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.283 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 16.9 ptp180 -100.97 131.06 47.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.044 0.449 . . . . 0.0 111.446 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 23.7 pt -99.35 131.77 46.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.778 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.463 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -95.72 133.43 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.0 111.392 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.495 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 5.9 m-85 -98.95 137.86 36.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 55.7 m -153.5 115.01 4.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 74.1 m -75.55 150.93 38.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.809 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 23.8 m -64.07 143.57 57.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.7 t -37.8 139.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.941 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.24 -40.87 2.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.548 ' HA ' ' O ' ' A' 1021 ' ' GLN . 6.4 m-70 -99.37 137.95 37.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.046 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.552 ' HE ' HG12 ' A' 1023 ' ' ILE . 14.2 ptp180 -97.36 147.22 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.533 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 9.8 tt -69.28 129.52 40.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.796 HD11 ' HG2' ' A' 1021 ' ' GLN . 31.7 mm -102.15 80.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 154.93 -131.13 3.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.697 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.435 ' O ' HD22 ' A' ' 996' ' ' LEU . 29.2 m80 -81.48 -116.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.515 0.197 . . . . 0.0 111.454 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 46.9 t -178.61 -30.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.955 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 52.6 m -155.58 148.88 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.88 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.601 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -153.36 133.04 13.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.636 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -100.2 136.9 39.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 13.0 t -71.14 124.22 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.25 -149.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.927 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' 1010 ' ' THR . 66.2 tp -150.89 139.61 20.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.248 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.552 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 97.6 p -88.62 -52.22 5.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.553 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 158.7 31.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.649 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' 1008 ' ' GLY . 25.4 t-20 176.14 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.418 ' O ' HD12 ' A' 1006 ' ' LEU . 56.9 m -139.27 134.93 33.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.281 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.25 140.34 36.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.552 ' NE2' ' HB3' ' A' 1007 ' ' SER . 9.9 p80 -158.37 146.19 18.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 78.2 m95 -64.38 146.47 54.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.934 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.6 t -49.91 -34.28 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.723 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.8 p -144.74 139.39 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.056 0.455 . . . . 0.0 111.821 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.597 ' HD2' ' N ' ' A' 1017 ' ' PRO . 3.8 tmmm? -62.88 136.21 96.39 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.345 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.597 ' N ' ' HD2' ' A' 1016 ' ' LYS . 10.4 Cg_endo -54.08 124.87 17.03 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.786 2.324 . . . . 0.0 112.801 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.737 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 44.4 Cg_endo -67.3 -150.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.799 2.332 . . . . 0.0 112.65 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -133.18 -158.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.839 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.695 ' H ' HG22 ' A' 1019 ' ' ILE . 78.6 m -159.54 135.97 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.566 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.796 ' HG2' HD11 ' A' ' 997' ' ' ILE . 19.0 pt20 -151.31 141.89 22.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.521 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' 1022 ' ' ARG . 27.5 ptt85 -64.01 22.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.574 ' H ' ' C ' ' A' 1021 ' ' GLN . 58.0 mt 64.61 132.08 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 52.5 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.836 2.357 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -66.12 -165.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.279 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.44 139.28 0.19 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.998 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 66.69 143.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.508 ' C ' HD22 ' A' ' 949' ' ' LEU . 45.7 m80 -148.99 140.05 23.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 86.5 m -81.6 131.61 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.701 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -54.6 158.73 2.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 111.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 919' ' ' ALA . . . -48.27 123.32 10.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.846 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.506 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 34.3 Cg_exo -59.17 136.83 75.34 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 122.669 2.246 . . . . 0.0 112.94 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.2 143.79 57.48 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 131.92 39.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 911' ' ' ALA . 2.0 m-85 -85.29 150.14 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.987 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -81.17 -57.07 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.047 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.8 OUTLIER -85.47 10.77 11.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -152.14 151.62 31.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.49 136.3 39.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.526 HD11 ' HG ' ' A' ' 928' ' ' LEU . 57.5 tp -45.77 130.58 9.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.593 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 930' ' ' TYR . 11.7 tmtt? -94.59 -51.19 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 52.9 m -66.52 136.58 55.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.616 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -64.76 138.54 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.828 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.627 HG21 HD11 ' A' ' 928' ' ' LEU . 81.0 p -154.25 -170.2 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 40.1 p -156.15 34.28 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.644 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 919' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 904' ' ' ALA . . . 41.05 -146.0 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.799 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t 62.39 44.52 7.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 902' ' ' CYS . 1.5 m-20 66.61 153.54 0.08 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.503 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 919' ' ' ALA . 63.6 m-85 -136.4 145.97 53.97 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.209 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 138.24 83.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.729 2.286 . . . . 0.0 111.896 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.623 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.4 mt -58.96 155.73 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.47 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 85.42 -32.36 3.63 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.674 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 40.9 m -55.97 126.29 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 47.3 t -96.36 127.87 42.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.781 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.627 HD11 HG21 ' A' ' 917' ' ' THR . 8.6 tp -105.47 120.52 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 0.0 110.903 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 915' ' ' THR . 40.2 ttmt -85.68 140.98 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.561 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 6.3 m-85 -129.15 168.48 16.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 914' ' ' LYS . 16.6 pt-20 -144.47 137.38 26.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.926 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.69 143.26 37.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.02 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.0 mtp180 -85.52 158.69 56.94 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 7.6 Cg_endo -49.64 139.74 30.34 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.579 2.186 . . . . 0.0 111.745 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 50.5 mt-10 81.38 25.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.334 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 88.2 m-85 -146.87 135.66 22.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.796 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.8 p90 -102.34 137.47 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.885 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 157.62 146.06 4.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.877 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.519 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 77.2 mtp180 -72.82 162.72 72.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.662 0.268 . . . . 0.0 110.82 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 73.5 Cg_endo -78.75 114.66 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.384 2.056 . . . . 0.0 112.278 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 48.2 p90 -91.68 -160.17 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.5 p -175.28 132.92 0.3 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' A' ' 954' ' ' PRO . 11.0 pt -93.99 -166.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.188 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.491 ' O ' HD22 ' A' ' 946' ' ' LEU . 26.5 m -166.61 132.6 2.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.5 t -73.79 120.47 19.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 950' ' ' VAL . 1.8 mm? -87.02 174.22 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.219 1.009 . . . . 0.0 112.803 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.05 -42.69 73.01 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.135 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 950' ' ' VAL . 48.7 t30 -84.51 35.09 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.998 HD21 ' HB1' ' A' ' 900' ' ' ALA . 83.0 mt 46.42 59.66 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.815 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -138.48 -157.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.117 0.484 . . . . 0.0 111.393 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.506 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 94.3 m95 -149.13 115.98 5.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.731 ' N ' HD21 ' A' ' 946' ' ' LEU . 72.4 m -52.12 147.51 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.4 t -78.16 122.97 86.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.578 ' HG3' HG22 ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.09 26.77 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.866 2.377 . . . . 0.0 112.831 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.635 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 7.2 mtmp? 39.82 -143.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.01 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.594 ' OD1' ' HE2' ' A' ' 959' ' ' LYS . 60.3 t0 -79.5 134.26 36.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -150.68 -98.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.719 ' H ' HG23 ' A' ' 957' ' ' VAL . 63.7 m -77.13 147.36 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.014 0.435 . . . . 0.0 111.374 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.594 ' HE2' ' OD1' ' A' ' 956' ' ' ASP . 68.5 mttm -144.93 157.15 44.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.172 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.832 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -59.95 114.98 3.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.851 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' 1011 ' ' ALA . 24.6 ttmm -56.23 150.34 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.513 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 82.8 p -144.51 141.02 29.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.985 0.421 . . . . 0.0 111.38 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 82.0 m -79.9 151.6 30.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.156 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.48 131.06 45.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 29.4 m -55.77 122.94 49.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.462 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.9 Cg_endo -69.58 134.71 29.05 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.428 2.085 . . . . 0.0 111.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.84 124.49 15.99 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.047 1.831 . . . . 0.0 111.433 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -58.29 122.86 62.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.788 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.65 138.4 83.09 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.064 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' 1020 ' ' CYS . 21.7 t -52.79 130.47 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.678 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 25.9 m120 70.36 36.78 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.888 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -172.48 -153.16 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.055 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 177.41 145.44 0.11 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 110.636 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 7.7 p -93.81 120.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -78.87 112.97 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.62 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.99 -18.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.189 0.519 . . . . 0.0 109.748 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 8.9 mt 74.07 -44.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.953 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.3 p -146.77 -54.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.622 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 45.1 m-20 -159.18 -144.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.505 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 7.0 pt -151.09 31.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.156 0.503 . . . . 0.0 110.944 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.832 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 47.6 mm-40 -76.87 156.01 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.504 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' 1005 ' ' ILE . 94.5 t -55.44 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 159.0 -37.99 0.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.278 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.9 p -76.58 139.1 40.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 111.626 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.769 ' HG2' ' HB2' ' A' 1003 ' ' GLU . 87.2 mtm180 -90.64 159.08 16.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.999 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.9 pt -132.72 123.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.9 p -103.85 138.68 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.457 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.482 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.2 m-85 -100.79 138.57 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.266 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 81.9 p -153.48 131.41 11.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 71.5 m -74.17 126.04 29.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.603 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.888 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 6.0 t -76.58 55.1 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.468 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 991' ' ' THR . 99.9 m -177.64 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 992' ' ' THR . . . -168.66 39.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.499 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.743 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 3.0 m80 -93.65 159.73 15.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.641 ' HB3' HG12 ' A' 1023 ' ' ILE . 37.3 ptt180 -89.87 135.56 33.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.1 tm? -71.98 132.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 3.3 mt -118.29 135.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.387 . . . . 0.0 111.487 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.17 -125.57 8.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -79.3 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.8 p -174.58 -37.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.9 p -150.85 151.71 32.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.537 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -151.92 133.17 14.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.087 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.769 ' HB2' ' HG2' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.36 136.62 36.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.208 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 35.5 t -71.25 121.8 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.639 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.5 pt -133.46 -153.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.411 . . . . 0.0 111.934 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' 1010 ' ' THR . 57.7 tp -150.85 136.11 17.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.038 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.604 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.9 t -89.41 -40.88 12.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.713 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.55 -37.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.035 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.401 ' C ' HD11 ' A' 1006 ' ' LEU . 5.5 m120 -140.92 -48.03 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.063 0.458 . . . . 0.0 110.5 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.456 ' O ' HD12 ' A' 1006 ' ' LEU . 57.8 m -94.53 135.76 35.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.227 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.583 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -80.78 145.64 31.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.604 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.5 p80 -157.66 144.06 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.371 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 70.7 m95 -66.0 147.05 53.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.4 t -55.81 -35.11 65.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.594 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -143.12 143.78 31.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.462 . . . . 0.0 111.726 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -56.83 137.59 78.71 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.907 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 53.1 Cg_exo -52.9 129.89 35.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.379 2.053 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1017 ' ' PRO . 38.3 Cg_exo -61.44 -158.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 112.683 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.2 mt -142.86 139.37 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.945 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 42.8 t -94.43 129.02 41.34 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 995' ' ' ARG . 2.5 tp-100 -145.74 128.62 16.38 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.664 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -54.39 133.29 45.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.35 0.595 . . . . 0.0 111.311 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 995' ' ' ARG . 57.5 mt -74.83 122.8 88.29 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.2 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.866 2.378 . . . . 0.0 112.347 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.596 0.236 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 63.91 131.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.204 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 62.62 122.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . 62.67 130.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.454 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.603 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 41.3 m80 -150.91 136.76 18.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.002 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.41 125.35 29.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.291 0.567 . . . . 0.0 111.213 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -57.7 168.83 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.607 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.5 133.51 13.37 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.567 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.42 145.97 78.84 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.55 2.167 . . . . 0.0 111.729 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.74 148.65 42.2 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.39 0.614 . . . . 0.0 111.332 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -81.19 115.02 20.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.027 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 9.5 m-85 -89.93 134.39 34.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.762 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 76.7 mt -76.96 -54.4 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 2.1 p90 -84.59 25.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.201 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.17 120.76 4.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.514 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -103.48 121.14 42.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.485 HD13 ' CE1' ' A' ' 930' ' ' TYR . 29.8 tp -49.25 122.05 5.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.004 0.43 . . . . 0.0 111.324 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.702 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 0.8 OUTLIER -90.94 -44.77 9.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.321 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 54.3 m -64.65 132.92 51.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.43 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.432 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.2 pm0 -65.12 143.64 57.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.267 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 80.7 p -150.22 -58.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.089 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 82.6 p 46.25 56.16 6.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.51 -152.43 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.0 111.491 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 60.1 m -146.58 -44.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.51 135.37 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.113 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 55.1 m-85 -137.69 141.37 32.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.939 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.491 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 70.0 Cg_endo -73.93 136.98 23.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.634 2.223 . . . . 0.0 111.647 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 947' ' ' ASP . 53.4 mt -52.6 151.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 91.31 -28.38 8.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.491 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 31.8 m -55.43 138.99 44.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.994 0.426 . . . . 0.0 111.553 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.7 m -118.0 142.5 47.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.76 120.49 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.519 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -89.83 133.38 34.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.567 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 2.9 m-85 -116.12 134.77 54.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.702 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 65.7 mm-40 -94.45 117.25 29.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.801 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 68.7 m -59.41 140.63 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.344 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.0 mtp180 -85.37 158.74 57.31 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 9.2 Cg_endo -52.71 149.47 24.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.519 2.146 . . . . 0.0 110.886 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 49.6 mt-10 83.5 19.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.72 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 960' ' ' ARG . 94.3 m-85 -144.95 125.11 13.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 5.1 p90 -95.96 141.4 29.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.46 147.39 5.46 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.087 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.27 159.03 86.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.83 126.11 16.04 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.585 2.19 . . . . 0.0 112.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 5.2 p90 -90.88 -162.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.712 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 941' ' ' PHE . 64.1 m -170.12 133.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.2 pt -95.76 168.94 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.277 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.419 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.4 m -162.6 135.26 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 52.8 m -73.8 126.83 31.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.6 mm? -85.19 -53.55 5.18 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.841 ' HA ' HD13 ' A' ' 924' ' ' ILE . 50.9 t0 171.73 -38.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.691 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.07 28.07 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 60.8 43.22 12.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.32 149.75 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.886 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -94.02 141.06 28.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.166 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.0 p -52.34 138.11 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.9 t -79.19 108.61 8.84 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.756 0.312 . . . . 0.0 111.196 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 952' ' ' SER . 6.4 Cg_exo -72.75 136.03 24.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.675 2.25 . . . . 0.0 111.497 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -158.99 143.37 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.373 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.49 36.72 16.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.572 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.8 m -92.4 -111.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.009 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.467 ' H ' HG23 ' A' ' 957' ' ' VAL . 51.0 m -86.82 87.29 7.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.78 ' HD2' ' H ' ' A' ' 959' ' ' LYS . 8.3 mptt -67.75 154.59 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 936' ' ' TYR . 37.7 ttm180 -54.54 136.52 44.73 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.85 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.514 ' HG2' ' HB2' ' A' 1011 ' ' ALA . 16.6 tppt? -53.78 152.32 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.508 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 70.9 p -143.95 124.08 13.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.775 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.508 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.1 p -83.54 37.95 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 53.4 tptt 60.09 138.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.386 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 9.2 m -57.47 131.86 81.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.137 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.709 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.2 Cg_endo -65.02 125.0 13.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.471 2.114 . . . . 0.0 112.462 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 17.3 Cg_exo -66.27 120.57 7.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.305 2.003 . . . . 0.0 111.498 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 973' ' ' MET . 1.5 m-20 -62.55 122.28 72.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 968' ' ' ASP . 37.4 Cg_exo -57.62 144.91 91.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 111.877 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.3 p -48.32 127.44 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 970' ' ' VAL . 34.0 m120 63.75 46.4 4.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.907 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.79 -154.07 9.02 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.513 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.447 ' HA ' ' HB3' ' A' ' 968' ' ' ASP . 24.8 ptt? 175.69 143.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.287 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 986' ' ' ILE . 13.5 p -93.79 127.18 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -89.55 110.53 21.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.377 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 34.8 m -71.99 134.62 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 978' ' ' THR . 47.6 mm -73.45 -38.74 53.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 110.503 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 977' ' ' ILE . 76.8 p -144.76 -42.61 0.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 54.3 t0 -160.72 -136.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.197 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.524 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 9.5 pt -151.07 1.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 110.981 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -75.62 164.5 26.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.558 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 53.4 t -50.1 133.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 102.67 -39.03 2.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.566 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 95.8 p -76.06 138.09 40.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -98.87 157.18 16.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.232 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 974' ' ' VAL . 47.8 pt -141.96 137.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 111.685 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 4.7 p -108.33 133.25 52.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 988' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.66 143.2 26.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.789 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.74 123.31 9.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 61.9 m -88.94 146.47 24.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -64.93 147.47 53.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.448 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 86.8 m -45.61 117.1 1.34 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.979 0.419 . . . . 0.0 111.192 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 141.49 -48.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.151 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -113.04 139.2 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.618 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.3 ptt180 -93.0 140.9 28.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.9 tt -72.01 126.1 28.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.215 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.988 ' HB ' HG23 ' A' 1019 ' ' ILE . 2.4 mp -102.93 130.92 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.344 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.54 -142.89 15.62 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.617 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.527 ' O ' ' HG3' ' A' 1018 ' ' PRO . 87.5 m-70 -84.03 132.19 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.574 0.226 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.4 t -81.32 -55.87 4.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.5 p -89.2 153.17 21.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.6 123.37 5.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.116 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -104.59 131.25 52.21 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 49.1 t -75.0 131.0 40.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.7 pt -135.8 -155.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.581 -0.447 . . . . 0.0 112.007 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' 1010 ' ' THR . 56.3 tp -150.39 131.9 14.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.564 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 26.3 t -90.08 -134.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.395 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -67.65 -49.77 47.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.643 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -152.11 27.56 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.449 ' C ' HD12 ' A' 1006 ' ' LEU . 6.6 m -149.73 130.99 14.58 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.489 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 961' ' ' LYS . . . -81.52 137.94 35.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.765 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.564 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.9 p80 -159.76 144.33 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.593 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.508 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 93.1 m95 -64.48 146.74 54.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.704 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.7 t -57.56 -31.5 66.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.6 p -144.35 138.77 28.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.583 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.547 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 1.6 pptp? -62.52 160.7 32.14 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 18.6 Cg_endo -59.57 129.03 29.2 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.499 2.133 . . . . 0.0 112.271 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.527 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 16.8 Cg_exo -67.22 -160.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.988 HG23 ' HB ' ' A' ' 997' ' ' ILE . 1.2 tt -144.55 121.3 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.217 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.9 m -78.92 132.91 36.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -146.68 130.93 17.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.406 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -44.29 132.8 5.72 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.524 0.678 . . . . 0.0 111.928 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 22.2 mt -76.07 130.44 78.04 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.303 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.482 2.122 . . . . 0.0 112.421 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.788 0.327 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -66.3 135.51 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 64.77 141.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.992 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -165.19 127.29 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 44.9 m170 -119.87 123.12 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.757 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 5.4 p -82.13 127.19 32.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.547 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -58.34 169.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.12 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -45.86 135.68 6.39 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.554 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 3.0 Cg_exo -74.64 61.86 5.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.063 2.508 . . . . 0.0 111.909 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 48.4 t0 41.45 -143.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.55 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 70.9 t60 -161.78 116.7 1.98 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.726 0.298 . . . . 0.0 110.974 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.47 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 74.3 m-85 -85.93 135.26 33.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.076 0.465 . . . . 0.0 110.779 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.633 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 5.3 mp -74.97 -48.33 24.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.569 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.58 17.7 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.621 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.51 121.88 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 111.788 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 933' ' ' ARG . 59.7 pttt -102.7 128.87 49.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.21 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 928' ' ' LEU . 0.8 OUTLIER -48.61 125.34 9.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.607 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -94.47 -31.47 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.56 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 86.8 m -62.2 135.92 57.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 111.786 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.622 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.1 pm0 -78.34 61.25 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.672 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 918' ' ' THR . 3.4 t -80.62 -53.02 6.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 917' ' ' THR . 24.9 m 51.81 55.1 9.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.31 155.36 9.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 48.4 t -86.58 -44.83 11.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.21 138.96 32.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.524 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.467 ' HB2' ' SG ' ' A' ' 902' ' ' CYS . 17.0 m-85 -127.67 137.88 31.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.84 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 60.0 Cg_endo -72.13 131.97 18.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.484 2.123 . . . . 0.0 110.922 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.64 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.6 mt -57.1 149.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.926 0.393 . . . . 0.0 111.327 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 91.69 -34.37 4.39 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.663 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 15.8 m -57.19 129.9 43.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 942' ' ' SER . 47.6 t -87.89 151.74 22.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.541 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 913' ' ' LEU . 10.0 tp -140.85 102.18 4.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.51 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.775 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 17.8 ptpt -85.37 132.76 34.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.191 0.52 . . . . 0.0 111.99 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.564 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 2.0 m-85 -111.49 133.9 53.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.791 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 912' ' ' LYS . 23.4 pt-20 -95.57 126.47 40.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.3 m -57.87 148.59 24.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 76.9 mtt-85 -85.15 161.95 50.68 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 75.3 Cg_exo -45.64 139.96 9.68 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.234 1.956 . . . . 0.0 112.176 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 95.0 mt-10 82.49 23.43 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.507 ' N ' ' HG3' ' A' ' 961' ' ' LYS . 85.9 m-85 -146.81 145.41 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.558 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 16.1 p90 -144.07 140.84 29.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 110.942 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.36 21.89 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.651 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.621 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 79.5 mtp180 62.81 164.61 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.85 0.357 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 63.6 Cg_endo -77.65 115.42 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.146 1.897 . . . . 0.0 110.676 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 42.3 p90 -89.67 108.1 19.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.525 0.678 . . . . 0.0 112.068 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.775 ' HA ' ' HA ' ' A' ' 929' ' ' LYS . 80.3 p -77.21 125.64 29.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.844 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 928' ' ' LEU . 10.0 pt -94.92 -161.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 4.0 m -161.14 121.42 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -72.08 102.16 2.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.719 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 48.9 mt -80.89 161.37 24.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.568 0.699 . . . . 0.0 112.713 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' A' ' 924' ' ' ILE . 9.8 t70 -42.55 -38.4 1.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.005 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 950' ' ' VAL . 75.2 m-20 -83.08 36.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.992 HD11 ' HB1' ' A' ' 900' ' ' ALA . 8.2 mp 44.82 46.33 8.76 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.222 0.534 . . . . 0.0 110.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.719 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.4 m -123.61 -162.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.16 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.554 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 90.1 m95 -152.69 122.77 7.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.289 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.9 t -43.43 146.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.531 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 38.9 t -79.39 117.55 67.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.599 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 908' ' ' PHE . 4.0 Cg_exo -76.8 60.93 6.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.55 2.833 . . . . 0.0 111.794 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -77.1 131.77 38.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.017 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 54.99 81.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.545 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 12.7 m -150.9 -21.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.834 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 12.1 t -151.45 133.37 15.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -143.26 146.86 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.181 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.805 ' HD3' ' HB3' ' A' ' 981' ' ' GLN . 29.9 ttt85 -53.2 143.53 17.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.057 0.456 . . . . 0.0 111.655 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 28.1 mtpp -56.29 152.34 11.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.563 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.605 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 96.3 p -141.61 121.13 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.564 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 4.4 p -81.67 153.68 26.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.596 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.33 132.35 48.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 34.4 m -56.57 134.3 77.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.928 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.788 ' HG2' HG11 ' A' ' 974' ' ' VAL . 9.2 Cg_endo -52.65 150.98 20.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.764 2.309 . . . . 0.0 111.992 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' 1017 ' ' PRO . 64.7 Cg_endo -73.14 45.5 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.678 2.252 . . . . 0.0 112.814 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 967' ' ' PRO . 1.5 m-20 18.02 109.73 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 124.074 0.859 . . . . 0.0 113.165 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.44 142.49 9.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 5.1 p -48.6 131.67 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.638 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.9 m120 75.43 -48.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.634 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -75.44 -152.62 3.61 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.097 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 1.8 pmm? 177.75 143.48 0.1 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.274 0.23 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.788 HG11 ' HG2' ' A' ' 966' ' ' PRO . 10.1 p -93.62 128.94 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.236 0.541 . . . . 0.0 111.201 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -104.46 118.1 35.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.403 HG11 HG23 ' A' ' 980' ' ' ILE . 28.2 m -70.95 141.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.925 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 985' ' ' ARG . 24.4 mm -74.92 -36.68 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.476 . . . . 0.0 110.295 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.2 p -144.69 -47.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.186 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 49.0 t0 -160.19 -137.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.559 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.479 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 7.6 pt -151.02 36.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.231 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' A' ' 960' ' ' ARG . 13.1 mm100 -76.5 166.69 23.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.715 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.32 29.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.3 -25.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.3 t -76.1 136.72 39.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.004 0.431 . . . . 0.0 111.256 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 69.0 ttt180 -89.65 158.72 17.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.602 HD12 HG21 ' A' ' 974' ' ' VAL . 47.4 pt -137.56 129.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.918 0.39 . . . . 0.0 111.025 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' 1001 ' ' SER . 2.3 p -105.22 139.58 39.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.02 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.3 m-85 -103.94 146.99 27.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.677 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -153.48 124.19 7.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.482 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 96.6 m -72.95 -119.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 993' ' ' GLY . 8.0 t -169.55 158.91 8.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.628 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 61.0 m -52.8 84.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 991' ' ' THR . . . 168.6 -42.22 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.47 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.432 ' HB3' ' N ' ' A' 1021 ' ' GLN . 7.8 m80 -126.13 142.25 51.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.653 ' O ' HD12 ' A' ' 997' ' ' ILE . 39.3 ptt180 -91.9 145.28 24.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.6 tt -72.73 135.42 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.571 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.874 ' HB ' HG23 ' A' 1019 ' ' ILE . 3.9 mp -126.49 139.42 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.94 -124.2 7.99 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.51 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -80.1 -136.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.4 p -176.76 -43.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.465 ' HB3' HG22 ' A' ' 987' ' ' THR . 69.2 p -155.22 141.58 18.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.516 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -149.49 143.48 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 112.025 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.6 tt0 -95.92 138.24 33.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 47.9 t -71.27 129.62 39.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.1 pt -139.39 146.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 961' ' ' LYS . 60.8 tp -89.16 137.28 32.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.589 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.664 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 98.8 p -88.97 -40.09 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.372 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -177.72 -36.03 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.415 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -145.29 -44.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.277 0.561 . . . . 0.0 109.707 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 94.2 m -94.5 131.89 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.53 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.64 138.8 34.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.01 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.664 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.8 p80 -155.66 142.61 19.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.083 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 70.7 m95 -66.46 146.35 54.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -51.32 -33.73 30.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.092 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -141.04 -152.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.557 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -126.8 149.75 69.55 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.4 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 966' ' ' PRO . 41.5 Cg_exo -57.46 135.65 71.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.838 2.359 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.457 ' HG2' HD11 ' A' ' 996' ' ' LEU . 27.0 Cg_exo -62.81 -159.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.728 2.286 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.874 HG23 ' HB ' ' A' ' 997' ' ' ILE . 3.8 tt -146.57 128.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.868 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 77.3 m -84.29 138.5 32.88 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 997' ' ' ILE . 62.1 tt0 -149.74 135.7 18.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.081 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' 1022 ' ' ARG . 42.4 ttp85 -48.63 130.39 17.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.512 0.673 . . . . 0.0 111.695 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 995' ' ' ARG . 71.2 mt -74.94 127.12 87.44 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.623 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.563 2.175 . . . . 0.0 112.219 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -171.23 135.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.01 140.08 57.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.037 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 949' ' ' LEU . . . 62.8 -150.76 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.572 ' N ' HD22 ' A' ' 949' ' ' LEU . 15.9 m80 67.21 144.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 84.7 m -79.78 122.63 26.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 903' ' ' GLN . 0.8 OUTLIER -65.65 163.99 15.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.78 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.92 125.33 4.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.663 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 16.6 Cg_exo -67.1 135.26 36.75 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.731 2.287 . . . . 0.0 112.509 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.77 152.24 43.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.107 0.48 . . . . 0.0 110.87 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -78.17 134.59 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.091 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 8.3 m-85 -90.07 1.25 56.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.8 mp 71.61 -63.35 0.43 Allowed 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.602 0.564 . . . . 0.0 111.388 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.477 ' HA ' ' CD ' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -85.35 25.66 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.83 120.86 5.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -103.71 138.77 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.476 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.751 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.1 tm? -46.47 150.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.751 ' H ' HD22 ' A' ' 913' ' ' LEU . 11.8 tmtt? -137.71 -46.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 913' ' ' LEU . 2.7 m -68.76 139.14 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.499 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 17.6 mp0 -58.21 112.57 1.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 69.8 p -83.34 132.85 34.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 0.0 112.106 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.7 p -89.97 82.71 6.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.135 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 60.32 -152.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.9 p -86.59 -47.76 8.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -85.43 121.99 28.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.158 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 928' ' ' LEU . 77.7 m-85 -103.87 136.02 19.27 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 112.137 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.39 136.09 35.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 111.67 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.723 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 38.6 mt -56.69 143.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.065 0.46 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 101.87 -41.4 2.14 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.8 m -57.27 144.43 35.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.267 -0.466 . . . . 0.0 111.056 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 46.6 m -126.61 128.01 46.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.756 0.312 . . . . 0.0 111.235 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.3 mt -100.71 122.1 42.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.0 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.726 ' HG2' ' HB3' ' A' ' 942' ' ' SER . 52.0 mtmt -87.58 127.54 35.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.0 111.251 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 940' ' ' PRO . 4.8 m-85 -116.77 120.21 37.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.54 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.11 127.79 41.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.68 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 59.3 m -58.58 -174.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.531 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 43.5 mtp85 -84.42 159.68 58.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.323 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 936' ' ' TYR . 87.4 Cg_exo -45.83 -48.75 11.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.498 2.132 . . . . 0.0 112.466 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -74.44 28.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.304 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 12.4 m-85 -141.85 150.77 42.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 23.3 p90 -137.56 136.27 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.349 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.94 11.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 55.4 mtp85 61.41 151.98 0.1 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.348 0.594 . . . . 0.0 111.983 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 930' ' ' TYR . 13.4 Cg_exo -67.46 117.83 5.13 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.795 2.33 . . . . 0.0 111.246 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -90.35 115.37 27.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.392 0.615 . . . . 0.0 111.768 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.726 ' HB3' ' HG2' ' A' ' 929' ' ' LYS . 80.1 p -78.38 131.36 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.061 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -101.86 114.24 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 0.0 110.567 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 2.6 m -83.05 125.96 32.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.723 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 49.7 t -73.7 112.34 9.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 89.1 mt -81.45 -64.51 1.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -174.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 59.9 t0 173.84 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.947 0.403 . . . . 0.0 110.593 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.534 ' HB3' HG12 ' A' ' 950' ' ' VAL . 34.8 t30 -79.16 9.57 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 901' ' ' HIS . 45.9 mt 69.25 40.42 1.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.44 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 948' ' ' ASN . 3.3 p -137.52 154.94 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.607 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.863 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 29.1 m95 -89.76 145.25 25.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.313 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 79.5 p -47.2 144.94 2.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 66.1 m -77.71 108.65 7.66 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.459 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 952' ' ' SER . 15.4 Cg_exo -66.65 142.88 65.97 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.643 2.229 . . . . 0.0 111.339 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.37 129.33 8.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.147 0.499 . . . . 0.0 111.832 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 55.4 t0 51.75 33.65 11.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.431 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.647 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -91.99 -59.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.647 ' H ' HG23 ' A' ' 957' ' ' VAL . 5.9 t -89.31 141.48 28.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 40.1 mtmt -152.37 133.75 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.44 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.885 ' HE ' ' HB3' ' A' ' 981' ' ' GLN . 0.3 OUTLIER -65.88 128.52 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.02 0.438 . . . . 0.0 110.915 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.671 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.2 ttmp? -56.21 161.99 2.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.514 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 73.3 p -149.79 147.81 28.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.472 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.2 m -80.11 147.91 31.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.938 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 965' ' ' THR . 6.3 tmtm? -65.96 131.06 45.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.635 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 25.1 m -52.98 124.24 36.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.002 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.2 Cg_endo -68.87 133.66 27.82 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.64 2.227 . . . . 0.0 112.611 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 38.0 Cg_exo -59.94 137.55 76.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.351 2.034 . . . . 0.0 111.313 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.71 113.83 7.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.12 151.51 85.02 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.795 2.33 . . . . 0.0 111.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.6 p -49.6 127.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.24 46.09 23.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.84 137.97 4.59 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.45 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -127.95 142.74 51.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 966' ' ' PRO . 12.6 p -94.23 121.44 44.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.753 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.9 OUTLIER -88.66 128.13 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.51 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 979' ' ' ASP . 95.3 t -83.95 123.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.9 -40.49 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.707 0.289 . . . . 0.0 111.154 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 78.6 p -144.68 -50.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.402 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.543 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 37.1 m-20 -158.26 -152.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.994 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.458 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 14.8 pt -149.9 23.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.885 ' HB3' ' HE ' ' A' ' 960' ' ' ARG . 15.1 mp0 -77.01 154.08 33.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.675 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' 1005 ' ' ILE . 66.6 t -50.85 85.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 111.301 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.98 -41.47 0.29 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 77.2 p -75.38 -168.83 0.87 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 111.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.489 HH21 ' HB2' ' A' 1001 ' ' SER . 79.2 ttt180 -151.31 131.35 13.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.089 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.575 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 31.2 pt -98.07 142.57 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.539 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.7 p -116.96 135.12 53.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.138 0.494 . . . . 0.0 111.723 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.472 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 1.8 m-85 -103.12 148.66 25.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 47.5 t -148.74 120.05 7.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.095 0.474 . . . . 0.0 110.974 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 71.4 m -83.02 151.55 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.0 p -64.6 149.11 49.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -49.4 92.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 158.51 -46.94 0.44 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.275 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -99.96 148.25 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.596 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.442 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -91.55 148.4 22.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.548 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.496 ' C ' HD13 ' A' ' 996' ' ' LEU . 3.4 tm? -65.2 130.19 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.071 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' 1021 ' ' GLN . 34.6 mm -100.13 73.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.757 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 156.62 -149.62 20.52 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.126 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.603 ' ND1' HG21 ' A' 1015 ' ' THR . 34.5 m170 -85.91 -9.51 56.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.614 0.245 . . . . 0.0 111.173 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m 71.8 -5.44 1.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.458 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.489 ' HB2' HH21 ' A' ' 985' ' ' ARG . 57.5 m -156.02 149.55 24.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.435 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -154.58 133.15 12.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.6 tt0 -96.07 132.54 41.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 38.2 t -71.19 121.36 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.595 ' HA ' HG13 ' A' ' 982' ' ' VAL . 35.8 pt -135.52 -151.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 111.617 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.503 HD23 ' C ' ' A' 1006 ' ' LEU . 8.7 tt -155.87 139.77 16.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.498 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -87.51 -57.72 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 169.05 35.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.239 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' 1008 ' ' GLY . 49.5 t-20 176.65 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.39 0.614 . . . . 0.0 109.988 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -143.96 143.64 31.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.89 143.87 35.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.0 p80 -157.72 148.83 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.806 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.469 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.1 m95 -64.38 140.18 58.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -54.26 -30.48 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.811 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' ND1' ' A' ' 999' ' ' HIS . 63.0 p -140.82 143.31 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 111.712 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 58.0 mtpt -51.26 146.09 12.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 28.0 Cg_exo -61.92 118.8 5.7 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.446 2.097 . . . . 0.0 111.856 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.472 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 35.7 Cg_endo -65.99 145.89 80.92 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.544 2.162 . . . . 0.0 112.569 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.71 -149.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.247 0.546 . . . . 0.0 110.846 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' 1019 ' ' ILE . 74.7 m -154.76 138.75 16.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.188 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 997' ' ' ILE . 3.8 tt0 -147.13 129.57 15.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.902 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -48.56 130.1 16.79 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.449 0.642 . . . . 0.0 111.466 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.442 HG12 ' HB3' ' A' ' 995' ' ' ARG . 73.8 mt -75.26 128.45 84.53 Favored Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.154 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.776 2.317 . . . . 0.0 112.303 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.43 136.01 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.007 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -58.93 125.99 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.052 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -167.32 -136.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.81 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 11.0 m80 69.8 134.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 10.9 p -80.79 119.16 23.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.818 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.53 -176.81 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.402 . . . . 0.0 111.042 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 922' ' ' PHE . . . -49.02 127.03 14.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.329 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.518 ' HG3' HD22 ' A' ' 928' ' ' LEU . 64.7 Cg_endo -73.33 70.16 3.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.809 2.34 . . . . 0.0 112.162 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.2 t0 35.21 -132.06 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.494 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.447 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 1.4 m-70 -156.97 121.82 4.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.661 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.94 139.52 30.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.714 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.6 OUTLIER -102.14 -45.63 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.562 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.422 ' C ' ' HG3' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -80.62 9.66 5.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.969 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.31 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.478 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.62 133.86 40.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.593 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.702 HD21 HG23 ' A' ' 917' ' ' THR . 65.0 tp -47.07 161.0 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.686 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.447 ' N ' ' HG ' ' A' ' 913' ' ' LEU . 31.0 mmmt -144.33 -52.29 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 928' ' ' LEU . 4.3 m -68.78 137.09 53.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -62.35 123.35 18.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 913' ' ' LEU . 49.7 p -83.42 136.06 34.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.029 0.443 . . . . 0.0 111.989 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 70.8 p -90.1 79.5 6.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.547 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 64.57 -154.54 0.3 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.082 0.468 . . . . 0.0 111.96 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.6 p -85.79 -46.07 11.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.38 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.3 120.88 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 54.7 m-85 -102.31 135.47 19.59 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.54 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 74.3 Cg_endo -74.26 133.2 17.44 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.739 2.293 . . . . 0.0 111.446 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 947' ' ' ASP . 50.5 mt -56.89 144.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.933 0.397 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' ' 945' ' ' CYS . . . 101.6 -35.19 5.08 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.54 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 24.0 m -56.17 128.59 36.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.442 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 79.3 p -101.47 123.84 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.518 HD22 ' HG3' ' A' ' 905' ' ' PRO . 8.1 tp -102.74 119.85 39.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.99 140.85 29.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.188 0.518 . . . . 0.0 112.07 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.44 ' CE1' HD23 ' A' ' 928' ' ' LEU . 26.7 m-85 -133.95 133.51 41.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 931' ' ' GLU . 14.9 pt-20 -92.84 121.73 34.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.995 0.426 . . . . 0.0 111.279 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.76 153.86 19.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 78.5 mtp180 -81.35 145.37 55.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.604 0.24 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 936' ' ' TYR . 70.9 Cg_exo -49.23 -42.74 39.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.346 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.88 24.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 24.3 m-85 -142.04 139.81 32.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.95 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.501 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 7.9 p90 -93.26 134.7 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.412 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 133.9 148.44 5.83 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.701 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.0 ptp180 -72.52 166.24 43.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.478 0.18 . . . . 0.0 110.543 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 42.2 Cg_endo -68.38 122.85 9.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.327 2.018 . . . . 0.0 112.112 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.573 ' CD2' ' HB ' ' A' ' 957' ' ' VAL . 48.8 p90 -91.29 -165.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.9 p -175.29 137.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -91.27 176.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.2 m -161.37 127.54 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 62.2 m -71.64 117.26 12.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 85.7 mt -87.55 -53.53 4.75 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.657 ' HA ' HD13 ' A' ' 924' ' ' ILE . 53.8 t0 171.06 -39.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.221 0.326 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -83.54 34.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.48 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.7 mp 50.77 47.39 24.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.345 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.0 148.54 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 111.087 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 94.2 m95 -89.65 46.66 1.39 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.76 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 953' ' ' SER . 37.8 t 49.03 29.73 2.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.2 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 952' ' ' SER . 19.8 m 34.58 100.44 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.611 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 133.98 54.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.371 2.047 . . . . 0.0 112.797 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -159.1 135.94 9.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 60.6 t0 56.54 67.09 1.04 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 19.6 m -147.75 68.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.513 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 957' ' ' VAL . 80.8 m 77.28 144.54 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.322 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 95.0 mttt -142.17 166.9 23.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -53.29 119.07 4.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 -179.053 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 39.8 tptt -56.22 148.69 17.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.433 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 54.6 p -149.44 125.04 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.95 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.428 ' O ' HD12 ' A' ' 980' ' ' ILE . 2.1 p -82.23 141.07 33.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.851 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.78 137.42 57.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.079 0.466 . . . . 0.0 111.141 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.4 m -53.69 126.61 49.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.647 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.626 ' HG2' HG11 ' A' ' 974' ' ' VAL . 28.9 Cg_endo -62.78 125.79 16.77 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.335 2.023 . . . . 0.0 111.878 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.24 134.47 60.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.209 1.939 . . . . 0.0 111.425 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -56.34 117.13 14.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.749 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 970' ' ' VAL . 22.3 Cg_exo -65.28 -146.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.873 2.382 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.87 ' HB ' ' HB2' ' A' 1020 ' ' CYS . 2.5 t -57.75 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.148 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.591 ' H ' HG12 ' A' ' 970' ' ' VAL . 34.8 m120 -72.33 68.53 0.76 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.506 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.408 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -164.96 -160.2 12.12 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.716 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 179.84 144.12 0.17 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.973 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.673 HG21 HD12 ' A' ' 986' ' ' ILE . 9.9 p -94.32 138.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.15 0.5 . . . . 0.0 111.309 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -120.14 117.92 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.909 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.8 t -70.14 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 31.3 mm -75.13 -43.24 44.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 77.6 p -147.03 -53.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.649 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.788 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 48.5 m-20 -157.57 151.01 23.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.102 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.46 HG22 ' HH2' ' A' 1013 ' ' TRP . 18.7 pt -88.34 32.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.781 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.788 ' NE2' ' HB3' ' A' ' 979' ' ' ASP . 2.1 mp0 -78.4 142.11 37.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.061 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' 1005 ' ' ILE . 80.1 t -50.39 104.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.937 0.398 . . . . 0.0 111.32 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 151.5 -51.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.431 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' 1003 ' ' GLU . 80.5 p -76.27 -152.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 0.0 111.046 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -151.4 178.37 9.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.235 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 974' ' ' VAL . 26.9 pt -142.0 129.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.524 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -98.26 138.57 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.587 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.572 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 8.8 m-85 -105.79 151.23 24.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.69 114.18 5.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 111.275 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 75.0 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 971' ' ' ASN . 6.2 t -64.52 146.71 54.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.718 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.3 m -44.26 130.32 6.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.428 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.14 -49.81 0.89 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -102.02 139.67 37.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.683 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.756 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.8 ptt85 -91.45 140.28 29.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.344 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.9 tt -71.79 130.44 41.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.9 mp -100.34 133.64 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.73 -155.41 25.66 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.454 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.676 ' O ' ' HG3' ' A' 1018 ' ' PRO . 14.6 m170 -82.98 125.29 31.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.522 0.201 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 43.8 t -73.6 12.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.0 p -156.82 150.74 24.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.407 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -152.03 135.87 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 984' ' ' SER . 38.4 tt0 -95.15 128.92 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.434 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 44.8 t -71.28 122.87 21.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.504 ' HA ' HG13 ' A' ' 982' ' ' VAL . 32.4 pt -133.64 -151.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.728 ' HG ' ' H ' ' A' 1008 ' ' GLY . 19.4 tp -151.11 131.38 13.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.395 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.671 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 37.7 t -93.01 31.69 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.728 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 77.22 -48.74 2.84 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.701 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.52 -44.94 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.789 0.328 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.581 ' C ' HD12 ' A' 1006 ' ' LEU . 88.7 m -146.63 148.07 31.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.427 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.4 139.35 38.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.97 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.671 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.8 p80 -158.11 154.17 27.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.46 ' HH2' HG22 ' A' ' 980' ' ' ILE . 75.9 m95 -64.21 145.58 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -59.57 -30.45 68.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.433 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.506 HG21 ' ND1' ' A' ' 999' ' ' HIS . 65.7 p -140.59 142.97 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.119 0.485 . . . . 0.0 112.089 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 5.8 ttpm? -55.1 139.35 64.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.755 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.11 128.46 22.44 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.524 2.149 . . . . 0.0 112.701 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.676 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 35.7 Cg_exo -57.36 147.02 79.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.019 2.479 . . . . 0.0 112.408 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 29.8 mt -103.0 132.89 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.722 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.87 ' HB2' ' HB ' ' A' ' 970' ' ' VAL . 71.4 m -86.37 123.17 31.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -143.81 130.59 20.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.472 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' 1022 ' ' ARG . 41.2 ttp85 -45.19 133.88 6.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 111.832 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.756 HG12 ' HB3' ' A' ' 995' ' ' ARG . 53.6 mt -74.94 129.01 84.13 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.908 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.695 0.283 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 61.29 -153.56 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.234 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 65.02 133.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.334 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.73 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 64.39 121.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.671 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.461 ' C ' HD22 ' A' ' 949' ' ' LEU . 66.1 m80 -155.31 141.31 18.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 87.7 m -81.03 128.18 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -68.12 171.6 6.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.183 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.06 132.38 3.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 943' ' ' ILE . 15.7 Cg_exo -68.75 63.19 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.17 2.58 . . . . 0.0 112.589 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 50.6 t0 33.95 -135.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 38.9 m80 -152.54 119.24 5.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.963 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 9.6 m-85 -85.29 136.81 33.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.158 0.504 . . . . 0.0 111.368 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.739 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 1.8 mm? -84.99 -51.65 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.2 OUTLIER -86.13 15.09 5.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.316 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -153.62 155.77 36.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.343 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.639 ' HE2' ' NE ' ' A' ' 933' ' ' ARG . 68.2 mttm -136.51 134.11 37.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -49.43 149.75 2.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.173 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.834 ' HG3' ' HG2' ' A' ' 931' ' ' GLU . 31.2 mmmt -143.22 -35.81 0.39 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 915' ' ' THR . 56.5 m -69.89 65.04 0.22 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 917' ' ' THR . 17.0 pt20 37.2 -148.43 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 916' ' ' GLN . 15.1 t 50.87 139.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 113.027 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 77.5 p -146.18 15.84 1.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.685 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -74.49 174.96 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t -89.74 -51.47 5.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.3 145.16 27.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 917' ' ' THR . 31.7 m-85 -136.25 136.72 22.98 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.414 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.407 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.4 Cg_endo -69.3 140.95 45.72 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.737 2.291 . . . . 0.0 111.867 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.675 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.0 mt -56.74 155.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.4 -40.79 3.08 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.407 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 46.9 m -56.37 137.66 52.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.511 -0.345 . . . . 0.0 111.119 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 78.6 p -131.35 134.82 46.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.656 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 913' ' ' LEU . 2.7 mm? -99.08 136.63 38.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.021 0.439 . . . . 0.0 111.786 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.642 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 4.4 tppp? -88.18 135.46 33.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.409 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 13.3 m-85 -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.373 . . . . 0.0 111.227 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.834 ' HG2' ' HG3' ' A' ' 914' ' ' LYS . 5.2 mm-40 -97.38 132.74 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.3 m -59.7 137.53 58.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.739 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.2 mtp180 -87.53 156.89 53.27 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 10.3 Cg_endo -51.24 139.47 44.04 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.539 2.159 . . . . 0.0 111.317 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.642 ' HB3' HG11 ' A' ' 982' ' ' VAL . 90.3 mt-10 83.34 27.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.888 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.585 ' C ' ' HE2' ' A' ' 961' ' ' LYS . 95.7 m-85 -148.23 129.28 14.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.74 ' HB3' ' HZ3' ' A' ' 961' ' ' LYS . 1.4 p90 -101.18 142.0 33.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.066 0.46 . . . . 0.0 111.334 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.56 -130.34 2.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.393 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.439 HH11 ' HG2' ' A' ' 939' ' ' ARG . 4.3 ptp85 -166.14 156.75 11.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.506 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 37.5 Cg_exo -59.99 108.62 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.447 2.098 . . . . 0.0 112.434 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.642 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 36.2 p90 -95.51 -168.72 1.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.525 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.04 127.48 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 905' ' ' PRO . 17.4 pt -97.63 120.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.107 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 946' ' ' LEU . 54.9 m -91.19 134.83 34.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.675 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -73.72 118.23 16.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 109.995 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.903 HD23 HG23 ' A' ' 950' ' ' VAL . 2.1 mm? -87.13 171.61 10.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.255 1.026 . . . . 0.0 113.242 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.72 -43.2 68.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.367 -1.742 . . . . 0.0 111.682 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -83.85 29.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.73 HD21 ' HB1' ' A' ' 900' ' ' ALA . 29.7 mt 48.12 63.13 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.697 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.903 HG23 HD23 ' A' ' 946' ' ' LEU . 9.4 m -135.81 -164.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.408 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 98.1 m95 -144.12 46.69 1.43 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.24 0.543 . . . . 0.0 111.487 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.427 ' H ' HD23 ' A' ' 946' ' ' LEU . 79.4 p 40.08 26.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.289 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 955' ' ' LYS . 45.5 t 35.34 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.002 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.46 137.64 31.91 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.356 2.037 . . . . 0.0 112.751 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 0.1 OUTLIER -159.09 134.87 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.272 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.9 t70 59.28 82.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.436 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -148.64 -107.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.863 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.625 ' H ' HG23 ' A' ' 957' ' ' VAL . 56.8 m -81.75 57.52 3.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 0.0 110.751 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.884 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.5 mmpt? -55.41 155.45 5.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.203 0.525 . . . . 0.0 112.142 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.592 ' CG ' ' HB3' ' A' ' 981' ' ' GLN . 19.6 tpp180 -55.11 116.45 2.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.249 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.931 ' HG3' ' H ' ' A' ' 962' ' ' SER . 15.0 tppt? -61.11 -176.12 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.929 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.931 ' H ' ' HG3' ' A' ' 961' ' ' LYS . 80.6 p -149.75 -155.96 0.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.147 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.689 ' HA ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -154.74 33.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.621 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 60.62 128.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 15.8 m -59.76 135.78 89.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.432 ' CG ' HG11 ' A' ' 974' ' ' VAL . 9.6 Cg_endo -50.94 136.49 44.01 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 112.121 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.2 Cg_endo -75.11 47.43 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.697 2.264 . . . . 0.0 112.773 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 967' ' ' PRO . 11.2 p-10 22.77 78.9 0.2 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.67 0.606 . . . . 0.0 112.121 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.46 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 98.2 Cg_exo -43.89 142.16 3.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.719 2.28 . . . . 0.0 112.449 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 970' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.86 127.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.633 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 32.3 m120 47.65 48.72 16.99 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.065 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -133.14 -152.5 6.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.388 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.412 ' HB3' ' HE2' ' A' ' 973' ' ' MET . 42.4 ttp 176.19 141.87 0.07 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 987' ' ' THR . 10.5 p -136.98 127.85 40.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.972 0.415 . . . . 0.0 111.719 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -87.76 114.86 24.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.878 ' HA ' HG22 ' A' ' 986' ' ' ILE . 81.7 t -65.44 -24.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.138 0.494 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.568 HD11 HG22 ' A' ' 987' ' ' THR . 14.0 mm 74.46 -49.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.15 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 63.8 p -149.51 -60.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 984' ' ' SER . 11.7 p-10 -159.42 144.71 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.307 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.623 HG23 HG13 ' A' ' 976' ' ' VAL . 8.2 pt -85.99 19.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.252 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.592 ' HB3' ' CG ' ' A' ' 960' ' ' ARG . 29.1 mt-30 -80.87 156.48 26.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.788 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 935' ' ' GLU . 57.0 t -55.79 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.48 26.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.643 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 70.2 m -163.89 139.57 6.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.311 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ptt85 -100.12 131.22 46.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.132 0.491 . . . . 0.0 112.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 976' ' ' VAL . 40.9 pt -100.3 126.21 53.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.583 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.568 HG22 HD11 ' A' ' 977' ' ' ILE . 3.3 t -104.56 160.14 15.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.34 0.591 . . . . 0.0 111.583 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.478 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 3.6 m-85 -114.97 153.39 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.5 p -148.61 69.67 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.625 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 84.6 m -44.51 145.6 0.84 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 19.2 p -65.12 149.32 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 82.2 m -44.56 -37.49 3.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.928 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -57.26 -56.39 25.3 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.151 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.832 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 2.3 m80 -95.56 143.23 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.748 HH21 HG23 ' A' 1023 ' ' ILE . 14.3 ptp180 -88.83 138.72 31.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.982 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 997' ' ' ILE . 8.1 tt -71.85 138.07 47.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.312 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.616 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.9 mp -117.62 137.32 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.79 -143.39 18.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.019 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 996' ' ' LEU . 19.4 m170 -81.47 -134.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.633 0.254 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.529 ' HA ' ' HG2' ' A' 1018 ' ' PRO . 48.3 t -170.9 -54.66 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.84 0.352 . . . . 0.0 110.522 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.9 p -91.3 142.14 28.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.438 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -156.61 122.33 4.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.791 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.31 139.86 31.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 982' ' ' VAL . 15.2 t -69.52 122.83 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' 1006 ' ' LEU . 20.6 pt -139.48 142.29 33.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.91 HD13 ' N ' ' A' 1007 ' ' SER . 3.4 tm? 45.73 148.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.236 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.91 ' N ' HD13 ' A' 1006 ' ' LEU . 20.4 m -156.9 -95.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.561 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.73 ' H ' ' HE3' ' A' ' 961' ' ' LYS . . . 60.8 -109.78 2.6 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -66.89 -32.13 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.637 ' O ' ' HA ' ' A' 1007 ' ' SER . 17.6 m -148.94 119.91 7.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.609 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -86.88 138.48 31.52 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.646 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.3 OUTLIER -152.07 131.52 12.97 Favored 'General case' 0 C--N 1.337 0.057 0 C-N-CA 119.413 -0.915 . . . . 0.0 113.268 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 80.4 m95 -70.28 165.05 23.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.178 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.519 ' HA ' HD11 ' A' 1005 ' ' ILE . 88.8 p -63.19 -34.79 78.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.43 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 70.2 p -146.27 143.91 29.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.89 144.9 73.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.033 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 28.2 Cg_exo -62.19 127.13 20.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.716 2.277 . . . . 0.0 112.75 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.529 ' HG2' ' HA ' ' A' 1000 ' ' SER . 34.4 Cg_exo -61.52 150.39 85.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.466 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 51.0 mt -98.92 136.77 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.484 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 73.5 m -99.13 79.58 2.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 997' ' ' ILE . 41.9 tt0 -90.92 118.9 30.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.616 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 15.1 ptp180 -41.54 142.59 0.59 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.54 0.685 . . . . 0.0 111.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.748 HG23 HH21 ' A' ' 995' ' ' ARG . 70.7 mt -74.4 133.7 77.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.885 2.39 . . . . 0.0 112.489 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 897' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 897' ' ' GLU . 17.5 tp10 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.18 133.21 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 63.79 133.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.252 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.887 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -166.08 128.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 921' ' ' ASP . 52.6 m80 -153.47 144.84 23.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.752 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 99.4 m -80.8 128.92 34.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 903' ' ' GLN . . . . . 0.579 ' CD ' ' H ' ' A' ' 903' ' ' GLN . 0.4 OUTLIER -68.99 157.13 37.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.648 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -43.19 131.44 3.38 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.041 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.4 -160.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 907' ' ' HIS . 4.2 t0 -173.6 151.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 906' ' ' ASP . 48.1 m80 70.11 68.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.369 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.485 ' CZ ' HD13 ' A' ' 943' ' ' ILE . 11.4 m-85 -139.91 43.63 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.582 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.532 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 15.7 mt -70.25 -32.29 70.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.281 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.21 10.67 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.618 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.52 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.669 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.3 120.88 33.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 915' ' ' THR . 1.3 tt -49.17 129.25 17.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.163 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.622 ' HB2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -86.48 -52.29 5.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.636 ' O ' HD22 ' A' ' 913' ' ' LEU . 47.6 m -64.59 138.34 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.253 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 916' ' ' GLN . 2.7 pp0? -61.94 141.56 57.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.899 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 70.5 p -151.67 149.33 28.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 93.8 m -154.04 -41.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 152.04 44.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.1 p -84.99 -44.41 13.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.585 ' HB2' ' HB2' ' A' ' 901' ' ' HIS . 12.1 p-10 -85.36 132.33 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -118.68 138.89 26.39 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.407 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.469 ' O ' ' HB ' ' A' ' 926' ' ' THR . 25.4 Cg_endo -61.4 137.32 69.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.603 2.202 . . . . 0.0 112.062 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 20.8 mt -60.97 154.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.347 . . . . 0.0 110.846 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.68 -38.09 2.8 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 923' ' ' PRO . 19.9 m -56.0 131.82 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.02 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 49.7 m -111.3 130.52 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 942' ' ' SER . 94.5 mt -96.53 128.26 43.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 16.3 tppt? -85.16 137.59 32.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.031 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.505 ' CE2' ' HG ' ' A' ' 913' ' ' LEU . 20.5 m-85 -132.31 131.43 41.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.622 ' HG3' ' HB2' ' A' ' 914' ' ' LYS . 45.8 mt-10 -95.18 114.0 25.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.39 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 1.5 t -58.03 144.59 39.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 4.4 ptm180 -82.7 158.88 64.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.93 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 933' ' ' ARG . 39.5 Cg_endo -66.2 68.6 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.203 2.602 . . . . 0.0 113.484 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -172.41 -2.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.091 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.523 ' HB2' ' SG ' ' A' ' 932' ' ' CYS . 44.1 m-85 -142.04 134.91 28.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.264 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.651 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 9.4 p90 -102.1 138.61 38.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.562 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.31 8.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.168 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.434 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 71.1 mtt-85 63.62 157.5 0.12 Allowed Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 38.2 Cg_endo -66.68 116.62 4.19 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.2 1.934 . . . . 0.0 111.352 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.593 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 49.5 p90 -93.56 -160.82 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.197 0.522 . . . . 0.0 111.812 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.2 p -172.84 130.05 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.13 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.485 HD13 ' CZ ' ' A' ' 908' ' ' PHE . 39.6 pt -95.85 117.57 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.876 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 946' ' ' LEU . 52.0 m -84.04 128.96 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.3 t -73.81 121.6 21.12 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.1 mm? -85.34 167.92 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 0.0 113.318 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -51.73 -42.66 62.46 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.014 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.569 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.0 m-80 -84.45 32.46 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.707 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.887 HD21 ' HB1' ' A' ' 900' ' ' ALA . 24.4 mt 48.25 56.29 7.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.669 HG23 HD23 ' A' ' 946' ' ' LEU . 30.0 m -138.43 -157.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 112.38 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' A' ' 953' ' ' SER . 50.5 m95 -150.1 125.75 10.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.637 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.488 ' H ' HD21 ' A' ' 946' ' ' LEU . 79.8 p -68.54 27.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 951' ' ' TRP . 30.3 t 51.81 129.52 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 14.7 Cg_exo -69.95 69.83 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.086 2.524 . . . . 0.0 111.912 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -79.46 131.59 36.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.075 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 9.8 t70 55.1 72.66 0.46 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.512 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 18.1 m -150.9 -17.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.856 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 9.0 m -152.18 48.36 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.9 mmtp -56.55 143.81 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.495 ' HA ' ' CD2' ' A' ' 936' ' ' TYR . 38.8 ttm180 -53.23 132.33 38.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.655 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.651 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 0.0 OUTLIER -56.29 154.57 7.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.813 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 981' ' ' GLN . 80.3 p -149.8 136.27 19.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.847 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 66.7 m -81.65 36.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.0 tptt 61.08 133.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.565 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.629 ' HA ' HD12 ' A' ' 980' ' ' ILE . 21.6 m -54.48 127.73 58.87 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.257 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.405 ' HG3' HD13 ' A' ' 986' ' ' ILE . 55.1 Cg_endo -68.37 124.87 12.14 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.604 2.203 . . . . 0.0 112.736 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 129.2 16.83 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.189 1.926 . . . . 0.0 111.099 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 37.8 m-20 -57.95 120.68 44.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.878 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 33.2 Cg_exo -61.28 145.83 98.01 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 112.036 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 25.7 t -49.34 124.65 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.819 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 34.6 m120 75.87 -48.65 0.6 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -78.44 -151.78 5.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.5 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.533 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.7 pmm? 177.21 142.81 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.69 0.281 . . . . 0.0 110.818 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.684 HG21 HD12 ' A' ' 986' ' ' ILE . 14.9 p -93.67 129.57 43.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.868 0.366 . . . . 0.0 110.676 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -91.52 121.73 33.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.81 104.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.435 HD11 ' OG1' ' A' ' 987' ' ' THR . 3.0 mt -74.38 -38.69 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 79.8 p -144.73 -58.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 984' ' ' SER . 2.8 p30 -159.91 140.97 12.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.143 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -86.67 -5.4 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.293 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.709 ' HG3' ' HB3' ' A' ' 962' ' ' SER . 3.9 mp0 -76.12 156.4 33.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.655 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.12 97.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.382 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.73 19.26 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.221 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' 1003 ' ' GLU . 26.2 t -165.12 -165.39 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.044 0.422 . . . . 0.0 111.34 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.527 ' HG3' ' C ' ' A' 1002 ' ' ALA . 55.6 ttp180 -147.79 136.74 22.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.684 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -97.83 138.08 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.435 ' OG1' HD11 ' A' ' 977' ' ' ILE . 7.6 p -106.23 129.92 54.19 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.691 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 13.3 m-85 -96.48 152.73 18.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.216 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 59.1 m -148.2 129.65 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.68 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.441 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.751 HG22 ' SG ' ' A' 1020 ' ' CYS . 8.8 t -171.01 149.42 2.93 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 993' ' ' GLY . 10.7 m 8.81 -118.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.12 0.887 . . . . 0.0 113.218 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1022 ' ' ARG . . . -77.03 48.93 2.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.612 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.594 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 6.7 m80 -137.21 134.76 36.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.339 . . . . 0.0 110.19 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.561 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.3 ptm180 -94.5 135.7 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' 1018 ' ' PRO . 7.0 tt -68.58 132.26 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.2 mp -100.11 138.49 24.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 85.61 -131.3 10.38 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.569 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -79.07 -131.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.227 0.211 . . . . 0.0 111.484 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.4 p -175.16 -28.43 0.01 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.932 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.7 p -150.91 150.08 30.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.704 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.527 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.02 133.71 14.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 984' ' ' SER . 42.3 tt0 -96.23 133.42 40.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.403 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.7 t -71.18 121.04 17.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.84 -157.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.402 . . . . 0.0 111.767 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 58.7 tp -150.85 134.39 16.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.25 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.2 t -88.8 -48.13 7.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.369 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.98 -51.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.154 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -91.27 -38.36 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.42 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 83.8 m -145.47 145.49 31.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.47 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.11 147.82 32.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.9 p80 -158.7 148.59 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.425 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 86.2 m95 -64.41 145.15 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.767 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -53.0 -33.07 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.641 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 69.3 p -145.13 141.65 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.687 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.1 137.55 73.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 988' ' ' TYR . 51.1 Cg_exo -53.68 126.7 22.72 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.533 2.155 . . . . 0.0 112.319 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.629 ' HB2' HD21 ' A' ' 996' ' ' LEU . 39.9 Cg_endo -67.11 -159.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.41 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.768 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -140.67 -161.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.768 ' H ' HG22 ' A' 1019 ' ' ILE . 44.5 t -158.69 131.24 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 4.5 tt0 -153.44 135.24 14.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.66 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 51.1 ttp180 -48.97 134.89 16.48 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 111.532 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.7 mt -74.89 128.82 84.53 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.959 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 42.6 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.709 2.273 . . . . 0.0 112.358 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 897' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 898' ' ' ALA . 15.5 tp10 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 898' ' ' ALA . . . . . 0.517 ' H ' ' HG3' ' A' ' 897' ' ' GLU . . . -63.62 133.08 53.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -175.5 135.1 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.71 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -166.07 136.74 3.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.413 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 949' ' ' LEU . 48.7 m80 -149.66 127.5 11.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.382 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 7.8 p -82.26 114.5 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 903' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 921' ' ' ASP . 18.3 pt20 -66.86 178.39 1.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -48.13 131.52 12.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.005 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.4 Cg_exo -62.1 -164.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.547 2.165 . . . . 0.0 112.325 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.12 -14.47 61.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.391 0.615 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 74.2 t60 62.26 114.42 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.582 ' HZ ' ' HG2' ' A' ' 954' ' ' PRO . 49.4 m-85 -90.0 133.56 34.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.254 0.55 . . . . 0.0 111.268 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.1 mp -70.43 -45.74 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.125 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.698 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 2.3 p90 -82.8 31.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.071 0.462 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.09 121.39 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.879 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -96.54 129.76 43.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -44.85 144.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 22.8 tptm -135.09 -38.93 0.77 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.459 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.575 ' O ' HD11 ' A' ' 913' ' ' LEU . 95.9 m -64.56 136.41 57.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.702 0.287 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.455 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 19.4 mp0 -50.94 125.11 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.803 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.464 HG22 HD11 ' A' ' 913' ' ' LEU . 7.0 t -159.43 148.39 18.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 918' ' ' THR . 20.7 m -156.85 47.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.387 0.613 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -169.55 164.03 10.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.717 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 37.0 t -84.56 -39.47 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 903' ' ' GLN . 37.6 p-10 -85.01 118.81 24.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 17.0 m-85 -101.17 139.36 20.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.784 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.589 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 38.3 Cg_endo -66.42 139.17 53.16 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.732 2.288 . . . . 0.0 112.104 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.673 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 61.4 mt -61.3 151.91 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.31 -31.25 3.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.886 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.589 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 17.1 m -56.01 131.05 46.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.023 0.44 . . . . 0.0 111.982 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 942' ' ' SER . 74.8 p -90.96 116.66 28.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.672 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.638 HD23 ' OH ' ' A' ' 930' ' ' TYR . 11.7 tp -96.28 97.87 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 38.3 ttpt -82.52 131.03 35.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.31 0.576 . . . . 0.0 112.157 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.842 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 17.9 m-85 -113.78 139.17 49.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.473 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 5.0 mm-40 -91.41 118.42 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.73 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 75.3 m -57.67 143.2 42.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.6 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.698 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 94.5 mtt180 -84.89 160.78 54.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.092 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 5.9 Cg_endo -47.69 139.18 18.91 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.56 2.173 . . . . 0.0 112.096 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.551 ' HG2' HG11 ' A' ' 982' ' ' VAL . 90.0 mt-10 83.76 26.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.736 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.619 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 62.2 m-85 -145.75 148.19 32.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.302 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -137.56 -155.83 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.045 0.45 . . . . 0.0 111.839 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 78.69 33.16 38.84 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.713 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.6 ptp85 47.22 164.95 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.54 0.736 . . . . 0.0 112.962 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.713 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 70.9 Cg_endo -73.96 138.66 26.12 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.925 2.417 . . . . 0.0 112.808 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.893 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 43.6 p90 -95.4 120.82 36.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.371 0.605 . . . . 0.0 111.438 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 927' ' ' SER . 78.2 p -75.3 -37.33 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.762 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.506 ' O ' HG13 ' A' ' 943' ' ' ILE . 44.7 pt 49.23 104.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.393 0.616 . . . . 0.0 111.441 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 51.6 m -78.62 124.93 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.486 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 0.5 OUTLIER -73.74 130.77 40.67 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.085 0.469 . . . . 0.0 110.057 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.776 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -90.83 166.96 12.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.333 1.063 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 924' ' ' ILE . 9.4 t70 -50.23 -42.28 51.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.322 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.56 ' O ' HG13 ' A' ' 950' ' ' VAL . 16.4 p-10 -83.36 43.97 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.8 mp 44.68 53.52 7.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.089 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.776 HG23 HD23 ' A' ' 946' ' ' LEU . 26.3 m -133.91 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 111.115 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.57 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 84.9 m95 -150.95 125.74 9.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.0 t -41.58 152.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.7 t -77.19 118.54 72.64 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.582 ' HG2' ' HZ ' ' A' ' 908' ' ' PHE . 5.9 Cg_exo -79.51 58.24 6.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.468 2.779 . . . . 0.0 112.931 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -80.25 128.6 33.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.778 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 1.5 m-20 55.61 38.41 30.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.893 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 16.7 m -89.31 -35.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.908 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 48.4 t -152.92 60.77 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.5 mmtt -56.52 148.29 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.243 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 17.4 ttm105 -55.59 137.35 49.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 111.575 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.823 ' HD3' ' N ' ' A' ' 962' ' ' SER . 6.4 tmtt? -56.29 144.25 30.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.618 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.823 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 47.5 t -138.66 137.21 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.492 . . . . 0.0 111.099 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.21 148.45 32.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -65.49 139.01 58.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 111.301 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 60.3 m -58.32 135.95 85.12 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.194 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 974' ' ' VAL . 51.3 Cg_exo -53.31 146.68 39.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.422 2.081 . . . . 0.0 111.938 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 10.7 Cg_exo -72.22 46.31 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 0.0 112.687 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 8.4 t70 22.03 97.68 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.825 0.703 . . . . 0.0 112.476 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 968' ' ' ASP . 21.9 Cg_endo -60.43 145.25 99.05 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.491 2.128 . . . . 0.0 111.641 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 24.1 t -47.26 122.49 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' 1020 ' ' CYS . 33.0 m120 75.48 -43.11 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.86 151.18 45.54 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.101 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 68.4 mtm -146.76 132.23 18.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.317 . . . . 0.0 110.586 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 986' ' ' ILE . 14.8 p -98.66 129.93 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.927 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 122.05 38.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.654 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.644 ' HA ' HG22 ' A' ' 986' ' ' ILE . 98.0 t -70.62 136.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.302 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 986' ' ' ILE . 37.1 mm -82.92 64.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.933 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 6.6 p 76.4 -43.9 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -157.5 135.43 10.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.699 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 976' ' ' VAL . 20.3 pt -88.96 26.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.591 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 85.0 mt-30 -76.61 146.34 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.551 HG11 ' HG2' ' A' ' 935' ' ' GLU . 69.9 t -50.12 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.144 0.497 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 166.99 -62.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 84.6 p -81.71 -150.07 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.985 0.422 . . . . 0.0 110.225 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' 1002 ' ' ALA . 5.0 ptp85 -151.38 -165.87 2.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.875 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.644 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.4 pt -147.7 131.6 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.25 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' 1001 ' ' SER . 1.3 p -97.8 134.35 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 111.555 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 974' ' ' VAL . 3.7 m-85 -103.03 143.94 31.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.262 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -154.37 127.01 8.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.454 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 15.6 t -63.6 162.35 13.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 992' ' ' THR . 4.2 t -64.83 -53.72 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 991' ' ' THR . 12.2 t 173.84 147.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' 1023 ' ' ILE . . . 84.79 -40.9 3.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.926 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.541 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.1 m80 -100.51 143.51 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.067 0.433 . . . . 0.0 111.194 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -91.89 148.82 21.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.95 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 999' ' ' HIS . 10.2 tt -71.82 128.81 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 997' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.61 122.43 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 131.32 -57.83 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.908 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.574 ' O ' HD22 ' A' ' 996' ' ' LEU . 40.3 t-80 -162.2 -121.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.8 p 177.31 -22.82 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.537 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 987' ' ' THR . 48.9 m -155.22 159.18 39.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.772 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -151.96 130.14 11.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -94.81 135.11 36.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.204 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 26.2 t -72.67 121.53 19.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.9 pt -134.55 141.93 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.506 HD22 ' H ' ' A' ' 935' ' ' GLU . 49.4 tp -84.52 130.44 34.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.032 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.582 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 42.3 t -96.09 50.38 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 82.19 -37.05 2.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.483 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -147.93 -50.67 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 62.4 m -94.16 125.14 38.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 961' ' ' LYS . . . -82.61 136.19 34.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.561 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.582 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.9 p80 -157.73 148.91 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 22.0 m95 -68.59 145.45 53.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 64.2 m -55.35 -42.96 74.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.268 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.502 HG21 ' CD2' ' A' ' 999' ' ' HIS . 80.9 p -100.15 -148.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.176 0.513 . . . . 0.0 112.114 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.573 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -148.66 153.39 39.47 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.563 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.78 130.31 33.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.754 2.303 . . . . 0.0 112.713 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.511 ' HG3' HD11 ' A' ' 996' ' ' LEU . 79.1 Cg_endo -76.9 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.767 2.311 . . . . 0.0 112.696 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.09 142.0 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.379 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 32.9 m -81.49 129.77 34.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.541 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 18.2 tp60 -143.49 127.14 17.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 30.7 ptt85 -49.12 142.19 7.23 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.487 0.661 . . . . 0.0 111.38 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 993' ' ' GLY . 23.3 mt -74.75 131.51 79.36 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.182 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.741 2.294 . . . . 0.0 112.407 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.856 0.36 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.38 136.23 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.981 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 899' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 899' ' ' GLU . 0.4 OUTLIER -58.86 132.02 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . -166.27 -141.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.315 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 900' ' ' ALA . 21.2 m80 68.88 129.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.856 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.8 p -82.21 124.19 29.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.629 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -69.65 166.75 18.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.142 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 920' ' ' SER . . . -47.44 127.79 10.15 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.122 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.579 ' HG3' HD12 ' A' ' 928' ' ' LEU . 53.9 Cg_endo -69.47 133.13 25.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.389 2.06 . . . . 0.0 112.018 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.19 153.2 35.26 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.216 0.532 . . . . 0.0 111.161 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -78.29 139.29 38.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.92 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.417 ' O ' HD23 ' A' ' 909' ' ' LEU . 2.9 m-85 -89.48 -140.32 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.955 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 908' ' ' PHE . 63.1 mt -154.03 -38.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -6.3 59.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.683 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -157.85 128.81 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.324 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -98.81 135.06 40.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.839 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 930' ' ' TYR . 36.8 tp -48.86 125.35 10.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.372 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -94.52 -43.34 8.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 38.1 m -64.84 135.44 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.806 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.421 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -64.08 144.55 57.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.046 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.685 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 46.5 p -150.53 -86.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.419 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 917' ' ' THR . 91.3 m 73.26 -38.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.4 136.49 51.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.365 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 920' ' ' SER . . . . . 0.571 ' HA ' ' HB2' ' A' ' 904' ' ' ALA . 79.5 p -89.67 34.51 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.389 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.53 135.85 11.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.885 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.685 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 72.8 m-85 -143.4 138.36 15.43 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.46 140.48 12.01 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.913 2.409 . . . . 0.0 111.414 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.545 ' HA ' ' HB2' ' A' ' 945' ' ' CYS . 29.8 mt -51.59 141.18 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 110.583 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 105.8 -29.09 11.87 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.523 HG21 ' HD2' ' A' ' 922' ' ' PHE . 30.4 m -55.45 140.08 41.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.0 m -121.19 140.39 52.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.579 HD12 ' HG3' ' A' ' 905' ' ' PRO . 90.3 mt -132.36 118.94 20.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 39.4 ttmt -89.18 128.43 35.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.409 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.596 ' CE1' HD13 ' A' ' 913' ' ' LEU . 2.5 m-85 -110.99 129.18 55.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -97.58 129.41 44.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.5 m -56.75 160.01 3.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.558 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 67.6 mtt-85 -81.47 158.33 68.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.485 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 936' ' ' TYR . 68.9 Cg_exo -39.17 -55.64 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.922 2.415 . . . . 0.0 113.26 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 936' ' ' TYR . 14.4 pt-20 -75.23 36.51 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.56 ' CE1' ' HG3' ' A' ' 935' ' ' GLU . 56.4 m-85 -142.7 150.87 40.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.739 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 35.9 p90 -145.43 135.46 23.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.326 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 957' ' ' VAL . . . 153.16 28.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.17 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 80.6 mtp180 61.05 148.0 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.451 0.643 . . . . 0.0 112.239 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 939' ' ' ARG . 4.4 Cg_exo -75.18 123.04 7.49 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.263 2.642 . . . . 0.0 111.989 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.537 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 46.3 p90 -90.37 -161.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.615 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 135.93 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.425 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 4.6 pt -92.61 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -164.0 132.12 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 59.5 m -72.12 110.88 6.89 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 97.5 mt -83.41 -52.85 6.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.6 t70 174.32 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 110.905 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.449 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.5 m-80 -83.13 31.78 0.44 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 900' ' ' ALA . 78.3 mt 50.75 42.38 27.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 948' ' ' ASN . 19.9 m -137.44 150.91 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 121.632 0.73 . . . . 0.0 112.343 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 68.6 m95 -91.49 124.71 35.87 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.323 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.2 t -43.37 142.07 1.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t -79.86 113.08 34.91 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.702 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.07 67.12 6.05 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.49 2.793 . . . . 0.0 111.766 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -76.42 131.68 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.296 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.3 t70 57.87 96.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.802 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -152.85 -70.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.802 ' H ' HG23 ' A' ' 957' ' ' VAL . 80.9 m -88.44 140.62 29.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -143.12 127.21 17.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.188 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 981' ' ' GLN . 53.8 ttp180 -53.24 137.3 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.165 0.507 . . . . 0.0 112.042 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.739 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 32.1 mmmt -56.34 170.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.127 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.658 ' HB3' HE21 ' A' ' 981' ' ' GLN . 69.5 p -150.24 134.69 17.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.075 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 980' ' ' ILE . 83.0 m -81.58 144.26 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.085 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -65.89 134.84 53.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.45 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.7 m -54.48 117.31 12.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.31 129.98 15.67 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.402 2.068 . . . . 0.0 111.835 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.04 125.15 18.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.098 1.866 . . . . 0.0 111.507 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.25 126.55 82.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.81 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.01 142.68 82.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.549 2.166 . . . . 0.0 112.076 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.3 p -46.97 129.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.425 ' OD1' HG22 ' A' ' 970' ' ' VAL . 33.7 m120 63.74 47.2 3.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.796 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -166.96 -155.38 8.99 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.447 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 23.7 ptp 175.23 140.33 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.63 0.252 . . . . 0.0 111.013 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.875 HG21 HD12 ' A' ' 986' ' ' ILE . 8.4 p -93.84 135.41 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.769 0.318 . . . . 0.0 111.029 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -94.29 108.96 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.179 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -65.41 -22.83 31.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 985' ' ' ARG . 7.2 mm 73.88 -52.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.748 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 73.3 p -150.25 -56.68 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.484 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 31.0 m-20 -157.13 157.69 34.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.595 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.647 HG23 HG13 ' A' ' 976' ' ' VAL . 14.6 pt -95.51 32.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.664 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' A' ' 962' ' ' SER . 5.4 mp0 -79.22 151.15 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 961' ' ' LYS . 73.7 t -53.93 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.079 0.466 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 160.56 -46.52 0.4 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.7 m -78.72 135.91 37.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.742 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 55.6 ttp180 -98.24 132.32 43.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.875 HD12 HG21 ' A' ' 974' ' ' VAL . 28.6 pt -93.97 130.09 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.316 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.519 HG22 ' OG ' ' A' 1001 ' ' SER . 7.8 p -102.52 130.99 49.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.461 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.7 m-85 -95.15 145.35 25.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.195 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 88.9 p -148.64 121.44 8.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.744 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.99 149.27 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.7 t -64.32 146.02 55.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.491 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 88.5 m -46.42 125.14 6.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.257 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' 1023 ' ' ILE . . . 127.72 -46.81 1.06 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.464 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.9 m80 -100.19 140.24 34.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.618 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.5 ptm180 -92.36 144.13 25.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.371 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.8 tt -72.81 135.39 45.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.0 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.656 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.6 mp -115.07 139.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 90.47 -125.71 8.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.262 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -78.33 -134.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.463 0.173 . . . . 0.0 111.314 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.5 p -177.9 -27.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 987' ' ' THR . 50.0 m -151.63 153.0 33.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.577 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.58 128.9 11.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.742 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 20.5 pt-20 -95.66 137.85 34.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.805 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.26 95.89 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.604 HG23 ' HG3' ' A' 1003 ' ' GLU . 32.1 pt -103.56 -157.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.869 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' 1010 ' ' THR . 57.3 tp -153.68 137.73 16.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.474 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.509 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.8 t -90.03 -40.09 12.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.777 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -169.92 -34.08 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.45 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.485 ' C ' HD11 ' A' 1006 ' ' LEU . 14.4 p-10 -152.95 -40.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.528 ' O ' HD12 ' A' 1006 ' ' LEU . 70.5 m -91.2 130.08 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.608 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.98 141.02 37.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.106 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.0 p80 -157.01 145.95 20.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.33 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.4 m95 -68.27 141.89 55.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -57.74 -32.32 67.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.38 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 71.5 p -142.88 139.07 30.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.958 0.409 . . . . 0.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' 1017 ' ' PRO . 4.7 tmmm? -64.82 138.37 97.45 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.558 ' N ' ' HD2' ' A' 1016 ' ' LYS . 97.8 Cg_exo -44.75 134.74 10.15 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.964 2.443 . . . . 0.0 113.207 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 40.3 Cg_endo -66.54 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.861 2.374 . . . . 0.0 112.844 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 55.9 mt -141.09 144.85 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.837 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 74.2 m -103.89 123.97 48.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 0.6 OUTLIER -142.84 127.48 18.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.669 0.271 . . . . 0.0 110.754 -178.363 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 0.0 OUTLIER -49.66 136.95 16.46 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.447 0.642 . . . . 0.0 111.168 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 995' ' ' ARG . 16.0 mt -75.96 132.46 74.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.188 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.733 0.301 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 57.22 -153.17 0.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 899' ' ' GLU . . . . . 0.445 ' HB3' ' HE1' ' A' ' 901' ' ' HIS . 95.1 mt-10 -57.99 134.38 56.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -73.9 128.68 36.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.054 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.447 ' C ' HD22 ' A' ' 949' ' ' LEU . 74.0 m80 -156.04 141.08 17.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.276 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 92.1 m -81.05 128.6 33.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -76.14 172.14 13.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.397 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.1 126.06 7.15 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.984 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.693 ' HG2' HD23 ' A' ' 928' ' ' LEU . 50.5 Cg_exo -56.75 138.08 83.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.623 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.22 157.21 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -78.11 123.74 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.87 ' HB2' ' HB3' ' A' ' 911' ' ' ALA . 2.8 m-85 -85.22 24.1 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.25 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 14.1 mt 61.33 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.17 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.592 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -82.49 35.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.392 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 908' ' ' PHE . . . -154.48 143.12 20.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.228 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.28 144.61 32.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 915' ' ' THR . 59.3 tp -43.03 152.49 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.394 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.875 ' HA ' ' HE3' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -147.9 48.1 1.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.036 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 917' ' ' THR . 16.2 m -170.72 137.32 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -52.91 132.09 36.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.808 0.337 . . . . 0.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.833 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 82.7 p -152.88 57.9 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 85.0 m -51.5 -44.74 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.6 51.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 49.4 m -86.78 -41.57 14.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.87 145.98 27.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.382 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.833 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 37.9 m-85 -134.95 138.51 29.69 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 0.0 112.037 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.478 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 58.0 Cg_endo -70.59 141.1 41.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.367 . . . . 0.0 111.67 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.75 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.7 mt -56.53 143.05 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.994 0.425 . . . . 0.0 111.312 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.2 16.44 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.492 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 19.5 m -55.88 132.76 50.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 143.19 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.835 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.693 HD23 ' HG2' ' A' ' 905' ' ' PRO . 8.6 tp -135.18 125.19 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.29 134.22 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.515 ' HE1' HD23 ' A' ' 928' ' ' LEU . 8.5 m-85 -132.13 122.79 25.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.392 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -95.62 130.46 42.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.346 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 36.0 m -56.79 -173.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.401 . . . . 0.0 111.363 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.592 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 93.7 mtt180 -82.46 152.72 67.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.758 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 936' ' ' TYR . 91.9 Cg_exo -44.51 -40.01 13.28 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.78 2.32 . . . . 0.0 112.547 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.04 21.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 111.082 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.3 m-85 -142.75 137.22 29.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.486 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.473 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 3.7 p90 -102.12 36.56 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.215 0.531 . . . . 0.0 110.962 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . -83.87 139.74 18.81 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.79 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 37.1 ptt85 -72.89 163.52 67.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -63.63 112.69 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.352 2.035 . . . . 0.0 112.017 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.636 ' HB3' HG11 ' A' ' 957' ' ' VAL . 53.1 p90 -91.04 114.85 27.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.46 0.648 . . . . 0.0 110.612 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.2 p -79.58 122.09 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.955 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 954' ' ' PRO . 9.4 pt -97.46 -174.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 0.7 OUTLIER -166.82 134.42 2.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.75 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 52.7 t -66.53 116.16 7.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.648 HD11 ' HA ' ' A' ' 952' ' ' SER . 77.4 mt -80.96 -55.56 4.71 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.571 ' HA ' HD13 ' A' ' 924' ' ' ILE . 49.8 t0 173.21 -48.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.53 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -83.87 33.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.278 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 900' ' ' ALA . 40.4 mt 60.92 56.77 2.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.637 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 2.1 m -139.4 -163.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.219 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.554 ' HA ' ' O ' ' A' ' 944' ' ' THR . 74.7 m95 -145.41 125.03 13.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.766 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.648 ' HA ' HD11 ' A' ' 946' ' ' LEU . 47.5 t -38.59 135.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 79.9 p -76.97 111.38 16.04 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 943' ' ' ILE . 18.6 Cg_exo -65.85 132.64 31.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.576 ' HG2' ' H ' ' A' ' 956' ' ' ASP . 79.2 tttt -78.23 -134.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.576 ' H ' ' HG2' ' A' ' 955' ' ' LYS . 38.9 p-10 -78.98 127.0 31.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.847 0.356 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.636 HG11 ' HB3' ' A' ' 941' ' ' PHE . 21.0 m -150.36 -48.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.5 ' N ' HG23 ' A' ' 957' ' ' VAL . 71.3 m -84.18 138.17 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.4 mmtt -143.88 131.47 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 20.5 mmt180 -58.96 113.95 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.052 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.962 ' HE3' ' HB2' ' A' 1011 ' ' ALA . 38.3 ttpt -58.33 166.06 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.473 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 90.1 p -144.46 141.61 29.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.965 0.412 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.408 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 49.2 m -81.54 36.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.979 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 60.18 128.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 14.6 m -61.17 132.81 92.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.484 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.456 ' CG ' HG11 ' A' ' 974' ' ' VAL . 11.6 Cg_endo -55.37 135.68 70.2 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 112.384 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 968' ' ' ASP . 72.2 Cg_endo -76.23 52.31 3.47 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 967' ' ' PRO . 8.1 t70 29.59 102.03 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.24 0.616 . . . . 0.0 112.423 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.509 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 52.1 Cg_exo -52.62 143.97 44.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.743 2.295 . . . . 0.0 112.322 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' 1020 ' ' CYS . 6.4 p -53.04 133.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.484 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 34.3 m120 52.65 47.3 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.415 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.51 -158.77 16.21 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.631 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 176.29 140.42 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.151 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.576 HG21 HD12 ' A' ' 986' ' ' ILE . 7.2 p -99.82 128.77 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.483 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.5 OUTLIER -89.76 124.31 34.52 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 979' ' ' ASP . 87.3 t -76.4 124.55 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.5 mm -75.49 -41.65 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.9 p -144.71 -52.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.317 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.7 m-20 -153.33 -156.57 0.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 986' ' ' ILE . 15.8 pt -151.08 22.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 960' ' ' ARG . 4.8 mm100 -80.88 174.86 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' 1006 ' ' LEU . 88.0 t -58.83 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.91 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 146.99 -34.44 1.32 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.4 m -75.06 140.4 43.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.631 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' 1002 ' ' ALA . 38.8 ttm180 -104.16 150.63 24.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.576 HD12 HG21 ' A' ' 974' ' ' VAL . 40.8 pt -131.21 135.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' 1001 ' ' SER . 11.6 p -103.61 132.7 49.63 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.509 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 5.2 m-85 -98.7 145.63 26.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 989' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 46.8 t -152.32 119.13 5.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.028 0.442 . . . . 0.0 110.984 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 62.6 m -80.92 144.85 31.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.854 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.8 t -65.0 158.37 25.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.4 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.0 t -46.47 134.57 9.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.624 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 113.83 -51.01 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.979 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -101.88 141.3 34.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.524 ' O ' HD12 ' A' ' 997' ' ' ILE . 2.6 ptp180 -93.33 146.44 23.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.354 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' 1018 ' ' PRO . 10.0 tt -69.64 129.78 40.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.775 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -98.34 142.26 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.72 -133.57 11.89 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.945 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -78.63 -121.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 20.3 m -164.67 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.574 0.226 . . . . 0.0 111.177 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.575 ' HB3' HG22 ' A' ' 987' ' ' THR . 80.0 p -155.17 117.87 4.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.973 0.415 . . . . 0.0 111.274 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -91.09 179.45 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.478 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -145.41 132.13 19.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.339 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.3 t -71.19 122.35 20.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 982' ' ' VAL . 29.8 pt -138.38 148.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.179 0.514 . . . . 0.0 111.911 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' 1007 ' ' SER . 1.2 tt -88.47 129.86 35.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.496 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.651 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -89.98 -44.92 9.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -173.5 -32.27 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.993 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.63 -49.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 26.2 m -94.46 133.01 38.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.802 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.962 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.01 139.29 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.243 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.651 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -157.67 144.61 18.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 62.3 m95 -68.56 138.35 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.599 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.5 p -52.9 -28.42 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.674 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 53.2 p -141.54 142.43 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.639 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -56.63 153.97 19.32 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.751 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.19 122.15 8.97 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.302 2.001 . . . . 0.0 112.597 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.568 ' HB3' HD21 ' A' ' 996' ' ' LEU . 51.3 Cg_exo -54.42 148.8 40.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.779 2.319 . . . . 0.0 112.225 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.86 -159.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.752 ' H ' HG22 ' A' 1019 ' ' ILE . 84.5 m -153.31 134.69 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.011 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 997' ' ' ILE . 4.4 tt0 -151.85 136.85 17.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.26 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -48.02 133.59 14.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.374 0.607 . . . . 0.0 111.018 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 995' ' ' ARG . 60.0 mt -74.79 129.48 83.34 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.976 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 112.501 -179.868 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 897' ' ' GLU . . . . . 0.421 ' N ' ' OE1' ' A' ' 897' ' ' GLU . 54.5 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.786 0.327 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 65.63 130.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -152.03 139.41 19.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -166.18 126.89 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.559 ' C ' HD12 ' A' ' 949' ' ' LEU . 36.3 m80 -151.6 138.51 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.525 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 83.3 m -81.1 124.94 29.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.706 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -69.38 173.14 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.0 134.86 6.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.226 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 52.5 Cg_exo -54.07 149.4 35.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.525 2.15 . . . . 0.0 111.942 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 29.2 t0 -63.23 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.751 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.475 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 26.3 m80 -77.77 134.36 38.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.03 47.07 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.217 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.935 HD12 ' N ' ' A' ' 910' ' ' PHE . 4.2 pp -53.26 -34.44 57.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.4 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.935 ' N ' HD12 ' A' ' 909' ' ' LEU . 0.2 OUTLIER -87.11 26.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.485 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -155.09 129.98 9.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -101.62 126.2 48.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.382 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -55.49 119.89 6.34 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.536 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.645 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 74.4 mmtt -95.4 -39.04 10.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.651 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 916' ' ' GLN . 18.5 m -64.55 -119.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.142 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.505 ' N ' HG22 ' A' ' 915' ' ' THR . 12.0 tm0? -171.06 134.05 0.92 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.4 t -160.35 159.44 31.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.566 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.2 m -155.95 -31.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.403 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.3 158.74 35.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.03 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.3 p -84.67 -50.68 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.35 126.19 33.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.328 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 20.0 m-85 -102.0 134.13 20.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.439 . . . . 0.0 111.906 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.487 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 71.5 Cg_endo -73.36 137.36 25.58 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.833 2.355 . . . . 0.0 112.003 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.596 HG12 ' SG ' ' A' ' 945' ' ' CYS . 25.9 mt -59.99 151.58 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 93.94 -36.2 3.85 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.9 m -56.12 133.53 52.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.271 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 42.6 t -114.08 121.72 44.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.435 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.579 ' HB3' ' HE1' ' A' ' 930' ' ' TYR . 92.9 mt -103.38 124.82 49.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 17.1 tppt? -87.39 132.52 33.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.579 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 15.0 m-85 -135.27 123.03 22.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.544 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.979 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 90.4 mt-10 -103.29 129.59 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.691 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 74.2 m -54.09 168.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.548 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 77.6 mtp180 -79.03 148.46 71.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.53 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 936' ' ' TYR . 83.3 Cg_exo -45.45 -42.64 17.98 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.831 2.354 . . . . 0.0 112.682 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.431 ' CD ' HG11 ' A' ' 982' ' ' VAL . 4.2 mm-40 -73.33 20.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.227 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.6 m-85 -144.6 135.12 24.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.746 0.308 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -102.67 37.35 1.95 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 110.922 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -77.03 0.12 67.88 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.764 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 939' ' ' ARG . 62.0 mtt85 64.58 144.12 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.429 . . . . 0.0 111.353 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.979 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 19.6 Cg_exo -66.36 110.43 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.796 2.331 . . . . 0.0 112.505 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.431 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 52.3 p90 -95.54 -164.3 1.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.496 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.524 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 80.5 p -172.83 135.98 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 10.8 pt -97.01 166.26 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.838 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 946' ' ' LEU . 2.9 m -161.41 120.48 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.814 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 34.8 t -68.6 112.87 5.65 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 82.2 mt -83.79 -52.5 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 50.0 t0 173.49 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.787 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -85.9 36.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.471 0.653 . . . . 0.0 109.84 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 2.3 mm? 54.88 63.69 2.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.384 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 19.0 m -141.64 146.19 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 111.891 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.716 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 97.7 m95 -93.8 47.88 1.25 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.051 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 89.3 p 53.03 26.85 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t 38.23 75.16 0.57 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.23 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 951' ' ' TRP . 92.5 Cg_endo -79.84 53.71 4.86 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.429 2.086 . . . . 0.0 112.376 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.36 129.07 35.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.916 0.389 . . . . 0.0 110.71 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.3 t0 60.88 106.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.3 m -153.86 -56.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 1.035 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 72.6 m -83.55 141.53 31.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.042 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -143.03 148.12 36.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.268 0.556 . . . . 0.0 112.08 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 981' ' ' GLN . 10.8 tpt180 -53.48 113.9 1.32 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.366 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.711 ' HZ1' ' H ' ' A' 1011 ' ' ALA . 27.8 tptp -56.99 158.33 5.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.371 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.423 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 77.4 p -150.81 138.36 19.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.581 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 964' ' ' LYS . 65.4 m -81.6 35.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 963' ' ' CYS . 87.4 tttt 55.45 131.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.416 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 980' ' ' ILE . 24.3 m -54.11 129.05 58.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.526 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 72.8 Cg_endo -74.87 124.94 9.06 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.511 2.141 . . . . 0.0 112.67 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 15.5 Cg_exo -67.99 125.76 13.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.456 2.104 . . . . 0.0 111.533 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.24 128.53 91.21 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.243 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 970' ' ' VAL . 72.6 Cg_endo -76.26 -152.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.685 2.256 . . . . 0.0 111.979 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' 1020 ' ' CYS . 12.7 t -53.94 116.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.596 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 18.3 p30 39.53 32.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -67.02 177.56 19.05 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.111 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 50.6 ttm -175.45 73.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.323 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.7 p -90.35 122.05 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 111.328 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.62 131.61 41.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.166 0.507 . . . . 0.0 109.902 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.573 ' HB ' HG23 ' A' ' 980' ' ' ILE . 2.1 m -75.4 135.63 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.626 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.557 ' N ' HD12 ' A' ' 977' ' ' ILE . 2.5 mp -76.46 -32.14 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.475 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 977' ' ' ILE . 64.8 p -140.4 -66.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.0 t0 -162.16 14.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 965' ' ' THR . 29.3 pt 51.77 24.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.361 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 7.3 mm100 -80.93 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.654 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 14.7 t -55.51 130.31 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.333 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 96.26 -23.05 36.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.852 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' 1003 ' ' GLU . 52.3 m -74.61 -165.45 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.587 ' HE ' ' HB2' ' A' 1001 ' ' SER . 74.1 ttt180 -151.35 161.51 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.406 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 980' ' ' ILE . 20.3 pt -136.42 132.05 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' 1001 ' ' SER . 2.5 p -124.59 136.11 53.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 111.575 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -94.04 156.51 16.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.443 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 57.7 m -147.84 69.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 85.7 m -44.93 151.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.368 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 21.0 p -64.04 150.68 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -48.32 137.74 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.134 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' 1023 ' ' ILE . . . 106.02 -40.14 2.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.656 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 4.2 m80 -96.38 138.68 33.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.4 ptt180 -94.91 151.04 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.552 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 997' ' ' ILE . 0.4 OUTLIER -73.48 125.05 27.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.0 mp -103.05 138.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.707 0.289 . . . . 0.0 110.78 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 81.09 -125.13 6.72 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -78.57 -132.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.1 p -177.21 -30.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.606 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 987' ' ' THR . 83.3 p -150.93 167.51 27.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.56 139.03 14.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.5 tt0 -96.25 134.94 38.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.654 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 40.5 t -71.96 125.83 28.21 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.24 -155.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.805 0.336 . . . . 0.0 111.537 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 36.8 tp -152.05 124.75 8.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.643 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.3 t -91.35 -48.37 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' 1010 ' ' THR . . . 168.85 124.15 0.71 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.867 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.6 m120 71.38 -28.82 0.19 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' 1008 ' ' GLY . 96.7 m -145.43 135.43 23.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.774 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.711 ' H ' ' HZ1' ' A' ' 961' ' ' LYS . . . -82.25 149.07 28.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.643 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.4 p80 -157.93 151.37 23.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.538 ' CZ2' ' HB ' ' A' ' 980' ' ' ILE . 81.2 m95 -68.46 144.05 54.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.253 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -56.8 -31.06 64.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.673 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 80.8 p -144.06 138.41 28.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 111.923 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.57 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -66.45 155.74 87.61 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.182 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.16 135.31 52.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.759 2.306 . . . . 0.0 112.782 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 988' ' ' TYR . 53.6 Cg_endo -68.81 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.818 2.346 . . . . 0.0 112.605 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 54.4 mt -140.16 137.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -98.75 123.37 42.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 997' ' ' ILE . 36.3 tt0 -145.74 129.12 16.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.692 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 36.5 ttm180 -51.16 135.45 25.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.439 0.638 . . . . 0.0 111.475 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 995' ' ' ARG . 48.4 mt -74.92 125.78 89.0 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.627 2.218 . . . . 0.0 112.475 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.879 0.371 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -64.83 136.35 56.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.045 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -173.74 138.33 0.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 65.99 128.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.427 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.455 ' C ' HD22 ' A' ' 949' ' ' LEU . 50.9 m80 -153.86 143.93 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 66.1 m -80.47 122.95 27.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.596 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -68.14 170.68 8.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.687 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.35 133.18 5.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.945 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.48 ' HG3' ' OH ' ' A' ' 930' ' ' TYR . 26.6 Cg_endo -61.7 -168.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.642 2.228 . . . . 0.0 112.333 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 8.3 t70 -174.96 161.04 2.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.053 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.417 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 78.0 t60 72.11 62.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.587 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.695 ' O ' HD13 ' A' ' 909' ' ' LEU . 45.1 m-85 -146.01 120.15 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.084 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.0 OUTLIER -132.58 -45.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.012 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.97 13.87 3.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.126 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.475 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -152.0 126.81 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.115 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.546 ' HG3' ' HZ3' ' A' ' 914' ' ' LYS . 20.8 pttp -107.92 123.85 49.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.684 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -51.13 146.81 6.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.086 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.748 ' N ' HD13 ' A' ' 913' ' ' LEU . 42.6 mmtm -147.88 11.89 0.97 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 915' ' ' THR . . . . . 1.041 HG21 HD22 ' A' ' 928' ' ' LEU . 14.3 t -70.88 -151.18 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.879 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 915' ' ' THR . 0.7 OUTLIER -86.55 -44.45 11.91 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-O 121.221 0.534 . . . . 0.0 110.978 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 915' ' ' THR . 21.4 p 50.67 -121.12 1.7 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.187 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 916' ' ' GLN . 68.8 p 55.7 33.14 20.74 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.47 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.557 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.0 t -85.72 -49.37 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.744 0.306 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.74 126.01 33.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.593 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.482 ' CD2' HD21 ' A' ' 928' ' ' LEU . 36.0 m-85 -108.46 138.18 20.15 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.922 0.391 . . . . 0.0 111.756 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.526 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.1 Cg_endo -69.39 143.25 51.98 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.923 2.415 . . . . 0.0 112.302 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.1 mt -57.66 154.79 2.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.845 0.355 . . . . 0.0 110.914 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.81 -40.37 2.89 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.526 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.4 m -57.11 132.1 51.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.865 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 22.6 t -115.44 133.41 56.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 1.041 HD22 HG21 ' A' ' 915' ' ' THR . 78.3 mt -95.47 125.81 40.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.956 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.441 ' O ' HD22 ' A' ' 913' ' ' LEU . 40.4 ttmt -85.35 136.82 33.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.48 ' OH ' ' HG3' ' A' ' 905' ' ' PRO . 11.1 m-85 -128.75 131.28 47.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.61 123.03 44.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 80.5 m -57.25 163.54 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 73.9 mtp180 -81.89 151.55 67.55 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 936' ' ' TYR . 6.7 Cg_endo -49.44 -44.23 35.48 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.972 2.448 . . . . 0.0 112.609 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.416 ' HB3' HG21 ' A' ' 982' ' ' VAL . 55.4 mt-10 -73.27 20.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.77 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 45.4 m-85 -143.08 134.99 26.86 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.837 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 13.2 p90 -96.17 135.82 37.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.631 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 164.95 141.17 3.05 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.87 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 939' ' ' ARG . 0.6 OUTLIER -72.75 157.12 89.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.931 0.396 . . . . 0.0 110.505 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 19.2 Cg_endo -60.75 147.27 95.55 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.986 2.457 . . . . 0.0 112.092 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 53.1 p90 -144.44 -171.27 3.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 44.9 t -172.92 142.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 10.7 pt -100.46 116.93 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.445 ' O ' HD22 ' A' ' 946' ' ' LEU . 36.9 m -81.45 131.68 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.38 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.6 t -73.74 123.22 23.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 109.903 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 950' ' ' VAL . 1.9 mm? -87.44 169.03 12.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.338 1.066 . . . . 0.0 113.622 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.4 -40.4 62.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.146 -1.843 . . . . 0.0 112.043 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 950' ' ' VAL . 50.0 t30 -83.33 32.89 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 900' ' ' ALA . 56.7 mt 46.39 57.99 4.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.237 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.872 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -135.59 -159.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.385 0.612 . . . . 0.0 111.697 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.417 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 91.8 m95 -144.72 122.31 11.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.137 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.45 ' N ' HD21 ' A' ' 946' ' ' LEU . 79.1 p -42.16 136.29 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.818 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 34.0 t -77.93 112.35 24.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 955' ' ' LYS . 15.4 Cg_exo -68.64 -153.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.713 2.275 . . . . 0.0 111.885 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.533 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 32.4 mtmt -159.84 -147.37 0.16 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.69 0.757 . . . . 0.0 111.6 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.533 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 56.5 m-20 -81.28 58.63 3.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.406 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 958' ' ' CYS . 29.5 m -81.6 -50.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.409 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.535 ' N ' HG23 ' A' ' 957' ' ' VAL . 97.5 m -89.0 52.3 2.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.422 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -57.64 138.7 55.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.754 ' HD2' ' HB2' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -55.37 120.56 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.844 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.837 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 35.6 ttmt -56.45 142.36 38.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 78.5 p -144.44 141.23 29.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.512 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.1 m -81.63 23.79 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 964' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 965' ' ' THR . 13.8 tmtt? 55.6 136.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.414 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 4.4 m -51.12 118.19 10.1 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.316 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG3' HD11 ' A' ' 986' ' ' ILE . 43.9 Cg_endo -64.5 141.73 75.07 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 122.664 2.243 . . . . 0.0 111.694 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.35 115.87 2.75 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.124 1.883 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -62.54 134.98 95.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 17.7 Cg_endo -59.6 138.1 81.48 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.433 2.089 . . . . 0.0 111.872 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.4 p -50.7 129.29 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.481 ' OD1' HG22 ' A' ' 970' ' ' VAL . 33.3 m120 64.04 48.24 3.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -170.82 -145.54 4.81 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.725 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER -178.83 156.6 0.85 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 986' ' ' ILE . 14.2 p -87.55 128.07 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.466 0.65 . . . . 0.0 110.851 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.977 ' HB3' HG23 ' A' ' 987' ' ' THR . 12.3 t-160 -75.05 70.97 2.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.341 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.593 HG23 HG13 ' A' ' 974' ' ' VAL . 99.3 t -59.06 122.84 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.97 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 987' ' ' THR . 32.0 mm -78.44 -40.64 24.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.29 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 59.0 p -144.67 -50.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 976' ' ' VAL . 56.5 m-20 -154.45 -142.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.495 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 17.0 pt -145.56 -3.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.436 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HB2' ' HD2' ' A' ' 960' ' ' ARG . 15.8 pt20 -75.56 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 5.9 m -47.92 150.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 111.366 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 85.17 -40.75 3.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.257 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 40.6 t -77.63 131.28 37.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 111.436 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ttm180 -100.33 150.15 22.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.157 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.709 HD12 HG21 ' A' ' 974' ' ' VAL . 48.2 pt -141.73 127.58 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.381 . . . . 0.0 111.51 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.977 HG23 ' HB3' ' A' ' 975' ' ' HIS . 1.6 t -98.62 -168.31 1.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.578 ' HA ' ' H ' ' A' ' 975' ' ' HIS . 22.0 m-85 -136.87 154.15 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 0.0 111.176 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.4 t -148.44 125.21 11.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 72.6 m -100.04 147.39 25.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -65.03 146.85 54.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.525 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 87.0 m -45.87 126.48 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' 1023 ' ' ILE . . . 126.09 -46.93 1.05 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -102.23 137.48 40.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.065 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.701 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.8 ptm85 -93.33 146.59 23.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.196 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.4 tt -71.77 133.2 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.984 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.513 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.2 mp -110.22 133.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 98.5 -128.9 9.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.306 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -79.04 -129.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.0 p -172.24 -31.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.319 . . . . 0.0 111.247 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 47.2 t -150.84 159.82 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.529 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.6 133.77 12.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.989 0.424 . . . . 0.0 111.83 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 4.6 pm0 -104.05 138.24 40.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.451 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.9 t -76.9 125.82 29.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' 1011 ' ' ALA . 29.9 pt -131.56 -151.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.669 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' 1010 ' ' THR . 28.8 tp -147.18 -26.57 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.335 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' 1006 ' ' LEU . 47.6 t 69.42 -42.94 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -175.83 -45.66 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -156.18 21.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.418 0.151 . . . . 0.0 111.025 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.667 ' C ' HD12 ' A' 1006 ' ' LEU . 3.3 m -150.58 121.04 7.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.283 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -76.15 129.13 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 0.0 110.888 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.468 ' CE1' HD11 ' A' 1005 ' ' ILE . 20.7 p80 -160.15 144.16 14.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 96.3 m95 -68.63 136.28 52.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.063 0.458 . . . . 0.0 110.453 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' 1003 ' ' GLU . 73.7 m -56.36 -27.25 55.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.888 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 72.8 p -145.86 143.9 29.9 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.176 0.512 . . . . 0.0 112.324 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.468 ' HG3' ' HD2' ' A' 1017 ' ' PRO . 26.0 ttpp -65.79 140.9 97.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.778 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' 1016 ' ' LYS . 18.2 Cg_endo -58.15 131.25 42.2 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.524 2.149 . . . . 0.0 112.277 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.448 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -65.02 -160.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.746 2.297 . . . . 0.0 113.01 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 58.3 mt -143.16 139.65 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.814 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 71.9 m -92.58 124.66 36.77 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.62 134.67 22.68 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.199 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -45.7 135.5 6.7 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 111.851 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.701 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.1 mt -74.88 128.41 85.27 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 40.2 Cg_exo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.851 2.367 . . . . 0.0 112.253 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.866 0.365 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.88 135.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 899' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 899' ' ' GLU . 87.9 tt0 -175.19 54.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.834 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -166.14 127.53 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.621 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.556 ' C ' HD12 ' A' ' 949' ' ' LEU . 61.1 m80 -152.58 139.8 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.267 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 76.5 m -81.08 132.48 35.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.987 0.422 . . . . 0.0 111.491 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -76.54 171.57 14.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.652 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.01 149.75 1.52 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.544 ' HB2' ' CD1' ' A' ' 908' ' ' PHE . 10.1 Cg_endo -50.84 135.17 42.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.961 2.441 . . . . 0.0 112.341 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.455 ' O ' ' HD1' ' A' ' 908' ' ' PHE . 46.6 m-20 -67.51 116.3 8.09 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.481 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.437 ' O ' HD12 ' A' ' 909' ' ' LEU . 23.9 p80 38.0 46.67 0.84 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 905' ' ' PRO . 5.5 m-85 -81.64 137.47 35.45 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.652 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.691 HD22 ' N ' ' A' ' 910' ' ' PHE . 0.0 OUTLIER -159.63 -27.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.691 ' N ' HD22 ' A' ' 909' ' ' LEU . 0.1 OUTLIER -80.0 0.63 30.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.45 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.577 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -153.05 134.37 14.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.347 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.21 126.35 39.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.554 ' HG ' ' CZ ' ' A' ' 930' ' ' TYR . 1.2 tt -51.19 131.94 28.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.62 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.806 ' HD3' ' HG2' ' A' ' 929' ' ' LYS . 7.0 mtpm? -85.22 -49.61 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.795 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.54 ' O ' HD22 ' A' ' 913' ' ' LEU . 60.2 m -64.77 136.72 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.219 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -60.37 130.48 46.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.31 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 82.0 p -152.08 147.36 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.325 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.4 p -143.66 -42.87 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 141.76 52.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 40.0 t -86.97 39.18 0.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -157.23 138.72 13.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.36 139.31 29.33 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.493 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.6 Cg_endo -69.33 146.95 64.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.559 . . . . 0.0 112.227 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.762 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 18.3 mt -59.55 158.18 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.892 0.377 . . . . 0.0 111.386 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 81.23 -35.43 2.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.938 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 39.7 m -56.02 129.25 39.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 111.364 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 66.3 p -108.9 125.77 52.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 913' ' ' LEU . 91.5 mt -105.02 122.76 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.889 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.806 ' HG2' ' HD3' ' A' ' 914' ' ' LYS . 37.6 ttmt -90.01 133.35 34.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.554 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 1.5 m-85 -120.65 168.78 11.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.374 . . . . 0.0 111.075 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 914' ' ' LYS . 11.8 pt-20 -140.95 125.43 17.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.822 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 79.2 m -57.51 154.88 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.011 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 99.7 mtt180 -82.77 165.0 44.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 54.7 Cg_endo -69.94 56.08 1.42 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.892 2.395 . . . . 0.0 112.868 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.743 ' O ' ' HD2' ' A' ' 961' ' ' LYS . 55.3 mt-10 -164.94 9.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 936' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -149.18 135.31 19.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 10.8 p90 -95.02 136.38 35.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 0.0 111.221 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 167.73 141.25 3.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.52 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.35 156.0 92.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.744 0.307 . . . . 0.0 110.435 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -60.99 109.15 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.411 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.518 ' HB3' ' NH1' ' A' ' 939' ' ' ARG . 52.6 p90 -96.08 -164.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.91 132.09 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.565 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 5.1 pt -97.34 120.31 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 111.643 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 17.5 m -84.08 122.72 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.83 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.762 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.8 t -73.7 102.84 4.07 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 83.9 mt -84.01 162.2 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -43.09 -38.4 2.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.869 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.6 m-80 -82.29 33.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.164 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.834 HD11 ' HB1' ' A' ' 900' ' ' ALA . 1.7 mm? 44.82 52.28 8.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 29.6 m -127.64 -160.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.537 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.767 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 75.5 m95 -149.01 121.81 8.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.67 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 87.8 p -42.72 143.85 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.918 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 41.8 t -77.08 117.29 64.12 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 17.0 Cg_exo -66.4 -8.74 21.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.596 2.198 . . . . 0.0 111.289 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 46.97 57.26 5.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.865 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 59.9 t0 61.19 126.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.966 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 941' ' ' PHE . 5.1 m -150.94 -48.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.756 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 911' ' ' ALA . 99.5 m -83.51 54.37 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 0.0 110.648 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 93.5 mttt -61.39 151.83 31.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.719 ' HD2' ' NZ ' ' A' ' 961' ' ' LYS . 15.1 tpp85 -53.37 125.22 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.861 ' HG2' HG13 ' A' ' 982' ' ' VAL . 0.0 OUTLIER -56.38 125.67 22.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.38 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 91.9 p -144.45 127.9 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.107 0.48 . . . . 0.0 111.083 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.9 p -82.0 44.19 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.189 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.7 tptt 62.86 135.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.073 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.802 ' HA ' HD12 ' A' ' 980' ' ' ILE . 14.0 m -59.85 131.32 88.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.558 ' HG3' HD13 ' A' ' 986' ' ' ILE . 37.6 Cg_endo -65.21 132.64 32.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.596 2.197 . . . . 0.0 112.459 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.35 138.9 52.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.4 2.067 . . . . 0.0 111.793 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -57.94 116.87 15.9 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.77 141.82 55.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.211 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' 1020 ' ' CYS . 11.3 p -53.74 129.13 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 33.3 m120 44.97 46.66 9.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.992 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -168.01 135.05 3.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.58 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 54.4 mtm -103.68 136.65 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 986' ' ' ILE . 12.1 p -99.75 132.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -95.9 115.66 27.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 986' ' ' ILE . 94.7 t -66.01 -25.34 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.094 0.473 . . . . 0.0 109.993 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.596 HD11 ' OG1' ' A' ' 987' ' ' THR . 14.6 mm 74.21 -51.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.988 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 70.9 p -148.92 -59.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 34.4 m-20 -157.41 143.84 17.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.168 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 965' ' ' THR . 6.0 pt -84.64 21.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.651 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 75.8 mm-40 -78.95 159.94 27.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.219 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 961' ' ' LYS . 2.2 m -56.45 -7.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.836 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -95.64 22.46 38.97 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 67.5 m -163.95 -160.89 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.778 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' 1002 ' ' ALA . 17.2 ptp180 -151.39 -168.19 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.223 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 976' ' ' VAL . 33.3 pt -146.37 129.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.596 ' OG1' HD11 ' A' ' 977' ' ' ILE . 11.0 p -103.28 134.52 46.54 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.129 0.49 . . . . 0.0 111.134 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.521 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 1.5 m-85 -95.44 145.2 25.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.2 t -146.46 74.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 59.4 m -51.64 147.34 6.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.4 p -64.3 150.48 46.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 62.2 m -47.78 112.45 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.163 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 144.72 -50.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -102.3 142.98 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.622 ' O ' HD12 ' A' ' 997' ' ' ILE . 13.3 ptp180 -92.92 145.0 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.504 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.5 tm? -72.45 129.53 38.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.696 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' 1021 ' ' GLN . 4.6 mp -118.41 123.52 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.64 0.257 . . . . 0.0 110.72 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.28 43.22 3.04 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.723 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.538 ' O ' ' HG3' ' A' 1018 ' ' PRO . 93.2 m-70 60.86 125.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 0.0 111.672 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.543 ' HB3' ' HG ' ' A' ' 996' ' ' LEU . 79.9 p -81.39 32.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 50.2 m -158.59 145.72 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.671 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -155.8 125.5 6.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.645 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.47 130.13 40.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.227 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 120.97 17.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.06 137.71 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.414 0.625 . . . . 0.0 112.082 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' 1011 ' ' ALA . 22.5 tp -84.51 120.4 26.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.014 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.2 t -96.08 52.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 81.43 -124.51 6.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.773 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.9 m120 -55.62 -46.96 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.764 HG22 ' H ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -94.52 -164.02 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.972 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.778 ' HB2' HD12 ' A' 1006 ' ' LEU . . . -158.25 147.38 19.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.054 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.26 152.04 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.478 ' HZ2' ' HD3' ' A' ' 966' ' ' PRO . 85.1 m95 -68.69 146.1 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.385 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -56.52 -30.78 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.723 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 8.1 t -146.97 145.69 29.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.93 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -53.81 137.46 54.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.093 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.515 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 73.8 Cg_exo -49.53 113.1 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.197 1.931 . . . . 0.0 112.668 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.538 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 11.0 Cg_endo -54.27 142.28 68.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.927 2.418 . . . . 0.0 112.138 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.686 ' H ' HD12 ' A' 1019 ' ' ILE . 0.1 OUTLIER -107.11 143.7 17.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.031 0.443 . . . . 0.0 111.9 -179.405 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 57.8 m -83.49 141.09 31.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.667 ' HB2' HD13 ' A' ' 997' ' ' ILE . 2.8 tt0 -145.8 131.24 18.68 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.862 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -49.75 130.92 21.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.405 0.622 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.533 HG23 HH21 ' A' ' 995' ' ' ARG . 64.9 mt -74.86 126.32 88.48 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.066 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.831 2.354 . . . . 0.0 112.314 -179.92 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.82 0.343 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -78.8 44.41 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.314 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.13 140.54 58.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.768 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.86 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -165.98 137.05 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.632 ' C ' HD22 ' A' ' 949' ' ' LEU . 26.8 m80 -148.17 131.46 16.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 8.9 p -82.3 127.8 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 903' ' ' GLN . . . . . 0.569 ' CD ' ' H ' ' A' ' 903' ' ' GLN . 1.5 pm0 -64.17 159.26 20.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.48 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.21 131.7 5.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.708 ' HG3' HD12 ' A' ' 928' ' ' LEU . 31.3 Cg_endo -63.89 149.57 90.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.829 2.353 . . . . 0.0 112.48 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -62.37 162.94 9.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.06 124.77 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.501 ' HZ ' HG21 ' A' ' 943' ' ' ILE . 4.6 m-30 -85.28 129.06 34.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.56 25.63 4.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.443 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 8.5 p90 -154.01 1.63 0.23 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.066 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -157.43 131.38 8.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.402 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -102.01 136.16 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.991 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 66.0 tp -47.8 157.0 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.389 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.703 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 3.9 mmmp? -145.36 -36.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 19.5 m -64.4 139.45 58.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -58.46 136.13 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.542 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 77.1 p -152.18 140.33 20.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 918' ' ' THR . 25.5 m -158.4 53.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.197 0.522 . . . . 0.0 110.548 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.31 154.27 7.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.787 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.3 p -84.08 -49.44 8.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.535 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -85.32 124.59 32.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.227 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.44 ' CE2' HD11 ' A' ' 928' ' ' LEU . 25.8 m-85 -103.71 136.49 19.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.014 0.435 . . . . 0.0 111.819 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.49 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 61.2 Cg_endo -72.24 139.33 32.01 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 0.0 112.071 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.639 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 26.4 mt -57.54 158.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.66 -40.91 2.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.49 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 30.7 m -56.01 136.64 51.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.003 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.2 m -123.63 131.86 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.708 HD12 ' HG3' ' A' ' 905' ' ' PRO . 88.7 mt -97.92 129.26 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.695 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 40.0 ttmt -85.25 136.81 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.767 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 17.2 m-85 -134.44 125.3 27.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.734 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.703 ' HG3' ' HG3' ' A' ' 914' ' ' LYS . 96.1 mt-10 -95.63 136.11 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 80.7 m -51.69 158.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 0.0 110.91 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.521 ' HG3' ' C ' ' A' ' 910' ' ' PHE . 44.1 mtp85 -80.09 160.26 68.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.279 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 38.2 Cg_endo -66.51 62.4 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.831 2.354 . . . . 0.0 112.452 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.0 mt-10 -163.73 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.392 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 2.6 m-85 -104.48 -176.96 3.23 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.458 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 4.9 p90 -150.51 32.77 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.966 0.412 . . . . 0.0 111.336 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.918 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -76.68 27.42 1.6 Allowed Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.294 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.74 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.9 ptp180 46.02 166.14 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.356 0.662 . . . . 0.0 112.633 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 41.8 Cg_endo -67.72 145.6 69.95 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.341 2.027 . . . . 0.0 112.427 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.562 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 45.3 p90 -144.46 -162.07 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.299 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.534 ' HG ' ' HA ' ' A' ' 929' ' ' LYS . 57.5 m -169.78 136.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.501 HG21 ' HZ ' ' A' ' 908' ' ' PHE . 7.8 pt -93.0 120.85 43.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.002 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 946' ' ' LEU . 16.6 m -81.52 123.48 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.76 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 10.7 t -73.72 104.23 4.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 74.4 mt -81.76 161.55 23.26 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.503 ' HA ' HG21 ' A' ' 924' ' ' ILE . 64.2 t0 -42.09 -47.5 4.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.381 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 948' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 950' ' ' VAL . 24.2 p-10 -82.27 40.96 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.975 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.86 HD21 ' HB1' ' A' ' 900' ' ' ALA . 43.7 mt 45.85 59.18 3.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.247 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.696 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 34.9 m -135.98 -161.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -151.02 122.94 8.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.975 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.5 p -41.87 137.64 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 39.7 t -79.4 110.95 17.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 0.0 112.073 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 952' ' ' SER . 57.9 Cg_endo -90.96 54.07 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.471 2.781 . . . . 0.0 110.828 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.593 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -75.63 132.82 40.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.422 -178.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 52.95 44.95 29.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.3 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 958' ' ' CYS . 0.5 OUTLIER -87.83 -50.95 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.247 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.918 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 93.1 m -89.13 111.77 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 72.7 mmtt -83.78 124.84 31.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 40.4 ttm180 -61.96 133.69 55.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.277 0.561 . . . . 0.0 112.386 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.509 ' HA ' ' CE2' ' A' ' 937' ' ' TYR . 20.3 tptm -56.35 168.48 0.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.809 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.518 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 51.0 m -149.85 134.81 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.005 0.431 . . . . 0.0 111.235 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.92 141.77 35.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.804 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -65.54 136.09 55.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 66.5 m -52.62 121.86 23.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.809 ' HG2' HG11 ' A' ' 974' ' ' VAL . 30.9 Cg_endo -62.46 135.02 51.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 0.0 112.088 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.09 121.2 9.65 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.988 1.792 . . . . 0.0 110.94 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 968' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 973' ' ' MET . 14.2 m-20 -57.96 118.66 28.17 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.06 148.7 91.41 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.654 2.236 . . . . 0.0 111.873 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 970' ' ' VAL . 19.3 t -45.25 122.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.959 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 32.7 m120 60.71 45.61 9.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.537 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -179.71 139.71 3.95 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.956 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 968' ' ' ASP . 3.5 mpp? -133.54 150.03 51.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.809 HG11 ' HG2' ' A' ' 966' ' ' PRO . 8.4 p -89.92 121.77 40.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.17 0.509 . . . . 0.0 111.051 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 121.84 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.83 135.1 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.764 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 978' ' ' THR . 26.7 mm -74.47 -53.27 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.787 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 978' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 977' ' ' ILE . 82.0 p -147.66 -52.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.312 0.577 . . . . 0.0 110.87 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.73 139.35 18.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.02 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.6 pt -88.33 34.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.897 0.379 . . . . 0.0 111.656 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.554 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 33.0 mt-30 -80.81 151.19 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' A' 1005 ' ' ILE . 76.2 t -54.48 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 165.63 -48.35 0.28 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HG3' ' A' 1003 ' ' GLU . 93.9 p -80.04 -160.38 0.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 985' ' ' ARG . 4.0 ptp85 -151.39 134.97 16.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.705 HD12 HG21 ' A' ' 974' ' ' VAL . 34.6 pt -97.72 136.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.0 p -102.47 135.25 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.1 m-85 -96.24 143.69 27.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -148.71 120.72 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 60.9 m -83.58 119.71 25.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.463 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 992' ' ' THR . 7.6 t -72.57 137.4 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.547 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 991' ' ' THR . 96.6 m 111.23 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.309 1.005 . . . . 0.0 111.168 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 992' ' ' THR . . . -170.66 32.45 0.15 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.215 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -95.74 144.36 26.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.69 ' HB3' HG12 ' A' 1023 ' ' ILE . 7.6 ptm180 -89.28 136.23 33.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.23 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.414 HD11 ' HG3' ' A' 1018 ' ' PRO . 10.3 tt -72.26 132.28 43.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.3 mp -99.73 125.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.031 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.2 -139.87 14.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.389 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -85.86 135.02 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.544 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.5 p -102.96 20.31 17.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.58 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 47.4 t -159.19 146.84 17.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -153.68 134.31 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.062 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 984' ' ' SER . 39.3 tt0 -95.0 129.08 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.199 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.28 120.34 16.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.664 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.3 pt -129.9 -159.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.889 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' 1009 ' ' ASN . 41.6 tp -150.78 136.84 18.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.3 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.506 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -90.0 -40.31 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.828 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.68 -32.02 0.03 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.292 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.434 ' C ' HD11 ' A' 1006 ' ' LEU . 49.7 t30 -150.04 -44.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 110.511 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.421 ' O ' HD12 ' A' 1006 ' ' LEU . 37.4 m -92.66 131.44 37.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.979 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.97 143.59 32.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.819 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.506 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -155.76 144.06 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.307 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.494 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 49.1 m95 -68.29 144.09 54.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -53.55 -29.05 35.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.61 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 68.4 p -140.91 138.8 34.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.713 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.571 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.5 pptp? -62.31 152.47 79.16 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.014 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.76 132.36 41.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.635 2.224 . . . . 0.0 112.643 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.414 ' HG3' HD11 ' A' ' 996' ' ' LEU . 56.1 Cg_endo -69.88 -153.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.783 2.322 . . . . 0.0 112.578 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.7 mt -139.01 141.97 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.015 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 97.9 m -99.66 124.18 44.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -142.23 129.52 21.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.184 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -50.45 133.89 24.22 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.68 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.2 mt -74.83 123.91 89.27 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.797 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.813 2.342 . . . . 0.0 112.343 -179.892 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.768 0.318 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.82 139.51 0.69 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 66.07 132.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.454 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . 51.54 -150.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.567 ' N ' HD22 ' A' ' 949' ' ' LEU . 11.7 m80 66.92 140.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.928 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 47.8 m -80.11 129.07 34.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -64.65 168.19 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.23 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.69 125.32 6.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.38 123.64 8.34 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 122.457 2.105 . . . . 0.0 112.82 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 136.11 54.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.011 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -77.25 138.55 39.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.503 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 14.5 m-85 -89.09 24.02 2.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.503 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.666 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 6.5 mp 68.74 -59.01 0.47 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 5.4 p90 -81.82 31.03 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -152.63 122.36 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 111.589 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -99.68 124.29 44.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.311 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.708 HD11 ' O ' ' A' ' 915' ' ' THR . 2.1 tm? -48.97 118.51 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.267 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.673 ' HE2' ' HD2' ' A' ' 929' ' ' LYS . 0.7 OUTLIER -95.89 -47.96 5.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.159 -179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.708 ' O ' HD11 ' A' ' 913' ' ' LEU . 31.7 m -64.59 128.39 35.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.613 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -52.36 135.14 33.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.875 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 915' ' ' THR . 79.4 p -152.02 144.67 24.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 918' ' ' THR . 24.9 m -156.46 53.36 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.73 156.2 9.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.5 t -86.4 -46.87 9.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.99 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.28 141.94 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -129.9 133.79 25.41 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.516 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -70.52 141.89 43.23 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.656 2.237 . . . . 0.0 112.229 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 947' ' ' ASP . 34.2 mt -55.44 152.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 925' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 88.47 -29.54 5.67 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.452 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.516 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.4 m -55.05 137.74 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 51.1 m -115.99 142.6 46.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.733 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.21 119.09 19.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.625 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.673 ' HD2' ' HE2' ' A' ' 914' ' ' LYS . 40.0 ttmt -89.4 138.52 31.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.395 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.582 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 5.9 m-85 -129.03 134.45 48.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -95.18 121.57 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 64.2 m -59.92 149.98 30.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.0 mtp180 -84.13 162.89 50.39 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.617 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 10.0 Cg_endo -51.88 146.23 29.46 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.241 1.961 . . . . 0.0 110.966 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 1.045 ' HB3' HG21 ' A' ' 982' ' ' VAL . 95.6 mt-10 83.23 25.89 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.888 0.742 . . . . 0.0 109.968 -178.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.794 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 78.8 m-85 -143.91 142.35 30.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.839 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.624 ' HB3' ' NZ ' ' A' ' 961' ' ' LYS . 36.2 p90 -144.06 134.73 24.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 111.439 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.811 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 155.75 28.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.41 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 63.09 144.43 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.0 111.784 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.57 124.93 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.524 2.15 . . . . 0.0 110.703 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 6.5 p90 -90.17 -166.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.66 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 59.2 m -170.21 132.27 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.414 ' HB ' ' CE3' ' A' ' 951' ' ' TRP . 13.5 pt -94.01 168.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.676 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.497 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.5 m -162.62 136.09 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 38.7 t -73.82 125.78 28.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.621 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.8 mm? -84.86 -57.03 3.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -176.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.709 ' HA ' HD13 ' A' ' 924' ' ' ILE . 23.7 t70 171.67 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.218 0.324 . . . . 0.0 111.031 -178.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -82.77 32.1 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 109.636 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 901' ' ' HIS . 22.2 mt 51.67 43.25 30.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.762 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.9 m -143.41 154.41 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.644 0.735 . . . . 0.0 112.467 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.495 ' C ' ' H ' ' A' ' 953' ' ' SER . 72.9 m95 -91.51 130.85 37.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.381 -1.282 . . . . 0.0 109.128 177.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.561 ' HB2' HD21 ' A' ' 946' ' ' LEU . 45.3 t -51.47 -10.22 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.372 0.606 . . . . 0.0 111.524 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 951' ' ' TRP . 48.0 t 61.93 121.55 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.744 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 11.5 Cg_exo -71.08 141.31 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.978 2.452 . . . . 0.0 110.74 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 11.0 tmtt? -154.59 134.64 13.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.212 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.68 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 38.7 t70 60.82 41.01 15.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.123 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.79 -111.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.089 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.811 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 26.8 p -87.97 103.29 15.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.4 mmtt -82.05 134.68 35.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.799 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 35.7 ptt180 -56.76 143.56 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.592 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.624 ' NZ ' ' HB3' ' A' ' 937' ' ' TYR . 5.3 mptp? -47.12 150.47 0.8 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.528 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.2 p -142.65 127.19 17.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 70.5 m -79.48 138.21 37.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.302 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.57 135.28 55.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.895 0.379 . . . . 0.0 110.757 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 83.2 m -48.59 114.45 3.61 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.548 ' HG2' HG11 ' A' ' 974' ' ' VAL . 20.0 Cg_endo -60.57 135.42 60.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.489 2.126 . . . . 0.0 112.013 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.12 117.18 3.34 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.068 1.845 . . . . 0.0 111.327 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.14 125.11 80.41 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 144.54 99.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.681 2.254 . . . . 0.0 112.076 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.4 t -46.42 129.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 991' ' ' THR . 33.7 m120 61.76 45.65 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.9 -162.94 23.08 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.585 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 178.63 147.44 0.17 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 110.993 -179.641 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.906 HG21 HD12 ' A' ' 986' ' ' ILE . 8.6 p -91.08 102.79 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.773 0.797 . . . . 0.0 110.845 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.17 107.9 2.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.307 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.46 133.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 985' ' ' ARG . 44.9 mm -74.28 -36.07 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.088 0.47 . . . . 0.0 110.263 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.9 p -144.71 -49.54 0.26 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.88 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.1 t70 -161.57 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.822 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.465 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 6.2 pt -151.03 9.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 110.849 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 3.7 mt-30 -75.75 161.16 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 1.045 HG21 ' HB3' ' A' ' 935' ' ' GLU . 10.4 m -49.27 149.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.695 0.283 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 82.94 -32.76 2.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.976 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.0 m -75.84 131.71 39.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.153 0.501 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 977' ' ' ILE . 78.7 ttt180 -93.38 155.82 17.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.906 HD12 HG21 ' A' ' 974' ' ' VAL . 43.9 pt -141.78 123.81 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.255 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.3 p -107.61 136.9 46.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.466 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.483 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 5.2 m-85 -94.06 146.58 23.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.418 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -148.65 109.83 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.997 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 79.8 m -79.96 147.87 31.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 971' ' ' ASN . 5.6 t -64.31 146.39 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.7 m -44.02 123.69 3.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.49 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 134.73 -51.23 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.331 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.452 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.5 m80 -102.54 141.12 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.356 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.583 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.6 ptm180 -92.38 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.348 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.7 tt -71.77 132.73 44.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.2 mp -108.91 132.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 83.94 -144.25 21.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.15 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -81.34 130.24 34.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.767 0.317 . . . . 0.0 111.278 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.421 ' HA ' HD11 ' A' ' 996' ' ' LEU . 47.6 t -85.04 -51.84 6.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.665 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 33.1 t -90.37 155.02 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.707 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.545 ' H ' ' HB3' ' A' 1014 ' ' SER . 88.3 tt0 -111.56 129.94 55.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.766 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.531 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 43.2 t -71.25 125.62 27.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' 1012 ' ' HIS . 26.7 pt -129.42 -155.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.615 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 45.3 tp -150.62 -21.86 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.832 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 36.8 t 53.27 26.96 5.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 35.54 48.52 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.522 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -163.21 -49.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.539 ' C ' HD12 ' A' 1006 ' ' LEU . 40.2 m -145.54 136.45 24.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.843 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.02 124.94 28.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.873 0.368 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.485 ' CD2' HG13 ' A' 1005 ' ' ILE . 0.3 OUTLIER -161.2 152.91 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.761 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.531 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 93.7 m95 -64.92 144.38 57.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.985 0.422 . . . . 0.0 110.784 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1014 ' ' SER . . . . . 0.545 ' HB3' ' H ' ' A' 1003 ' ' GLU . 45.4 t -64.18 -31.59 72.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 40.9 p -144.19 138.67 28.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.871 0.367 . . . . 0.0 111.266 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 22.5 pttp -61.03 148.63 83.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 33.0 Cg_exo -58.3 130.3 37.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.613 2.209 . . . . 0.0 112.338 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.483 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.29 -160.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.758 2.306 . . . . 0.0 112.665 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.4 mt -142.33 138.59 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.885 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 82.1 m -92.66 124.42 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.452 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 34.0 tt0 -143.75 135.39 26.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.464 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' 1022 ' ' ARG . 15.1 tpp85 -49.04 131.92 18.99 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.398 0.618 . . . . 0.0 111.621 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.2 mt -76.89 124.96 87.57 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.878 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 32.8 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.809 2.34 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.829 0.347 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -63.0 135.99 57.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 899' ' ' GLU . . . . . 0.592 ' HB2' ' HE1' ' A' ' 901' ' ' HIS . 56.1 mt-10 -60.27 138.5 57.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.675 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.946 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -75.03 143.32 43.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.229 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.623 ' C ' HD22 ' A' ' 949' ' ' LEU . 58.1 m80 -150.4 127.41 11.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.403 178.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 11.3 p -82.9 128.15 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -73.15 175.45 6.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.43 129.1 10.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 906' ' ' ASP . 50.8 Cg_endo -68.46 91.5 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.483 2.122 . . . . 0.0 112.421 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 906' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 905' ' ' PRO . 6.5 t0 29.75 -133.02 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 O-C-N 123.606 0.566 . . . . 0.0 111.123 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 907' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 31.7 t-80 -161.8 109.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 911' ' ' ALA . 22.7 m-85 -86.5 137.15 32.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 62.5 mt -80.08 -52.96 7.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.18 29.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 908' ' ' PHE . . . -155.91 139.98 16.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.402 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -136.47 130.9 33.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 929' ' ' LYS . 66.0 tp -48.42 156.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.332 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.857 ' HA ' ' HE2' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -145.49 -39.82 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.411 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 917' ' ' THR . 4.4 m -64.52 141.87 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.92 133.54 37.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.318 179.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 915' ' ' THR . 62.7 p -150.92 -65.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 917' ' ' THR . 32.1 p 66.28 -50.96 0.43 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.892 0.745 . . . . 0.0 112.555 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.36 151.93 44.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.1 p -85.04 -42.92 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 901' ' ' HIS . 63.9 t0 -85.02 126.26 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -106.78 136.13 19.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.63 140.6 18.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.106 2.538 . . . . 0.0 111.829 178.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.772 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 46.7 mt -55.88 148.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.059 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 73.55 77.57 0.61 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 2.2 m -176.72 122.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 54.9 m -83.43 129.69 35.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.981 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 917' ' ' THR . 6.0 tp -106.87 118.55 36.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.994 179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 929' ' ' LYS . 0.1 OUTLIER -85.63 135.15 33.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.785 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 930' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -135.4 129.34 33.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.258 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 940' ' ' PRO . 90.0 mt-10 -95.48 123.09 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 6.1 t -58.77 153.38 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.559 HH11 ' HG3' ' A' ' 933' ' ' ARG . 38.9 mtt85 -81.35 155.48 71.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 51.6 Cg_endo -68.45 66.4 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.024 2.483 . . . . 0.0 112.543 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.6 mt-10 -163.15 -9.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 959' ' ' LYS . 33.9 m-85 -134.79 140.6 46.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.402 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.1 p90 -99.91 137.7 38.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 938' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 148.13 21.38 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.456 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 938' ' ' GLY . 18.9 ptp180 46.72 164.28 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.654 0.782 . . . . 0.0 112.59 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.737 ' HB3' ' HA ' ' A' ' 931' ' ' GLU . 18.5 Cg_exo -66.39 127.32 17.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.782 2.322 . . . . 0.0 112.386 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.526 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 43.6 p90 -93.01 -161.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.5 p -172.86 134.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.066 0.46 . . . . 0.0 111.25 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.416 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 4.9 pt -95.05 -168.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.933 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 1.4 m -167.28 127.13 1.43 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.772 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 17.0 t -69.99 110.64 5.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 92.1 mt -82.75 -57.3 3.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.654 ' HA ' HD13 ' A' ' 924' ' ' ILE . 56.0 t0 173.01 -43.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.013 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -82.88 36.65 0.51 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.946 HD21 ' HB1' ' A' ' 900' ' ' ALA . 31.0 mt 51.67 46.15 26.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.5 OUTLIER -128.57 -173.6 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.988 -179.357 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 944' ' ' THR . 73.5 m95 -144.71 130.73 19.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.161 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 45.6 t -44.05 146.25 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -79.59 115.88 56.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.6 Cg_exo -76.31 61.05 6.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.496 2.797 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -76.43 139.27 40.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.486 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.569 ' HA ' ' NZ ' ' A' ' 959' ' ' LYS . 9.9 t70 58.11 82.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.041 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 30.9 m -149.69 -24.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.653 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 936' ' ' TYR . 72.6 m -150.47 133.19 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.569 ' NZ ' ' HA ' ' A' ' 956' ' ' ASP . 45.6 mmtm -140.72 150.53 43.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.303 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.463 ' HG3' ' OE1' ' A' ' 981' ' ' GLN . 12.2 tpt180 -53.34 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.971 0.415 . . . . 0.0 111.311 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.506 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 40.4 ttmt -56.32 149.63 16.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.501 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.515 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 60.4 p -141.14 140.36 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.257 0.551 . . . . 0.0 111.506 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.87 154.69 28.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.06 134.21 53.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.323 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 32.5 m -54.28 126.67 54.58 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 80.1 Cg_endo -76.3 134.25 15.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.778 2.319 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 31.7 Cg_exo -58.51 128.58 28.89 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.221 1.948 . . . . 0.0 111.511 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.86 129.52 85.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.87 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.07 142.67 88.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.864 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 39.5 t -47.5 124.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.244 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 32.6 m120 76.42 -46.39 0.53 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.826 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -71.29 -151.61 0.95 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.438 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 178.79 140.33 0.1 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.934 HG21 HD12 ' A' ' 986' ' ' ILE . 11.1 p -96.51 143.1 12.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.684 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.489 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.5 m-70 -102.7 114.5 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 77.9 t -63.78 -39.01 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.22 0.533 . . . . 0.0 110.021 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 975' ' ' HIS . 9.3 mt 71.64 -33.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.409 178.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 48.1 p -144.84 -86.14 0.12 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 980' ' ' ILE . 2.8 m-20 -154.59 13.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.312 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 36.9 pt 50.65 34.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.366 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.515 ' OE1' ' HB3' ' A' ' 962' ' ' SER . 50.0 mm-40 -76.64 151.13 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.81 88.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.068 0.461 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 160.09 -42.67 0.44 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.217 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 49.2 m -76.09 -168.64 0.96 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.668 ' HD3' ' HB2' ' A' 1001 ' ' SER . 38.1 ttm180 -151.35 134.9 16.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.934 HD12 HG21 ' A' ' 974' ' ' VAL . 25.7 pt -95.26 131.75 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.761 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -99.3 129.27 45.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 111.797 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' 1000 ' ' SER . 7.1 m-85 -96.58 139.73 32.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.0 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.1 t -153.69 112.14 3.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.684 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.535 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t -81.38 142.13 33.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.602 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.2 t -65.01 154.09 38.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 992' ' ' THR . 6.0 t -45.64 109.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 111.246 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 159.57 -44.42 0.44 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.438 ' HB3' ' N ' ' A' 1021 ' ' GLN . 15.3 m80 -126.87 147.58 50.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.206 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.9 ptm180 -90.04 138.98 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' 1018 ' ' PRO . 9.8 tt -71.89 130.84 42.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.987 -178.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 997' ' ' ILE . 2.0 mp -109.73 93.39 2.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.464 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 158.31 -153.53 24.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.594 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.598 ' HB2' HG21 ' A' 1015 ' ' THR . 38.7 m170 -85.93 -35.43 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1000 ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 996' ' ' LEU . 48.2 t 67.27 16.39 10.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.668 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.3 p -157.6 59.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.764 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -79.77 126.51 31.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.8 tt0 -96.09 131.48 42.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.923 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1004 ' ' CYS . . . . . 0.437 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 45.0 t -71.77 119.93 16.64 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' 1006 ' ' LEU . 41.2 pt -133.28 -156.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 112.131 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 56.4 tp -152.24 135.06 15.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.02 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.587 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -88.39 -45.39 10.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.29 -49.74 0.26 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.038 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.16 -37.19 12.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -145.45 144.91 30.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.696 -178.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.22 144.58 34.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.704 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.587 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.0 p80 -158.15 154.62 27.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.883 0.373 . . . . 0.0 111.514 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 72.3 m95 -68.63 149.49 49.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.9 m -58.92 -34.6 71.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.81 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 999' ' ' HIS . 6.4 t -143.08 149.33 38.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.228 0.537 . . . . 0.0 112.357 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.508 ' HD3' ' N ' ' A' 1017 ' ' PRO . 1.0 OUTLIER -59.54 136.86 89.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.939 179.052 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' 1016 ' ' LYS . 77.7 Cg_exo -50.75 119.86 5.78 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.541 2.161 . . . . 0.0 112.971 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.597 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 14.6 Cg_endo -57.28 147.72 75.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.822 2.348 . . . . 0.0 112.447 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.18 147.13 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 95.3 m -81.39 136.34 35.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.438 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 44.2 tt0 -145.72 132.31 19.85 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.353 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -44.03 136.04 3.95 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.5 0.667 . . . . 0.0 111.779 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' 1024 ' ' PRO . 59.6 mt -74.86 127.04 87.68 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.012 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1024 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.848 2.365 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.81 0.338 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 57.1 -157.18 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.23 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 64.01 132.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.305 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . 65.52 137.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.661 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 901' ' ' HIS . . . . . 0.6 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 53.4 m80 -149.86 135.46 18.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 922' ' ' PHE . 10.0 p -80.72 121.43 25.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -69.23 172.36 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.539 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.08 8.46 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.567 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.509 ' HG2' ' OH ' ' A' ' 930' ' ' TYR . 51.1 Cg_exo -53.71 127.08 24.03 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.89 2.393 . . . . 0.0 112.624 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.74 119.61 14.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.854 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 38.7 m170 42.77 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.075 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 943' ' ' ILE . 21.8 m-85 -145.93 47.51 1.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.987 178.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 38.9 mt -75.08 -7.2 53.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.736 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -12.12 54.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.806 179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.02 137.22 16.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.321 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 912' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 931' ' ' GLU . 0.0 OUTLIER -91.61 123.79 35.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.083 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.584 HD11 ' HB ' ' A' ' 915' ' ' THR . 3.4 tm? -47.18 129.51 12.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.107 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -94.56 -31.26 13.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.93 -178.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.584 ' HB ' HD11 ' A' ' 913' ' ' LEU . 86.4 m -57.19 154.02 10.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.609 -179.012 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 917' ' ' THR . 0.0 OUTLIER -57.49 -47.91 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.533 -179.41 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 916' ' ' GLN . 52.8 p 51.76 138.77 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.802 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 918' ' ' THR . 16.3 m -161.31 32.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.232 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.78 140.51 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 45.6 m -86.74 37.86 0.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.456 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -154.68 127.72 8.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.862 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.421 ' O ' ' SG ' ' A' ' 902' ' ' CYS . 36.4 m-85 -119.12 142.29 31.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.929 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.21 136.73 10.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.949 2.433 . . . . 0.0 111.9 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.749 HG21 ' HA ' ' A' ' 947' ' ' ASP . 61.6 mt -52.02 150.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 72.83 74.79 0.76 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.738 -178.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 944' ' ' THR . 3.6 m -174.82 130.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.856 -178.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 927' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 75.5 p -99.99 155.35 17.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.114 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 942' ' ' SER . 95.4 mt -141.05 128.37 21.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.117 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.84 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 43.4 mmtm -85.07 141.5 30.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.509 ' OH ' ' HG2' ' A' ' 905' ' ' PRO . 11.4 m-85 -129.12 133.19 47.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 912' ' ' LYS . 50.1 mt-10 -92.53 118.39 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.138 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.68 148.94 18.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.728 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.438 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 59.2 mtt85 -83.01 155.96 67.29 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.893 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 936' ' ' TYR . 62.6 Cg_exo -38.56 -53.75 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.881 2.388 . . . . 0.0 113.613 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.92 31.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 72.2 m-85 -145.19 133.78 22.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.677 0.275 . . . . 0.0 111.184 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.59 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 2.2 p90 -103.89 138.88 39.84 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 137.24 143.57 4.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.868 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -73.02 170.69 12.66 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.547 0.213 . . . . 0.0 110.769 179.703 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.868 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 9.2 Cg_endo -59.39 114.71 2.15 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.399 2.066 . . . . 0.0 112.958 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 27.2 p90 -90.24 -164.62 1.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.036 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 942' ' ' SER . . . . . 0.84 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 79.7 p -171.95 130.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.289 0.566 . . . . 0.0 112.352 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 943' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 908' ' ' PHE . 8.1 pt -96.14 -174.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.632 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 944' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 926' ' ' THR . 15.9 m -165.9 136.74 3.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 73.5 m -73.29 126.64 30.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.708 HD23 HG23 ' A' ' 950' ' ' VAL . 2.5 mm? -83.61 -60.51 2.1 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.749 ' HA ' HG21 ' A' ' 924' ' ' ILE . 4.7 t70 171.84 -40.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.262 0.352 . . . . 0.0 110.814 -178.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -86.38 39.67 0.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.819 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.2 mp 53.5 46.12 26.81 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.481 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.708 HG23 HD23 ' A' ' 946' ' ' LEU . 3.2 m -125.68 -179.98 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.798 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 943' ' ' ILE . 41.3 m95 -142.04 131.8 24.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.756 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.475 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.4 p -40.83 143.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.3 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 40.7 t -78.7 114.45 43.67 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.52 57.6 6.37 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.473 2.782 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 1.2 tmtp? -78.6 127.04 31.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 956' ' ' ASP . . . . . 0.775 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 38.8 t70 53.34 41.59 32.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.25 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.14 -41.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.424 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 17.2 t -157.64 68.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.478 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.775 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.4 mmtp -56.43 144.55 30.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.697 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 12.8 ptt-85 -55.43 147.39 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.151 0.5 . . . . 0.0 111.986 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.59 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 26.9 tptp -47.64 155.77 0.36 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.56 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.783 ' HB2' ' HG3' ' A' ' 981' ' ' GLN . 48.2 t -144.47 139.88 28.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.473 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.3 m -81.57 37.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.293 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 59.52 135.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.066 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.591 ' HA ' HD12 ' A' ' 980' ' ' ILE . 11.8 m -56.1 128.4 71.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.496 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 39.6 Cg_endo -66.4 127.14 16.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.489 2.126 . . . . 0.0 112.64 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 16.7 Cg_exo -67.0 132.85 29.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.499 2.133 . . . . 0.0 111.515 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.68 114.22 8.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.745 0.307 . . . . 0.0 110.781 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 144.15 29.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.685 2.257 . . . . 0.0 112.224 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 970' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.63 129.01 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.411 ' C ' HG22 ' A' ' 991' ' ' THR . 30.5 m120 54.47 44.64 28.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.475 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -170.9 147.99 10.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.939 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.2 136.98 40.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.571 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.712 HG21 HD12 ' A' ' 986' ' ' ILE . 10.1 p -98.18 127.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.913 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 977' ' ' ILE . 25.1 m-70 -86.45 114.74 23.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 0.623 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.11 -28.14 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.017 0.436 . . . . 0.0 110.203 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 73.07 -43.54 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.134 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.0 p -146.11 -51.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.577 179.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.54 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 8.2 p-10 -160.26 -143.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.146 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 965' ' ' THR . 4.6 pt -151.0 6.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.783 ' HG3' ' HB2' ' A' ' 962' ' ' SER . 14.5 mp0 -76.65 177.32 7.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.601 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.55 132.66 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.233 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 106.83 -46.27 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.278 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.0 m -76.09 134.36 40.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 77.5 ttt180 -104.12 124.09 48.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.154 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.712 HD12 HG21 ' A' ' 974' ' ' VAL . 34.4 pt -97.1 136.51 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 0.0 111.535 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.4 p -103.84 136.38 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.566 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 14.9 m-85 -103.19 142.57 33.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.231 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.9 t -153.57 127.56 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.617 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 99.8 m -58.37 135.84 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.258 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 992' ' ' THR . 10.2 t -73.41 43.59 0.14 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.433 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 991' ' ' THR . 8.5 t 175.41 -130.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 992' ' ' THR . . . -133.69 51.25 0.85 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.499 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.604 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 3.8 m80 -94.49 -137.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' 1021 ' ' GLN . 13.5 ttt85 -140.88 112.06 7.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.921 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 996' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.83 131.86 45.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.818 0.342 . . . . 0.0 110.702 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -97.27 136.21 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 84.33 -152.25 27.78 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.383 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.72 ' ND1' HG21 ' A' 1015 ' ' THR . 22.4 m170 -81.55 129.74 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.688 0.244 . . . . 0.0 110.731 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 50.2 m -74.79 10.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.338 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 30.7 t -159.29 151.42 20.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.07 128.86 8.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.383 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 12.7 pt-20 -96.48 134.24 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.539 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.2 t -71.83 123.17 22.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.67 139.18 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.262 0.553 . . . . 0.0 112.139 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 60.8 tp -84.5 120.57 26.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 94.1 p -96.03 36.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.053 179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.556 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 67.19 123.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.058 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1009 ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 73.17 -37.38 0.38 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 122.373 0.269 . . . . 0.0 111.671 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' 1008 ' ' GLY . 98.6 m -145.48 129.09 17.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 111.632 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1011 ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -87.36 147.32 25.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.66 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.9 p80 -157.64 149.1 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.384 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1013 ' ' TRP . . . . . 0.453 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 91.7 m95 -65.79 139.21 58.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -51.39 -27.68 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.886 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.72 HG21 ' ND1' ' A' ' 999' ' ' HIS . 75.4 p -141.02 141.57 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.963 0.411 . . . . 0.0 111.611 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -53.82 153.15 8.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.09 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 44.9 Cg_exo -56.17 123.78 14.66 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.446 2.097 . . . . 0.0 112.733 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.566 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 14.0 Cg_exo -69.0 148.71 70.62 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.185 2.59 . . . . 0.0 112.243 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -100.35 -153.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.616 ' H ' HG22 ' A' 1019 ' ' ILE . 35.5 t -161.64 141.24 10.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.819 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.856 ' HB2' HD11 ' A' ' 997' ' ' ILE . 7.2 tt0 -151.36 127.98 10.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.563 -178.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -51.42 131.9 29.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 111.658 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 995' ' ' ARG . 62.9 mt -74.82 129.16 83.97 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.974 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.889 2.392 . . . . 0.0 112.287 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.522 0.201 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -174.84 44.41 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.794 0.33 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 63.73 135.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.1 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 900' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -73.78 121.92 21.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.119 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -110.52 124.45 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.998 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 902' ' ' CYS . . . . . 0.895 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 1.8 p -82.11 124.0 29.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -60.02 172.01 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.63 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 904' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -44.78 134.4 4.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 905' ' ' PRO . . . . . 0.615 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 3.5 Cg_exo -73.79 44.06 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.738 2.292 . . . . 0.0 112.582 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 4.0 t70 57.93 153.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.472 0.653 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -82.42 122.31 27.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.704 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.791 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 8.3 m-85 -85.88 141.98 29.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 909' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -87.53 -65.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.688 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.595 ' O ' ' HG3' ' A' ' 933' ' ' ARG . 2.5 p90 -82.77 -22.12 34.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.469 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 911' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -87.04 142.94 27.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.54 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -129.81 123.41 30.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -49.17 116.56 1.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.428 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 914' ' ' LYS . . . . . 0.494 ' HD2' ' C ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -93.07 -42.28 9.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 915' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 916' ' ' GLN . 5.0 m -66.16 -127.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 916' ' ' GLN . . . . . 0.451 ' H ' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -173.5 139.43 0.74 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.676 0.274 . . . . 0.0 110.44 179.589 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 917' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 918' ' ' THR . 1.8 t -157.18 -54.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 918' ' ' THR . . . . . 0.498 ' H ' HG23 ' A' ' 917' ' ' THR . 27.9 m 53.9 57.77 5.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.044 0.45 . . . . 0.0 110.599 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.44 156.66 14.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.4 t -87.9 -44.99 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.72 141.8 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 922' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 928' ' ' LEU . 46.2 m-85 -135.35 137.84 27.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 923' ' ' PRO . . . . . 0.603 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 65.3 Cg_endo -73.12 132.01 17.47 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.569 2.179 . . . . 0.0 111.427 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 924' ' ' ILE . . . . . 0.697 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.5 mt -56.78 147.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 95.7 -32.97 5.82 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 926' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 20.6 m -56.21 135.68 53.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.426 . . . . 0.0 112.145 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 61.6 p -107.2 142.99 36.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.388 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 928' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.1 mt -133.3 117.82 17.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.063 0.459 . . . . 0.0 110.974 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 38.1 ttmt -90.04 132.4 35.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.035 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 930' ' ' TYR . . . . . 0.43 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 4.2 m-85 -122.33 125.75 46.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.037 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 931' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 95.4 mt-10 -96.51 117.32 30.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.543 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 932' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 81.0 m -59.27 169.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.451 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 910' ' ' PHE . 46.5 mtp85 -84.36 151.16 58.92 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.142 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.507 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 19.7 Cg_exo -66.48 66.0 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.303 2.669 . . . . 0.0 112.994 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 935' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' 1006 ' ' LEU . 54.4 mt-10 -163.39 -29.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 109.925 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 936' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 910' ' ' PHE . 1.6 m-85 -94.96 147.26 23.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 937' ' ' TYR . . . . . 0.793 ' HB3' ' HD2' ' A' ' 961' ' ' LYS . 1.7 p90 -89.18 132.94 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.241 0.543 . . . . 0.0 111.152 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.37 139.48 4.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.382 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 939' ' ' ARG . . . . . 0.88 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -71.88 171.11 10.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.513 0.197 . . . . 0.0 110.549 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 940' ' ' PRO . . . . . 0.88 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 40.4 Cg_endo -67.89 121.61 8.66 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.385 2.057 . . . . 0.0 112.26 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.521 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 36.8 p90 -90.15 -161.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.73 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 82.5 p -172.79 134.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.16 -172.6 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.822 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -167.09 123.61 1.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 945' ' ' CYS . . . . . 0.697 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 33.7 t -63.91 112.09 2.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 946' ' ' LEU . . . . . 0.631 ' HB2' HG23 ' A' ' 950' ' ' VAL . 87.6 mt -81.25 -53.11 6.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.134 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 947' ' ' ASP . . . . . 0.679 ' HA ' HD13 ' A' ' 924' ' ' ILE . 19.2 t70 172.54 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.202 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -84.49 37.35 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 949' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.4 mp 53.5 48.96 20.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.994 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 946' ' ' LEU . 6.7 m -120.63 179.97 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.327 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 951' ' ' TRP . . . . . 0.615 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 97.2 m95 -145.13 49.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.231 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 23.5 t 49.5 -141.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 953' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 29.7 t -155.44 109.66 2.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.56 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 954' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.3 Cg_exo -75.05 53.99 3.53 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.121 2.547 . . . . 0.0 111.348 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 955' ' ' LYS . . . . . 0.606 ' HB3' ' NZ ' ' A' ' 955' ' ' LYS . 5.8 ttpm? -78.79 133.14 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.666 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 58.4 t0 57.42 40.59 27.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.281 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 957' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 958' ' ' CYS . 27.8 m -90.44 -42.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.511 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 958' ' ' CYS . . . . . 0.408 ' N ' HG23 ' A' ' 957' ' ' VAL . 84.6 m -155.0 141.63 18.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.164 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 959' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.5 mmtt -146.21 145.16 30.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.706 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 960' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 982' ' ' VAL . 14.8 tpp85 -53.24 103.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.141 0.496 . . . . 0.0 110.726 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 961' ' ' LYS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 937' ' ' TYR . 51.5 tttp -59.3 -179.06 0.07 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.566 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 962' ' ' SER . . . . . 0.705 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 83.9 p -149.66 142.58 24.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.625 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 77.2 m -79.51 164.69 23.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.16 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.9 133.16 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.363 . . . . 0.0 110.554 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 56.8 m -55.12 131.99 68.58 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 966' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 3.0 Cg_exo -74.15 125.12 9.54 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.736 2.291 . . . . 0.0 112.056 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.0 122.46 11.76 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.122 1.882 . . . . 0.0 111.305 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.05 116.07 17.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 969' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 64.5 Cg_endo -73.49 133.96 19.83 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.614 2.209 . . . . 0.0 111.993 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 970' ' ' VAL . . . . . 0.581 HG13 ' H ' ' A' ' 971' ' ' ASN . 1.1 p -53.77 -57.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.202 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 971' ' ' ASN . . . . . 0.581 ' H ' HG13 ' A' ' 970' ' ' VAL . 75.9 m-20 -79.01 34.23 0.23 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.356 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . 177.04 -147.77 8.53 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.953 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 973' ' ' MET . . . . . 0.498 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 22.5 ptt? 174.49 139.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 974' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 15.0 p -95.69 138.87 20.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.324 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 975' ' ' HIS . . . . . 0.477 ' O ' HG13 ' A' ' 977' ' ' ILE . 24.1 m170 -94.82 113.11 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 976' ' ' VAL . . . . . 1.029 HG13 HG23 ' A' ' 980' ' ' ILE . 92.2 t -65.63 -27.64 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 977' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 985' ' ' ARG . 4.8 mt 56.22 59.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.094 179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 12.3 p 76.61 -49.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.931 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 979' ' ' ASP . . . . . 0.58 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 2.6 p30 -159.88 138.52 10.57 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.459 -178.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 1.029 HG23 HG13 ' A' ' 976' ' ' VAL . 15.3 pt -91.46 32.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.974 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 981' ' ' GLN . . . . . 0.705 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -75.5 156.64 34.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.319 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 982' ' ' VAL . . . . . 0.803 HG13 ' HA ' ' A' 1005 ' ' ILE . 57.4 t -54.4 86.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.3 -49.25 0.3 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.922 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 984' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 979' ' ' ASP . 48.0 t -80.44 141.69 35.02 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.972 0.415 . . . . 0.0 110.691 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 985' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 13.9 ptm180 -101.08 137.39 39.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 986' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 16.6 pt -89.07 126.45 42.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.152 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 987' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' 1001 ' ' SER . 7.0 p -103.84 128.63 51.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.346 0.593 . . . . 0.0 112.017 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 988' ' ' TYR . . . . . 0.535 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 2.0 m-85 -96.4 143.75 27.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.164 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 86.1 p -148.67 117.05 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 990' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 994' ' ' HIS . 57.6 m -66.71 133.7 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.823 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 991' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 992' ' ' THR . 13.3 t -68.15 -147.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 992' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 991' ' ' THR . 49.5 m 8.75 -91.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.66 0.784 . . . . 0.0 113.044 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -158.38 44.93 0.47 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.294 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 994' ' ' HIS . . . . . 0.544 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 15.1 m80 -93.76 155.36 17.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.675 ' HB2' HG12 ' A' 1023 ' ' ILE . 7.6 tpt180 -90.04 130.73 36.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.609 -179.134 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 996' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' 1018 ' ' PRO . 8.5 tt -67.58 134.54 51.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.699 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 997' ' ' ILE . . . . . 0.932 HD11 ' HG2' ' A' 1021 ' ' GLN . 14.8 mm -107.36 123.31 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 998' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 59.94 134.51 0.01 OUTLIER Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.197 178.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 999' ' ' HIS . . . . . 0.698 ' ND1' ' HB ' ' A' 1015 ' ' THR . 47.0 m170 48.32 -141.98 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.9 p -177.95 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.79 0.329 . . . . 0.0 111.231 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1001 ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 987' ' ' THR . 70.9 p -152.27 157.2 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1002 ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -151.99 133.42 14.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 111.391 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1003 ' ' GLU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 18.9 pt-20 -96.22 141.91 29.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -70.95 126.46 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1005 ' ' ILE . . . . . 0.803 ' HA ' HG13 ' A' ' 982' ' ' VAL . 30.9 pt -138.98 162.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1006 ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' 1007 ' ' SER . 3.2 tm? 58.82 -77.76 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.459 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1007 ' ' SER . . . . . 1.035 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 97.1 p 59.59 -111.36 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.458 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.494 ' N ' ' HD3' ' A' ' 961' ' ' LYS . . . 64.43 -112.32 4.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.428 -178.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -65.82 -32.55 74.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1010 ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' 1007 ' ' SER . 77.2 m -150.06 122.53 8.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.493 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1011 ' ' ALA . . . . . 1.035 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -83.58 137.97 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.365 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1012 ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.4 OUTLIER -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.178 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 67.0 m95 -68.86 150.92 47.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 40.5 t -60.22 -34.6 73.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.476 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1015 ' ' THR . . . . . 0.698 ' HB ' ' ND1' ' A' ' 999' ' ' HIS . 74.8 p -141.78 149.38 40.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.775 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1016 ' ' LYS . . . . . 0.655 ' O ' ' HD3' ' A' 1016 ' ' LYS . 0.0 OUTLIER -56.85 147.72 52.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.56 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A 1017 ' ' PRO . . . . . 0.535 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 25.2 Cg_exo -64.8 123.38 11.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.906 2.404 . . . . 0.0 113.032 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1018 ' ' PRO . . . . . 0.636 ' HB3' HD21 ' A' ' 996' ' ' LEU . 23.6 Cg_exo -64.37 149.43 90.12 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 112.262 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1019 ' ' ILE . . . . . 0.877 HG22 ' H ' ' A' 1020 ' ' CYS . 2.7 mt -98.12 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.486 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1020 ' ' CYS . . . . . 0.877 ' H ' HG22 ' A' 1019 ' ' ILE . 23.1 m -163.29 128.58 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.433 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1021 ' ' GLN . . . . . 0.932 ' HG2' HD11 ' A' ' 997' ' ' ILE . 10.6 pt20 -153.21 130.98 11.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1022 ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 32.4 tpt85 -28.19 134.67 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1023 ' ' ILE . . . . . 0.675 HG12 ' HB2' ' A' ' 995' ' ' ARG . 33.6 mt -73.07 124.79 91.04 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.783 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.543 2.162 . . . . 0.0 112.468 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.965 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.921 0.391 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.643 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 30.4 m80 -149.08 144.16 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.509 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.29 119.09 19.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.24 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.419 ' HA ' HE21 ' A' ' 903' ' ' GLN . 2.8 mm100 -55.88 166.21 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.628 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.97 131.58 8.86 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.127 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.27 138.32 65.76 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.415 2.077 . . . . 0.0 111.937 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.71 156.99 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -78.43 126.98 31.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.306 0.574 . . . . 0.0 111.542 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.57 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 2.0 m-85 -90.81 -33.36 15.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.614 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.9 mp 75.72 -48.44 0.6 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.8 OUTLIER -85.72 18.41 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.021 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.32 126.39 6.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 914' ' ' LYS . 52.2 mtmt -96.74 132.94 41.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.092 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.3 tm? -48.71 141.65 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.587 ' H ' HD22 ' A' ' 913' ' ' LEU . 74.7 mmtt -147.14 64.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.453 ' H ' HD13 ' A' ' 913' ' ' LEU . 17.6 m -167.46 139.55 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.066 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -51.33 124.81 12.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.586 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 915' ' ' THR . 75.1 p -152.06 135.42 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.6 p -148.59 44.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.491 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.64 156.09 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.0 m -84.1 -44.91 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.819 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.34 120.34 26.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -96.81 141.32 22.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.02 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.58 132.43 14.67 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.581 2.188 . . . . 0.0 112.382 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.743 HD13 ' HA ' ' A' ' 947' ' ' ASP . 65.7 mt -54.15 147.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 78.27 67.25 1.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 1.8 m -174.83 121.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.4 m -90.3 128.43 36.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.645 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 942' ' ' SER . 8.5 tp -97.64 127.51 43.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -80.64 133.59 35.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.49 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 19.7 m-85 -138.5 124.09 19.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.616 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.776 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 55.5 mt-10 -102.03 125.34 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.991 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 99.0 m -57.95 166.09 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.325 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 44.8 mtp85 -82.75 158.94 64.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 936' ' ' TYR . 90.1 Cg_exo -44.07 -46.44 11.13 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.635 2.223 . . . . 0.0 112.697 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.547 ' HA ' HD22 ' A' 1006 ' ' LEU . 56.1 mt-10 -73.77 26.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.43 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 67.3 m-85 -145.15 157.64 44.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.618 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 31.6 p90 -144.09 137.08 27.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 155.94 29.69 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.8 ptp85 46.71 164.36 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.497 0.719 . . . . 0.0 112.464 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.776 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 74.2 Cg_endo -75.2 116.44 4.55 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.294 1.996 . . . . 0.0 112.515 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.557 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 16.1 p90 -95.57 -159.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 81.1 p -171.86 136.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.719 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 3.3 pt -96.27 117.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.976 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.421 HG22 HD23 ' A' ' 946' ' ' LEU . 2.8 m -84.23 126.27 32.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 85.2 m -73.48 115.18 12.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 94.5 mt -83.19 -59.93 2.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.743 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.5 t0 172.91 -37.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.874 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -81.85 26.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.312 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.965 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 61.3 40.43 14.36 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 951' ' ' TRP . 7.1 p -136.43 152.71 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.341 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.657 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 46.7 m95 -93.72 141.46 28.47 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.907 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 88.5 p -48.14 140.96 6.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 59.9 p -79.02 108.53 8.48 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.919 0.39 . . . . 0.0 111.387 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 952' ' ' SER . 2.9 Cg_exo -76.29 129.59 11.33 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.054 2.503 . . . . 0.0 111.974 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.601 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -80.65 -145.11 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.466 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -80.71 60.97 4.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 958' ' ' CYS . 26.0 m -80.53 -56.36 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.585 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.615 ' N ' HG23 ' A' ' 957' ' ' VAL . 6.2 t -89.87 135.03 33.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 44.0 mtmt -150.36 130.12 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.871 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 935' ' ' GLU . 40.6 ttm180 -53.91 142.67 23.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.008 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.618 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 13.3 mmmm -54.51 149.28 10.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.161 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.759 ' HB3' HE21 ' A' ' 981' ' ' GLN . 63.7 p -142.49 131.57 23.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -81.53 146.74 30.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.64 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 965' ' ' THR . 2.0 tmtp? -66.77 133.41 50.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.047 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.663 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 47.4 m -53.22 130.77 51.56 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.332 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.556 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 60.1 Cg_endo -70.9 136.13 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.744 2.296 . . . . 0.0 112.384 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.54 134.58 64.25 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.151 1.901 . . . . 0.0 111.296 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -57.3 122.62 55.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 0.0 111.054 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.21 143.25 58.32 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.111 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.479 HG12 ' ND2' ' A' ' 971' ' ' ASN . 22.0 t -49.21 129.2 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.479 ' ND2' HG12 ' A' ' 970' ' ' VAL . 74.5 m-20 58.23 45.77 16.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.031 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -174.54 -166.75 32.98 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.528 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -178.88 146.71 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.226 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 986' ' ' ILE . 7.1 p -98.66 133.54 40.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.823 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.0 OUTLIER -109.89 117.77 34.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.625 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 986' ' ' ILE . 33.9 m -74.46 131.03 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.83 -30.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.875 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.8 p -144.72 -54.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -158.64 -142.18 0.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.488 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -151.05 37.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.759 HE21 ' HB3' ' A' ' 962' ' ' SER . 7.9 mp0 -76.99 174.17 10.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.198 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 961' ' ' LYS . 28.1 m -63.91 30.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.62 -32.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.272 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 47.7 t -75.97 134.63 40.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 39.1 ptt180 -104.14 134.95 46.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 974' ' ' VAL . 37.3 pt -97.94 137.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.0 p -96.98 135.48 38.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 0.0 111.697 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.442 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 6.7 m-85 -101.68 138.19 39.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 51.1 m -153.54 121.61 6.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.966 0.412 . . . . 0.0 111.146 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 64.4 m -80.87 157.67 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.3 t -63.93 146.23 54.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.38 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 89.3 m -44.46 122.07 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 128.91 -54.11 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -102.99 138.56 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.663 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -95.13 147.24 23.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.314 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 997' ' ' ILE . 4.7 pp -71.63 139.74 49.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.601 ' CD1' ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -122.17 111.15 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 151.76 -60.36 0.41 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.246 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.464 ' CD2' ' HB ' ' A' 1015 ' ' THR . 98.1 m-70 -154.08 -122.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.518 0.199 . . . . 0.0 110.827 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 77.7 p -168.31 -46.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.4 p -156.0 107.62 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.63 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.409 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' 1003 ' ' GLU . 7.4 pm0 -96.27 133.1 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.126 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 42.4 t -77.43 126.9 31.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.8 pt -135.75 -159.73 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.096 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.547 HD22 ' HA ' ' A' ' 935' ' ' GLU . 28.0 tp -150.9 138.05 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.914 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 70.4 m -88.17 -44.21 11.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.34 -45.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.001 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.6 m120 -105.15 -31.48 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.43 ' C ' HD12 ' A' 1006 ' ' LEU . 98.5 m -142.69 138.53 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.051 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -82.68 145.71 29.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.102 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.8 p80 -158.55 151.37 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.537 ' CZ2' ' HD3' ' A' ' 966' ' ' PRO . 66.1 m95 -66.16 141.7 57.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 t -60.92 -30.78 70.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.464 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 61.8 p -144.06 139.29 28.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.52 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.7 pptp? -63.32 155.22 75.52 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.413 ' HB3' ' HE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -66.01 130.09 23.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.523 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.442 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_exo -64.88 -150.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.901 2.401 . . . . 0.0 112.628 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.772 HG22 ' H ' ' A' 1020 ' ' CYS . 1.5 mt -136.91 -158.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.772 ' H ' HG22 ' A' 1019 ' ' ILE . 73.7 m -155.07 132.01 10.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.312 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.601 ' HG2' ' CD1' ' A' ' 997' ' ' ILE . 3.0 pt20 -152.42 142.26 22.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -48.51 128.92 15.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.359 0.599 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 37.8 mt -74.83 128.98 84.34 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.039 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.742 2.295 . . . . 0.0 112.34 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.912 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.55 ' C ' HD22 ' A' ' 949' ' ' LEU . 41.9 m80 -150.75 132.23 14.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.672 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 6.1 p -82.15 128.96 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.408 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.3 mm100 -69.85 170.63 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.291 0.567 . . . . 0.0 111.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.42 134.3 12.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.41 149.96 84.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 907' ' ' HIS . 27.5 t70 -61.64 172.72 1.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.401 ' HD2' ' OD2' ' A' ' 906' ' ' ASP . 0.5 OUTLIER -77.96 130.4 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.242 0.544 . . . . 0.0 111.553 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 943' ' ' ILE . 1.5 m-85 -89.98 -43.46 10.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.6 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 82.2 mt 75.0 -43.01 0.5 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.929 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 908' ' ' PHE . 0.1 OUTLIER -83.55 -1.03 52.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -153.65 128.96 9.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.48 132.65 40.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -44.65 144.89 0.99 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.995 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 913' ' ' LEU . 38.5 ttpt -138.54 -36.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.514 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 917' ' ' THR . 4.6 m -64.63 143.64 57.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.686 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -49.4 125.29 10.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.221 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 915' ' ' THR . 81.0 p -152.04 143.77 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.239 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.3 m -159.48 -47.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.558 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.25 160.32 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.4 p -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -85.37 145.38 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -132.03 136.0 27.51 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.488 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.417 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.9 Cg_endo -69.54 141.86 47.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.838 2.358 . . . . 0.0 112.198 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 949' ' ' LEU . 15.9 mm -54.63 151.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 90.09 -30.74 5.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.0 m -55.9 125.25 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 112.015 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 34.9 t -95.94 135.14 38.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.855 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' A' ' 917' ' ' THR . 9.0 tp -117.1 114.19 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.685 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 24.9 ttmm -89.91 139.66 30.38 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.426 ' CZ ' HD23 ' A' ' 913' ' ' LEU . 7.0 m-85 -130.06 130.67 45.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.463 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 8.6 pt-20 -92.73 125.4 37.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.193 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 91.3 m -52.65 143.9 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.402 . . . . 0.0 111.42 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.9 mtp180 -82.93 155.94 67.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' 1006 ' ' LEU . 27.5 Cg_endo -63.44 64.75 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.721 2.28 . . . . 0.0 112.753 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.463 ' HG2' ' HE ' ' A' ' 960' ' ' ARG . 39.1 tt0 -174.85 2.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.22 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 40.1 m-85 -141.24 136.32 31.56 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.402 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.747 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 16.4 p90 -102.73 139.78 37.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.256 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.803 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 150.45 27.68 0.05 OUTLIER Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.58 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 938' ' ' GLY . 16.6 ptm180 45.79 171.04 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 122.971 0.508 . . . . 0.0 112.019 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.481 ' CD ' ' HB2' ' A' ' 939' ' ' ARG . 2.6 Cg_endo -77.86 112.89 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.109 1.873 . . . . 0.0 111.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.403 ' HD1' ' N ' ' A' ' 942' ' ' SER . 23.1 p90 -94.43 -160.52 0.78 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.467 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.403 ' N ' ' HD1' ' A' ' 941' ' ' PHE . 41.9 t -172.89 143.09 1.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.568 HD13 ' HZ ' ' A' ' 908' ' ' PHE . 3.5 pt -94.03 -170.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.986 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.42 HG22 HD23 ' A' ' 946' ' ' LEU . 1.0 OUTLIER -164.63 127.59 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.721 ' SG ' HD13 ' A' ' 924' ' ' ILE . 12.1 t -66.94 112.64 4.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 87.6 mt -82.18 -57.79 3.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -174.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.8 t70 172.74 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.948 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -83.5 34.95 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.912 HD21 ' HB1' ' A' ' 900' ' ' ALA . 30.7 mt 51.9 47.3 25.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.314 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.8 OUTLIER -135.43 -168.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.766 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.425 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 47.9 m95 -146.02 128.77 16.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 47.7 t -43.96 143.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.085 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.4 t -78.58 115.6 52.9 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.04 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.471 ' HG2' ' CE2' ' A' ' 908' ' ' PHE . 5.1 Cg_exo -75.95 53.49 3.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.372 2.714 . . . . 0.0 112.151 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.39 132.33 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.692 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.0 t0 56.99 77.89 0.25 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.231 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 24.5 m -149.31 -30.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.548 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.803 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 34.8 t -151.6 62.97 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.469 . . . . 0.0 110.913 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 11.3 mmpt? -55.23 153.77 6.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.646 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.824 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -58.43 132.25 53.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.669 -179.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.747 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 21.4 mmtp -56.37 135.64 53.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.082 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.629 ' HB2' ' HG2' ' A' ' 981' ' ' GLN . 48.3 t -152.66 129.08 10.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.998 0.428 . . . . 0.0 111.018 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 6.1 p -81.58 154.76 26.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.294 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -65.15 137.96 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 0.0 110.92 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 69.4 m -54.17 128.53 57.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 32.6 Cg_endo -63.67 134.41 43.97 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.439 2.092 . . . . 0.0 111.732 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 52.2 Cg_exo -52.58 127.89 26.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.104 1.869 . . . . 0.0 111.525 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -57.49 125.46 71.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.95 138.74 41.21 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.5 p -50.89 124.2 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.681 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.496 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.2 m-20 59.24 48.04 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 110.706 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.521 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -156.87 -155.13 7.32 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.534 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 42.8 ttp 173.94 135.74 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.867 HG21 HD12 ' A' ' 986' ' ' ILE . 15.0 p -98.65 123.99 51.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 977' ' ' ILE . 33.3 m-70 -76.98 108.51 10.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 979' ' ' ASP . 89.1 t -62.58 -32.16 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 71.83 -47.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.82 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -148.38 -60.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.596 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.9 m-20 -155.01 -152.89 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.065 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.585 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -148.64 22.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.934 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 84.9 mt-30 -79.36 156.5 27.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.007 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.596 HG11 ' HG ' ' A' 1006 ' ' LEU . 49.2 t -49.95 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.158 0.504 . . . . 0.0 111.065 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 151.8 -40.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.266 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.0 p -76.01 138.54 40.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.517 ' HE ' ' HB2' ' A' 1001 ' ' SER . 76.9 ttt180 -104.19 125.97 50.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.867 HD12 HG21 ' A' ' 974' ' ' VAL . 41.3 pt -98.94 129.22 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.818 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.1 p -96.95 134.2 40.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 22.9 m-85 -96.13 139.02 32.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.454 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 52.5 m -152.42 116.45 4.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.476 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.8 146.92 41.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.521 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 94.0 m -64.64 142.96 58.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.245 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.0 t -41.94 124.38 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.025 0.441 . . . . 0.0 111.553 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.85 -48.35 0.97 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.742 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -102.33 144.5 30.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.545 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.2 ptt180 -92.63 143.7 26.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 997' ' ' ILE . 7.5 tt -71.81 132.32 44.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.555 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.7 mp -110.05 134.55 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.8 -128.22 9.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.359 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' 1015 ' ' THR . 93.8 m-70 -78.3 -132.51 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.437 0.16 . . . . 0.0 111.394 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.8 t -174.25 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.65 0.262 . . . . 0.0 111.191 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.517 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 76.2 p -150.89 150.29 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.893 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.496 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.58 130.53 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.0 tt0 -99.08 135.52 40.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 30.5 t -71.44 119.19 15.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.649 HD13 ' H ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -140.78 160.39 23.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.541 0.686 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.596 ' HG ' HG11 ' A' ' 982' ' ' VAL . 93.1 mt -89.22 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.793 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 68.7 m -149.99 -32.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -157.05 57.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.274 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' 1009 ' ' ASN . 1.9 m120 61.44 27.74 17.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.009 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 8.0 m -149.11 131.99 16.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 128.65 34.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.859 0.362 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.465 ' O ' HD13 ' A' 1005 ' ' ILE . 8.2 p80 -158.09 145.8 18.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.487 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' HG22 ' A' ' 980' ' ' ILE . 58.7 m95 -67.48 137.73 56.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.9 p -54.8 -28.71 51.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.701 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 81.5 p -139.34 138.9 37.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.957 0.408 . . . . 0.0 111.815 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1017 ' ' PRO . 7.5 tmtm? -57.38 134.76 81.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.499 ' O ' ' HD3' ' A' 1016 ' ' LYS . 50.7 Cg_exo -54.56 126.67 23.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 31.8 Cg_exo -59.75 -157.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.832 2.355 . . . . 0.0 112.716 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.783 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -139.75 -161.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.257 0.551 . . . . 0.0 110.964 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.783 ' H ' HG22 ' A' 1019 ' ' ILE . 84.4 m -155.93 138.51 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 1.6 tt0 -151.25 134.77 16.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.309 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -46.21 128.46 9.62 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.3 mt -74.87 126.65 88.11 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.765 2.31 . . . . 0.0 112.555 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.715 0.293 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -153.65 133.64 13.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.5 p -82.27 110.92 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.314 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -83.23 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.88 124.85 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.568 ' HB3' ' CG ' ' A' ' 951' ' ' TRP . 86.8 Cg_endo -82.33 124.09 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.701 2.268 . . . . 0.0 113.395 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 35.8 t0 26.05 -137.09 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.061 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 35.4 p-80 -161.05 151.43 17.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.168 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -145.51 134.0 21.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.2 mp -83.04 -49.16 9.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.212 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.515 ' HA ' ' HD3' ' A' ' 933' ' ' ARG . 0.8 OUTLIER -84.97 28.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -156.46 135.11 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.509 ' HD3' ' C ' ' A' ' 911' ' ' ALA . 0.0 OUTLIER -136.44 124.52 22.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.193 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 58.7 tp -49.38 144.67 5.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.137 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.735 ' HD2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -154.75 27.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 0.0 110.986 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.578 HG22 ' HG3' ' A' ' 916' ' ' GLN . 24.2 m -69.96 -111.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.572 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' A' ' 915' ' ' THR . 2.5 pp0? -169.13 34.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.452 0.644 . . . . 0.0 110.413 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.1 t -87.35 154.78 20.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.898 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.7 p -136.5 46.54 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.448 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -166.67 159.31 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.015 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.2 p -85.01 -36.95 20.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -84.58 146.03 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.6 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 87.6 m-85 -134.75 145.57 55.34 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 111.526 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.1 Cg_endo -84.5 137.51 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.453 2.769 . . . . 0.0 112.386 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.803 HG21 ' HA ' ' A' ' 947' ' ' ASP . 53.3 mt -54.34 154.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.196 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 74.24 58.14 4.43 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.642 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 3.8 m -175.23 127.26 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.43 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.627 ' HB3' ' OG1' ' A' ' 944' ' ' THR . 79.4 p -105.68 135.42 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.652 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.619 ' HB2' ' HE1' ' A' ' 930' ' ' TYR . 93.5 mt -96.85 128.29 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.363 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 15.3 tppt? -82.88 121.05 26.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.748 0.309 . . . . 0.0 111.383 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 9.2 m-85 -111.72 127.95 55.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.735 ' HG3' ' HD2' ' A' ' 914' ' ' LYS . 61.9 mm-40 -92.16 107.0 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 110.637 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 83.1 m -59.62 178.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.856 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 910' ' ' PHE . 78.9 mtp180 -85.67 151.7 55.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.134 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 936' ' ' TYR . 53.2 Cg_exo -52.85 -37.17 76.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.904 2.403 . . . . 0.0 112.872 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.96 12.39 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.662 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 934' ' ' PRO . 33.8 m-85 -139.6 128.75 23.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 19.3 p90 -96.2 137.05 35.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.425 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 147.33 152.67 5.71 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.72 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.61 142.16 83.44 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.344 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.746 ' HB2' ' HD2' ' A' ' 929' ' ' LYS . 40.9 Cg_exo -56.36 137.02 78.62 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.918 2.412 . . . . 0.0 111.85 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.727 ' HB3' HG11 ' A' ' 957' ' ' VAL . 30.4 p90 -89.71 124.7 34.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.55 0.691 . . . . 0.0 111.336 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 928' ' ' LEU . 75.1 p -75.52 -38.65 59.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.877 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' A' ' 930' ' ' TYR . 47.7 pt 49.32 93.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.618 0.723 . . . . 0.0 111.702 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 927' ' ' SER . 11.9 m -84.29 139.56 32.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.586 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 98.2 m -73.7 129.06 37.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 950' ' ' VAL . 2.2 mm? -82.56 -65.98 0.94 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.803 ' HA ' HG21 ' A' ' 924' ' ' ILE . 24.6 t70 172.82 -41.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.397 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -85.54 41.9 0.93 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.071 0.462 . . . . 0.0 109.89 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 900' ' ' ALA . 63.5 mt 53.28 48.87 21.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.783 HG23 HD23 ' A' ' 946' ' ' LEU . 6.6 m -131.87 177.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.483 0.658 . . . . 0.0 112.005 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.568 ' CG ' ' HB3' ' A' ' 905' ' ' PRO . 46.8 m95 -135.23 126.88 28.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.84 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.741 ' N ' HD21 ' A' ' 946' ' ' LEU . 11.0 m -42.43 148.85 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.274 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 35.4 t -76.98 121.52 84.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.0 Cg_exo -76.55 56.44 5.13 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.538 2.826 . . . . 0.0 111.734 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.525 ' HG2' ' OD1' ' A' ' 956' ' ' ASP . 57.8 tttp -75.87 123.61 25.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.431 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.525 ' OD1' ' HG2' ' A' ' 955' ' ' LYS . 1.4 m-20 57.76 98.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.384 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 941' ' ' PHE . 16.1 m -151.07 -31.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 92.5 m -152.05 65.4 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.6 mmtt -60.52 137.65 58.13 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 36.8 ttm180 -59.59 135.56 57.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.649 ' NZ ' HD11 ' A' 1006 ' ' LEU . 98.0 mttt -57.52 145.91 31.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.517 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.708 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 75.6 p -142.47 137.34 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 68.8 m -81.03 154.93 26.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.137 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.81 127.7 33.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.842 0.353 . . . . 0.0 110.667 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 19.4 m -57.15 136.83 80.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.765 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 974' ' ' VAL . 5.8 Cg_endo -48.15 140.45 19.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.229 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 968' ' ' ASP . 65.5 Cg_endo -73.62 49.4 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.791 2.327 . . . . 0.0 112.983 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 967' ' ' PRO . 1.7 p30 26.06 67.29 0.47 Allowed Pre-proline 0 N--CA 1.465 0.289 0 O-C-N 123.507 0.505 . . . . 0.0 112.153 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -40.56 134.56 2.18 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.76 2.307 . . . . 0.0 112.635 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.593 HG22 ' ND2' ' A' ' 971' ' ' ASN . 2.6 p -53.1 132.95 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.764 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.593 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.7 m-20 58.66 53.14 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.332 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -155.66 -153.51 6.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.554 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 38.9 ttm 176.52 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.543 0.211 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.616 HG21 ' HG3' ' A' ' 966' ' ' PRO . 1.9 p -93.83 168.44 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.23 0.538 . . . . 0.0 110.652 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.732 ' NE2' HG13 ' A' ' 977' ' ' ILE . 8.4 t60 -152.83 104.01 2.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.297 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 26.9 m -66.72 -24.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.802 HG22 HG23 ' A' ' 978' ' ' THR . 3.8 mp 76.86 -42.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 0.0 110.435 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 977' ' ' ILE . 81.5 p -144.77 -59.76 0.36 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.664 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.8 m-20 -157.39 -145.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.389 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.491 HG22 ' HH2' ' A' 1013 ' ' TRP . 4.2 pt -148.25 20.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.068 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.729 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 3.7 mm100 -76.63 177.2 7.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.87 -24.13 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 109.869 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -107.9 53.67 0.59 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.606 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 54.9 m -158.31 127.68 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.014 0.435 . . . . 0.0 110.604 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.595 ' O ' HD13 ' A' ' 977' ' ' ILE . 74.0 ttt180 -104.22 129.13 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.186 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 976' ' ' VAL . 42.7 pt -103.07 151.77 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.807 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.467 ' OG1' HD11 ' A' ' 977' ' ' ILE . 8.5 p -135.79 138.65 42.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.077 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 966' ' ' PRO . 2.0 m-85 -96.48 151.44 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.399 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 53.6 m -153.61 69.6 0.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.601 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 66.5 m -44.5 151.08 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.776 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 146.2 50.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 77.6 m -40.59 -38.68 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.183 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -55.03 -49.49 62.51 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.826 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.2 m80 -102.45 141.6 35.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.018 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.606 ' HB3' HG12 ' A' 1023 ' ' ILE . 33.6 ptt85 -90.65 141.43 28.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.32 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 997' ' ' ILE . 5.5 tt -71.87 133.82 45.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.719 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.0 mp -104.71 135.07 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.26 -139.19 15.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.453 ' CE1' ' HG3' ' A' 1018 ' ' PRO . 23.1 p80 -79.58 -135.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.436 ' N ' ' ND1' ' A' ' 999' ' ' HIS . 80.1 p -177.41 16.08 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.594 0.235 . . . . 0.0 111.358 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 32.1 t -159.43 145.05 15.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.43 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.519 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.64 124.02 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.1 tt0 -98.45 137.73 36.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 50.0 t -71.2 124.27 24.1 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 27.4 pt -133.39 -154.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.952 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.649 HD11 ' NZ ' ' A' ' 961' ' ' LYS . 2.5 tt -154.27 125.36 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.476 ' N ' HD23 ' A' 1006 ' ' LEU . 40.4 t -90.1 42.95 1.12 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.206 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 26.8 27.82 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.671 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -158.93 -47.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.2 m -147.82 143.53 27.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.054 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -79.83 131.92 36.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.6 p80 -160.18 155.95 25.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.491 ' HH2' HG22 ' A' ' 980' ' ' ILE . 80.9 m95 -64.29 144.72 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -54.54 -33.21 59.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 1.7 t -146.75 148.42 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.382 0.611 . . . . 0.0 112.29 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.63 138.04 86.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.985 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 77.5 Cg_exo -50.8 138.01 42.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.723 2.282 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 999' ' ' HIS . 24.1 Cg_exo -63.02 -160.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.29 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 42.3 mt -141.75 136.45 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.0 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 70.9 m -97.15 125.31 41.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.14 128.3 18.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 13.0 ptp180 -47.5 140.36 5.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.588 0.708 . . . . 0.0 111.535 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.9 mt -74.84 130.87 80.3 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.162 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 46.0 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.809 2.34 . . . . 0.0 112.265 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.604 0.24 . . . . 0.0 111.479 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -152.69 132.02 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.7 p -82.34 118.51 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.99 173.51 9.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.982 0.42 . . . . 0.0 111.307 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.42 135.55 7.38 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.272 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 54.7 Cg_exo -51.9 136.14 51.46 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.59 2.193 . . . . 0.0 112.068 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 907' ' ' HIS . 35.4 m-20 -64.83 105.1 0.94 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 906' ' ' ASP . 0.4 OUTLIER 11.27 110.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.173 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.671 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 3.6 m-85 -90.02 131.47 35.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 110.227 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.2 mm? -75.19 -68.71 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.685 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.5 OUTLIER -85.29 21.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -149.35 150.75 32.97 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.135 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.472 ' HD3' ' NH1' ' A' ' 933' ' ' ARG . 23.8 pttm -140.51 136.67 33.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.5 tm? -45.27 139.68 3.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.609 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.606 ' N ' HD13 ' A' ' 913' ' ' LEU . 30.7 mmmt -150.82 58.06 0.92 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.731 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 917' ' ' THR . 15.5 m -167.88 134.95 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.885 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.512 ' NE2' HG23 ' A' ' 915' ' ' THR . 3.4 pm0 -55.74 138.37 47.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 915' ' ' THR . 60.0 p -150.75 -57.22 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.396 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 22.6 p 68.79 -50.11 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.831 0.707 . . . . 0.0 112.255 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.32 148.14 48.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.43 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.7 p -85.8 -48.29 8.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.25 123.27 30.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.182 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 50.1 m-85 -103.86 146.2 32.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.486 . . . . 0.0 112.019 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.6 Cg_endo -83.8 139.9 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.488 2.792 . . . . 0.0 111.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.768 HD13 ' HA ' ' A' ' 947' ' ' ASP . 48.1 mt -52.77 152.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.341 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 944' ' ' THR . . . 89.65 -40.74 3.02 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 38.1 m -56.85 137.69 54.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.345 . . . . 0.0 110.458 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.582 ' HB2' ' OG ' ' A' ' 942' ' ' SER . 82.2 p -120.8 132.33 54.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.113 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 942' ' ' SER . 72.8 mt -106.21 136.41 45.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.04 0.447 . . . . 0.0 111.741 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.525 ' HB2' ' OG1' ' A' ' 915' ' ' THR . 99.3 mttt -86.5 133.41 33.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.723 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 11.6 m-85 -132.64 125.27 30.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.531 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 914' ' ' LYS . 95.4 mt-10 -95.29 133.18 39.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 72.8 m -58.51 150.31 23.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.018 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 41.5 mtp85 -82.84 163.36 51.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.518 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 40.6 Cg_endo -66.75 64.57 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 95.1 mt-10 -165.43 -18.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.232 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 3.0 m-85 -129.38 -168.75 1.99 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 958' ' ' CYS . 16.5 p90 -150.03 138.26 20.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.985 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 167.22 4.84 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.353 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.935 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 6.6 ppt_? 46.06 173.27 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 123.013 0.525 . . . . 0.0 112.286 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 13.6 Cg_endo -58.93 89.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.41 2.073 . . . . 0.0 113.059 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.503 ' HA ' ' NH1' ' A' ' 939' ' ' ARG . 42.2 p90 -90.17 120.85 31.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.879 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 927' ' ' SER . 23.8 t -74.03 160.21 31.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.809 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.533 HG22 ' HG3' ' A' ' 954' ' ' PRO . 5.4 pt -137.64 104.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 925' ' ' GLY . 30.3 m -82.33 130.79 35.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 97.9 m -73.71 132.08 42.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.5 mm? -84.54 -60.22 2.14 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.768 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.1 t0 171.66 -36.81 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.691 0.282 . . . . 0.0 110.953 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 950' ' ' VAL . 73.3 m-80 -82.94 37.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 900' ' ' ALA . 79.6 mt 50.5 42.98 27.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.934 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 948' ' ' ASN . 22.2 m -136.13 147.99 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.796 0.808 . . . . 0.0 112.07 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 952' ' ' SER . 52.2 m95 -91.82 122.16 34.1 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.596 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -38.68 126.13 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 70.3 m -78.15 107.14 4.96 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 110.909 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 943' ' ' ILE . 60.4 Cg_endo -100.92 55.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 124.013 3.142 . . . . 0.0 112.608 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -77.44 38.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.539 0.685 . . . . 0.0 110.09 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 954' ' ' PRO . 34.3 t70 -159.92 53.78 0.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.692 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 941' ' ' PHE . 8.8 m -147.05 -17.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.871 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 937' ' ' TYR . 11.1 t -147.57 135.38 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.123 0.487 . . . . 0.0 110.901 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 32.0 mtmt -147.77 149.87 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.252 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 52.2 ttm-85 -53.31 135.38 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 937' ' ' TYR . 30.2 mmtp -56.29 164.73 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.36 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.756 ' HB3' HE22 ' A' ' 981' ' ' GLN . 85.1 p -145.5 132.84 20.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.797 0.332 . . . . 0.0 110.216 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 49.2 m -81.57 36.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 61.7 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 980' ' ' ILE . 30.7 m -55.79 129.06 71.06 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 57.5 Cg_endo -70.71 121.3 7.79 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.462 2.108 . . . . 0.0 112.693 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 11.8 Cg_exo -69.76 123.76 10.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.455 2.103 . . . . 0.0 111.364 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.54 120.95 64.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.36 141.27 50.89 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.38 2.053 . . . . 0.0 111.752 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.615 HG22 ' ND2' ' A' ' 971' ' ' ASN . 2.2 p -45.96 127.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.615 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.4 m-20 66.16 49.34 1.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.888 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -163.82 -158.15 9.82 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.867 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 40.0 ttm 176.72 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.536 0.208 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.5 p -100.56 131.47 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.819 0.343 . . . . 0.0 111.52 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -91.87 111.46 23.0 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 30.1 m -64.22 -18.69 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 109.913 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 987' ' ' THR . 12.4 mm 74.57 -47.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 67.9 p -148.18 -49.97 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.759 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.4 m-20 -157.49 -149.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.866 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -151.08 25.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 111.143 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.756 HE22 ' HB3' ' A' ' 962' ' ' SER . 3.0 mm100 -80.91 163.7 23.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.143 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 961' ' ' LYS . 54.8 t -55.43 93.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.078 0.466 . . . . 0.0 111.14 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.66 -47.6 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.232 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.5 t -76.4 141.31 41.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 111.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 3.5 ptm85 -104.22 131.86 51.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.546 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.7 pt -98.13 127.48 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.569 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -97.07 132.69 42.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.977 0.417 . . . . 0.0 110.953 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.516 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 10.8 m-85 -96.6 139.96 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.443 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -152.74 116.43 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.181 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 83.9 m -73.02 147.21 45.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.454 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.56 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 8.6 t -64.86 149.16 50.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.614 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 84.8 m -46.68 108.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.317 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 152.92 -57.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.265 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.415 ' HB3' ' C ' ' A' 1021 ' ' GLN . 7.6 m80 -102.46 145.92 28.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.77 ' HB3' HG12 ' A' 1023 ' ' ILE . 15.6 ptm180 -90.02 139.16 30.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.166 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.689 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.3 tt -71.84 132.7 44.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.942 0.401 . . . . 0.0 110.734 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.689 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.5 mp -106.07 130.84 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.52 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 96.56 -138.75 14.1 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.085 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -81.27 -140.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.414 0.15 . . . . 0.0 111.146 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 42.7 t 178.9 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.424 ' HB2' HH21 ' A' ' 985' ' ' ARG . 66.1 p -158.8 148.95 19.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.045 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.55 118.16 3.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.2 tt0 -96.33 128.61 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 50.6 t -71.32 119.39 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.404 ' HA ' HG13 ' A' ' 982' ' ' VAL . 37.4 pt -136.6 143.6 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.244 0.545 . . . . 0.0 111.892 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 53.8 tp -84.61 124.48 31.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.998 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.5 t -95.96 -50.24 4.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' 1010 ' ' THR . . . 169.26 122.16 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.71 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 72.99 -37.14 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.164 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' 1008 ' ' GLY . 84.6 m -145.72 136.26 24.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.216 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 151.09 26.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.372 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.7 p80 -153.07 147.59 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 86.9 m95 -64.37 139.13 58.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.162 0.506 . . . . 0.0 111.297 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 m -62.42 -21.75 65.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.282 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.8 m -138.9 135.74 34.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.4 pttm -72.73 148.28 89.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.768 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.85 129.02 28.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.589 2.193 . . . . 0.0 112.397 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.24 -154.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.735 2.29 . . . . 0.0 112.465 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 53.1 mt -139.91 141.54 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 97.5 m -100.85 125.65 47.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.415 ' C ' ' HB3' ' A' ' 994' ' ' HIS . 3.3 tt0 -145.51 138.11 25.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.387 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -45.55 135.62 6.33 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 111.703 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.77 HG12 ' HB3' ' A' ' 995' ' ' ARG . 54.8 mt -74.76 126.94 87.92 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.711 2.274 . . . . 0.0 112.482 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.78 0.324 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.501 ' C ' HD22 ' A' ' 949' ' ' LEU . 8.5 m170 -147.5 120.78 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.52 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 24.9 p -82.25 122.33 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.02 167.69 20.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.476 0.655 . . . . 0.0 112.045 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -47.53 133.23 10.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.509 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.5 Cg_exo -62.32 154.54 62.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.926 2.418 . . . . 0.0 112.407 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 907' ' ' HIS . 27.1 t70 -62.23 173.08 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.677 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.437 ' N ' ' CG ' ' A' ' 906' ' ' ASP . 42.6 m170 -77.68 121.48 24.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.288 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 1.9 m-85 -86.43 -36.09 19.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.48 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 92.0 mt 75.98 -46.03 0.54 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.748 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 6.05 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.66 126.44 5.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.2 124.81 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.309 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 929' ' ' LYS . 63.2 tp -51.61 156.79 1.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.503 ' H ' HD12 ' A' ' 913' ' ' LEU . 73.9 mmtt -145.29 -66.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.568 HG22 HE21 ' A' ' 916' ' ' GLN . 17.9 m 19.88 -117.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.687 0.617 . . . . 0.0 111.884 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.568 HE21 HG22 ' A' ' 915' ' ' THR . 2.6 pp0? -175.95 41.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.201 0.524 . . . . 0.0 110.476 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.669 HG21 HD11 ' A' ' 928' ' ' LEU . 39.0 p -82.8 -172.82 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 98.0 m -169.1 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.478 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.4 157.76 37.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -84.61 -43.62 14.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.37 124.8 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.53 ' HE2' HG21 ' A' ' 917' ' ' THR . 80.4 m-85 -103.69 134.55 19.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.574 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 59.9 Cg_endo -71.94 141.92 37.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 112.126 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.689 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 32.7 mt -59.69 156.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 82.71 -35.6 2.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.716 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.574 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 18.7 m -56.04 127.42 30.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.526 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 48.7 m -101.72 131.42 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 917' ' ' THR . 5.2 tp -95.79 -168.07 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.177 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.695 ' O ' HD12 ' A' ' 913' ' ' LEU . 40.6 ttmt -157.44 130.36 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.591 ' CE1' HD23 ' A' ' 928' ' ' LEU . 5.4 m-85 -129.09 135.64 49.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.384 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.653 ' OE1' ' HB3' ' A' ' 940' ' ' PRO . 2.9 mm-40 -96.26 134.78 38.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.363 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 86.6 m -55.33 155.35 5.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.566 ' HG2' ' HD2' ' A' ' 934' ' ' PRO . 65.1 ttt180 -82.37 145.13 51.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 933' ' ' ARG . 67.6 Cg_exo -39.35 -41.2 2.15 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.717 2.278 . . . . 0.0 112.884 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 961' ' ' LYS . 50.2 mt-10 -69.14 -34.74 75.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.487 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.43 ' HD1' ' HB3' ' A' ' 933' ' ' ARG . 18.3 m-85 -94.85 142.61 27.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.144 0.497 . . . . 0.0 112.305 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 8.3 p90 -100.08 141.99 32.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.655 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 153.44 147.65 4.69 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.222 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.688 ' H ' ' HD2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -73.08 158.84 86.47 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.653 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 31.2 Cg_exo -60.03 115.45 2.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.573 2.182 . . . . 0.0 112.208 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 930' ' ' TYR . 49.3 p90 -95.6 -168.21 1.74 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 928' ' ' LEU . 68.8 m -166.93 134.6 2.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.099 0.476 . . . . 0.0 111.33 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.412 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 5.1 pt -102.38 125.69 56.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.443 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 18.0 m -82.77 122.09 27.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.28 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 8.4 t -71.44 103.07 2.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 88.0 mt -82.72 162.02 21.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.437 ' HA ' HG21 ' A' ' 924' ' ' ILE . 62.6 t0 -45.44 -34.23 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.135 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.663 ' O ' HG13 ' A' ' 950' ' ' VAL . 2.6 m120 -81.32 28.89 0.37 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.623 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 900' ' ' ALA . 45.7 mt 47.79 31.78 2.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.323 0.582 . . . . 0.0 109.918 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 948' ' ' ASN . 29.5 m -107.92 -160.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.62 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.511 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 81.9 m95 -150.67 121.41 7.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.817 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.9 p -41.49 142.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.497 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.479 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 39.7 t -78.58 115.08 48.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.051 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.8 Cg_exo -74.61 130.81 14.07 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.995 2.463 . . . . 0.0 111.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.484 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 29.8 mmmt -80.77 -133.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.464 0.65 . . . . 0.0 111.755 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 6.7 t70 -78.36 60.32 2.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.314 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 33.9 m -81.51 -34.09 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.885 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.48 ' O ' ' HE3' ' A' ' 959' ' ' LYS . 30.0 m -150.41 125.7 10.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.12 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.1 mmpt? -137.48 149.53 46.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.834 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 14.7 mmt85 -53.2 120.7 6.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 28.8 mtpp -58.29 -171.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.417 ' HB3' HE21 ' A' ' 981' ' ' GLN . 81.1 p -153.14 137.7 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.8 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.411 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 58.5 m -81.58 38.85 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt 59.0 130.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.433 ' HA ' HD12 ' A' ' 980' ' ' ILE . 49.6 m -57.74 126.7 76.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 986' ' ' ILE . 52.6 Cg_endo -68.6 128.75 17.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.418 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 34.9 Cg_exo -59.66 131.18 38.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.365 2.043 . . . . 0.0 111.614 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -61.28 120.63 56.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.954 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 139.22 36.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.072 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' 1020 ' ' CYS . 20.4 t -52.01 130.06 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.439 ' ND2' HG12 ' A' ' 970' ' ' VAL . 72.8 m-20 56.82 52.8 8.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.694 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -158.26 -153.3 6.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.243 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 32.2 ttp 175.01 119.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.607 0.241 . . . . 0.0 111.002 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 974' ' ' VAL . 12.0 p -101.02 124.21 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.728 0.775 . . . . 0.0 111.355 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.62 ' CD2' HG12 ' A' ' 977' ' ' ILE . 5.5 t60 -87.28 103.08 15.11 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.6 m -53.02 -20.51 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 985' ' ' ARG . 12.9 mt 66.58 60.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.583 0.706 . . . . 0.0 109.395 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 14.1 p 80.79 -48.42 0.29 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.234 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.562 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 55.3 m-20 -156.27 -158.57 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.86 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.485 HG22 ' CG2' ' A' ' 986' ' ' ILE . 12.8 pt -151.04 23.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.35 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.562 ' OE1' ' HB3' ' A' ' 979' ' ' ASP . 7.2 mp0 -76.54 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 96.2 t -55.49 84.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.125 0.488 . . . . 0.0 110.736 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.9 -45.94 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.108 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 50.5 m -76.05 138.85 41.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 111.257 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.686 ' HE ' ' HB3' ' A' 1003 ' ' GLU . 38.3 ttm180 -103.37 139.1 39.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.351 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 20.3 pt -98.62 122.45 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.678 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.483 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.7 p -101.93 135.56 43.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.095 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 3.1 m-85 -96.49 140.4 31.18 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.747 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 43.9 t -151.75 64.45 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 35.8 m -35.75 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.618 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 9.0 t -174.18 165.87 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 9.0 t -52.84 -36.28 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.659 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' 1023 ' ' ILE . . . -63.69 -55.14 26.68 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.488 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -101.81 136.73 41.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.413 . . . . 0.0 111.26 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.7 ptt180 -92.57 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.511 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.7 tt -72.36 132.23 43.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -111.25 132.78 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 111.302 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 68.04 131.84 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.217 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 47.5 -139.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.652 0.263 . . . . 0.0 111.449 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.1 t -177.05 -30.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 46.8 t -154.56 168.66 26.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.511 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.96 133.65 14.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.045 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.686 ' HB3' ' HE ' ' A' ' 985' ' ' ARG . 19.3 pt-20 -96.15 134.14 39.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.122 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.453 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.8 t -76.42 124.76 28.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' 1014 ' ' SER . 41.9 pt -135.94 -154.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.471 . . . . 0.0 112.115 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' 1010 ' ' THR . 62.3 tp -151.85 138.55 18.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.009 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.507 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.6 t -87.91 -48.22 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.17 20.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.13 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 10.3 p-10 174.94 -53.79 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.782 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.488 ' O ' HD12 ' A' 1006 ' ' LEU . 10.3 m -98.88 130.56 45.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.606 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -81.21 134.8 35.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.507 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.1 p80 -158.82 147.64 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 111.65 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.493 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 60.5 m95 -68.23 134.96 51.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.771 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' 1005 ' ' ILE . 91.4 p -68.37 -12.22 60.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 6.4 m -140.93 139.24 34.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 pttm -69.76 146.0 95.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.057 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.468 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 23.9 Cg_exo -64.63 135.71 46.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.869 2.379 . . . . 0.0 112.55 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 38.0 Cg_endo -66.28 -156.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.568 2.178 . . . . 0.0 112.449 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.7 mt -142.22 139.95 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.694 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 71.7 m -93.41 124.3 37.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -145.79 133.3 20.84 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.6 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -48.12 133.2 15.38 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.559 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.645 HG12 ' HB3' ' A' ' 995' ' ' ARG . 44.8 mt -75.14 124.93 89.6 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.803 2.336 . . . . 0.0 112.253 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.612 ' N ' HD22 ' A' ' 949' ' ' LEU . 16.1 m80 67.8 127.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.703 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 2.4 p -82.27 130.03 35.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.453 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -67.22 -177.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.576 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.21 137.9 6.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 2.7 Cg_exo -75.07 63.41 6.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.202 2.601 . . . . 0.0 112.167 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.1 t0 36.32 -131.99 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.676 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 17.6 t-160 -160.45 120.21 2.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.848 0.356 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.595 ' HE2' ' HG2' ' A' ' 954' ' ' PRO . 21.9 m-85 -88.15 136.35 33.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.98 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.25 -58.58 3.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.347 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -84.84 26.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.4 122.33 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.443 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 912' ' ' LYS . 10.3 mtmp? -100.52 131.49 46.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.548 HD21 ' OG1' ' A' ' 917' ' ' THR . 52.1 tp -48.22 129.71 15.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.491 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.564 ' HD3' ' HD2' ' A' ' 929' ' ' LYS . 51.6 tttp -94.51 -43.08 8.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 42.7 m -64.6 144.43 57.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.853 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 916' ' ' GLN . 1.3 pp0? -77.54 49.29 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.548 ' OG1' HD21 ' A' ' 913' ' ' LEU . 39.5 p -81.42 146.28 30.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 72.9 p -136.39 -33.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.576 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.47 156.22 39.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 54.6 m -84.78 -38.83 19.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.9 145.29 28.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.32 137.68 25.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.511 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -69.74 136.6 33.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.716 2.277 . . . . 0.0 111.764 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 39.9 mt -58.04 154.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.205 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.02 -34.02 3.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 22.9 m -55.93 122.24 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.659 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.6 m -94.91 120.72 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.885 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 942' ' ' SER . 10.0 tp -99.24 118.85 36.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.316 . . . . 0.0 110.737 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.564 ' HD2' ' HD3' ' A' ' 914' ' ' LYS . 39.9 ttmt -85.34 138.76 32.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.106 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 941' ' ' PHE . 7.2 m-85 -131.65 134.85 46.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.515 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.495 ' HG2' ' HD2' ' A' ' 914' ' ' LYS . 56.6 mm-40 -95.58 130.53 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.607 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.16 156.52 9.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 45.0 mtt-85 -84.8 151.84 58.61 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 936' ' ' TYR . 86.6 Cg_exo -47.48 -46.75 19.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.685 2.257 . . . . 0.0 112.859 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.587 ' HB3' HG21 ' A' ' 982' ' ' VAL . 4.8 mm-40 -73.29 20.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.745 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 82.2 m-85 -145.17 137.32 25.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.402 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.721 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 14.3 p90 -97.71 138.0 35.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.423 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 158.57 142.59 3.43 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.082 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -73.06 159.07 86.09 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.258 . . . . 0.0 110.362 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.84 149.17 71.13 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.275 1.983 . . . . 0.0 111.294 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 957' ' ' VAL . 50.7 p90 -140.01 -167.91 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.78 0.324 . . . . 0.0 110.93 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.4 p -172.88 134.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.483 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 15.3 pt -97.21 113.55 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 47.1 m -78.49 126.67 31.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.828 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.2 t -72.96 125.1 26.8 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.155 0.502 . . . . 0.0 109.936 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.915 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -88.35 167.9 13.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 0.0 113.606 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -50.6 -38.63 46.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.293 -1.776 . . . . 0.0 112.25 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.549 ' O ' HG13 ' A' ' 950' ' ' VAL . 50.9 t30 -81.6 34.25 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 900' ' ' ALA . 21.0 mt 47.93 36.73 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.196 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.915 HG23 HD23 ' A' ' 946' ' ' LEU . 29.1 m -112.85 -159.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.241 0.543 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 85.4 m95 -147.32 124.89 11.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.473 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.9 p -39.68 141.75 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.803 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 33.7 m -79.51 112.91 32.6 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.595 ' HG2' ' HE2' ' A' ' 908' ' ' PHE . 5.8 Cg_exo -79.63 143.56 16.96 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.456 2.771 . . . . 0.0 112.346 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -159.01 137.22 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 7.2 m-20 58.95 33.8 23.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.246 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 941' ' ' PHE . 29.4 m -94.15 -32.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.209 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 37.4 m -149.82 59.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.205 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 74.2 mmtt -58.07 152.47 16.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.995 0.426 . . . . 0.0 111.762 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 981' ' ' GLN . 20.8 tpp180 -53.33 116.53 2.48 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.721 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 63.6 tttt -56.26 147.57 20.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 78.7 p -144.61 139.71 28.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 964' ' ' LYS . 37.4 m -81.56 36.18 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.563 ' NZ ' ' HB3' ' A' ' 964' ' ' LYS . 6.3 ttpm? 56.22 134.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.727 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.4 m -60.31 124.15 76.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.331 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.568 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 59.5 Cg_endo -71.48 130.43 17.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.469 2.112 . . . . 0.0 112.565 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 24.9 Cg_exo -62.67 135.04 50.41 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.445 2.097 . . . . 0.0 111.61 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.03 115.13 10.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.655 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 138.92 66.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.712 2.275 . . . . 0.0 112.388 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.3 t -53.86 134.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.411 ' N ' HD22 ' A' ' 971' ' ' ASN . 2.4 m120 56.98 42.56 26.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.873 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -160.28 -155.75 7.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.518 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 35.7 ttp 174.22 131.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.985 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -101.4 128.98 53.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.814 0.34 . . . . 0.0 111.459 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.549 ' O ' HG13 ' A' ' 977' ' ' ILE . 28.3 m-70 -87.85 114.34 24.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 980' ' ' ILE . 69.9 t -62.13 -33.67 59.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.018 0.437 . . . . 0.0 109.859 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 975' ' ' HIS . 15.0 mt 71.39 -48.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.285 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 977' ' ' ILE . 74.6 p -146.12 -60.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.859 0.362 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.6 m-20 -152.47 -161.88 1.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.862 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 976' ' ' VAL . 10.0 pt -146.78 19.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.531 . . . . 0.0 110.492 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' A' 1004 ' ' CYS . 6.7 mm100 -80.82 -178.17 6.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.643 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 935' ' ' GLU . 30.0 m -64.9 25.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -157.19 44.16 0.51 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.754 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.4 p -160.54 132.97 6.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.283 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 16.9 ptp180 -100.97 131.06 47.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.044 0.449 . . . . 0.0 111.446 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 23.7 pt -99.35 131.77 46.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.778 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.463 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -95.72 133.43 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.0 111.392 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.495 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 5.9 m-85 -98.95 137.86 36.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 55.7 m -153.5 115.01 4.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 74.1 m -75.55 150.93 38.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.809 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 23.8 m -64.07 143.57 57.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.7 t -37.8 139.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.941 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.24 -40.87 2.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.548 ' HA ' ' O ' ' A' 1021 ' ' GLN . 3.0 m80 -99.37 137.95 37.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.046 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.552 ' HE ' HG12 ' A' 1023 ' ' ILE . 14.2 ptp180 -97.36 147.22 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.533 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 9.8 tt -69.28 129.52 40.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.796 HD11 ' HG2' ' A' 1021 ' ' GLN . 31.7 mm -102.15 80.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 154.93 -131.13 3.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.697 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.435 ' O ' HD22 ' A' ' 996' ' ' LEU . 29.2 m80 -81.48 -116.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.515 0.197 . . . . 0.0 111.454 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 46.9 t -178.61 -30.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.955 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 52.6 m -155.58 148.88 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.88 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.601 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -153.36 133.04 13.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.636 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -100.2 136.9 39.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 13.0 t -71.14 124.22 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.25 -149.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.927 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' 1010 ' ' THR . 66.2 tp -150.89 139.61 20.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.248 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.552 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 97.6 p -88.62 -52.22 5.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.553 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 158.7 31.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.649 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' 1008 ' ' GLY . 25.4 t-20 176.14 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.418 ' O ' HD12 ' A' 1006 ' ' LEU . 56.9 m -139.27 134.93 33.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.281 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.25 140.34 36.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.552 ' NE2' ' HB3' ' A' 1007 ' ' SER . 9.9 p80 -158.37 146.19 18.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 78.2 m95 -64.38 146.47 54.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.934 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.6 t -49.91 -34.28 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.723 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.8 p -144.74 139.39 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.056 0.455 . . . . 0.0 111.821 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.597 ' HD2' ' N ' ' A' 1017 ' ' PRO . 3.8 tmmm? -62.88 136.21 96.39 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.345 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.597 ' N ' ' HD2' ' A' 1016 ' ' LYS . 10.4 Cg_endo -54.08 124.87 17.03 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.786 2.324 . . . . 0.0 112.801 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.737 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 44.4 Cg_endo -67.3 -150.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.799 2.332 . . . . 0.0 112.65 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -133.18 -158.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.839 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.695 ' H ' HG22 ' A' 1019 ' ' ILE . 78.6 m -159.54 135.97 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.566 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.796 ' HG2' HD11 ' A' ' 997' ' ' ILE . 3.6 pt20 -151.31 141.89 22.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.521 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' 1022 ' ' ARG . 27.5 ptt85 -64.01 22.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.574 ' H ' ' C ' ' A' 1021 ' ' GLN . 58.0 mt 64.61 132.08 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 52.5 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.836 2.357 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.998 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.89 0.376 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.508 ' C ' HD22 ' A' ' 949' ' ' LEU . 45.7 m80 -148.99 140.05 23.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 86.5 m -81.6 131.61 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.701 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -54.6 158.73 2.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 111.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 919' ' ' ALA . . . -48.27 123.32 10.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.846 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.506 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 34.3 Cg_exo -59.17 136.83 75.34 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 122.669 2.246 . . . . 0.0 112.94 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.2 143.79 57.48 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.93 131.92 39.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 911' ' ' ALA . 2.0 m-85 -85.29 150.14 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.987 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -81.17 -57.07 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.047 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.8 OUTLIER -85.47 10.77 11.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -152.14 151.62 31.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.49 136.3 39.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.526 HD11 ' HG ' ' A' ' 928' ' ' LEU . 57.5 tp -45.77 130.58 9.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.593 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 930' ' ' TYR . 11.7 tmtt? -94.59 -51.19 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 52.9 m -66.52 136.58 55.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.616 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -64.76 138.54 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.828 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.627 HG21 HD11 ' A' ' 928' ' ' LEU . 81.0 p -154.25 -170.2 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 40.1 p -156.15 34.28 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.644 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 904' ' ' ALA . . . 41.05 -146.0 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.799 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t 62.39 44.52 7.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 902' ' ' CYS . 1.5 m-20 66.61 153.54 0.08 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.503 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 919' ' ' ALA . 63.6 m-85 -136.4 145.97 53.97 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.209 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 138.24 83.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.729 2.286 . . . . 0.0 111.896 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.623 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.4 mt -58.96 155.73 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.47 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 85.42 -32.36 3.63 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.674 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 40.9 m -55.97 126.29 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 47.3 t -96.36 127.87 42.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.781 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.627 HD11 HG21 ' A' ' 917' ' ' THR . 8.6 tp -105.47 120.52 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 0.0 110.903 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 915' ' ' THR . 40.2 ttmt -85.68 140.98 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.561 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 6.3 m-85 -129.15 168.48 16.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 914' ' ' LYS . 16.6 pt-20 -144.47 137.38 26.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.926 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.69 143.26 37.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.02 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.0 mtp180 -85.52 158.69 56.94 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 7.6 Cg_endo -49.64 139.74 30.34 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.579 2.186 . . . . 0.0 111.745 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 50.5 mt-10 81.38 25.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.334 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 88.2 m-85 -146.87 135.66 22.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.796 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.8 p90 -102.34 137.47 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.885 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 157.62 146.06 4.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.877 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.519 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 77.2 mtp180 -72.82 162.72 72.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.662 0.268 . . . . 0.0 110.82 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 73.5 Cg_endo -78.75 114.66 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.384 2.056 . . . . 0.0 112.278 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 48.2 p90 -91.68 -160.17 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.5 p -175.28 132.92 0.3 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' A' ' 954' ' ' PRO . 11.0 pt -93.99 -166.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.188 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.491 ' O ' HD22 ' A' ' 946' ' ' LEU . 26.5 m -166.61 132.6 2.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.5 t -73.79 120.47 19.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 950' ' ' VAL . 1.8 mm? -87.02 174.22 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.219 1.009 . . . . 0.0 112.803 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.05 -42.69 73.01 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.135 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 950' ' ' VAL . 48.7 t30 -84.51 35.09 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.998 HD21 ' HB1' ' A' ' 900' ' ' ALA . 83.0 mt 46.42 59.66 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.815 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -138.48 -157.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.117 0.484 . . . . 0.0 111.393 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.506 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 94.3 m95 -149.13 115.98 5.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.731 ' N ' HD21 ' A' ' 946' ' ' LEU . 72.4 m -52.12 147.51 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.4 t -78.16 122.97 86.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.578 ' HG3' HG22 ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.09 26.77 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.866 2.377 . . . . 0.0 112.831 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.635 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 7.2 mtmp? 39.82 -143.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.01 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.594 ' OD1' ' HE2' ' A' ' 959' ' ' LYS . 60.3 t0 -79.5 134.26 36.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -150.68 -98.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.719 ' H ' HG23 ' A' ' 957' ' ' VAL . 63.7 m -77.13 147.36 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.014 0.435 . . . . 0.0 111.374 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.594 ' HE2' ' OD1' ' A' ' 956' ' ' ASP . 68.5 mttm -144.93 157.15 44.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.172 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.832 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -59.95 114.98 3.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.851 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' 1011 ' ' ALA . 24.6 ttmm -56.23 150.34 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.663 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 82.8 p -144.51 141.02 29.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.985 0.421 . . . . 0.0 111.38 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 82.0 m -79.9 151.6 30.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.156 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.48 131.06 45.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 29.4 m -55.77 122.94 49.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.462 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.9 Cg_endo -69.58 134.71 29.05 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.428 2.085 . . . . 0.0 111.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.84 124.49 15.99 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.047 1.831 . . . . 0.0 111.433 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -58.29 122.86 62.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.788 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.65 138.4 83.09 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.064 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' 1020 ' ' CYS . 21.7 t -52.79 130.47 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.678 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 70.36 36.78 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.888 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -172.48 -153.16 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.055 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 177.41 145.44 0.11 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 110.636 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 7.7 p -93.81 120.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -78.87 112.97 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.62 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.99 -18.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.189 0.519 . . . . 0.0 109.748 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 8.9 mt 74.07 -44.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.953 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.3 p -146.77 -54.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.622 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 45.1 m-20 -159.18 -144.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.505 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 7.0 pt -151.09 31.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.156 0.503 . . . . 0.0 110.944 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.832 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 3.2 mm100 -76.87 156.01 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.504 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' 1005 ' ' ILE . 94.5 t -55.44 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 159.0 -37.99 0.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.278 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.9 p -76.58 139.1 40.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 111.626 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.769 ' HG2' ' HB2' ' A' 1003 ' ' GLU . 87.2 mtm180 -90.64 159.08 16.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.999 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.9 pt -132.72 123.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.9 p -103.85 138.68 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.457 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.482 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.2 m-85 -100.79 138.57 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.266 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 81.9 p -153.48 131.41 11.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 71.5 m -74.17 126.04 29.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.603 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.888 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 6.0 t -76.58 55.1 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.468 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 991' ' ' THR . 99.9 m -177.64 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 992' ' ' THR . . . -168.66 39.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.499 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.743 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 3.0 m80 -93.65 159.73 15.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.641 ' HB3' HG12 ' A' 1023 ' ' ILE . 37.3 ptt180 -89.87 135.56 33.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.1 tm? -71.98 132.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 3.3 mt -118.29 135.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.387 . . . . 0.0 111.487 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.17 -125.57 8.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.423 ' CD2' ' HB ' ' A' 1015 ' ' THR . 95.8 m-70 -79.3 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.8 p -174.58 -37.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.9 p -150.85 151.71 32.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.537 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -151.92 133.17 14.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.087 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.769 ' HB2' ' HG2' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.36 136.62 36.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.208 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 35.5 t -71.25 121.8 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.639 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.5 pt -133.46 -153.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.411 . . . . 0.0 111.934 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' 1010 ' ' THR . 57.7 tp -150.85 136.11 17.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.038 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.604 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.9 t -89.41 -40.88 12.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.713 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.55 -37.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.035 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.401 ' C ' HD11 ' A' 1006 ' ' LEU . 5.5 m120 -140.92 -48.03 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.063 0.458 . . . . 0.0 110.5 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.456 ' O ' HD12 ' A' 1006 ' ' LEU . 57.8 m -94.53 135.76 35.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.227 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.583 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -80.78 145.64 31.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.604 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.5 p80 -157.66 144.06 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.371 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 70.7 m95 -66.0 147.05 53.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.4 t -55.81 -35.11 65.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.594 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -143.12 143.78 31.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.462 . . . . 0.0 111.726 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -56.83 137.59 78.71 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.907 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 53.1 Cg_exo -52.9 129.89 35.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.379 2.053 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1017 ' ' PRO . 38.3 Cg_exo -61.44 -158.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 112.683 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.2 mt -142.86 139.37 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.945 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 42.8 t -94.43 129.02 41.34 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 995' ' ' ARG . 2.5 tp-100 -145.74 128.62 16.38 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.664 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -54.39 133.29 45.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.35 0.595 . . . . 0.0 111.311 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 995' ' ' ARG . 57.5 mt -74.83 122.8 88.29 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.2 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.866 2.378 . . . . 0.0 112.347 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.113 0.483 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.603 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 41.3 m80 -150.91 136.76 18.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.002 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.41 125.35 29.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.291 0.567 . . . . 0.0 111.213 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -57.7 168.83 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.607 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.5 133.51 13.37 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.567 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.42 145.97 78.84 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.55 2.167 . . . . 0.0 111.729 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.74 148.65 42.2 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.39 0.614 . . . . 0.0 111.332 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -81.19 115.02 20.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.027 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 9.5 m-85 -89.93 134.39 34.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.762 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 76.7 mt -76.96 -54.4 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 2.1 p90 -84.59 25.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.201 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.17 120.76 4.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.514 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -103.48 121.14 42.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.485 HD13 ' CE1' ' A' ' 930' ' ' TYR . 29.8 tp -49.25 122.05 5.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.004 0.43 . . . . 0.0 111.324 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.702 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 0.8 OUTLIER -90.94 -44.77 9.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.321 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 54.3 m -64.65 132.92 51.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.43 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.432 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.2 pm0 -65.12 143.64 57.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.267 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 80.7 p -150.22 -58.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.089 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 82.6 p 46.25 56.16 6.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.51 -152.43 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.0 111.491 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 60.1 m -146.58 -44.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.51 135.37 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.113 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 55.1 m-85 -137.69 141.37 32.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.939 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.491 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 70.0 Cg_endo -73.93 136.98 23.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.634 2.223 . . . . 0.0 111.647 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 947' ' ' ASP . 53.4 mt -52.6 151.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 91.31 -28.38 8.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.491 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 31.8 m -55.43 138.99 44.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.994 0.426 . . . . 0.0 111.553 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.7 m -118.0 142.5 47.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.76 120.49 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.519 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -89.83 133.38 34.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.567 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 2.9 m-85 -116.12 134.77 54.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.702 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 65.7 mm-40 -94.45 117.25 29.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.801 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 68.7 m -59.41 140.63 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.344 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.0 mtp180 -85.37 158.74 57.31 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 9.2 Cg_endo -52.71 149.47 24.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.519 2.146 . . . . 0.0 110.886 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 49.6 mt-10 83.5 19.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.72 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 960' ' ' ARG . 94.3 m-85 -144.95 125.11 13.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 5.1 p90 -95.96 141.4 29.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.46 147.39 5.46 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.087 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.27 159.03 86.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.83 126.11 16.04 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.585 2.19 . . . . 0.0 112.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 5.2 p90 -90.88 -162.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.712 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 941' ' ' PHE . 64.1 m -170.12 133.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.2 pt -95.76 168.94 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.277 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.419 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.4 m -162.6 135.26 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 52.8 m -73.8 126.83 31.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.6 mm? -85.19 -53.55 5.18 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.841 ' HA ' HD13 ' A' ' 924' ' ' ILE . 50.9 t0 171.73 -38.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.691 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.07 28.07 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 60.8 43.22 12.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.32 149.75 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.886 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -94.02 141.06 28.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.166 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.0 p -52.34 138.11 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.9 t -79.19 108.61 8.84 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.756 0.312 . . . . 0.0 111.196 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 952' ' ' SER . 6.4 Cg_exo -72.75 136.03 24.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.675 2.25 . . . . 0.0 111.497 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -158.99 143.37 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.373 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.49 36.72 16.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.572 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.8 m -92.4 -111.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.009 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.467 ' H ' HG23 ' A' ' 957' ' ' VAL . 51.0 m -86.82 87.29 7.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.78 ' HD2' ' H ' ' A' ' 959' ' ' LYS . 8.3 mptt -67.75 154.59 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 936' ' ' TYR . 37.7 ttm180 -54.54 136.52 44.73 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.85 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.514 ' HG2' ' HB2' ' A' 1011 ' ' ALA . 16.6 tppt? -53.78 152.32 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.508 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 70.9 p -143.95 124.08 13.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.775 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.508 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.1 p -83.54 37.95 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 53.4 tptt 60.09 138.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.386 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 9.2 m -57.47 131.86 81.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.137 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.709 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.2 Cg_endo -65.02 125.0 13.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.471 2.114 . . . . 0.0 112.462 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 17.3 Cg_exo -66.27 120.57 7.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.305 2.003 . . . . 0.0 111.498 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 973' ' ' MET . 1.5 m-20 -62.55 122.28 72.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 968' ' ' ASP . 37.4 Cg_exo -57.62 144.91 91.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 111.877 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.3 p -48.32 127.44 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.563 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.8 m-20 63.75 46.4 4.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.907 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.79 -154.07 9.02 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.513 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.447 ' HA ' ' HB3' ' A' ' 968' ' ' ASP . 24.8 ptt? 175.69 143.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.287 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 986' ' ' ILE . 13.5 p -93.79 127.18 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -89.55 110.53 21.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.377 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 34.8 m -71.99 134.62 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 978' ' ' THR . 47.6 mm -73.45 -38.74 53.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 110.503 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 977' ' ' ILE . 76.8 p -144.76 -42.61 0.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 54.3 t0 -160.72 -136.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.197 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.524 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 9.5 pt -151.07 1.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 110.981 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -75.62 164.5 26.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.558 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 53.4 t -50.1 133.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 102.67 -39.03 2.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.566 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 95.8 p -76.06 138.09 40.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -98.87 157.18 16.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.232 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 974' ' ' VAL . 47.8 pt -141.96 137.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 111.685 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 4.7 p -108.33 133.25 52.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.66 143.2 26.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.789 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.74 123.31 9.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 61.9 m -88.94 146.47 24.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -64.93 147.47 53.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.448 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 86.8 m -45.61 117.1 1.34 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.979 0.419 . . . . 0.0 111.192 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 141.49 -48.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.151 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -113.04 139.2 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.618 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.3 ptt180 -93.0 140.9 28.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.9 tt -72.01 126.1 28.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.215 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.988 ' HB ' HG23 ' A' 1019 ' ' ILE . 2.4 mp -102.93 130.92 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.344 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.54 -142.89 15.62 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.617 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.527 ' O ' ' HG3' ' A' 1018 ' ' PRO . 87.5 m-70 -84.03 132.19 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.574 0.226 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.4 t -81.32 -55.87 4.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.5 p -89.2 153.17 21.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.6 123.37 5.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.116 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -104.59 131.25 52.21 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 49.1 t -75.0 131.0 40.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.7 pt -135.8 -155.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.581 -0.447 . . . . 0.0 112.007 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' 1010 ' ' THR . 56.3 tp -150.39 131.9 14.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.564 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 26.3 t -90.08 -134.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.395 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -67.65 -49.77 47.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.643 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -152.11 27.56 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.449 ' C ' HD12 ' A' 1006 ' ' LEU . 6.6 m -149.73 130.99 14.58 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.489 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 961' ' ' LYS . . . -81.52 137.94 35.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.765 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.564 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.9 p80 -159.76 144.33 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.593 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.508 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 93.1 m95 -64.48 146.74 54.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.704 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.7 t -57.56 -31.5 66.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.6 p -144.35 138.77 28.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.583 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.547 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 1.6 pptp? -62.52 160.7 32.14 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 18.6 Cg_endo -59.57 129.03 29.2 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.499 2.133 . . . . 0.0 112.271 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.527 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 16.8 Cg_exo -67.22 -160.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.988 HG23 ' HB ' ' A' ' 997' ' ' ILE . 1.2 tt -144.55 121.3 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.217 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.9 m -78.92 132.91 36.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -146.68 130.93 17.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.406 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -44.29 132.8 5.72 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.524 0.678 . . . . 0.0 111.928 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 22.2 mt -76.07 130.44 78.04 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.303 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.482 2.122 . . . . 0.0 112.421 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.992 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.912 0.387 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 44.9 m170 -119.87 123.12 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.757 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 5.4 p -82.13 127.19 32.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.547 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.2 mm100 -58.34 169.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.12 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -45.86 135.68 6.39 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.554 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 3.0 Cg_exo -74.64 61.86 5.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.063 2.508 . . . . 0.0 111.909 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 48.4 t0 41.45 -143.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.55 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 70.9 t60 -161.78 116.7 1.98 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.726 0.298 . . . . 0.0 110.974 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.47 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 74.3 m-85 -85.93 135.26 33.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.076 0.465 . . . . 0.0 110.779 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.633 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 5.3 mp -74.97 -48.33 24.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.569 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.58 17.7 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.621 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.51 121.88 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 111.788 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 933' ' ' ARG . 59.7 pttt -102.7 128.87 49.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.21 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 928' ' ' LEU . 0.8 OUTLIER -48.61 125.34 9.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.607 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -94.47 -31.47 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.56 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 86.8 m -62.2 135.92 57.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 111.786 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.622 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.1 pm0 -78.34 61.25 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.672 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 918' ' ' THR . 3.4 t -80.62 -53.02 6.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 917' ' ' THR . 24.9 m 51.81 55.1 9.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.31 155.36 9.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 48.4 t -86.58 -44.83 11.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.21 138.96 32.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.524 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.467 ' HB2' ' SG ' ' A' ' 902' ' ' CYS . 17.0 m-85 -127.67 137.88 31.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.84 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 60.0 Cg_endo -72.13 131.97 18.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.484 2.123 . . . . 0.0 110.922 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.64 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.6 mt -57.1 149.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.926 0.393 . . . . 0.0 111.327 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 91.69 -34.37 4.39 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.663 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 15.8 m -57.19 129.9 43.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 942' ' ' SER . 47.6 t -87.89 151.74 22.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.541 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 913' ' ' LEU . 10.0 tp -140.85 102.18 4.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.51 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.775 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 17.8 ptpt -85.37 132.76 34.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.191 0.52 . . . . 0.0 111.99 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.564 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 2.0 m-85 -111.49 133.9 53.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.791 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 912' ' ' LYS . 23.4 pt-20 -95.57 126.47 40.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.3 m -57.87 148.59 24.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 76.9 mtt-85 -85.15 161.95 50.68 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 75.3 Cg_exo -45.64 139.96 9.68 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.234 1.956 . . . . 0.0 112.176 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 95.0 mt-10 82.49 23.43 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.507 ' N ' ' HG3' ' A' ' 961' ' ' LYS . 85.9 m-85 -146.81 145.41 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.558 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 16.1 p90 -144.07 140.84 29.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 110.942 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.36 21.89 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.651 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.621 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 79.5 mtp180 62.81 164.61 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.85 0.357 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 63.6 Cg_endo -77.65 115.42 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.146 1.897 . . . . 0.0 110.676 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 42.3 p90 -89.67 108.1 19.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.525 0.678 . . . . 0.0 112.068 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.775 ' HA ' ' HA ' ' A' ' 929' ' ' LYS . 80.3 p -77.21 125.64 29.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.844 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 928' ' ' LEU . 10.0 pt -94.92 -161.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 4.0 m -161.14 121.42 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -72.08 102.16 2.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.719 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 48.9 mt -80.89 161.37 24.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.568 0.699 . . . . 0.0 112.713 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' A' ' 924' ' ' ILE . 9.8 t70 -42.55 -38.4 1.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.005 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 950' ' ' VAL . 75.2 m-20 -83.08 36.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.992 HD11 ' HB1' ' A' ' 900' ' ' ALA . 8.2 mp 44.82 46.33 8.76 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.222 0.534 . . . . 0.0 110.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.719 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.4 m -123.61 -162.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.16 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.554 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 90.1 m95 -152.69 122.77 7.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.289 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.9 t -43.43 146.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.531 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 38.9 t -79.39 117.55 67.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.599 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 908' ' ' PHE . 4.0 Cg_exo -76.8 60.93 6.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.55 2.833 . . . . 0.0 111.794 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -77.1 131.77 38.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.017 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 54.99 81.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.545 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 12.7 m -150.9 -21.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.834 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 12.1 t -151.45 133.37 15.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -143.26 146.86 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.181 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.805 ' HD3' ' HB3' ' A' ' 981' ' ' GLN . 29.9 ttt85 -53.2 143.53 17.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.057 0.456 . . . . 0.0 111.655 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 28.1 mtpp -56.29 152.34 11.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.563 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.605 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 96.3 p -141.61 121.13 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.564 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 4.4 p -81.67 153.68 26.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.596 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.33 132.35 48.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 34.4 m -56.57 134.3 77.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.928 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.788 ' HG2' HG11 ' A' ' 974' ' ' VAL . 9.2 Cg_endo -52.65 150.98 20.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.764 2.309 . . . . 0.0 111.992 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' 1017 ' ' PRO . 64.7 Cg_endo -73.14 45.5 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.678 2.252 . . . . 0.0 112.814 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 967' ' ' PRO . 1.5 m-20 18.02 109.73 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 124.074 0.859 . . . . 0.0 113.165 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.44 142.49 9.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.539 HG22 ' ND2' ' A' ' 971' ' ' ASN . 5.1 p -48.6 131.67 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.638 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 970' ' ' VAL . 74.2 m-20 75.43 -48.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.634 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -75.44 -152.62 3.61 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.097 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 1.8 pmm? 177.75 143.48 0.1 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.274 0.23 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.788 HG11 ' HG2' ' A' ' 966' ' ' PRO . 10.1 p -93.62 128.94 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.236 0.541 . . . . 0.0 111.201 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -104.46 118.1 35.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.403 HG11 HG23 ' A' ' 980' ' ' ILE . 28.2 m -70.95 141.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.925 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 985' ' ' ARG . 24.4 mm -74.92 -36.68 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.476 . . . . 0.0 110.295 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.2 p -144.69 -47.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.186 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 49.0 t0 -160.19 -137.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.559 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.479 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 7.6 pt -151.02 36.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.231 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' A' ' 960' ' ' ARG . 13.1 mm100 -76.5 166.69 23.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.715 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.32 29.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.3 -25.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.3 t -76.1 136.72 39.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.004 0.431 . . . . 0.0 111.256 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 69.0 ttt180 -89.65 158.72 17.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.602 HD12 HG21 ' A' ' 974' ' ' VAL . 47.4 pt -137.56 129.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.918 0.39 . . . . 0.0 111.025 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' 1001 ' ' SER . 2.3 p -105.22 139.58 39.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.02 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.3 m-85 -103.94 146.99 27.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.677 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -153.48 124.19 7.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.482 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 96.6 m -72.95 -119.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 993' ' ' GLY . 8.0 t -169.55 158.91 8.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.628 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 61.0 m -52.8 84.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 991' ' ' THR . . . 168.6 -42.22 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.47 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.432 ' HB3' ' N ' ' A' 1021 ' ' GLN . 7.8 m80 -126.13 142.25 51.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.653 ' O ' HD12 ' A' ' 997' ' ' ILE . 39.3 ptt180 -91.9 145.28 24.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.6 tt -72.73 135.42 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.571 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.874 ' HB ' HG23 ' A' 1019 ' ' ILE . 3.9 mp -126.49 139.42 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.94 -124.2 7.99 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.51 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -80.1 -136.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.4 p -176.76 -43.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.465 ' HB3' HG22 ' A' ' 987' ' ' THR . 69.2 p -155.22 141.58 18.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.516 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -149.49 143.48 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 112.025 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.6 tt0 -95.92 138.24 33.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 47.9 t -71.27 129.62 39.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.1 pt -139.39 146.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 961' ' ' LYS . 60.8 tp -89.16 137.28 32.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.589 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.664 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 98.8 p -88.97 -40.09 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.372 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -177.72 -36.03 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.415 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -145.29 -44.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.277 0.561 . . . . 0.0 109.707 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 94.2 m -94.5 131.89 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.53 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.64 138.8 34.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.01 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.664 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.8 p80 -155.66 142.61 19.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.083 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 70.7 m95 -66.46 146.35 54.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -51.32 -33.73 30.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.092 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -141.04 -152.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.557 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -126.8 149.75 69.55 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.4 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 966' ' ' PRO . 41.5 Cg_exo -57.46 135.65 71.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.838 2.359 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.457 ' HG2' HD11 ' A' ' 996' ' ' LEU . 27.0 Cg_exo -62.81 -159.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.728 2.286 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.874 HG23 ' HB ' ' A' ' 997' ' ' ILE . 3.8 tt -146.57 128.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.868 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 77.3 m -84.29 138.5 32.88 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 997' ' ' ILE . 7.8 tt0 -149.74 135.7 18.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.081 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' 1022 ' ' ARG . 42.4 ttp85 -48.63 130.39 17.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.512 0.673 . . . . 0.0 111.695 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 995' ' ' ARG . 71.2 mt -74.94 127.12 87.44 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.623 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.563 2.175 . . . . 0.0 112.219 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.849 0.357 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.572 ' N ' HD22 ' A' ' 949' ' ' LEU . 15.9 m80 67.21 144.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 84.7 m -79.78 122.63 26.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -65.65 163.99 15.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.78 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.92 125.33 4.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.663 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 16.6 Cg_exo -67.1 135.26 36.75 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.731 2.287 . . . . 0.0 112.509 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.77 152.24 43.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.107 0.48 . . . . 0.0 110.87 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -78.17 134.59 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.091 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 8.3 m-85 -90.07 1.25 56.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.8 mp 71.61 -63.35 0.43 Allowed 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.602 0.564 . . . . 0.0 111.388 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.477 ' HA ' ' CD ' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -85.35 25.66 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.83 120.86 5.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -103.71 138.77 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.476 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.751 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.1 tm? -46.47 150.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.751 ' H ' HD22 ' A' ' 913' ' ' LEU . 11.8 tmtt? -137.71 -46.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 913' ' ' LEU . 2.7 m -68.76 139.14 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.499 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.724 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -58.21 112.57 1.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 69.8 p -83.34 132.85 34.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 0.0 112.106 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.7 p -89.97 82.71 6.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.135 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 60.32 -152.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.9 p -86.59 -47.76 8.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -85.43 121.99 28.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.158 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 928' ' ' LEU . 77.7 m-85 -103.87 136.02 19.27 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 112.137 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.39 136.09 35.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 111.67 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.723 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 38.6 mt -56.69 143.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.065 0.46 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 101.87 -41.4 2.14 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.8 m -57.27 144.43 35.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.267 -0.466 . . . . 0.0 111.056 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 46.6 m -126.61 128.01 46.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.756 0.312 . . . . 0.0 111.235 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.3 mt -100.71 122.1 42.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.0 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.726 ' HG2' ' HB3' ' A' ' 942' ' ' SER . 52.0 mtmt -87.58 127.54 35.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.0 111.251 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 940' ' ' PRO . 4.8 m-85 -116.77 120.21 37.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.54 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.11 127.79 41.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.68 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 59.3 m -58.58 -174.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.531 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 43.5 mtp85 -84.42 159.68 58.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.323 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 936' ' ' TYR . 87.4 Cg_exo -45.83 -48.75 11.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.498 2.132 . . . . 0.0 112.466 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -74.44 28.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.304 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 12.4 m-85 -141.85 150.77 42.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 23.3 p90 -137.56 136.27 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.349 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.94 11.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 55.4 mtp85 61.41 151.98 0.1 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.348 0.594 . . . . 0.0 111.983 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 930' ' ' TYR . 13.4 Cg_exo -67.46 117.83 5.13 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.795 2.33 . . . . 0.0 111.246 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -90.35 115.37 27.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.392 0.615 . . . . 0.0 111.768 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.726 ' HB3' ' HG2' ' A' ' 929' ' ' LYS . 80.1 p -78.38 131.36 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.061 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -101.86 114.24 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 0.0 110.567 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 2.6 m -83.05 125.96 32.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.723 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 49.7 t -73.7 112.34 9.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 89.1 mt -81.45 -64.51 1.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -174.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 59.9 t0 173.84 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.947 0.403 . . . . 0.0 110.593 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.534 ' HB3' HG12 ' A' ' 950' ' ' VAL . 34.8 t30 -79.16 9.57 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 901' ' ' HIS . 45.9 mt 69.25 40.42 1.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.44 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 948' ' ' ASN . 3.3 p -137.52 154.94 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.607 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.863 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 29.1 m95 -89.76 145.25 25.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.313 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 79.5 p -47.2 144.94 2.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 66.1 m -77.71 108.65 7.66 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.459 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 952' ' ' SER . 15.4 Cg_exo -66.65 142.88 65.97 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.643 2.229 . . . . 0.0 111.339 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.37 129.33 8.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.147 0.499 . . . . 0.0 111.832 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 55.4 t0 51.75 33.65 11.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.431 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.647 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -91.99 -59.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.647 ' H ' HG23 ' A' ' 957' ' ' VAL . 5.9 t -89.31 141.48 28.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 40.1 mtmt -152.37 133.75 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.44 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.885 ' HE ' ' HB3' ' A' ' 981' ' ' GLN . 0.3 OUTLIER -65.88 128.52 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.02 0.438 . . . . 0.0 110.915 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.671 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.2 ttmp? -56.21 161.99 2.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.514 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 73.3 p -149.79 147.81 28.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.472 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.2 m -80.11 147.91 31.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.938 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 965' ' ' THR . 6.3 tmtm? -65.96 131.06 45.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.635 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 25.1 m -52.98 124.24 36.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.002 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.2 Cg_endo -68.87 133.66 27.82 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.64 2.227 . . . . 0.0 112.611 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 38.0 Cg_exo -59.94 137.55 76.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.351 2.034 . . . . 0.0 111.313 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.71 113.83 7.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.12 151.51 85.02 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.795 2.33 . . . . 0.0 111.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.6 p -49.6 127.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 49.24 46.09 23.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.84 137.97 4.59 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.45 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -127.95 142.74 51.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 966' ' ' PRO . 12.6 p -94.23 121.44 44.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.753 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.9 OUTLIER -88.66 128.13 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.51 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 979' ' ' ASP . 95.3 t -83.95 123.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.9 -40.49 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.707 0.289 . . . . 0.0 111.154 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 78.6 p -144.68 -50.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.402 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.543 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 37.1 m-20 -158.26 -152.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.994 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.458 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 14.8 pt -149.9 23.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.885 ' HB3' ' HE ' ' A' ' 960' ' ' ARG . 15.1 mp0 -77.01 154.08 33.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.675 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' 1005 ' ' ILE . 66.6 t -50.85 85.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 111.301 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.98 -41.47 0.29 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 77.2 p -75.38 -168.83 0.87 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 111.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.489 HH21 ' HB2' ' A' 1001 ' ' SER . 79.2 ttt180 -151.31 131.35 13.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.089 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.575 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 31.2 pt -98.07 142.57 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.539 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.7 p -116.96 135.12 53.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.138 0.494 . . . . 0.0 111.723 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.472 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 1.8 m-85 -103.12 148.66 25.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 47.5 t -148.74 120.05 7.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.095 0.474 . . . . 0.0 110.974 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 71.4 m -83.02 151.55 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.0 p -64.6 149.11 49.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -49.4 92.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 158.51 -46.94 0.44 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.275 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -99.96 148.25 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.596 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.442 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -91.55 148.4 22.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.548 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.496 ' C ' HD13 ' A' ' 996' ' ' LEU . 3.4 tm? -65.2 130.19 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.071 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' 1021 ' ' GLN . 34.6 mm -100.13 73.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.757 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 156.62 -149.62 20.52 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.126 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.603 ' ND1' HG21 ' A' 1015 ' ' THR . 34.5 m170 -85.91 -9.51 56.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.614 0.245 . . . . 0.0 111.173 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m 71.8 -5.44 1.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.458 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.489 ' HB2' HH21 ' A' ' 985' ' ' ARG . 57.5 m -156.02 149.55 24.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.435 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -154.58 133.15 12.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.6 tt0 -96.07 132.54 41.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 38.2 t -71.19 121.36 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.595 ' HA ' HG13 ' A' ' 982' ' ' VAL . 35.8 pt -135.52 -151.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 111.617 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.503 HD23 ' C ' ' A' 1006 ' ' LEU . 8.7 tt -155.87 139.77 16.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.498 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -87.51 -57.72 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 169.05 35.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.239 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' 1008 ' ' GLY . 0.7 OUTLIER 176.65 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.39 0.614 . . . . 0.0 109.988 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -143.96 143.64 31.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.89 143.87 35.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.0 p80 -157.72 148.83 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.806 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.469 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.1 m95 -64.38 140.18 58.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -54.26 -30.48 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.811 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' ND1' ' A' ' 999' ' ' HIS . 63.0 p -140.82 143.31 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 111.712 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 58.0 mtpt -51.26 146.09 12.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 28.0 Cg_exo -61.92 118.8 5.7 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.446 2.097 . . . . 0.0 111.856 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.472 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 35.7 Cg_endo -65.99 145.89 80.92 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.544 2.162 . . . . 0.0 112.569 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.71 -149.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.247 0.546 . . . . 0.0 110.846 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' 1019 ' ' ILE . 74.7 m -154.76 138.75 16.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.188 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 997' ' ' ILE . 3.8 tt0 -147.13 129.57 15.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.902 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -48.56 130.1 16.79 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.449 0.642 . . . . 0.0 111.466 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.442 HG12 ' HB3' ' A' ' 995' ' ' ARG . 73.8 mt -75.26 128.45 84.53 Favored Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.154 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.776 2.317 . . . . 0.0 112.303 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.794 0.33 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 11.0 m80 69.8 134.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 10.9 p -80.79 119.16 23.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.818 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.415 ' HB2' HE21 ' A' ' 903' ' ' GLN . 1.2 pt20 -72.53 -176.81 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.402 . . . . 0.0 111.042 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 922' ' ' PHE . . . -49.02 127.03 14.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.329 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.518 ' HG3' HD22 ' A' ' 928' ' ' LEU . 64.7 Cg_endo -73.33 70.16 3.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.809 2.34 . . . . 0.0 112.162 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.2 t0 35.21 -132.06 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.494 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.447 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 4.7 m170 -156.97 121.82 4.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.661 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.94 139.52 30.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.714 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.6 OUTLIER -102.14 -45.63 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.562 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.422 ' C ' ' HG3' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -80.62 9.66 5.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.969 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.31 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.478 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.62 133.86 40.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.593 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.702 HD21 HG23 ' A' ' 917' ' ' THR . 65.0 tp -47.07 161.0 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.686 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.447 ' N ' ' HG ' ' A' ' 913' ' ' LEU . 31.0 mmmt -144.33 -52.29 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 928' ' ' LEU . 4.3 m -68.78 137.09 53.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -62.35 123.35 18.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 913' ' ' LEU . 49.7 p -83.42 136.06 34.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.029 0.443 . . . . 0.0 111.989 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 70.8 p -90.1 79.5 6.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.547 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 64.57 -154.54 0.3 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.082 0.468 . . . . 0.0 111.96 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.6 p -85.79 -46.07 11.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.38 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.3 120.88 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 54.7 m-85 -102.31 135.47 19.59 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.54 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 74.3 Cg_endo -74.26 133.2 17.44 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.739 2.293 . . . . 0.0 111.446 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 947' ' ' ASP . 50.5 mt -56.89 144.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.933 0.397 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' ' 945' ' ' CYS . . . 101.6 -35.19 5.08 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.54 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 24.0 m -56.17 128.59 36.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.442 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 79.3 p -101.47 123.84 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.518 HD22 ' HG3' ' A' ' 905' ' ' PRO . 8.1 tp -102.74 119.85 39.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.99 140.85 29.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.188 0.518 . . . . 0.0 112.07 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.44 ' CE1' HD23 ' A' ' 928' ' ' LEU . 26.7 m-85 -133.95 133.51 41.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 931' ' ' GLU . 14.9 pt-20 -92.84 121.73 34.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.995 0.426 . . . . 0.0 111.279 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.76 153.86 19.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 78.5 mtp180 -81.35 145.37 55.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.604 0.24 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 936' ' ' TYR . 70.9 Cg_exo -49.23 -42.74 39.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.346 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.88 24.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 24.3 m-85 -142.04 139.81 32.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.95 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.501 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 7.9 p90 -93.26 134.7 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.412 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 133.9 148.44 5.83 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.701 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.0 ptp180 -72.52 166.24 43.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.478 0.18 . . . . 0.0 110.543 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 42.2 Cg_endo -68.38 122.85 9.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.327 2.018 . . . . 0.0 112.112 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.573 ' CD2' ' HB ' ' A' ' 957' ' ' VAL . 48.8 p90 -91.29 -165.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.9 p -175.29 137.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -91.27 176.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.2 m -161.37 127.54 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 62.2 m -71.64 117.26 12.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 85.7 mt -87.55 -53.53 4.75 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.657 ' HA ' HD13 ' A' ' 924' ' ' ILE . 53.8 t0 171.06 -39.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.221 0.326 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -83.54 34.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.48 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.7 mp 50.77 47.39 24.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.345 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.0 148.54 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 111.087 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 94.2 m95 -89.65 46.66 1.39 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.76 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 953' ' ' SER . 37.8 t 49.03 29.73 2.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.2 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 952' ' ' SER . 19.8 m 34.58 100.44 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.611 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 133.98 54.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.371 2.047 . . . . 0.0 112.797 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -159.1 135.94 9.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 60.6 t0 56.54 67.09 1.04 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 19.6 m -147.75 68.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.513 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 957' ' ' VAL . 80.8 m 77.28 144.54 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.322 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 95.0 mttt -142.17 166.9 23.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -53.29 119.07 4.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 -179.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 39.8 tptt -56.22 148.69 17.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.805 ' HB3' HE21 ' A' ' 981' ' ' GLN . 54.6 p -149.44 125.04 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.95 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.428 ' O ' HD12 ' A' ' 980' ' ' ILE . 2.1 p -82.23 141.07 33.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.851 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.78 137.42 57.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.079 0.466 . . . . 0.0 111.141 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.4 m -53.69 126.61 49.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.647 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.626 ' HG2' HG11 ' A' ' 974' ' ' VAL . 28.9 Cg_endo -62.78 125.79 16.77 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.335 2.023 . . . . 0.0 111.878 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.24 134.47 60.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.209 1.939 . . . . 0.0 111.425 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -56.34 117.13 14.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.749 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 970' ' ' VAL . 22.3 Cg_exo -65.28 -146.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.873 2.382 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.87 ' HB ' ' HB2' ' A' 1020 ' ' CYS . 2.5 t -57.75 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.148 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.591 ' H ' HG12 ' A' ' 970' ' ' VAL . 76.1 m-20 -72.33 68.53 0.76 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.506 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.408 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -164.96 -160.2 12.12 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.716 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 179.84 144.12 0.17 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.973 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.673 HG21 HD12 ' A' ' 986' ' ' ILE . 9.9 p -94.32 138.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.15 0.5 . . . . 0.0 111.309 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -120.14 117.92 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.909 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.8 t -70.14 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 31.3 mm -75.13 -43.24 44.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 77.6 p -147.03 -53.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.649 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.638 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 48.5 m-20 -157.57 151.01 23.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.102 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.46 HG22 ' HH2' ' A' 1013 ' ' TRP . 18.7 pt -88.34 32.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.781 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.805 HE21 ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -78.4 142.11 37.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.061 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' 1005 ' ' ILE . 80.1 t -50.39 104.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.937 0.398 . . . . 0.0 111.32 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 151.5 -51.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.431 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' 1003 ' ' GLU . 80.5 p -76.27 -152.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 0.0 111.046 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -151.4 178.37 9.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.235 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 974' ' ' VAL . 26.9 pt -142.0 129.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.524 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -98.26 138.57 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.587 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.572 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 8.8 m-85 -105.79 151.23 24.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.69 114.18 5.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 111.275 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 75.0 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 971' ' ' ASN . 6.2 t -64.52 146.71 54.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.718 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.3 m -44.26 130.32 6.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.428 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.14 -49.81 0.89 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -102.02 139.67 37.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.683 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.756 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.8 ptt85 -91.45 140.28 29.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.344 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.9 tt -71.79 130.44 41.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.9 mp -100.34 133.64 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.73 -155.41 25.66 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.454 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.676 ' O ' ' HG3' ' A' 1018 ' ' PRO . 14.6 m170 -82.98 125.29 31.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.522 0.201 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 43.8 t -73.6 12.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.0 p -156.82 150.74 24.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.407 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -152.03 135.87 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 984' ' ' SER . 38.4 tt0 -95.15 128.92 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.434 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 44.8 t -71.28 122.87 21.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.504 ' HA ' HG13 ' A' ' 982' ' ' VAL . 32.4 pt -133.64 -151.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.728 ' HG ' ' H ' ' A' 1008 ' ' GLY . 19.4 tp -151.11 131.38 13.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.395 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.671 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 37.7 t -93.01 31.69 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.728 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 77.22 -48.74 2.84 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.701 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.52 -44.94 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.789 0.328 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.581 ' C ' HD12 ' A' 1006 ' ' LEU . 88.7 m -146.63 148.07 31.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.427 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.4 139.35 38.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.97 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.671 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.8 p80 -158.11 154.17 27.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.46 ' HH2' HG22 ' A' ' 980' ' ' ILE . 75.9 m95 -64.21 145.58 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -59.57 -30.45 68.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.433 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.506 HG21 ' ND1' ' A' ' 999' ' ' HIS . 65.7 p -140.59 142.97 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.119 0.485 . . . . 0.0 112.089 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 5.8 ttpm? -55.1 139.35 64.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.755 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.11 128.46 22.44 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.524 2.149 . . . . 0.0 112.701 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.676 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 35.7 Cg_exo -57.36 147.02 79.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.019 2.479 . . . . 0.0 112.408 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 29.8 mt -103.0 132.89 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.722 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.87 ' HB2' ' HB ' ' A' ' 970' ' ' VAL . 71.4 m -86.37 123.17 31.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -143.81 130.59 20.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.472 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' 1022 ' ' ARG . 41.2 ttp85 -45.19 133.88 6.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 111.832 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.756 HG12 ' HB3' ' A' ' 995' ' ' ARG . 53.6 mt -74.94 129.01 84.13 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.908 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.73 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.941 0.4 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.461 ' C ' HD22 ' A' ' 949' ' ' LEU . 66.1 m80 -155.31 141.31 18.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 87.7 m -81.03 128.18 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.5 mm100 -68.12 171.6 6.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.183 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.06 132.38 3.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 943' ' ' ILE . 15.7 Cg_exo -68.75 63.19 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.17 2.58 . . . . 0.0 112.589 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 50.6 t0 33.95 -135.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 38.9 m80 -152.54 119.24 5.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.963 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 9.6 m-85 -85.29 136.81 33.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.158 0.504 . . . . 0.0 111.368 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.739 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 1.8 mm? -84.99 -51.65 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.2 OUTLIER -86.13 15.09 5.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.316 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -153.62 155.77 36.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.343 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.639 ' HE2' ' NE ' ' A' ' 933' ' ' ARG . 68.2 mttm -136.51 134.11 37.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -49.43 149.75 2.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.173 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.834 ' HG3' ' HG2' ' A' ' 931' ' ' GLU . 31.2 mmmt -143.22 -35.81 0.39 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 915' ' ' THR . 56.5 m -69.89 65.04 0.22 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 917' ' ' THR . 17.0 pt20 37.2 -148.43 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 916' ' ' GLN . 15.1 t 50.87 139.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 113.027 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 77.5 p -146.18 15.84 1.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.685 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -74.49 174.96 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t -89.74 -51.47 5.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.3 145.16 27.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 917' ' ' THR . 31.7 m-85 -136.25 136.72 22.98 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.414 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.407 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.4 Cg_endo -69.3 140.95 45.72 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.737 2.291 . . . . 0.0 111.867 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.675 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.0 mt -56.74 155.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.4 -40.79 3.08 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.407 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 46.9 m -56.37 137.66 52.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.511 -0.345 . . . . 0.0 111.119 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 78.6 p -131.35 134.82 46.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.656 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 913' ' ' LEU . 2.7 mm? -99.08 136.63 38.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.021 0.439 . . . . 0.0 111.786 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.642 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 4.4 tppp? -88.18 135.46 33.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.409 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 13.3 m-85 -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.373 . . . . 0.0 111.227 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.834 ' HG2' ' HG3' ' A' ' 914' ' ' LYS . 5.2 mm-40 -97.38 132.74 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.3 m -59.7 137.53 58.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.739 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.2 mtp180 -87.53 156.89 53.27 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 10.3 Cg_endo -51.24 139.47 44.04 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.539 2.159 . . . . 0.0 111.317 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.642 ' HB3' HG11 ' A' ' 982' ' ' VAL . 90.3 mt-10 83.34 27.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.888 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.585 ' C ' ' HE2' ' A' ' 961' ' ' LYS . 95.7 m-85 -148.23 129.28 14.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.74 ' HB3' ' HZ3' ' A' ' 961' ' ' LYS . 1.4 p90 -101.18 142.0 33.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.066 0.46 . . . . 0.0 111.334 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.56 -130.34 2.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.393 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.439 HH11 ' HG2' ' A' ' 939' ' ' ARG . 4.3 ptp85 -166.14 156.75 11.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.506 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 37.5 Cg_exo -59.99 108.62 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.447 2.098 . . . . 0.0 112.434 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.642 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 36.2 p90 -95.51 -168.72 1.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.525 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.04 127.48 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 905' ' ' PRO . 17.4 pt -97.63 120.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.107 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 946' ' ' LEU . 54.9 m -91.19 134.83 34.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.675 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -73.72 118.23 16.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 109.995 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.903 HD23 HG23 ' A' ' 950' ' ' VAL . 2.1 mm? -87.13 171.61 10.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.255 1.026 . . . . 0.0 113.242 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.72 -43.2 68.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.367 -1.742 . . . . 0.0 111.682 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -83.85 29.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.73 HD21 ' HB1' ' A' ' 900' ' ' ALA . 29.7 mt 48.12 63.13 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.697 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.903 HG23 HD23 ' A' ' 946' ' ' LEU . 9.4 m -135.81 -164.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.408 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 98.1 m95 -144.12 46.69 1.43 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.24 0.543 . . . . 0.0 111.487 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.427 ' H ' HD23 ' A' ' 946' ' ' LEU . 79.4 p 40.08 26.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.289 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 955' ' ' LYS . 45.5 t 35.34 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.002 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.46 137.64 31.91 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.356 2.037 . . . . 0.0 112.751 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 0.1 OUTLIER -159.09 134.87 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.272 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.9 t70 59.28 82.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.436 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -148.64 -107.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.863 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.625 ' H ' HG23 ' A' ' 957' ' ' VAL . 56.8 m -81.75 57.52 3.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 0.0 110.751 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.884 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.5 mmpt? -55.41 155.45 5.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.203 0.525 . . . . 0.0 112.142 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.592 ' CG ' ' HB3' ' A' ' 981' ' ' GLN . 19.6 tpp180 -55.11 116.45 2.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.249 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.931 ' HG3' ' H ' ' A' ' 962' ' ' SER . 15.0 tppt? -61.11 -176.12 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.929 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.931 ' H ' ' HG3' ' A' ' 961' ' ' LYS . 80.6 p -149.75 -155.96 0.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.147 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.689 ' HA ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -154.74 33.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.621 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 60.62 128.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 15.8 m -59.76 135.78 89.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.432 ' CG ' HG11 ' A' ' 974' ' ' VAL . 9.6 Cg_endo -50.94 136.49 44.01 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 112.121 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.2 Cg_endo -75.11 47.43 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.697 2.264 . . . . 0.0 112.773 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 967' ' ' PRO . 11.2 p-10 22.77 78.9 0.2 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.67 0.606 . . . . 0.0 112.121 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.46 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 98.2 Cg_exo -43.89 142.16 3.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.719 2.28 . . . . 0.0 112.449 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.411 HG22 ' ND2' ' A' ' 971' ' ' ASN . 2.7 p -48.86 127.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.633 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.411 ' ND2' HG22 ' A' ' 970' ' ' VAL . 74.2 m-20 47.65 48.72 16.99 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.065 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -133.14 -152.5 6.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.388 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.412 ' HB3' ' HE2' ' A' ' 973' ' ' MET . 42.4 ttp 176.19 141.87 0.07 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 987' ' ' THR . 10.5 p -136.98 127.85 40.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.972 0.415 . . . . 0.0 111.719 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -87.76 114.86 24.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.878 ' HA ' HG22 ' A' ' 986' ' ' ILE . 81.7 t -65.44 -24.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.138 0.494 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.568 HD11 HG22 ' A' ' 987' ' ' THR . 14.0 mm 74.46 -49.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.15 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 63.8 p -149.51 -60.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 984' ' ' SER . 11.7 p-10 -159.42 144.71 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.307 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.623 HG23 HG13 ' A' ' 976' ' ' VAL . 8.2 pt -85.99 19.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.252 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.592 ' HB3' ' CG ' ' A' ' 960' ' ' ARG . 83.7 mt-30 -80.87 156.48 26.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.788 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 935' ' ' GLU . 57.0 t -55.79 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.48 26.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.643 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 70.2 m -163.89 139.57 6.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.311 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ptt85 -100.12 131.22 46.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.132 0.491 . . . . 0.0 112.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 976' ' ' VAL . 40.9 pt -100.3 126.21 53.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.583 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.568 HG22 HD11 ' A' ' 977' ' ' ILE . 3.3 t -104.56 160.14 15.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.34 0.591 . . . . 0.0 111.583 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.478 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 3.6 m-85 -114.97 153.39 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.5 p -148.61 69.67 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.625 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 84.6 m -44.51 145.6 0.84 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 19.2 p -65.12 149.32 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 82.2 m -44.56 -37.49 3.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.928 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -57.26 -56.39 25.3 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.151 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.832 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 2.3 m80 -95.56 143.23 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.748 HH21 HG23 ' A' 1023 ' ' ILE . 14.3 ptp180 -88.83 138.72 31.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.982 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 997' ' ' ILE . 8.1 tt -71.85 138.07 47.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.312 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.616 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.9 mp -117.62 137.32 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.79 -143.39 18.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.019 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 996' ' ' LEU . 19.4 m170 -81.47 -134.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.633 0.254 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.529 ' HA ' ' HG2' ' A' 1018 ' ' PRO . 48.3 t -170.9 -54.66 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.84 0.352 . . . . 0.0 110.522 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.9 p -91.3 142.14 28.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.438 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -156.61 122.33 4.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.791 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.31 139.86 31.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 982' ' ' VAL . 15.2 t -69.52 122.83 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' 1006 ' ' LEU . 20.6 pt -139.48 142.29 33.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.91 HD13 ' N ' ' A' 1007 ' ' SER . 3.4 tm? 45.73 148.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.236 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.91 ' N ' HD13 ' A' 1006 ' ' LEU . 20.4 m -156.9 -95.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.561 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.73 ' H ' ' HE3' ' A' ' 961' ' ' LYS . . . 60.8 -109.78 2.6 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -66.89 -32.13 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.637 ' O ' ' HA ' ' A' 1007 ' ' SER . 17.6 m -148.94 119.91 7.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.609 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -86.88 138.48 31.52 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.646 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.3 OUTLIER -152.07 131.52 12.97 Favored 'General case' 0 C--N 1.337 0.057 0 C-N-CA 119.413 -0.915 . . . . 0.0 113.268 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 80.4 m95 -70.28 165.05 23.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.178 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.519 ' HA ' HD11 ' A' 1005 ' ' ILE . 88.8 p -63.19 -34.79 78.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.43 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 70.2 p -146.27 143.91 29.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.89 144.9 73.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.033 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 28.2 Cg_exo -62.19 127.13 20.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.716 2.277 . . . . 0.0 112.75 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.529 ' HG2' ' HA ' ' A' 1000 ' ' SER . 34.4 Cg_exo -61.52 150.39 85.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.466 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 51.0 mt -98.92 136.77 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.484 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 73.5 m -99.13 79.58 2.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 997' ' ' ILE . 41.9 tt0 -90.92 118.9 30.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.616 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 15.1 ptp180 -41.54 142.59 0.59 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.54 0.685 . . . . 0.0 111.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.748 HG23 HH21 ' A' ' 995' ' ' ARG . 70.7 mt -74.4 133.7 77.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.885 2.39 . . . . 0.0 112.489 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.887 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.729 0.299 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 921' ' ' ASP . 52.6 m80 -153.47 144.84 23.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.752 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 99.4 m -80.8 128.92 34.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.579 ' CD ' ' H ' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -68.99 157.13 37.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.648 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -43.19 131.44 3.38 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.041 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.4 -160.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 907' ' ' HIS . 4.2 t0 -173.6 151.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 906' ' ' ASP . 48.1 m80 70.11 68.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.369 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.485 ' CZ ' HD13 ' A' ' 943' ' ' ILE . 11.4 m-85 -139.91 43.63 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.582 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.532 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 15.7 mt -70.25 -32.29 70.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.281 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.21 10.67 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.618 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.52 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.669 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.3 120.88 33.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 915' ' ' THR . 1.3 tt -49.17 129.25 17.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.163 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.622 ' HB2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -86.48 -52.29 5.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.636 ' O ' HD22 ' A' ' 913' ' ' LEU . 47.6 m -64.59 138.34 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.253 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 916' ' ' GLN . 2.7 pp0? -61.94 141.56 57.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.899 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 70.5 p -151.67 149.33 28.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 93.8 m -154.04 -41.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 152.04 44.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.1 p -84.99 -44.41 13.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . 0.585 ' HB2' ' HB2' ' A' ' 901' ' ' HIS . 12.1 p-10 -85.36 132.33 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -118.68 138.89 26.39 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.407 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.469 ' O ' ' HB ' ' A' ' 926' ' ' THR . 25.4 Cg_endo -61.4 137.32 69.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.603 2.202 . . . . 0.0 112.062 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 20.8 mt -60.97 154.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.347 . . . . 0.0 110.846 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.68 -38.09 2.8 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 923' ' ' PRO . 19.9 m -56.0 131.82 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.02 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 49.7 m -111.3 130.52 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 942' ' ' SER . 94.5 mt -96.53 128.26 43.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 16.3 tppt? -85.16 137.59 32.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.031 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.505 ' CE2' ' HG ' ' A' ' 913' ' ' LEU . 20.5 m-85 -132.31 131.43 41.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.622 ' HG3' ' HB2' ' A' ' 914' ' ' LYS . 45.8 mt-10 -95.18 114.0 25.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.39 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 1.5 t -58.03 144.59 39.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 4.4 ptm180 -82.7 158.88 64.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.93 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 933' ' ' ARG . 39.5 Cg_endo -66.2 68.6 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.203 2.602 . . . . 0.0 113.484 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -172.41 -2.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.091 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.523 ' HB2' ' SG ' ' A' ' 932' ' ' CYS . 44.1 m-85 -142.04 134.91 28.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.264 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.651 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 9.4 p90 -102.1 138.61 38.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.562 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.31 8.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.168 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.434 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 71.1 mtt-85 63.62 157.5 0.12 Allowed Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 38.2 Cg_endo -66.68 116.62 4.19 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.2 1.934 . . . . 0.0 111.352 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.593 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 49.5 p90 -93.56 -160.82 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.197 0.522 . . . . 0.0 111.812 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.2 p -172.84 130.05 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.13 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.485 HD13 ' CZ ' ' A' ' 908' ' ' PHE . 39.6 pt -95.85 117.57 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.876 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 946' ' ' LEU . 52.0 m -84.04 128.96 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.3 t -73.81 121.6 21.12 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.1 mm? -85.34 167.92 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 0.0 113.318 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -51.73 -42.66 62.46 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.014 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.569 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.0 m-80 -84.45 32.46 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.707 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.887 HD21 ' HB1' ' A' ' 900' ' ' ALA . 24.4 mt 48.25 56.29 7.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.669 HG23 HD23 ' A' ' 946' ' ' LEU . 30.0 m -138.43 -157.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 112.38 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' A' ' 953' ' ' SER . 50.5 m95 -150.1 125.75 10.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.637 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.488 ' H ' HD21 ' A' ' 946' ' ' LEU . 79.8 p -68.54 27.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 951' ' ' TRP . 30.3 t 51.81 129.52 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 14.7 Cg_exo -69.95 69.83 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.086 2.524 . . . . 0.0 111.912 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -79.46 131.59 36.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.075 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 9.8 t70 55.1 72.66 0.46 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.512 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 18.1 m -150.9 -17.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.856 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 9.0 m -152.18 48.36 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.9 mmtp -56.55 143.81 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.495 ' HA ' ' CD2' ' A' ' 936' ' ' TYR . 38.8 ttm180 -53.23 132.33 38.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.655 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.651 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 0.0 OUTLIER -56.29 154.57 7.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.813 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 981' ' ' GLN . 80.3 p -149.8 136.27 19.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.847 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 66.7 m -81.65 36.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.0 tptt 61.08 133.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.565 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.629 ' HA ' HD12 ' A' ' 980' ' ' ILE . 21.6 m -54.48 127.73 58.87 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.257 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.405 ' HG3' HD13 ' A' ' 986' ' ' ILE . 55.1 Cg_endo -68.37 124.87 12.14 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.604 2.203 . . . . 0.0 112.736 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 129.2 16.83 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.189 1.926 . . . . 0.0 111.099 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 37.8 m-20 -57.95 120.68 44.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.878 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 33.2 Cg_exo -61.28 145.83 98.01 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 112.036 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 25.7 t -49.34 124.65 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.819 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.1 m-80 75.87 -48.65 0.6 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -78.44 -151.78 5.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.5 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.533 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.7 pmm? 177.21 142.81 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.69 0.281 . . . . 0.0 110.818 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.684 HG21 HD12 ' A' ' 986' ' ' ILE . 14.9 p -93.67 129.57 43.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.868 0.366 . . . . 0.0 110.676 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -91.52 121.73 33.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.81 104.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.435 HD11 ' OG1' ' A' ' 987' ' ' THR . 3.0 mt -74.38 -38.69 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 79.8 p -144.73 -58.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 984' ' ' SER . 2.8 p30 -159.91 140.97 12.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.143 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -86.67 -5.4 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.293 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.709 ' HG3' ' HB3' ' A' ' 962' ' ' SER . 14.0 mp0 -76.12 156.4 33.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.655 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.12 97.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.382 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.73 19.26 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.221 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' 1003 ' ' GLU . 26.2 t -165.12 -165.39 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.044 0.422 . . . . 0.0 111.34 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.527 ' HG3' ' C ' ' A' 1002 ' ' ALA . 55.6 ttp180 -147.79 136.74 22.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.684 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -97.83 138.08 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.435 ' OG1' HD11 ' A' ' 977' ' ' ILE . 7.6 p -106.23 129.92 54.19 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.691 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 13.3 m-85 -96.48 152.73 18.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.216 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 59.1 m -148.2 129.65 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.68 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.441 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.751 HG22 ' SG ' ' A' 1020 ' ' CYS . 8.8 t -171.01 149.42 2.93 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 993' ' ' GLY . 10.7 m 8.81 -118.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.12 0.887 . . . . 0.0 113.218 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1022 ' ' ARG . . . -77.03 48.93 2.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.612 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.594 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 6.7 m80 -137.21 134.76 36.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.339 . . . . 0.0 110.19 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.561 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.3 ptm180 -94.5 135.7 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' 1018 ' ' PRO . 7.0 tt -68.58 132.26 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.2 mp -100.11 138.49 24.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 85.61 -131.3 10.38 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.569 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.508 ' CD2' ' HB ' ' A' 1015 ' ' THR . 85.9 m-70 -79.07 -131.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.227 0.211 . . . . 0.0 111.484 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.4 p -175.16 -28.43 0.01 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.932 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.7 p -150.91 150.08 30.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.704 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.527 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.02 133.71 14.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 984' ' ' SER . 42.3 tt0 -96.23 133.42 40.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.403 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.7 t -71.18 121.04 17.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.84 -157.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.402 . . . . 0.0 111.767 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 58.7 tp -150.85 134.39 16.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.25 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.2 t -88.8 -48.13 7.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.369 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.98 -51.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.154 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -91.27 -38.36 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.42 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 83.8 m -145.47 145.49 31.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.47 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.11 147.82 32.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.9 p80 -158.7 148.59 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.425 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 86.2 m95 -64.41 145.15 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.767 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -53.0 -33.07 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.641 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.508 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 69.3 p -145.13 141.65 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.687 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.1 137.55 73.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 988' ' ' TYR . 51.1 Cg_exo -53.68 126.7 22.72 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.533 2.155 . . . . 0.0 112.319 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.629 ' HB2' HD21 ' A' ' 996' ' ' LEU . 39.9 Cg_endo -67.11 -159.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.41 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.768 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -140.67 -161.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.768 ' H ' HG22 ' A' 1019 ' ' ILE . 44.5 t -158.69 131.24 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 1.0 OUTLIER -153.44 135.24 14.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.66 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 51.1 ttp180 -48.97 134.89 16.48 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 111.532 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.7 mt -74.89 128.82 84.53 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.959 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 42.6 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.709 2.273 . . . . 0.0 112.358 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 949' ' ' LEU . 48.7 m80 -149.66 127.5 11.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.382 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 7.8 p -82.26 114.5 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 921' ' ' ASP . 2.6 pt20 -66.86 178.39 1.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -48.13 131.52 12.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.005 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.4 Cg_exo -62.1 -164.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.547 2.165 . . . . 0.0 112.325 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.12 -14.47 61.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.391 0.615 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 74.2 t60 62.26 114.42 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.582 ' HZ ' ' HG2' ' A' ' 954' ' ' PRO . 49.4 m-85 -90.0 133.56 34.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.254 0.55 . . . . 0.0 111.268 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.1 mp -70.43 -45.74 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.125 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.698 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 2.3 p90 -82.8 31.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.071 0.462 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.09 121.39 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.879 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -96.54 129.76 43.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -44.85 144.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 22.8 tptm -135.09 -38.93 0.77 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.459 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.575 ' O ' HD11 ' A' ' 913' ' ' LEU . 95.9 m -64.56 136.41 57.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.702 0.287 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.715 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -50.94 125.11 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.803 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.464 HG22 HD11 ' A' ' 913' ' ' LEU . 7.0 t -159.43 148.39 18.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 918' ' ' THR . 20.7 m -156.85 47.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.387 0.613 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -169.55 164.03 10.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.717 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 37.0 t -84.56 -39.47 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 903' ' ' GLN . 37.6 p-10 -85.01 118.81 24.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 17.0 m-85 -101.17 139.36 20.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.784 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.589 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 38.3 Cg_endo -66.42 139.17 53.16 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.732 2.288 . . . . 0.0 112.104 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.673 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 61.4 mt -61.3 151.91 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.31 -31.25 3.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.886 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.589 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 17.1 m -56.01 131.05 46.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.023 0.44 . . . . 0.0 111.982 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 942' ' ' SER . 74.8 p -90.96 116.66 28.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.672 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.638 HD23 ' OH ' ' A' ' 930' ' ' TYR . 11.7 tp -96.28 97.87 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 38.3 ttpt -82.52 131.03 35.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.31 0.576 . . . . 0.0 112.157 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.842 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 17.9 m-85 -113.78 139.17 49.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.473 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 5.0 mm-40 -91.41 118.42 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.73 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 75.3 m -57.67 143.2 42.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.6 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.698 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 94.5 mtt180 -84.89 160.78 54.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.092 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 5.9 Cg_endo -47.69 139.18 18.91 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.56 2.173 . . . . 0.0 112.096 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.551 ' HG2' HG11 ' A' ' 982' ' ' VAL . 90.0 mt-10 83.76 26.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.736 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.619 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 62.2 m-85 -145.75 148.19 32.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.302 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -137.56 -155.83 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.045 0.45 . . . . 0.0 111.839 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 78.69 33.16 38.84 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.713 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.6 ptp85 47.22 164.95 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.54 0.736 . . . . 0.0 112.962 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.713 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 70.9 Cg_endo -73.96 138.66 26.12 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.925 2.417 . . . . 0.0 112.808 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.893 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 43.6 p90 -95.4 120.82 36.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.371 0.605 . . . . 0.0 111.438 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 927' ' ' SER . 78.2 p -75.3 -37.33 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.762 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.506 ' O ' HG13 ' A' ' 943' ' ' ILE . 44.7 pt 49.23 104.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.393 0.616 . . . . 0.0 111.441 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 51.6 m -78.62 124.93 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.486 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 0.5 OUTLIER -73.74 130.77 40.67 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.085 0.469 . . . . 0.0 110.057 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.776 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -90.83 166.96 12.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.333 1.063 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 924' ' ' ILE . 9.4 t70 -50.23 -42.28 51.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.322 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.56 ' O ' HG13 ' A' ' 950' ' ' VAL . 16.4 p-10 -83.36 43.97 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.8 mp 44.68 53.52 7.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.089 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.776 HG23 HD23 ' A' ' 946' ' ' LEU . 26.3 m -133.91 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 111.115 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.57 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 84.9 m95 -150.95 125.74 9.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.0 t -41.58 152.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.7 t -77.19 118.54 72.64 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.582 ' HG2' ' HZ ' ' A' ' 908' ' ' PHE . 5.9 Cg_exo -79.51 58.24 6.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.468 2.779 . . . . 0.0 112.931 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -80.25 128.6 33.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.778 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 1.5 m-20 55.61 38.41 30.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.893 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 16.7 m -89.31 -35.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.908 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 48.4 t -152.92 60.77 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.5 mmtt -56.52 148.29 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.243 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 17.4 ttm105 -55.59 137.35 49.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 111.575 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.823 ' HD3' ' N ' ' A' ' 962' ' ' SER . 6.4 tmtt? -56.29 144.25 30.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.618 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.823 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 47.5 t -138.66 137.21 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.492 . . . . 0.0 111.099 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.21 148.45 32.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -65.49 139.01 58.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 111.301 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 60.3 m -58.32 135.95 85.12 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.194 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 974' ' ' VAL . 51.3 Cg_exo -53.31 146.68 39.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.422 2.081 . . . . 0.0 111.938 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 10.7 Cg_exo -72.22 46.31 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 0.0 112.687 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 8.4 t70 22.03 97.68 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.825 0.703 . . . . 0.0 112.476 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 968' ' ' ASP . 21.9 Cg_endo -60.43 145.25 99.05 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.491 2.128 . . . . 0.0 111.641 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 24.1 t -47.26 122.49 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' 1020 ' ' CYS . 73.0 m-80 75.48 -43.11 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.86 151.18 45.54 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.101 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 68.4 mtm -146.76 132.23 18.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.317 . . . . 0.0 110.586 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 986' ' ' ILE . 14.8 p -98.66 129.93 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.927 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 122.05 38.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.654 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.644 ' HA ' HG22 ' A' ' 986' ' ' ILE . 98.0 t -70.62 136.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.302 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 986' ' ' ILE . 37.1 mm -82.92 64.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.933 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 6.6 p 76.4 -43.9 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -157.5 135.43 10.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.699 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 976' ' ' VAL . 20.3 pt -88.96 26.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.591 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 85.0 mt-30 -76.61 146.34 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.551 HG11 ' HG2' ' A' ' 935' ' ' GLU . 69.9 t -50.12 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.144 0.497 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 166.99 -62.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 84.6 p -81.71 -150.07 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.985 0.422 . . . . 0.0 110.225 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' 1002 ' ' ALA . 5.0 ptp85 -151.38 -165.87 2.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.875 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.644 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.4 pt -147.7 131.6 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.25 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' 1001 ' ' SER . 1.3 p -97.8 134.35 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 111.555 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 974' ' ' VAL . 3.7 m-85 -103.03 143.94 31.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.262 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -154.37 127.01 8.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.454 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 15.6 t -63.6 162.35 13.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 992' ' ' THR . 4.2 t -64.83 -53.72 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 991' ' ' THR . 12.2 t 173.84 147.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' 1023 ' ' ILE . . . 84.79 -40.9 3.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.926 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.541 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.1 m80 -100.51 143.51 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.067 0.433 . . . . 0.0 111.194 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -91.89 148.82 21.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.95 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 999' ' ' HIS . 10.2 tt -71.82 128.81 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.61 122.43 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 131.32 -57.83 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.908 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.574 ' O ' HD22 ' A' ' 996' ' ' LEU . 40.3 t-80 -162.2 -121.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.8 p 177.31 -22.82 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.537 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 987' ' ' THR . 48.9 m -155.22 159.18 39.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.772 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -151.96 130.14 11.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -94.81 135.11 36.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.204 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 26.2 t -72.67 121.53 19.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.9 pt -134.55 141.93 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.506 HD22 ' H ' ' A' ' 935' ' ' GLU . 49.4 tp -84.52 130.44 34.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.032 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.582 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 42.3 t -96.09 50.38 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 82.19 -37.05 2.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.483 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -147.93 -50.67 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 62.4 m -94.16 125.14 38.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 961' ' ' LYS . . . -82.61 136.19 34.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.561 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.582 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.9 p80 -157.73 148.91 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 22.0 m95 -68.59 145.45 53.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 64.2 m -55.35 -42.96 74.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.268 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.502 HG21 ' CD2' ' A' ' 999' ' ' HIS . 80.9 p -100.15 -148.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.176 0.513 . . . . 0.0 112.114 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.573 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -148.66 153.39 39.47 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.563 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.78 130.31 33.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.754 2.303 . . . . 0.0 112.713 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.511 ' HG3' HD11 ' A' ' 996' ' ' LEU . 79.1 Cg_endo -76.9 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.767 2.311 . . . . 0.0 112.696 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.09 142.0 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.379 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 32.9 m -81.49 129.77 34.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.541 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 2.3 tp-100 -143.49 127.14 17.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 30.7 ptt85 -49.12 142.19 7.23 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.487 0.661 . . . . 0.0 111.38 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 993' ' ' GLY . 23.3 mt -74.75 131.51 79.36 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.182 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.741 2.294 . . . . 0.0 112.407 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.936 0.398 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 900' ' ' ALA . 21.2 m80 68.88 129.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.856 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.8 p -82.21 124.19 29.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.629 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.419 ' HA ' HE21 ' A' ' 903' ' ' GLN . 3.0 mm100 -69.65 166.75 18.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.142 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 920' ' ' SER . . . -47.44 127.79 10.15 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.122 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.579 ' HG3' HD12 ' A' ' 928' ' ' LEU . 53.9 Cg_endo -69.47 133.13 25.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.389 2.06 . . . . 0.0 112.018 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.19 153.2 35.26 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.216 0.532 . . . . 0.0 111.161 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -78.29 139.29 38.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.92 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.417 ' O ' HD23 ' A' ' 909' ' ' LEU . 2.9 m-85 -89.48 -140.32 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.955 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 908' ' ' PHE . 63.1 mt -154.03 -38.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -6.3 59.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.683 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -157.85 128.81 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.324 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -98.81 135.06 40.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.839 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 930' ' ' TYR . 36.8 tp -48.86 125.35 10.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.372 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -94.52 -43.34 8.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 38.1 m -64.84 135.44 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.806 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.421 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.2 pm0 -64.08 144.55 57.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.046 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.685 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 46.5 p -150.53 -86.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.419 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 917' ' ' THR . 91.3 m 73.26 -38.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.4 136.49 51.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.365 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . 0.571 ' HA ' ' HB2' ' A' ' 904' ' ' ALA . 79.5 p -89.67 34.51 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.389 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.53 135.85 11.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.885 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.685 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 72.8 m-85 -143.4 138.36 15.43 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.46 140.48 12.01 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.913 2.409 . . . . 0.0 111.414 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.545 ' HA ' ' HB2' ' A' ' 945' ' ' CYS . 29.8 mt -51.59 141.18 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 110.583 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 105.8 -29.09 11.87 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.523 HG21 ' HD2' ' A' ' 922' ' ' PHE . 30.4 m -55.45 140.08 41.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.0 m -121.19 140.39 52.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.579 HD12 ' HG3' ' A' ' 905' ' ' PRO . 90.3 mt -132.36 118.94 20.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 39.4 ttmt -89.18 128.43 35.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.409 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.596 ' CE1' HD13 ' A' ' 913' ' ' LEU . 2.5 m-85 -110.99 129.18 55.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -97.58 129.41 44.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.5 m -56.75 160.01 3.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.558 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 67.6 mtt-85 -81.47 158.33 68.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.485 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 936' ' ' TYR . 68.9 Cg_exo -39.17 -55.64 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.922 2.415 . . . . 0.0 113.26 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 936' ' ' TYR . 14.4 pt-20 -75.23 36.51 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.56 ' CE1' ' HG3' ' A' ' 935' ' ' GLU . 56.4 m-85 -142.7 150.87 40.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.739 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 35.9 p90 -145.43 135.46 23.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.326 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 957' ' ' VAL . . . 153.16 28.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.17 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 80.6 mtp180 61.05 148.0 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.451 0.643 . . . . 0.0 112.239 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 939' ' ' ARG . 4.4 Cg_exo -75.18 123.04 7.49 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.263 2.642 . . . . 0.0 111.989 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.537 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 46.3 p90 -90.37 -161.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.615 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 135.93 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.425 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 4.6 pt -92.61 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -164.0 132.12 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 59.5 m -72.12 110.88 6.89 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 97.5 mt -83.41 -52.85 6.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.6 t70 174.32 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 110.905 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.449 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.5 m-80 -83.13 31.78 0.44 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 900' ' ' ALA . 78.3 mt 50.75 42.38 27.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 948' ' ' ASN . 19.9 m -137.44 150.91 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 121.632 0.73 . . . . 0.0 112.343 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 68.6 m95 -91.49 124.71 35.87 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.323 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.2 t -43.37 142.07 1.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t -79.86 113.08 34.91 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.702 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.07 67.12 6.05 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.49 2.793 . . . . 0.0 111.766 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -76.42 131.68 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.296 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.3 t70 57.87 96.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.802 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -152.85 -70.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.802 ' H ' HG23 ' A' ' 957' ' ' VAL . 80.9 m -88.44 140.62 29.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -143.12 127.21 17.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.188 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 981' ' ' GLN . 53.8 ttp180 -53.24 137.3 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.165 0.507 . . . . 0.0 112.042 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.739 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 32.1 mmmt -56.34 170.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.127 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.658 ' HB3' HE21 ' A' ' 981' ' ' GLN . 69.5 p -150.24 134.69 17.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.075 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 980' ' ' ILE . 83.0 m -81.58 144.26 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.085 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -65.89 134.84 53.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.45 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.7 m -54.48 117.31 12.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.31 129.98 15.67 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.402 2.068 . . . . 0.0 111.835 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.04 125.15 18.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.098 1.866 . . . . 0.0 111.507 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.25 126.55 82.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.81 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.01 142.68 82.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.549 2.166 . . . . 0.0 112.076 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.3 p -46.97 129.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.575 ' ND2' HG22 ' A' ' 970' ' ' VAL . 77.3 m-20 63.74 47.2 3.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.796 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -166.96 -155.38 8.99 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.447 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 23.7 ptp 175.23 140.33 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.63 0.252 . . . . 0.0 111.013 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.875 HG21 HD12 ' A' ' 986' ' ' ILE . 8.4 p -93.84 135.41 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.769 0.318 . . . . 0.0 111.029 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -94.29 108.96 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.179 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -65.41 -22.83 31.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 985' ' ' ARG . 7.2 mm 73.88 -52.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.748 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 73.3 p -150.25 -56.68 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.484 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 31.0 m-20 -157.13 157.69 34.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.595 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.647 HG23 HG13 ' A' ' 976' ' ' VAL . 14.6 pt -95.51 32.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.664 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' A' ' 962' ' ' SER . 5.4 mp0 -79.22 151.15 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 961' ' ' LYS . 73.7 t -53.93 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.079 0.466 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 160.56 -46.52 0.4 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.7 m -78.72 135.91 37.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.742 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 55.6 ttp180 -98.24 132.32 43.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.875 HD12 HG21 ' A' ' 974' ' ' VAL . 28.6 pt -93.97 130.09 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.316 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.519 HG22 ' OG ' ' A' 1001 ' ' SER . 7.8 p -102.52 130.99 49.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.461 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.7 m-85 -95.15 145.35 25.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.195 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 88.9 p -148.64 121.44 8.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.744 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.99 149.27 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.7 t -64.32 146.02 55.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.491 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 88.5 m -46.42 125.14 6.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.257 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' 1023 ' ' ILE . . . 127.72 -46.81 1.06 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.464 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.9 m80 -100.19 140.24 34.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.618 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.5 ptm180 -92.36 144.13 25.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.371 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.8 tt -72.81 135.39 45.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.0 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.656 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.6 mp -115.07 139.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 90.47 -125.71 8.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.262 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.546 ' CD2' ' HB ' ' A' 1015 ' ' THR . 85.0 m-70 -78.33 -134.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.463 0.173 . . . . 0.0 111.314 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.5 p -177.9 -27.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 987' ' ' THR . 50.0 m -151.63 153.0 33.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.577 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.58 128.9 11.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.742 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 20.5 pt-20 -95.66 137.85 34.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.805 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.26 95.89 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.604 HG23 ' HG3' ' A' 1003 ' ' GLU . 32.1 pt -103.56 -157.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.869 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' 1010 ' ' THR . 57.3 tp -153.68 137.73 16.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.474 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.509 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.8 t -90.03 -40.09 12.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.777 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -169.92 -34.08 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.45 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.485 ' C ' HD11 ' A' 1006 ' ' LEU . 14.4 p-10 -152.95 -40.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.528 ' O ' HD12 ' A' 1006 ' ' LEU . 70.5 m -91.2 130.08 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.608 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.98 141.02 37.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.106 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.0 p80 -157.01 145.95 20.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.33 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.4 m95 -68.27 141.89 55.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -57.74 -32.32 67.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.38 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.546 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 71.5 p -142.88 139.07 30.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.958 0.409 . . . . 0.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' 1017 ' ' PRO . 4.7 tmmm? -64.82 138.37 97.45 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.558 ' N ' ' HD2' ' A' 1016 ' ' LYS . 97.8 Cg_exo -44.75 134.74 10.15 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.964 2.443 . . . . 0.0 113.207 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 40.3 Cg_endo -66.54 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.861 2.374 . . . . 0.0 112.844 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 55.9 mt -141.09 144.85 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.837 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 74.2 m -103.89 123.97 48.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 0.6 OUTLIER -142.84 127.48 18.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.669 0.271 . . . . 0.0 110.754 -178.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 0.0 OUTLIER -49.66 136.95 16.46 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.447 0.642 . . . . 0.0 111.168 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 995' ' ' ARG . 16.0 mt -75.96 132.46 74.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.188 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.14 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.447 ' C ' HD22 ' A' ' 949' ' ' LEU . 74.0 m80 -156.04 141.08 17.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.276 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 92.1 m -81.05 128.6 33.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -76.14 172.14 13.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.397 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.1 126.06 7.15 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.984 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.693 ' HG2' HD23 ' A' ' 928' ' ' LEU . 50.5 Cg_exo -56.75 138.08 83.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.623 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.22 157.21 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -78.11 123.74 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.87 ' HB2' ' HB3' ' A' ' 911' ' ' ALA . 2.8 m-85 -85.22 24.1 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.25 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 14.1 mt 61.33 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.17 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.592 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -82.49 35.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.392 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 908' ' ' PHE . . . -154.48 143.12 20.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.228 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.28 144.61 32.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 915' ' ' THR . 59.3 tp -43.03 152.49 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.394 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.875 ' HA ' ' HE3' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -147.9 48.1 1.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.036 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 917' ' ' THR . 16.2 m -170.72 137.32 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -52.91 132.09 36.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.808 0.337 . . . . 0.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.833 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 82.7 p -152.88 57.9 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 85.0 m -51.5 -44.74 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.6 51.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 49.4 m -86.78 -41.57 14.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.87 145.98 27.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.382 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.833 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 37.9 m-85 -134.95 138.51 29.69 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 0.0 112.037 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.478 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 58.0 Cg_endo -70.59 141.1 41.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.367 . . . . 0.0 111.67 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.75 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.7 mt -56.53 143.05 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.994 0.425 . . . . 0.0 111.312 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.2 16.44 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.492 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 19.5 m -55.88 132.76 50.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 143.19 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.835 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.693 HD23 ' HG2' ' A' ' 905' ' ' PRO . 8.6 tp -135.18 125.19 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.29 134.22 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.515 ' HE1' HD23 ' A' ' 928' ' ' LEU . 8.5 m-85 -132.13 122.79 25.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.392 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -95.62 130.46 42.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.346 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 36.0 m -56.79 -173.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.401 . . . . 0.0 111.363 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.592 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 93.7 mtt180 -82.46 152.72 67.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.758 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 936' ' ' TYR . 91.9 Cg_exo -44.51 -40.01 13.28 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.78 2.32 . . . . 0.0 112.547 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.04 21.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 111.082 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.3 m-85 -142.75 137.22 29.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.486 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.473 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 3.7 p90 -102.12 36.56 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.215 0.531 . . . . 0.0 110.962 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . -83.87 139.74 18.81 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.79 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 37.1 ptt85 -72.89 163.52 67.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -63.63 112.69 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.352 2.035 . . . . 0.0 112.017 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.636 ' HB3' HG11 ' A' ' 957' ' ' VAL . 53.1 p90 -91.04 114.85 27.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.46 0.648 . . . . 0.0 110.612 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.2 p -79.58 122.09 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.955 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 954' ' ' PRO . 9.4 pt -97.46 -174.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 0.7 OUTLIER -166.82 134.42 2.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.75 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 52.7 t -66.53 116.16 7.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.648 HD11 ' HA ' ' A' ' 952' ' ' SER . 77.4 mt -80.96 -55.56 4.71 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.571 ' HA ' HD13 ' A' ' 924' ' ' ILE . 49.8 t0 173.21 -48.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.53 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -83.87 33.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.278 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 900' ' ' ALA . 40.4 mt 60.92 56.77 2.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.637 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 2.1 m -139.4 -163.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.219 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.554 ' HA ' ' O ' ' A' ' 944' ' ' THR . 74.7 m95 -145.41 125.03 13.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.766 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.648 ' HA ' HD11 ' A' ' 946' ' ' LEU . 47.5 t -38.59 135.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 79.9 p -76.97 111.38 16.04 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 943' ' ' ILE . 18.6 Cg_exo -65.85 132.64 31.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.576 ' HG2' ' H ' ' A' ' 956' ' ' ASP . 79.2 tttt -78.23 -134.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.576 ' H ' ' HG2' ' A' ' 955' ' ' LYS . 38.9 p-10 -78.98 127.0 31.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.847 0.356 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.636 HG11 ' HB3' ' A' ' 941' ' ' PHE . 21.0 m -150.36 -48.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.5 ' N ' HG23 ' A' ' 957' ' ' VAL . 71.3 m -84.18 138.17 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.4 mmtt -143.88 131.47 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 20.5 mmt180 -58.96 113.95 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.052 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.962 ' HE3' ' HB2' ' A' 1011 ' ' ALA . 38.3 ttpt -58.33 166.06 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.473 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 90.1 p -144.46 141.61 29.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.965 0.412 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.408 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 49.2 m -81.54 36.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.979 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 60.18 128.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 14.6 m -61.17 132.81 92.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.484 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.456 ' CG ' HG11 ' A' ' 974' ' ' VAL . 11.6 Cg_endo -55.37 135.68 70.2 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 112.384 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 968' ' ' ASP . 72.2 Cg_endo -76.23 52.31 3.47 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 967' ' ' PRO . 8.1 t70 29.59 102.03 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.24 0.616 . . . . 0.0 112.423 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.509 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 52.1 Cg_exo -52.62 143.97 44.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.743 2.295 . . . . 0.0 112.322 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.523 HG22 ' ND2' ' A' ' 971' ' ' ASN . 6.4 p -53.04 133.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.484 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.523 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.1 m-20 52.65 47.3 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.415 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.51 -158.77 16.21 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.631 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 176.29 140.42 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.151 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.576 HG21 HD12 ' A' ' 986' ' ' ILE . 7.2 p -99.82 128.77 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.483 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.5 OUTLIER -89.76 124.31 34.52 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 979' ' ' ASP . 87.3 t -76.4 124.55 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.5 mm -75.49 -41.65 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.9 p -144.71 -52.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.317 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.7 m-20 -153.33 -156.57 0.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 986' ' ' ILE . 15.8 pt -151.08 22.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 960' ' ' ARG . 4.8 mm100 -80.88 174.86 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' 1006 ' ' LEU . 88.0 t -58.83 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.91 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 146.99 -34.44 1.32 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.4 m -75.06 140.4 43.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.631 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' 1002 ' ' ALA . 38.8 ttm180 -104.16 150.63 24.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.576 HD12 HG21 ' A' ' 974' ' ' VAL . 40.8 pt -131.21 135.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' 1001 ' ' SER . 11.6 p -103.61 132.7 49.63 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.509 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 5.2 m-85 -98.7 145.63 26.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 46.8 t -152.32 119.13 5.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.028 0.442 . . . . 0.0 110.984 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 62.6 m -80.92 144.85 31.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.854 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.8 t -65.0 158.37 25.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.4 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.0 t -46.47 134.57 9.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.624 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 113.83 -51.01 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.979 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -101.88 141.3 34.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.524 ' O ' HD12 ' A' ' 997' ' ' ILE . 2.6 ptp180 -93.33 146.44 23.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.354 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' 1018 ' ' PRO . 10.0 tt -69.64 129.78 40.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.775 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -98.34 142.26 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.72 -133.57 11.89 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.945 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.499 ' CD2' ' HB ' ' A' 1015 ' ' THR . 96.0 m-70 -78.63 -121.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 20.3 m -164.67 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.574 0.226 . . . . 0.0 111.177 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.575 ' HB3' HG22 ' A' ' 987' ' ' THR . 80.0 p -155.17 117.87 4.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.973 0.415 . . . . 0.0 111.274 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -91.09 179.45 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.478 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -145.41 132.13 19.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.339 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.3 t -71.19 122.35 20.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 982' ' ' VAL . 29.8 pt -138.38 148.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.179 0.514 . . . . 0.0 111.911 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' 1007 ' ' SER . 1.2 tt -88.47 129.86 35.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.496 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.651 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -89.98 -44.92 9.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -173.5 -32.27 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.993 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.63 -49.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 26.2 m -94.46 133.01 38.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.802 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.962 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.01 139.29 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.243 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.651 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -157.67 144.61 18.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 62.3 m95 -68.56 138.35 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.599 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.5 p -52.9 -28.42 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.674 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.499 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 53.2 p -141.54 142.43 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.639 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -56.63 153.97 19.32 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.751 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.19 122.15 8.97 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.302 2.001 . . . . 0.0 112.597 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.568 ' HB3' HD21 ' A' ' 996' ' ' LEU . 51.3 Cg_exo -54.42 148.8 40.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.779 2.319 . . . . 0.0 112.225 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.86 -159.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.752 ' H ' HG22 ' A' 1019 ' ' ILE . 84.5 m -153.31 134.69 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.011 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 997' ' ' ILE . 1.0 OUTLIER -151.85 136.85 17.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.26 -178.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -48.02 133.59 14.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.374 0.607 . . . . 0.0 111.018 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 995' ' ' ARG . 60.0 mt -74.79 129.48 83.34 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.976 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 112.501 -179.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.559 ' C ' HD12 ' A' ' 949' ' ' LEU . 36.3 m80 -151.6 138.51 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.525 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 83.3 m -81.1 124.94 29.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.706 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -69.38 173.14 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.0 134.86 6.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.226 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 52.5 Cg_exo -54.07 149.4 35.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.525 2.15 . . . . 0.0 111.942 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 29.2 t0 -63.23 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.751 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.475 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 26.3 m80 -77.77 134.36 38.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.03 47.07 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.217 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.935 HD12 ' N ' ' A' ' 910' ' ' PHE . 4.2 pp -53.26 -34.44 57.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.4 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.935 ' N ' HD12 ' A' ' 909' ' ' LEU . 0.2 OUTLIER -87.11 26.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.485 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -155.09 129.98 9.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -101.62 126.2 48.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.382 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -55.49 119.89 6.34 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.536 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.645 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 74.4 mmtt -95.4 -39.04 10.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.651 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 916' ' ' GLN . 18.5 m -64.55 -119.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.142 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.505 ' N ' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -171.06 134.05 0.92 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.4 t -160.35 159.44 31.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.566 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.2 m -155.95 -31.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.403 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.3 158.74 35.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.03 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.3 p -84.67 -50.68 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.35 126.19 33.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.328 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 20.0 m-85 -102.0 134.13 20.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.439 . . . . 0.0 111.906 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.487 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 71.5 Cg_endo -73.36 137.36 25.58 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.833 2.355 . . . . 0.0 112.003 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.596 HG12 ' SG ' ' A' ' 945' ' ' CYS . 25.9 mt -59.99 151.58 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 93.94 -36.2 3.85 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.9 m -56.12 133.53 52.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.271 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 42.6 t -114.08 121.72 44.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.435 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.579 ' HB3' ' HE1' ' A' ' 930' ' ' TYR . 92.9 mt -103.38 124.82 49.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 17.1 tppt? -87.39 132.52 33.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.579 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 15.0 m-85 -135.27 123.03 22.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.544 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.979 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 90.4 mt-10 -103.29 129.59 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.691 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 74.2 m -54.09 168.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.548 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 77.6 mtp180 -79.03 148.46 71.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.53 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 936' ' ' TYR . 83.3 Cg_exo -45.45 -42.64 17.98 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.831 2.354 . . . . 0.0 112.682 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.431 ' CD ' HG11 ' A' ' 982' ' ' VAL . 4.2 mm-40 -73.33 20.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.227 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.6 m-85 -144.6 135.12 24.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.746 0.308 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -102.67 37.35 1.95 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 110.922 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -77.03 0.12 67.88 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.764 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 939' ' ' ARG . 62.0 mtt85 64.58 144.12 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.429 . . . . 0.0 111.353 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.979 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 19.6 Cg_exo -66.36 110.43 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.796 2.331 . . . . 0.0 112.505 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.431 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 52.3 p90 -95.54 -164.3 1.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.496 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.524 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 80.5 p -172.83 135.98 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 10.8 pt -97.01 166.26 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.838 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 946' ' ' LEU . 2.9 m -161.41 120.48 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.814 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 34.8 t -68.6 112.87 5.65 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 82.2 mt -83.79 -52.5 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 50.0 t0 173.49 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.787 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -85.9 36.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.471 0.653 . . . . 0.0 109.84 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 2.3 mm? 54.88 63.69 2.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.384 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 19.0 m -141.64 146.19 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 111.891 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.716 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 97.7 m95 -93.8 47.88 1.25 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.051 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 89.3 p 53.03 26.85 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t 38.23 75.16 0.57 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.23 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 951' ' ' TRP . 92.5 Cg_endo -79.84 53.71 4.86 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.429 2.086 . . . . 0.0 112.376 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.36 129.07 35.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.916 0.389 . . . . 0.0 110.71 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.3 t0 60.88 106.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.3 m -153.86 -56.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 1.035 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 72.6 m -83.55 141.53 31.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.042 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -143.03 148.12 36.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.268 0.556 . . . . 0.0 112.08 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 981' ' ' GLN . 10.8 tpt180 -53.48 113.9 1.32 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.366 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.711 ' HZ1' ' H ' ' A' 1011 ' ' ALA . 27.8 tptp -56.99 158.33 5.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.371 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.423 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 77.4 p -150.81 138.36 19.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.581 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 964' ' ' LYS . 65.4 m -81.6 35.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 963' ' ' CYS . 87.4 tttt 55.45 131.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.416 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 980' ' ' ILE . 24.3 m -54.11 129.05 58.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.526 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 72.8 Cg_endo -74.87 124.94 9.06 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.511 2.141 . . . . 0.0 112.67 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 15.5 Cg_exo -67.99 125.76 13.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.456 2.104 . . . . 0.0 111.533 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.24 128.53 91.21 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.243 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 970' ' ' VAL . 72.6 Cg_endo -76.26 -152.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.685 2.256 . . . . 0.0 111.979 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' 1020 ' ' CYS . 12.7 t -53.94 116.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.596 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 18.3 p30 39.53 32.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -67.02 177.56 19.05 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.111 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 50.6 ttm -175.45 73.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.323 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.7 p -90.35 122.05 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 111.328 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.404 ' O ' ' HD2' ' A' ' 975' ' ' HIS . 0.7 OUTLIER -95.62 131.61 41.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.166 0.507 . . . . 0.0 109.902 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.573 ' HB ' HG23 ' A' ' 980' ' ' ILE . 2.1 m -75.4 135.63 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.626 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.557 ' N ' HD12 ' A' ' 977' ' ' ILE . 2.5 mp -76.46 -32.14 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.475 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 977' ' ' ILE . 64.8 p -140.4 -66.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.0 t0 -162.16 14.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 965' ' ' THR . 29.3 pt 51.77 24.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.361 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 7.3 mm100 -80.93 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.654 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 14.7 t -55.51 130.31 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.333 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 96.26 -23.05 36.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.852 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' 1003 ' ' GLU . 52.3 m -74.61 -165.45 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.587 ' HE ' ' HB2' ' A' 1001 ' ' SER . 74.1 ttt180 -151.35 161.51 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.406 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 980' ' ' ILE . 20.3 pt -136.42 132.05 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' 1001 ' ' SER . 2.5 p -124.59 136.11 53.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 111.575 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -94.04 156.51 16.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.443 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 57.7 m -147.84 69.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 85.7 m -44.93 151.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.368 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 21.0 p -64.04 150.68 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -48.32 137.74 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.134 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' 1023 ' ' ILE . . . 106.02 -40.14 2.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.656 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 4.2 m80 -96.38 138.68 33.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.4 ptt180 -94.91 151.04 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.552 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 997' ' ' ILE . 0.4 OUTLIER -73.48 125.05 27.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.0 mp -103.05 138.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.707 0.289 . . . . 0.0 110.78 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 81.09 -125.13 6.72 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -78.57 -132.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.1 p -177.21 -30.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.606 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 987' ' ' THR . 83.3 p -150.93 167.51 27.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.56 139.03 14.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.5 tt0 -96.25 134.94 38.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.654 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 40.5 t -71.96 125.83 28.21 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.24 -155.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.805 0.336 . . . . 0.0 111.537 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 36.8 tp -152.05 124.75 8.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.643 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.3 t -91.35 -48.37 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' 1010 ' ' THR . . . 168.85 124.15 0.71 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.867 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.6 m120 71.38 -28.82 0.19 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' 1008 ' ' GLY . 96.7 m -145.43 135.43 23.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.774 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.711 ' H ' ' HZ1' ' A' ' 961' ' ' LYS . . . -82.25 149.07 28.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.643 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.4 p80 -157.93 151.37 23.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.538 ' CZ2' ' HB ' ' A' ' 980' ' ' ILE . 81.2 m95 -68.46 144.05 54.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.253 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -56.8 -31.06 64.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.673 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 80.8 p -144.06 138.41 28.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 111.923 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.57 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -66.45 155.74 87.61 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.182 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.16 135.31 52.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.759 2.306 . . . . 0.0 112.782 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 988' ' ' TYR . 53.6 Cg_endo -68.81 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.818 2.346 . . . . 0.0 112.605 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 54.4 mt -140.16 137.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -98.75 123.37 42.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 997' ' ' ILE . 36.3 tt0 -145.74 129.12 16.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.692 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 36.5 ttm180 -51.16 135.45 25.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.439 0.638 . . . . 0.0 111.475 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 995' ' ' ARG . 48.4 mt -74.92 125.78 89.0 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.627 2.218 . . . . 0.0 112.475 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.861 0.362 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.455 ' C ' HD22 ' A' ' 949' ' ' LEU . 50.9 m80 -153.86 143.93 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 66.1 m -80.47 122.95 27.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.596 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.4 mm100 -68.14 170.68 8.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.687 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.35 133.18 5.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.945 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.48 ' HG3' ' OH ' ' A' ' 930' ' ' TYR . 26.6 Cg_endo -61.7 -168.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.642 2.228 . . . . 0.0 112.333 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 8.3 t70 -174.96 161.04 2.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.053 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.417 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 78.0 t60 72.11 62.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.587 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.695 ' O ' HD13 ' A' ' 909' ' ' LEU . 45.1 m-85 -146.01 120.15 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.084 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.0 OUTLIER -132.58 -45.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.012 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.97 13.87 3.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.126 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.475 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -152.0 126.81 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.115 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.546 ' HG3' ' HZ3' ' A' ' 914' ' ' LYS . 20.8 pttp -107.92 123.85 49.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.684 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -51.13 146.81 6.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.086 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.748 ' N ' HD13 ' A' ' 913' ' ' LEU . 42.6 mmtm -147.88 11.89 0.97 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 1.041 HG21 HD22 ' A' ' 928' ' ' LEU . 14.3 t -70.88 -151.18 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.879 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 915' ' ' THR . 0.7 OUTLIER -86.55 -44.45 11.91 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-O 121.221 0.534 . . . . 0.0 110.978 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 915' ' ' THR . 21.4 p 50.67 -121.12 1.7 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.187 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 916' ' ' GLN . 68.8 p 55.7 33.14 20.74 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.47 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.557 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.0 t -85.72 -49.37 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.744 0.306 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.74 126.01 33.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.593 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.482 ' CD2' HD21 ' A' ' 928' ' ' LEU . 36.0 m-85 -108.46 138.18 20.15 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.922 0.391 . . . . 0.0 111.756 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.526 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.1 Cg_endo -69.39 143.25 51.98 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.923 2.415 . . . . 0.0 112.302 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.1 mt -57.66 154.79 2.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.845 0.355 . . . . 0.0 110.914 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.81 -40.37 2.89 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.526 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.4 m -57.11 132.1 51.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.865 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 22.6 t -115.44 133.41 56.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 1.041 HD22 HG21 ' A' ' 915' ' ' THR . 78.3 mt -95.47 125.81 40.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.956 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.441 ' O ' HD22 ' A' ' 913' ' ' LEU . 40.4 ttmt -85.35 136.82 33.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.48 ' OH ' ' HG3' ' A' ' 905' ' ' PRO . 11.1 m-85 -128.75 131.28 47.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.61 123.03 44.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 80.5 m -57.25 163.54 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 73.9 mtp180 -81.89 151.55 67.55 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 936' ' ' TYR . 6.7 Cg_endo -49.44 -44.23 35.48 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.972 2.448 . . . . 0.0 112.609 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.416 ' HB3' HG21 ' A' ' 982' ' ' VAL . 55.4 mt-10 -73.27 20.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.77 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 45.4 m-85 -143.08 134.99 26.86 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.837 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 13.2 p90 -96.17 135.82 37.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.631 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 164.95 141.17 3.05 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.87 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 939' ' ' ARG . 0.6 OUTLIER -72.75 157.12 89.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.931 0.396 . . . . 0.0 110.505 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 19.2 Cg_endo -60.75 147.27 95.55 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.986 2.457 . . . . 0.0 112.092 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 53.1 p90 -144.44 -171.27 3.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 44.9 t -172.92 142.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 10.7 pt -100.46 116.93 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.445 ' O ' HD22 ' A' ' 946' ' ' LEU . 36.9 m -81.45 131.68 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.38 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.6 t -73.74 123.22 23.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 109.903 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 950' ' ' VAL . 1.9 mm? -87.44 169.03 12.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.338 1.066 . . . . 0.0 113.622 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.4 -40.4 62.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.146 -1.843 . . . . 0.0 112.043 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 950' ' ' VAL . 50.0 t30 -83.33 32.89 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 900' ' ' ALA . 56.7 mt 46.39 57.99 4.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.237 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.872 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -135.59 -159.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.385 0.612 . . . . 0.0 111.697 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.417 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 91.8 m95 -144.72 122.31 11.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.137 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.45 ' N ' HD21 ' A' ' 946' ' ' LEU . 79.1 p -42.16 136.29 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.818 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 34.0 t -77.93 112.35 24.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 955' ' ' LYS . 15.4 Cg_exo -68.64 -153.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.713 2.275 . . . . 0.0 111.885 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.533 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 32.4 mtmt -159.84 -147.37 0.16 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.69 0.757 . . . . 0.0 111.6 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.533 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 56.5 m-20 -81.28 58.63 3.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.406 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 958' ' ' CYS . 29.5 m -81.6 -50.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.409 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.535 ' N ' HG23 ' A' ' 957' ' ' VAL . 97.5 m -89.0 52.3 2.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.422 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -57.64 138.7 55.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.754 ' HD2' ' HB2' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -55.37 120.56 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.844 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.837 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 35.6 ttmt -56.45 142.36 38.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 78.5 p -144.44 141.23 29.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.512 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.1 m -81.63 23.79 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 965' ' ' THR . 13.8 tmtt? 55.6 136.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.414 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 4.4 m -51.12 118.19 10.1 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.316 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG3' HD11 ' A' ' 986' ' ' ILE . 43.9 Cg_endo -64.5 141.73 75.07 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 122.664 2.243 . . . . 0.0 111.694 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.35 115.87 2.75 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.124 1.883 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -62.54 134.98 95.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 17.7 Cg_endo -59.6 138.1 81.48 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.433 2.089 . . . . 0.0 111.872 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.632 HG22 ' ND2' ' A' ' 971' ' ' ASN . 3.4 p -50.7 129.29 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.632 ' ND2' HG22 ' A' ' 970' ' ' VAL . 74.9 m-20 64.04 48.24 3.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -170.82 -145.54 4.81 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.725 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER -178.83 156.6 0.85 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 986' ' ' ILE . 14.2 p -87.55 128.07 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.466 0.65 . . . . 0.0 110.851 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.977 ' HB3' HG23 ' A' ' 987' ' ' THR . 12.3 t-160 -75.05 70.97 2.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.341 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.593 HG23 HG13 ' A' ' 974' ' ' VAL . 99.3 t -59.06 122.84 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.97 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 987' ' ' THR . 32.0 mm -78.44 -40.64 24.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.29 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 59.0 p -144.67 -50.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 976' ' ' VAL . 56.5 m-20 -154.45 -142.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.495 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 17.0 pt -145.56 -3.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.436 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HB2' ' HD2' ' A' ' 960' ' ' ARG . 3.2 pt20 -75.56 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 5.9 m -47.92 150.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 111.366 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 85.17 -40.75 3.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.257 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 40.6 t -77.63 131.28 37.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 111.436 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ttm180 -100.33 150.15 22.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.157 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.709 HD12 HG21 ' A' ' 974' ' ' VAL . 48.2 pt -141.73 127.58 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.381 . . . . 0.0 111.51 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.977 HG23 ' HB3' ' A' ' 975' ' ' HIS . 1.6 t -98.62 -168.31 1.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.578 ' HA ' ' H ' ' A' ' 975' ' ' HIS . 22.0 m-85 -136.87 154.15 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 0.0 111.176 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.4 t -148.44 125.21 11.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 72.6 m -100.04 147.39 25.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -65.03 146.85 54.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.525 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 87.0 m -45.87 126.48 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' 1023 ' ' ILE . . . 126.09 -46.93 1.05 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -102.23 137.48 40.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.065 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.701 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.8 ptm85 -93.33 146.59 23.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.196 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.4 tt -71.77 133.2 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.984 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.513 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.2 mp -110.22 133.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 98.5 -128.9 9.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.306 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.536 ' CD2' ' HB ' ' A' 1015 ' ' THR . 94.2 m-70 -79.04 -129.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.0 p -172.24 -31.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.319 . . . . 0.0 111.247 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 47.2 t -150.84 159.82 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.529 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.6 133.77 12.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.989 0.424 . . . . 0.0 111.83 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 4.6 pm0 -104.05 138.24 40.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.451 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.9 t -76.9 125.82 29.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' 1011 ' ' ALA . 29.9 pt -131.56 -151.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.669 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' 1010 ' ' THR . 28.8 tp -147.18 -26.57 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.335 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' 1006 ' ' LEU . 47.6 t 69.42 -42.94 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -175.83 -45.66 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -156.18 21.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.418 0.151 . . . . 0.0 111.025 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.667 ' C ' HD12 ' A' 1006 ' ' LEU . 3.3 m -150.58 121.04 7.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.283 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -76.15 129.13 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 0.0 110.888 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.468 ' CE1' HD11 ' A' 1005 ' ' ILE . 20.7 p80 -160.15 144.16 14.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 96.3 m95 -68.63 136.28 52.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.063 0.458 . . . . 0.0 110.453 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' 1003 ' ' GLU . 73.7 m -56.36 -27.25 55.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.888 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 72.8 p -145.86 143.9 29.9 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.176 0.512 . . . . 0.0 112.324 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.468 ' HG3' ' HD2' ' A' 1017 ' ' PRO . 26.0 ttpp -65.79 140.9 97.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.778 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' 1016 ' ' LYS . 18.2 Cg_endo -58.15 131.25 42.2 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.524 2.149 . . . . 0.0 112.277 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.448 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -65.02 -160.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.746 2.297 . . . . 0.0 113.01 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 58.3 mt -143.16 139.65 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.814 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 71.9 m -92.58 124.66 36.77 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.62 134.67 22.68 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.199 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -45.7 135.5 6.7 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 111.851 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.701 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.1 mt -74.88 128.41 85.27 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 40.2 Cg_exo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.851 2.367 . . . . 0.0 112.253 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.834 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.946 0.403 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.556 ' C ' HD12 ' A' ' 949' ' ' LEU . 61.1 m80 -152.58 139.8 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.267 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 76.5 m -81.08 132.48 35.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.987 0.422 . . . . 0.0 111.491 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.54 171.57 14.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.652 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.01 149.75 1.52 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.544 ' HB2' ' CD1' ' A' ' 908' ' ' PHE . 10.1 Cg_endo -50.84 135.17 42.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.961 2.441 . . . . 0.0 112.341 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.455 ' O ' ' HD1' ' A' ' 908' ' ' PHE . 46.6 m-20 -67.51 116.3 8.09 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.481 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.437 ' O ' HD12 ' A' ' 909' ' ' LEU . 23.9 p80 38.0 46.67 0.84 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 905' ' ' PRO . 5.5 m-85 -81.64 137.47 35.45 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.652 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.691 HD22 ' N ' ' A' ' 910' ' ' PHE . 0.0 OUTLIER -159.63 -27.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.691 ' N ' HD22 ' A' ' 909' ' ' LEU . 0.1 OUTLIER -80.0 0.63 30.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.45 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.577 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -153.05 134.37 14.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.347 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.21 126.35 39.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.554 ' HG ' ' CZ ' ' A' ' 930' ' ' TYR . 1.2 tt -51.19 131.94 28.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.62 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.806 ' HD3' ' HG2' ' A' ' 929' ' ' LYS . 7.0 mtpm? -85.22 -49.61 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.795 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.54 ' O ' HD22 ' A' ' 913' ' ' LEU . 60.2 m -64.77 136.72 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.219 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -60.37 130.48 46.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.31 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 82.0 p -152.08 147.36 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.325 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.4 p -143.66 -42.87 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 141.76 52.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 40.0 t -86.97 39.18 0.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -157.23 138.72 13.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.36 139.31 29.33 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.493 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.6 Cg_endo -69.33 146.95 64.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.559 . . . . 0.0 112.227 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.762 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 18.3 mt -59.55 158.18 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.892 0.377 . . . . 0.0 111.386 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 81.23 -35.43 2.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.938 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 39.7 m -56.02 129.25 39.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 111.364 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 66.3 p -108.9 125.77 52.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 913' ' ' LEU . 91.5 mt -105.02 122.76 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.889 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.806 ' HG2' ' HD3' ' A' ' 914' ' ' LYS . 37.6 ttmt -90.01 133.35 34.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.554 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 1.5 m-85 -120.65 168.78 11.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.374 . . . . 0.0 111.075 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 914' ' ' LYS . 11.8 pt-20 -140.95 125.43 17.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.822 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 79.2 m -57.51 154.88 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.011 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 99.7 mtt180 -82.77 165.0 44.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 54.7 Cg_endo -69.94 56.08 1.42 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.892 2.395 . . . . 0.0 112.868 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.743 ' O ' ' HD2' ' A' ' 961' ' ' LYS . 55.3 mt-10 -164.94 9.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -149.18 135.31 19.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 10.8 p90 -95.02 136.38 35.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 0.0 111.221 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 167.73 141.25 3.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.52 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.35 156.0 92.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.744 0.307 . . . . 0.0 110.435 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -60.99 109.15 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.411 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.518 ' HB3' ' NH1' ' A' ' 939' ' ' ARG . 52.6 p90 -96.08 -164.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.91 132.09 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.565 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 5.1 pt -97.34 120.31 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 111.643 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 17.5 m -84.08 122.72 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.83 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.762 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.8 t -73.7 102.84 4.07 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 83.9 mt -84.01 162.2 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -43.09 -38.4 2.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.869 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.6 m-80 -82.29 33.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.164 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.834 HD11 ' HB1' ' A' ' 900' ' ' ALA . 1.7 mm? 44.82 52.28 8.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 29.6 m -127.64 -160.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.537 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.767 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 75.5 m95 -149.01 121.81 8.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.67 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 87.8 p -42.72 143.85 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.918 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 41.8 t -77.08 117.29 64.12 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 17.0 Cg_exo -66.4 -8.74 21.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.596 2.198 . . . . 0.0 111.289 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 46.97 57.26 5.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.865 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 59.9 t0 61.19 126.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.966 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 941' ' ' PHE . 5.1 m -150.94 -48.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.756 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 911' ' ' ALA . 99.5 m -83.51 54.37 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 0.0 110.648 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 93.5 mttt -61.39 151.83 31.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.719 ' HD2' ' NZ ' ' A' ' 961' ' ' LYS . 15.1 tpp85 -53.37 125.22 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.861 ' HG2' HG13 ' A' ' 982' ' ' VAL . 0.0 OUTLIER -56.38 125.67 22.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.38 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 91.9 p -144.45 127.9 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.107 0.48 . . . . 0.0 111.083 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.9 p -82.0 44.19 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.189 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.7 tptt 62.86 135.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.073 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.802 ' HA ' HD12 ' A' ' 980' ' ' ILE . 14.0 m -59.85 131.32 88.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.558 ' HG3' HD13 ' A' ' 986' ' ' ILE . 37.6 Cg_endo -65.21 132.64 32.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.596 2.197 . . . . 0.0 112.459 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.35 138.9 52.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.4 2.067 . . . . 0.0 111.793 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -57.94 116.87 15.9 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.77 141.82 55.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.211 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' 1020 ' ' CYS . 11.3 p -53.74 129.13 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.413 ' ND2' HG22 ' A' ' 970' ' ' VAL . 73.5 m-80 44.97 46.66 9.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.992 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -168.01 135.05 3.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.58 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 54.4 mtm -103.68 136.65 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 986' ' ' ILE . 12.1 p -99.75 132.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -95.9 115.66 27.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 986' ' ' ILE . 94.7 t -66.01 -25.34 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.094 0.473 . . . . 0.0 109.993 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.596 HD11 ' OG1' ' A' ' 987' ' ' THR . 14.6 mm 74.21 -51.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.988 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 70.9 p -148.92 -59.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 34.4 m-20 -157.41 143.84 17.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.168 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 965' ' ' THR . 6.0 pt -84.64 21.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.651 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 75.8 mm-40 -78.95 159.94 27.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.219 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 961' ' ' LYS . 2.2 m -56.45 -7.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.836 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -95.64 22.46 38.97 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 67.5 m -163.95 -160.89 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.778 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' 1002 ' ' ALA . 17.2 ptp180 -151.39 -168.19 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.223 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 976' ' ' VAL . 33.3 pt -146.37 129.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.596 ' OG1' HD11 ' A' ' 977' ' ' ILE . 11.0 p -103.28 134.52 46.54 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.129 0.49 . . . . 0.0 111.134 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.521 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 1.5 m-85 -95.44 145.2 25.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.2 t -146.46 74.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 59.4 m -51.64 147.34 6.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.4 p -64.3 150.48 46.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 62.2 m -47.78 112.45 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.163 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 144.72 -50.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -102.3 142.98 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.622 ' O ' HD12 ' A' ' 997' ' ' ILE . 13.3 ptp180 -92.92 145.0 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.504 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.5 tm? -72.45 129.53 38.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.696 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' 1021 ' ' GLN . 4.6 mp -118.41 123.52 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.64 0.257 . . . . 0.0 110.72 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.28 43.22 3.04 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.723 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.538 ' O ' ' HG3' ' A' 1018 ' ' PRO . 93.2 m-70 60.86 125.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 0.0 111.672 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.543 ' HB3' ' HG ' ' A' ' 996' ' ' LEU . 79.9 p -81.39 32.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 50.2 m -158.59 145.72 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.671 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -155.8 125.5 6.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.645 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.47 130.13 40.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.227 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 120.97 17.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.06 137.71 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.414 0.625 . . . . 0.0 112.082 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' 1011 ' ' ALA . 22.5 tp -84.51 120.4 26.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.014 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.2 t -96.08 52.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 81.43 -124.51 6.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.773 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.9 m120 -55.62 -46.96 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.764 HG22 ' H ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -94.52 -164.02 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.972 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.778 ' HB2' HD12 ' A' 1006 ' ' LEU . . . -158.25 147.38 19.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.054 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.26 152.04 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.478 ' HZ2' ' HD3' ' A' ' 966' ' ' PRO . 85.1 m95 -68.69 146.1 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.385 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -56.52 -30.78 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.723 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 8.1 t -146.97 145.69 29.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.93 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -53.81 137.46 54.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.093 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.515 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 73.8 Cg_exo -49.53 113.1 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.197 1.931 . . . . 0.0 112.668 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.538 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 11.0 Cg_endo -54.27 142.28 68.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.927 2.418 . . . . 0.0 112.138 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.686 ' H ' HD12 ' A' 1019 ' ' ILE . 0.1 OUTLIER -107.11 143.7 17.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.031 0.443 . . . . 0.0 111.9 -179.405 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 57.8 m -83.49 141.09 31.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.667 ' HB2' HD13 ' A' ' 997' ' ' ILE . 0.5 OUTLIER -145.8 131.24 18.68 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.862 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -49.75 130.92 21.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.405 0.622 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.533 HG23 HH21 ' A' ' 995' ' ' ARG . 64.9 mt -74.86 126.32 88.48 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.066 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.831 2.354 . . . . 0.0 112.314 -179.92 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.86 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.794 0.331 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.632 ' C ' HD22 ' A' ' 949' ' ' LEU . 26.8 m80 -148.17 131.46 16.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 8.9 p -82.3 127.8 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.595 ' H ' ' NE2' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -64.17 159.26 20.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.48 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.21 131.7 5.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.708 ' HG3' HD12 ' A' ' 928' ' ' LEU . 31.3 Cg_endo -63.89 149.57 90.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.829 2.353 . . . . 0.0 112.48 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -62.37 162.94 9.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.06 124.77 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.501 ' HZ ' HG21 ' A' ' 943' ' ' ILE . 4.6 m-30 -85.28 129.06 34.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.56 25.63 4.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.443 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 8.5 p90 -154.01 1.63 0.23 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.066 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -157.43 131.38 8.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.402 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -102.01 136.16 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.991 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 66.0 tp -47.8 157.0 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.389 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.703 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 3.9 mmmp? -145.36 -36.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 19.5 m -64.4 139.45 58.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -58.46 136.13 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.542 179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 77.1 p -152.18 140.33 20.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 918' ' ' THR . 25.5 m -158.4 53.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.197 0.522 . . . . 0.0 110.548 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.31 154.27 7.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.787 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.3 p -84.08 -49.44 8.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.535 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -85.32 124.59 32.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.227 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.44 ' CE2' HD11 ' A' ' 928' ' ' LEU . 25.8 m-85 -103.71 136.49 19.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.014 0.435 . . . . 0.0 111.819 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.49 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 61.2 Cg_endo -72.24 139.33 32.01 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 0.0 112.071 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.639 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 26.4 mt -57.54 158.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.66 -40.91 2.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.49 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 30.7 m -56.01 136.64 51.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.003 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.2 m -123.63 131.86 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.708 HD12 ' HG3' ' A' ' 905' ' ' PRO . 88.7 mt -97.92 129.26 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.695 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 40.0 ttmt -85.25 136.81 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.767 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 17.2 m-85 -134.44 125.3 27.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.734 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.703 ' HG3' ' HG3' ' A' ' 914' ' ' LYS . 96.1 mt-10 -95.63 136.11 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 80.7 m -51.69 158.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 0.0 110.91 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.521 ' HG3' ' C ' ' A' ' 910' ' ' PHE . 44.1 mtp85 -80.09 160.26 68.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.279 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 38.2 Cg_endo -66.51 62.4 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.831 2.354 . . . . 0.0 112.452 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.0 mt-10 -163.73 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.392 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 2.6 m-85 -104.48 -176.96 3.23 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.458 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 4.9 p90 -150.51 32.77 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.966 0.412 . . . . 0.0 111.336 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.918 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -76.68 27.42 1.6 Allowed Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.294 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.74 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.9 ptp180 46.02 166.14 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.356 0.662 . . . . 0.0 112.633 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 41.8 Cg_endo -67.72 145.6 69.95 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.341 2.027 . . . . 0.0 112.427 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.562 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 45.3 p90 -144.46 -162.07 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.299 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.534 ' HG ' ' HA ' ' A' ' 929' ' ' LYS . 57.5 m -169.78 136.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.501 HG21 ' HZ ' ' A' ' 908' ' ' PHE . 7.8 pt -93.0 120.85 43.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.002 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 946' ' ' LEU . 16.6 m -81.52 123.48 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.76 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 10.7 t -73.72 104.23 4.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 74.4 mt -81.76 161.55 23.26 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.503 ' HA ' HG21 ' A' ' 924' ' ' ILE . 64.2 t0 -42.09 -47.5 4.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.381 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 948' ' ' ASN . 0.0 OUTLIER -82.27 40.96 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.975 -178.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.86 HD21 ' HB1' ' A' ' 900' ' ' ALA . 43.7 mt 45.85 59.18 3.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.247 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.696 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 34.9 m -135.98 -161.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -151.02 122.94 8.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.975 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.5 p -41.87 137.64 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 39.7 t -79.4 110.95 17.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 0.0 112.073 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 952' ' ' SER . 57.9 Cg_endo -90.96 54.07 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.471 2.781 . . . . 0.0 110.828 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.593 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -75.63 132.82 40.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.422 -178.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 52.95 44.95 29.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.3 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 958' ' ' CYS . 0.5 OUTLIER -87.83 -50.95 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.247 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.918 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 93.1 m -89.13 111.77 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 72.7 mmtt -83.78 124.84 31.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 40.4 ttm180 -61.96 133.69 55.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.277 0.561 . . . . 0.0 112.386 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.509 ' HA ' ' CE2' ' A' ' 937' ' ' TYR . 20.3 tptm -56.35 168.48 0.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.809 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.518 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 51.0 m -149.85 134.81 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.005 0.431 . . . . 0.0 111.235 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.92 141.77 35.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.804 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -65.54 136.09 55.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 66.5 m -52.62 121.86 23.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.809 ' HG2' HG11 ' A' ' 974' ' ' VAL . 30.9 Cg_endo -62.46 135.02 51.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 0.0 112.088 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.09 121.2 9.65 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.988 1.792 . . . . 0.0 110.94 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 973' ' ' MET . 14.2 m-20 -57.96 118.66 28.17 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.06 148.7 91.41 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.654 2.236 . . . . 0.0 111.873 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.475 HG12 ' ND2' ' A' ' 971' ' ' ASN . 19.3 t -45.25 122.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.959 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.475 ' ND2' HG12 ' A' ' 970' ' ' VAL . 72.9 m-20 60.71 45.61 9.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.537 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -179.71 139.71 3.95 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.956 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 968' ' ' ASP . 3.5 mpp? -133.54 150.03 51.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.809 HG11 ' HG2' ' A' ' 966' ' ' PRO . 8.4 p -89.92 121.77 40.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.17 0.509 . . . . 0.0 111.051 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 121.84 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.83 135.1 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.764 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 978' ' ' THR . 26.7 mm -74.47 -53.27 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.787 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 977' ' ' ILE . 82.0 p -147.66 -52.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.312 0.577 . . . . 0.0 110.87 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.73 139.35 18.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.02 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.6 pt -88.33 34.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.897 0.379 . . . . 0.0 111.656 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.554 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 80.6 mt-30 -80.81 151.19 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' A' 1005 ' ' ILE . 76.2 t -54.48 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 165.63 -48.35 0.28 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HG3' ' A' 1003 ' ' GLU . 93.9 p -80.04 -160.38 0.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 985' ' ' ARG . 4.0 ptp85 -151.39 134.97 16.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.705 HD12 HG21 ' A' ' 974' ' ' VAL . 34.6 pt -97.72 136.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.0 p -102.47 135.25 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.1 m-85 -96.24 143.69 27.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -148.71 120.72 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 60.9 m -83.58 119.71 25.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.463 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 992' ' ' THR . 7.6 t -72.57 137.4 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.547 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 991' ' ' THR . 96.6 m 111.23 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.309 1.005 . . . . 0.0 111.168 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 992' ' ' THR . . . -170.66 32.45 0.15 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.215 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -95.74 144.36 26.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.69 ' HB3' HG12 ' A' 1023 ' ' ILE . 7.6 ptm180 -89.28 136.23 33.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.23 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.414 HD11 ' HG3' ' A' 1018 ' ' PRO . 10.3 tt -72.26 132.28 43.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.3 mp -99.73 125.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.031 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.2 -139.87 14.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.389 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -85.86 135.02 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.544 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.5 p -102.96 20.31 17.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.58 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 47.4 t -159.19 146.84 17.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -153.68 134.31 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.062 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 984' ' ' SER . 39.3 tt0 -95.0 129.08 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.199 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.28 120.34 16.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.664 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.3 pt -129.9 -159.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.889 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' 1009 ' ' ASN . 41.6 tp -150.78 136.84 18.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.3 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.506 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -90.0 -40.31 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.828 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.68 -32.02 0.03 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.292 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.434 ' C ' HD11 ' A' 1006 ' ' LEU . 49.7 t30 -150.04 -44.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 110.511 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.421 ' O ' HD12 ' A' 1006 ' ' LEU . 37.4 m -92.66 131.44 37.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.979 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.97 143.59 32.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.819 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.506 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -155.76 144.06 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.307 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.494 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 49.1 m95 -68.29 144.09 54.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -53.55 -29.05 35.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.61 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 68.4 p -140.91 138.8 34.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.713 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.571 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.5 pptp? -62.31 152.47 79.16 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.014 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.76 132.36 41.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.635 2.224 . . . . 0.0 112.643 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.414 ' HG3' HD11 ' A' ' 996' ' ' LEU . 56.1 Cg_endo -69.88 -153.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.783 2.322 . . . . 0.0 112.578 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.7 mt -139.01 141.97 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.015 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 97.9 m -99.66 124.18 44.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -142.23 129.52 21.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.184 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -50.45 133.89 24.22 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.68 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.2 mt -74.83 123.91 89.27 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.797 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.813 2.342 . . . . 0.0 112.343 -179.892 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.454 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.771 0.32 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.567 ' N ' HD22 ' A' ' 949' ' ' LEU . 11.7 m80 66.92 140.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.928 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 47.8 m -80.11 129.07 34.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.1 mm100 -64.65 168.19 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.69 125.32 6.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.38 123.64 8.34 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 122.457 2.105 . . . . 0.0 112.82 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 136.11 54.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.011 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -77.25 138.55 39.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.503 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 14.5 m-85 -89.09 24.02 2.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.503 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.666 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 6.5 mp 68.74 -59.01 0.47 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 5.4 p90 -81.82 31.03 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -152.63 122.36 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 111.589 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -99.68 124.29 44.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.311 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.708 HD11 ' O ' ' A' ' 915' ' ' THR . 2.1 tm? -48.97 118.51 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.267 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.673 ' HE2' ' HD2' ' A' ' 929' ' ' LYS . 0.7 OUTLIER -95.89 -47.96 5.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.159 -179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.708 ' O ' HD11 ' A' ' 913' ' ' LEU . 31.7 m -64.59 128.39 35.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.613 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -52.36 135.14 33.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.875 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 915' ' ' THR . 79.4 p -152.02 144.67 24.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 918' ' ' THR . 24.9 m -156.46 53.36 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.73 156.2 9.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.5 t -86.4 -46.87 9.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.99 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.28 141.94 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -129.9 133.79 25.41 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.516 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -70.52 141.89 43.23 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.656 2.237 . . . . 0.0 112.229 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 947' ' ' ASP . 34.2 mt -55.44 152.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 88.47 -29.54 5.67 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.452 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.516 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.4 m -55.05 137.74 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 51.1 m -115.99 142.6 46.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.733 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.21 119.09 19.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.625 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.673 ' HD2' ' HE2' ' A' ' 914' ' ' LYS . 40.0 ttmt -89.4 138.52 31.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.395 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.582 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 5.9 m-85 -129.03 134.45 48.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -95.18 121.57 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 64.2 m -59.92 149.98 30.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.0 mtp180 -84.13 162.89 50.39 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.617 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 10.0 Cg_endo -51.88 146.23 29.46 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.241 1.961 . . . . 0.0 110.966 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 1.045 ' HB3' HG21 ' A' ' 982' ' ' VAL . 95.6 mt-10 83.23 25.89 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.888 0.742 . . . . 0.0 109.968 -178.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.794 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 78.8 m-85 -143.91 142.35 30.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.839 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.624 ' HB3' ' NZ ' ' A' ' 961' ' ' LYS . 36.2 p90 -144.06 134.73 24.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 111.439 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.811 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 155.75 28.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.41 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 63.09 144.43 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.0 111.784 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.57 124.93 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.524 2.15 . . . . 0.0 110.703 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 6.5 p90 -90.17 -166.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.66 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 59.2 m -170.21 132.27 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.414 ' HB ' ' CE3' ' A' ' 951' ' ' TRP . 13.5 pt -94.01 168.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.676 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.497 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.5 m -162.62 136.09 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 38.7 t -73.82 125.78 28.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.621 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.8 mm? -84.86 -57.03 3.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -176.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.709 ' HA ' HD13 ' A' ' 924' ' ' ILE . 23.7 t70 171.67 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.218 0.324 . . . . 0.0 111.031 -178.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -82.77 32.1 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 109.636 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 901' ' ' HIS . 22.2 mt 51.67 43.25 30.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.762 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.9 m -143.41 154.41 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.644 0.735 . . . . 0.0 112.467 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.495 ' C ' ' H ' ' A' ' 953' ' ' SER . 72.9 m95 -91.51 130.85 37.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.381 -1.282 . . . . 0.0 109.128 177.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.561 ' HB2' HD21 ' A' ' 946' ' ' LEU . 45.3 t -51.47 -10.22 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.372 0.606 . . . . 0.0 111.524 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 951' ' ' TRP . 48.0 t 61.93 121.55 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.744 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 11.5 Cg_exo -71.08 141.31 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.978 2.452 . . . . 0.0 110.74 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 11.0 tmtt? -154.59 134.64 13.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.212 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.68 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 38.7 t70 60.82 41.01 15.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.123 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.79 -111.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.089 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.811 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 26.8 p -87.97 103.29 15.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.4 mmtt -82.05 134.68 35.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.799 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 35.7 ptt180 -56.76 143.56 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.592 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.624 ' NZ ' ' HB3' ' A' ' 937' ' ' TYR . 5.3 mptp? -47.12 150.47 0.8 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.528 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.2 p -142.65 127.19 17.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 70.5 m -79.48 138.21 37.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.302 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.57 135.28 55.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.895 0.379 . . . . 0.0 110.757 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 83.2 m -48.59 114.45 3.61 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.548 ' HG2' HG11 ' A' ' 974' ' ' VAL . 20.0 Cg_endo -60.57 135.42 60.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.489 2.126 . . . . 0.0 112.013 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.12 117.18 3.34 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.068 1.845 . . . . 0.0 111.327 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.14 125.11 80.41 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 144.54 99.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.681 2.254 . . . . 0.0 112.076 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.4 t -46.42 129.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 991' ' ' THR . 75.3 m-20 61.76 45.65 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.9 -162.94 23.08 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.585 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 178.63 147.44 0.17 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 110.993 -179.641 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.906 HG21 HD12 ' A' ' 986' ' ' ILE . 8.6 p -91.08 102.79 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.773 0.797 . . . . 0.0 110.845 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -68.17 107.9 2.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.307 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.46 133.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 985' ' ' ARG . 44.9 mm -74.28 -36.07 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.088 0.47 . . . . 0.0 110.263 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.9 p -144.71 -49.54 0.26 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.88 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.1 t70 -161.57 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.822 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.465 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 6.2 pt -151.03 9.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 110.849 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 21.2 mt-30 -75.75 161.16 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 1.045 HG21 ' HB3' ' A' ' 935' ' ' GLU . 10.4 m -49.27 149.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.695 0.283 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 82.94 -32.76 2.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.976 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.0 m -75.84 131.71 39.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.153 0.501 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 977' ' ' ILE . 78.7 ttt180 -93.38 155.82 17.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.906 HD12 HG21 ' A' ' 974' ' ' VAL . 43.9 pt -141.78 123.81 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.255 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.3 p -107.61 136.9 46.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.466 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.483 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 5.2 m-85 -94.06 146.58 23.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.418 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -148.65 109.83 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.997 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 79.8 m -79.96 147.87 31.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 971' ' ' ASN . 5.6 t -64.31 146.39 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.7 m -44.02 123.69 3.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.49 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 134.73 -51.23 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.331 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.452 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.5 m80 -102.54 141.12 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.356 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.583 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.6 ptm180 -92.38 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.348 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.7 tt -71.77 132.73 44.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.2 mp -108.91 132.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 83.94 -144.25 21.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.15 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -81.34 130.24 34.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.767 0.317 . . . . 0.0 111.278 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.421 ' HA ' HD11 ' A' ' 996' ' ' LEU . 47.6 t -85.04 -51.84 6.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.665 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 33.1 t -90.37 155.02 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.707 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.545 ' H ' ' HB3' ' A' 1014 ' ' SER . 88.3 tt0 -111.56 129.94 55.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.766 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.531 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 43.2 t -71.25 125.62 27.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' 1012 ' ' HIS . 26.7 pt -129.42 -155.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.615 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 45.3 tp -150.62 -21.86 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.832 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 36.8 t 53.27 26.96 5.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 35.54 48.52 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.522 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -163.21 -49.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.539 ' C ' HD12 ' A' 1006 ' ' LEU . 40.2 m -145.54 136.45 24.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.843 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.02 124.94 28.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.873 0.368 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.485 ' CD2' HG13 ' A' 1005 ' ' ILE . 0.3 OUTLIER -161.2 152.91 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.761 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.531 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 93.7 m95 -64.92 144.38 57.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.985 0.422 . . . . 0.0 110.784 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . 0.545 ' HB3' ' H ' ' A' 1003 ' ' GLU . 45.4 t -64.18 -31.59 72.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . . . . . . . . . 40.9 p -144.19 138.67 28.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.871 0.367 . . . . 0.0 111.266 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 22.5 pttp -61.03 148.63 83.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 33.0 Cg_exo -58.3 130.3 37.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.613 2.209 . . . . 0.0 112.338 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.483 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.29 -160.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.758 2.306 . . . . 0.0 112.665 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.4 mt -142.33 138.59 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.885 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 82.1 m -92.66 124.42 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.452 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 34.0 tt0 -143.75 135.39 26.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.464 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' 1022 ' ' ARG . 15.1 tpp85 -49.04 131.92 18.99 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.398 0.618 . . . . 0.0 111.621 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.2 mt -76.89 124.96 87.57 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.878 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 32.8 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.809 2.34 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.946 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.232 0.147 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.623 ' C ' HD22 ' A' ' 949' ' ' LEU . 58.1 m80 -150.4 127.41 11.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.403 178.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 11.3 p -82.9 128.15 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -73.15 175.45 6.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.43 129.1 10.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 906' ' ' ASP . 50.8 Cg_endo -68.46 91.5 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.483 2.122 . . . . 0.0 112.421 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 905' ' ' PRO . 6.5 t0 29.75 -133.02 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 O-C-N 123.606 0.566 . . . . 0.0 111.123 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 31.7 t-80 -161.8 109.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 911' ' ' ALA . 22.7 m-85 -86.5 137.15 32.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 62.5 mt -80.08 -52.96 7.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.18 29.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 908' ' ' PHE . . . -155.91 139.98 16.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.402 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -136.47 130.9 33.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 929' ' ' LYS . 66.0 tp -48.42 156.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.332 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.857 ' HA ' ' HE2' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -145.49 -39.82 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.411 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 917' ' ' THR . 4.4 m -64.52 141.87 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.92 133.54 37.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.318 179.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 915' ' ' THR . 62.7 p -150.92 -65.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 917' ' ' THR . 32.1 p 66.28 -50.96 0.43 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.892 0.745 . . . . 0.0 112.555 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.36 151.93 44.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.1 p -85.04 -42.92 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 901' ' ' HIS . 63.9 t0 -85.02 126.26 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -106.78 136.13 19.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.63 140.6 18.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.106 2.538 . . . . 0.0 111.829 178.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.772 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 46.7 mt -55.88 148.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.059 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 73.55 77.57 0.61 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 2.2 m -176.72 122.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 54.9 m -83.43 129.69 35.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.981 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 917' ' ' THR . 6.0 tp -106.87 118.55 36.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.994 179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 929' ' ' LYS . 0.1 OUTLIER -85.63 135.15 33.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.785 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -135.4 129.34 33.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.258 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 940' ' ' PRO . 90.0 mt-10 -95.48 123.09 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 6.1 t -58.77 153.38 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.559 HH11 ' HG3' ' A' ' 933' ' ' ARG . 38.9 mtt85 -81.35 155.48 71.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 51.6 Cg_endo -68.45 66.4 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.024 2.483 . . . . 0.0 112.543 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.6 mt-10 -163.15 -9.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 959' ' ' LYS . 33.9 m-85 -134.79 140.6 46.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.402 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.1 p90 -99.91 137.7 38.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 148.13 21.38 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.456 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 938' ' ' GLY . 18.9 ptp180 46.72 164.28 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.654 0.782 . . . . 0.0 112.59 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.737 ' HB3' ' HA ' ' A' ' 931' ' ' GLU . 18.5 Cg_exo -66.39 127.32 17.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.782 2.322 . . . . 0.0 112.386 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.526 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 43.6 p90 -93.01 -161.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.5 p -172.86 134.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.066 0.46 . . . . 0.0 111.25 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.416 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 4.9 pt -95.05 -168.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.933 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 1.4 m -167.28 127.13 1.43 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.772 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 17.0 t -69.99 110.64 5.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 92.1 mt -82.75 -57.3 3.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.654 ' HA ' HD13 ' A' ' 924' ' ' ILE . 56.0 t0 173.01 -43.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.013 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -82.88 36.65 0.51 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.946 HD21 ' HB1' ' A' ' 900' ' ' ALA . 31.0 mt 51.67 46.15 26.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.5 OUTLIER -128.57 -173.6 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.988 -179.357 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 944' ' ' THR . 73.5 m95 -144.71 130.73 19.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.161 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 45.6 t -44.05 146.25 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -79.59 115.88 56.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.6 Cg_exo -76.31 61.05 6.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.496 2.797 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -76.43 139.27 40.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.486 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.569 ' HA ' ' NZ ' ' A' ' 959' ' ' LYS . 9.9 t70 58.11 82.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.041 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 30.9 m -149.69 -24.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.653 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 936' ' ' TYR . 72.6 m -150.47 133.19 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.569 ' NZ ' ' HA ' ' A' ' 956' ' ' ASP . 45.6 mmtm -140.72 150.53 43.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.303 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.613 ' HG3' ' NE2' ' A' ' 981' ' ' GLN . 12.2 tpt180 -53.34 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.971 0.415 . . . . 0.0 111.311 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.506 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 40.4 ttmt -56.32 149.63 16.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.501 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.665 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 60.4 p -141.14 140.36 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.257 0.551 . . . . 0.0 111.506 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.87 154.69 28.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.06 134.21 53.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.323 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 32.5 m -54.28 126.67 54.58 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 80.1 Cg_endo -76.3 134.25 15.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.778 2.319 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 31.7 Cg_exo -58.51 128.58 28.89 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.221 1.948 . . . . 0.0 111.511 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.86 129.52 85.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.87 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.07 142.67 88.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.864 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 39.5 t -47.5 124.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.244 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 73.1 m-20 76.42 -46.39 0.53 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.826 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -71.29 -151.61 0.95 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.438 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 178.79 140.33 0.1 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.934 HG21 HD12 ' A' ' 986' ' ' ILE . 11.1 p -96.51 143.1 12.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.684 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.489 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.5 m-70 -102.7 114.5 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 77.9 t -63.78 -39.01 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.22 0.533 . . . . 0.0 110.021 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 975' ' ' HIS . 9.3 mt 71.64 -33.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.409 178.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 48.1 p -144.84 -86.14 0.12 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 980' ' ' ILE . 2.8 m-20 -154.59 13.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.312 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 36.9 pt 50.65 34.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.366 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.665 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 3.8 mm100 -76.64 151.13 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.81 88.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.068 0.461 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 160.09 -42.67 0.44 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.217 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 49.2 m -76.09 -168.64 0.96 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.668 ' HD3' ' HB2' ' A' 1001 ' ' SER . 38.1 ttm180 -151.35 134.9 16.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.934 HD12 HG21 ' A' ' 974' ' ' VAL . 25.7 pt -95.26 131.75 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.761 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -99.3 129.27 45.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 111.797 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' 1000 ' ' SER . 7.1 m-85 -96.58 139.73 32.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.0 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.1 t -153.69 112.14 3.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.684 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.535 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t -81.38 142.13 33.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.602 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.2 t -65.01 154.09 38.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 992' ' ' THR . 6.0 t -45.64 109.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 111.246 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 159.57 -44.42 0.44 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.438 ' HB3' ' N ' ' A' 1021 ' ' GLN . 15.3 m80 -126.87 147.58 50.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.206 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.9 ptm180 -90.04 138.98 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' 1018 ' ' PRO . 9.8 tt -71.89 130.84 42.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.987 -178.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 997' ' ' ILE . 2.0 mp -109.73 93.39 2.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.464 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 158.31 -153.53 24.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.594 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.598 ' HB2' HG21 ' A' 1015 ' ' THR . 38.7 m170 -85.93 -35.43 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 996' ' ' LEU . 48.2 t 67.27 16.39 10.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.668 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.3 p -157.6 59.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.764 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -79.77 126.51 31.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.8 tt0 -96.09 131.48 42.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.923 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . 0.437 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 45.0 t -71.77 119.93 16.64 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' 1006 ' ' LEU . 41.2 pt -133.28 -156.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 112.131 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 56.4 tp -152.24 135.06 15.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.02 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 0.587 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -88.39 -45.39 10.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.29 -49.74 0.26 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.038 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.16 -37.19 12.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -145.45 144.91 30.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.696 -178.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.22 144.58 34.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.704 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.587 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.0 p80 -158.15 154.62 27.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.883 0.373 . . . . 0.0 111.514 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 72.3 m95 -68.63 149.49 49.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.9 m -58.92 -34.6 71.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.81 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 999' ' ' HIS . 6.4 t -143.08 149.33 38.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.228 0.537 . . . . 0.0 112.357 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.508 ' HD3' ' N ' ' A' 1017 ' ' PRO . 1.0 OUTLIER -59.54 136.86 89.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.939 179.052 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' 1016 ' ' LYS . 77.7 Cg_exo -50.75 119.86 5.78 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.541 2.161 . . . . 0.0 112.971 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.597 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 14.6 Cg_endo -57.28 147.72 75.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.822 2.348 . . . . 0.0 112.447 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.18 147.13 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 95.3 m -81.39 136.34 35.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.438 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 6.2 tt0 -145.72 132.31 19.85 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.353 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -44.03 136.04 3.95 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.5 0.667 . . . . 0.0 111.779 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' 1024 ' ' PRO . 59.6 mt -74.86 127.04 87.68 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.012 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.848 2.365 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 N--CA 1.462 0.125 0 CA-C-O 121.017 0.437 . . . . 0.0 111.661 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . 0.6 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 53.4 m80 -149.86 135.46 18.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 922' ' ' PHE . 10.0 p -80.72 121.43 25.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -69.23 172.36 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.539 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.08 8.46 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.567 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.509 ' HG2' ' OH ' ' A' ' 930' ' ' TYR . 51.1 Cg_exo -53.71 127.08 24.03 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.89 2.393 . . . . 0.0 112.624 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.74 119.61 14.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.854 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 38.7 m170 42.77 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.075 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 943' ' ' ILE . 21.8 m-85 -145.93 47.51 1.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.987 178.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 38.9 mt -75.08 -7.2 53.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.736 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -12.12 54.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.806 179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.02 137.22 16.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.321 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 931' ' ' GLU . 0.0 OUTLIER -91.61 123.79 35.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.083 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.584 HD11 ' HB ' ' A' ' 915' ' ' THR . 3.4 tm? -47.18 129.51 12.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.107 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -94.56 -31.26 13.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.93 -178.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.584 ' HB ' HD11 ' A' ' 913' ' ' LEU . 86.4 m -57.19 154.02 10.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.609 -179.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.582 ' NE2' ' H ' ' A' ' 917' ' ' THR . 3.0 pp0? -57.49 -47.91 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.533 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.582 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 52.8 p 51.76 138.77 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.802 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 918' ' ' THR . 16.3 m -161.31 32.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.232 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.78 140.51 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 45.6 m -86.74 37.86 0.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.456 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -154.68 127.72 8.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.862 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.421 ' O ' ' SG ' ' A' ' 902' ' ' CYS . 36.4 m-85 -119.12 142.29 31.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.929 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.21 136.73 10.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.949 2.433 . . . . 0.0 111.9 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.749 HG21 ' HA ' ' A' ' 947' ' ' ASP . 61.6 mt -52.02 150.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 72.83 74.79 0.76 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.738 -178.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 944' ' ' THR . 3.6 m -174.82 130.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.856 -178.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 75.5 p -99.99 155.35 17.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.114 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 942' ' ' SER . 95.4 mt -141.05 128.37 21.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.117 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.84 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 43.4 mmtm -85.07 141.5 30.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.509 ' OH ' ' HG2' ' A' ' 905' ' ' PRO . 11.4 m-85 -129.12 133.19 47.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 912' ' ' LYS . 50.1 mt-10 -92.53 118.39 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.138 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.68 148.94 18.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.728 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.438 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 59.2 mtt85 -83.01 155.96 67.29 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.893 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 936' ' ' TYR . 62.6 Cg_exo -38.56 -53.75 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.881 2.388 . . . . 0.0 113.613 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.92 31.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 72.2 m-85 -145.19 133.78 22.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.677 0.275 . . . . 0.0 111.184 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.59 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 2.2 p90 -103.89 138.88 39.84 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 137.24 143.57 4.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.868 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -73.02 170.69 12.66 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.547 0.213 . . . . 0.0 110.769 179.703 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.868 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 9.2 Cg_endo -59.39 114.71 2.15 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.399 2.066 . . . . 0.0 112.958 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 27.2 p90 -90.24 -164.62 1.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . 0.84 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 79.7 p -171.95 130.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.289 0.566 . . . . 0.0 112.352 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 908' ' ' PHE . 8.1 pt -96.14 -174.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.632 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 926' ' ' THR . 15.9 m -165.9 136.74 3.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 73.5 m -73.29 126.64 30.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.708 HD23 HG23 ' A' ' 950' ' ' VAL . 2.5 mm? -83.61 -60.51 2.1 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.749 ' HA ' HG21 ' A' ' 924' ' ' ILE . 4.7 t70 171.84 -40.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.262 0.352 . . . . 0.0 110.814 -178.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -86.38 39.67 0.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.819 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.2 mp 53.5 46.12 26.81 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.481 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.708 HG23 HD23 ' A' ' 946' ' ' LEU . 3.2 m -125.68 -179.98 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.798 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 943' ' ' ILE . 41.3 m95 -142.04 131.8 24.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.756 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.475 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.4 p -40.83 143.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.3 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 40.7 t -78.7 114.45 43.67 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.52 57.6 6.37 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.473 2.782 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 1.2 tmtp? -78.6 127.04 31.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . 0.775 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 38.8 t70 53.34 41.59 32.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.25 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.14 -41.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.424 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 17.2 t -157.64 68.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.478 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.775 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.4 mmtp -56.43 144.55 30.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.697 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 12.8 ptt-85 -55.43 147.39 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.151 0.5 . . . . 0.0 111.986 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.59 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 26.9 tptp -47.64 155.77 0.36 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.56 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.783 ' HB2' ' HG3' ' A' ' 981' ' ' GLN . 48.2 t -144.47 139.88 28.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.473 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.3 m -81.57 37.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.293 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 59.52 135.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.066 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.591 ' HA ' HD12 ' A' ' 980' ' ' ILE . 11.8 m -56.1 128.4 71.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.496 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 39.6 Cg_endo -66.4 127.14 16.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.489 2.126 . . . . 0.0 112.64 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 16.7 Cg_exo -67.0 132.85 29.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.499 2.133 . . . . 0.0 111.515 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.68 114.22 8.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.745 0.307 . . . . 0.0 110.781 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 144.15 29.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.685 2.257 . . . . 0.0 112.224 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.452 HG12 ' ND2' ' A' ' 971' ' ' ASN . 21.5 t -50.63 129.01 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.452 ' ND2' HG12 ' A' ' 970' ' ' VAL . 71.9 m-20 54.47 44.64 28.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.475 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -170.9 147.99 10.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.939 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.2 136.98 40.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.571 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.712 HG21 HD12 ' A' ' 986' ' ' ILE . 10.1 p -98.18 127.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.913 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 977' ' ' ILE . 25.1 m-70 -86.45 114.74 23.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 0.623 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.11 -28.14 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.017 0.436 . . . . 0.0 110.203 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 73.07 -43.54 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.134 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.0 p -146.11 -51.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.577 179.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.54 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 8.2 p-10 -160.26 -143.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.146 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 965' ' ' THR . 4.6 pt -151.0 6.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.783 ' HG3' ' HB2' ' A' ' 962' ' ' SER . 14.5 mp0 -76.65 177.32 7.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.601 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.55 132.66 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.233 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 106.83 -46.27 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.278 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.0 m -76.09 134.36 40.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 77.5 ttt180 -104.12 124.09 48.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.154 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.712 HD12 HG21 ' A' ' 974' ' ' VAL . 34.4 pt -97.1 136.51 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 0.0 111.535 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.4 p -103.84 136.38 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.566 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 14.9 m-85 -103.19 142.57 33.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.231 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.9 t -153.57 127.56 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.617 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 99.8 m -58.37 135.84 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.258 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 992' ' ' THR . 10.2 t -73.41 43.59 0.14 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.433 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 991' ' ' THR . 8.5 t 175.41 -130.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 992' ' ' THR . . . -133.69 51.25 0.85 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.499 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.604 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 3.8 m80 -94.49 -137.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' 1021 ' ' GLN . 13.5 ttt85 -140.88 112.06 7.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.921 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.83 131.86 45.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.818 0.342 . . . . 0.0 110.702 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -97.27 136.21 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 84.33 -152.25 27.78 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.383 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.72 ' ND1' HG21 ' A' 1015 ' ' THR . 22.4 m170 -81.55 129.74 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.688 0.244 . . . . 0.0 110.731 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 50.2 m -74.79 10.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.338 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . . . . . . . . . 30.7 t -159.29 151.42 20.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.07 128.86 8.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.383 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 12.7 pt-20 -96.48 134.24 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.539 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.2 t -71.83 123.17 22.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.67 139.18 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.262 0.553 . . . . 0.0 112.139 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 60.8 tp -84.5 120.57 26.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . . . . . . . . . 94.1 p -96.03 36.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.053 179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.556 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 67.19 123.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.058 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 73.17 -37.38 0.38 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 122.373 0.269 . . . . 0.0 111.671 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' 1008 ' ' GLY . 98.6 m -145.48 129.09 17.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 111.632 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -87.36 147.32 25.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.66 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.9 p80 -157.64 149.1 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.384 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . 0.453 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 91.7 m95 -65.79 139.21 58.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -51.39 -27.68 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.886 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.72 HG21 ' ND1' ' A' ' 999' ' ' HIS . 75.4 p -141.02 141.57 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.963 0.411 . . . . 0.0 111.611 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -53.82 153.15 8.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.09 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 44.9 Cg_exo -56.17 123.78 14.66 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.446 2.097 . . . . 0.0 112.733 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.566 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 14.0 Cg_exo -69.0 148.71 70.62 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.185 2.59 . . . . 0.0 112.243 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -100.35 -153.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.616 ' H ' HG22 ' A' 1019 ' ' ILE . 35.5 t -161.64 141.24 10.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.819 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.856 ' HB2' HD11 ' A' ' 997' ' ' ILE . 1.4 tt0 -151.36 127.98 10.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.563 -178.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -51.42 131.9 29.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 111.658 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 995' ' ' ARG . 62.9 mt -74.82 129.16 83.97 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.974 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.889 2.392 . . . . 0.0 112.287 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 900' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.912 0.387 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -110.52 124.45 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.998 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 902' ' ' CYS . . . . . 0.895 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 1.8 p -82.11 124.0 29.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -60.02 172.01 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.63 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 904' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -44.78 134.4 4.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 905' ' ' PRO . . . . . 0.615 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 3.5 Cg_exo -73.79 44.06 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.738 2.292 . . . . 0.0 112.582 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 4.0 t70 57.93 153.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.472 0.653 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -82.42 122.31 27.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.704 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 908' ' ' PHE . . . . . 0.791 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 8.3 m-85 -85.88 141.98 29.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 909' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -87.53 -65.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.688 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.595 ' O ' ' HG3' ' A' ' 933' ' ' ARG . 2.5 p90 -82.77 -22.12 34.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.469 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 911' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -87.04 142.94 27.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.54 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -129.81 123.41 30.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -49.17 116.56 1.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.428 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 914' ' ' LYS . . . . . 0.494 ' HD2' ' C ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -93.07 -42.28 9.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 915' ' ' THR . . . . . 0.597 HG22 ' NE2' ' A' ' 916' ' ' GLN . 5.0 m -66.16 -127.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 916' ' ' GLN . . . . . 0.597 ' NE2' HG22 ' A' ' 915' ' ' THR . 3.0 pm0 -173.5 139.43 0.74 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.676 0.274 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 917' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 918' ' ' THR . 1.8 t -157.18 -54.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 918' ' ' THR . . . . . 0.498 ' H ' HG23 ' A' ' 917' ' ' THR . 27.9 m 53.9 57.77 5.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.044 0.45 . . . . 0.0 110.599 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.44 156.66 14.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.4 t -87.9 -44.99 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.72 141.8 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 922' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 928' ' ' LEU . 46.2 m-85 -135.35 137.84 27.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 923' ' ' PRO . . . . . 0.603 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 65.3 Cg_endo -73.12 132.01 17.47 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.569 2.179 . . . . 0.0 111.427 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 924' ' ' ILE . . . . . 0.697 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.5 mt -56.78 147.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 95.7 -32.97 5.82 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 20.6 m -56.21 135.68 53.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.426 . . . . 0.0 112.145 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 61.6 p -107.2 142.99 36.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.388 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 928' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.1 mt -133.3 117.82 17.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.063 0.459 . . . . 0.0 110.974 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 38.1 ttmt -90.04 132.4 35.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.035 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 930' ' ' TYR . . . . . 0.43 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 4.2 m-85 -122.33 125.75 46.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.037 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 931' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 95.4 mt-10 -96.51 117.32 30.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.543 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 932' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 81.0 m -59.27 169.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.451 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 910' ' ' PHE . 46.5 mtp85 -84.36 151.16 58.92 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.142 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.507 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 19.7 Cg_exo -66.48 66.0 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.303 2.669 . . . . 0.0 112.994 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 935' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' 1006 ' ' LEU . 54.4 mt-10 -163.39 -29.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 109.925 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 936' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 910' ' ' PHE . 1.6 m-85 -94.96 147.26 23.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 937' ' ' TYR . . . . . 0.793 ' HB3' ' HD2' ' A' ' 961' ' ' LYS . 1.7 p90 -89.18 132.94 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.241 0.543 . . . . 0.0 111.152 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.37 139.48 4.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.382 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 939' ' ' ARG . . . . . 0.88 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -71.88 171.11 10.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.513 0.197 . . . . 0.0 110.549 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 940' ' ' PRO . . . . . 0.88 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 40.4 Cg_endo -67.89 121.61 8.66 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.385 2.057 . . . . 0.0 112.26 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.521 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 36.8 p90 -90.15 -161.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.73 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 82.5 p -172.79 134.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.16 -172.6 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.822 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -167.09 123.61 1.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 945' ' ' CYS . . . . . 0.697 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 33.7 t -63.91 112.09 2.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 946' ' ' LEU . . . . . 0.631 ' HB2' HG23 ' A' ' 950' ' ' VAL . 87.6 mt -81.25 -53.11 6.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 947' ' ' ASP . . . . . 0.679 ' HA ' HD13 ' A' ' 924' ' ' ILE . 19.2 t70 172.54 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.202 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -84.49 37.35 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 949' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.4 mp 53.5 48.96 20.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.994 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 946' ' ' LEU . 6.7 m -120.63 179.97 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.327 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 951' ' ' TRP . . . . . 0.615 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 97.2 m95 -145.13 49.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.231 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 23.5 t 49.5 -141.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 953' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 29.7 t -155.44 109.66 2.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.56 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 954' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.3 Cg_exo -75.05 53.99 3.53 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.121 2.547 . . . . 0.0 111.348 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 955' ' ' LYS . . . . . 0.606 ' HB3' ' NZ ' ' A' ' 955' ' ' LYS . 5.8 ttpm? -78.79 133.14 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.666 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 58.4 t0 57.42 40.59 27.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.281 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 957' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 958' ' ' CYS . 27.8 m -90.44 -42.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.511 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 958' ' ' CYS . . . . . 0.408 ' N ' HG23 ' A' ' 957' ' ' VAL . 84.6 m -155.0 141.63 18.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.164 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.5 mmtt -146.21 145.16 30.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.706 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 960' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 982' ' ' VAL . 14.8 tpp85 -53.24 103.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.141 0.496 . . . . 0.0 110.726 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 961' ' ' LYS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 937' ' ' TYR . 51.5 tttp -59.3 -179.06 0.07 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.566 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 962' ' ' SER . . . . . 0.705 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 83.9 p -149.66 142.58 24.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.625 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 77.2 m -79.51 164.69 23.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.16 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.9 133.16 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.363 . . . . 0.0 110.554 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 56.8 m -55.12 131.99 68.58 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 3.0 Cg_exo -74.15 125.12 9.54 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.736 2.291 . . . . 0.0 112.056 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.0 122.46 11.76 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.122 1.882 . . . . 0.0 111.305 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.05 116.07 17.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 969' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 64.5 Cg_endo -73.49 133.96 19.83 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.614 2.209 . . . . 0.0 111.993 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 970' ' ' VAL . . . . . 0.581 HG13 ' H ' ' A' ' 971' ' ' ASN . 1.1 p -53.77 -57.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.202 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 971' ' ' ASN . . . . . 0.581 ' H ' HG13 ' A' ' 970' ' ' VAL . 75.9 m-20 -79.01 34.23 0.23 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.356 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . 177.04 -147.77 8.53 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.953 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 973' ' ' MET . . . . . 0.498 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 22.5 ptt? 174.49 139.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 974' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 15.0 p -95.69 138.87 20.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.324 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 975' ' ' HIS . . . . . 0.477 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.9 m-70 -94.82 113.11 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 976' ' ' VAL . . . . . 1.029 HG13 HG23 ' A' ' 980' ' ' ILE . 92.2 t -65.63 -27.64 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 977' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 985' ' ' ARG . 4.8 mt 56.22 59.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.094 179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 12.3 p 76.61 -49.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.931 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 979' ' ' ASP . . . . . 0.58 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 2.6 p30 -159.88 138.52 10.57 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.459 -178.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 1.029 HG23 HG13 ' A' ' 976' ' ' VAL . 15.3 pt -91.46 32.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.974 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 981' ' ' GLN . . . . . 0.705 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -75.5 156.64 34.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.319 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 982' ' ' VAL . . . . . 0.803 HG13 ' HA ' ' A' 1005 ' ' ILE . 57.4 t -54.4 86.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.3 -49.25 0.3 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.922 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 984' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 979' ' ' ASP . 48.0 t -80.44 141.69 35.02 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.972 0.415 . . . . 0.0 110.691 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 985' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 13.9 ptm180 -101.08 137.39 39.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 986' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 16.6 pt -89.07 126.45 42.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.152 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 987' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' 1001 ' ' SER . 7.0 p -103.84 128.63 51.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.346 0.593 . . . . 0.0 112.017 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 988' ' ' TYR . . . . . 0.535 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 2.0 m-85 -96.4 143.75 27.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.164 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 86.1 p -148.67 117.05 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 990' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 994' ' ' HIS . 57.6 m -66.71 133.7 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.823 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 991' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 992' ' ' THR . 13.3 t -68.15 -147.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 992' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 991' ' ' THR . 49.5 m 8.75 -91.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.66 0.784 . . . . 0.0 113.044 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -158.38 44.93 0.47 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.294 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . 0.544 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 15.1 m80 -93.76 155.36 17.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . 0.675 ' HB2' HG12 ' A' 1023 ' ' ILE . 7.6 tpt180 -90.04 130.73 36.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.609 -179.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 996' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' 1018 ' ' PRO . 8.5 tt -67.58 134.54 51.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.699 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 997' ' ' ILE . . . . . 0.932 HD11 ' HG2' ' A' 1021 ' ' GLN . 14.8 mm -107.36 123.31 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 998' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 59.94 134.51 0.01 OUTLIER Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.197 178.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 999' ' ' HIS . . . . . 0.698 ' ND1' ' HB ' ' A' 1015 ' ' THR . 47.0 m170 48.32 -141.98 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.9 p -177.95 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.79 0.329 . . . . 0.0 111.231 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1001 ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 987' ' ' THR . 70.9 p -152.27 157.2 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1002 ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -151.99 133.42 14.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 111.391 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1003 ' ' GLU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 18.9 pt-20 -96.22 141.91 29.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -70.95 126.46 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1005 ' ' ILE . . . . . 0.803 ' HA ' HG13 ' A' ' 982' ' ' VAL . 30.9 pt -138.98 162.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1006 ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' 1007 ' ' SER . 3.2 tm? 58.82 -77.76 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.459 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1007 ' ' SER . . . . . 1.035 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 97.1 p 59.59 -111.36 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.458 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1008 ' ' GLY . . . . . 0.494 ' N ' ' HD3' ' A' ' 961' ' ' LYS . . . 64.43 -112.32 4.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.428 -178.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1009 ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' 1009 ' ' ASN . 2.7 m120 -65.82 -32.55 74.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1010 ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' 1007 ' ' SER . 77.2 m -150.06 122.53 8.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.493 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1011 ' ' ALA . . . . . 1.035 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -83.58 137.97 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.365 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1012 ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.4 OUTLIER -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.178 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 67.0 m95 -68.86 150.92 47.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1014 ' ' SER . . . . . . . . . . . . . 40.5 t -60.22 -34.6 73.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.476 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1015 ' ' THR . . . . . 0.698 ' HB ' ' ND1' ' A' ' 999' ' ' HIS . 74.8 p -141.78 149.38 40.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.775 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1016 ' ' LYS . . . . . 0.655 ' O ' ' HD3' ' A' 1016 ' ' LYS . 0.0 OUTLIER -56.85 147.72 52.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.56 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A 1017 ' ' PRO . . . . . 0.535 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 25.2 Cg_exo -64.8 123.38 11.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.906 2.404 . . . . 0.0 113.032 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1018 ' ' PRO . . . . . 0.636 ' HB3' HD21 ' A' ' 996' ' ' LEU . 23.6 Cg_exo -64.37 149.43 90.12 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 112.262 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1019 ' ' ILE . . . . . 0.877 HG22 ' H ' ' A' 1020 ' ' CYS . 2.7 mt -98.12 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.486 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1020 ' ' CYS . . . . . 0.877 ' H ' HG22 ' A' 1019 ' ' ILE . 23.1 m -163.29 128.58 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.433 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1021 ' ' GLN . . . . . 0.932 ' HG2' HD11 ' A' ' 997' ' ' ILE . 22.8 pt20 -153.21 130.98 11.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1022 ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 32.4 tpt85 -28.19 134.67 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1023 ' ' ILE . . . . . 0.675 HG12 ' HB2' ' A' ' 995' ' ' ARG . 33.6 mt -73.07 124.79 91.04 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.783 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.543 2.162 . . . . 0.0 112.468 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.778 0.323 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -174.13 45.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 900' ' ' ALA . 39.4 tt0 -60.23 143.88 51.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.107 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.965 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . 70.47 143.32 0.05 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.653 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.643 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 30.4 m80 -149.08 144.16 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.509 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.29 119.09 19.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.24 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.419 ' HA ' HE21 ' A' ' 903' ' ' GLN . 2.8 mm100 -55.88 166.21 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.628 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.97 131.58 8.86 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.127 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.27 138.32 65.76 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.415 2.077 . . . . 0.0 111.937 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.71 156.99 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -78.43 126.98 31.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.306 0.574 . . . . 0.0 111.542 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.57 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 2.0 m-85 -90.81 -33.36 15.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.614 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.9 mp 75.72 -48.44 0.6 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.8 OUTLIER -85.72 18.41 2.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.021 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.32 126.39 6.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 914' ' ' LYS . 52.2 mtmt -96.74 132.94 41.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.092 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.3 tm? -48.71 141.65 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.587 ' H ' HD22 ' A' ' 913' ' ' LEU . 74.7 mmtt -147.14 64.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.453 ' H ' HD13 ' A' ' 913' ' ' LEU . 17.6 m -167.46 139.55 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.066 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -51.33 124.81 12.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.586 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 915' ' ' THR . 75.1 p -152.06 135.42 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.6 p -148.59 44.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.491 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.64 156.09 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.702 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.0 m -84.1 -44.91 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.819 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.34 120.34 26.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -96.81 141.32 22.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.02 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.58 132.43 14.67 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.581 2.188 . . . . 0.0 112.382 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.743 HD13 ' HA ' ' A' ' 947' ' ' ASP . 65.7 mt -54.15 147.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 78.27 67.25 1.64 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 1.8 m -174.83 121.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 40.4 m -90.3 128.43 36.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.645 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 942' ' ' SER . 8.5 tp -97.64 127.51 43.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -80.64 133.59 35.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.49 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 19.7 m-85 -138.5 124.09 19.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.616 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.776 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 55.5 mt-10 -102.03 125.34 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.991 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 99.0 m -57.95 166.09 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.325 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 44.8 mtp85 -82.75 158.94 64.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 936' ' ' TYR . 90.1 Cg_exo -44.07 -46.44 11.13 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.635 2.223 . . . . 0.0 112.697 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.547 ' HA ' HD22 ' A' 1006 ' ' LEU . 56.1 mt-10 -73.77 26.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.43 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 67.3 m-85 -145.15 157.64 44.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.618 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 31.6 p90 -144.09 137.08 27.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 155.94 29.69 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.8 ptp85 46.71 164.36 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.497 0.719 . . . . 0.0 112.464 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.776 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 74.2 Cg_endo -75.2 116.44 4.55 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.294 1.996 . . . . 0.0 112.515 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.557 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 16.1 p90 -95.57 -159.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 81.1 p -171.86 136.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.719 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.657 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 3.3 pt -96.27 117.09 39.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.976 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.421 HG22 HD23 ' A' ' 946' ' ' LEU . 2.8 m -84.23 126.27 32.99 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 85.2 m -73.48 115.18 12.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 94.5 mt -83.19 -59.93 2.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.743 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.5 t0 172.91 -37.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.874 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -81.85 26.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.312 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.965 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 61.3 40.43 14.36 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 951' ' ' TRP . 7.1 p -136.43 152.71 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.341 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.657 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 46.7 m95 -93.72 141.46 28.47 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.907 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 88.5 p -48.14 140.96 6.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 59.9 p -79.02 108.53 8.48 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 120.919 0.39 . . . . 0.0 111.387 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 952' ' ' SER . 2.9 Cg_exo -76.29 129.59 11.33 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.054 2.503 . . . . 0.0 111.974 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.601 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -80.65 -145.11 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.466 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -80.71 60.97 4.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 958' ' ' CYS . 26.0 m -80.53 -56.36 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.585 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.615 ' N ' HG23 ' A' ' 957' ' ' VAL . 6.2 t -89.87 135.03 33.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 44.0 mtmt -150.36 130.12 13.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.871 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 935' ' ' GLU . 40.6 ttm180 -53.91 142.67 23.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.008 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.618 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 13.3 mmmm -54.51 149.28 10.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.161 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.759 ' HB3' HE21 ' A' ' 981' ' ' GLN . 63.7 p -142.49 131.57 23.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -81.53 146.74 30.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.64 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 965' ' ' THR . 2.0 tmtp? -66.77 133.41 50.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.047 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.663 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 47.4 m -53.22 130.77 51.56 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.332 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.556 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 60.1 Cg_endo -70.9 136.13 29.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.744 2.296 . . . . 0.0 112.384 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.54 134.58 64.25 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.151 1.901 . . . . 0.0 111.296 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -57.3 122.62 55.93 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 0.0 111.054 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.21 143.25 58.32 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.111 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.479 HG12 ' ND2' ' A' ' 971' ' ' ASN . 22.0 t -49.21 129.2 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.479 ' ND2' HG12 ' A' ' 970' ' ' VAL . 74.5 m-20 58.23 45.77 16.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.031 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -174.54 -166.75 32.98 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.528 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -178.88 146.71 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.226 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.956 HG21 HD12 ' A' ' 986' ' ' ILE . 7.1 p -98.66 133.54 40.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.823 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 989' ' ' SER . 0.0 OUTLIER -109.89 117.77 34.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.625 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 986' ' ' ILE . 33.9 m -74.46 131.03 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.83 -30.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.875 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.8 p -144.72 -54.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -158.64 -142.18 0.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.488 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -151.05 37.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.759 HE21 ' HB3' ' A' ' 962' ' ' SER . 7.9 mp0 -76.99 174.17 10.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.198 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 961' ' ' LYS . 28.1 m -63.91 30.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.62 -32.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.272 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 47.7 t -75.97 134.63 40.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 39.1 ptt180 -104.14 134.95 46.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.956 HD12 HG21 ' A' ' 974' ' ' VAL . 37.3 pt -97.94 137.38 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.0 p -96.98 135.48 38.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 0.0 111.697 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.442 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 6.7 m-85 -101.68 138.19 39.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 975' ' ' HIS . 51.1 m -153.54 121.61 6.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.966 0.412 . . . . 0.0 111.146 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 64.4 m -80.87 157.67 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.678 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.3 t -63.93 146.23 54.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.38 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 89.3 m -44.46 122.07 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 128.91 -54.11 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.284 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -102.99 138.56 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.663 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -95.13 147.24 23.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.314 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 997' ' ' ILE . 4.7 pp -71.63 139.74 49.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.601 ' CD1' ' HG2' ' A' 1021 ' ' GLN . 1.7 mp -122.17 111.15 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 151.76 -60.36 0.41 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.246 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.464 ' CD2' ' HB ' ' A' 1015 ' ' THR . 98.1 m-70 -154.08 -122.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.518 0.199 . . . . 0.0 110.827 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 77.7 p -168.31 -46.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.4 p -156.0 107.62 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.63 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.409 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' 1003 ' ' GLU . 7.4 pm0 -96.27 133.1 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.126 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 42.4 t -77.43 126.9 31.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 37.8 pt -135.75 -159.73 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.096 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.547 HD22 ' HA ' ' A' ' 935' ' ' GLU . 28.0 tp -150.9 138.05 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.914 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 70.4 m -88.17 -44.21 11.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.34 -45.2 0.27 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.001 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 4.6 m120 -105.15 -31.48 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.43 ' C ' HD12 ' A' 1006 ' ' LEU . 98.5 m -142.69 138.53 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.051 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -82.68 145.71 29.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.102 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 7.8 p80 -158.55 151.37 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.537 ' CZ2' ' HD3' ' A' ' 966' ' ' PRO . 66.1 m95 -66.16 141.7 57.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.1 t -60.92 -30.78 70.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.215 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.464 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 61.8 p -144.06 139.29 28.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.52 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.7 pptp? -63.32 155.22 75.52 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.413 ' HB3' ' HE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -66.01 130.09 23.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.523 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.442 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 23.5 Cg_exo -64.88 -150.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.901 2.401 . . . . 0.0 112.628 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.772 HG22 ' H ' ' A' 1020 ' ' CYS . 1.5 mt -136.91 -158.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.531 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.772 ' H ' HG22 ' A' 1019 ' ' ILE . 73.7 m -155.07 132.01 10.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.312 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.601 ' HG2' ' CD1' ' A' ' 997' ' ' ILE . 3.0 pt20 -152.42 142.26 22.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -48.51 128.92 15.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.359 0.599 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 37.8 mt -74.83 128.98 84.34 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.039 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.742 2.295 . . . . 0.0 112.34 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.64 138.7 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.061 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -56.18 136.72 52.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.912 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -166.16 131.94 2.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.55 ' C ' HD22 ' A' ' 949' ' ' LEU . 41.9 m80 -150.75 132.23 14.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.672 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 6.1 p -82.15 128.96 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.408 ' HA ' ' NE2' ' A' ' 903' ' ' GLN . 3.3 mm100 -69.85 170.63 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.291 0.567 . . . . 0.0 111.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.42 134.3 12.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.422 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.41 149.96 84.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.68 2.253 . . . . 0.0 112.305 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 907' ' ' HIS . 27.5 t70 -61.64 172.72 1.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.401 ' HD2' ' OD2' ' A' ' 906' ' ' ASP . 0.5 OUTLIER -77.96 130.4 36.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.242 0.544 . . . . 0.0 111.553 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 943' ' ' ILE . 1.5 m-85 -89.98 -43.46 10.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.6 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 82.2 mt 75.0 -43.01 0.5 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.929 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 908' ' ' PHE . 0.1 OUTLIER -83.55 -1.03 52.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -153.65 128.96 9.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.107 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -95.48 132.65 40.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -44.65 144.89 0.99 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.995 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 913' ' ' LEU . 38.5 ttpt -138.54 -36.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.514 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 917' ' ' THR . 4.6 m -64.63 143.64 57.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.686 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -49.4 125.29 10.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.221 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 915' ' ' THR . 81.0 p -152.04 143.77 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.239 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.3 m -159.48 -47.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.558 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.25 160.32 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.4 p -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -85.37 145.38 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -132.03 136.0 27.51 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.488 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.417 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.9 Cg_endo -69.54 141.86 47.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.838 2.358 . . . . 0.0 112.198 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 949' ' ' LEU . 15.9 mm -54.63 151.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 90.09 -30.74 5.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.0 m -55.9 125.25 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 112.015 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 34.9 t -95.94 135.14 38.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.855 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' A' ' 917' ' ' THR . 9.0 tp -117.1 114.19 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.685 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 24.9 ttmm -89.91 139.66 30.38 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.426 ' CZ ' HD23 ' A' ' 913' ' ' LEU . 7.0 m-85 -130.06 130.67 45.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.463 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 8.6 pt-20 -92.73 125.4 37.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.193 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 91.3 m -52.65 143.9 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.402 . . . . 0.0 111.42 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.9 mtp180 -82.93 155.94 67.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' 1006 ' ' LEU . 27.5 Cg_endo -63.44 64.75 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.721 2.28 . . . . 0.0 112.753 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.463 ' HG2' ' HE ' ' A' ' 960' ' ' ARG . 39.1 tt0 -174.85 2.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.22 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 40.1 m-85 -141.24 136.32 31.56 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.402 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.747 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 16.4 p90 -102.73 139.78 37.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.256 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.803 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 150.45 27.68 0.05 OUTLIER Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.58 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 938' ' ' GLY . 16.6 ptm180 45.79 171.04 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 122.971 0.508 . . . . 0.0 112.019 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.481 ' CD ' ' HB2' ' A' ' 939' ' ' ARG . 2.6 Cg_endo -77.86 112.89 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.109 1.873 . . . . 0.0 111.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.403 ' HD1' ' N ' ' A' ' 942' ' ' SER . 23.1 p90 -94.43 -160.52 0.78 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.467 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.403 ' N ' ' HD1' ' A' ' 941' ' ' PHE . 41.9 t -172.89 143.09 1.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.568 HD13 ' HZ ' ' A' ' 908' ' ' PHE . 3.5 pt -94.03 -170.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.986 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.42 HG22 HD23 ' A' ' 946' ' ' LEU . 1.0 OUTLIER -164.63 127.59 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.721 ' SG ' HD13 ' A' ' 924' ' ' ILE . 12.1 t -66.94 112.64 4.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 87.6 mt -82.18 -57.79 3.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -174.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.8 t70 172.74 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.948 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -83.5 34.95 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.912 HD21 ' HB1' ' A' ' 900' ' ' ALA . 30.7 mt 51.9 47.3 25.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.314 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.8 OUTLIER -135.43 -168.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.766 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.425 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 47.9 m95 -146.02 128.77 16.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 47.7 t -43.96 143.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.085 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.4 t -78.58 115.6 52.9 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.04 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.471 ' HG2' ' CE2' ' A' ' 908' ' ' PHE . 5.1 Cg_exo -75.95 53.49 3.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.372 2.714 . . . . 0.0 112.151 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.39 132.33 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.692 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.0 t0 56.99 77.89 0.25 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.231 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 24.5 m -149.31 -30.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.548 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.803 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 34.8 t -151.6 62.97 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.469 . . . . 0.0 110.913 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 11.3 mmpt? -55.23 153.77 6.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.646 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.824 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -58.43 132.25 53.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.669 -179.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.747 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 21.4 mmtp -56.37 135.64 53.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.082 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.629 ' HB2' ' HG2' ' A' ' 981' ' ' GLN . 48.3 t -152.66 129.08 10.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.998 0.428 . . . . 0.0 111.018 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 6.1 p -81.58 154.76 26.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.294 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -65.15 137.96 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.874 0.368 . . . . 0.0 110.92 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 69.4 m -54.17 128.53 57.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 32.6 Cg_endo -63.67 134.41 43.97 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.439 2.092 . . . . 0.0 111.732 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 52.2 Cg_exo -52.58 127.89 26.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.104 1.869 . . . . 0.0 111.525 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -57.49 125.46 71.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.95 138.74 41.21 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.5 p -50.89 124.2 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.681 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.496 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.2 m-20 59.24 48.04 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 110.706 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.521 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -156.87 -155.13 7.32 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.534 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 42.8 ttp 173.94 135.74 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.655 0.264 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.867 HG21 HD12 ' A' ' 986' ' ' ILE . 15.0 p -98.65 123.99 51.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 977' ' ' ILE . 33.3 m-70 -76.98 108.51 10.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 979' ' ' ASP . 89.1 t -62.58 -32.16 54.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 71.83 -47.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.82 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 74.8 p -148.38 -60.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.596 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.9 m-20 -155.01 -152.89 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.065 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.585 HG22 ' HH2' ' A' 1013 ' ' TRP . 11.5 pt -148.64 22.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.934 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 84.9 mt-30 -79.36 156.5 27.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.007 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.596 HG11 ' HG ' ' A' 1006 ' ' LEU . 49.2 t -49.95 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.158 0.504 . . . . 0.0 111.065 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 151.8 -40.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.266 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.0 p -76.01 138.54 40.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.517 ' HE ' ' HB2' ' A' 1001 ' ' SER . 76.9 ttt180 -104.19 125.97 50.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.867 HD12 HG21 ' A' ' 974' ' ' VAL . 41.3 pt -98.94 129.22 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.818 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 6.1 p -96.95 134.2 40.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 22.9 m-85 -96.13 139.02 32.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.454 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 52.5 m -152.42 116.45 4.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.476 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 70.8 m -74.8 146.92 41.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.29 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.521 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 94.0 m -64.64 142.96 58.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.245 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.0 t -41.94 124.38 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.025 0.441 . . . . 0.0 111.553 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.85 -48.35 0.97 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.742 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -102.33 144.5 30.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 111.346 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.545 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.2 ptt180 -92.63 143.7 26.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 997' ' ' ILE . 7.5 tt -71.81 132.32 44.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.555 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.7 mp -110.05 134.55 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.8 -128.22 9.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.359 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' 1015 ' ' THR . 93.8 m-70 -78.3 -132.51 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.437 0.16 . . . . 0.0 111.394 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.8 t -174.25 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.65 0.262 . . . . 0.0 111.191 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.517 ' HB2' ' HE ' ' A' ' 985' ' ' ARG . 76.2 p -150.89 150.29 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.893 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.496 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.58 130.53 10.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.0 tt0 -99.08 135.52 40.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 30.5 t -71.44 119.19 15.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.649 HD13 ' H ' ' A' 1005 ' ' ILE . 0.2 OUTLIER -140.78 160.39 23.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.541 0.686 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.596 ' HG ' HG11 ' A' ' 982' ' ' VAL . 93.1 mt -89.22 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.793 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 68.7 m -149.99 -32.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -157.05 57.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.274 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' 1009 ' ' ASN . 1.9 m120 61.44 27.74 17.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.009 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 8.0 m -149.11 131.99 16.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 128.65 34.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.859 0.362 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.465 ' O ' HD13 ' A' 1005 ' ' ILE . 8.2 p80 -158.09 145.8 18.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.487 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.585 ' HH2' HG22 ' A' ' 980' ' ' ILE . 58.7 m95 -67.48 137.73 56.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.9 p -54.8 -28.71 51.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.701 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 81.5 p -139.34 138.9 37.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.957 0.408 . . . . 0.0 111.815 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1017 ' ' PRO . 7.5 tmtm? -57.38 134.76 81.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.499 ' O ' ' HD3' ' A' 1016 ' ' LYS . 50.7 Cg_exo -54.56 126.67 23.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 31.8 Cg_exo -59.75 -157.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.832 2.355 . . . . 0.0 112.716 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.783 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -139.75 -161.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.257 0.551 . . . . 0.0 110.964 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.783 ' H ' HG22 ' A' 1019 ' ' ILE . 84.4 m -155.93 138.51 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 1.6 tt0 -151.25 134.77 16.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.309 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -46.21 128.46 9.62 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.3 mt -74.87 126.65 88.11 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.765 2.31 . . . . 0.0 112.555 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.812 0.339 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -170.27 134.29 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.46 -154.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.327 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -74.12 130.12 39.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.406 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -153.65 133.64 13.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.5 p -82.27 110.92 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.314 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -83.23 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.88 124.85 10.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.568 ' HB3' ' CG ' ' A' ' 951' ' ' TRP . 86.8 Cg_endo -82.33 124.09 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.701 2.268 . . . . 0.0 113.395 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 35.8 t0 26.05 -137.09 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.061 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 35.4 p-80 -161.05 151.43 17.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.168 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -145.51 134.0 21.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.2 mp -83.04 -49.16 9.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.212 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.515 ' HA ' ' HD3' ' A' ' 933' ' ' ARG . 0.8 OUTLIER -84.97 28.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -156.46 135.11 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.509 ' HD3' ' C ' ' A' ' 911' ' ' ALA . 0.0 OUTLIER -136.44 124.52 22.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.193 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 58.7 tp -49.38 144.67 5.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.137 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.735 ' HD2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -154.75 27.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 0.0 110.986 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.578 HG22 ' HG3' ' A' ' 916' ' ' GLN . 24.2 m -69.96 -111.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.572 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' A' ' 915' ' ' THR . 2.5 pp0? -169.13 34.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.452 0.644 . . . . 0.0 110.413 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.1 t -87.35 154.78 20.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.898 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 66.7 p -136.5 46.54 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.448 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -166.67 159.31 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.015 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.2 p -85.01 -36.95 20.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -84.58 146.03 27.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.6 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 87.6 m-85 -134.75 145.57 55.34 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 111.526 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.1 Cg_endo -84.5 137.51 6.92 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.453 2.769 . . . . 0.0 112.386 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.803 HG21 ' HA ' ' A' ' 947' ' ' ASP . 53.3 mt -54.34 154.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.196 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 74.24 58.14 4.43 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.642 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 3.8 m -175.23 127.26 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.43 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.627 ' HB3' ' OG1' ' A' ' 944' ' ' THR . 79.4 p -105.68 135.42 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.652 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.619 ' HB2' ' HE1' ' A' ' 930' ' ' TYR . 93.5 mt -96.85 128.29 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.363 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 940' ' ' PRO . 15.3 tppt? -82.88 121.05 26.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.748 0.309 . . . . 0.0 111.383 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 9.2 m-85 -111.72 127.95 55.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.735 ' HG3' ' HD2' ' A' ' 914' ' ' LYS . 61.9 mm-40 -92.16 107.0 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 110.637 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 83.1 m -59.62 178.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.856 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 910' ' ' PHE . 78.9 mtp180 -85.67 151.7 55.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.134 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 936' ' ' TYR . 53.2 Cg_exo -52.85 -37.17 76.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.904 2.403 . . . . 0.0 112.872 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -68.96 12.39 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.662 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 934' ' ' PRO . 33.8 m-85 -139.6 128.75 23.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 19.3 p90 -96.2 137.05 35.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.425 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 147.33 152.67 5.71 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.72 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.61 142.16 83.44 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.948 0.404 . . . . 0.0 111.344 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.746 ' HB2' ' HD2' ' A' ' 929' ' ' LYS . 40.9 Cg_exo -56.36 137.02 78.62 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.918 2.412 . . . . 0.0 111.85 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.727 ' HB3' HG11 ' A' ' 957' ' ' VAL . 30.4 p90 -89.71 124.7 34.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.55 0.691 . . . . 0.0 111.336 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 928' ' ' LEU . 75.1 p -75.52 -38.65 59.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.877 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' A' ' 930' ' ' TYR . 47.7 pt 49.32 93.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.618 0.723 . . . . 0.0 111.702 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 927' ' ' SER . 11.9 m -84.29 139.56 32.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.586 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 98.2 m -73.7 129.06 37.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 950' ' ' VAL . 2.2 mm? -82.56 -65.98 0.94 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.803 ' HA ' HG21 ' A' ' 924' ' ' ILE . 24.6 t70 172.82 -41.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.397 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -85.54 41.9 0.93 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.071 0.462 . . . . 0.0 109.89 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 900' ' ' ALA . 63.5 mt 53.28 48.87 21.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.312 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.783 HG23 HD23 ' A' ' 946' ' ' LEU . 6.6 m -131.87 177.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.483 0.658 . . . . 0.0 112.005 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.568 ' CG ' ' HB3' ' A' ' 905' ' ' PRO . 46.8 m95 -135.23 126.88 28.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.84 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.741 ' N ' HD21 ' A' ' 946' ' ' LEU . 11.0 m -42.43 148.85 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.274 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 35.4 t -76.98 121.52 84.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.0 Cg_exo -76.55 56.44 5.13 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.538 2.826 . . . . 0.0 111.734 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.525 ' HG2' ' OD1' ' A' ' 956' ' ' ASP . 57.8 tttp -75.87 123.61 25.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.431 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.525 ' OD1' ' HG2' ' A' ' 955' ' ' LYS . 1.4 m-20 57.76 98.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.384 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 941' ' ' PHE . 16.1 m -151.07 -31.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 92.5 m -152.05 65.4 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.6 mmtt -60.52 137.65 58.13 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 36.8 ttm180 -59.59 135.56 57.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.649 ' NZ ' HD11 ' A' 1006 ' ' LEU . 98.0 mttt -57.52 145.91 31.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.517 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.708 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 75.6 p -142.47 137.34 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 68.8 m -81.03 154.93 26.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.137 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.81 127.7 33.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.842 0.353 . . . . 0.0 110.667 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 19.4 m -57.15 136.83 80.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.765 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 974' ' ' VAL . 5.8 Cg_endo -48.15 140.45 19.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.229 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 968' ' ' ASP . 65.5 Cg_endo -73.62 49.4 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.791 2.327 . . . . 0.0 112.983 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 967' ' ' PRO . 1.7 p30 26.06 67.29 0.47 Allowed Pre-proline 0 N--CA 1.465 0.289 0 O-C-N 123.507 0.505 . . . . 0.0 112.153 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -40.56 134.56 2.18 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.76 2.307 . . . . 0.0 112.635 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.593 HG22 ' ND2' ' A' ' 971' ' ' ASN . 2.6 p -53.1 132.95 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.764 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.593 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.7 m-20 58.66 53.14 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.332 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -155.66 -153.51 6.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.554 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 38.9 ttm 176.52 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.543 0.211 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.616 HG21 ' HG3' ' A' ' 966' ' ' PRO . 1.9 p -93.83 168.44 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.23 0.538 . . . . 0.0 110.652 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.732 ' NE2' HG13 ' A' ' 977' ' ' ILE . 8.4 t60 -152.83 104.01 2.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.297 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' A' ' 979' ' ' ASP . 26.9 m -66.72 -24.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.802 HG22 HG23 ' A' ' 978' ' ' THR . 3.8 mp 76.86 -42.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 0.0 110.435 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 977' ' ' ILE . 81.5 p -144.77 -59.76 0.36 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.69 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.664 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.8 m-20 -157.39 -145.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.389 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.491 HG22 ' HH2' ' A' 1013 ' ' TRP . 4.2 pt -148.25 20.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.068 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.729 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 3.7 mm100 -76.63 177.2 7.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.87 -24.13 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 109.869 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -107.9 53.67 0.59 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.606 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 54.9 m -158.31 127.68 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.014 0.435 . . . . 0.0 110.604 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.595 ' O ' HD13 ' A' ' 977' ' ' ILE . 74.0 ttt180 -104.22 129.13 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.186 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 976' ' ' VAL . 42.7 pt -103.07 151.77 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.807 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.467 ' OG1' HD11 ' A' ' 977' ' ' ILE . 8.5 p -135.79 138.65 42.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.077 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 966' ' ' PRO . 2.0 m-85 -96.48 151.44 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.399 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 53.6 m -153.61 69.6 0.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.601 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 66.5 m -44.5 151.08 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.776 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 146.2 50.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 77.6 m -40.59 -38.68 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.183 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -55.03 -49.49 62.51 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.826 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.2 m80 -102.45 141.6 35.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.018 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.606 ' HB3' HG12 ' A' 1023 ' ' ILE . 33.6 ptt85 -90.65 141.43 28.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.32 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.719 HD23 ' N ' ' A' ' 997' ' ' ILE . 5.5 tt -71.87 133.82 45.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.719 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.0 mp -104.71 135.07 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.26 -139.19 15.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.453 ' CE1' ' HG3' ' A' 1018 ' ' PRO . 23.1 p80 -79.58 -135.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.436 ' N ' ' ND1' ' A' ' 999' ' ' HIS . 80.1 p -177.41 16.08 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.594 0.235 . . . . 0.0 111.358 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 32.1 t -159.43 145.05 15.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.43 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.519 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.64 124.02 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.1 tt0 -98.45 137.73 36.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 50.0 t -71.2 124.27 24.1 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 27.4 pt -133.39 -154.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.952 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.649 HD11 ' NZ ' ' A' ' 961' ' ' LYS . 2.5 tt -154.27 125.36 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.166 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.476 ' N ' HD23 ' A' 1006 ' ' LEU . 40.4 t -90.1 42.95 1.12 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.206 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 26.8 27.82 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.671 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -158.93 -47.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 93.2 m -147.82 143.53 27.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.054 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -79.83 131.92 36.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.6 p80 -160.18 155.95 25.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.491 ' HH2' HG22 ' A' ' 980' ' ' ILE . 80.9 m95 -64.29 144.72 56.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -54.54 -33.21 59.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 1.7 t -146.75 148.42 31.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.382 0.611 . . . . 0.0 112.29 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.63 138.04 86.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.985 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 77.5 Cg_exo -50.8 138.01 42.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.723 2.282 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 999' ' ' HIS . 24.1 Cg_exo -63.02 -160.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.29 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 42.3 mt -141.75 136.45 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.0 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 70.9 m -97.15 125.31 41.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.14 128.3 18.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.656 0.265 . . . . 0.0 110.689 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 13.0 ptp180 -47.5 140.36 5.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.588 0.708 . . . . 0.0 111.535 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.606 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.9 mt -74.84 130.87 80.3 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.162 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 46.0 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.809 2.34 . . . . 0.0 112.265 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 897' ' ' GLU . 53.0 mp0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.823 0.344 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -81.39 48.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.059 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 59.66 46.03 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.818 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -74.65 135.74 41.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -152.69 132.02 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.061 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 24.7 p -82.34 118.51 23.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.99 173.51 9.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.982 0.42 . . . . 0.0 111.307 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.42 135.55 7.38 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.272 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 54.7 Cg_exo -51.9 136.14 51.46 Favored 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 122.59 2.193 . . . . 0.0 112.068 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 907' ' ' HIS . 35.4 m-20 -64.83 105.1 0.94 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 906' ' ' ASP . 0.4 OUTLIER 11.27 110.77 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.173 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.671 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 3.6 m-85 -90.02 131.47 35.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 110.227 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.2 mm? -75.19 -68.71 0.53 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.685 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 0.5 OUTLIER -85.29 21.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -149.35 150.75 32.97 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.135 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.472 ' HD3' ' NH1' ' A' ' 933' ' ' ARG . 23.8 pttm -140.51 136.67 33.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.5 tm? -45.27 139.68 3.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.609 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.606 ' N ' HD13 ' A' ' 913' ' ' LEU . 30.7 mmmt -150.82 58.06 0.92 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.731 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 917' ' ' THR . 15.5 m -167.88 134.95 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.885 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.512 ' NE2' HG23 ' A' ' 915' ' ' THR . 3.4 pm0 -55.74 138.37 47.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 915' ' ' THR . 60.0 p -150.75 -57.22 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.396 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 22.6 p 68.79 -50.11 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.831 0.707 . . . . 0.0 112.255 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.32 148.14 48.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.43 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.7 p -85.8 -48.29 8.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.25 123.27 30.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.182 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 50.1 m-85 -103.86 146.2 32.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.486 . . . . 0.0 112.019 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 922' ' ' PHE . 1.6 Cg_endo -83.8 139.9 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.488 2.792 . . . . 0.0 111.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.768 HD13 ' HA ' ' A' ' 947' ' ' ASP . 48.1 mt -52.77 152.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.341 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 944' ' ' THR . . . 89.65 -40.74 3.02 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 38.1 m -56.85 137.69 54.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.345 . . . . 0.0 110.458 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.582 ' HB2' ' OG ' ' A' ' 942' ' ' SER . 82.2 p -120.8 132.33 54.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.113 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 942' ' ' SER . 72.8 mt -106.21 136.41 45.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.04 0.447 . . . . 0.0 111.741 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.525 ' HB2' ' OG1' ' A' ' 915' ' ' THR . 99.3 mttt -86.5 133.41 33.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.723 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 11.6 m-85 -132.64 125.27 30.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.531 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 914' ' ' LYS . 95.4 mt-10 -95.29 133.18 39.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.346 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 72.8 m -58.51 150.31 23.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.018 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 41.5 mtp85 -82.84 163.36 51.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.518 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 40.6 Cg_endo -66.75 64.57 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 95.1 mt-10 -165.43 -18.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.232 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 3.0 m-85 -129.38 -168.75 1.99 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 958' ' ' CYS . 16.5 p90 -150.03 138.26 20.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.985 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 167.22 4.84 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.353 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.935 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 6.6 ppt_? 46.06 173.27 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 123.013 0.525 . . . . 0.0 112.286 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 13.6 Cg_endo -58.93 89.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.41 2.073 . . . . 0.0 113.059 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.503 ' HA ' ' NH1' ' A' ' 939' ' ' ARG . 42.2 p90 -90.17 120.85 31.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.879 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 927' ' ' SER . 23.8 t -74.03 160.21 31.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.809 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.533 HG22 ' HG3' ' A' ' 954' ' ' PRO . 5.4 pt -137.64 104.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 925' ' ' GLY . 30.3 m -82.33 130.79 35.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 97.9 m -73.71 132.08 42.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.5 mm? -84.54 -60.22 2.14 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.768 ' HA ' HD13 ' A' ' 924' ' ' ILE . 55.1 t0 171.66 -36.81 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.691 0.282 . . . . 0.0 110.953 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 950' ' ' VAL . 73.3 m-80 -82.94 37.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 900' ' ' ALA . 79.6 mt 50.5 42.98 27.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.934 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 948' ' ' ASN . 22.2 m -136.13 147.99 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.796 0.808 . . . . 0.0 112.07 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 952' ' ' SER . 52.2 m95 -91.82 122.16 34.1 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.596 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -38.68 126.13 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 70.3 m -78.15 107.14 4.96 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 110.909 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 943' ' ' ILE . 60.4 Cg_endo -100.92 55.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 124.013 3.142 . . . . 0.0 112.608 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -77.44 38.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.539 0.685 . . . . 0.0 110.09 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 954' ' ' PRO . 34.3 t70 -159.92 53.78 0.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.692 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 941' ' ' PHE . 8.8 m -147.05 -17.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.871 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 937' ' ' TYR . 11.1 t -147.57 135.38 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.123 0.487 . . . . 0.0 110.901 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 32.0 mtmt -147.77 149.87 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.252 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 52.2 ttm-85 -53.31 135.38 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 937' ' ' TYR . 30.2 mmtp -56.29 164.73 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.36 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.756 ' HB3' HE22 ' A' ' 981' ' ' GLN . 85.1 p -145.5 132.84 20.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.797 0.332 . . . . 0.0 110.216 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 49.2 m -81.57 36.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 964' ' ' LYS . 0.8 OUTLIER 61.7 136.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 980' ' ' ILE . 30.7 m -55.79 129.06 71.06 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 57.5 Cg_endo -70.71 121.3 7.79 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.462 2.108 . . . . 0.0 112.693 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 11.8 Cg_exo -69.76 123.76 10.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.455 2.103 . . . . 0.0 111.364 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.54 120.95 64.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.36 141.27 50.89 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 C-N-CA 122.38 2.053 . . . . 0.0 111.752 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.615 HG22 ' ND2' ' A' ' 971' ' ' ASN . 2.2 p -45.96 127.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.615 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.4 m-20 66.16 49.34 1.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.888 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -163.82 -158.15 9.82 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.867 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 40.0 ttm 176.72 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.536 0.208 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.5 p -100.56 131.47 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.819 0.343 . . . . 0.0 111.52 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -91.87 111.46 23.0 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 30.1 m -64.22 -18.69 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 109.913 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 987' ' ' THR . 12.4 mm 74.57 -47.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 67.9 p -148.18 -49.97 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.759 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 55.4 m-20 -157.49 -149.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.866 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -151.08 25.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 111.143 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.756 HE22 ' HB3' ' A' ' 962' ' ' SER . 3.0 mm100 -80.91 163.7 23.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.143 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 961' ' ' LYS . 54.8 t -55.43 93.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.078 0.466 . . . . 0.0 111.14 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.66 -47.6 0.54 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.232 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.5 t -76.4 141.31 41.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 111.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 3.5 ptm85 -104.22 131.86 51.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.546 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.7 pt -98.13 127.48 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.345 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.569 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -97.07 132.69 42.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.977 0.417 . . . . 0.0 110.953 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.516 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 10.8 m-85 -96.6 139.96 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.443 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -152.74 116.43 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.181 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.688 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 83.9 m -73.02 147.21 45.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.454 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.56 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 8.6 t -64.86 149.16 50.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.614 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 84.8 m -46.68 108.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.317 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 152.92 -57.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.265 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.415 ' HB3' ' C ' ' A' 1021 ' ' GLN . 7.6 m80 -102.46 145.92 28.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.77 ' HB3' HG12 ' A' 1023 ' ' ILE . 15.6 ptm180 -90.02 139.16 30.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.166 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.689 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.3 tt -71.84 132.7 44.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.942 0.401 . . . . 0.0 110.734 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.689 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.5 mp -106.07 130.84 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.52 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 96.56 -138.75 14.1 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.085 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -81.27 -140.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.414 0.15 . . . . 0.0 111.146 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 42.7 t 178.9 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.424 ' HB2' HH21 ' A' ' 985' ' ' ARG . 66.1 p -158.8 148.95 19.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.045 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.55 118.16 3.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 88.2 tt0 -96.33 128.61 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 50.6 t -71.32 119.39 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.404 ' HA ' HG13 ' A' ' 982' ' ' VAL . 37.4 pt -136.6 143.6 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.244 0.545 . . . . 0.0 111.892 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . . . . . . . . . 53.8 tp -84.61 124.48 31.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.998 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.5 t -95.96 -50.24 4.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' 1010 ' ' THR . . . 169.26 122.16 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.71 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 72.99 -37.14 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.164 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' 1008 ' ' GLY . 84.6 m -145.72 136.26 24.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.216 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -82.49 151.09 26.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.372 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.7 p80 -153.07 147.59 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 86.9 m95 -64.37 139.13 58.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.162 0.506 . . . . 0.0 111.297 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 44.6 m -62.42 -21.75 65.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.282 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 37.8 m -138.9 135.74 34.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.4 pttm -72.73 148.28 89.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.768 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.85 129.02 28.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.589 2.193 . . . . 0.0 112.397 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.24 -154.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.735 2.29 . . . . 0.0 112.465 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 53.1 mt -139.91 141.54 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 97.5 m -100.85 125.65 47.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.415 ' C ' ' HB3' ' A' ' 994' ' ' HIS . 3.3 tt0 -145.51 138.11 25.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.387 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -45.55 135.62 6.33 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 111.703 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.77 HG12 ' HB3' ' A' ' 995' ' ' ARG . 54.8 mt -74.76 126.94 87.92 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.711 2.274 . . . . 0.0 112.482 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.732 0.301 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -178.67 136.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -151.39 130.38 12.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.776 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 64.65 136.3 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.52 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.501 ' C ' HD22 ' A' ' 949' ' ' LEU . 8.5 m170 -147.5 120.78 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.52 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 24.9 p -82.25 122.33 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.02 167.69 20.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.476 0.655 . . . . 0.0 112.045 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -47.53 133.23 10.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.509 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.5 Cg_exo -62.32 154.54 62.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.926 2.418 . . . . 0.0 112.407 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 907' ' ' HIS . 27.1 t70 -62.23 173.08 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.677 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.437 ' N ' ' CG ' ' A' ' 906' ' ' ASP . 42.6 m170 -77.68 121.48 24.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.288 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 1.9 m-85 -86.43 -36.09 19.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.48 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 92.0 mt 75.98 -46.03 0.54 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.748 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 6.05 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.66 126.44 5.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.2 124.81 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.309 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 929' ' ' LYS . 63.2 tp -51.61 156.79 1.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.503 ' H ' HD12 ' A' ' 913' ' ' LEU . 73.9 mmtt -145.29 -66.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.568 HG22 HE21 ' A' ' 916' ' ' GLN . 17.9 m 19.88 -117.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.687 0.617 . . . . 0.0 111.884 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.568 HE21 HG22 ' A' ' 915' ' ' THR . 2.6 pp0? -175.95 41.71 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.201 0.524 . . . . 0.0 110.476 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.669 HG21 HD11 ' A' ' 928' ' ' LEU . 39.0 p -82.8 -172.82 4.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 98.0 m -169.1 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.478 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.4 157.76 37.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -84.61 -43.62 14.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.37 124.8 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.53 ' HE2' HG21 ' A' ' 917' ' ' THR . 80.4 m-85 -103.69 134.55 19.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.574 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 59.9 Cg_endo -71.94 141.92 37.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 112.126 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.689 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 32.7 mt -59.69 156.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 82.71 -35.6 2.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.716 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.574 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 18.7 m -56.04 127.42 30.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.526 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 48.7 m -101.72 131.42 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 917' ' ' THR . 5.2 tp -95.79 -168.07 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.177 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.695 ' O ' HD12 ' A' ' 913' ' ' LEU . 40.6 ttmt -157.44 130.36 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.591 ' CE1' HD23 ' A' ' 928' ' ' LEU . 5.4 m-85 -129.09 135.64 49.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.384 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.653 ' OE1' ' HB3' ' A' ' 940' ' ' PRO . 2.9 mm-40 -96.26 134.78 38.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.363 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 86.6 m -55.33 155.35 5.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.566 ' HG2' ' HD2' ' A' ' 934' ' ' PRO . 65.1 ttt180 -82.37 145.13 51.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 933' ' ' ARG . 67.6 Cg_exo -39.35 -41.2 2.15 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.717 2.278 . . . . 0.0 112.884 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 961' ' ' LYS . 50.2 mt-10 -69.14 -34.74 75.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.487 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.43 ' HD1' ' HB3' ' A' ' 933' ' ' ARG . 18.3 m-85 -94.85 142.61 27.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.144 0.497 . . . . 0.0 112.305 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 8.3 p90 -100.08 141.99 32.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.655 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 153.44 147.65 4.69 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.222 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.688 ' H ' ' HD2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -73.08 158.84 86.47 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.653 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 31.2 Cg_exo -60.03 115.45 2.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.573 2.182 . . . . 0.0 112.208 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 930' ' ' TYR . 49.3 p90 -95.6 -168.21 1.74 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 928' ' ' LEU . 68.8 m -166.93 134.6 2.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.099 0.476 . . . . 0.0 111.33 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.412 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 5.1 pt -102.38 125.69 56.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.443 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 18.0 m -82.77 122.09 27.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.28 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 8.4 t -71.44 103.07 2.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 88.0 mt -82.72 162.02 21.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.437 ' HA ' HG21 ' A' ' 924' ' ' ILE . 62.6 t0 -45.44 -34.23 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.135 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.663 ' O ' HG13 ' A' ' 950' ' ' VAL . 2.6 m120 -81.32 28.89 0.37 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.623 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 900' ' ' ALA . 45.7 mt 47.79 31.78 2.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.323 0.582 . . . . 0.0 109.918 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 948' ' ' ASN . 29.5 m -107.92 -160.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.62 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.511 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 81.9 m95 -150.67 121.41 7.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.817 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 79.9 p -41.49 142.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.497 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.479 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 39.7 t -78.58 115.08 48.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.051 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.8 Cg_exo -74.61 130.81 14.07 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.995 2.463 . . . . 0.0 111.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.484 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 29.8 mmmt -80.77 -133.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.464 0.65 . . . . 0.0 111.755 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 6.7 t70 -78.36 60.32 2.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.314 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 33.9 m -81.51 -34.09 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.885 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.48 ' O ' ' HE3' ' A' ' 959' ' ' LYS . 30.0 m -150.41 125.7 10.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.12 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.1 mmpt? -137.48 149.53 46.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.834 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.479 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 14.7 mmt85 -53.2 120.7 6.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 28.8 mtpp -58.29 -171.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.417 ' HB3' HE21 ' A' ' 981' ' ' GLN . 81.1 p -153.14 137.7 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.8 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.411 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 58.5 m -81.58 38.85 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt 59.0 130.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.433 ' HA ' HD12 ' A' ' 980' ' ' ILE . 49.6 m -57.74 126.7 76.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 986' ' ' ILE . 52.6 Cg_endo -68.6 128.75 17.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.418 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 34.9 Cg_exo -59.66 131.18 38.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.365 2.043 . . . . 0.0 111.614 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -61.28 120.63 56.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.954 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.62 139.22 36.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.072 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' 1020 ' ' CYS . 20.4 t -52.01 130.06 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.439 ' ND2' HG12 ' A' ' 970' ' ' VAL . 72.8 m-20 56.82 52.8 8.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.694 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -158.26 -153.3 6.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.243 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 32.2 ttp 175.01 119.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.607 0.241 . . . . 0.0 111.002 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 974' ' ' VAL . 12.0 p -101.02 124.21 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.728 0.775 . . . . 0.0 111.355 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.62 ' CD2' HG12 ' A' ' 977' ' ' ILE . 5.5 t60 -87.28 103.08 15.11 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.6 m -53.02 -20.51 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 985' ' ' ARG . 12.9 mt 66.58 60.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.583 0.706 . . . . 0.0 109.395 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 14.1 p 80.79 -48.42 0.29 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.234 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.562 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 55.3 m-20 -156.27 -158.57 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.86 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.485 HG22 ' CG2' ' A' ' 986' ' ' ILE . 12.8 pt -151.04 23.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.35 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.562 ' OE1' ' HB3' ' A' ' 979' ' ' ASP . 7.2 mp0 -76.54 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.15 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 96.2 t -55.49 84.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.125 0.488 . . . . 0.0 110.736 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.9 -45.94 0.45 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.108 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 50.5 m -76.05 138.85 41.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 111.257 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.686 ' HE ' ' HB3' ' A' 1003 ' ' GLU . 38.3 ttm180 -103.37 139.1 39.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.351 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 976' ' ' VAL . 20.3 pt -98.62 122.45 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.678 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.483 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.7 p -101.93 135.56 43.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.095 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 3.1 m-85 -96.49 140.4 31.18 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.747 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 43.9 t -151.75 64.45 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 35.8 m -35.75 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.618 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 9.0 t -174.18 165.87 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 9.0 t -52.84 -36.28 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.659 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' 1023 ' ' ILE . . . -63.69 -55.14 26.68 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.488 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -101.81 136.73 41.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.413 . . . . 0.0 111.26 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' 1023 ' ' ILE . 38.7 ptt180 -92.57 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.511 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.7 tt -72.36 132.23 43.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -111.25 132.78 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 111.302 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 68.04 131.84 0.04 OUTLIER Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.217 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 47.5 -139.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.652 0.263 . . . . 0.0 111.449 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.1 t -177.05 -30.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 46.8 t -154.56 168.66 26.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.511 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.96 133.65 14.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.045 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.686 ' HB3' ' HE ' ' A' ' 985' ' ' ARG . 19.3 pt-20 -96.15 134.14 39.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.122 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.453 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.8 t -76.42 124.76 28.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' 1014 ' ' SER . 41.9 pt -135.94 -154.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.471 . . . . 0.0 112.115 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' 1010 ' ' THR . 62.3 tp -151.85 138.55 18.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.009 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.507 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 46.6 t -87.91 -48.22 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 172.17 20.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.13 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 10.3 p-10 174.94 -53.79 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.782 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.488 ' O ' HD12 ' A' 1006 ' ' LEU . 10.3 m -98.88 130.56 45.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.606 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -81.21 134.8 35.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.507 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.1 p80 -158.82 147.64 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 111.65 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.493 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 60.5 m95 -68.23 134.96 51.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.771 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' 1005 ' ' ILE . 91.4 p -68.37 -12.22 60.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.46 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 6.4 m -140.93 139.24 34.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 pttm -69.76 146.0 95.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.057 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.468 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 23.9 Cg_exo -64.63 135.71 46.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.869 2.379 . . . . 0.0 112.55 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 998' ' ' GLY . 38.0 Cg_endo -66.28 -156.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.568 2.178 . . . . 0.0 112.449 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.7 mt -142.22 139.95 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.694 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 71.7 m -93.41 124.3 37.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -145.79 133.3 20.84 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.6 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -48.12 133.2 15.38 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.559 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.645 HG12 ' HB3' ' A' ' 995' ' ' ARG . 44.8 mt -75.14 124.93 89.6 Favored Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.803 2.336 . . . . 0.0 112.253 -179.85 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.75 0.31 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -171.41 135.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 900' ' ' ALA . 5.5 mm-40 -152.58 -155.33 0.6 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.71 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . 59.69 -145.4 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.612 ' N ' HD22 ' A' ' 949' ' ' LEU . 16.1 m80 67.8 127.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.703 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 2.4 p -82.27 130.03 35.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.453 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -67.22 -177.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.576 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.21 137.9 6.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 2.7 Cg_exo -75.07 63.41 6.05 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.202 2.601 . . . . 0.0 112.167 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.1 t0 36.32 -131.99 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.676 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 17.6 t-160 -160.45 120.21 2.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.848 0.356 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.595 ' HE2' ' HG2' ' A' ' 954' ' ' PRO . 21.9 m-85 -88.15 136.35 33.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.98 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.25 -58.58 3.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.347 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -84.84 26.99 0.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -156.4 122.33 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.443 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.584 ' NZ ' ' HB2' ' A' ' 912' ' ' LYS . 10.3 mtmp? -100.52 131.49 46.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.548 HD21 ' OG1' ' A' ' 917' ' ' THR . 52.1 tp -48.22 129.71 15.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.491 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.564 ' HD3' ' HD2' ' A' ' 929' ' ' LYS . 51.6 tttp -94.51 -43.08 8.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 42.7 m -64.6 144.43 57.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.853 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 916' ' ' GLN . 1.3 pp0? -77.54 49.29 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.548 ' OG1' HD21 ' A' ' 913' ' ' LEU . 39.5 p -81.42 146.28 30.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 72.9 p -136.39 -33.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.576 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.47 156.22 39.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 54.6 m -84.78 -38.83 19.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.9 145.29 28.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.32 137.68 25.06 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.511 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -69.74 136.6 33.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.716 2.277 . . . . 0.0 111.764 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 39.9 mt -58.04 154.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.205 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.02 -34.02 3.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 22.9 m -55.93 122.24 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.659 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.6 m -94.91 120.72 35.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.885 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 942' ' ' SER . 10.0 tp -99.24 118.85 36.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.316 . . . . 0.0 110.737 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.564 ' HD2' ' HD3' ' A' ' 914' ' ' LYS . 39.9 ttmt -85.34 138.76 32.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.106 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 941' ' ' PHE . 7.2 m-85 -131.65 134.85 46.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.515 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.495 ' HG2' ' HD2' ' A' ' 914' ' ' LYS . 56.6 mm-40 -95.58 130.53 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.607 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.16 156.52 9.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 45.0 mtt-85 -84.8 151.84 58.61 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 936' ' ' TYR . 86.6 Cg_exo -47.48 -46.75 19.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.685 2.257 . . . . 0.0 112.859 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.587 ' HB3' HG21 ' A' ' 982' ' ' VAL . 4.8 mm-40 -73.29 20.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.745 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 82.2 m-85 -145.17 137.32 25.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.402 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.721 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 14.3 p90 -97.71 138.0 35.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.423 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 158.57 142.59 3.43 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.082 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 23.0 ptt-85 -73.06 159.07 86.09 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.258 . . . . 0.0 110.362 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.84 149.17 71.13 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.275 1.983 . . . . 0.0 111.294 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 957' ' ' VAL . 50.7 p90 -140.01 -167.91 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.78 0.324 . . . . 0.0 110.93 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.4 p -172.88 134.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.483 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 15.3 pt -97.21 113.55 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 47.1 m -78.49 126.67 31.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.828 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.2 t -72.96 125.1 26.8 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.155 0.502 . . . . 0.0 109.936 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.915 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -88.35 167.9 13.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 0.0 113.606 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -50.6 -38.63 46.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.293 -1.776 . . . . 0.0 112.25 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.549 ' O ' HG13 ' A' ' 950' ' ' VAL . 50.9 t30 -81.6 34.25 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 900' ' ' ALA . 21.0 mt 47.93 36.73 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.196 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.915 HG23 HD23 ' A' ' 946' ' ' LEU . 29.1 m -112.85 -159.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.241 0.543 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 85.4 m95 -147.32 124.89 11.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.473 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.9 p -39.68 141.75 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.803 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 33.7 m -79.51 112.91 32.6 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.595 ' HG2' ' HE2' ' A' ' 908' ' ' PHE . 5.8 Cg_exo -79.63 143.56 16.96 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.456 2.771 . . . . 0.0 112.346 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -159.01 137.22 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.716 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 7.2 m-20 58.95 33.8 23.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.246 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 941' ' ' PHE . 29.4 m -94.15 -32.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.209 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 37.4 m -149.82 59.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.205 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 74.2 mmtt -58.07 152.47 16.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.995 0.426 . . . . 0.0 111.762 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 981' ' ' GLN . 20.8 tpp180 -53.33 116.53 2.48 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.721 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 63.6 tttt -56.26 147.57 20.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 78.7 p -144.61 139.71 28.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 964' ' ' LYS . 37.4 m -81.56 36.18 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.563 ' NZ ' ' HB3' ' A' ' 964' ' ' LYS . 6.3 ttpm? 56.22 134.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.727 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 24.4 m -60.31 124.15 76.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.331 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.568 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 59.5 Cg_endo -71.48 130.43 17.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.469 2.112 . . . . 0.0 112.565 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 24.9 Cg_exo -62.67 135.04 50.41 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.445 2.097 . . . . 0.0 111.61 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.03 115.13 10.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.655 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.73 138.92 66.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.712 2.275 . . . . 0.0 112.388 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.3 t -53.86 134.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.411 ' N ' HD22 ' A' ' 971' ' ' ASN . 2.4 m120 56.98 42.56 26.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.873 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -160.28 -155.75 7.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.518 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 972' ' ' GLY . 35.7 ttp 174.22 131.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.985 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 14.8 p -101.4 128.98 53.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.814 0.34 . . . . 0.0 111.459 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.549 ' O ' HG13 ' A' ' 977' ' ' ILE . 28.3 m-70 -87.85 114.34 24.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 980' ' ' ILE . 69.9 t -62.13 -33.67 59.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.018 0.437 . . . . 0.0 109.859 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 975' ' ' HIS . 15.0 mt 71.39 -48.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.285 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 977' ' ' ILE . 74.6 p -146.12 -60.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.859 0.362 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.6 m-20 -152.47 -161.88 1.39 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.862 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 976' ' ' VAL . 10.0 pt -146.78 19.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.531 . . . . 0.0 110.492 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' A' 1004 ' ' CYS . 6.7 mm100 -80.82 -178.17 6.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.643 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.587 HG21 ' HB3' ' A' ' 935' ' ' GLU . 30.0 m -64.9 25.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -157.19 44.16 0.51 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.754 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 68.4 p -160.54 132.97 6.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.283 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 16.9 ptp180 -100.97 131.06 47.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.044 0.449 . . . . 0.0 111.446 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 23.7 pt -99.35 131.77 46.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.778 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.463 ' OG1' HD11 ' A' ' 977' ' ' ILE . 6.0 p -95.72 133.43 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.0 111.392 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.495 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 5.9 m-85 -98.95 137.86 36.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 55.7 m -153.5 115.01 4.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 74.1 m -75.55 150.93 38.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.809 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 23.8 m -64.07 143.57 57.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 6.7 t -37.8 139.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.941 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 98.24 -40.87 2.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.548 ' HA ' ' O ' ' A' 1021 ' ' GLN . 3.0 m80 -99.37 137.95 37.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.046 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.552 ' HE ' HG12 ' A' 1023 ' ' ILE . 14.2 ptp180 -97.36 147.22 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.533 ' HA ' ' SG ' ' A' ' 990' ' ' CYS . 9.8 tt -69.28 129.52 40.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.796 HD11 ' HG2' ' A' 1021 ' ' GLN . 31.7 mm -102.15 80.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 154.93 -131.13 3.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.697 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.435 ' O ' HD22 ' A' ' 996' ' ' LEU . 29.2 m80 -81.48 -116.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.515 0.197 . . . . 0.0 111.454 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 46.9 t -178.61 -30.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.955 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 52.6 m -155.58 148.88 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.88 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.601 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -153.36 133.04 13.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.636 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -100.2 136.9 39.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 13.0 t -71.14 124.22 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.25 -149.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 111.927 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' 1010 ' ' THR . 66.2 tp -150.89 139.61 20.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.248 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.552 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 97.6 p -88.62 -52.22 5.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.553 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 158.7 31.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.649 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' 1008 ' ' GLY . 25.4 t-20 176.14 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.418 ' O ' HD12 ' A' 1006 ' ' LEU . 56.9 m -139.27 134.93 33.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.281 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.25 140.34 36.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.552 ' NE2' ' HB3' ' A' 1007 ' ' SER . 9.9 p80 -158.37 146.19 18.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 78.2 m95 -64.38 146.47 54.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.934 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.6 t -49.91 -34.28 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.723 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 75.8 p -144.74 139.39 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.056 0.455 . . . . 0.0 111.821 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.597 ' HD2' ' N ' ' A' 1017 ' ' PRO . 3.8 tmmm? -62.88 136.21 96.39 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.345 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.597 ' N ' ' HD2' ' A' 1016 ' ' LYS . 10.4 Cg_endo -54.08 124.87 17.03 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.786 2.324 . . . . 0.0 112.801 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.737 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 44.4 Cg_endo -67.3 -150.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.799 2.332 . . . . 0.0 112.65 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -133.18 -158.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.839 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.695 ' H ' HG22 ' A' 1019 ' ' ILE . 78.6 m -159.54 135.97 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.566 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.796 ' HG2' HD11 ' A' ' 997' ' ' ILE . 3.6 pt20 -151.31 141.89 22.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.521 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' 1022 ' ' ARG . 27.5 ptt85 -64.01 22.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.574 ' H ' ' C ' ' A' 1021 ' ' GLN . 58.0 mt 64.61 132.08 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 52.5 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.836 2.357 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -66.12 -165.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.279 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.44 139.28 0.19 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.998 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 66.69 143.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.508 ' C ' HD22 ' A' ' 949' ' ' LEU . 45.7 m80 -148.99 140.05 23.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 86.5 m -81.6 131.61 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.701 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -54.6 158.73 2.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 111.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 919' ' ' ALA . . . -48.27 123.32 10.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.846 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.506 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 34.3 Cg_exo -59.17 136.83 75.34 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 122.669 2.246 . . . . 0.0 112.94 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.2 143.79 57.48 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.93 131.92 39.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.201 0.524 . . . . 0.0 111.123 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 911' ' ' ALA . 2.0 m-85 -85.29 150.14 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.987 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -81.17 -57.07 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.047 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.8 OUTLIER -85.47 10.77 11.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -152.14 151.62 31.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.49 136.3 39.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.526 HD11 ' HG ' ' A' ' 928' ' ' LEU . 57.5 tp -45.77 130.58 9.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.593 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 930' ' ' TYR . 11.7 tmtt? -94.59 -51.19 4.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 929' ' ' LYS . 52.9 m -66.52 136.58 55.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.616 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -64.76 138.54 58.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.828 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.627 HG21 HD11 ' A' ' 928' ' ' LEU . 81.0 p -154.25 -170.2 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 40.1 p -156.15 34.28 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.644 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 904' ' ' ALA . . . 41.05 -146.0 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.799 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t 62.39 44.52 7.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 902' ' ' CYS . 1.5 m-20 66.61 153.54 0.08 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.503 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 919' ' ' ALA . 63.6 m-85 -136.4 145.97 53.97 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.209 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 138.24 83.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.729 2.286 . . . . 0.0 111.896 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.623 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.4 mt -58.96 155.73 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.47 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 85.42 -32.36 3.63 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.674 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 40.9 m -55.97 126.29 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 47.3 t -96.36 127.87 42.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.781 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.627 HD11 HG21 ' A' ' 917' ' ' THR . 8.6 tp -105.47 120.52 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 0.0 110.903 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 915' ' ' THR . 40.2 ttmt -85.68 140.98 30.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.561 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 6.3 m-85 -129.15 168.48 16.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 914' ' ' LYS . 16.6 pt-20 -144.47 137.38 26.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.926 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.69 143.26 37.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.02 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.0 mtp180 -85.52 158.69 56.94 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 7.6 Cg_endo -49.64 139.74 30.34 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.579 2.186 . . . . 0.0 111.745 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 50.5 mt-10 81.38 25.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.334 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 960' ' ' ARG . 88.2 m-85 -146.87 135.66 22.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.796 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.8 p90 -102.34 137.47 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.885 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 157.62 146.06 4.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.877 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.519 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 77.2 mtp180 -72.82 162.72 72.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.662 0.268 . . . . 0.0 110.82 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 73.5 Cg_endo -78.75 114.66 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.384 2.056 . . . . 0.0 112.278 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 48.2 p90 -91.68 -160.17 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.5 p -175.28 132.92 0.3 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' A' ' 954' ' ' PRO . 11.0 pt -93.99 -166.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.188 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.491 ' O ' HD22 ' A' ' 946' ' ' LEU . 26.5 m -166.61 132.6 2.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 6.5 t -73.79 120.47 19.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.685 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 950' ' ' VAL . 1.8 mm? -87.02 174.22 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.219 1.009 . . . . 0.0 112.803 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.05 -42.69 73.01 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.135 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 950' ' ' VAL . 48.7 t30 -84.51 35.09 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.998 HD21 ' HB1' ' A' ' 900' ' ' ALA . 83.0 mt 46.42 59.66 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.815 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -138.48 -157.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.117 0.484 . . . . 0.0 111.393 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.506 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 94.3 m95 -149.13 115.98 5.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.731 ' N ' HD21 ' A' ' 946' ' ' LEU . 72.4 m -52.12 147.51 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.4 t -78.16 122.97 86.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.578 ' HG3' HG22 ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.09 26.77 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.866 2.377 . . . . 0.0 112.831 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.635 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 7.2 mtmp? 39.82 -143.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.01 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.594 ' OD1' ' HE2' ' A' ' 959' ' ' LYS . 60.3 t0 -79.5 134.26 36.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -150.68 -98.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.719 ' H ' HG23 ' A' ' 957' ' ' VAL . 63.7 m -77.13 147.36 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.014 0.435 . . . . 0.0 111.374 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.594 ' HE2' ' OD1' ' A' ' 956' ' ' ASP . 68.5 mttm -144.93 157.15 44.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.172 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.832 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -59.95 114.98 3.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.851 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.583 ' HD3' ' HB2' ' A' 1011 ' ' ALA . 24.6 ttmm -56.23 150.34 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.663 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 82.8 p -144.51 141.02 29.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.985 0.421 . . . . 0.0 111.38 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 82.0 m -79.9 151.6 30.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.156 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.48 131.06 45.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 29.4 m -55.77 122.94 49.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.462 ' HG2' HG11 ' A' ' 974' ' ' VAL . 56.9 Cg_endo -69.58 134.71 29.05 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.428 2.085 . . . . 0.0 111.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.84 124.49 15.99 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.047 1.831 . . . . 0.0 111.433 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -58.29 122.86 62.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.788 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.65 138.4 83.09 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.064 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' 1020 ' ' CYS . 21.7 t -52.79 130.47 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.678 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 70.36 36.78 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.644 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.888 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . -172.48 -153.16 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.055 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 177.41 145.44 0.11 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 110.636 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 7.7 p -93.81 120.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -78.87 112.97 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.62 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.99 -18.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 121.189 0.519 . . . . 0.0 109.748 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 8.9 mt 74.07 -44.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.953 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.3 p -146.77 -54.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.622 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 976' ' ' VAL . 45.1 m-20 -159.18 -144.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.505 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 7.0 pt -151.09 31.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.156 0.503 . . . . 0.0 110.944 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.832 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 3.2 mm100 -76.87 156.01 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.504 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' 1005 ' ' ILE . 94.5 t -55.44 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.081 0.467 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 159.0 -37.99 0.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.278 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 79.9 p -76.58 139.1 40.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.956 0.408 . . . . 0.0 111.626 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.769 ' HG2' ' HB2' ' A' 1003 ' ' GLU . 87.2 mtm180 -90.64 159.08 16.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.999 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 976' ' ' VAL . 41.9 pt -132.72 123.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.9 p -103.85 138.68 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.457 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.482 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 2.2 m-85 -100.79 138.57 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.266 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 81.9 p -153.48 131.41 11.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 71.5 m -74.17 126.04 29.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.603 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.888 ' H ' ' HA2' ' A' ' 972' ' ' GLY . 6.0 t -76.58 55.1 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.468 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 991' ' ' THR . 99.9 m -177.64 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 992' ' ' THR . . . -168.66 39.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.499 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.743 ' HB2' ' SG ' ' A' ' 990' ' ' CYS . 3.0 m80 -93.65 159.73 15.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.641 ' HB3' HG12 ' A' 1023 ' ' ILE . 37.3 ptt180 -89.87 135.56 33.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.1 tm? -71.98 132.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 3.3 mt -118.29 135.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.387 . . . . 0.0 111.487 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.17 -125.57 8.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.423 ' CD2' ' HB ' ' A' 1015 ' ' THR . 95.8 m-70 -79.3 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.8 p -174.58 -37.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.9 p -150.85 151.71 32.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.537 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -151.92 133.17 14.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.087 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.769 ' HB2' ' HG2' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.36 136.62 36.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.208 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 35.5 t -71.25 121.8 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.639 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.5 pt -133.46 -153.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.411 . . . . 0.0 111.934 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' 1010 ' ' THR . 57.7 tp -150.85 136.11 17.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.038 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.604 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.9 t -89.41 -40.88 12.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.713 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.55 -37.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.035 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.401 ' C ' HD11 ' A' 1006 ' ' LEU . 5.5 m120 -140.92 -48.03 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.063 0.458 . . . . 0.0 110.5 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.456 ' O ' HD12 ' A' 1006 ' ' LEU . 57.8 m -94.53 135.76 35.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.227 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.583 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -80.78 145.64 31.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.604 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.5 p80 -157.66 144.06 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.371 . . . . 0.0 111.348 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 70.7 m95 -66.0 147.05 53.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.4 t -55.81 -35.11 65.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.594 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -143.12 143.78 31.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.462 . . . . 0.0 111.726 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -56.83 137.59 78.71 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.907 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 53.1 Cg_exo -52.9 129.89 35.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.379 2.053 . . . . 0.0 112.311 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1017 ' ' PRO . 38.3 Cg_exo -61.44 -158.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 112.683 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 56.2 mt -142.86 139.37 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.945 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 42.8 t -94.43 129.02 41.34 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 995' ' ' ARG . 2.5 tp-100 -145.74 128.62 16.38 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.664 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -54.39 133.29 45.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.35 0.595 . . . . 0.0 111.311 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 995' ' ' ARG . 57.5 mt -74.83 122.8 88.29 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.832 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.2 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.866 2.378 . . . . 0.0 112.347 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.596 0.236 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 63.91 131.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.204 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 62.62 122.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.944 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . 62.67 130.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.454 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.603 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 41.3 m80 -150.91 136.76 18.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.002 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.41 125.35 29.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.291 0.567 . . . . 0.0 111.213 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -57.7 168.83 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.607 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.5 133.51 13.37 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.567 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.42 145.97 78.84 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.55 2.167 . . . . 0.0 111.729 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.74 148.65 42.2 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.39 0.614 . . . . 0.0 111.332 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -81.19 115.02 20.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.027 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.469 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 9.5 m-85 -89.93 134.39 34.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.762 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 76.7 mt -76.96 -54.4 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.62 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 2.1 p90 -84.59 25.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.201 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -157.17 120.76 4.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.514 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -103.48 121.14 42.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.485 HD13 ' CE1' ' A' ' 930' ' ' TYR . 29.8 tp -49.25 122.05 5.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.004 0.43 . . . . 0.0 111.324 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.702 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 0.8 OUTLIER -90.94 -44.77 9.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.321 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 54.3 m -64.65 132.92 51.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.43 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.432 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.2 pm0 -65.12 143.64 57.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.267 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 80.7 p -150.22 -58.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.089 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 82.6 p 46.25 56.16 6.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.51 -152.43 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.0 111.491 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 60.1 m -146.58 -44.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.51 135.37 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.113 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 917' ' ' THR . 55.1 m-85 -137.69 141.37 32.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.939 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.491 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 70.0 Cg_endo -73.93 136.98 23.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.634 2.223 . . . . 0.0 111.647 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 947' ' ' ASP . 53.4 mt -52.6 151.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.403 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 91.31 -28.38 8.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.491 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 31.8 m -55.43 138.99 44.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.994 0.426 . . . . 0.0 111.553 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.7 m -118.0 142.5 47.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.76 120.49 21.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.519 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -89.83 133.38 34.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.567 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 2.9 m-85 -116.12 134.77 54.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.702 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 65.7 mm-40 -94.45 117.25 29.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.801 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 68.7 m -59.41 140.63 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.344 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 75.0 mtp180 -85.37 158.74 57.31 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 9.2 Cg_endo -52.71 149.47 24.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.519 2.146 . . . . 0.0 110.886 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 49.6 mt-10 83.5 19.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.72 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 960' ' ' ARG . 94.3 m-85 -144.95 125.11 13.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 5.1 p90 -95.96 141.4 29.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.46 147.39 5.46 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.087 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.27 159.03 86.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.83 126.11 16.04 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.585 2.19 . . . . 0.0 112.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 5.2 p90 -90.88 -162.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.712 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 941' ' ' PHE . 64.1 m -170.12 133.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 13.2 pt -95.76 168.94 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.277 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.419 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.4 m -162.6 135.26 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 52.8 m -73.8 126.83 31.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.6 mm? -85.19 -53.55 5.18 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.841 ' HA ' HD13 ' A' ' 924' ' ' ILE . 50.9 t0 171.73 -38.7 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.691 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.07 28.07 0.63 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 900' ' ' ALA . 7.0 mp 60.8 43.22 12.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.32 149.75 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.886 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -94.02 141.06 28.96 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.166 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.0 p -52.34 138.11 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 44.9 t -79.19 108.61 8.84 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.756 0.312 . . . . 0.0 111.196 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 952' ' ' SER . 6.4 Cg_exo -72.75 136.03 24.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.675 2.25 . . . . 0.0 111.497 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -158.99 143.37 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.373 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.49 36.72 16.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.572 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.8 m -92.4 -111.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.009 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.467 ' H ' HG23 ' A' ' 957' ' ' VAL . 51.0 m -86.82 87.29 7.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.78 ' HD2' ' H ' ' A' ' 959' ' ' LYS . 8.3 mptt -67.75 154.59 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 936' ' ' TYR . 37.7 ttm180 -54.54 136.52 44.73 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.85 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.514 ' HG2' ' HB2' ' A' 1011 ' ' ALA . 16.6 tppt? -53.78 152.32 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.508 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . . . . . . . . . 70.9 p -143.95 124.08 13.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.775 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.508 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.1 p -83.54 37.95 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.141 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 53.4 tptt 60.09 138.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.386 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 9.2 m -57.47 131.86 81.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.137 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.709 ' HG2' HG11 ' A' ' 974' ' ' VAL . 37.2 Cg_endo -65.02 125.0 13.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.471 2.114 . . . . 0.0 112.462 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 17.3 Cg_exo -66.27 120.57 7.73 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.305 2.003 . . . . 0.0 111.498 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 973' ' ' MET . 1.5 m-20 -62.55 122.28 72.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 968' ' ' ASP . 37.4 Cg_exo -57.62 144.91 91.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 111.877 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.3 p -48.32 127.44 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.563 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.8 m-20 63.75 46.4 4.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.907 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.79 -154.07 9.02 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.513 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.447 ' HA ' ' HB3' ' A' ' 968' ' ' ASP . 24.8 ptt? 175.69 143.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.287 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.936 HG21 HD12 ' A' ' 986' ' ' ILE . 13.5 p -93.79 127.18 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -89.55 110.53 21.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.377 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 34.8 m -71.99 134.62 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 978' ' ' THR . 47.6 mm -73.45 -38.74 53.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 110.503 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 977' ' ' ILE . 76.8 p -144.76 -42.61 0.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 54.3 t0 -160.72 -136.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.197 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.524 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 9.5 pt -151.07 1.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 110.981 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -75.62 164.5 26.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.558 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 53.4 t -50.1 133.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 102.67 -39.03 2.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.566 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 95.8 p -76.06 138.09 40.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -98.87 157.18 16.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.232 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.936 HD12 HG21 ' A' ' 974' ' ' VAL . 47.8 pt -141.96 137.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 111.685 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 4.7 p -108.33 133.25 52.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -94.66 143.2 26.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.789 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.74 123.31 9.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 61.9 m -88.94 146.47 24.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -64.93 147.47 53.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.448 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 86.8 m -45.61 117.1 1.34 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.979 0.419 . . . . 0.0 111.192 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 141.49 -48.95 0.78 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.151 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -113.04 139.2 48.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.618 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 997' ' ' ILE . 38.3 ptt180 -93.0 140.9 28.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.9 tt -72.01 126.1 28.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.215 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.988 ' HB ' HG23 ' A' 1019 ' ' ILE . 2.4 mp -102.93 130.92 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.344 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.54 -142.89 15.62 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.617 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.527 ' O ' ' HG3' ' A' 1018 ' ' PRO . 87.5 m-70 -84.03 132.19 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.574 0.226 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 47.4 t -81.32 -55.87 4.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 77.5 p -89.2 153.17 21.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.6 123.37 5.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.116 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -104.59 131.25 52.21 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.863 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 49.1 t -75.0 131.0 40.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.7 pt -135.8 -155.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.581 -0.447 . . . . 0.0 112.007 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' 1010 ' ' THR . 56.3 tp -150.39 131.9 14.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.564 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 26.3 t -90.08 -134.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.395 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -67.65 -49.77 47.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.643 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -152.11 27.56 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.449 ' C ' HD12 ' A' 1006 ' ' LEU . 6.6 m -149.73 130.99 14.58 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.489 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 961' ' ' LYS . . . -81.52 137.94 35.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.765 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.564 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.9 p80 -159.76 144.33 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.593 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.508 ' CE2' ' SG ' ' A' ' 963' ' ' CYS . 93.1 m95 -64.48 146.74 54.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.704 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.7 t -57.56 -31.5 66.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 81.6 p -144.35 138.77 28.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.583 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.547 ' HB2' ' HD2' ' A' 1017 ' ' PRO . 1.6 pptp? -62.52 160.7 32.14 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' 1016 ' ' LYS . 18.6 Cg_endo -59.57 129.03 29.2 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.499 2.133 . . . . 0.0 112.271 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.527 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 16.8 Cg_exo -67.22 -160.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.988 HG23 ' HB ' ' A' ' 997' ' ' ILE . 1.2 tt -144.55 121.3 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.217 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 84.9 m -78.92 132.91 36.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -146.68 130.93 17.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.406 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -44.29 132.8 5.72 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.524 0.678 . . . . 0.0 111.928 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . . . . . . . . . 22.2 mt -76.07 130.44 78.04 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.303 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.482 2.122 . . . . 0.0 112.421 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.788 0.327 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -66.3 135.51 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 64.77 141.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.992 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -165.19 127.29 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 44.9 m170 -119.87 123.12 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.757 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 5.4 p -82.13 127.19 32.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.547 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.2 mm100 -58.34 169.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.12 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -45.86 135.68 6.39 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.492 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.554 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 3.0 Cg_exo -74.64 61.86 5.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.063 2.508 . . . . 0.0 111.909 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 48.4 t0 41.45 -143.05 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.55 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 70.9 t60 -161.78 116.7 1.98 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.726 0.298 . . . . 0.0 110.974 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.47 ' CZ ' ' HG2' ' A' ' 954' ' ' PRO . 74.3 m-85 -85.93 135.26 33.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.076 0.465 . . . . 0.0 110.779 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.633 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 5.3 mp -74.97 -48.33 24.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.569 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.58 17.7 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.621 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.51 121.88 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 111.788 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 933' ' ' ARG . 59.7 pttt -102.7 128.87 49.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.21 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 928' ' ' LEU . 0.8 OUTLIER -48.61 125.34 9.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.607 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -94.47 -31.47 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.56 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 86.8 m -62.2 135.92 57.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 111.786 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.622 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.1 pm0 -78.34 61.25 2.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.672 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 918' ' ' THR . 3.4 t -80.62 -53.02 6.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 917' ' ' THR . 24.9 m 51.81 55.1 9.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.31 155.36 9.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 48.4 t -86.58 -44.83 11.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -84.21 138.96 32.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.524 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.467 ' HB2' ' SG ' ' A' ' 902' ' ' CYS . 17.0 m-85 -127.67 137.88 31.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.84 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 60.0 Cg_endo -72.13 131.97 18.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.484 2.123 . . . . 0.0 110.922 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.64 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.6 mt -57.1 149.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.926 0.393 . . . . 0.0 111.327 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 91.69 -34.37 4.39 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.663 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 15.8 m -57.19 129.9 43.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 942' ' ' SER . 47.6 t -87.89 151.74 22.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.541 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 913' ' ' LEU . 10.0 tp -140.85 102.18 4.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.51 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.775 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 17.8 ptpt -85.37 132.76 34.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.191 0.52 . . . . 0.0 111.99 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.564 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 2.0 m-85 -111.49 133.9 53.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.791 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 912' ' ' LYS . 23.4 pt-20 -95.57 126.47 40.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 74.3 m -57.87 148.59 24.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 76.9 mtt-85 -85.15 161.95 50.68 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 75.3 Cg_exo -45.64 139.96 9.68 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.234 1.956 . . . . 0.0 112.176 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 934' ' ' PRO . 95.0 mt-10 82.49 23.43 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.699 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.507 ' N ' ' HG3' ' A' ' 961' ' ' LYS . 85.9 m-85 -146.81 145.41 29.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.558 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.576 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 16.1 p90 -144.07 140.84 29.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 110.942 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.36 21.89 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.651 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.621 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 79.5 mtp180 62.81 164.61 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.85 0.357 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 63.6 Cg_endo -77.65 115.42 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.146 1.897 . . . . 0.0 110.676 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 42.3 p90 -89.67 108.1 19.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.525 0.678 . . . . 0.0 112.068 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.775 ' HA ' ' HA ' ' A' ' 929' ' ' LYS . 80.3 p -77.21 125.64 29.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.844 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 928' ' ' LEU . 10.0 pt -94.92 -161.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 4.0 m -161.14 121.42 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -72.08 102.16 2.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.719 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 48.9 mt -80.89 161.37 24.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.568 0.699 . . . . 0.0 112.713 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.575 ' HA ' HD13 ' A' ' 924' ' ' ILE . 9.8 t70 -42.55 -38.4 1.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.005 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 950' ' ' VAL . 75.2 m-20 -83.08 36.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.992 HD11 ' HB1' ' A' ' 900' ' ' ALA . 8.2 mp 44.82 46.33 8.76 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.222 0.534 . . . . 0.0 110.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.719 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 30.4 m -123.61 -162.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.16 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.554 ' CZ2' ' HG3' ' A' ' 905' ' ' PRO . 90.1 m95 -152.69 122.77 7.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.289 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.9 t -43.43 146.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.531 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 38.9 t -79.39 117.55 67.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.599 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 908' ' ' PHE . 4.0 Cg_exo -76.8 60.93 6.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.55 2.833 . . . . 0.0 111.794 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -77.1 131.77 38.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.017 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 54.99 81.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.545 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 12.7 m -150.9 -21.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.834 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 12.1 t -151.45 133.37 15.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -143.26 146.86 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.181 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.805 ' HD3' ' HB3' ' A' ' 981' ' ' GLN . 29.9 ttt85 -53.2 143.53 17.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.057 0.456 . . . . 0.0 111.655 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 28.1 mtpp -56.29 152.34 11.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.563 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.605 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 96.3 p -141.61 121.13 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.564 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 4.4 p -81.67 153.68 26.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.596 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.33 132.35 48.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 34.4 m -56.57 134.3 77.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.928 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.788 ' HG2' HG11 ' A' ' 974' ' ' VAL . 9.2 Cg_endo -52.65 150.98 20.31 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.764 2.309 . . . . 0.0 111.992 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' 1017 ' ' PRO . 64.7 Cg_endo -73.14 45.5 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.678 2.252 . . . . 0.0 112.814 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 967' ' ' PRO . 1.5 m-20 18.02 109.73 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 124.074 0.859 . . . . 0.0 113.165 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.44 142.49 9.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.522 2.148 . . . . 0.0 112.211 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.539 HG22 ' ND2' ' A' ' 971' ' ' ASN . 5.1 p -48.6 131.67 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.638 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 970' ' ' VAL . 74.2 m-20 75.43 -48.73 0.62 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.634 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 990' ' ' CYS . . . -75.44 -152.62 3.61 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.097 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 1.8 pmm? 177.75 143.48 0.1 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.274 0.23 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.788 HG11 ' HG2' ' A' ' 966' ' ' PRO . 10.1 p -93.62 128.94 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.236 0.541 . . . . 0.0 111.201 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -104.46 118.1 35.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.403 HG11 HG23 ' A' ' 980' ' ' ILE . 28.2 m -70.95 141.98 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.925 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 985' ' ' ARG . 24.4 mm -74.92 -36.68 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.476 . . . . 0.0 110.295 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.2 p -144.69 -47.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.186 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 49.0 t0 -160.19 -137.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.559 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.479 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 7.6 pt -151.02 36.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 111.231 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' A' ' 960' ' ' ARG . 13.1 mm100 -76.5 166.69 23.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.715 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.32 29.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 981' ' ' GLN . . . -151.3 -25.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 48.3 t -76.1 136.72 39.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.004 0.431 . . . . 0.0 111.256 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 69.0 ttt180 -89.65 158.72 17.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.602 HD12 HG21 ' A' ' 974' ' ' VAL . 47.4 pt -137.56 129.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.918 0.39 . . . . 0.0 111.025 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' 1001 ' ' SER . 2.3 p -105.22 139.58 39.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.02 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.3 m-85 -103.94 146.99 27.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.677 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -153.48 124.19 7.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.482 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 972' ' ' GLY . 96.6 m -72.95 -119.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 993' ' ' GLY . 8.0 t -169.55 158.91 8.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.628 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 61.0 m -52.8 84.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.357 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 991' ' ' THR . . . 168.6 -42.22 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.47 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.432 ' HB3' ' N ' ' A' 1021 ' ' GLN . 7.8 m80 -126.13 142.25 51.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.653 ' O ' HD12 ' A' ' 997' ' ' ILE . 39.3 ptt180 -91.9 145.28 24.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.6 tt -72.73 135.42 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.571 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.874 ' HB ' HG23 ' A' 1019 ' ' ILE . 3.9 mp -126.49 139.42 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 103.94 -124.2 7.99 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.51 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -80.1 -136.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.4 p -176.76 -43.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.465 ' HB3' HG22 ' A' ' 987' ' ' THR . 69.2 p -155.22 141.58 18.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.516 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -149.49 143.48 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 112.025 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 38.6 tt0 -95.92 138.24 33.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.607 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 47.9 t -71.27 129.62 39.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.1 pt -139.39 146.14 26.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 961' ' ' LYS . 60.8 tp -89.16 137.28 32.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.589 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.664 ' HB3' ' NE2' ' A' 1012 ' ' HIS . 98.8 p -88.97 -40.09 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.372 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -177.72 -36.03 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.415 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.6 m120 -145.29 -44.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.277 0.561 . . . . 0.0 109.707 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 94.2 m -94.5 131.89 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.188 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.53 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.64 138.8 34.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.01 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.664 ' NE2' ' HB3' ' A' 1007 ' ' SER . 10.8 p80 -155.66 142.61 19.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.083 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 70.7 m95 -66.46 146.35 54.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -51.32 -33.73 30.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.092 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 82.8 p -141.04 -152.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.557 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -126.8 149.75 69.55 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.4 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 966' ' ' PRO . 41.5 Cg_exo -57.46 135.65 71.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.838 2.359 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.457 ' HG2' HD11 ' A' ' 996' ' ' LEU . 27.0 Cg_exo -62.81 -159.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.728 2.286 . . . . 0.0 112.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.874 HG23 ' HB ' ' A' ' 997' ' ' ILE . 3.8 tt -146.57 128.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.868 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 77.3 m -84.29 138.5 32.88 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 997' ' ' ILE . 7.8 tt0 -149.74 135.7 18.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.081 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' 1022 ' ' ARG . 42.4 ttp85 -48.63 130.39 17.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.512 0.673 . . . . 0.0 111.695 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 995' ' ' ARG . 71.2 mt -74.94 127.12 87.44 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.623 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.563 2.175 . . . . 0.0 112.219 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -171.23 135.4 0.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.01 140.08 57.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.037 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 949' ' ' LEU . . . 62.8 -150.76 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.572 ' N ' HD22 ' A' ' 949' ' ' LEU . 15.9 m80 67.21 144.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 84.7 m -79.78 122.63 26.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -65.65 163.99 15.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.78 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.92 125.33 4.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.663 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 951' ' ' TRP . 16.6 Cg_exo -67.1 135.26 36.75 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.731 2.287 . . . . 0.0 112.509 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -64.77 152.24 43.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.107 0.48 . . . . 0.0 110.87 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -78.17 134.59 37.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.091 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 8.3 m-85 -90.07 1.25 56.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.923 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 908' ' ' PHE . 5.8 mp 71.61 -63.35 0.43 Allowed 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.602 0.564 . . . . 0.0 111.388 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.477 ' HA ' ' CD ' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -85.35 25.66 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 932' ' ' CYS . . . -154.83 120.86 5.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -103.71 138.77 39.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.476 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.751 HD22 ' H ' ' A' ' 914' ' ' LYS . 3.1 tm? -46.47 150.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.751 ' H ' HD22 ' A' ' 913' ' ' LEU . 11.8 tmtt? -137.71 -46.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 913' ' ' LEU . 2.7 m -68.76 139.14 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.499 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.724 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -58.21 112.57 1.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 922' ' ' PHE . 69.8 p -83.34 132.85 34.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 0.0 112.106 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.7 p -89.97 82.71 6.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.135 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 60.32 -152.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.9 p -86.59 -47.76 8.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -85.43 121.99 28.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.158 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.648 ' CE2' HD11 ' A' ' 928' ' ' LEU . 77.7 m-85 -103.87 136.02 19.27 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 112.137 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.39 136.09 35.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 111.67 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.723 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 38.6 mt -56.69 143.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.065 0.46 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 101.87 -41.4 2.14 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.8 m -57.27 144.43 35.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.267 -0.466 . . . . 0.0 111.056 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 46.6 m -126.61 128.01 46.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.756 0.312 . . . . 0.0 111.235 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.648 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.3 mt -100.71 122.1 42.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.0 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.726 ' HG2' ' HB3' ' A' ' 942' ' ' SER . 52.0 mtmt -87.58 127.54 35.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.0 111.251 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 940' ' ' PRO . 4.8 m-85 -116.77 120.21 37.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.54 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.11 127.79 41.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.68 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 59.3 m -58.58 -174.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.531 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 43.5 mtp85 -84.42 159.68 58.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.323 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 936' ' ' TYR . 87.4 Cg_exo -45.83 -48.75 11.96 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.498 2.132 . . . . 0.0 112.466 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -74.44 28.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.304 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 12.4 m-85 -141.85 150.77 42.03 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 23.3 p90 -137.56 136.27 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.349 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.94 11.26 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 55.4 mtp85 61.41 151.98 0.1 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.348 0.594 . . . . 0.0 111.983 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 930' ' ' TYR . 13.4 Cg_exo -67.46 117.83 5.13 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.795 2.33 . . . . 0.0 111.246 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -90.35 115.37 27.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.392 0.615 . . . . 0.0 111.768 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.726 ' HB3' ' HG2' ' A' ' 929' ' ' LYS . 80.1 p -78.38 131.36 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.061 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -101.86 114.24 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 0.0 110.567 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 2.6 m -83.05 125.96 32.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.723 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 49.7 t -73.7 112.34 9.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 89.1 mt -81.45 -64.51 1.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -174.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 59.9 t0 173.84 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.947 0.403 . . . . 0.0 110.593 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.534 ' HB3' HG12 ' A' ' 950' ' ' VAL . 34.8 t30 -79.16 9.57 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 901' ' ' HIS . 45.9 mt 69.25 40.42 1.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.44 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 948' ' ' ASN . 3.3 p -137.52 154.94 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.607 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.863 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 29.1 m95 -89.76 145.25 25.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.313 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 79.5 p -47.2 144.94 2.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 66.1 m -77.71 108.65 7.66 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 0.0 111.459 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 952' ' ' SER . 15.4 Cg_exo -66.65 142.88 65.97 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.643 2.229 . . . . 0.0 111.339 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -155.37 129.33 8.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.147 0.499 . . . . 0.0 111.832 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 55.4 t0 51.75 33.65 11.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.431 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.647 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -91.99 -59.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.647 ' H ' HG23 ' A' ' 957' ' ' VAL . 5.9 t -89.31 141.48 28.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 958' ' ' CYS . 40.1 mtmt -152.37 133.75 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.44 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.885 ' HE ' ' HB3' ' A' ' 981' ' ' GLN . 0.3 OUTLIER -65.88 128.52 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.02 0.438 . . . . 0.0 110.915 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.671 ' HB2' ' NZ ' ' A' ' 961' ' ' LYS . 4.2 ttmp? -56.21 161.99 2.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.514 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 73.3 p -149.79 147.81 28.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.472 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 83.2 m -80.11 147.91 31.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.938 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 965' ' ' THR . 6.3 tmtm? -65.96 131.06 45.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.635 ' N ' ' HD3' ' A' ' 964' ' ' LYS . 25.1 m -52.98 124.24 36.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.002 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 974' ' ' VAL . 55.2 Cg_endo -68.87 133.66 27.82 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.64 2.227 . . . . 0.0 112.611 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 38.0 Cg_exo -59.94 137.55 76.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.351 2.034 . . . . 0.0 111.313 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.71 113.83 7.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.12 151.51 85.02 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.795 2.33 . . . . 0.0 111.959 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' 1020 ' ' CYS . 3.6 p -49.6 127.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 49.24 46.09 23.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.84 137.97 4.59 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.45 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -127.95 142.74 51.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 966' ' ' PRO . 12.6 p -94.23 121.44 44.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.753 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.9 OUTLIER -88.66 128.13 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.51 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 979' ' ' ASP . 95.3 t -83.95 123.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.9 -40.49 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.707 0.289 . . . . 0.0 111.154 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 78.6 p -144.68 -50.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.402 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.543 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 37.1 m-20 -158.26 -152.57 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.994 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.458 ' H ' ' HB3' ' A' ' 979' ' ' ASP . 14.8 pt -149.9 23.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.144 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.885 ' HB3' ' HE ' ' A' ' 960' ' ' ARG . 15.1 mp0 -77.01 154.08 33.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.675 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' 1005 ' ' ILE . 66.6 t -50.85 85.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.052 0.453 . . . . 0.0 111.301 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.98 -41.47 0.29 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 77.2 p -75.38 -168.83 0.87 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 111.128 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.489 HH21 ' HB2' ' A' 1001 ' ' SER . 79.2 ttt180 -151.31 131.35 13.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.089 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.575 ' CD1' ' HG3' ' A' ' 966' ' ' PRO . 31.2 pt -98.07 142.57 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.539 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 8.7 p -116.96 135.12 53.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.138 0.494 . . . . 0.0 111.723 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.472 ' CG ' ' HG2' ' A' 1018 ' ' PRO . 1.8 m-85 -103.12 148.66 25.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 47.5 t -148.74 120.05 7.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.095 0.474 . . . . 0.0 110.974 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 71.4 m -83.02 151.55 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.0 p -64.6 149.11 49.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -49.4 92.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 158.51 -46.94 0.44 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.275 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -99.96 148.25 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.596 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.442 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.3 ptm180 -91.55 148.4 22.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.548 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.496 ' C ' HD13 ' A' ' 996' ' ' LEU . 3.4 tm? -65.2 130.19 42.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.071 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.723 HD11 ' HB2' ' A' 1021 ' ' GLN . 34.6 mm -100.13 73.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.757 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 156.62 -149.62 20.52 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.126 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.603 ' ND1' HG21 ' A' 1015 ' ' THR . 34.5 m170 -85.91 -9.51 56.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.614 0.245 . . . . 0.0 111.173 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 15.3 m 71.8 -5.44 1.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.458 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.489 ' HB2' HH21 ' A' ' 985' ' ' ARG . 57.5 m -156.02 149.55 24.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.435 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -154.58 133.15 12.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.6 tt0 -96.07 132.54 41.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 38.2 t -71.19 121.36 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.595 ' HA ' HG13 ' A' ' 982' ' ' VAL . 35.8 pt -135.52 -151.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 111.617 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.503 HD23 ' C ' ' A' 1006 ' ' LEU . 8.7 tt -155.87 139.77 16.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.498 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -87.51 -57.72 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' 1009 ' ' ASN . . . 169.05 35.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.239 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' 1008 ' ' GLY . 0.7 OUTLIER 176.65 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.39 0.614 . . . . 0.0 109.988 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -143.96 143.64 31.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.89 143.87 35.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 9.0 p80 -157.72 148.83 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.806 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.469 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.1 m95 -64.38 140.18 58.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 46.8 t -54.26 -30.48 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.811 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.603 HG21 ' ND1' ' A' ' 999' ' ' HIS . 63.0 p -140.82 143.31 34.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 111.712 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 58.0 mtpt -51.26 146.09 12.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 28.0 Cg_exo -61.92 118.8 5.7 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.446 2.097 . . . . 0.0 111.856 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.472 ' HG2' ' CG ' ' A' ' 988' ' ' TYR . 35.7 Cg_endo -65.99 145.89 80.92 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.544 2.162 . . . . 0.0 112.569 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.71 -149.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.247 0.546 . . . . 0.0 110.846 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' 1019 ' ' ILE . 74.7 m -154.76 138.75 16.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.188 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.723 ' HB2' HD11 ' A' ' 997' ' ' ILE . 3.8 tt0 -147.13 129.57 15.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.902 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -48.56 130.1 16.79 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.449 0.642 . . . . 0.0 111.466 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.442 HG12 ' HB3' ' A' ' 995' ' ' ARG . 73.8 mt -75.26 128.45 84.53 Favored Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.154 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.249 1.045 0 C-N-CA 122.776 2.317 . . . . 0.0 112.303 -179.918 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.43 136.01 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.007 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -58.93 125.99 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.052 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -167.32 -136.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.81 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 11.0 m80 69.8 134.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 922' ' ' PHE . 10.9 p -80.79 119.16 23.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.818 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.415 ' HB2' HE21 ' A' ' 903' ' ' GLN . 1.2 pt20 -72.53 -176.81 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.402 . . . . 0.0 111.042 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 922' ' ' PHE . . . -49.02 127.03 14.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.329 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.518 ' HG3' HD22 ' A' ' 928' ' ' LEU . 64.7 Cg_endo -73.33 70.16 3.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.809 2.34 . . . . 0.0 112.162 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 7.2 t0 35.21 -132.06 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.494 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.447 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 4.7 m170 -156.97 121.82 4.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.661 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.94 139.52 30.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.714 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.6 OUTLIER -102.14 -45.63 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.562 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.422 ' C ' ' HG3' ' A' ' 933' ' ' ARG . 0.2 OUTLIER -80.62 9.66 5.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.969 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.31 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.478 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.62 133.86 40.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.593 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.702 HD21 HG23 ' A' ' 917' ' ' THR . 65.0 tp -47.07 161.0 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.686 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.447 ' N ' ' HG ' ' A' ' 913' ' ' LEU . 31.0 mmmt -144.33 -52.29 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 928' ' ' LEU . 4.3 m -68.78 137.09 53.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -62.35 123.35 18.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 913' ' ' LEU . 49.7 p -83.42 136.06 34.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.029 0.443 . . . . 0.0 111.989 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 70.8 p -90.1 79.5 6.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.547 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . 64.57 -154.54 0.3 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.082 0.468 . . . . 0.0 111.96 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.6 p -85.79 -46.07 11.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.38 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -85.3 120.88 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 54.7 m-85 -102.31 135.47 19.59 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.54 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 74.3 Cg_endo -74.26 133.2 17.44 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.739 2.293 . . . . 0.0 111.446 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 947' ' ' ASP . 50.5 mt -56.89 144.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.933 0.397 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' ' 945' ' ' CYS . . . 101.6 -35.19 5.08 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.54 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 24.0 m -56.17 128.59 36.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.442 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 79.3 p -101.47 123.84 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.518 HD22 ' HG3' ' A' ' 905' ' ' PRO . 8.1 tp -102.74 119.85 39.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.99 140.85 29.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.188 0.518 . . . . 0.0 112.07 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.44 ' CE1' HD23 ' A' ' 928' ' ' LEU . 26.7 m-85 -133.95 133.51 41.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 931' ' ' GLU . 14.9 pt-20 -92.84 121.73 34.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.995 0.426 . . . . 0.0 111.279 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.76 153.86 19.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 78.5 mtp180 -81.35 145.37 55.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.604 0.24 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 936' ' ' TYR . 70.9 Cg_exo -49.23 -42.74 39.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.346 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.88 24.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 933' ' ' ARG . 24.3 m-85 -142.04 139.81 32.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.95 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.501 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 7.9 p90 -93.26 134.7 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.412 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 133.9 148.44 5.83 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.701 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.0 ptp180 -72.52 166.24 43.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.478 0.18 . . . . 0.0 110.543 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 42.2 Cg_endo -68.38 122.85 9.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.327 2.018 . . . . 0.0 112.112 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.573 ' CD2' ' HB ' ' A' ' 957' ' ' VAL . 48.8 p90 -91.29 -165.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.9 p -175.29 137.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 2.8 pt -91.27 176.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.2 m -161.37 127.54 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 924' ' ' ILE . 62.2 m -71.64 117.26 12.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 85.7 mt -87.55 -53.53 4.75 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.657 ' HA ' HD13 ' A' ' 924' ' ' ILE . 53.8 t0 171.06 -39.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.221 0.326 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -83.54 34.75 0.49 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.109 0.48 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.7 mp 50.77 47.39 24.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.345 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.0 148.54 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 111.087 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 94.2 m95 -89.65 46.66 1.39 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.76 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 953' ' ' SER . 37.8 t 49.03 29.73 2.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.2 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 952' ' ' SER . 19.8 m 34.58 100.44 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.611 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.15 133.98 54.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.371 2.047 . . . . 0.0 112.797 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -159.1 135.94 9.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 60.6 t0 56.54 67.09 1.04 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 941' ' ' PHE . 19.6 m -147.75 68.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.513 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 957' ' ' VAL . 80.8 m 77.28 144.54 0.08 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.322 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 95.0 mttt -142.17 166.9 23.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -53.29 119.07 4.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 -179.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.501 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 39.8 tptt -56.22 148.69 17.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.805 ' HB3' HE21 ' A' ' 981' ' ' GLN . 54.6 p -149.44 125.04 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.95 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.428 ' O ' HD12 ' A' ' 980' ' ' ILE . 2.1 p -82.23 141.07 33.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.851 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.78 137.42 57.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.079 0.466 . . . . 0.0 111.141 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 95.4 m -53.69 126.61 49.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.647 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.626 ' HG2' HG11 ' A' ' 974' ' ' VAL . 28.9 Cg_endo -62.78 125.79 16.77 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.335 2.023 . . . . 0.0 111.878 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.24 134.47 60.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.209 1.939 . . . . 0.0 111.425 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -56.34 117.13 14.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.749 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 970' ' ' VAL . 22.3 Cg_exo -65.28 -146.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.873 2.382 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.87 ' HB ' ' HB2' ' A' 1020 ' ' CYS . 2.5 t -57.75 -136.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.148 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.591 ' H ' HG12 ' A' ' 970' ' ' VAL . 76.1 m-20 -72.33 68.53 0.76 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.506 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.408 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -164.96 -160.2 12.12 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.716 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 179.84 144.12 0.17 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.726 0.298 . . . . 0.0 110.973 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.673 HG21 HD12 ' A' ' 986' ' ' ILE . 9.9 p -94.32 138.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.15 0.5 . . . . 0.0 111.309 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -120.14 117.92 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.909 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.402 ' HA ' HG22 ' A' ' 986' ' ' ILE . 35.8 t -70.14 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 31.3 mm -75.13 -43.24 44.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 77.6 p -147.03 -53.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.649 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.638 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 48.5 m-20 -157.57 151.01 23.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.102 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.46 HG22 ' HH2' ' A' 1013 ' ' TRP . 18.7 pt -88.34 32.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.781 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.805 HE21 ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -78.4 142.11 37.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.061 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' 1005 ' ' ILE . 80.1 t -50.39 104.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.937 0.398 . . . . 0.0 111.32 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 151.5 -51.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.431 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' 1003 ' ' GLU . 80.5 p -76.27 -152.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 0.0 111.046 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -151.4 178.37 9.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.235 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.673 HD12 HG21 ' A' ' 974' ' ' VAL . 26.9 pt -142.0 129.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.524 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -98.26 138.57 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.587 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.572 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 8.8 m-85 -105.79 151.23 24.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.7 t -148.69 114.18 5.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 111.275 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 75.0 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 971' ' ' ASN . 6.2 t -64.52 146.71 54.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.718 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.3 m -44.26 130.32 6.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.428 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 125.14 -49.81 0.89 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.251 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -102.02 139.67 37.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.683 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.756 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.8 ptt85 -91.45 140.28 29.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.344 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.9 tt -71.79 130.44 41.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 1.9 mp -100.34 133.64 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.73 -155.41 25.66 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.454 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.676 ' O ' ' HG3' ' A' 1018 ' ' PRO . 14.6 m170 -82.98 125.29 31.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.522 0.201 . . . . 0.0 110.683 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 43.8 t -73.6 12.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 999' ' ' HIS . 80.0 p -156.82 150.74 24.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.407 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -152.03 135.87 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 984' ' ' SER . 38.4 tt0 -95.15 128.92 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.434 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 44.8 t -71.28 122.87 21.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.504 ' HA ' HG13 ' A' ' 982' ' ' VAL . 32.4 pt -133.64 -151.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.728 ' HG ' ' H ' ' A' 1008 ' ' GLY . 19.4 tp -151.11 131.38 13.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.395 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.671 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 37.7 t -93.01 31.69 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.728 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 77.22 -48.74 2.84 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.701 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.52 -44.94 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.789 0.328 . . . . 0.0 111.33 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.581 ' C ' HD12 ' A' 1006 ' ' LEU . 88.7 m -146.63 148.07 31.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.427 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.4 139.35 38.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.97 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.671 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.8 p80 -158.11 154.17 27.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.46 ' HH2' HG22 ' A' ' 980' ' ' ILE . 75.9 m95 -64.21 145.58 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 48.0 t -59.57 -30.45 68.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.433 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.506 HG21 ' ND1' ' A' ' 999' ' ' HIS . 65.7 p -140.59 142.97 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.119 0.485 . . . . 0.0 112.089 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.621 ' NZ ' ' HB3' ' A' 1016 ' ' LYS . 5.8 ttpm? -55.1 139.35 64.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.755 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.11 128.46 22.44 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.524 2.149 . . . . 0.0 112.701 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.676 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 35.7 Cg_exo -57.36 147.02 79.91 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.019 2.479 . . . . 0.0 112.408 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 29.8 mt -103.0 132.89 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.722 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.87 ' HB2' ' HB ' ' A' ' 970' ' ' VAL . 71.4 m -86.37 123.17 31.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -143.81 130.59 20.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.472 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' 1022 ' ' ARG . 41.2 ttp85 -45.19 133.88 6.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 111.832 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.756 HG12 ' HB3' ' A' ' 995' ' ' ARG . 53.6 mt -74.94 129.01 84.13 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.691 2.26 . . . . 0.0 112.345 -179.908 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.695 0.283 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 61.29 -153.56 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.234 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 65.02 133.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.334 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.73 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 64.39 121.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.671 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.461 ' C ' HD22 ' A' ' 949' ' ' LEU . 66.1 m80 -155.31 141.31 18.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 87.7 m -81.03 128.18 33.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.5 mm100 -68.12 171.6 6.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.183 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -43.06 132.38 3.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 943' ' ' ILE . 15.7 Cg_exo -68.75 63.19 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.17 2.58 . . . . 0.0 112.589 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 50.6 t0 33.95 -135.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 38.9 m80 -152.54 119.24 5.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.963 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 9.6 m-85 -85.29 136.81 33.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.158 0.504 . . . . 0.0 111.368 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.739 ' O ' ' HD3' ' A' ' 933' ' ' ARG . 1.8 mm? -84.99 -51.65 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 958' ' ' CYS . 0.2 OUTLIER -86.13 15.09 5.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.316 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -153.62 155.77 36.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.343 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.639 ' HE2' ' NE ' ' A' ' 933' ' ' ARG . 68.2 mttm -136.51 134.11 37.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.826 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.3 tm? -49.43 149.75 2.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.173 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.834 ' HG3' ' HG2' ' A' ' 931' ' ' GLU . 31.2 mmmt -143.22 -35.81 0.39 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 915' ' ' THR . 56.5 m -69.89 65.04 0.22 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 917' ' ' THR . 17.0 pt20 37.2 -148.43 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 916' ' ' GLN . 15.1 t 50.87 139.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 113.027 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 77.5 p -146.18 15.84 1.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.685 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -74.49 174.96 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.6 t -89.74 -51.47 5.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.3 145.16 27.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 917' ' ' THR . 31.7 m-85 -136.25 136.72 22.98 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.414 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.407 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 55.4 Cg_endo -69.3 140.95 45.72 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.737 2.291 . . . . 0.0 111.867 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.675 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 44.0 mt -56.74 155.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 87.4 -40.79 3.08 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.407 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 46.9 m -56.37 137.66 52.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.511 -0.345 . . . . 0.0 111.119 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 78.6 p -131.35 134.82 46.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.656 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 913' ' ' LEU . 2.7 mm? -99.08 136.63 38.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.021 0.439 . . . . 0.0 111.786 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.642 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 4.4 tppp? -88.18 135.46 33.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.409 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 928' ' ' LEU . 13.3 m-85 -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.882 0.373 . . . . 0.0 111.227 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.834 ' HG2' ' HG3' ' A' ' 914' ' ' LYS . 5.2 mm-40 -97.38 132.74 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 84.3 m -59.7 137.53 58.01 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.739 ' HD3' ' O ' ' A' ' 909' ' ' LEU . 78.2 mtp180 -87.53 156.89 53.27 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 10.3 Cg_endo -51.24 139.47 44.04 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.539 2.159 . . . . 0.0 111.317 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.642 ' HB3' HG11 ' A' ' 982' ' ' VAL . 90.3 mt-10 83.34 27.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.888 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.585 ' C ' ' HE2' ' A' ' 961' ' ' LYS . 95.7 m-85 -148.23 129.28 14.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.74 ' HB3' ' HZ3' ' A' ' 961' ' ' LYS . 1.4 p90 -101.18 142.0 33.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.066 0.46 . . . . 0.0 111.334 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 163.56 -130.34 2.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.393 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.439 HH11 ' HG2' ' A' ' 939' ' ' ARG . 4.3 ptp85 -166.14 156.75 11.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.506 ' HB3' ' OE1' ' A' ' 931' ' ' GLU . 37.5 Cg_exo -59.99 108.62 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.447 2.098 . . . . 0.0 112.434 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.642 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 36.2 p90 -95.51 -168.72 1.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.525 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.04 127.48 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.615 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 905' ' ' PRO . 17.4 pt -97.63 120.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.107 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 946' ' ' LEU . 54.9 m -91.19 134.83 34.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.675 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.9 t -73.72 118.23 16.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 109.995 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.903 HD23 HG23 ' A' ' 950' ' ' VAL . 2.1 mm? -87.13 171.61 10.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.255 1.026 . . . . 0.0 113.242 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.72 -43.2 68.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.367 -1.742 . . . . 0.0 111.682 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -83.85 29.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.73 HD21 ' HB1' ' A' ' 900' ' ' ALA . 29.7 mt 48.12 63.13 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.697 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.903 HG23 HD23 ' A' ' 946' ' ' LEU . 9.4 m -135.81 -164.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.408 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 98.1 m95 -144.12 46.69 1.43 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.24 0.543 . . . . 0.0 111.487 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.427 ' H ' HD23 ' A' ' 946' ' ' LEU . 79.4 p 40.08 26.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.289 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 955' ' ' LYS . 45.5 t 35.34 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.002 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.46 137.64 31.91 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.356 2.037 . . . . 0.0 112.751 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 0.1 OUTLIER -159.09 134.87 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.272 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.9 t70 59.28 82.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.436 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.7 m -148.64 -107.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.863 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.625 ' H ' HG23 ' A' ' 957' ' ' VAL . 56.8 m -81.75 57.52 3.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 0.0 110.751 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.884 ' HE2' ' HA ' ' A' ' 959' ' ' LYS . 10.5 mmpt? -55.41 155.45 5.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.203 0.525 . . . . 0.0 112.142 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.592 ' CG ' ' HB3' ' A' ' 981' ' ' GLN . 19.6 tpp180 -55.11 116.45 2.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.249 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.931 ' HG3' ' H ' ' A' ' 962' ' ' SER . 15.0 tppt? -61.11 -176.12 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.929 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.931 ' H ' ' HG3' ' A' ' 961' ' ' LYS . 80.6 p -149.75 -155.96 0.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.147 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.689 ' HA ' ' HB1' ' A' 1011 ' ' ALA . 73.8 m -154.74 33.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.621 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 60.62 128.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.997 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 15.8 m -59.76 135.78 89.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.432 ' CG ' HG11 ' A' ' 974' ' ' VAL . 9.6 Cg_endo -50.94 136.49 44.01 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 112.121 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 968' ' ' ASP . 73.2 Cg_endo -75.11 47.43 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.697 2.264 . . . . 0.0 112.773 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 967' ' ' PRO . 11.2 p-10 22.77 78.9 0.2 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.67 0.606 . . . . 0.0 112.121 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.46 ' HG2' ' HE2' ' A' ' 988' ' ' TYR . 98.2 Cg_exo -43.89 142.16 3.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.719 2.28 . . . . 0.0 112.449 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.411 HG22 ' ND2' ' A' ' 971' ' ' ASN . 2.7 p -48.86 127.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.633 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.411 ' ND2' HG22 ' A' ' 970' ' ' VAL . 74.2 m-20 47.65 48.72 16.99 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.065 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -133.14 -152.5 6.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.388 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.412 ' HB3' ' HE2' ' A' ' 973' ' ' MET . 42.4 ttp 176.19 141.87 0.07 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 987' ' ' THR . 10.5 p -136.98 127.85 40.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.972 0.415 . . . . 0.0 111.719 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -87.76 114.86 24.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.878 ' HA ' HG22 ' A' ' 986' ' ' ILE . 81.7 t -65.44 -24.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.138 0.494 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.568 HD11 HG22 ' A' ' 987' ' ' THR . 14.0 mm 74.46 -49.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.15 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 63.8 p -149.51 -60.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 984' ' ' SER . 11.7 p-10 -159.42 144.71 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.307 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.623 HG23 HG13 ' A' ' 976' ' ' VAL . 8.2 pt -85.99 19.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.252 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.592 ' HB3' ' CG ' ' A' ' 960' ' ' ARG . 83.7 mt-30 -80.87 156.48 26.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.788 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 935' ' ' GLU . 57.0 t -55.79 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 158.48 26.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.643 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 70.2 m -163.89 139.57 6.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.311 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ptt85 -100.12 131.22 46.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.132 0.491 . . . . 0.0 112.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 976' ' ' VAL . 40.9 pt -100.3 126.21 53.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.583 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.568 HG22 HD11 ' A' ' 977' ' ' ILE . 3.3 t -104.56 160.14 15.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.34 0.591 . . . . 0.0 111.583 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.478 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 3.6 m-85 -114.97 153.39 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 77.5 p -148.61 69.67 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.625 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 84.6 m -44.51 145.6 0.84 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 19.2 p -65.12 149.32 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 82.2 m -44.56 -37.49 3.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.928 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -57.26 -56.39 25.3 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.151 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.832 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 2.3 m80 -95.56 143.23 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.748 HH21 HG23 ' A' 1023 ' ' ILE . 14.3 ptp180 -88.83 138.72 31.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.982 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 997' ' ' ILE . 8.1 tt -71.85 138.07 47.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.312 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.616 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.9 mp -117.62 137.32 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 87.79 -143.39 18.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.019 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 996' ' ' LEU . 19.4 m170 -81.47 -134.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.633 0.254 . . . . 0.0 111.02 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.529 ' HA ' ' HG2' ' A' 1018 ' ' PRO . 48.3 t -170.9 -54.66 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.84 0.352 . . . . 0.0 110.522 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 88.9 p -91.3 142.14 28.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.438 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -156.61 122.33 4.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.791 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 39.1 tt0 -96.31 139.86 31.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 982' ' ' VAL . 15.2 t -69.52 122.83 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' 1006 ' ' LEU . 20.6 pt -139.48 142.29 33.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.91 HD13 ' N ' ' A' 1007 ' ' SER . 3.4 tm? 45.73 148.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.236 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.91 ' N ' HD13 ' A' 1006 ' ' LEU . 20.4 m -156.9 -95.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.561 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.73 ' H ' ' HE3' ' A' ' 961' ' ' LYS . . . 60.8 -109.78 2.6 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -66.89 -32.13 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.637 ' O ' ' HA ' ' A' 1007 ' ' SER . 17.6 m -148.94 119.91 7.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.609 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -86.88 138.48 31.52 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.646 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.3 OUTLIER -152.07 131.52 12.97 Favored 'General case' 0 C--N 1.337 0.057 0 C-N-CA 119.413 -0.915 . . . . 0.0 113.268 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 80.4 m95 -70.28 165.05 23.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.178 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.519 ' HA ' HD11 ' A' 1005 ' ' ILE . 88.8 p -63.19 -34.79 78.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.43 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' 1002 ' ' ALA . 70.2 p -146.27 143.91 29.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.89 144.9 73.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.033 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 28.2 Cg_exo -62.19 127.13 20.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.716 2.277 . . . . 0.0 112.75 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.529 ' HG2' ' HA ' ' A' 1000 ' ' SER . 34.4 Cg_exo -61.52 150.39 85.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.466 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 51.0 mt -98.92 136.77 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.484 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 73.5 m -99.13 79.58 2.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 997' ' ' ILE . 41.9 tt0 -90.92 118.9 30.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.616 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 15.1 ptp180 -41.54 142.59 0.59 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.54 0.685 . . . . 0.0 111.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.748 HG23 HH21 ' A' ' 995' ' ' ARG . 70.7 mt -74.4 133.7 77.28 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.885 2.39 . . . . 0.0 112.489 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 897' ' ' GLU . 17.5 tp10 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.18 133.21 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 63.79 133.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.252 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.887 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -166.08 128.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 921' ' ' ASP . 52.6 m80 -153.47 144.84 23.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.752 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 99.4 m -80.8 128.92 34.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.875 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.579 ' CD ' ' H ' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -68.99 157.13 37.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.648 179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -43.19 131.44 3.38 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.041 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.4 -160.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.266 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 907' ' ' HIS . 4.2 t0 -173.6 151.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 906' ' ' ASP . 48.1 m80 70.11 68.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.369 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.485 ' CZ ' HD13 ' A' ' 943' ' ' ILE . 11.4 m-85 -139.91 43.63 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.582 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.532 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 15.7 mt -70.25 -32.29 70.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.281 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.21 10.67 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.618 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -157.52 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.669 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -92.3 120.88 33.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.425 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 915' ' ' THR . 1.3 tt -49.17 129.25 17.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.163 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.622 ' HB2' ' HG3' ' A' ' 931' ' ' GLU . 39.0 ttmt -86.48 -52.29 5.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.636 ' O ' HD22 ' A' ' 913' ' ' LEU . 47.6 m -64.59 138.34 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.253 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 916' ' ' GLN . 2.7 pp0? -61.94 141.56 57.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.899 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 70.5 p -151.67 149.33 28.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 93.8 m -154.04 -41.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 152.04 44.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.655 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.1 p -84.99 -44.41 13.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.585 ' HB2' ' HB2' ' A' ' 901' ' ' HIS . 12.1 p-10 -85.36 132.33 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -118.68 138.89 26.39 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.407 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.469 ' O ' ' HB ' ' A' ' 926' ' ' THR . 25.4 Cg_endo -61.4 137.32 69.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.603 2.202 . . . . 0.0 112.062 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 20.8 mt -60.97 154.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.347 . . . . 0.0 110.846 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.68 -38.09 2.8 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 923' ' ' PRO . 19.9 m -56.0 131.82 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.02 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 49.7 m -111.3 130.52 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 942' ' ' SER . 94.5 mt -96.53 128.26 43.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 941' ' ' PHE . 16.3 tppt? -85.16 137.59 32.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.031 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.505 ' CE2' ' HG ' ' A' ' 913' ' ' LEU . 20.5 m-85 -132.31 131.43 41.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.622 ' HG3' ' HB2' ' A' ' 914' ' ' LYS . 45.8 mt-10 -95.18 114.0 25.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.39 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 1.5 t -58.03 144.59 39.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 4.4 ptm180 -82.7 158.88 64.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.93 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 933' ' ' ARG . 39.5 Cg_endo -66.2 68.6 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.203 2.602 . . . . 0.0 113.484 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -172.41 -2.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.091 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.523 ' HB2' ' SG ' ' A' ' 932' ' ' CYS . 44.1 m-85 -142.04 134.91 28.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.264 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.651 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 9.4 p90 -102.1 138.61 38.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.562 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 162.31 8.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.168 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.434 ' HB3' ' HD2' ' A' ' 940' ' ' PRO . 71.1 mtt-85 63.62 157.5 0.12 Allowed Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 939' ' ' ARG . 38.2 Cg_endo -66.68 116.62 4.19 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.2 1.934 . . . . 0.0 111.352 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.593 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 49.5 p90 -93.56 -160.82 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.197 0.522 . . . . 0.0 111.812 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 928' ' ' LEU . 80.2 p -172.84 130.05 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.13 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.485 HD13 ' CZ ' ' A' ' 908' ' ' PHE . 39.6 pt -95.85 117.57 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.876 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 946' ' ' LEU . 52.0 m -84.04 128.96 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 5.3 t -73.81 121.6 21.12 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.1 mm? -85.34 167.92 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 0.0 113.318 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -51.73 -42.66 62.46 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.014 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.569 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.0 m-80 -84.45 32.46 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.707 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.887 HD21 ' HB1' ' A' ' 900' ' ' ALA . 24.4 mt 48.25 56.29 7.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.669 HG23 HD23 ' A' ' 946' ' ' LEU . 30.0 m -138.43 -157.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 112.38 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' A' ' 953' ' ' SER . 50.5 m95 -150.1 125.75 10.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.637 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.488 ' H ' HD21 ' A' ' 946' ' ' LEU . 79.8 p -68.54 27.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 951' ' ' TRP . 30.3 t 51.81 129.52 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 14.7 Cg_exo -69.95 69.83 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.086 2.524 . . . . 0.0 111.912 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -79.46 131.59 36.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.075 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 9.8 t70 55.1 72.66 0.46 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.512 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 18.1 m -150.9 -17.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.856 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 9.0 m -152.18 48.36 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.9 mmtp -56.55 143.81 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.495 ' HA ' ' CD2' ' A' ' 936' ' ' TYR . 38.8 ttm180 -53.23 132.33 38.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.655 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.651 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 0.0 OUTLIER -56.29 154.57 7.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.813 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 981' ' ' GLN . 80.3 p -149.8 136.27 19.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.847 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 66.7 m -81.65 36.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 58.0 tptt 61.08 133.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.565 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.629 ' HA ' HD12 ' A' ' 980' ' ' ILE . 21.6 m -54.48 127.73 58.87 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.257 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.405 ' HG3' HD13 ' A' ' 986' ' ' ILE . 55.1 Cg_endo -68.37 124.87 12.14 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.604 2.203 . . . . 0.0 112.736 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 129.2 16.83 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.189 1.926 . . . . 0.0 111.099 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 969' ' ' PRO . 37.8 m-20 -57.95 120.68 44.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.878 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 33.2 Cg_exo -61.28 145.83 98.01 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 112.036 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 25.7 t -49.34 124.65 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.819 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 75.1 m-80 75.87 -48.65 0.6 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -78.44 -151.78 5.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.5 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.533 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 1.7 pmm? 177.21 142.81 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.69 0.281 . . . . 0.0 110.818 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.684 HG21 HD12 ' A' ' 986' ' ' ILE . 14.9 p -93.67 129.57 43.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.868 0.366 . . . . 0.0 110.676 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -91.52 121.73 33.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.81 104.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.435 HD11 ' OG1' ' A' ' 987' ' ' THR . 3.0 mt -74.38 -38.69 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 79.8 p -144.73 -58.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 984' ' ' SER . 2.8 p30 -159.91 140.97 12.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.143 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 965' ' ' THR . 13.2 pt -86.67 -5.4 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.293 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.709 ' HG3' ' HB3' ' A' ' 962' ' ' SER . 14.0 mp0 -76.12 156.4 33.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.655 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.12 97.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.382 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 153.73 19.26 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.221 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' 1003 ' ' GLU . 26.2 t -165.12 -165.39 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.044 0.422 . . . . 0.0 111.34 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.527 ' HG3' ' C ' ' A' 1002 ' ' ALA . 55.6 ttp180 -147.79 136.74 22.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.684 HD12 HG21 ' A' ' 974' ' ' VAL . 20.3 pt -97.83 138.08 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.435 ' OG1' HD11 ' A' ' 977' ' ' ILE . 7.6 p -106.23 129.92 54.19 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.691 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' 1017 ' ' PRO . 13.3 m-85 -96.48 152.73 18.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.216 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 59.1 m -148.2 129.65 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.68 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.441 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.751 HG22 ' SG ' ' A' 1020 ' ' CYS . 8.8 t -171.01 149.42 2.93 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 993' ' ' GLY . 10.7 m 8.81 -118.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.12 0.887 . . . . 0.0 113.218 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1022 ' ' ARG . . . -77.03 48.93 2.81 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.612 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.594 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 6.7 m80 -137.21 134.76 36.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.811 0.339 . . . . 0.0 110.19 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.561 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.3 ptm180 -94.5 135.7 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' 1018 ' ' PRO . 7.0 tt -68.58 132.26 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 996' ' ' LEU . 3.2 mp -100.11 138.49 24.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 85.61 -131.3 10.38 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.569 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.508 ' CD2' ' HB ' ' A' 1015 ' ' THR . 85.9 m-70 -79.07 -131.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.227 0.211 . . . . 0.0 111.484 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.4 p -175.16 -28.43 0.01 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.932 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 79.7 p -150.91 150.08 30.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.704 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.527 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -152.02 133.71 14.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 984' ' ' SER . 42.3 tt0 -96.23 133.42 40.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.403 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 42.7 t -71.18 121.04 17.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.84 -157.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.402 . . . . 0.0 111.767 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 58.7 tp -150.85 134.39 16.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.25 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.562 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.2 t -88.8 -48.13 7.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.369 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 167.98 -51.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.154 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -91.27 -38.36 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.42 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 83.8 m -145.47 145.49 31.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.47 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.11 147.82 32.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.9 p80 -158.7 148.59 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.425 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 86.2 m95 -64.41 145.15 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.767 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -53.0 -33.07 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.641 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.508 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 69.3 p -145.13 141.65 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.687 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.1 137.55 73.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 988' ' ' TYR . 51.1 Cg_exo -53.68 126.7 22.72 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.533 2.155 . . . . 0.0 112.319 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.629 ' HB2' HD21 ' A' ' 996' ' ' LEU . 39.9 Cg_endo -67.11 -159.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.41 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.768 HG22 ' H ' ' A' 1020 ' ' CYS . 1.2 mt -140.67 -161.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.257 0.551 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.768 ' H ' HG22 ' A' 1019 ' ' ILE . 44.5 t -158.69 131.24 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 997' ' ' ILE . 1.0 OUTLIER -153.44 135.24 14.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.66 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 51.1 ttp180 -48.97 134.89 16.48 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 111.532 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.7 mt -74.89 128.82 84.53 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.959 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 42.6 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.709 2.273 . . . . 0.0 112.358 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 898' ' ' ALA . 15.5 tp10 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . 0.517 ' H ' ' HG3' ' A' ' 897' ' ' GLU . . . -63.62 133.08 53.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -175.5 135.1 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.71 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -166.07 136.74 3.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.413 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 949' ' ' LEU . 48.7 m80 -149.66 127.5 11.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.382 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 7.8 p -82.26 114.5 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 921' ' ' ASP . 2.6 pt20 -66.86 178.39 1.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -48.13 131.52 12.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.005 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 27.4 Cg_exo -62.1 -164.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.547 2.165 . . . . 0.0 112.325 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.12 -14.47 61.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.391 0.615 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 74.2 t60 62.26 114.42 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.582 ' HZ ' ' HG2' ' A' ' 954' ' ' PRO . 49.4 m-85 -90.0 133.56 34.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.254 0.55 . . . . 0.0 111.268 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 909' ' ' LEU . 4.1 mp -70.43 -45.74 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.125 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.698 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 2.3 p90 -82.8 31.84 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.071 0.462 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -156.09 121.39 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.879 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -96.54 129.76 43.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -44.85 144.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 931' ' ' GLU . 22.8 tptm -135.09 -38.93 0.77 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.459 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.575 ' O ' HD11 ' A' ' 913' ' ' LEU . 95.9 m -64.56 136.41 57.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.702 0.287 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.715 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -50.94 125.11 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.803 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.464 HG22 HD11 ' A' ' 913' ' ' LEU . 7.0 t -159.43 148.39 18.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 918' ' ' THR . 20.7 m -156.85 47.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.387 0.613 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -169.55 164.03 10.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.717 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 37.0 t -84.56 -39.47 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 903' ' ' GLN . 37.6 p-10 -85.01 118.81 24.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 17.0 m-85 -101.17 139.36 20.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.784 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.589 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 38.3 Cg_endo -66.42 139.17 53.16 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.732 2.288 . . . . 0.0 112.104 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.673 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 61.4 mt -61.3 151.91 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.31 -31.25 3.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.886 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.589 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 17.1 m -56.01 131.05 46.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.023 0.44 . . . . 0.0 111.982 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 942' ' ' SER . 74.8 p -90.96 116.66 28.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.672 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.638 HD23 ' OH ' ' A' ' 930' ' ' TYR . 11.7 tp -96.28 97.87 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 942' ' ' SER . 38.3 ttpt -82.52 131.03 35.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.31 0.576 . . . . 0.0 112.157 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.842 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 17.9 m-85 -113.78 139.17 49.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.473 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 914' ' ' LYS . 5.0 mm-40 -91.41 118.42 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.73 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 75.3 m -57.67 143.2 42.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.6 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.698 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 94.5 mtt180 -84.89 160.78 54.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.092 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 935' ' ' GLU . 5.9 Cg_endo -47.69 139.18 18.91 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.56 2.173 . . . . 0.0 112.096 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.551 ' HG2' HG11 ' A' ' 982' ' ' VAL . 90.0 mt-10 83.76 26.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.736 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.619 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 62.2 m-85 -145.75 148.19 32.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.302 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -137.56 -155.83 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.045 0.45 . . . . 0.0 111.839 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 78.69 33.16 38.84 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.713 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 4.6 ptp85 47.22 164.95 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.54 0.736 . . . . 0.0 112.962 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.713 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 70.9 Cg_endo -73.96 138.66 26.12 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.925 2.417 . . . . 0.0 112.808 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.893 ' HB3' ' HB ' ' A' ' 957' ' ' VAL . 43.6 p90 -95.4 120.82 36.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.371 0.605 . . . . 0.0 111.438 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 927' ' ' SER . 78.2 p -75.3 -37.33 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.762 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.506 ' O ' HG13 ' A' ' 943' ' ' ILE . 44.7 pt 49.23 104.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.393 0.616 . . . . 0.0 111.441 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 51.6 m -78.62 124.93 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.486 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 0.5 OUTLIER -73.74 130.77 40.67 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.085 0.469 . . . . 0.0 110.057 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.776 HD23 HG23 ' A' ' 950' ' ' VAL . 1.6 mm? -90.83 166.96 12.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.333 1.063 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 924' ' ' ILE . 9.4 t70 -50.23 -42.28 51.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.322 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.56 ' O ' HG13 ' A' ' 950' ' ' VAL . 16.4 p-10 -83.36 43.97 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.8 mp 44.68 53.52 7.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.089 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.776 HG23 HD23 ' A' ' 946' ' ' LEU . 26.3 m -133.91 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.188 0.518 . . . . 0.0 111.115 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.57 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 84.9 m95 -150.95 125.74 9.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.0 t -41.58 152.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.799 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 46.7 t -77.19 118.54 72.64 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.582 ' HG2' ' HZ ' ' A' ' 908' ' ' PHE . 5.9 Cg_exo -79.51 58.24 6.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.468 2.779 . . . . 0.0 112.931 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -80.25 128.6 33.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.778 ' HA ' ' HE2' ' A' ' 959' ' ' LYS . 1.5 m-20 55.61 38.41 30.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.16 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.893 ' HB ' ' HB3' ' A' ' 941' ' ' PHE . 16.7 m -89.31 -35.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.908 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 48.4 t -152.92 60.77 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.5 mmtt -56.52 148.29 19.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.243 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.591 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 17.4 ttm105 -55.59 137.35 49.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 111.575 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.823 ' HD3' ' N ' ' A' ' 962' ' ' SER . 6.4 tmtt? -56.29 144.25 30.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.618 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.823 ' N ' ' HD3' ' A' ' 961' ' ' LYS . 47.5 t -138.66 137.21 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.492 . . . . 0.0 111.099 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 p -79.21 148.45 32.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -65.49 139.01 58.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 111.301 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 60.3 m -58.32 135.95 85.12 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.194 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 974' ' ' VAL . 51.3 Cg_exo -53.31 146.68 39.43 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.422 2.081 . . . . 0.0 111.938 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 10.7 Cg_exo -72.22 46.31 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 0.0 112.687 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 8.4 t70 22.03 97.68 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 123.825 0.703 . . . . 0.0 112.476 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 968' ' ' ASP . 21.9 Cg_endo -60.43 145.25 99.05 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.491 2.128 . . . . 0.0 111.641 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 24.1 t -47.26 122.49 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' 1020 ' ' CYS . 73.0 m-80 75.48 -43.11 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.86 151.18 45.54 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.101 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 68.4 mtm -146.76 132.23 18.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.317 . . . . 0.0 110.586 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 986' ' ' ILE . 14.8 p -98.66 129.93 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.927 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 122.05 38.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.654 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.644 ' HA ' HG22 ' A' ' 986' ' ' ILE . 98.0 t -70.62 136.79 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.302 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 986' ' ' ILE . 37.1 mm -82.92 64.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.933 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 6.6 p 76.4 -43.9 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -157.5 135.43 10.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.699 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.468 HG23 ' CG1' ' A' ' 976' ' ' VAL . 20.3 pt -88.96 26.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.591 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 85.0 mt-30 -76.61 146.34 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.191 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.551 HG11 ' HG2' ' A' ' 935' ' ' GLU . 69.9 t -50.12 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.144 0.497 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 166.99 -62.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 84.6 p -81.71 -150.07 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.985 0.422 . . . . 0.0 110.225 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' 1002 ' ' ALA . 5.0 ptp85 -151.38 -165.87 2.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.875 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.644 HG22 ' HA ' ' A' ' 976' ' ' VAL . 26.4 pt -147.7 131.6 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.25 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' 1001 ' ' SER . 1.3 p -97.8 134.35 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 111.555 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 974' ' ' VAL . 3.7 m-85 -103.03 143.94 31.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.262 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.4 t -154.37 127.01 8.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.454 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 994' ' ' HIS . 15.6 t -63.6 162.35 13.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 992' ' ' THR . 4.2 t -64.83 -53.72 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 991' ' ' THR . 12.2 t 173.84 147.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' 1023 ' ' ILE . . . 84.79 -40.9 3.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.926 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.541 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.1 m80 -100.51 143.51 30.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.067 0.433 . . . . 0.0 111.194 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -91.89 148.82 21.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.95 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 999' ' ' HIS . 10.2 tt -71.82 128.81 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.61 122.43 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 131.32 -57.83 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.908 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.574 ' O ' HD22 ' A' ' 996' ' ' LEU . 40.3 t-80 -162.2 -121.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.8 p 177.31 -22.82 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.537 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 987' ' ' THR . 48.9 m -155.22 159.18 39.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.772 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -151.96 130.14 11.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -94.81 135.11 36.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.204 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 26.2 t -72.67 121.53 19.94 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 28.9 pt -134.55 141.93 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.506 HD22 ' H ' ' A' ' 935' ' ' GLU . 49.4 tp -84.52 130.44 34.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.032 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.582 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 42.3 t -96.09 50.38 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 82.19 -37.05 2.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.483 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -147.93 -50.67 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 62.4 m -94.16 125.14 38.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 961' ' ' LYS . . . -82.61 136.19 34.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.561 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.582 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.9 p80 -157.73 148.91 21.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 22.0 m95 -68.59 145.45 53.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 64.2 m -55.35 -42.96 74.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.268 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.502 HG21 ' CD2' ' A' ' 999' ' ' HIS . 80.9 p -100.15 -148.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.176 0.513 . . . . 0.0 112.114 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.573 ' HD3' ' N ' ' A' 1016 ' ' LYS . 0.0 OUTLIER -148.66 153.39 39.47 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.563 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.78 130.31 33.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.754 2.303 . . . . 0.0 112.713 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.511 ' HG3' HD11 ' A' ' 996' ' ' LEU . 79.1 Cg_endo -76.9 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.767 2.311 . . . . 0.0 112.696 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 1.6 mt -145.09 142.0 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.379 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 971' ' ' ASN . 32.9 m -81.49 129.77 34.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.541 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 2.3 tp-100 -143.49 127.14 17.04 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 30.7 ptt85 -49.12 142.19 7.23 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.487 0.661 . . . . 0.0 111.38 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 993' ' ' GLY . 23.3 mt -74.75 131.51 79.36 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.182 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.741 2.294 . . . . 0.0 112.407 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.856 0.36 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -59.38 136.23 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.981 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . 0.464 ' N ' ' OE1' ' A' ' 899' ' ' GLU . 0.4 OUTLIER -58.86 132.02 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . -166.27 -141.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.315 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 900' ' ' ALA . 21.2 m80 68.88 129.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.856 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 6.8 p -82.21 124.19 29.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.629 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.419 ' HA ' HE21 ' A' ' 903' ' ' GLN . 3.0 mm100 -69.65 166.75 18.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.142 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 920' ' ' SER . . . -47.44 127.79 10.15 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.122 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.579 ' HG3' HD12 ' A' ' 928' ' ' LEU . 53.9 Cg_endo -69.47 133.13 25.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.389 2.06 . . . . 0.0 112.018 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.19 153.2 35.26 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.216 0.532 . . . . 0.0 111.161 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -78.29 139.29 38.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.92 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.417 ' O ' HD23 ' A' ' 909' ' ' LEU . 2.9 m-85 -89.48 -140.32 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.955 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 908' ' ' PHE . 63.1 mt -154.03 -38.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -6.3 59.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.683 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -157.85 128.81 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.324 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -98.81 135.06 40.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.839 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 930' ' ' TYR . 36.8 tp -48.86 125.35 10.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.372 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -94.52 -43.34 8.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 38.1 m -64.84 135.44 55.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.806 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.421 ' CD ' ' H ' ' A' ' 916' ' ' GLN . 3.2 pm0 -64.08 144.55 57.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.046 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.685 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 46.5 p -150.53 -86.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.419 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 917' ' ' THR . 91.3 m 73.26 -38.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -69.4 136.49 51.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.365 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . 0.571 ' HA ' ' HB2' ' A' ' 904' ' ' ALA . 79.5 p -89.67 34.51 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.389 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -157.53 135.85 11.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.885 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.685 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 72.8 m-85 -143.4 138.36 15.43 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.46 140.48 12.01 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.913 2.409 . . . . 0.0 111.414 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.545 ' HA ' ' HB2' ' A' ' 945' ' ' CYS . 29.8 mt -51.59 141.18 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 110.583 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 105.8 -29.09 11.87 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.523 HG21 ' HD2' ' A' ' 922' ' ' PHE . 30.4 m -55.45 140.08 41.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.122 -0.539 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.0 m -121.19 140.39 52.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.579 HD12 ' HG3' ' A' ' 905' ' ' PRO . 90.3 mt -132.36 118.94 20.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 39.4 ttmt -89.18 128.43 35.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.409 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.596 ' CE1' HD13 ' A' ' 913' ' ' LEU . 2.5 m-85 -110.99 129.18 55.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -97.58 129.41 44.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.5 m -56.75 160.01 3.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.558 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 67.6 mtt-85 -81.47 158.33 68.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.485 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 936' ' ' TYR . 68.9 Cg_exo -39.17 -55.64 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.922 2.415 . . . . 0.0 113.26 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 936' ' ' TYR . 14.4 pt-20 -75.23 36.51 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.56 ' CE1' ' HG3' ' A' ' 935' ' ' GLU . 56.4 m-85 -142.7 150.87 40.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.036 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.739 ' HD2' ' HD2' ' A' ' 961' ' ' LYS . 35.9 p90 -145.43 135.46 23.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.326 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 957' ' ' VAL . . . 153.16 28.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.17 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 940' ' ' PRO . 80.6 mtp180 61.05 148.0 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.451 0.643 . . . . 0.0 112.239 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 939' ' ' ARG . 4.4 Cg_exo -75.18 123.04 7.49 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.263 2.642 . . . . 0.0 111.989 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.537 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 46.3 p90 -90.37 -161.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.615 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 135.93 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.425 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 4.6 pt -92.61 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -164.0 132.12 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 924' ' ' ILE . 59.5 m -72.12 110.88 6.89 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 97.5 mt -83.41 -52.85 6.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 4.6 t70 174.32 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 110.905 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.449 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.5 m-80 -83.13 31.78 0.44 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 900' ' ' ALA . 78.3 mt 50.75 42.38 27.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 948' ' ' ASN . 19.9 m -137.44 150.91 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 121.632 0.73 . . . . 0.0 112.343 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 68.6 m95 -91.49 124.71 35.87 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.323 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 48.2 t -43.37 142.07 1.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t -79.86 113.08 34.91 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.702 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.07 67.12 6.05 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.49 2.793 . . . . 0.0 111.766 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -76.42 131.68 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.296 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 8.3 t70 57.87 96.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.802 HG23 ' H ' ' A' ' 958' ' ' CYS . 2.5 m -152.85 -70.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.802 ' H ' HG23 ' A' ' 957' ' ' VAL . 80.9 m -88.44 140.62 29.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.893 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -143.12 127.21 17.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.188 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 981' ' ' GLN . 53.8 ttp180 -53.24 137.3 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.165 0.507 . . . . 0.0 112.042 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.739 ' HD2' ' HD2' ' A' ' 937' ' ' TYR . 32.1 mmmt -56.34 170.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.127 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.658 ' HB3' HE21 ' A' ' 981' ' ' GLN . 69.5 p -150.24 134.69 17.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.075 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 980' ' ' ILE . 83.0 m -81.58 144.26 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.085 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -65.89 134.84 53.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.45 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 61.7 m -54.48 117.31 12.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.31 129.98 15.67 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.402 2.068 . . . . 0.0 111.835 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.04 125.15 18.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.098 1.866 . . . . 0.0 111.507 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.25 126.55 82.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.81 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.01 142.68 82.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.549 2.166 . . . . 0.0 112.076 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' 1020 ' ' CYS . 2.3 p -46.97 129.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.575 ' ND2' HG22 ' A' ' 970' ' ' VAL . 77.3 m-20 63.74 47.2 3.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.796 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 973' ' ' MET . . . -166.96 -155.38 8.99 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.447 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 972' ' ' GLY . 23.7 ptp 175.23 140.33 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.63 0.252 . . . . 0.0 111.013 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.875 HG21 HD12 ' A' ' 986' ' ' ILE . 8.4 p -93.84 135.41 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.769 0.318 . . . . 0.0 111.029 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -94.29 108.96 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.179 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.757 ' HA ' HG22 ' A' ' 986' ' ' ILE . 57.3 t -65.41 -22.83 31.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 985' ' ' ARG . 7.2 mm 73.88 -52.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.748 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 73.3 p -150.25 -56.68 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.484 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 31.0 m-20 -157.13 157.69 34.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.595 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.647 HG23 HG13 ' A' ' 976' ' ' VAL . 14.6 pt -95.51 32.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.664 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' A' ' 962' ' ' SER . 5.4 mp0 -79.22 151.15 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 961' ' ' LYS . 73.7 t -53.93 89.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.079 0.466 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 160.56 -46.52 0.4 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.7 m -78.72 135.91 37.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.742 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 55.6 ttp180 -98.24 132.32 43.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.875 HD12 HG21 ' A' ' 974' ' ' VAL . 28.6 pt -93.97 130.09 43.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.316 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.519 HG22 ' OG ' ' A' 1001 ' ' SER . 7.8 p -102.52 130.99 49.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.461 ' CD2' ' HD2' ' A' 1018 ' ' PRO . 7.7 m-85 -95.15 145.35 25.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.195 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 88.9 p -148.64 121.44 8.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.744 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.99 149.27 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 7.7 t -64.32 146.02 55.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.491 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 88.5 m -46.42 125.14 6.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.257 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' 1023 ' ' ILE . . . 127.72 -46.81 1.06 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.464 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.6 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 3.9 m80 -100.19 140.24 34.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.618 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.5 ptm180 -92.36 144.13 25.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.371 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 997' ' ' ILE . 6.8 tt -72.81 135.39 45.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.0 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.656 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.6 mp -115.07 139.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 90.47 -125.71 8.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.262 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.546 ' CD2' ' HB ' ' A' 1015 ' ' THR . 85.0 m-70 -78.33 -134.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.463 0.173 . . . . 0.0 111.314 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 79.5 p -177.9 -27.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 987' ' ' THR . 50.0 m -151.63 153.0 33.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.577 ' C ' ' HG3' ' A' ' 985' ' ' ARG . . . -151.58 128.9 11.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.742 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 20.5 pt-20 -95.66 137.85 34.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.805 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.26 95.89 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.604 HG23 ' HG3' ' A' 1003 ' ' GLU . 32.1 pt -103.56 -157.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.869 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' 1010 ' ' THR . 57.3 tp -153.68 137.73 16.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.474 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.509 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.8 t -90.03 -40.09 12.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.777 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -169.92 -34.08 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.45 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.485 ' C ' HD11 ' A' 1006 ' ' LEU . 14.4 p-10 -152.95 -40.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.528 ' O ' HD12 ' A' 1006 ' ' LEU . 70.5 m -91.2 130.08 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.608 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -78.98 141.02 37.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.106 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.509 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.0 p80 -157.01 145.95 20.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.33 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 66.4 m95 -68.27 141.89 55.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 92.7 p -57.74 -32.32 67.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.38 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.546 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 71.5 p -142.88 139.07 30.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.958 0.409 . . . . 0.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' 1017 ' ' PRO . 4.7 tmmm? -64.82 138.37 97.45 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.558 ' N ' ' HD2' ' A' 1016 ' ' LYS . 97.8 Cg_exo -44.75 134.74 10.15 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.964 2.443 . . . . 0.0 113.207 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 988' ' ' TYR . 40.3 Cg_endo -66.54 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.861 2.374 . . . . 0.0 112.844 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 55.9 mt -141.09 144.85 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.837 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 74.2 m -103.89 123.97 48.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.436 ' HG3' HH11 ' A' 1022 ' ' ARG . 0.6 OUTLIER -142.84 127.48 18.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.669 0.271 . . . . 0.0 110.754 -178.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 0.0 OUTLIER -49.66 136.95 16.46 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.447 0.642 . . . . 0.0 111.168 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.618 HG12 ' HB3' ' A' ' 995' ' ' ARG . 16.0 mt -75.96 132.46 74.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.188 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.733 0.301 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 57.22 -153.17 0.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . 0.445 ' HB3' ' HE1' ' A' ' 901' ' ' HIS . 95.1 mt-10 -57.99 134.38 56.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.825 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -73.9 128.68 36.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.054 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.447 ' C ' HD22 ' A' ' 949' ' ' LEU . 74.0 m80 -156.04 141.08 17.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.276 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 92.1 m -81.05 128.6 33.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -76.14 172.14 13.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.397 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -46.1 126.06 7.15 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.984 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.693 ' HG2' HD23 ' A' ' 928' ' ' LEU . 50.5 Cg_exo -56.75 138.08 83.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.623 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.22 157.21 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -78.11 123.74 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.87 ' HB2' ' HB3' ' A' ' 911' ' ' ALA . 2.8 m-85 -85.22 24.1 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.25 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 14.1 mt 61.33 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.17 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.592 ' HA ' ' HD2' ' A' ' 933' ' ' ARG . 0.3 OUTLIER -82.49 35.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.392 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.87 ' HB3' ' HB2' ' A' ' 908' ' ' PHE . . . -154.48 143.12 20.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.228 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.28 144.61 32.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 915' ' ' THR . 59.3 tp -43.03 152.49 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.394 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.875 ' HA ' ' HE3' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -147.9 48.1 1.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.036 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 917' ' ' THR . 16.2 m -170.72 137.32 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -52.91 132.09 36.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.808 0.337 . . . . 0.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.833 ' HB ' ' HZ ' ' A' ' 922' ' ' PHE . 82.7 p -152.88 57.9 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 85.0 m -51.5 -44.74 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.6 51.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 49.4 m -86.78 -41.57 14.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.87 145.98 27.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.382 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.833 ' HZ ' ' HB ' ' A' ' 917' ' ' THR . 37.9 m-85 -134.95 138.51 29.69 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 0.0 112.037 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.478 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 58.0 Cg_endo -70.59 141.1 41.03 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.367 . . . . 0.0 111.67 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.75 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 37.7 mt -56.53 143.05 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.994 0.425 . . . . 0.0 111.312 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.2 16.44 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.492 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 19.5 m -55.88 132.76 50.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 32.1 t -96.97 143.19 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.835 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.693 HD23 ' HG2' ' A' ' 905' ' ' PRO . 8.6 tp -135.18 125.19 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.29 134.22 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.515 ' HE1' HD23 ' A' ' 928' ' ' LEU . 8.5 m-85 -132.13 122.79 25.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.392 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -95.62 130.46 42.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.346 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 36.0 m -56.79 -173.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.401 . . . . 0.0 111.363 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.592 ' HD2' ' HA ' ' A' ' 910' ' ' PHE . 93.7 mtt180 -82.46 152.72 67.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.758 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 936' ' ' TYR . 91.9 Cg_exo -44.51 -40.01 13.28 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.78 2.32 . . . . 0.0 112.547 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.04 21.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 111.082 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.3 m-85 -142.75 137.22 29.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.486 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.473 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 3.7 p90 -102.12 36.56 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.215 0.531 . . . . 0.0 110.962 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . -83.87 139.74 18.81 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.79 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 37.1 ptt85 -72.89 163.52 67.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -63.63 112.69 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.352 2.035 . . . . 0.0 112.017 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.636 ' HB3' HG11 ' A' ' 957' ' ' VAL . 53.1 p90 -91.04 114.85 27.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.46 0.648 . . . . 0.0 110.612 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.2 p -79.58 122.09 26.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.955 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 954' ' ' PRO . 9.4 pt -97.46 -174.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 0.7 OUTLIER -166.82 134.42 2.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.75 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 52.7 t -66.53 116.16 7.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.648 HD11 ' HA ' ' A' ' 952' ' ' SER . 77.4 mt -80.96 -55.56 4.71 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.571 ' HA ' HD13 ' A' ' 924' ' ' ILE . 49.8 t0 173.21 -48.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.53 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -83.87 33.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.278 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.825 HD21 ' HB1' ' A' ' 900' ' ' ALA . 40.4 mt 60.92 56.77 2.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.637 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 2.1 m -139.4 -163.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.219 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.554 ' HA ' ' O ' ' A' ' 944' ' ' THR . 74.7 m95 -145.41 125.03 13.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.766 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.648 ' HA ' HD11 ' A' ' 946' ' ' LEU . 47.5 t -38.59 135.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.94 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 79.9 p -76.97 111.38 16.04 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 943' ' ' ILE . 18.6 Cg_exo -65.85 132.64 31.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.576 ' HG2' ' H ' ' A' ' 956' ' ' ASP . 79.2 tttt -78.23 -134.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.576 ' H ' ' HG2' ' A' ' 955' ' ' LYS . 38.9 p-10 -78.98 127.0 31.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.847 0.356 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.636 HG11 ' HB3' ' A' ' 941' ' ' PHE . 21.0 m -150.36 -48.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.5 ' N ' HG23 ' A' ' 957' ' ' VAL . 71.3 m -84.18 138.17 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.4 mmtt -143.88 131.47 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 981' ' ' GLN . 20.5 mmt180 -58.96 113.95 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.052 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.962 ' HE3' ' HB2' ' A' 1011 ' ' ALA . 38.3 ttpt -58.33 166.06 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.473 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 90.1 p -144.46 141.61 29.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.965 0.412 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.408 ' SG ' ' HB1' ' A' 1011 ' ' ALA . 49.2 m -81.54 36.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.979 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 60.18 128.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 14.6 m -61.17 132.81 92.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.484 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.456 ' CG ' HG11 ' A' ' 974' ' ' VAL . 11.6 Cg_endo -55.37 135.68 70.2 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 112.384 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 968' ' ' ASP . 72.2 Cg_endo -76.23 52.31 3.47 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 967' ' ' PRO . 8.1 t70 29.59 102.03 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.24 0.616 . . . . 0.0 112.423 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.509 ' HG2' ' HD2' ' A' ' 988' ' ' TYR . 52.1 Cg_exo -52.62 143.97 44.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.743 2.295 . . . . 0.0 112.322 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.523 HG22 ' ND2' ' A' ' 971' ' ' ASN . 6.4 p -53.04 133.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.484 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.523 ' ND2' HG22 ' A' ' 970' ' ' VAL . 76.1 m-20 52.65 47.3 25.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.415 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.51 -158.77 16.21 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.631 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 24.1 ptt? 176.29 140.42 0.06 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.151 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.576 HG21 HD12 ' A' ' 986' ' ' ILE . 7.2 p -99.82 128.77 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.483 ' CE1' ' HB3' ' A' ' 989' ' ' SER . 0.5 OUTLIER -89.76 124.31 34.52 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 979' ' ' ASP . 87.3 t -76.4 124.55 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . . . . . . . . . 3.5 mm -75.49 -41.65 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 81.9 p -144.71 -52.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.317 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 976' ' ' VAL . 2.7 m-20 -153.33 -156.57 0.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 986' ' ' ILE . 15.8 pt -151.08 22.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 960' ' ' ARG . 4.8 mm100 -80.88 174.86 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' 1006 ' ' LEU . 88.0 t -58.83 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.91 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 146.99 -34.44 1.32 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.4 m -75.06 140.4 43.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.631 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' 1002 ' ' ALA . 38.8 ttm180 -104.16 150.63 24.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.576 HD12 HG21 ' A' ' 974' ' ' VAL . 40.8 pt -131.21 135.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' 1001 ' ' SER . 11.6 p -103.61 132.7 49.63 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.509 ' HD2' ' HG2' ' A' ' 969' ' ' PRO . 5.2 m-85 -98.7 145.63 26.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 975' ' ' HIS . 46.8 t -152.32 119.13 5.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.028 0.442 . . . . 0.0 110.984 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 996' ' ' LEU . 62.6 m -80.92 144.85 31.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.854 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.8 t -65.0 158.37 25.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.4 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 10.0 t -46.47 134.57 9.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.624 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 113.83 -51.01 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.979 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -101.88 141.3 34.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.524 ' O ' HD12 ' A' ' 997' ' ' ILE . 2.6 ptp180 -93.33 146.44 23.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.354 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' 1018 ' ' PRO . 10.0 tt -69.64 129.78 40.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.775 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 995' ' ' ARG . 2.1 mp -98.34 142.26 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 88.72 -133.57 11.89 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.945 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.499 ' CD2' ' HB ' ' A' 1015 ' ' THR . 96.0 m-70 -78.63 -121.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 20.3 m -164.67 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.574 0.226 . . . . 0.0 111.177 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.575 ' HB3' HG22 ' A' ' 987' ' ' THR . 80.0 p -155.17 117.87 4.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.973 0.415 . . . . 0.0 111.274 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 985' ' ' ARG . . . -91.09 179.45 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.478 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -145.41 132.13 19.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.339 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 981' ' ' GLN . 44.3 t -71.19 122.35 20.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 982' ' ' VAL . 29.8 pt -138.38 148.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.179 0.514 . . . . 0.0 111.911 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' 1007 ' ' SER . 1.2 tt -88.47 129.86 35.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.496 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.651 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -89.98 -44.92 9.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -173.5 -32.27 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.993 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.63 -49.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 0.0 109.992 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 26.2 m -94.46 133.01 38.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.802 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.962 ' HB2' ' HE3' ' A' ' 961' ' ' LYS . . . -82.01 139.29 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.243 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.651 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -157.67 144.61 18.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 62.3 m95 -68.56 138.35 55.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.599 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 91.5 p -52.9 -28.42 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.674 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.499 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 53.2 p -141.54 142.43 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.639 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -56.63 153.97 19.32 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.751 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.19 122.15 8.97 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.302 2.001 . . . . 0.0 112.597 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.568 ' HB3' HD21 ' A' ' 996' ' ' LEU . 51.3 Cg_exo -54.42 148.8 40.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.779 2.319 . . . . 0.0 112.225 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' 1020 ' ' CYS . 1.3 mt -97.86 -159.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.752 ' H ' HG22 ' A' 1019 ' ' ILE . 84.5 m -153.31 134.69 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.011 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 997' ' ' ILE . 1.0 OUTLIER -151.85 136.85 17.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.26 -178.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -48.02 133.59 14.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.374 0.607 . . . . 0.0 111.018 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 995' ' ' ARG . 60.0 mt -74.79 129.48 83.34 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.976 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 112.501 -179.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . 0.421 ' N ' ' OE1' ' A' ' 897' ' ' GLU . 54.5 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.786 0.327 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 65.63 130.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -152.03 139.41 19.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . . . . . . . . . . . -166.18 126.89 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.559 ' C ' HD12 ' A' ' 949' ' ' LEU . 36.3 m80 -151.6 138.51 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.525 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 83.3 m -81.1 124.94 29.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.706 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -69.38 173.14 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -46.0 134.86 6.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.226 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 904' ' ' ALA . 52.5 Cg_exo -54.07 149.4 35.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.525 2.15 . . . . 0.0 111.942 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 907' ' ' HIS . 29.2 t0 -63.23 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.751 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.475 ' H ' ' CG ' ' A' ' 906' ' ' ASP . 26.3 m80 -77.77 134.36 38.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.03 47.07 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.217 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.935 HD12 ' N ' ' A' ' 910' ' ' PHE . 4.2 pp -53.26 -34.44 57.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.4 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.935 ' N ' HD12 ' A' ' 909' ' ' LEU . 0.2 OUTLIER -87.11 26.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.485 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -155.09 129.98 9.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -101.62 126.2 48.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.382 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -55.49 119.89 6.34 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.536 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.645 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 74.4 mmtt -95.4 -39.04 10.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.651 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 916' ' ' GLN . 18.5 m -64.55 -119.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.142 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.505 ' N ' HG22 ' A' ' 915' ' ' THR . 0.0 OUTLIER -171.06 134.05 0.92 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 3.4 t -160.35 159.44 31.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.566 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 87.2 m -155.95 -31.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.403 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.3 158.74 35.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.03 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 79.3 p -84.67 -50.68 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.35 126.19 33.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.328 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 902' ' ' CYS . 20.0 m-85 -102.0 134.13 20.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.023 0.439 . . . . 0.0 111.906 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.487 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 71.5 Cg_endo -73.36 137.36 25.58 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.833 2.355 . . . . 0.0 112.003 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.596 HG12 ' SG ' ' A' ' 945' ' ' CYS . 25.9 mt -59.99 151.58 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 93.94 -36.2 3.85 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.9 m -56.12 133.53 52.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.428 -0.386 . . . . 0.0 111.271 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 42.6 t -114.08 121.72 44.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.435 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.579 ' HB3' ' HE1' ' A' ' 930' ' ' TYR . 92.9 mt -103.38 124.82 49.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 17.1 tppt? -87.39 132.52 33.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.579 ' HE1' ' HB3' ' A' ' 928' ' ' LEU . 15.0 m-85 -135.27 123.03 22.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.544 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.979 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 90.4 mt-10 -103.29 129.59 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.691 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 74.2 m -54.09 168.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.548 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 77.6 mtp180 -79.03 148.46 71.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.53 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 936' ' ' TYR . 83.3 Cg_exo -45.45 -42.64 17.98 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.831 2.354 . . . . 0.0 112.682 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.431 ' CD ' HG11 ' A' ' 982' ' ' VAL . 4.2 mm-40 -73.33 20.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.227 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 934' ' ' PRO . 48.6 m-85 -144.6 135.12 24.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.746 0.308 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 961' ' ' LYS . 0.1 OUTLIER -102.67 37.35 1.95 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 110.922 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -77.03 0.12 67.88 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.764 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 939' ' ' ARG . 62.0 mtt85 64.58 144.12 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.429 . . . . 0.0 111.353 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.979 ' HB3' ' HG2' ' A' ' 931' ' ' GLU . 19.6 Cg_exo -66.36 110.43 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.796 2.331 . . . . 0.0 112.505 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.431 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 52.3 p90 -95.54 -164.3 1.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.496 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.524 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 80.5 p -172.83 135.98 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 10.8 pt -97.01 166.26 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.838 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 946' ' ' LEU . 2.9 m -161.41 120.48 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.814 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 34.8 t -68.6 112.87 5.65 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 82.2 mt -83.79 -52.5 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 946' ' ' LEU . 50.0 t0 173.49 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.787 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -85.9 36.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.471 0.653 . . . . 0.0 109.84 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' A' ' 902' ' ' CYS . 2.3 mm? 54.88 63.69 2.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.384 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 19.0 m -141.64 146.19 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 111.891 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.716 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 97.7 m95 -93.8 47.88 1.25 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.051 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 89.3 p 53.03 26.85 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 43.0 t 38.23 75.16 0.57 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.23 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 951' ' ' TRP . 92.5 Cg_endo -79.84 53.71 4.86 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.429 2.086 . . . . 0.0 112.376 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.36 129.07 35.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.916 0.389 . . . . 0.0 110.71 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 65.3 t0 60.88 106.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 958' ' ' CYS . 3.3 m -153.86 -56.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 1.035 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 72.6 m -83.55 141.53 31.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.042 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -143.03 148.12 36.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.268 0.556 . . . . 0.0 112.08 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 981' ' ' GLN . 10.8 tpt180 -53.48 113.9 1.32 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.366 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.711 ' HZ1' ' H ' ' A' 1011 ' ' ALA . 27.8 tptp -56.99 158.33 5.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.371 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.423 ' HB3' ' OE1' ' A' ' 981' ' ' GLN . 77.4 p -150.81 138.36 19.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.581 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 964' ' ' LYS . 65.4 m -81.6 35.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 963' ' ' CYS . 87.4 tttt 55.45 131.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.416 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.603 ' HA ' HD12 ' A' ' 980' ' ' ILE . 24.3 m -54.11 129.05 58.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.526 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 72.8 Cg_endo -74.87 124.94 9.06 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.511 2.141 . . . . 0.0 112.67 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 15.5 Cg_exo -67.99 125.76 13.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.456 2.104 . . . . 0.0 111.533 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.24 128.53 91.21 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.243 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 970' ' ' VAL . 72.6 Cg_endo -76.26 -152.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.685 2.256 . . . . 0.0 111.979 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' 1020 ' ' CYS . 12.7 t -53.94 116.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.596 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . . . . . . . . . 18.3 p30 39.53 32.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' 1020 ' ' CYS . . . -67.02 177.56 19.05 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.111 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 50.6 ttm -175.45 73.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.323 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 988' ' ' TYR . 3.7 p -90.35 122.05 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 111.328 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.404 ' O ' ' HD2' ' A' ' 975' ' ' HIS . 0.7 OUTLIER -95.62 131.61 41.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.166 0.507 . . . . 0.0 109.902 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.573 ' HB ' HG23 ' A' ' 980' ' ' ILE . 2.1 m -75.4 135.63 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.626 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.557 ' N ' HD12 ' A' ' 977' ' ' ILE . 2.5 mp -76.46 -32.14 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.475 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 977' ' ' ILE . 64.8 p -140.4 -66.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 980' ' ' ILE . 53.0 t0 -162.16 14.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 965' ' ' THR . 29.3 pt 51.77 24.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.361 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 7.3 mm100 -80.93 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.654 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 14.7 t -55.51 130.31 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.333 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 96.26 -23.05 36.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.852 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' 1003 ' ' GLU . 52.3 m -74.61 -165.45 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.587 ' HE ' ' HB2' ' A' 1001 ' ' SER . 74.1 ttt180 -151.35 161.51 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.406 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 980' ' ' ILE . 20.3 pt -136.42 132.05 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' 1001 ' ' SER . 2.5 p -124.59 136.11 53.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 111.575 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 2.0 m-85 -94.04 156.51 16.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.443 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 57.7 m -147.84 69.32 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.611 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 85.7 m -44.93 151.44 0.3 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.368 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 21.0 p -64.04 150.68 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 79.8 m -48.32 137.74 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.134 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' 1023 ' ' ILE . . . 106.02 -40.14 2.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.656 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 4.2 m80 -96.38 138.68 33.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.582 ' HB3' HG12 ' A' 1023 ' ' ILE . 39.4 ptt180 -94.91 151.04 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.552 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 997' ' ' ILE . 0.4 OUTLIER -73.48 125.05 27.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.293 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.0 mp -103.05 138.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.707 0.289 . . . . 0.0 110.78 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 81.09 -125.13 6.72 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.011 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -78.57 -132.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.1 p -177.21 -30.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.606 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 987' ' ' THR . 83.3 p -150.93 167.51 27.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -156.56 139.03 14.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.5 tt0 -96.25 134.94 38.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.654 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 40.5 t -71.96 125.83 28.21 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.24 -155.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.805 0.336 . . . . 0.0 111.537 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 36.8 tp -152.05 124.75 8.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.643 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.3 t -91.35 -48.37 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' 1010 ' ' THR . . . 168.85 124.15 0.71 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.867 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.6 m120 71.38 -28.82 0.19 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' 1008 ' ' GLY . 96.7 m -145.43 135.43 23.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.774 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.711 ' H ' ' HZ1' ' A' ' 961' ' ' LYS . . . -82.25 149.07 28.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.643 ' NE2' ' HB2' ' A' 1007 ' ' SER . 7.4 p80 -157.93 151.37 23.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.538 ' CZ2' ' HB ' ' A' ' 980' ' ' ILE . 81.2 m95 -68.46 144.05 54.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.253 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.5 t -56.8 -31.06 64.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.673 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 80.8 p -144.06 138.41 28.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.047 0.451 . . . . 0.0 111.923 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.57 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -66.45 155.74 87.61 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.182 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.16 135.31 52.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.759 2.306 . . . . 0.0 112.782 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 988' ' ' TYR . 53.6 Cg_endo -68.81 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.818 2.346 . . . . 0.0 112.605 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.745 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 54.4 mt -140.16 137.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 78.6 m -98.75 123.37 42.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 997' ' ' ILE . 36.3 tt0 -145.74 129.12 16.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.692 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 36.5 ttm180 -51.16 135.45 25.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.439 0.638 . . . . 0.0 111.475 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 995' ' ' ARG . 48.4 mt -74.92 125.78 89.0 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 C--O 1.25 1.081 0 C-N-CA 122.627 2.218 . . . . 0.0 112.475 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.879 0.371 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -64.83 136.35 56.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.045 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -173.74 138.33 0.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . 65.99 128.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.427 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.455 ' C ' HD22 ' A' ' 949' ' ' LEU . 50.9 m80 -153.86 143.93 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 66.1 m -80.47 122.95 27.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.596 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.4 mm100 -68.14 170.68 8.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.687 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.35 133.18 5.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.945 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.48 ' HG3' ' OH ' ' A' ' 930' ' ' TYR . 26.6 Cg_endo -61.7 -168.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.642 2.228 . . . . 0.0 112.333 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 907' ' ' HIS . 8.3 t70 -174.96 161.04 2.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.053 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.417 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 78.0 t60 72.11 62.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.587 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.695 ' O ' HD13 ' A' ' 909' ' ' LEU . 45.1 m-85 -146.01 120.15 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.084 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 909' ' ' LEU . 0.0 OUTLIER -132.58 -45.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.012 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.97 13.87 3.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.126 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.475 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -152.0 126.81 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.115 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.546 ' HG3' ' HZ3' ' A' ' 914' ' ' LYS . 20.8 pttp -107.92 123.85 49.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.684 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 914' ' ' LYS . 3.4 tm? -51.13 146.81 6.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.086 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.748 ' N ' HD13 ' A' ' 913' ' ' LEU . 42.6 mmtm -147.88 11.89 0.97 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 1.041 HG21 HD22 ' A' ' 928' ' ' LEU . 14.3 t -70.88 -151.18 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.879 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.494 ' N ' HG23 ' A' ' 915' ' ' THR . 0.7 OUTLIER -86.55 -44.45 11.91 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-O 121.221 0.534 . . . . 0.0 110.978 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 915' ' ' THR . 21.4 p 50.67 -121.12 1.7 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.187 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 916' ' ' GLN . 68.8 p 55.7 33.14 20.74 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.47 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.557 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.0 t -85.72 -49.37 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.744 0.306 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.74 126.01 33.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.593 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.482 ' CD2' HD21 ' A' ' 928' ' ' LEU . 36.0 m-85 -108.46 138.18 20.15 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.922 0.391 . . . . 0.0 111.756 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.526 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.1 Cg_endo -69.39 143.25 51.98 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.923 2.415 . . . . 0.0 112.302 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.731 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.1 mt -57.66 154.79 2.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.845 0.355 . . . . 0.0 110.914 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.81 -40.37 2.89 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.526 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 23.4 m -57.11 132.1 51.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.865 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 22.6 t -115.44 133.41 56.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 1.041 HD22 HG21 ' A' ' 915' ' ' THR . 78.3 mt -95.47 125.81 40.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.956 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.441 ' O ' HD22 ' A' ' 913' ' ' LEU . 40.4 ttmt -85.35 136.82 33.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.48 ' OH ' ' HG3' ' A' ' 905' ' ' PRO . 11.1 m-85 -128.75 131.28 47.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.61 123.03 44.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 80.5 m -57.25 163.54 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 73.9 mtp180 -81.89 151.55 67.55 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 936' ' ' TYR . 6.7 Cg_endo -49.44 -44.23 35.48 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.972 2.448 . . . . 0.0 112.609 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.416 ' HB3' HG21 ' A' ' 982' ' ' VAL . 55.4 mt-10 -73.27 20.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.77 ' HA ' ' H ' ' A' ' 961' ' ' LYS . 45.4 m-85 -143.08 134.99 26.86 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.837 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 13.2 p90 -96.17 135.82 37.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.631 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 164.95 141.17 3.05 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.87 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 939' ' ' ARG . 0.6 OUTLIER -72.75 157.12 89.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.931 0.396 . . . . 0.0 110.505 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 19.2 Cg_endo -60.75 147.27 95.55 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.986 2.457 . . . . 0.0 112.092 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 53.1 p90 -144.44 -171.27 3.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 44.9 t -172.92 142.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 10.7 pt -100.46 116.93 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.445 ' O ' HD22 ' A' ' 946' ' ' LEU . 36.9 m -81.45 131.68 35.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.38 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.6 t -73.74 123.22 23.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.074 0.464 . . . . 0.0 109.903 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.872 HD23 HG23 ' A' ' 950' ' ' VAL . 1.9 mm? -87.44 169.03 12.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.338 1.066 . . . . 0.0 113.622 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -52.4 -40.4 62.07 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.146 -1.843 . . . . 0.0 112.043 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 950' ' ' VAL . 50.0 t30 -83.33 32.89 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 900' ' ' ALA . 56.7 mt 46.39 57.99 4.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.237 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.872 HG23 HD23 ' A' ' 946' ' ' LEU . 16.0 m -135.59 -159.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.385 0.612 . . . . 0.0 111.697 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.417 ' H ' ' HB ' ' A' ' 950' ' ' VAL . 91.8 m95 -144.72 122.31 11.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.137 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.45 ' N ' HD21 ' A' ' 946' ' ' LEU . 79.1 p -42.16 136.29 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.818 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 34.0 t -77.93 112.35 24.46 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.842 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 955' ' ' LYS . 15.4 Cg_exo -68.64 -153.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.713 2.275 . . . . 0.0 111.885 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.533 ' HB3' ' H ' ' A' ' 956' ' ' ASP . 32.4 mtmt -159.84 -147.37 0.16 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.69 0.757 . . . . 0.0 111.6 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.533 ' H ' ' HB3' ' A' ' 955' ' ' LYS . 56.5 m-20 -81.28 58.63 3.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.406 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 958' ' ' CYS . 29.5 m -81.6 -50.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.409 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.535 ' N ' HG23 ' A' ' 957' ' ' VAL . 97.5 m -89.0 52.3 2.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.422 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -57.64 138.7 55.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.754 ' HD2' ' HB2' ' A' ' 981' ' ' GLN . 0.0 OUTLIER -55.37 120.56 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.844 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.837 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 35.6 ttmt -56.45 142.36 38.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 78.5 p -144.44 141.23 29.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.512 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.1 m -81.63 23.79 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 965' ' ' THR . 13.8 tmtt? 55.6 136.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.414 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 964' ' ' LYS . 4.4 m -51.12 118.19 10.1 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.316 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.6 ' HG3' HD11 ' A' ' 986' ' ' ILE . 43.9 Cg_endo -64.5 141.73 75.07 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 122.664 2.243 . . . . 0.0 111.694 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.35 115.87 2.75 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.124 1.883 . . . . 0.0 111.575 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -62.54 134.98 95.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.902 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' 1019 ' ' ILE . 17.7 Cg_endo -59.6 138.1 81.48 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.433 2.089 . . . . 0.0 111.872 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.632 HG22 ' ND2' ' A' ' 971' ' ' ASN . 3.4 p -50.7 129.29 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.632 ' ND2' HG22 ' A' ' 970' ' ' VAL . 74.9 m-20 64.04 48.24 3.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -170.82 -145.54 4.81 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.725 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER -178.83 156.6 0.85 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 986' ' ' ILE . 14.2 p -87.55 128.07 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.466 0.65 . . . . 0.0 110.851 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.977 ' HB3' HG23 ' A' ' 987' ' ' THR . 12.3 t-160 -75.05 70.97 2.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.341 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.593 HG23 HG13 ' A' ' 974' ' ' VAL . 99.3 t -59.06 122.84 10.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.97 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.754 HD11 HG22 ' A' ' 987' ' ' THR . 32.0 mm -78.44 -40.64 24.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.29 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 59.0 p -144.67 -50.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 976' ' ' VAL . 56.5 m-20 -154.45 -142.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.495 ' HA ' ' HH2' ' A' 1013 ' ' TRP . 17.0 pt -145.56 -3.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.436 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HB2' ' HD2' ' A' ' 960' ' ' ARG . 3.2 pt20 -75.56 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.448 ' HA ' ' SG ' ' A' 1004 ' ' CYS . 5.9 m -47.92 150.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 111.366 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 85.17 -40.75 3.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.257 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 40.6 t -77.63 131.28 37.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 111.436 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 36.4 ttm180 -100.33 150.15 22.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.157 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.709 HD12 HG21 ' A' ' 974' ' ' VAL . 48.2 pt -141.73 127.58 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.381 . . . . 0.0 111.51 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.977 HG23 ' HB3' ' A' ' 975' ' ' HIS . 1.6 t -98.62 -168.31 1.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.578 ' HA ' ' H ' ' A' ' 975' ' ' HIS . 22.0 m-85 -136.87 154.15 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 0.0 111.176 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 46.4 t -148.44 125.21 11.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 72.6 m -100.04 147.39 25.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 8.1 t -65.03 146.85 54.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.525 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 87.0 m -45.87 126.48 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' 1023 ' ' ILE . . . 126.09 -46.93 1.05 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -102.23 137.48 40.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.065 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.701 ' HB3' HG12 ' A' 1023 ' ' ILE . 2.8 ptm85 -93.33 146.59 23.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.196 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 996' ' ' LEU . 8.4 tt -71.77 133.2 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.984 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.513 ' N ' HD23 ' A' ' 996' ' ' LEU . 2.2 mp -110.22 133.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 98.5 -128.9 9.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.306 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.536 ' CD2' ' HB ' ' A' 1015 ' ' THR . 94.2 m-70 -79.04 -129.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.0 p -172.24 -31.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.319 . . . . 0.0 111.247 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' A' ' 987' ' ' THR . 47.2 t -150.84 159.82 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.529 ' HB2' ' OG1' ' A' 1015 ' ' THR . . . -154.6 133.77 12.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.989 0.424 . . . . 0.0 111.83 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 4.6 pm0 -104.05 138.24 40.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.451 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 42.9 t -76.9 125.82 29.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' 1011 ' ' ALA . 29.9 pt -131.56 -151.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.669 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' 1010 ' ' THR . 28.8 tp -147.18 -26.57 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.335 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' 1006 ' ' LEU . 47.6 t 69.42 -42.94 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -175.83 -45.66 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -156.18 21.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.418 0.151 . . . . 0.0 111.025 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.667 ' C ' HD12 ' A' 1006 ' ' LEU . 3.3 m -150.58 121.04 7.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.283 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 961' ' ' LYS . . . -76.15 129.13 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 0.0 110.888 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.468 ' CE1' HD11 ' A' 1005 ' ' ILE . 20.7 p80 -160.15 144.16 14.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 963' ' ' CYS . 96.3 m95 -68.63 136.28 52.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.063 0.458 . . . . 0.0 110.453 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' 1003 ' ' GLU . 73.7 m -56.36 -27.25 55.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.888 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 999' ' ' HIS . 72.8 p -145.86 143.9 29.9 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.176 0.512 . . . . 0.0 112.324 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.468 ' HG3' ' HD2' ' A' 1017 ' ' PRO . 26.0 ttpp -65.79 140.9 97.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.778 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' 1016 ' ' LYS . 18.2 Cg_endo -58.15 131.25 42.2 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.524 2.149 . . . . 0.0 112.277 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.448 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 36.2 Cg_endo -65.02 -160.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.746 2.297 . . . . 0.0 113.01 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 969' ' ' PRO . 58.3 mt -143.16 139.65 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.814 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 71.9 m -92.58 124.66 36.77 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.62 134.67 22.68 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.199 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -45.7 135.5 6.7 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 111.851 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.701 HG12 ' HB3' ' A' ' 995' ' ' ARG . 62.1 mt -74.88 128.41 85.27 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 40.2 Cg_exo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.851 2.367 . . . . 0.0 112.253 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.866 0.365 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.88 135.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 899' ' ' GLU . 87.9 tt0 -175.19 54.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.834 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -166.14 127.53 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.621 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.556 ' C ' HD12 ' A' ' 949' ' ' LEU . 61.1 m80 -152.58 139.8 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.267 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 949' ' ' LEU . 76.5 m -81.08 132.48 35.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.987 0.422 . . . . 0.0 111.491 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.54 171.57 14.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.652 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.01 149.75 1.52 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.544 ' HB2' ' CD1' ' A' ' 908' ' ' PHE . 10.1 Cg_endo -50.84 135.17 42.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.961 2.441 . . . . 0.0 112.341 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.455 ' O ' ' HD1' ' A' ' 908' ' ' PHE . 46.6 m-20 -67.51 116.3 8.09 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.481 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.437 ' O ' HD12 ' A' ' 909' ' ' LEU . 23.9 p80 38.0 46.67 0.84 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 905' ' ' PRO . 5.5 m-85 -81.64 137.47 35.45 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.652 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.691 HD22 ' N ' ' A' ' 910' ' ' PHE . 0.0 OUTLIER -159.63 -27.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.029 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.691 ' N ' HD22 ' A' ' 909' ' ' LEU . 0.1 OUTLIER -80.0 0.63 30.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.45 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.577 ' HB2' ' SG ' ' A' ' 958' ' ' CYS . . . -153.05 134.37 14.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.347 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.21 126.35 39.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.554 ' HG ' ' CZ ' ' A' ' 930' ' ' TYR . 1.2 tt -51.19 131.94 28.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.62 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.806 ' HD3' ' HG2' ' A' ' 929' ' ' LYS . 7.0 mtpm? -85.22 -49.61 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 110.795 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.54 ' O ' HD22 ' A' ' 913' ' ' LEU . 60.2 m -64.77 136.72 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.219 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -60.37 130.48 46.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.31 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 82.0 p -152.08 147.36 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.325 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . . . . . . . . . 76.4 p -143.66 -42.87 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.35 141.76 52.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 40.0 t -86.97 39.18 0.84 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -157.23 138.72 13.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -136.36 139.31 29.33 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.493 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.6 Cg_endo -69.33 146.95 64.52 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.559 . . . . 0.0 112.227 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.762 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 18.3 mt -59.55 158.18 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.892 0.377 . . . . 0.0 111.386 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 81.23 -35.43 2.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.938 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 39.7 m -56.02 129.25 39.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 111.364 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 66.3 p -108.9 125.77 52.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 913' ' ' LEU . 91.5 mt -105.02 122.76 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.889 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.806 ' HG2' ' HD3' ' A' ' 914' ' ' LYS . 37.6 ttmt -90.01 133.35 34.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.554 ' CZ ' ' HG ' ' A' ' 913' ' ' LEU . 1.5 m-85 -120.65 168.78 11.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.374 . . . . 0.0 111.075 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 914' ' ' LYS . 11.8 pt-20 -140.95 125.43 17.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.822 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 79.2 m -57.51 154.88 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.011 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 934' ' ' PRO . 99.7 mtt180 -82.77 165.0 44.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 54.7 Cg_endo -69.94 56.08 1.42 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.892 2.395 . . . . 0.0 112.868 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.743 ' O ' ' HD2' ' A' ' 961' ' ' LYS . 55.3 mt-10 -164.94 9.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -149.18 135.31 19.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.225 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 10.8 p90 -95.02 136.38 35.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 0.0 111.221 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 167.73 141.25 3.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.52 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 939' ' ' ARG . 0.0 OUTLIER -71.35 156.0 92.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.744 0.307 . . . . 0.0 110.435 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 18.5 Cg_endo -60.99 109.15 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.411 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.518 ' HB3' ' NH1' ' A' ' 939' ' ' ARG . 52.6 p90 -96.08 -164.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.1 p -172.91 132.09 0.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.565 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 951' ' ' TRP . 5.1 pt -97.34 120.31 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 111.643 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 17.5 m -84.08 122.72 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.83 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.762 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 1.8 t -73.7 102.84 4.07 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 83.9 mt -84.01 162.2 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -43.09 -38.4 2.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.869 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 950' ' ' VAL . 74.6 m-80 -82.29 33.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.164 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.834 HD11 ' HB1' ' A' ' 900' ' ' ALA . 1.7 mm? 44.82 52.28 8.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 29.6 m -127.64 -160.3 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.537 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.767 ' HB3' ' HB ' ' A' ' 943' ' ' ILE . 75.5 m95 -149.01 121.81 8.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.67 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 87.8 p -42.72 143.85 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.918 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 41.8 t -77.08 117.29 64.12 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 17.0 Cg_exo -66.4 -8.74 21.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.596 2.198 . . . . 0.0 111.289 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? 46.97 57.26 5.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.865 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 59.9 t0 61.19 126.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.966 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 941' ' ' PHE . 5.1 m -150.94 -48.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.756 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 911' ' ' ALA . 99.5 m -83.51 54.37 2.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 0.0 110.648 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 93.5 mttt -61.39 151.83 31.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.719 ' HD2' ' NZ ' ' A' ' 961' ' ' LYS . 15.1 tpp85 -53.37 125.22 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.14 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.861 ' HG2' HG13 ' A' ' 982' ' ' VAL . 0.0 OUTLIER -56.38 125.67 22.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.38 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.545 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 91.9 p -144.45 127.9 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.107 0.48 . . . . 0.0 111.083 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' 1013 ' ' TRP . 6.9 p -82.0 44.19 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.189 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 56.7 tptt 62.86 135.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.073 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.802 ' HA ' HD12 ' A' ' 980' ' ' ILE . 14.0 m -59.85 131.32 88.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.558 ' HG3' HD13 ' A' ' 986' ' ' ILE . 37.6 Cg_endo -65.21 132.64 32.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.596 2.197 . . . . 0.0 112.459 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.35 138.9 52.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.4 2.067 . . . . 0.0 111.793 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -57.94 116.87 15.9 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.77 141.82 55.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.211 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' 1020 ' ' CYS . 11.3 p -53.74 129.13 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.413 ' ND2' HG22 ' A' ' 970' ' ' VAL . 73.5 m-80 44.97 46.66 9.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.992 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -168.01 135.05 3.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.58 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 54.4 mtm -103.68 136.65 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 986' ' ' ILE . 12.1 p -99.75 132.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -95.9 115.66 27.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 986' ' ' ILE . 94.7 t -66.01 -25.34 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.094 0.473 . . . . 0.0 109.993 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.596 HD11 ' OG1' ' A' ' 987' ' ' THR . 14.6 mm 74.21 -51.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.988 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 70.9 p -148.92 -59.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 981' ' ' GLN . 34.4 m-20 -157.41 143.84 17.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.168 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.802 HD12 ' HA ' ' A' ' 965' ' ' THR . 6.0 pt -84.64 21.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.651 ' HG2' ' HB3' ' A' ' 979' ' ' ASP . 75.8 mm-40 -78.95 159.94 27.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.219 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 961' ' ' LYS . 2.2 m -56.45 -7.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.836 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -95.64 22.46 38.97 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 979' ' ' ASP . 67.5 m -163.95 -160.89 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.778 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' 1002 ' ' ALA . 17.2 ptp180 -151.39 -168.19 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.223 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 976' ' ' VAL . 33.3 pt -146.37 129.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.596 ' OG1' HD11 ' A' ' 977' ' ' ILE . 11.0 p -103.28 134.52 46.54 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.129 0.49 . . . . 0.0 111.134 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.521 ' CD2' ' HG2' ' A' 1018 ' ' PRO . 1.5 m-85 -95.44 145.2 25.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.2 t -146.46 74.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 59.4 m -51.64 147.34 6.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.048 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 17.4 p -64.3 150.48 46.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 62.2 m -47.78 112.45 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.163 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 144.72 -50.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -102.3 142.98 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.622 ' O ' HD12 ' A' ' 997' ' ' ILE . 13.3 ptp180 -92.92 145.0 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.504 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 997' ' ' ILE . 2.5 tm? -72.45 129.53 38.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.696 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' 1021 ' ' GLN . 4.6 mp -118.41 123.52 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.64 0.257 . . . . 0.0 110.72 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 97.28 43.22 3.04 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.723 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.538 ' O ' ' HG3' ' A' 1018 ' ' PRO . 93.2 m-70 60.86 125.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 0.0 111.672 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.543 ' HB3' ' HG ' ' A' ' 996' ' ' LEU . 79.9 p -81.39 32.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 50.2 m -158.59 145.72 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.671 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 985' ' ' ARG . . . -155.8 125.5 6.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.645 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.47 130.13 40.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.227 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 120.97 17.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.06 137.71 55.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.414 0.625 . . . . 0.0 112.082 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' 1011 ' ' ALA . 22.5 tp -84.51 120.4 26.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.014 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 45.2 t -96.08 52.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 81.43 -124.51 6.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.773 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 5.9 m120 -55.62 -46.96 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.764 HG22 ' H ' ' A' 1011 ' ' ALA . 0.4 OUTLIER -94.52 -164.02 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.972 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.778 ' HB2' HD12 ' A' 1006 ' ' LEU . . . -158.25 147.38 19.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.054 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 8.1 p80 -158.26 152.04 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.478 ' HZ2' ' HD3' ' A' ' 966' ' ' PRO . 85.1 m95 -68.69 146.1 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.385 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -56.52 -30.78 63.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.723 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 8.1 t -146.97 145.69 29.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 111.93 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -53.81 137.46 54.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.093 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.515 ' HA ' ' HD2' ' A' 1018 ' ' PRO . 73.8 Cg_exo -49.53 113.1 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.197 1.931 . . . . 0.0 112.668 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.538 ' HG3' ' O ' ' A' ' 999' ' ' HIS . 11.0 Cg_endo -54.27 142.28 68.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.927 2.418 . . . . 0.0 112.138 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.686 ' H ' HD12 ' A' 1019 ' ' ILE . 0.1 OUTLIER -107.11 143.7 17.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.031 0.443 . . . . 0.0 111.9 -179.405 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 57.8 m -83.49 141.09 31.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.667 ' HB2' HD13 ' A' ' 997' ' ' ILE . 0.5 OUTLIER -145.8 131.24 18.68 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.862 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -49.75 130.92 21.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.405 0.622 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.533 HG23 HH21 ' A' ' 995' ' ' ARG . 64.9 mt -74.86 126.32 88.48 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.066 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.831 2.354 . . . . 0.0 112.314 -179.92 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.82 0.343 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -78.8 44.41 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.314 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.13 140.54 58.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.768 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.86 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -165.98 137.05 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.632 ' C ' HD22 ' A' ' 949' ' ' LEU . 26.8 m80 -148.17 131.46 16.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 8.9 p -82.3 127.8 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.595 ' H ' ' NE2' ' A' ' 903' ' ' GLN . 0.0 OUTLIER -64.17 159.26 20.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.48 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.21 131.7 5.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.708 ' HG3' HD12 ' A' ' 928' ' ' LEU . 31.3 Cg_endo -63.89 149.57 90.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.829 2.353 . . . . 0.0 112.48 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -62.37 162.94 9.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.06 124.77 27.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.501 ' HZ ' HG21 ' A' ' 943' ' ' ILE . 4.6 m-30 -85.28 129.06 34.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.56 25.63 4.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.443 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 8.5 p90 -154.01 1.63 0.23 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.066 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 908' ' ' PHE . . . -157.43 131.38 8.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.402 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -102.01 136.16 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.991 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 66.0 tp -47.8 157.0 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.389 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.703 ' HG3' ' HG3' ' A' ' 931' ' ' GLU . 3.9 mmmp? -145.36 -36.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . . . . . . . . . 19.5 m -64.4 139.45 58.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 916' ' ' GLN . 0.0 OUTLIER -58.46 136.13 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.542 179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . . . . . . . . . 77.1 p -152.18 140.33 20.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 918' ' ' THR . 25.5 m -158.4 53.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.197 0.522 . . . . 0.0 110.548 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -168.31 154.27 7.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.787 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 80.3 p -84.08 -49.44 8.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.535 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -85.32 124.59 32.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.227 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.44 ' CE2' HD11 ' A' ' 928' ' ' LEU . 25.8 m-85 -103.71 136.49 19.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.014 0.435 . . . . 0.0 111.819 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.49 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 61.2 Cg_endo -72.24 139.33 32.01 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 0.0 112.071 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.639 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 26.4 mt -57.54 158.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 83.66 -40.91 2.9 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.49 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 30.7 m -56.01 136.64 51.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.689 0.28 . . . . 0.0 111.003 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 50.2 m -123.63 131.86 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.708 HD12 ' HG3' ' A' ' 905' ' ' PRO . 88.7 mt -97.92 129.26 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.695 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 40.0 ttmt -85.25 136.81 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.767 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 17.2 m-85 -134.44 125.3 27.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.734 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.703 ' HG3' ' HG3' ' A' ' 914' ' ' LYS . 96.1 mt-10 -95.63 136.11 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 80.7 m -51.69 158.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 0.0 110.91 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.521 ' HG3' ' C ' ' A' ' 910' ' ' PHE . 44.1 mtp85 -80.09 160.26 68.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.279 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 38.2 Cg_endo -66.51 62.4 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.831 2.354 . . . . 0.0 112.452 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.0 mt-10 -163.73 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.392 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 2.6 m-85 -104.48 -176.96 3.23 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.458 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 959' ' ' LYS . 4.9 p90 -150.51 32.77 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.966 0.412 . . . . 0.0 111.336 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.918 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . -76.68 27.42 1.6 Allowed Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.294 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.74 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 16.9 ptp180 46.02 166.14 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.356 0.662 . . . . 0.0 112.633 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 41.8 Cg_endo -67.72 145.6 69.95 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.341 2.027 . . . . 0.0 112.427 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.562 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 45.3 p90 -144.46 -162.07 1.41 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.299 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.534 ' HG ' ' HA ' ' A' ' 929' ' ' LYS . 57.5 m -169.78 136.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.501 HG21 ' HZ ' ' A' ' 908' ' ' PHE . 7.8 pt -93.0 120.85 43.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.002 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 946' ' ' LEU . 16.6 m -81.52 123.48 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.76 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 10.7 t -73.72 104.23 4.56 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 950' ' ' VAL . 74.4 mt -81.76 161.55 23.26 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.503 ' HA ' HG21 ' A' ' 924' ' ' ILE . 64.2 t0 -42.09 -47.5 4.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.381 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 948' ' ' ASN . 0.0 OUTLIER -82.27 40.96 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.975 -178.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.86 HD21 ' HB1' ' A' ' 900' ' ' ALA . 43.7 mt 45.85 59.18 3.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.247 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.696 ' CG2' ' HB2' ' A' ' 946' ' ' LEU . 34.9 m -135.98 -161.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -151.02 122.94 8.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.975 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 954' ' ' PRO . 80.5 p -41.87 137.64 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . . . . . . . . . 39.7 t -79.4 110.95 17.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 0.0 112.073 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 952' ' ' SER . 57.9 Cg_endo -90.96 54.07 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.471 2.781 . . . . 0.0 110.828 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.593 ' HB2' ' NZ ' ' A' ' 955' ' ' LYS . 0.0 OUTLIER -75.63 132.82 40.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.422 -178.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 52.95 44.95 29.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.3 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 958' ' ' CYS . 0.5 OUTLIER -87.83 -50.95 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.247 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.918 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 93.1 m -89.13 111.77 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 72.7 mmtt -83.78 124.84 31.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 981' ' ' GLN . 40.4 ttm180 -61.96 133.69 55.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.277 0.561 . . . . 0.0 112.386 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.509 ' HA ' ' CE2' ' A' ' 937' ' ' TYR . 20.3 tptm -56.35 168.48 0.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.809 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.518 ' OG ' ' HG2' ' A' ' 981' ' ' GLN . 51.0 m -149.85 134.81 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.005 0.431 . . . . 0.0 111.235 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.92 141.77 35.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.804 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -65.54 136.09 55.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 66.5 m -52.62 121.86 23.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.809 ' HG2' HG11 ' A' ' 974' ' ' VAL . 30.9 Cg_endo -62.46 135.02 51.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 0.0 112.088 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.09 121.2 9.65 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.988 1.792 . . . . 0.0 110.94 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 973' ' ' MET . 14.2 m-20 -57.96 118.66 28.17 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.06 148.7 91.41 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.654 2.236 . . . . 0.0 111.873 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.475 HG12 ' ND2' ' A' ' 971' ' ' ASN . 19.3 t -45.25 122.9 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.959 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.475 ' ND2' HG12 ' A' ' 970' ' ' VAL . 72.9 m-20 60.71 45.61 9.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.537 ' HA3' ' SG ' ' A' 1020 ' ' CYS . . . -179.71 139.71 3.95 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.956 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 968' ' ' ASP . 3.5 mpp? -133.54 150.03 51.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.809 HG11 ' HG2' ' A' ' 966' ' ' PRO . 8.4 p -89.92 121.77 40.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.17 0.509 . . . . 0.0 111.051 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 121.84 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.83 135.1 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.764 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 978' ' ' THR . 26.7 mm -74.47 -53.27 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.787 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 977' ' ' ILE . 82.0 p -147.66 -52.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.312 0.577 . . . . 0.0 110.87 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.73 139.35 18.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.02 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.6 pt -88.33 34.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.897 0.379 . . . . 0.0 111.656 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.554 ' HB3' ' HD2' ' A' ' 960' ' ' ARG . 80.6 mt-30 -80.81 151.19 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' A' 1005 ' ' ILE . 76.2 t -54.48 91.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.202 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 165.63 -48.35 0.28 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.506 ' O ' ' HG3' ' A' 1003 ' ' GLU . 93.9 p -80.04 -160.38 0.28 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.053 0.454 . . . . 0.0 111.39 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 985' ' ' ARG . 4.0 ptp85 -151.39 134.97 16.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.705 HD12 HG21 ' A' ' 974' ' ' VAL . 34.6 pt -97.72 136.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.0 p -102.47 135.25 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 0.0 111.106 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 974' ' ' VAL . 3.1 m-85 -96.24 143.69 27.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.3 t -148.71 120.72 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 60.9 m -83.58 119.71 25.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.463 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 992' ' ' THR . 7.6 t -72.57 137.4 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.547 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 991' ' ' THR . 96.6 m 111.23 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.309 1.005 . . . . 0.0 111.168 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 992' ' ' THR . . . -170.66 32.45 0.15 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.215 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -95.74 144.36 26.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.69 ' HB3' HG12 ' A' 1023 ' ' ILE . 7.6 ptm180 -89.28 136.23 33.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.23 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.414 HD11 ' HG3' ' A' 1018 ' ' PRO . 10.3 tt -72.26 132.28 43.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.3 mp -99.73 125.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.031 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 92.2 -139.87 14.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.389 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -85.86 135.02 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.544 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 80.5 p -102.96 20.31 17.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.58 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 47.4 t -159.19 146.84 17.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -153.68 134.31 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.062 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 984' ' ' SER . 39.3 tt0 -95.0 129.08 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.199 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 982' ' ' VAL . 44.8 t -71.28 120.34 16.71 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.664 ' HA ' HG13 ' A' ' 982' ' ' VAL . 33.3 pt -129.9 -159.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.889 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' 1009 ' ' ASN . 41.6 tp -150.78 136.84 18.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.3 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.506 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 47.6 t -90.0 -40.31 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.828 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . -172.68 -32.02 0.03 OUTLIER Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.292 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.434 ' C ' HD11 ' A' 1006 ' ' LEU . 49.7 t30 -150.04 -44.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 110.511 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.421 ' O ' HD12 ' A' 1006 ' ' LEU . 37.4 m -92.66 131.44 37.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.979 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . . . . . . . . . . . -80.97 143.59 32.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.819 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.506 ' NE2' ' HB2' ' A' 1007 ' ' SER . 10.1 p80 -155.76 144.06 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.307 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.494 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 49.1 m95 -68.29 144.09 54.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.4 m -53.55 -29.05 35.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.61 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 68.4 p -140.91 138.8 34.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.713 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.571 ' O ' ' HD2' ' A' 1016 ' ' LYS . 1.5 pptp? -62.31 152.47 79.16 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.014 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.76 132.36 41.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.635 2.224 . . . . 0.0 112.643 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.414 ' HG3' HD11 ' A' ' 996' ' ' LEU . 56.1 Cg_endo -69.88 -153.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.783 2.322 . . . . 0.0 112.578 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.7 mt -139.01 141.97 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.015 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 972' ' ' GLY . 97.9 m -99.66 124.18 44.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -142.23 129.52 21.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.184 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -50.45 133.89 24.22 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.68 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.69 HG12 ' HB3' ' A' ' 995' ' ' ARG . 59.2 mt -74.83 123.91 89.27 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.797 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.813 2.342 . . . . 0.0 112.343 -179.892 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.768 0.318 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -173.82 139.51 0.69 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 66.07 132.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.454 ' HA ' HD11 ' A' ' 949' ' ' LEU . . . 51.54 -150.38 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.722 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.567 ' N ' HD22 ' A' ' 949' ' ' LEU . 11.7 m80 66.92 140.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.928 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . . . . . . . . . 47.8 m -80.11 129.07 34.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 903' ' ' GLN . 3.1 mm100 -64.65 168.19 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -45.69 125.32 6.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.38 123.64 8.34 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 122.457 2.105 . . . . 0.0 112.82 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 136.11 54.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.011 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -77.25 138.55 39.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.503 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 909' ' ' LEU . 14.5 m-85 -89.09 24.02 2.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.503 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.666 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 6.5 mp 68.74 -59.01 0.47 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 932' ' ' CYS . 5.4 p90 -81.82 31.03 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 930' ' ' TYR . . . -152.63 122.36 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 111.589 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -99.68 124.29 44.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.311 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.708 HD11 ' O ' ' A' ' 915' ' ' THR . 2.1 tm? -48.97 118.51 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.267 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.673 ' HE2' ' HD2' ' A' ' 929' ' ' LYS . 0.7 OUTLIER -95.89 -47.96 5.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.159 -179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.708 ' O ' HD11 ' A' ' 913' ' ' LEU . 31.7 m -64.59 128.39 35.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.613 -179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -52.36 135.14 33.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.875 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 915' ' ' THR . 79.4 p -152.02 144.67 24.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.017 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 918' ' ' THR . 24.9 m -156.46 53.36 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -167.73 156.2 9.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.5 t -86.4 -46.87 9.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 110.99 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.28 141.94 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -129.9 133.79 25.41 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.516 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 56.5 Cg_endo -70.52 141.89 43.23 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.656 2.237 . . . . 0.0 112.229 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 947' ' ' ASP . 34.2 mt -55.44 152.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 924' ' ' ILE . . . 88.47 -29.54 5.67 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.452 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.516 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 32.4 m -55.05 137.74 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 51.1 m -115.99 142.6 46.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.733 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . . . . . . . . . 98.0 mt -133.21 119.09 19.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.625 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.673 ' HD2' ' HE2' ' A' ' 914' ' ' LYS . 40.0 ttmt -89.4 138.52 31.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.395 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.582 ' HB3' ' HB1' ' A' ' 911' ' ' ALA . 5.9 m-85 -129.03 134.45 48.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -95.18 121.57 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 910' ' ' PHE . 64.2 m -59.92 149.98 30.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 909' ' ' LEU . 59.0 mtp180 -84.13 162.89 50.39 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.617 ' HD2' ' HB3' ' A' ' 933' ' ' ARG . 10.0 Cg_endo -51.88 146.23 29.46 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.241 1.961 . . . . 0.0 110.966 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 1.045 ' HB3' HG21 ' A' ' 982' ' ' VAL . 95.6 mt-10 83.23 25.89 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.888 0.742 . . . . 0.0 109.968 -178.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.794 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 78.8 m-85 -143.91 142.35 30.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.839 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.624 ' HB3' ' NZ ' ' A' ' 961' ' ' LYS . 36.2 p90 -144.06 134.73 24.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 111.439 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.811 ' HA3' ' HA ' ' A' ' 958' ' ' CYS . . . 155.75 28.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.41 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 63.09 144.43 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.0 111.784 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.57 124.93 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.524 2.15 . . . . 0.0 110.703 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 930' ' ' TYR . 6.5 p90 -90.17 -166.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 111.66 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 59.2 m -170.21 132.27 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.414 ' HB ' ' CE3' ' A' ' 951' ' ' TRP . 13.5 pt -94.01 168.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.676 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.497 ' O ' HD22 ' A' ' 946' ' ' LEU . 20.5 m -162.62 136.09 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 924' ' ' ILE . 38.7 t -73.82 125.78 28.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.621 HD22 ' N ' ' A' ' 946' ' ' LEU . 2.8 mm? -84.86 -57.03 3.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -176.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.709 ' HA ' HD13 ' A' ' 924' ' ' ILE . 23.7 t70 171.67 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.218 0.324 . . . . 0.0 111.031 -178.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -82.77 32.1 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 109.636 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 901' ' ' HIS . 22.2 mt 51.67 43.25 30.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.762 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.9 m -143.41 154.41 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.644 0.735 . . . . 0.0 112.467 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.495 ' C ' ' H ' ' A' ' 953' ' ' SER . 72.9 m95 -91.51 130.85 37.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.381 -1.282 . . . . 0.0 109.128 177.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.561 ' HB2' HD21 ' A' ' 946' ' ' LEU . 45.3 t -51.47 -10.22 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.372 0.606 . . . . 0.0 111.524 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 951' ' ' TRP . 48.0 t 61.93 121.55 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.744 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 11.5 Cg_exo -71.08 141.31 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.978 2.452 . . . . 0.0 110.74 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 11.0 tmtt? -154.59 134.64 13.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.212 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.68 ' N ' ' HD3' ' A' ' 955' ' ' LYS . 38.7 t70 60.82 41.01 15.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.123 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.79 -111.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.089 179.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.811 ' HA ' ' HA3' ' A' ' 938' ' ' GLY . 26.8 p -87.97 103.29 15.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 956' ' ' ASP . 75.4 mmtt -82.05 134.68 35.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.799 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 35.7 ptt180 -56.76 143.56 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.592 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.624 ' NZ ' ' HB3' ' A' ' 937' ' ' TYR . 5.3 mptp? -47.12 150.47 0.8 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.528 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 981' ' ' GLN . 79.2 p -142.65 127.19 17.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 70.5 m -79.48 138.21 37.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.302 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.57 135.28 55.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.895 0.379 . . . . 0.0 110.757 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 83.2 m -48.59 114.45 3.61 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.548 ' HG2' HG11 ' A' ' 974' ' ' VAL . 20.0 Cg_endo -60.57 135.42 60.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.489 2.126 . . . . 0.0 112.013 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.12 117.18 3.34 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.068 1.845 . . . . 0.0 111.327 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.14 125.11 80.41 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 144.54 99.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.681 2.254 . . . . 0.0 112.076 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' 1020 ' ' CYS . 21.4 t -46.42 129.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.967 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 991' ' ' THR . 75.3 m-20 61.76 45.65 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -169.9 -162.94 23.08 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.585 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 973' ' ' MET . 0.0 OUTLIER 178.63 147.44 0.17 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.65 0.262 . . . . 0.0 110.993 -179.641 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.906 HG21 HD12 ' A' ' 986' ' ' ILE . 8.6 p -91.08 102.79 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.773 0.797 . . . . 0.0 110.845 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -68.17 107.9 2.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.307 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.46 133.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 985' ' ' ARG . 44.9 mm -74.28 -36.07 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.088 0.47 . . . . 0.0 110.263 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 75.9 p -144.71 -49.54 0.26 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.88 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 980' ' ' ILE . 39.1 t70 -161.57 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.822 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.465 ' H ' ' CG ' ' A' ' 979' ' ' ASP . 6.2 pt -151.03 9.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 110.849 178.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.754 ' HA ' ' HA ' ' A' ' 962' ' ' SER . 21.2 mt-30 -75.75 161.16 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 1.045 HG21 ' HB3' ' A' ' 935' ' ' GLU . 10.4 m -49.27 149.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.695 0.283 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 82.94 -32.76 2.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.976 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 51.0 m -75.84 131.71 39.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.153 0.501 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 977' ' ' ILE . 78.7 ttt180 -93.38 155.82 17.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.906 HD12 HG21 ' A' ' 974' ' ' VAL . 43.9 pt -141.78 123.81 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.255 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 7.3 p -107.61 136.9 46.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.466 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.483 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 5.2 m-85 -94.06 146.58 23.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.418 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 49.3 m -148.65 109.83 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.029 0.443 . . . . 0.0 110.997 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . . . . . . . . . 79.8 m -79.96 147.87 31.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 971' ' ' ASN . 5.6 t -64.31 146.39 54.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.488 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . . . . . . . . . 85.7 m -44.02 123.69 3.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.49 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 134.73 -51.23 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.331 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.452 ' HB3' ' N ' ' A' 1021 ' ' GLN . 6.5 m80 -102.54 141.12 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.356 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.583 ' HB3' HG12 ' A' 1023 ' ' ILE . 16.6 ptm180 -92.38 146.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.348 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 996' ' ' LEU . 9.7 tt -71.77 132.73 44.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' 1019 ' ' ILE . 2.2 mp -108.91 132.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 83.94 -144.25 21.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.15 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -81.34 130.24 34.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.767 0.317 . . . . 0.0 111.278 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.421 ' HA ' HD11 ' A' ' 996' ' ' LEU . 47.6 t -85.04 -51.84 6.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.665 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 33.1 t -90.37 155.02 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -156.57 131.22 8.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.707 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.545 ' H ' ' HB3' ' A' 1014 ' ' SER . 88.3 tt0 -111.56 129.94 55.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.766 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.531 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 43.2 t -71.25 125.62 27.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.485 HG13 ' CD2' ' A' 1012 ' ' HIS . 26.7 pt -129.42 -155.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.615 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 45.3 tp -150.62 -21.86 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.832 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 36.8 t 53.27 26.96 5.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 -179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 52.94 35.54 48.52 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.522 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -163.21 -49.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.539 ' C ' HD12 ' A' 1006 ' ' LEU . 40.2 m -145.54 136.45 24.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.843 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -78.02 124.94 28.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.873 0.368 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.485 ' CD2' HG13 ' A' 1005 ' ' ILE . 0.3 OUTLIER -161.2 152.91 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.761 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.531 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 93.7 m95 -64.92 144.38 57.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.985 0.422 . . . . 0.0 110.784 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . 0.545 ' HB3' ' H ' ' A' 1003 ' ' GLU . 45.4 t -64.18 -31.59 72.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.285 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . . . . . . . . . 40.9 p -144.19 138.67 28.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.871 0.367 . . . . 0.0 111.266 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' 1017 ' ' PRO . 22.5 pttp -61.03 148.63 83.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1016 ' ' LYS . 33.0 Cg_exo -58.3 130.3 37.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.613 2.209 . . . . 0.0 112.338 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.483 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 34.5 Cg_endo -64.29 -160.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.758 2.306 . . . . 0.0 112.665 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 997' ' ' ILE . 60.4 mt -142.33 138.59 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.885 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 82.1 m -92.66 124.42 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.452 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 34.0 tt0 -143.75 135.39 26.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.464 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' 1022 ' ' ARG . 15.1 tpp85 -49.04 131.92 18.99 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.398 0.618 . . . . 0.0 111.621 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 995' ' ' ARG . 52.2 mt -76.89 124.96 87.57 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.878 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 32.8 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.809 2.34 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.829 0.347 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -63.0 135.99 57.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . 0.592 ' HB2' ' HE1' ' A' ' 901' ' ' HIS . 56.1 mt-10 -60.27 138.5 57.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.675 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.946 ' HB1' HD21 ' A' ' 949' ' ' LEU . . . -75.03 143.32 43.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.229 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.623 ' C ' HD22 ' A' ' 949' ' ' LEU . 58.1 m80 -150.4 127.41 11.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.403 178.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 11.3 p -82.9 128.15 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -73.15 175.45 6.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -47.43 129.1 10.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 906' ' ' ASP . 50.8 Cg_endo -68.46 91.5 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.483 2.122 . . . . 0.0 112.421 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 905' ' ' PRO . 6.5 t0 29.75 -133.02 0.02 OUTLIER 'General case' 0 C--O 1.232 0.135 0 O-C-N 123.606 0.566 . . . . 0.0 111.123 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' A' ' 906' ' ' ASP . 31.7 t-80 -161.8 109.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.517 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 911' ' ' ALA . 22.7 m-85 -86.5 137.15 32.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 62.5 mt -80.08 -52.96 7.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.18 29.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 908' ' ' PHE . . . -155.91 139.98 16.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.402 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -136.47 130.9 33.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 929' ' ' LYS . 66.0 tp -48.42 156.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.332 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.857 ' HA ' ' HE2' ' A' ' 914' ' ' LYS . 0.6 OUTLIER -145.49 -39.82 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.411 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 917' ' ' THR . 4.4 m -64.52 141.87 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.92 133.54 37.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.318 179.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 915' ' ' THR . 62.7 p -150.92 -65.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 917' ' ' THR . 32.1 p 66.28 -50.96 0.43 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.892 0.745 . . . . 0.0 112.555 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -70.36 151.93 44.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.443 -179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 81.1 p -85.04 -42.92 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 901' ' ' HIS . 63.9 t0 -85.02 126.26 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -106.78 136.13 19.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.63 140.6 18.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.106 2.538 . . . . 0.0 111.829 178.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.772 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 46.7 mt -55.88 148.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.059 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 73.55 77.57 0.61 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 2.2 m -176.72 122.01 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 54.9 m -83.43 129.69 35.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.981 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 917' ' ' THR . 6.0 tp -106.87 118.55 36.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.994 179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 929' ' ' LYS . 0.1 OUTLIER -85.63 135.15 33.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.785 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -135.4 129.34 33.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.258 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 940' ' ' PRO . 90.0 mt-10 -95.48 123.09 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 936' ' ' TYR . 6.1 t -58.77 153.38 16.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.559 HH11 ' HG3' ' A' ' 933' ' ' ARG . 38.9 mtt85 -81.35 155.48 71.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 51.6 Cg_endo -68.45 66.4 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.024 2.483 . . . . 0.0 112.543 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 934' ' ' PRO . 50.6 mt-10 -163.15 -9.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 959' ' ' LYS . 33.9 m-85 -134.79 140.6 46.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.402 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' A' ' 961' ' ' LYS . 10.1 p90 -99.91 137.7 38.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 939' ' ' ARG . . . 148.13 21.38 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.456 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 938' ' ' GLY . 18.9 ptp180 46.72 164.28 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.654 0.782 . . . . 0.0 112.59 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.737 ' HB3' ' HA ' ' A' ' 931' ' ' GLU . 18.5 Cg_exo -66.39 127.32 17.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.782 2.322 . . . . 0.0 112.386 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.526 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 43.6 p90 -93.01 -161.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 80.5 p -172.86 134.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.066 0.46 . . . . 0.0 111.25 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.416 ' CG2' ' HG3' ' A' ' 954' ' ' PRO . 4.9 pt -95.05 -168.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.933 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 951' ' ' TRP . 1.4 m -167.28 127.13 1.43 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.772 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 17.0 t -69.99 110.64 5.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 947' ' ' ASP . 92.1 mt -82.75 -57.3 3.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.654 ' HA ' HD13 ' A' ' 924' ' ' ILE . 56.0 t0 173.01 -43.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.013 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -82.88 36.65 0.51 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.946 HD21 ' HB1' ' A' ' 900' ' ' ALA . 31.0 mt 51.67 46.15 26.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 945' ' ' CYS . 0.5 OUTLIER -128.57 -173.6 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.988 -179.357 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 944' ' ' THR . 73.5 m95 -144.71 130.73 19.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.161 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 45.6 t -44.05 146.25 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 47.4 t -79.59 115.88 56.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 3.6 Cg_exo -76.31 61.05 6.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.496 2.797 . . . . 0.0 112.068 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -76.43 139.27 40.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.486 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.569 ' HA ' ' NZ ' ' A' ' 959' ' ' LYS . 9.9 t70 58.11 82.06 0.14 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.041 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 30.9 m -149.69 -24.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.653 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 936' ' ' TYR . 72.6 m -150.47 133.19 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.569 ' NZ ' ' HA ' ' A' ' 956' ' ' ASP . 45.6 mmtm -140.72 150.53 43.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.303 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.613 ' HG3' ' NE2' ' A' ' 981' ' ' GLN . 12.2 tpt180 -53.34 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.971 0.415 . . . . 0.0 111.311 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.506 ' HA ' ' CD2' ' A' ' 937' ' ' TYR . 40.4 ttmt -56.32 149.63 16.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.501 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.665 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 60.4 p -141.14 140.36 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.257 0.551 . . . . 0.0 111.506 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.7 p -79.87 154.69 28.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.06 134.21 53.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.323 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . . . . . . . . . 32.5 m -54.28 126.67 54.58 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -179.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.522 ' HG3' ' CD1' ' A' ' 986' ' ' ILE . 80.1 Cg_endo -76.3 134.25 15.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.778 2.319 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 31.7 Cg_exo -58.51 128.58 28.89 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.221 1.948 . . . . 0.0 111.511 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.86 129.52 85.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.87 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.07 142.67 88.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.864 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 971' ' ' ASN . 39.5 t -47.5 124.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.244 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 970' ' ' VAL . 73.1 m-20 76.42 -46.39 0.53 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.826 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -71.29 -151.61 0.95 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.438 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 178.79 140.33 0.1 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.934 HG21 HD12 ' A' ' 986' ' ' ILE . 11.1 p -96.51 143.1 12.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.684 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.489 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.5 m-70 -102.7 114.5 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 1.057 HG13 HG23 ' A' ' 980' ' ' ILE . 77.9 t -63.78 -39.01 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.22 0.533 . . . . 0.0 110.021 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 975' ' ' HIS . 9.3 mt 71.64 -33.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.409 178.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 48.1 p -144.84 -86.14 0.12 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 980' ' ' ILE . 2.8 m-20 -154.59 13.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.312 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 1.057 HG23 HG13 ' A' ' 976' ' ' VAL . 36.9 pt 50.65 34.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.366 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.665 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 3.8 mm100 -76.64 151.13 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.81 88.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.068 0.461 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 160.09 -42.67 0.44 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.217 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' 1003 ' ' GLU . 49.2 m -76.09 -168.64 0.96 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 111.07 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.668 ' HD3' ' HB2' ' A' 1001 ' ' SER . 38.1 ttm180 -151.35 134.9 16.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.934 HD12 HG21 ' A' ' 974' ' ' VAL . 25.7 pt -95.26 131.75 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.761 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.6 p -99.3 129.27 45.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 111.797 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.461 ' HB2' ' HA ' ' A' 1000 ' ' SER . 7.1 m-85 -96.58 139.73 32.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.0 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 44.1 t -153.69 112.14 3.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.684 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.535 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 3.2 t -81.38 142.13 33.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.602 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . . . . . . . . . 14.2 t -65.01 154.09 38.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 992' ' ' THR . 6.0 t -45.64 109.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 111.246 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 159.57 -44.42 0.44 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.112 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.438 ' HB3' ' N ' ' A' 1021 ' ' GLN . 15.3 m80 -126.87 147.58 50.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.206 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 997' ' ' ILE . 16.9 ptm180 -90.04 138.98 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' 1018 ' ' PRO . 9.8 tt -71.89 130.84 42.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.987 -178.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 997' ' ' ILE . 2.0 mp -109.73 93.39 2.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.464 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' 1018 ' ' PRO . . . 158.31 -153.53 24.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.594 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.598 ' HB2' HG21 ' A' 1015 ' ' THR . 38.7 m170 -85.93 -35.43 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 996' ' ' LEU . 48.2 t 67.27 16.39 10.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.831 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.668 ' HB2' ' HD3' ' A' ' 985' ' ' ARG . 81.3 p -157.6 59.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.764 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -79.77 126.51 31.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 984' ' ' SER . 88.8 tt0 -96.09 131.48 42.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.923 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . 0.437 ' HB2' ' CZ3' ' A' 1013 ' ' TRP . 45.0 t -71.77 119.93 16.64 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' 1006 ' ' LEU . 41.2 pt -133.28 -156.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 112.131 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 56.4 tp -152.24 135.06 15.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.02 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.587 ' HB2' ' NE2' ' A' 1012 ' ' HIS . 48.0 t -88.39 -45.39 10.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . 166.29 -49.74 0.26 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.038 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.16 -37.19 12.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . . . . . . . . . 79.6 m -145.45 144.91 30.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.696 -178.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -79.22 144.58 34.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.704 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.587 ' NE2' ' HB2' ' A' 1007 ' ' SER . 8.0 p80 -158.15 154.62 27.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.883 0.373 . . . . 0.0 111.514 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' 1004 ' ' CYS . 72.3 m95 -68.63 149.49 49.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 66.9 m -58.92 -34.6 71.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.81 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 999' ' ' HIS . 6.4 t -143.08 149.33 38.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.228 0.537 . . . . 0.0 112.357 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.508 ' HD3' ' N ' ' A' 1017 ' ' PRO . 1.0 OUTLIER -59.54 136.86 89.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.939 179.052 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' 1016 ' ' LYS . 77.7 Cg_exo -50.75 119.86 5.78 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.541 2.161 . . . . 0.0 112.971 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.597 ' HB3' ' HA3' ' A' ' 998' ' ' GLY . 14.6 Cg_endo -57.28 147.72 75.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.822 2.348 . . . . 0.0 112.447 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.18 147.13 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . . . . . . . . . 95.3 m -81.39 136.34 35.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.438 ' N ' ' HB3' ' A' ' 994' ' ' HIS . 6.2 tt0 -145.72 132.31 19.85 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.353 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -44.03 136.04 3.95 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.5 0.667 . . . . 0.0 111.779 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' 1024 ' ' PRO . 59.6 mt -74.86 127.04 87.68 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.012 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1023 ' ' ILE . 31.4 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.848 2.365 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.81 0.338 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . 57.1 -157.18 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.23 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 64.01 132.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.305 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . 65.52 137.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.661 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . 0.6 ' O ' ' HG ' ' A' ' 949' ' ' LEU . 53.4 m80 -149.86 135.46 18.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 922' ' ' PHE . 10.0 p -80.72 121.43 25.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.011 0.434 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -69.23 172.36 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.539 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.08 8.46 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.567 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.509 ' HG2' ' OH ' ' A' ' 930' ' ' TYR . 51.1 Cg_exo -53.71 127.08 24.03 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.89 2.393 . . . . 0.0 112.624 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -69.74 119.61 14.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.854 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 38.7 m170 42.77 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.075 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 943' ' ' ILE . 21.8 m-85 -145.93 47.51 1.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.987 178.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 933' ' ' ARG . 38.9 mt -75.08 -7.2 53.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.736 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -12.12 54.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.806 179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . . . . . . . . . . . -153.02 137.22 16.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.321 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 931' ' ' GLU . 0.0 OUTLIER -91.61 123.79 35.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.083 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.584 HD11 ' HB ' ' A' ' 915' ' ' THR . 3.4 tm? -47.18 129.51 12.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.107 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -94.56 -31.26 13.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.93 -178.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.584 ' HB ' HD11 ' A' ' 913' ' ' LEU . 86.4 m -57.19 154.02 10.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.609 -179.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.582 ' NE2' ' H ' ' A' ' 917' ' ' THR . 3.0 pp0? -57.49 -47.91 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.533 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.582 ' H ' ' NE2' ' A' ' 916' ' ' GLN . 52.8 p 51.76 138.77 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.802 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 918' ' ' THR . 16.3 m -161.31 32.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.232 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -170.78 140.51 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 45.6 m -86.74 37.86 0.77 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.456 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -154.68 127.72 8.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.862 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.421 ' O ' ' SG ' ' A' ' 902' ' ' CYS . 36.4 m-85 -119.12 142.29 31.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.929 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.21 136.73 10.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.949 2.433 . . . . 0.0 111.9 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.749 HG21 ' HA ' ' A' ' 947' ' ' ASP . 61.6 mt -52.02 150.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 72.83 74.79 0.76 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.738 -178.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 944' ' ' THR . 3.6 m -174.82 130.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.856 -178.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 943' ' ' ILE . 75.5 p -99.99 155.35 17.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.114 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 942' ' ' SER . 95.4 mt -141.05 128.37 21.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.117 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.84 ' HD3' ' HB3' ' A' ' 942' ' ' SER . 43.4 mmtm -85.07 141.5 30.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.927 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.509 ' OH ' ' HG2' ' A' ' 905' ' ' PRO . 11.4 m-85 -129.12 133.19 47.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 912' ' ' LYS . 50.1 mt-10 -92.53 118.39 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.138 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.68 148.94 18.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.728 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.438 ' HB2' ' CD1' ' A' ' 936' ' ' TYR . 59.2 mtt85 -83.01 155.96 67.29 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.893 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 936' ' ' TYR . 62.6 Cg_exo -38.56 -53.75 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.881 2.388 . . . . 0.0 113.613 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.92 31.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 960' ' ' ARG . 72.2 m-85 -145.19 133.78 22.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.677 0.275 . . . . 0.0 111.184 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.59 ' HD2' ' HA ' ' A' ' 961' ' ' LYS . 2.2 p90 -103.89 138.88 39.84 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 137.24 143.57 4.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.868 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -73.02 170.69 12.66 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.547 0.213 . . . . 0.0 110.769 179.703 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.868 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 9.2 Cg_endo -59.39 114.71 2.15 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.399 2.066 . . . . 0.0 112.958 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 929' ' ' LYS . 27.2 p90 -90.24 -164.62 1.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . 0.84 ' HB3' ' HD3' ' A' ' 929' ' ' LYS . 79.7 p -171.95 130.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.289 0.566 . . . . 0.0 112.352 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 908' ' ' PHE . 8.1 pt -96.14 -174.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.632 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 926' ' ' THR . 15.9 m -165.9 136.74 3.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 950' ' ' VAL . 73.5 m -73.29 126.64 30.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.708 HD23 HG23 ' A' ' 950' ' ' VAL . 2.5 mm? -83.61 -60.51 2.1 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.749 ' HA ' HG21 ' A' ' 924' ' ' ILE . 4.7 t70 171.84 -40.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.262 0.352 . . . . 0.0 110.814 -178.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -86.38 39.67 0.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.819 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.2 mp 53.5 46.12 26.81 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.481 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.708 HG23 HD23 ' A' ' 946' ' ' LEU . 3.2 m -125.68 -179.98 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.798 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 943' ' ' ILE . 41.3 m95 -142.04 131.8 24.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.756 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.475 ' N ' HD21 ' A' ' 946' ' ' LEU . 80.4 p -40.83 143.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.3 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 40.7 t -78.7 114.45 43.67 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 943' ' ' ILE . 5.9 Cg_exo -78.52 57.6 6.37 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.473 2.782 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 956' ' ' ASP . 1.2 tmtp? -78.6 127.04 31.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . 0.775 ' HA ' ' HE3' ' A' ' 959' ' ' LYS . 38.8 t70 53.34 41.59 32.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.25 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.14 -41.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.424 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . . . . . . . . . 17.2 t -157.64 68.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.478 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.775 ' HE3' ' HA ' ' A' ' 956' ' ' ASP . 34.4 mmtp -56.43 144.55 30.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.697 ' HA ' ' HA ' ' A' ' 936' ' ' TYR . 12.8 ptt-85 -55.43 147.39 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.151 0.5 . . . . 0.0 111.986 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.59 ' HA ' ' HD2' ' A' ' 937' ' ' TYR . 26.9 tptp -47.64 155.77 0.36 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.56 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.783 ' HB2' ' HG3' ' A' ' 981' ' ' GLN . 48.2 t -144.47 139.88 28.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.473 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' 1013 ' ' TRP . 59.3 m -81.57 37.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.293 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 59.52 135.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.066 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.591 ' HA ' HD12 ' A' ' 980' ' ' ILE . 11.8 m -56.1 128.4 71.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.496 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 967' ' ' PRO . 39.6 Cg_endo -66.4 127.14 16.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.489 2.126 . . . . 0.0 112.64 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 966' ' ' PRO . 16.7 Cg_exo -67.0 132.85 29.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.499 2.133 . . . . 0.0 111.515 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.68 114.22 8.43 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.745 0.307 . . . . 0.0 110.781 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 144.15 29.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.685 2.257 . . . . 0.0 112.224 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.452 HG12 ' ND2' ' A' ' 971' ' ' ASN . 21.5 t -50.63 129.01 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.851 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.452 ' ND2' HG12 ' A' ' 970' ' ' VAL . 71.9 m-20 54.47 44.64 28.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.475 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 990' ' ' CYS . . . -170.9 147.99 10.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.939 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.2 136.98 40.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.571 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.712 HG21 HD12 ' A' ' 986' ' ' ILE . 10.1 p -98.18 127.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.913 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 977' ' ' ILE . 25.1 m-70 -86.45 114.74 23.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 0.623 ' HA ' HG22 ' A' ' 986' ' ' ILE . 27.8 m -63.11 -28.14 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.017 0.436 . . . . 0.0 110.203 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 975' ' ' HIS . 10.0 mt 73.07 -43.54 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.134 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 71.0 p -146.11 -51.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.577 179.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.54 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 8.2 p-10 -160.26 -143.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.146 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 965' ' ' THR . 4.6 pt -151.0 6.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.783 ' HG3' ' HB2' ' A' ' 962' ' ' SER . 14.5 mp0 -76.65 177.32 7.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.601 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.55 132.66 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.233 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 106.83 -46.27 1.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.278 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . . . . . . . . . 52.0 m -76.09 134.36 40.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 77.5 ttt180 -104.12 124.09 48.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.154 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.712 HD12 HG21 ' A' ' 974' ' ' VAL . 34.4 pt -97.1 136.51 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 0.0 111.535 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . . . . . . . . . 3.4 p -103.84 136.38 43.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.566 ' CE2' ' HD2' ' A' 1018 ' ' PRO . 14.9 m-85 -103.19 142.57 33.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.231 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 47.9 t -153.57 127.56 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.617 ' HA ' ' HA2' ' A' ' 972' ' ' GLY . 99.8 m -58.37 135.84 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.258 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 992' ' ' THR . 10.2 t -73.41 43.59 0.14 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.433 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 991' ' ' THR . 8.5 t 175.41 -130.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.346 -179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 992' ' ' THR . . . -133.69 51.25 0.85 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.499 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.604 ' HB2' ' SG ' ' A' 1020 ' ' CYS . 3.8 m80 -94.49 -137.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' 1021 ' ' GLN . 13.5 ttt85 -140.88 112.06 7.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.921 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . . . . . . . . . 6.3 tt -68.83 131.86 45.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.818 0.342 . . . . 0.0 110.702 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' 1021 ' ' GLN . 2.6 mp -97.27 136.21 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . . . . . . . . . . . 84.33 -152.25 27.78 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.383 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.72 ' ND1' HG21 ' A' 1015 ' ' THR . 22.4 m170 -81.55 129.74 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.688 0.244 . . . . 0.0 110.731 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 50.2 m -74.79 10.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.338 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . . . . . . . . . 30.7 t -159.29 151.42 20.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . . . . . . . . . . . -155.07 128.86 8.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 111.383 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 12.7 pt-20 -96.48 134.24 39.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.539 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 41.2 t -71.83 123.17 22.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.67 139.18 43.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.262 0.553 . . . . 0.0 112.139 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 60.8 tp -84.5 120.57 26.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 94.1 p -96.03 36.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.053 179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.556 ' H ' ' HG ' ' A' 1006 ' ' LEU . . . 67.19 123.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.058 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' 1008 ' ' GLY . 4.9 m120 73.17 -37.38 0.38 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 122.373 0.269 . . . . 0.0 111.671 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' 1008 ' ' GLY . 98.6 m -145.48 129.09 17.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 111.632 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' 1006 ' ' LEU . . . -87.36 147.32 25.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.66 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . . . . . . . . . 6.9 p80 -157.64 149.1 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.384 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . 0.453 ' CZ3' HG12 ' A' ' 986' ' ' ILE . 91.7 m95 -65.79 139.21 58.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 47.6 t -51.39 -27.68 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.886 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.72 HG21 ' ND1' ' A' ' 999' ' ' HIS . 75.4 p -141.02 141.57 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.963 0.411 . . . . 0.0 111.611 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' 1016 ' ' LYS . 0.0 OUTLIER -53.82 153.15 8.82 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.09 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' 1018 ' ' PRO . 44.9 Cg_exo -56.17 123.78 14.66 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.446 2.097 . . . . 0.0 112.733 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.566 ' HD2' ' CE2' ' A' ' 988' ' ' TYR . 14.0 Cg_exo -69.0 148.71 70.62 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.185 2.59 . . . . 0.0 112.243 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' 1020 ' ' CYS . 1.0 OUTLIER -100.35 -153.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.616 ' H ' HG22 ' A' 1019 ' ' ILE . 35.5 t -161.64 141.24 10.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.819 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.856 ' HB2' HD11 ' A' ' 997' ' ' ILE . 1.4 tt0 -151.36 127.98 10.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.563 -178.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -51.42 131.9 29.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 111.658 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 995' ' ' ARG . 62.9 mt -74.82 129.16 83.97 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.974 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.889 2.392 . . . . 0.0 112.287 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 897' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.522 0.201 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -174.84 44.41 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.794 0.33 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 899' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 63.73 135.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.1 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 900' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 949' ' ' LEU . . . -73.78 121.92 21.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.119 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 901' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -110.52 124.45 51.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.998 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 902' ' ' CYS . . . . . 0.895 ' HB3' ' HA ' ' A' ' 949' ' ' LEU . 1.8 p -82.11 124.0 29.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.484 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 903' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -60.02 172.01 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.63 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 904' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 905' ' ' PRO . . . -44.78 134.4 4.89 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 905' ' ' PRO . . . . . 0.615 ' HG3' ' CE2' ' A' ' 951' ' ' TRP . 3.5 Cg_exo -73.79 44.06 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.738 2.292 . . . . 0.0 112.582 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 906' ' ' ASP . . . . . . . . . . . . . 4.0 t70 57.93 153.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.472 0.653 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 907' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -82.42 122.31 27.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.704 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.791 ' HB3' ' HB3' ' A' ' 911' ' ' ALA . 8.3 m-85 -85.88 141.98 29.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 909' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 909' ' ' LEU . 2.0 mm? -87.53 -65.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.688 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.595 ' O ' ' HG3' ' A' ' 933' ' ' ARG . 2.5 p90 -82.77 -22.12 34.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.469 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 911' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 908' ' ' PHE . . . -87.04 142.94 27.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.54 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 912' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -129.81 123.41 30.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 913' ' ' LEU . 3.3 tm? -49.17 116.56 1.74 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.428 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 914' ' ' LYS . . . . . 0.494 ' HD2' ' C ' ' A' ' 914' ' ' LYS . 0.8 OUTLIER -93.07 -42.28 9.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 915' ' ' THR . . . . . 0.597 HG22 ' NE2' ' A' ' 916' ' ' GLN . 5.0 m -66.16 -127.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.678 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 916' ' ' GLN . . . . . 0.597 ' NE2' HG22 ' A' ' 915' ' ' THR . 3.0 pm0 -173.5 139.43 0.74 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.676 0.274 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 917' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 918' ' ' THR . 1.8 t -157.18 -54.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 918' ' ' THR . . . . . 0.498 ' H ' HG23 ' A' ' 917' ' ' THR . 27.9 m 53.9 57.77 5.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.044 0.45 . . . . 0.0 110.599 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 919' ' ' ALA . . . . . . . . . . . . . . . -165.44 156.66 14.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 47.4 t -87.9 -44.99 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.72 141.8 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 922' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 928' ' ' LEU . 46.2 m-85 -135.35 137.84 27.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.653 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . 0.603 ' HG2' ' OG1' ' A' ' 926' ' ' THR . 65.3 Cg_endo -73.12 132.01 17.47 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.569 2.179 . . . . 0.0 111.427 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 924' ' ' ILE . . . . . 0.697 ' HA ' ' SG ' ' A' ' 945' ' ' CYS . 53.5 mt -56.78 147.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . 95.7 -32.97 5.82 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 923' ' ' PRO . 20.6 m -56.21 135.68 53.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.426 . . . . 0.0 112.145 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 927' ' ' SER . . . . . . . . . . . . . 61.6 p -107.2 142.99 36.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.388 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 928' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 922' ' ' PHE . 94.1 mt -133.3 117.82 17.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.063 0.459 . . . . 0.0 110.974 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 941' ' ' PHE . 38.1 ttmt -90.04 132.4 35.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.035 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 930' ' ' TYR . . . . . 0.43 ' HB2' ' CE1' ' A' ' 941' ' ' PHE . 4.2 m-85 -122.33 125.75 46.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.037 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 931' ' ' GLU . . . . . 0.641 ' HG2' ' HB3' ' A' ' 940' ' ' PRO . 95.4 mt-10 -96.51 117.32 30.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.543 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 932' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 911' ' ' ALA . 81.0 m -59.27 169.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.451 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 933' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 910' ' ' PHE . 46.5 mtp85 -84.36 151.16 58.92 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.142 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.507 ' O ' ' HG3' ' A' ' 935' ' ' GLU . 19.7 Cg_exo -66.48 66.0 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.303 2.669 . . . . 0.0 112.994 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 935' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' 1006 ' ' LEU . 54.4 mt-10 -163.39 -29.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 109.925 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 936' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 910' ' ' PHE . 1.6 m-85 -94.96 147.26 23.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 937' ' ' TYR . . . . . 0.793 ' HB3' ' HD2' ' A' ' 961' ' ' LYS . 1.7 p90 -89.18 132.94 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.241 0.543 . . . . 0.0 111.152 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 938' ' ' GLY . . . . . . . . . . . . . . . 135.37 139.48 4.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.382 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 939' ' ' ARG . . . . . 0.88 ' HB2' ' HD2' ' A' ' 940' ' ' PRO . 0.0 OUTLIER -71.88 171.11 10.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.513 0.197 . . . . 0.0 110.549 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 940' ' ' PRO . . . . . 0.88 ' HD2' ' HB2' ' A' ' 939' ' ' ARG . 40.4 Cg_endo -67.89 121.61 8.66 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.385 2.057 . . . . 0.0 112.26 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.521 ' O ' ' HG3' ' A' ' 929' ' ' LYS . 36.8 p90 -90.15 -161.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.73 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 942' ' ' SER . . . . . . . . . . . . . 82.5 p -172.79 134.69 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 943' ' ' ILE . . . . . . . . . . . . . 11.6 pt -96.16 -172.6 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.822 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 944' ' ' THR . . . . . . . . . . . . . 1.1 m -167.09 123.61 1.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 945' ' ' CYS . . . . . 0.697 ' SG ' ' HA ' ' A' ' 924' ' ' ILE . 33.7 t -63.91 112.09 2.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 946' ' ' LEU . . . . . 0.631 ' HB2' HG23 ' A' ' 950' ' ' VAL . 87.6 mt -81.25 -53.11 6.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 947' ' ' ASP . . . . . 0.679 ' HA ' HD13 ' A' ' 924' ' ' ILE . 19.2 t70 172.54 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.202 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 948' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -84.49 37.35 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 949' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 900' ' ' ALA . 6.4 mp 53.5 48.96 20.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.994 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 946' ' ' LEU . 6.7 m -120.63 179.97 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.327 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 951' ' ' TRP . . . . . 0.615 ' CE2' ' HG3' ' A' ' 905' ' ' PRO . 97.2 m95 -145.13 49.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.231 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 23.5 t 49.5 -141.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 953' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 954' ' ' PRO . 29.7 t -155.44 109.66 2.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.56 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 954' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 953' ' ' SER . 4.3 Cg_exo -75.05 53.99 3.53 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.121 2.547 . . . . 0.0 111.348 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 955' ' ' LYS . . . . . 0.606 ' HB3' ' NZ ' ' A' ' 955' ' ' LYS . 5.8 ttpm? -78.79 133.14 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.666 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 956' ' ' ASP . . . . . . . . . . . . . 58.4 t0 57.42 40.59 27.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.281 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 957' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 958' ' ' CYS . 27.8 m -90.44 -42.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.511 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 958' ' ' CYS . . . . . 0.408 ' N ' HG23 ' A' ' 957' ' ' VAL . 84.6 m -155.0 141.63 18.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.164 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 937' ' ' TYR . 75.5 mmtt -146.21 145.16 30.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.706 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 960' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 982' ' ' VAL . 14.8 tpp85 -53.24 103.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.141 0.496 . . . . 0.0 110.726 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 961' ' ' LYS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 937' ' ' TYR . 51.5 tttp -59.3 -179.06 0.07 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.566 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 962' ' ' SER . . . . . 0.705 ' HB3' ' NE2' ' A' ' 981' ' ' GLN . 83.9 p -149.66 142.58 24.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.625 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 77.2 m -79.51 164.69 23.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.16 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 964' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.9 133.16 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.363 . . . . 0.0 110.554 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 965' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 966' ' ' PRO . 56.8 m -55.12 131.99 68.58 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 965' ' ' THR . 3.0 Cg_exo -74.15 125.12 9.54 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.736 2.291 . . . . 0.0 112.056 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 967' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.0 122.46 11.76 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.122 1.882 . . . . 0.0 111.305 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 968' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.05 116.07 17.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 969' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 973' ' ' MET . 64.5 Cg_endo -73.49 133.96 19.83 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.614 2.209 . . . . 0.0 111.993 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 970' ' ' VAL . . . . . 0.581 HG13 ' H ' ' A' ' 971' ' ' ASN . 1.1 p -53.77 -57.06 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.202 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 971' ' ' ASN . . . . . 0.581 ' H ' HG13 ' A' ' 970' ' ' VAL . 75.9 m-20 -79.01 34.23 0.23 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.356 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 991' ' ' THR . . . 177.04 -147.77 8.53 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.953 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 973' ' ' MET . . . . . 0.498 ' HA ' ' HD2' ' A' ' 969' ' ' PRO . 22.5 ptt? 174.49 139.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 974' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 986' ' ' ILE . 15.0 p -95.69 138.87 20.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.324 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 975' ' ' HIS . . . . . 0.477 ' O ' HG13 ' A' ' 977' ' ' ILE . 38.9 m-70 -94.82 113.11 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 976' ' ' VAL . . . . . 1.029 HG13 HG23 ' A' ' 980' ' ' ILE . 92.2 t -65.63 -27.64 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 977' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 985' ' ' ARG . 4.8 mt 56.22 59.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.094 179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 978' ' ' THR . . . . . . . . . . . . . 12.3 p 76.61 -49.45 0.57 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.931 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 979' ' ' ASP . . . . . 0.58 ' HB2' ' OE1' ' A' ' 981' ' ' GLN . 2.6 p30 -159.88 138.52 10.57 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.459 -178.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 1.029 HG23 HG13 ' A' ' 976' ' ' VAL . 15.3 pt -91.46 32.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.974 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 981' ' ' GLN . . . . . 0.705 ' NE2' ' HB3' ' A' ' 962' ' ' SER . 6.5 mp0 -75.5 156.64 34.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.319 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 982' ' ' VAL . . . . . 0.803 HG13 ' HA ' ' A' 1005 ' ' ILE . 57.4 t -54.4 86.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 981' ' ' GLN . . . 164.3 -49.25 0.3 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.922 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 984' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 979' ' ' ASP . 48.0 t -80.44 141.69 35.02 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.972 0.415 . . . . 0.0 110.691 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 985' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' 1003 ' ' GLU . 13.9 ptm180 -101.08 137.39 39.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 986' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 974' ' ' VAL . 16.6 pt -89.07 126.45 42.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.152 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 987' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' 1001 ' ' SER . 7.0 p -103.84 128.63 51.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.346 0.593 . . . . 0.0 112.017 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 988' ' ' TYR . . . . . 0.535 ' OH ' ' HB3' ' A' 1017 ' ' PRO . 2.0 m-85 -96.4 143.75 27.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.164 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 989' ' ' SER . . . . . . . . . . . . . 86.1 p -148.67 117.05 6.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 990' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 994' ' ' HIS . 57.6 m -66.71 133.7 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.823 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 991' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 992' ' ' THR . 13.3 t -68.15 -147.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 992' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 991' ' ' THR . 49.5 m 8.75 -91.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.66 0.784 . . . . 0.0 113.044 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . -158.38 44.93 0.47 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.294 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . 0.544 ' HA ' ' HA ' ' A' 1022 ' ' ARG . 15.1 m80 -93.76 155.36 17.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.675 ' HB2' HG12 ' A' 1023 ' ' ILE . 7.6 tpt180 -90.04 130.73 36.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.609 -179.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 996' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' 1018 ' ' PRO . 8.5 tt -67.58 134.54 51.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.699 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 997' ' ' ILE . . . . . 0.932 HD11 ' HG2' ' A' 1021 ' ' GLN . 14.8 mm -107.36 123.31 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 998' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' 1018 ' ' PRO . . . 59.94 134.51 0.01 OUTLIER Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.197 178.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 999' ' ' HIS . . . . . 0.698 ' ND1' ' HB ' ' A' 1015 ' ' THR . 47.0 m170 48.32 -141.98 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 178.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1000 ' ' SER . . . . . . . . . . . . . 78.9 p -177.95 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.79 0.329 . . . . 0.0 111.231 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1001 ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 987' ' ' THR . 70.9 p -152.27 157.2 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1002 ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 986' ' ' ILE . . . -151.99 133.42 14.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 111.391 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1003 ' ' GLU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 985' ' ' ARG . 18.9 pt-20 -96.22 141.91 29.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1004 ' ' CYS . . . . . . . . . . . . . 46.4 t -70.95 126.46 29.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1005 ' ' ILE . . . . . 0.803 ' HA ' HG13 ' A' ' 982' ' ' VAL . 30.9 pt -138.98 162.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1006 ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' 1007 ' ' SER . 3.2 tm? 58.82 -77.76 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.459 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 1.035 ' HA ' ' HA ' ' A' 1011 ' ' ALA . 97.1 p 59.59 -111.36 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.458 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.494 ' N ' ' HD3' ' A' ' 961' ' ' LYS . . . 64.43 -112.32 4.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.428 -178.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1009 ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' 1009 ' ' ASN . 2.7 m120 -65.82 -32.55 74.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1010 ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' 1007 ' ' SER . 77.2 m -150.06 122.53 8.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.493 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1011 ' ' ALA . . . . . 1.035 ' HA ' ' HA ' ' A' 1007 ' ' SER . . . -83.58 137.97 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.365 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1012 ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' A' 1006 ' ' LEU . 0.4 OUTLIER -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.178 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A 1013 ' ' TRP . . . . . . . . . . . . . 67.0 m95 -68.86 150.92 47.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1014 ' ' SER . . . . . . . . . . . . . 40.5 t -60.22 -34.6 73.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.476 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1015 ' ' THR . . . . . 0.698 ' HB ' ' ND1' ' A' ' 999' ' ' HIS . 74.8 p -141.78 149.38 40.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.775 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1016 ' ' LYS . . . . . 0.655 ' O ' ' HD3' ' A' 1016 ' ' LYS . 0.0 OUTLIER -56.85 147.72 52.11 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.56 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A 1017 ' ' PRO . . . . . 0.535 ' HB3' ' OH ' ' A' ' 988' ' ' TYR . 25.2 Cg_exo -64.8 123.38 11.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.906 2.404 . . . . 0.0 113.032 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1018 ' ' PRO . . . . . 0.636 ' HB3' HD21 ' A' ' 996' ' ' LEU . 23.6 Cg_exo -64.37 149.43 90.12 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 112.262 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1019 ' ' ILE . . . . . 0.877 HG22 ' H ' ' A' 1020 ' ' CYS . 2.7 mt -98.12 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.486 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1020 ' ' CYS . . . . . 0.877 ' H ' HG22 ' A' 1019 ' ' ILE . 23.1 m -163.29 128.58 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.433 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1021 ' ' GLN . . . . . 0.932 ' HG2' HD11 ' A' ' 997' ' ' ILE . 22.8 pt20 -153.21 130.98 11.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1022 ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 994' ' ' HIS . 32.4 tpt85 -28.19 134.67 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1023 ' ' ILE . . . . . 0.675 HG12 ' HB2' ' A' ' 995' ' ' ARG . 33.6 mt -73.07 124.79 91.04 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.783 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1024 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.543 2.162 . . . . 0.0 112.468 -179.717 . . . . . . . . 0 0 . 1 stop_ save_